black african american m 20 $nan$hematology blood hematocrit  48.9  %; hematology blood hemoglobin  17.3  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  126  mg dl$nan
 
white f 22 $nan$nan$ranitidine  150  mg ; sertraline  100  mg ; prednisone  40  mg ; 
extrinsic asthma, unspecified headache anemia, unspecified endometriosis, site unspecified long-term (current) use of steroids dehydration tachycardia, unspecified other adrenal hypofunction
white f 22 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  84  mg dl; chemistry blood % hemoglobin a1c  5.2  %$ranitidine  150  mg ; sertraline  100  mg ; prednisone  40  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; zolpidem tartrate  5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; omeprazole  20  mg ; ondansetron odt  4  mg ; acetaminophen  650  mg ; xopenex neb  0.31  mg ; 
extrinsic asthma, unspecified headache anemia, unspecified endometriosis, site unspecified long-term (current) use of steroids dehydration tachycardia, unspecified other adrenal hypofunction
white f 22 $nan$nan$sertraline  100  mg ; prednisone  40  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; zolpidem tartrate  5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; ondansetron odt  4  mg ; acetaminophen  650  mg ; xopenex neb  0.31  mg ; zyflo cr  1200  mg ; 
extrinsic asthma, unspecified headache anemia, unspecified endometriosis, site unspecified long-term (current) use of steroids dehydration tachycardia, unspecified other adrenal hypofunction
unknown f 29 $nan$hematology blood hematocrit  39.2  %; hematology blood hematocrit  36.0  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  319  k ul; hematology blood platelet count  219  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  79  mg dl; chemistry blood glucose  97  mg dl; blood gas blood free calcium  1.01  mmol l; blood gas blood lactate  1.9  mmol l$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; propofol  1000  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; soln  50  ml ; fentanyl citrate  2.5  mg ; acetaminophen  650  mg ; fentanyl citrate  25-100  mcg ; lorazepam  0.5-2  mg ; hydromorphone (dilaudid)  0.25  mg ; 
 
unknown f 29 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; propofol  1000  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fentanyl citrate  25-100  mcg ; lorazepam  0.5-2  mg ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  0.125  mg ; hydromorphone (dilaudid)  0.5-1  mg ; sw  200  ml ; 
 
unknown f 29 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  80  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; bag  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fentanyl citrate  25-100  mcg ; hydromorphone (dilaudid)  0.5-1  mg ; sw  200  ml ; d5 1 2ns  1000  ml ; 
 
unknown f 29 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  121  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.5-1  mg ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; 
 
unknown f 29 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.5-1  mg ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
unknown f 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; hydromorphone (dilaudid)  2-4  mg ; senna  1  tab ; magnesium citrate  300  ml ; 
 
unknown f 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; hydromorphone (dilaudid)  2-4  mg ; senna  1  tab ; magnesium citrate  300  ml ; 
 
white f 50 $nan$hematology blood hematocrit  42.1  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  115  mg dl$nan
 
white f 50 $temp  97.9  heartrate  81.0  resprate  16.0  o2sat  98.0  sbp  120.0  dbp  72.0  rhythm    pain  5 10  $nan$sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; morphine sulfate  2-5  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; oxycodone (immediate release)   5  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; ezetimibe  10  mg ; ibuprofen  400  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 
 
white f 50 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; morphine sulfate  2-5  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; oxycodone (immediate release)   5  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; ezetimibe  10  mg ; ibuprofen  400  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 
 
white f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; morphine sulfate  2-5  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; ezetimibe  10  mg ; ibuprofen  400  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 
 
white f 84 $temp    heartrate  81.0  resprate  16.0  o2sat  97.0  sbp  115.0  dbp  81.0  rhythm    pain  0 10  ; temp  98.1  heartrate  65.0  resprate  16.0  o2sat  100.0  sbp  104.0  dbp  63.0  rhythm    pain  0 10  ; temp  97.7  heartrate  72.0  resprate  16.0  o2sat  100.0  sbp  117.0  dbp  76.0  rhythm    pain  0  ; temp    heartrate  70.0  resprate  16.0  o2sat    sbp  120.0  dbp  74.0  rhythm    pain  0  ; temp  97.6  heartrate  50.0  resprate  18.0  o2sat    sbp  116.0  dbp  85.0  rhythm    pain  0  $hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  93  mg dl$loperamide  2  mg ; levothyroxine sodium  25  mcg ; losartan potassium  12.5  mg ; digoxin  0.125  mg ; metoprolol succinate xl  75  mg ; aspirin  81  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  50  ml ; furosemide  250  mg ; diazepam  2  mg ; furosemide  80  mg ; acetaminophen  500  mg ; warfarin  2  mg ; 5% dextrose  40  ml ; furosemide  40  mg ; 
coronary atherosclerosis of unspecified type of vessel, native or graft hypotension, unspecified personal history, urinary (tract) infection other disorders of neurohypophysis percutaneous transluminal coronary angioplasty status cardiac pacemaker in situ acidosis cyanosis other chronic pulmonary heart diseases mitral valve disorders tricuspid valve disorders, specified as nonrheumatic unspecified essential hypertension fall from other slipping, tripping, or stumbling chronic passive congestion of liver personal history of irradiation, presenting hazards to health personal history of malignant neoplasm of breast congestive heart failure, unspecified contusion of chest wall long-term (current) use of anticoagulants old myocardial infarction other primary cardiomyopathies person boarding or alighting a pedal cycle injured in collision with pedestrian or animal person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle contusion of elbow atrial fibrillation acquired absence of breast and nipple acute on chronic systolic heart failure old myocardial infarction mitral valve disorders pressure ulcer, stage ii unspecified essential hypertension pressure ulcer, buttock tricuspid valve disorders, specified as nonrheumatic macular degeneration (senile), unspecified personal history of irradiation, presenting hazards to health streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified hemorrhoids with other complication other left bundle branch block personal history of malignant neoplasm of breast urinary tract infection, site not specified severe sepsis acquired absence of breast and nipple acute on chronic systolic heart failure unspecified septicemia pressure ulcer, lower back atrial fibrillation percutaneous transluminal coronary angioplasty status
white f 84 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  2.9  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  122  mg dl$loperamide  2  mg ; levothyroxine sodium  25  mcg ; losartan potassium  12.5  mg ; digoxin  0.125  mg ; metoprolol succinate xl  75  mg ; aspirin  81  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; diazepam  2  mg ; furosemide  80  mg ; acetaminophen  500  mg ; warfarin  2  mg ; 5% dextrose  40  ml ; furosemide  40  mg ; docusate sodium  100  mg ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; senna  2  tab ; potassium chloride  60  meq ; neutra-phos  2  pkt ; furosemide  120  mg ; 
coronary atherosclerosis of unspecified type of vessel, native or graft hypotension, unspecified personal history, urinary (tract) infection other disorders of neurohypophysis percutaneous transluminal coronary angioplasty status cardiac pacemaker in situ acidosis cyanosis other chronic pulmonary heart diseases mitral valve disorders tricuspid valve disorders, specified as nonrheumatic unspecified essential hypertension fall from other slipping, tripping, or stumbling chronic passive congestion of liver personal history of irradiation, presenting hazards to health personal history of malignant neoplasm of breast congestive heart failure, unspecified contusion of chest wall long-term (current) use of anticoagulants old myocardial infarction other primary cardiomyopathies person boarding or alighting a pedal cycle injured in collision with pedestrian or animal person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle contusion of elbow atrial fibrillation acquired absence of breast and nipple acute on chronic systolic heart failure old myocardial infarction mitral valve disorders pressure ulcer, stage ii unspecified essential hypertension pressure ulcer, buttock tricuspid valve disorders, specified as nonrheumatic macular degeneration (senile), unspecified personal history of irradiation, presenting hazards to health streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified hemorrhoids with other complication other left bundle branch block personal history of malignant neoplasm of breast urinary tract infection, site not specified severe sepsis acquired absence of breast and nipple acute on chronic systolic heart failure unspecified septicemia pressure ulcer, lower back atrial fibrillation percutaneous transluminal coronary angioplasty status
white f 84 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  102  mg dl$loperamide  2  mg ; levothyroxine sodium  25  mcg ; losartan potassium  12.5  mg ; digoxin  0.125  mg ; metoprolol succinate xl  75  mg ; aspirin  81  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; diazepam  2  mg ; acetaminophen  500  mg ; warfarin  2  mg ; docusate sodium  100  mg ; potassium chloride  40  meq ; senna  2  tab ; neutra-phos  2  pkt ; furosemide  120  mg ; furosemide  20  mg ; 
coronary atherosclerosis of unspecified type of vessel, native or graft hypotension, unspecified personal history, urinary (tract) infection other disorders of neurohypophysis percutaneous transluminal coronary angioplasty status cardiac pacemaker in situ acidosis cyanosis other chronic pulmonary heart diseases mitral valve disorders tricuspid valve disorders, specified as nonrheumatic unspecified essential hypertension fall from other slipping, tripping, or stumbling chronic passive congestion of liver personal history of irradiation, presenting hazards to health personal history of malignant neoplasm of breast congestive heart failure, unspecified contusion of chest wall long-term (current) use of anticoagulants old myocardial infarction other primary cardiomyopathies person boarding or alighting a pedal cycle injured in collision with pedestrian or animal person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle contusion of elbow atrial fibrillation acquired absence of breast and nipple acute on chronic systolic heart failure old myocardial infarction mitral valve disorders pressure ulcer, stage ii unspecified essential hypertension pressure ulcer, buttock tricuspid valve disorders, specified as nonrheumatic macular degeneration (senile), unspecified personal history of irradiation, presenting hazards to health streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified hemorrhoids with other complication other left bundle branch block personal history of malignant neoplasm of breast urinary tract infection, site not specified severe sepsis acquired absence of breast and nipple acute on chronic systolic heart failure unspecified septicemia pressure ulcer, lower back atrial fibrillation percutaneous transluminal coronary angioplasty status
white f 84 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  91  mg dl$loperamide  2  mg ; levothyroxine sodium  25  mcg ; losartan potassium  12.5  mg ; digoxin  0.125  mg ; metoprolol succinate xl  75  mg ; aspirin  81  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; diazepam  2  mg ; acetaminophen  500  mg ; warfarin  2  mg ; docusate sodium  100  mg ; senna  2  tab ; furosemide  20  mg ; 
coronary atherosclerosis of unspecified type of vessel, native or graft hypotension, unspecified personal history, urinary (tract) infection other disorders of neurohypophysis percutaneous transluminal coronary angioplasty status cardiac pacemaker in situ acidosis cyanosis other chronic pulmonary heart diseases mitral valve disorders tricuspid valve disorders, specified as nonrheumatic unspecified essential hypertension fall from other slipping, tripping, or stumbling chronic passive congestion of liver personal history of irradiation, presenting hazards to health personal history of malignant neoplasm of breast congestive heart failure, unspecified contusion of chest wall long-term (current) use of anticoagulants old myocardial infarction other primary cardiomyopathies person boarding or alighting a pedal cycle injured in collision with pedestrian or animal person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle contusion of elbow atrial fibrillation acquired absence of breast and nipple acute on chronic systolic heart failure old myocardial infarction mitral valve disorders pressure ulcer, stage ii unspecified essential hypertension pressure ulcer, buttock tricuspid valve disorders, specified as nonrheumatic macular degeneration (senile), unspecified personal history of irradiation, presenting hazards to health streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified hemorrhoids with other complication other left bundle branch block personal history of malignant neoplasm of breast urinary tract infection, site not specified severe sepsis acquired absence of breast and nipple acute on chronic systolic heart failure unspecified septicemia pressure ulcer, lower back atrial fibrillation percutaneous transluminal coronary angioplasty status
white f 84 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  3.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  97  mg dl$loperamide  2  mg ; levothyroxine sodium  25  mcg ; losartan potassium  12.5  mg ; digoxin  0.125  mg ; metoprolol succinate xl  75  mg ; aspirin  81  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; diazepam  2  mg ; acetaminophen  500  mg ; warfarin  2  mg ; docusate sodium  100  mg ; senna  2  tab ; diazepam  1  mg ; potassium chloride  20  meq ; 
coronary atherosclerosis of unspecified type of vessel, native or graft hypotension, unspecified personal history, urinary (tract) infection other disorders of neurohypophysis percutaneous transluminal coronary angioplasty status cardiac pacemaker in situ acidosis cyanosis other chronic pulmonary heart diseases mitral valve disorders tricuspid valve disorders, specified as nonrheumatic unspecified essential hypertension fall from other slipping, tripping, or stumbling chronic passive congestion of liver personal history of irradiation, presenting hazards to health personal history of malignant neoplasm of breast congestive heart failure, unspecified contusion of chest wall long-term (current) use of anticoagulants old myocardial infarction other primary cardiomyopathies person boarding or alighting a pedal cycle injured in collision with pedestrian or animal person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle contusion of elbow atrial fibrillation acquired absence of breast and nipple acute on chronic systolic heart failure old myocardial infarction mitral valve disorders pressure ulcer, stage ii unspecified essential hypertension pressure ulcer, buttock tricuspid valve disorders, specified as nonrheumatic macular degeneration (senile), unspecified personal history of irradiation, presenting hazards to health streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified hemorrhoids with other complication other left bundle branch block personal history of malignant neoplasm of breast urinary tract infection, site not specified severe sepsis acquired absence of breast and nipple acute on chronic systolic heart failure unspecified septicemia pressure ulcer, lower back atrial fibrillation percutaneous transluminal coronary angioplasty status
white f 84 $nan$nan$loperamide  2  mg ; levothyroxine sodium  25  mcg ; losartan potassium  12.5  mg ; digoxin  0.125  mg ; metoprolol succinate xl  75  mg ; aspirin  81  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; diazepam  2  mg ; acetaminophen  500  mg ; docusate sodium  100  mg ; senna  2  tab ; diazepam  1  mg ; potassium chloride  20  meq ; 
coronary atherosclerosis of unspecified type of vessel, native or graft hypotension, unspecified personal history, urinary (tract) infection other disorders of neurohypophysis percutaneous transluminal coronary angioplasty status cardiac pacemaker in situ acidosis cyanosis other chronic pulmonary heart diseases mitral valve disorders tricuspid valve disorders, specified as nonrheumatic unspecified essential hypertension fall from other slipping, tripping, or stumbling chronic passive congestion of liver personal history of irradiation, presenting hazards to health personal history of malignant neoplasm of breast congestive heart failure, unspecified contusion of chest wall long-term (current) use of anticoagulants old myocardial infarction other primary cardiomyopathies person boarding or alighting a pedal cycle injured in collision with pedestrian or animal person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle contusion of elbow atrial fibrillation acquired absence of breast and nipple acute on chronic systolic heart failure old myocardial infarction mitral valve disorders pressure ulcer, stage ii unspecified essential hypertension pressure ulcer, buttock tricuspid valve disorders, specified as nonrheumatic macular degeneration (senile), unspecified personal history of irradiation, presenting hazards to health streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified hemorrhoids with other complication other left bundle branch block personal history of malignant neoplasm of breast urinary tract infection, site not specified severe sepsis acquired absence of breast and nipple acute on chronic systolic heart failure unspecified septicemia pressure ulcer, lower back atrial fibrillation percutaneous transluminal coronary angioplasty status
white f 71 $temp  100.2  heartrate  78.0  resprate  12.0  o2sat  98.0  sbp  160.0  dbp  90.0  rhythm    pain  10  ; temp  99.0  heartrate  73.0  resprate  16.0  o2sat  98.0  sbp  196.0  dbp  92.0  rhythm    pain    ; temp  98.1  heartrate  62.0  resprate  16.0  o2sat  99.0  sbp  193.0  dbp  88.0  rhythm    pain    ; temp    heartrate  66.0  resprate  16.0  o2sat  95.0  sbp  151.0  dbp  59.0  rhythm    pain  7  ; temp  97.8  heartrate  74.0  resprate  16.0  o2sat  95.0  sbp  156.0  dbp  63.0  rhythm    pain  0  ; temp  97.9  heartrate  62.0  resprate  18.0  o2sat  96.0  sbp  137.0  dbp  58.0  rhythm    pain    $hematology urine wbc  31  # hpf; hematology urine glucose  250  mg dl; hematology urine bilirubin  neg  mg dl$nan
obesity, unspecified gastro-esophageal reflux disease without esophagitis hydronephrosis with renal and ureteral calculous obstruction unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult type 2 diabetes mellitus without complications acute kidney failure, unspecified personal history of malignant neoplasm of cervix uteri family history of malignant neoplasm of other organs or systems sprain of unspecified site of left knee, initial encounter essential (primary) hypertension contusion of scalp, initial encounter family history of ischemic heart disease and other diseases of the circulatory system unspecified place or not applicable striking against other object with subsequent fall, initial encounter contusion of left knee, initial encounter type 2 diabetes mellitus without complications unspecified injury of head, initial encounter obesity, unspecified unspecified asthma, uncomplicated hydronephrosis with renal and ureteral calculous obstruction essential (primary) hypertension gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus without complications body mass index (bmi) 50.0-59.9, adult personal history of malignant neoplasm of cervix uteri diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified hydronephrosis other acquired absence of organ unspecified essential hypertension asthma, unspecified type, unspecified calculus of kidney obesity, unspecified acquired absence of both cervix and uterus personal history of malignant neoplasm of cervix uteri diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux
white f 71 $temp  98.3  heartrate  72.0  resprate  18.0  o2sat  98.0  sbp  156.0  dbp  89.0  rhythm    pain  0  $hematology blood hematocrit  34.8  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  219  mg dl; chemistry blood glucose  172  mg dl; blood gas blood lactate  1.0  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; omeprazole  40  mg ; albuterol inhaler  2  puff ; fluticasone propionate 110mcg  2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; tamsulosin  0.4  mg ; tramadol  25-50  mg ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydrochlorothiazide  12.5  mg ; 
obesity, unspecified gastro-esophageal reflux disease without esophagitis hydronephrosis with renal and ureteral calculous obstruction unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult type 2 diabetes mellitus without complications acute kidney failure, unspecified personal history of malignant neoplasm of cervix uteri family history of malignant neoplasm of other organs or systems sprain of unspecified site of left knee, initial encounter essential (primary) hypertension contusion of scalp, initial encounter family history of ischemic heart disease and other diseases of the circulatory system unspecified place or not applicable striking against other object with subsequent fall, initial encounter contusion of left knee, initial encounter type 2 diabetes mellitus without complications unspecified injury of head, initial encounter obesity, unspecified unspecified asthma, uncomplicated hydronephrosis with renal and ureteral calculous obstruction essential (primary) hypertension gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus without complications body mass index (bmi) 50.0-59.9, adult personal history of malignant neoplasm of cervix uteri diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified hydronephrosis other acquired absence of organ unspecified essential hypertension asthma, unspecified type, unspecified calculus of kidney obesity, unspecified acquired absence of both cervix and uterus personal history of malignant neoplasm of cervix uteri diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux
white f 71 $nan$hematology blood hematocrit  34.3  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  187  k ul; hematology blood platelet count  185  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  89  mg dl; chemistry urine sodium, urine  137  meq l; chemistry urine urea nitrogen, urine  755  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  173  mg dl; chemistry blood glucose  182  mg dl; chemistry urine protein creatinine ratio  0.1  mg mg; hematology urine glucose  150  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; omeprazole  40  mg ; albuterol inhaler  2  puff ; fluticasone propionate 110mcg  2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; tamsulosin  0.4  mg ; tramadol  25-50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydrochlorothiazide  12.5  mg ; 
obesity, unspecified gastro-esophageal reflux disease without esophagitis hydronephrosis with renal and ureteral calculous obstruction unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult type 2 diabetes mellitus without complications acute kidney failure, unspecified personal history of malignant neoplasm of cervix uteri family history of malignant neoplasm of other organs or systems sprain of unspecified site of left knee, initial encounter essential (primary) hypertension contusion of scalp, initial encounter family history of ischemic heart disease and other diseases of the circulatory system unspecified place or not applicable striking against other object with subsequent fall, initial encounter contusion of left knee, initial encounter type 2 diabetes mellitus without complications unspecified injury of head, initial encounter obesity, unspecified unspecified asthma, uncomplicated hydronephrosis with renal and ureteral calculous obstruction essential (primary) hypertension gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus without complications body mass index (bmi) 50.0-59.9, adult personal history of malignant neoplasm of cervix uteri diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified hydronephrosis other acquired absence of organ unspecified essential hypertension asthma, unspecified type, unspecified calculus of kidney obesity, unspecified acquired absence of both cervix and uterus personal history of malignant neoplasm of cervix uteri diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux
white f 71 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  170  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; omeprazole  40  mg ; albuterol inhaler  2  puff ; fluticasone propionate 110mcg  2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; tamsulosin  0.4  mg ; tramadol  25-50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; 
obesity, unspecified gastro-esophageal reflux disease without esophagitis hydronephrosis with renal and ureteral calculous obstruction unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult type 2 diabetes mellitus without complications acute kidney failure, unspecified personal history of malignant neoplasm of cervix uteri family history of malignant neoplasm of other organs or systems sprain of unspecified site of left knee, initial encounter essential (primary) hypertension contusion of scalp, initial encounter family history of ischemic heart disease and other diseases of the circulatory system unspecified place or not applicable striking against other object with subsequent fall, initial encounter contusion of left knee, initial encounter type 2 diabetes mellitus without complications unspecified injury of head, initial encounter obesity, unspecified unspecified asthma, uncomplicated hydronephrosis with renal and ureteral calculous obstruction essential (primary) hypertension gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus without complications body mass index (bmi) 50.0-59.9, adult personal history of malignant neoplasm of cervix uteri diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified hydronephrosis other acquired absence of organ unspecified essential hypertension asthma, unspecified type, unspecified calculus of kidney obesity, unspecified acquired absence of both cervix and uterus personal history of malignant neoplasm of cervix uteri diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux
white f 71 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; omeprazole  40  mg ; albuterol inhaler  2  puff ; fluticasone propionate 110mcg  2  puff ; tamsulosin  0.4  mg ; tramadol  25-50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; 
obesity, unspecified gastro-esophageal reflux disease without esophagitis hydronephrosis with renal and ureteral calculous obstruction unspecified asthma, uncomplicated body mass index (bmi) 50.0-59.9, adult type 2 diabetes mellitus without complications acute kidney failure, unspecified personal history of malignant neoplasm of cervix uteri family history of malignant neoplasm of other organs or systems sprain of unspecified site of left knee, initial encounter essential (primary) hypertension contusion of scalp, initial encounter family history of ischemic heart disease and other diseases of the circulatory system unspecified place or not applicable striking against other object with subsequent fall, initial encounter contusion of left knee, initial encounter type 2 diabetes mellitus without complications unspecified injury of head, initial encounter obesity, unspecified unspecified asthma, uncomplicated hydronephrosis with renal and ureteral calculous obstruction essential (primary) hypertension gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus without complications body mass index (bmi) 50.0-59.9, adult personal history of malignant neoplasm of cervix uteri diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified hydronephrosis other acquired absence of organ unspecified essential hypertension asthma, unspecified type, unspecified calculus of kidney obesity, unspecified acquired absence of both cervix and uterus personal history of malignant neoplasm of cervix uteri diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux
black african american f 65 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  14  # hpf; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  209  iu l; blood gas blood lactate  1.2  mmol l$nan
adrenal cortical steroids causing adverse effects in therapeutic use osteoporosis, unspecified other and unspecified hyperlipidemia rheumatoid arthritis anemia, unspecified depressive disorder, not elsewhere classified secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified asthma, unspecified type, unspecified esophageal reflux intestinal infection due to clostridium difficile rheumatoid arthritis syncope and collapse esophageal reflux depressive disorder, not elsewhere classified other and unspecified hyperlipidemia anemia, unspecified asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, lower leg acute respiratory failure osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension asthma, unspecified type, unspecified esophageal reflux accidents occurring in unspecified place other specified complications of procedures not elsewhere classified disturbance of skin sensation unspecified essential hypertension depressive disorder, not elsewhere classified osteoporosis, unspecified disorders of bursae and tendons in shoulder region, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other musculoskeletal symptoms referable to limbs diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled rheumatoid arthritis other and unspecified hyperlipidemia esophageal reflux coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia rheumatoid arthritis depressive disorder, not elsewhere classified secondary diabetes mellitus with unspecified complication, uncontrolled unspecified essential hypertension osteoporosis, unspecified asthma, unspecified type, with (acute) exacerbation unspecified essential hypertension other overexertion and strenuous and repetitive movements or loads other and unspecified hyperlipidemia
black african american f 65 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  111  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; albuterol 0.083% neb soln  1  neb ; citalopram  10  mg ; diltiazem extended-release  300  mg ; lisinopril  40  mg ; lorazepam  0.5  mg ; morphine sulfate  2-4  mg ; pravastatin  40  mg ; multivitamins  1  tab ; omeprazole  20  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; enoxaparin sodium  30  mg ; heparin  5000  unit ; acetaminophen  650  mg ; theophylline sr  300  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 
adrenal cortical steroids causing adverse effects in therapeutic use osteoporosis, unspecified other and unspecified hyperlipidemia rheumatoid arthritis anemia, unspecified depressive disorder, not elsewhere classified secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified asthma, unspecified type, unspecified esophageal reflux intestinal infection due to clostridium difficile rheumatoid arthritis syncope and collapse esophageal reflux depressive disorder, not elsewhere classified other and unspecified hyperlipidemia anemia, unspecified asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, lower leg acute respiratory failure osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension asthma, unspecified type, unspecified esophageal reflux accidents occurring in unspecified place other specified complications of procedures not elsewhere classified disturbance of skin sensation unspecified essential hypertension depressive disorder, not elsewhere classified osteoporosis, unspecified disorders of bursae and tendons in shoulder region, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other musculoskeletal symptoms referable to limbs diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled rheumatoid arthritis other and unspecified hyperlipidemia esophageal reflux coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia rheumatoid arthritis depressive disorder, not elsewhere classified secondary diabetes mellitus with unspecified complication, uncontrolled unspecified essential hypertension osteoporosis, unspecified asthma, unspecified type, with (acute) exacerbation unspecified essential hypertension other overexertion and strenuous and repetitive movements or loads other and unspecified hyperlipidemia
black african american f 65 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  247  k ul$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; albuterol 0.083% neb soln  1  neb ; citalopram  10  mg ; diltiazem extended-release  300  mg ; lisinopril  40  mg ; lorazepam  0.5  mg ; morphine sulfate  2-4  mg ; pravastatin  40  mg ; multivitamins  1  tab ; omeprazole  20  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; enoxaparin sodium  30  mg ; acetaminophen  650  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; oxycodone-acetaminophen  1  tab ; sarna lotion  1  appl ; 
adrenal cortical steroids causing adverse effects in therapeutic use osteoporosis, unspecified other and unspecified hyperlipidemia rheumatoid arthritis anemia, unspecified depressive disorder, not elsewhere classified secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified asthma, unspecified type, unspecified esophageal reflux intestinal infection due to clostridium difficile rheumatoid arthritis syncope and collapse esophageal reflux depressive disorder, not elsewhere classified other and unspecified hyperlipidemia anemia, unspecified asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, lower leg acute respiratory failure osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension asthma, unspecified type, unspecified esophageal reflux accidents occurring in unspecified place other specified complications of procedures not elsewhere classified disturbance of skin sensation unspecified essential hypertension depressive disorder, not elsewhere classified osteoporosis, unspecified disorders of bursae and tendons in shoulder region, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other musculoskeletal symptoms referable to limbs diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled rheumatoid arthritis other and unspecified hyperlipidemia esophageal reflux coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia rheumatoid arthritis depressive disorder, not elsewhere classified secondary diabetes mellitus with unspecified complication, uncontrolled unspecified essential hypertension osteoporosis, unspecified asthma, unspecified type, with (acute) exacerbation unspecified essential hypertension other overexertion and strenuous and repetitive movements or loads other and unspecified hyperlipidemia
black african american f 65 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; citalopram  10  mg ; diltiazem extended-release  300  mg ; lisinopril  40  mg ; lorazepam  0.5  mg ; pravastatin  40  mg ; multivitamins  1  tab ; omeprazole  20  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; enoxaparin sodium  30  mg ; acetaminophen  650  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; oxycodone-acetaminophen  1  tab ; sarna lotion  1  appl ; 
adrenal cortical steroids causing adverse effects in therapeutic use osteoporosis, unspecified other and unspecified hyperlipidemia rheumatoid arthritis anemia, unspecified depressive disorder, not elsewhere classified secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified asthma, unspecified type, unspecified esophageal reflux intestinal infection due to clostridium difficile rheumatoid arthritis syncope and collapse esophageal reflux depressive disorder, not elsewhere classified other and unspecified hyperlipidemia anemia, unspecified asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, lower leg acute respiratory failure osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension asthma, unspecified type, unspecified esophageal reflux accidents occurring in unspecified place other specified complications of procedures not elsewhere classified disturbance of skin sensation unspecified essential hypertension depressive disorder, not elsewhere classified osteoporosis, unspecified disorders of bursae and tendons in shoulder region, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other musculoskeletal symptoms referable to limbs diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled rheumatoid arthritis other and unspecified hyperlipidemia esophageal reflux coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia rheumatoid arthritis depressive disorder, not elsewhere classified secondary diabetes mellitus with unspecified complication, uncontrolled unspecified essential hypertension osteoporosis, unspecified asthma, unspecified type, with (acute) exacerbation unspecified essential hypertension other overexertion and strenuous and repetitive movements or loads other and unspecified hyperlipidemia
black african american f 65 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood glucose  120  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; citalopram  10  mg ; diltiazem extended-release  300  mg ; lisinopril  40  mg ; lorazepam  0.5  mg ; pravastatin  40  mg ; multivitamins  1  tab ; omeprazole  20  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; enoxaparin sodium  30  mg ; acetaminophen  650  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; oxycodone-acetaminophen  1  tab ; sarna lotion  1  appl ; 
adrenal cortical steroids causing adverse effects in therapeutic use osteoporosis, unspecified other and unspecified hyperlipidemia rheumatoid arthritis anemia, unspecified depressive disorder, not elsewhere classified secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified asthma, unspecified type, unspecified esophageal reflux intestinal infection due to clostridium difficile rheumatoid arthritis syncope and collapse esophageal reflux depressive disorder, not elsewhere classified other and unspecified hyperlipidemia anemia, unspecified asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, lower leg acute respiratory failure osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension asthma, unspecified type, unspecified esophageal reflux accidents occurring in unspecified place other specified complications of procedures not elsewhere classified disturbance of skin sensation unspecified essential hypertension depressive disorder, not elsewhere classified osteoporosis, unspecified disorders of bursae and tendons in shoulder region, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other musculoskeletal symptoms referable to limbs diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled rheumatoid arthritis other and unspecified hyperlipidemia esophageal reflux coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia rheumatoid arthritis depressive disorder, not elsewhere classified secondary diabetes mellitus with unspecified complication, uncontrolled unspecified essential hypertension osteoporosis, unspecified asthma, unspecified type, with (acute) exacerbation unspecified essential hypertension other overexertion and strenuous and repetitive movements or loads other and unspecified hyperlipidemia
black african american f 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; citalopram  10  mg ; diltiazem extended-release  300  mg ; lisinopril  40  mg ; lorazepam  0.5  mg ; pravastatin  40  mg ; multivitamins  1  tab ; omeprazole  20  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; oxycodone-acetaminophen  1  tab ; sarna lotion  1  appl ; 
adrenal cortical steroids causing adverse effects in therapeutic use osteoporosis, unspecified other and unspecified hyperlipidemia rheumatoid arthritis anemia, unspecified depressive disorder, not elsewhere classified secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified asthma, unspecified type, unspecified esophageal reflux intestinal infection due to clostridium difficile rheumatoid arthritis syncope and collapse esophageal reflux depressive disorder, not elsewhere classified other and unspecified hyperlipidemia anemia, unspecified asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, lower leg acute respiratory failure osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension asthma, unspecified type, unspecified esophageal reflux accidents occurring in unspecified place other specified complications of procedures not elsewhere classified disturbance of skin sensation unspecified essential hypertension depressive disorder, not elsewhere classified osteoporosis, unspecified disorders of bursae and tendons in shoulder region, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other musculoskeletal symptoms referable to limbs diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled rheumatoid arthritis other and unspecified hyperlipidemia esophageal reflux coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia rheumatoid arthritis depressive disorder, not elsewhere classified secondary diabetes mellitus with unspecified complication, uncontrolled unspecified essential hypertension osteoporosis, unspecified asthma, unspecified type, with (acute) exacerbation unspecified essential hypertension other overexertion and strenuous and repetitive movements or loads other and unspecified hyperlipidemia
white m 82 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; milk of magnesia  30  ml ; senna  8.6  mg ; multivitamins  1  tab ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)  2.5-5  mg ; ketorolac  15  mg ; simvastatin  40  mg ; terazosin  5  mg ; 
personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus diverticulitis of colon (without mention of hemorrhage) personal history of malignant neoplasm of bladder 
white m 82 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  124  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; milk of magnesia  30  ml ; senna  8.6  mg ; multivitamins  1  tab ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)  2.5-5  mg ; ketorolac  15  mg ; simvastatin  40  mg ; terazosin  5  mg ; tramadol  50  mg ; enoxaparin sodium  30  mg ; finasteride  5  mg ; sodium chloride 0.9%  1000  ml ; 
personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus diverticulitis of colon (without mention of hemorrhage) personal history of malignant neoplasm of bladder 
white m 82 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  170  k ul$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; milk of magnesia  30  ml ; senna  8.6  mg ; multivitamins  1  tab ; ondansetron  4  mg ; simvastatin  40  mg ; terazosin  5  mg ; tramadol  50  mg ; enoxaparin sodium  30  mg ; finasteride  5  mg ; sodium chloride 0.9%  1000  ml ; lidocaine 5% patch  1  ptch ; 
personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus diverticulitis of colon (without mention of hemorrhage) personal history of malignant neoplasm of bladder 
white m 82 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  203  k ul$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; milk of magnesia  30  ml ; senna  8.6  mg ; multivitamins  1  tab ; ondansetron  4  mg ; simvastatin  40  mg ; terazosin  5  mg ; tramadol  50  mg ; enoxaparin sodium  30  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; 
personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus diverticulitis of colon (without mention of hemorrhage) personal history of malignant neoplasm of bladder 
white f 29 $temp    heartrate  118.0  resprate  16.0  o2sat  97.0  sbp  105.0  dbp  69.0  rhythm  sinus tachycardia  pain  sleeping  ; temp    heartrate  112.0  resprate  14.0  o2sat  97.0  sbp  96.0  dbp  54.0  rhythm    pain  sleeping  $hematology blood hematocrit  44.3  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  380  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  522  mg dl; chemistry blood albumin  4.4  g dl$nan
long-term (current) use of insulin background diabetic retinopathy borderline personality disorder alcohol abuse, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled home accidents suicide and self-inflicted injury by cutting and piercing instrument posttraumatic stress disorder open wound of wrist, without mention of complication depressive disorder, not elsewhere classified dysthymic disorder opioid abuse, unspecified background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled bacteremia gastroparesis cellulitis and abscess of upper arm and forearm phlebitis and thrombophlebitis of superficial veins of upper extremities diabetes with neurological manifestations, type i [juvenile type], uncontrolled depressive disorder, not elsewhere classified acute alcoholic intoxication in alcoholism, unspecified suicidal ideation diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled posttraumatic stress disorder gastroparesis alcohol abuse, unspecified background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled rash and other nonspecific skin eruption suicidal ideation background diabetic retinopathy poisoning by other antidepressants poisoning by other antipsychotics, neuroleptics, and major tranquilizers diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled alcohol abuse, unspecified major depressive affective disorder, recurrent episode, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents cocaine abuse, unspecified gastroparesis diabetes with neurological manifestations, type i [juvenile type], uncontrolled irritable bowel syndrome background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled major depressive affective disorder, single episode, unspecified other and unspecified hyperlipidemia acute pyelonephritis without lesion of renal medullary necrosis escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site
white f 32 $nan$hematology blood hematocrit  37.3  %; hematology blood hematocrit  34.0  %; hematology blood hematocrit  34.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  250  k ul; hematology blood platelet count  230  k ul; hematology blood platelet count  205  k ul; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; hematology blood inr(pt)  0.9  ; hematology blood inr(pt)  0.9  ; chemistry urine creatinine, urine  89  mg dl; chemistry urine protein creatinine ratio  0.2  ratio$naloxone  0.4  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; sw  500  ml ; magnesium sulfate (ob)  20  gm ; 
personal history of allergy to sulfonamides nonpurulent mastitis associated with childbirth, postpartum condition or complication methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site asthma, unspecified type, unspecified celiac disease unspecified pedal cyclist injured in collision with heavy transport vehicle or bus in nontraffic accident migraine, unspecified, without mention of intractable migraine without mention of status migrainosus motorcycle driver injured in collision with fixed or stationary object in nontraffic accident personal history of allergy to penicillin outcome of delivery, single liveborn coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition failed medical or unspecified induction of labor, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident celiac disease oligohydramnios, delivered, with or without mention of antepartum condition congenital deficiency of other clotting factors other current conditions classifiable elsewhere of mother, antepartum condition or complication migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white f 32 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  198  k ul; chemistry blood creatinine  0.5  mg dl$naloxone  0.4  mg ; naloxone  40-80  mcg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; sw  500  ml ; magnesium sulfate (ob)  20  gm ; oxycodone (immediate release)   5-10  mg ; acetaminophen-caff-butalbital  1-2  tab ; acetaminophen-caff-butalbital  1  tab ; prochlorperazine  10  mg ; enoxaparin sodium  40  mg ; acetaminophen  500-1000  mg ; 
personal history of allergy to sulfonamides nonpurulent mastitis associated with childbirth, postpartum condition or complication methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site asthma, unspecified type, unspecified celiac disease unspecified pedal cyclist injured in collision with heavy transport vehicle or bus in nontraffic accident migraine, unspecified, without mention of intractable migraine without mention of status migrainosus motorcycle driver injured in collision with fixed or stationary object in nontraffic accident personal history of allergy to penicillin outcome of delivery, single liveborn coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition failed medical or unspecified induction of labor, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident celiac disease oligohydramnios, delivered, with or without mention of antepartum condition congenital deficiency of other clotting factors other current conditions classifiable elsewhere of mother, antepartum condition or complication migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white f 32 $nan$chemistry blood bilirubin, total  0.5  mg dl$naloxone  0.4  mg ; naloxone  40-80  mcg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen-caff-butalbital  1  tab ; prochlorperazine  10  mg ; enoxaparin sodium  40  mg ; acetaminophen  500-1000  mg ; 
personal history of allergy to sulfonamides nonpurulent mastitis associated with childbirth, postpartum condition or complication methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site asthma, unspecified type, unspecified celiac disease unspecified pedal cyclist injured in collision with heavy transport vehicle or bus in nontraffic accident migraine, unspecified, without mention of intractable migraine without mention of status migrainosus motorcycle driver injured in collision with fixed or stationary object in nontraffic accident personal history of allergy to penicillin outcome of delivery, single liveborn coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition failed medical or unspecified induction of labor, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident celiac disease oligohydramnios, delivered, with or without mention of antepartum condition congenital deficiency of other clotting factors other current conditions classifiable elsewhere of mother, antepartum condition or complication migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white f 32 $nan$nan$naloxone  0.4  mg ; naloxone  40-80  mcg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; prochlorperazine  10  mg ; enoxaparin sodium  40  mg ; acetaminophen  500-1000  mg ; 
personal history of allergy to sulfonamides nonpurulent mastitis associated with childbirth, postpartum condition or complication methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site asthma, unspecified type, unspecified celiac disease unspecified pedal cyclist injured in collision with heavy transport vehicle or bus in nontraffic accident migraine, unspecified, without mention of intractable migraine without mention of status migrainosus motorcycle driver injured in collision with fixed or stationary object in nontraffic accident personal history of allergy to penicillin outcome of delivery, single liveborn coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition failed medical or unspecified induction of labor, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident celiac disease oligohydramnios, delivered, with or without mention of antepartum condition congenital deficiency of other clotting factors other current conditions classifiable elsewhere of mother, antepartum condition or complication migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 
white m 52 $temp  98.5  heartrate  49.0  resprate  18.0  o2sat  98.0  sbp  155.0  dbp  76.0  rhythm    pain  0  $hematology blood hematocrit  45.7  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  92  mg dl; chemistry blood % hemoglobin a1c  5.2  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5ns  1000  ml ; aspirin  81  mg ; heparin  5000  unit ; verapamil sr  180  mg ; 
 
white m 52 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; heparin  5000  unit ; verapamil sr  180  mg ; atorvastatin  10  mg ; amlodipine  5  mg ; nicotine patch  14  mg ; 
 
white f 80 $nan$nan$carbamazepine  200  mg ; lisinopril  10  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; multivitamins  1  tab ; prednisone  60  mg ; omeprazole  20  mg ; heparin  5000  unit ; gabapentin  100  mg ; 
anomalies of cerebrovascular system unspecified essential hypertension unspecified pleural effusion osteoporosis, unspecified nausea alone other pulmonary embolism and infarction trigeminal neuralgia 
white f 80 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  17  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  93  mg dl; chemistry blood albumin  4.0  g dl$carbamazepine  200  mg ; lisinopril  10  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; multivitamins  1  tab ; prednisone  60  mg ; omeprazole  20  mg ; heparin  5000  unit ; gabapentin  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; morphine sulfate  1-2  mg ; insulin  0  unit ; carbamazepine  400  mg ; morphine sulfate  1-4  mg ; sulfameth trimethoprim ds  1  tab ; gabapentin  200  mg ; morphine sulfate  50  mg ; ranitidine  150  mg ; 
anomalies of cerebrovascular system unspecified essential hypertension unspecified pleural effusion osteoporosis, unspecified nausea alone other pulmonary embolism and infarction trigeminal neuralgia 
white f 80 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  126  mg dl$carbamazepine  200  mg ; lisinopril  10  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; multivitamins  1  tab ; prednisone  60  mg ; omeprazole  20  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carbamazepine  400  mg ; sulfameth trimethoprim ds  1  tab ; ranitidine  150  mg ; lactulose  15  ml ; docusate sodium  100  mg ; 
anomalies of cerebrovascular system unspecified essential hypertension unspecified pleural effusion osteoporosis, unspecified nausea alone other pulmonary embolism and infarction trigeminal neuralgia 
white f 80 $nan$nan$carbamazepine  200  mg ; lisinopril  10  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; multivitamins  1  tab ; prednisone  60  mg ; omeprazole  20  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carbamazepine  400  mg ; sulfameth trimethoprim ds  1  tab ; ranitidine  150  mg ; lactulose  15  ml ; docusate sodium  100  mg ; 
anomalies of cerebrovascular system unspecified essential hypertension unspecified pleural effusion osteoporosis, unspecified nausea alone other pulmonary embolism and infarction trigeminal neuralgia 
white f 80 $nan$nan$carbamazepine  200  mg ; lisinopril  10  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; multivitamins  1  tab ; prednisone  60  mg ; omeprazole  20  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carbamazepine  400  mg ; sulfameth trimethoprim ds  1  tab ; ranitidine  150  mg ; lactulose  15  ml ; docusate sodium  100  mg ; oxycodone (immediate release)   5  mg ; 
anomalies of cerebrovascular system unspecified essential hypertension unspecified pleural effusion osteoporosis, unspecified nausea alone other pulmonary embolism and infarction trigeminal neuralgia 
white f 80 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  102  mg dl$carbamazepine  200  mg ; lisinopril  10  mg ; calcium carbonate  1000  mg ; vitamin d  800  unit ; multivitamins  1  tab ; prednisone  60  mg ; omeprazole  20  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carbamazepine  400  mg ; ranitidine  150  mg ; lactulose  15  ml ; docusate sodium  100  mg ; oxycodone (immediate release)   5  mg ; 
anomalies of cerebrovascular system unspecified essential hypertension unspecified pleural effusion osteoporosis, unspecified nausea alone other pulmonary embolism and infarction trigeminal neuralgia 
white f 39 $temp    heartrate  108.0  resprate  17.0  o2sat  100.0  sbp  134.0  dbp  90.0  rhythm    pain    $hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  111  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; albuterol inhaler  2  puff ; multivitamins  1  tab ; trazodone  25-50  mg ; acetaminophen  650  mg ; ibuprofen  600  mg ; venlafaxine xr  150  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; clindamycin  300  mg ; amphetamine-dextroamphetamine  20  mg ; ranitidine  150  mg ; 
first degree perineal laceration during delivery single live birth supervision of elderly multigravida, third trimester obesity complicating childbirth 39 weeks gestation of pregnancy labor and delivery complicated by cord around neck, with compression, not applicable or unspecified body mass index (bmi) 40.0-44.9, adult maternal care for benign tumor of corpus uteri, unspecified trimester leiomyoma of uterus, unspecified false labor at or after 37 completed weeks of gestation unspecified asthma, uncomplicated supervision of elderly multigravida, third trimester maternal care for benign tumor of corpus uteri, third trimester obesity complicating pregnancy, third trimester 39 weeks gestation of pregnancy body mass index (bmi) 40.0-44.9, adult other specified pregnancy related conditions, third trimester motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn second-degree perineal laceration, delivered, with or without mention of antepartum condition transient hypertension of pregnancy, delivered , with or without mention of antepartum condition 
white f 39 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  100  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; multivitamins  1  tab ; trazodone  25-50  mg ; acetaminophen  650  mg ; ibuprofen  600  mg ; venlafaxine xr  150  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; clindamycin  300  mg ; amphetamine-dextroamphetamine  20  mg ; ranitidine  150  mg ; mupirocin ointment 2%  1  appl ; penicillin v potassium  500  mg ; 
first degree perineal laceration during delivery single live birth supervision of elderly multigravida, third trimester obesity complicating childbirth 39 weeks gestation of pregnancy labor and delivery complicated by cord around neck, with compression, not applicable or unspecified body mass index (bmi) 40.0-44.9, adult maternal care for benign tumor of corpus uteri, unspecified trimester leiomyoma of uterus, unspecified false labor at or after 37 completed weeks of gestation unspecified asthma, uncomplicated supervision of elderly multigravida, third trimester maternal care for benign tumor of corpus uteri, third trimester obesity complicating pregnancy, third trimester 39 weeks gestation of pregnancy body mass index (bmi) 40.0-44.9, adult other specified pregnancy related conditions, third trimester motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn second-degree perineal laceration, delivered, with or without mention of antepartum condition transient hypertension of pregnancy, delivered , with or without mention of antepartum condition 
white f 39 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; multivitamins  1  tab ; trazodone  25-50  mg ; acetaminophen  650  mg ; ibuprofen  600  mg ; venlafaxine xr  150  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; clindamycin  300  mg ; amphetamine-dextroamphetamine  20  mg ; ranitidine  150  mg ; mupirocin ointment 2%  1  appl ; 
first degree perineal laceration during delivery single live birth supervision of elderly multigravida, third trimester obesity complicating childbirth 39 weeks gestation of pregnancy labor and delivery complicated by cord around neck, with compression, not applicable or unspecified body mass index (bmi) 40.0-44.9, adult maternal care for benign tumor of corpus uteri, unspecified trimester leiomyoma of uterus, unspecified false labor at or after 37 completed weeks of gestation unspecified asthma, uncomplicated supervision of elderly multigravida, third trimester maternal care for benign tumor of corpus uteri, third trimester obesity complicating pregnancy, third trimester 39 weeks gestation of pregnancy body mass index (bmi) 40.0-44.9, adult other specified pregnancy related conditions, third trimester motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn second-degree perineal laceration, delivered, with or without mention of antepartum condition transient hypertension of pregnancy, delivered , with or without mention of antepartum condition 
white m 56 $temp  98.5  heartrate  91.0  resprate  15.0  o2sat  94.0  sbp  119.0  dbp  68.0  rhythm    pain  0  $hematology blood hematocrit  37.2  %; hematology blood hematocrit  34.4  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  25  k ul; hematology blood platelet count  28  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  183  iu l$vial  1  vial ; pantoprazole  80  mg ; 0.9% sodium chloride  100  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; 0.45% sodium chloride  1000  ml ; rifaximin  550  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; lactulose  30  ml ; cyclobenzaprine  5  mg ; clonazepam  0.5  mg ; clonazepam  1  mg ; fleet enema  2  enema ; citalopram  40  mg ; ferrous sulfate  325  mg ; buprenorphine-naloxone (8mg-2mg)  0.5  tab ; bag  50  ml ; magnesium sulfate  2  gm ; neutra-phos  1  pkt ; bag  100  ml ; magnesium sulfate  4  gm ; quetiapine fumarate  100  mg ; nicotine patch  14  mg ; 
cirrhosis of liver without mention of alcohol other pancytopenia other encephalopathy hemorrhage of rectum and anus tobacco use disorder benign neoplasm of colon unspecified viral hepatitis c without hepatic coma esophageal varices in diseases classified elsewhere, without mention of bleeding dysthymic disorder other specified disorders of stomach and duodenum esophageal varices in diseases classified elsewhere, without mention of bleeding other pancytopenia blood in stool cirrhosis of liver without mention of alcohol portal hypertension chronic hepatitis c without mention of hepatic coma esophageal reflux internal hemorrhoids without mention of complication esophageal reflux bacteremia esophageal varices in diseases classified elsewhere, without mention of bleeding tobacco use disorder intestinal infection due to campylobacter personal history of alcoholism alcoholic cirrhosis of liver unspecified viral hepatitis c with hepatic coma dysthymic disorder pancytopenia person boarding or alighting a pedal cycle injured in collision with other pedal cycle other ascites dysthymic disorder unspecified viral hepatitis c without hepatic coma cirrhosis of liver without mention of alcohol internal hemorrhoids with other complication thrombocytopenia, unspecified dysthymic disorder chronic hepatitis c without mention of hepatic coma opioid type dependence, continuous esophageal reflux urinary tract infection, site not specified dehydration hereditary fructose intolerance cirrhosis of liver without mention of alcohol internal hemorrhoids with other complication other specified disorders of stomach and duodenum chronic hepatitis c with hepatic coma thrombocytopenia, unspecified tobacco use disorder
white m 56 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  23  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; rifaximin  550  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; cyclobenzaprine  5  mg ; clonazepam  0.5  mg ; clonazepam  1  mg ; citalopram  40  mg ; ferrous sulfate  325  mg ; buprenorphine-naloxone (8mg-2mg)  0.5  tab ; neutra-phos  1  pkt ; bag  100  ml ; magnesium sulfate  4  gm ; quetiapine fumarate  100  mg ; nicotine patch  14  mg ; furosemide  20  mg ; spironolactone  50  mg ; 
cirrhosis of liver without mention of alcohol other pancytopenia other encephalopathy hemorrhage of rectum and anus tobacco use disorder benign neoplasm of colon unspecified viral hepatitis c without hepatic coma esophageal varices in diseases classified elsewhere, without mention of bleeding dysthymic disorder other specified disorders of stomach and duodenum esophageal varices in diseases classified elsewhere, without mention of bleeding other pancytopenia blood in stool cirrhosis of liver without mention of alcohol portal hypertension chronic hepatitis c without mention of hepatic coma esophageal reflux internal hemorrhoids without mention of complication esophageal reflux bacteremia esophageal varices in diseases classified elsewhere, without mention of bleeding tobacco use disorder intestinal infection due to campylobacter personal history of alcoholism alcoholic cirrhosis of liver unspecified viral hepatitis c with hepatic coma dysthymic disorder pancytopenia person boarding or alighting a pedal cycle injured in collision with other pedal cycle other ascites dysthymic disorder unspecified viral hepatitis c without hepatic coma cirrhosis of liver without mention of alcohol internal hemorrhoids with other complication thrombocytopenia, unspecified dysthymic disorder chronic hepatitis c without mention of hepatic coma opioid type dependence, continuous esophageal reflux urinary tract infection, site not specified dehydration hereditary fructose intolerance cirrhosis of liver without mention of alcohol internal hemorrhoids with other complication other specified disorders of stomach and duodenum chronic hepatitis c with hepatic coma thrombocytopenia, unspecified tobacco use disorder
white f 51 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; ketorolac  15-30  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; lidocaine jelly 2% (urojet)  1  appl ; phenazopyridine  100  mg ; 
incisional hernia without mention of obstruction or gangrene other impaction of intestine lipoma of intra-abdominal organs peritoneal adhesions (postoperative) (postinfection) calculus of gallbladder and bile duct without cholecystitis, without mention of obstruction benign neoplasm of ovary diverticulosis of colon (without mention of hemorrhage) 
white f 51 $nan$hematology blood hematocrit  27.9  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  248  k ul; hematology blood platelet count  246  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; hematology urine wbc  7  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  136  mg dl; hematology blood bands  0  %$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; ketorolac  15-30  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; lidocaine jelly 2% (urojet)  1  appl ; phenazopyridine  100  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
incisional hernia without mention of obstruction or gangrene other impaction of intestine lipoma of intra-abdominal organs peritoneal adhesions (postoperative) (postinfection) calculus of gallbladder and bile duct without cholecystitis, without mention of obstruction benign neoplasm of ovary diverticulosis of colon (without mention of hemorrhage) 
white f 51 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  95  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; ketorolac  15-30  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; hydrocodone-acetaminophen  1-2  tab ; 
incisional hernia without mention of obstruction or gangrene other impaction of intestine lipoma of intra-abdominal organs peritoneal adhesions (postoperative) (postinfection) calculus of gallbladder and bile duct without cholecystitis, without mention of obstruction benign neoplasm of ovary diverticulosis of colon (without mention of hemorrhage) 
white f 51 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; ketorolac  15-30  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; ibuprofen  600  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; hydrocodone-acetaminophen  1-2  tab ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 
incisional hernia without mention of obstruction or gangrene other impaction of intestine lipoma of intra-abdominal organs peritoneal adhesions (postoperative) (postinfection) calculus of gallbladder and bile duct without cholecystitis, without mention of obstruction benign neoplasm of ovary diverticulosis of colon (without mention of hemorrhage) 
white f 51 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; ibuprofen  600  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; hydrocodone-acetaminophen  1-2  tab ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 
incisional hernia without mention of obstruction or gangrene other impaction of intestine lipoma of intra-abdominal organs peritoneal adhesions (postoperative) (postinfection) calculus of gallbladder and bile duct without cholecystitis, without mention of obstruction benign neoplasm of ovary diverticulosis of colon (without mention of hemorrhage) 
white f 51 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; ibuprofen  600  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; hydrocodone-acetaminophen  1-2  tab ; 
incisional hernia without mention of obstruction or gangrene other impaction of intestine lipoma of intra-abdominal organs peritoneal adhesions (postoperative) (postinfection) calculus of gallbladder and bile duct without cholecystitis, without mention of obstruction benign neoplasm of ovary diverticulosis of colon (without mention of hemorrhage) 
white m 79 $temp    heartrate  83.0  resprate  18.0  o2sat  100.0  sbp  134.0  dbp  96.0  rhythm    pain  0  $nan$phenobarbital  30  mg ; phenytoin sodium extended  100  mg ; aspirin  81  mg ; atenolol  25  mg ; losartan potassium  50  mg ; finasteride  5  mg ; 
 
white m 79 $temp  98.2  heartrate  84.0  resprate  18.0  o2sat  98.0  sbp  134.0  dbp  96.0  rhythm    pain  0  $hematology blood hematocrit  47.0  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.1  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  237  iu l; chemistry blood albumin  4.4  g dl$phenobarbital  30  mg ; phenytoin sodium extended  100  mg ; aspirin  81  mg ; atenolol  25  mg ; losartan potassium  50  mg ; finasteride  5  mg ; warfarin  4  mg ; sodium chloride 0.9%  flush  3  ml ; polyethylene glycol  17  g ; heparin  5000  unit ; omeprazole  20  mg ; tamsulosin  0.4  mg ; phenobarbital  60  mg ; phenytoin sodium extended  200  mg ; benzonatate  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
 
white m 79 $nan$nan$phenobarbital  30  mg ; phenytoin sodium extended  100  mg ; aspirin  81  mg ; atenolol  25  mg ; losartan potassium  50  mg ; finasteride  5  mg ; warfarin  4  mg ; sodium chloride 0.9%  flush  3  ml ; polyethylene glycol  17  g ; heparin  5000  unit ; omeprazole  20  mg ; tamsulosin  0.4  mg ; phenobarbital  60  mg ; phenytoin sodium extended  200  mg ; benzonatate  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
 
white f 80 $nan$hematology blood hematocrit  30.4  %; hematology blood platelet count  221  k ul; hematology blood platelet count  225  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  259  iu l; chemistry blood albumin  2.9  g dl$sodium chloride 0.9%  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; insulin  0  unit ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; amlodipine  5  mg ; metoprolol tartrate  12.5  mg ; bag  1  bag ; magnesium sulfate  2  gm ; heparin  5000  unit ; docusate sodium  100  mg ; memantine  10  mg ; atorvastatin  80  mg ; donepezil  5  mg ; aspirin ec  81  mg ; clopidogrel  75  mg ; paroxetine  10  mg ; 
 
white f 80 $nan$chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  102  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; insulin  0  unit ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; metoprolol tartrate  12.5  mg ; bag  1  bag ; magnesium sulfate  2  gm ; heparin  5000  unit ; docusate sodium  100  mg ; memantine  10  mg ; atorvastatin  80  mg ; donepezil  5  mg ; aspirin ec  81  mg ; clopidogrel  75  mg ; paroxetine  10  mg ; multivitamins w minerals  1  tab ; 
 
white f 80 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  91  mg dl; chemistry blood % hemoglobin a1c  6.0  %$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; insulin  0  unit ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; heparin  5000  unit ; docusate sodium  100  mg ; memantine  10  mg ; atorvastatin  80  mg ; donepezil  5  mg ; aspirin ec  81  mg ; clopidogrel  75  mg ; paroxetine  10  mg ; multivitamins w minerals  1  tab ; metoprolol succinate xl  50  mg ; 
 
white f 80 $nan$hematology blood hematocrit  27.8  %; hematology blood platelet count  192  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; insulin  0  unit ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; heparin  5000  unit ; docusate sodium  100  mg ; memantine  10  mg ; atorvastatin  80  mg ; donepezil  5  mg ; aspirin ec  81  mg ; clopidogrel  75  mg ; paroxetine  10  mg ; multivitamins w minerals  1  tab ; metoprolol succinate xl  50  mg ; 
 
white f 80 $nan$chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; insulin  0  unit ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; heparin  5000  unit ; docusate sodium  100  mg ; memantine  10  mg ; atorvastatin  80  mg ; donepezil  5  mg ; aspirin ec  81  mg ; clopidogrel  75  mg ; paroxetine  10  mg ; multivitamins w minerals  1  tab ; metoprolol succinate xl  25  mg ; 
 
white f 80 $nan$hematology blood hematocrit  29.4  %; hematology blood platelet count  219  k ul; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; insulin  0  unit ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; heparin  5000  unit ; docusate sodium  100  mg ; memantine  10  mg ; atorvastatin  80  mg ; donepezil  5  mg ; aspirin ec  81  mg ; clopidogrel  75  mg ; paroxetine  10  mg ; multivitamins w minerals  1  tab ; metoprolol succinate xl  25  mg ; 
 
white f 80 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; insulin  0  unit ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; heparin  5000  unit ; docusate sodium  100  mg ; memantine  10  mg ; atorvastatin  80  mg ; donepezil  5  mg ; aspirin ec  81  mg ; clopidogrel  75  mg ; paroxetine  10  mg ; multivitamins w minerals  1  tab ; metoprolol succinate xl  25  mg ; 
 
black african american f 64 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  98  mg dl; chemistry blood % hemoglobin a1c  4.8  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lorazepam  0.5  mg ; lisinopril  10  mg ; aspirin  81  mg ; 
chest pain, unspecified 
black african american f 64 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lisinopril  10  mg ; aspirin  81  mg ; 
chest pain, unspecified 
white f 71 $nan$hematology blood hematocrit  29.6  %; hematology blood hematocrit  30.5  %; hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  234  k ul; hematology blood platelet count  190  k ul; hematology blood platelet count  186  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  144  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  97  mg dl; blood gas blood glucose  101  mg dl; blood gas blood glucose  121  mg dl; blood gas blood hematocrit, calculated  37  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  12.4  g dl; blood gas blood hemoglobin  11.2  g dl; blood gas blood hemoglobin  9.1  g dl; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  141  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  139  meq l$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25  mg ; albuterol-ipratropium  1-2  puff ; heparin  5000  unit ; metoprolol tartrate  25  mg ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  50  ml ; potassium chloride  20  meq ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 
 
white f 71 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  24.0  %; hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  179  k ul; hematology blood platelet count  186  k ul; hematology blood platelet count  181  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25  mg ; albuterol-ipratropium  1-2  puff ; heparin  5000  unit ; metoprolol tartrate  25  mg ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  50  ml ; potassium chloride  20  meq ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin ec  81  mg ; 
 
white f 71 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; albuterol-ipratropium  1-2  puff ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin ec  81  mg ; acetaminophen  650  mg ; 
 
white f 71 $nan$hematology blood hematocrit  21.8  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; albuterol-ipratropium  1-2  puff ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin ec  81  mg ; acetaminophen  650  mg ; senna  1  tab ; potassium chloride  40  meq ; magnesium oxide  400  mg ; docusate sodium  100  mg ; 
 
white f 71 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; albuterol-ipratropium  1-2  puff ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin ec  81  mg ; senna  1  tab ; potassium chloride  40  meq ; magnesium oxide  400  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; 
 
white f 71 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; albuterol-ipratropium  1-2  puff ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; aspirin ec  81  mg ; senna  1  tab ; docusate sodium  100  mg ; milk of magnesia  30  ml ; omeprazole  20  mg ; 
 
asian f 83 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; morphine sulfate  1  mg ; lorazepam  0.5  mg ; enoxaparin sodium  50  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  40  mg ; 
postsurgical hypothyroidism other ascites unspecified essential hypertension malignant pleural effusion obstruction of bile duct acute venous embolism and thrombosis of deep vessels of proximal lower extremity malignant neoplasm of intrahepatic bile ducts secondary malignant neoplasm of lung other venous embolism and thrombosis of inferior vena cava malignant neoplasm of liver, secondary other pulmonary embolism and infarction long-term (current) use of anticoagulants unspecified acquired hypothyroidism primary hypercoagulable state other diseases of lung, not elsewhere classified anemia, unspecified long-term (current) use of anticoagulants abdominal pain, right upper quadrant unspecified disorder of liver unspecified essential hypertension esophageal reflux other pulmonary embolism and infarction acute venous embolism and thrombosis of unspecified deep vessels of lower extremity shortness of breath unspecified disease of pericardium chest pain, unspecified unspecified disease of pericardium secondary malignant neoplasm of lung postsurgical hypothyroidism acute venous embolism and thrombosis of deep vessels of distal lower extremity malignant neoplasm of intrahepatic bile ducts benign essential hypertension pure hypercholesterolemia esophageal reflux other pulmonary embolism and infarction 
asian f 83 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; acetaminophen  325-650  mg ; morphine sulfate  1  mg ; lorazepam  0.5  mg ; enoxaparin sodium  50  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  40  mg ; lorazepam  0.5-2  mg ; ondansetron odt  4  mg ; senna  1  tab ; morphine sulfate (concentrated oral soln)  2.5-10  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; 
postsurgical hypothyroidism other ascites unspecified essential hypertension malignant pleural effusion obstruction of bile duct acute venous embolism and thrombosis of deep vessels of proximal lower extremity malignant neoplasm of intrahepatic bile ducts secondary malignant neoplasm of lung other venous embolism and thrombosis of inferior vena cava malignant neoplasm of liver, secondary other pulmonary embolism and infarction long-term (current) use of anticoagulants unspecified acquired hypothyroidism primary hypercoagulable state other diseases of lung, not elsewhere classified anemia, unspecified long-term (current) use of anticoagulants abdominal pain, right upper quadrant unspecified disorder of liver unspecified essential hypertension esophageal reflux other pulmonary embolism and infarction acute venous embolism and thrombosis of unspecified deep vessels of lower extremity shortness of breath unspecified disease of pericardium chest pain, unspecified unspecified disease of pericardium secondary malignant neoplasm of lung postsurgical hypothyroidism acute venous embolism and thrombosis of deep vessels of distal lower extremity malignant neoplasm of intrahepatic bile ducts benign essential hypertension pure hypercholesterolemia esophageal reflux other pulmonary embolism and infarction 
asian f 83 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  40  mg ; lorazepam  0.5-2  mg ; ondansetron odt  4  mg ; senna  1  tab ; morphine sulfate (concentrated oral soln)  2.5-10  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; morphine sulfate (concentrated oral soln)  2.5-20  mg ; 
postsurgical hypothyroidism other ascites unspecified essential hypertension malignant pleural effusion obstruction of bile duct acute venous embolism and thrombosis of deep vessels of proximal lower extremity malignant neoplasm of intrahepatic bile ducts secondary malignant neoplasm of lung other venous embolism and thrombosis of inferior vena cava malignant neoplasm of liver, secondary other pulmonary embolism and infarction long-term (current) use of anticoagulants unspecified acquired hypothyroidism primary hypercoagulable state other diseases of lung, not elsewhere classified anemia, unspecified long-term (current) use of anticoagulants abdominal pain, right upper quadrant unspecified disorder of liver unspecified essential hypertension esophageal reflux other pulmonary embolism and infarction acute venous embolism and thrombosis of unspecified deep vessels of lower extremity shortness of breath unspecified disease of pericardium chest pain, unspecified unspecified disease of pericardium secondary malignant neoplasm of lung postsurgical hypothyroidism acute venous embolism and thrombosis of deep vessels of distal lower extremity malignant neoplasm of intrahepatic bile ducts benign essential hypertension pure hypercholesterolemia esophageal reflux other pulmonary embolism and infarction 
asian f 83 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  40  mg ; lorazepam  0.5-2  mg ; ondansetron odt  4  mg ; senna  1  tab ; docusate sodium  100  mg ; morphine sulfate (concentrated oral soln)  2.5-20  mg ; scopolamine patch  1  ptch ; 
postsurgical hypothyroidism other ascites unspecified essential hypertension malignant pleural effusion obstruction of bile duct acute venous embolism and thrombosis of deep vessels of proximal lower extremity malignant neoplasm of intrahepatic bile ducts secondary malignant neoplasm of lung other venous embolism and thrombosis of inferior vena cava malignant neoplasm of liver, secondary other pulmonary embolism and infarction long-term (current) use of anticoagulants unspecified acquired hypothyroidism primary hypercoagulable state other diseases of lung, not elsewhere classified anemia, unspecified long-term (current) use of anticoagulants abdominal pain, right upper quadrant unspecified disorder of liver unspecified essential hypertension esophageal reflux other pulmonary embolism and infarction acute venous embolism and thrombosis of unspecified deep vessels of lower extremity shortness of breath unspecified disease of pericardium chest pain, unspecified unspecified disease of pericardium secondary malignant neoplasm of lung postsurgical hypothyroidism acute venous embolism and thrombosis of deep vessels of distal lower extremity malignant neoplasm of intrahepatic bile ducts benign essential hypertension pure hypercholesterolemia esophageal reflux other pulmonary embolism and infarction 
asian f 83 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  40  mg ; lorazepam  0.5-2  mg ; ondansetron odt  4  mg ; senna  1  tab ; docusate sodium  100  mg ; morphine sulfate (concentrated oral soln)  2.5-20  mg ; scopolamine patch  1  ptch ; 
postsurgical hypothyroidism other ascites unspecified essential hypertension malignant pleural effusion obstruction of bile duct acute venous embolism and thrombosis of deep vessels of proximal lower extremity malignant neoplasm of intrahepatic bile ducts secondary malignant neoplasm of lung other venous embolism and thrombosis of inferior vena cava malignant neoplasm of liver, secondary other pulmonary embolism and infarction long-term (current) use of anticoagulants unspecified acquired hypothyroidism primary hypercoagulable state other diseases of lung, not elsewhere classified anemia, unspecified long-term (current) use of anticoagulants abdominal pain, right upper quadrant unspecified disorder of liver unspecified essential hypertension esophageal reflux other pulmonary embolism and infarction acute venous embolism and thrombosis of unspecified deep vessels of lower extremity shortness of breath unspecified disease of pericardium chest pain, unspecified unspecified disease of pericardium secondary malignant neoplasm of lung postsurgical hypothyroidism acute venous embolism and thrombosis of deep vessels of distal lower extremity malignant neoplasm of intrahepatic bile ducts benign essential hypertension pure hypercholesterolemia esophageal reflux other pulmonary embolism and infarction 
white f 89 $temp  98.1  heartrate    resprate  22.0  o2sat  94.0  sbp  111.0  dbp  50.0  rhythm    pain  0  $hematology blood hematocrit  36.1  %; hematology blood hematocrit  36.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  230  k ul; hematology blood platelet count  263  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  198  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; blood gas blood lactate  1.5  mmol l$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; atorvastatin  20  mg ; isosorbide mononitrate (extended release)  60  mg ; levothyroxine sodium  50  mcg ; amlodipine  2.5  mg ; metoprolol tartrate  25  mg ; apixaban  2.5  mg ; polyethylene glycol  17  g ; furosemide  40  mg ; metoprolol tartrate  37.5  mg ; potassium chloride  40  meq ; metoprolol tartrate  50  mg ; metoprolol tartrate  5  mg ; ondansetron  4  mg ; 
 
white f 89 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  144  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; atorvastatin  20  mg ; isosorbide mononitrate (extended release)  60  mg ; levothyroxine sodium  50  mcg ; amlodipine  2.5  mg ; apixaban  2.5  mg ; polyethylene glycol  17  g ; potassium chloride  40  meq ; metoprolol tartrate  50  mg ; metoprolol tartrate  5  mg ; ondansetron  4  mg ; 
 
white f 89 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; atorvastatin  20  mg ; isosorbide mononitrate (extended release)  60  mg ; levothyroxine sodium  50  mcg ; amlodipine  2.5  mg ; apixaban  2.5  mg ; polyethylene glycol  17  g ; ondansetron  4  mg ; 
 
white f 89 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; atorvastatin  20  mg ; isosorbide mononitrate (extended release)  60  mg ; levothyroxine sodium  50  mcg ; amlodipine  2.5  mg ; apixaban  2.5  mg ; polyethylene glycol  17  g ; ondansetron  4  mg ; 
 
black african american m 64 $temp  98.4  heartrate  85.0  resprate  16.0  o2sat  95.0  sbp  113.0  dbp  84.0  rhythm    pain    ; temp  98.4  heartrate  85.0  resprate  23.0  o2sat  91.0  sbp  130.0  dbp  79.0  rhythm    pain  0  $hematology blood hematocrit  44.3  %; hematology blood hematocrit  44.9  %; hematology blood hemoglobin  13.8  g dl; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  149  k ul; hematology blood platelet count  157  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  194  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  195  mg dl; chemistry blood glucose  199  mg dl; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.7  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  1800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; albuterol inhaler  2  puff ; allopurinol  150  mg ; amlodipine  10  mg ; aspirin  81  mg ; atorvastatin  80  mg ; carvedilol  25  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; gemfibrozil  600  mg ; losartan potassium  50  mg ; pyridoxine  50  mg ; ranitidine  300  mg ; tiotropium bromide  1  cap ; sildenafil  20  mg ; furosemide  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; furosemide  80  mg ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; aztreonam  1000  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  1000  ml ; d5w  250  ml ; dopamine  400  mg ; morphine sulfate  2-4  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; 
 
black african american m 64 $nan$hematology blood hematocrit  41.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  126  mg dl; chemistry blood albumin  3.0  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  1800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; ranitidine  300  mg ; tiotropium bromide  1  cap ; furosemide  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; furosemide  80  mg ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; aztreonam  1000  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  1000  ml ; d5w  250  ml ; dopamine  400  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; lidocaine jelly 2% (urojet)  1  appl ; 5% dextrose  50  ml ; furosemide  250  mg ; acetaminophen iv  1000  mg ; furosemide  120  mg ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; 
 
black african american m 64 $nan$hematology blood hematocrit  43.2  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood urea nitrogen  61  mg dl; chemistry blood urea nitrogen  63  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  111  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; ranitidine  300  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; d5w  250  ml ; dopamine  400  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; furosemide  120  mg ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; metolazone  5  mg ; 
 
black african american m 64 $nan$hematology blood hematocrit  44.9  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  61  mg dl; chemistry blood urea nitrogen  57  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 5%  150  ml ; levofloxacin  750  mg ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; metolazone  5  mg ; heparin  5000  unit ; ranitidine  150  mg ; potassium chloride  40  meq ; 
 
black african american m 64 $nan$hematology blood hematocrit  46.6  %; hematology blood hematocrit  48.3  %; hematology blood hemoglobin  14.1  g dl; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  206  k ul; hematology blood platelet count  215  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  229  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 5%  150  ml ; levofloxacin  750  mg ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
black african american m 64 $nan$hematology blood hematocrit  48.4  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 5%  150  ml ; levofloxacin  750  mg ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; bag  1  bag ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  2  bag ; magnesium sulfate  4  gm ; acetazolamide  500  mg ; 
 
black african american m 64 $nan$hematology blood hematocrit  46.2  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  291  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  173  mg dl$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levofloxacin  500  mg ; 
 
black african american m 64 $nan$hematology blood hematocrit  46.5  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  185  mg dl$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levofloxacin  500  mg ; 5% dextrose  40  ml ; 
 
black african american m 64 $nan$hematology blood hematocrit  46.0  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  159  mg dl$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levofloxacin  500  mg ; 5% dextrose  40  ml ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
black african american m 64 $nan$hematology blood hematocrit  44.8  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  171  mg dl$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levofloxacin  500  mg ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
black african american m 64 $nan$hematology blood hematocrit  45.4  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  116  mg dl$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levofloxacin  500  mg ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
black african american m 64 $nan$nan$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; 
 
black african american m 64 $nan$hematology blood hematocrit  44.6  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  116  mg dl$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; oxycodone (immediate release)   5  mg ; 
 
black african american m 64 $nan$hematology blood hematocrit  47.2  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  356  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  130  mg dl$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; oxycodone (immediate release)   5  mg ; capsaicin 0.025%  1  appl ; 
 
black african american m 64 $nan$nan$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; capsaicin 0.025%  1  appl ; 
 
black african american m 64 $nan$nan$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; capsaicin 0.025%  1  appl ; 
 
black african american m 64 $nan$hematology blood hematocrit  44.1  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  334  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  129  mg dl$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; capsaicin 0.025%  1  appl ; 
 
black african american m 64 $nan$nan$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; capsaicin 0.025%  1  appl ; 
 
black african american m 64 $nan$hematology blood hematocrit  45.5  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  10.3  mg dl; chemistry blood glucose  135  mg dl$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; capsaicin 0.025%  1  appl ; losartan potassium  25  mg ; sarna lotion  1  appl ; metformin (glucophage)  1000  mg ; carvedilol  6.25  mg ; 
 
black african american m 64 $nan$nan$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; capsaicin 0.025%  1  appl ; losartan potassium  25  mg ; sarna lotion  1  appl ; metformin (glucophage)  1000  mg ; carvedilol  6.25  mg ; 
 
black african american m 64 $nan$nan$allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; cyanocobalamin  50  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; pyridoxine  50  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simethicone  40-80  mg ; torsemide  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; capsaicin 0.025%  1  appl ; losartan potassium  25  mg ; sarna lotion  1  appl ; metformin (glucophage)  1000  mg ; carvedilol  6.25  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  158  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  150  mg dl; chemistry blood lactate dehydrogenase (ld)  241  iu l; chemistry blood albumin  3.2  g dl; chemistry blood albumin  2.6  g dl; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.3  mmol l$vancomycin  1000  mg ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  1000  mg ; propofol  200  mg ; midazolam  2  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; iso-osmotic dextrose  200  ml ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; phenobarbital  65  mg ; phenytoin sodium (iv)  100  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; levetiracetam  1000  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  250  ml ; thiamine  500  mg ; phenytoin sodium  400  mg ; 5% dextrose  100  ml ; phenobarbital  400  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  144  mg dl; chemistry blood albumin  2.8  g dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood glucose  110  mg dl; blood gas blood glucose  109  mg dl; blood gas blood potassium, whole blood  3.9  meq l$vancomycin  1000  mg ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  1000  mg ; propofol  200  mg ; midazolam  2  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; iso-osmotic dextrose  200  ml ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; phenobarbital  65  mg ; phenytoin sodium (iv)  100  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; levetiracetam  1000  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  250  ml ; thiamine  500  mg ; phenytoin sodium  400  mg ; 5% dextrose  100  ml ; phenobarbital  400  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  115  mg dl; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; phenobarbital  65  mg ; phenytoin sodium (iv)  100  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; levetiracetam  1000  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  250  ml ; thiamine  500  mg ; phenytoin sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; phenytoin sodium  300  mg ; phenytoin sodium  150  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; phenobarbital  65  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; levetiracetam  1000  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  250  ml ; thiamine  500  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; phenytoin sodium  300  mg ; phenytoin sodium  150  mg ; nafcillin  2  g ; phenytoin sodium  200  mg ; levetiracetam  1500  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  200  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; phenobarbital  65  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; folic acid  1  mg ; multivitamins w minerals  1  tab ; 5% dextrose  250  ml ; thiamine  500  mg ; nafcillin  2  g ; phenytoin sodium  200  mg ; levetiracetam  1500  mg ; phenobarbital  100  mg ; phenobarbital  850  mg ; sodium chloride 0.9%  1000  ml ; 
 
unknown m 57 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  197  iu l; chemistry blood albumin  2.5  g dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  200  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; folic acid  1  mg ; multivitamins w minerals  1  tab ; nafcillin  2  g ; phenytoin sodium  200  mg ; levetiracetam  1500  mg ; phenobarbital  100  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; acetaminophen iv  1000  mg ; phenobarbital  160  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  118  mg dl; chemistry blood albumin  2.5  g dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  200  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; folic acid  1  mg ; multivitamins w minerals  1  tab ; phenytoin sodium  200  mg ; levetiracetam  1500  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  150  mg ; acetaminophen (liquid)  650  mg ; phenobarbital  1660  mg ; acetaminophen  650  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  131  mg dl; chemistry blood albumin  2.3  g dl; hematology blood bands  2  %; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.0  mmol l$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  200  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; folic acid  1  mg ; multivitamins w minerals  1  tab ; phenytoin sodium  200  mg ; levetiracetam  1500  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  1660  mg ; acetaminophen  650  mg ; vancomycin  1250  mg ; soln  100  ml ; 
 
unknown m 57 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  136  mg dl; chemistry blood albumin  2.4  g dl; chemistry blood albumin  2.6  g dl; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  1.1  mmol l$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  200  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; folic acid  1  mg ; multivitamins w minerals  1  tab ; phenytoin sodium  200  mg ; levetiracetam  1500  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; vancomycin  1250  mg ; soln  100  ml ; 0.9% sodium chloride  150  ml ; furosemide  40  mg ; 0.9% sodium chloride  50  ml ; 
 
unknown m 57 $nan$hematology blood hematocrit  41.4  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  200  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; folic acid  1  mg ; multivitamins w minerals  1  tab ; levetiracetam  1500  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; furosemide  40  mg ; 0.9% sodium chloride  50  ml ; furosemide  20  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  140  mg dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; folic acid  1  mg ; multivitamins w minerals  1  tab ; levetiracetam  1500  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; 0.9% sodium chloride  50  ml ; furosemide  20  mg ; phenytoin infatab  200  mg ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
 
unknown m 57 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  123  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; multivitamins  5  ml ; lorazepam  2  mg ; lacosamide  100  mg ; lacosamide  200  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  146  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; multivitamins  5  ml ; lorazepam  2  mg ; lacosamide  200  mg ; senna  8.6  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; furosemide  80  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  34.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  314  k ul; hematology blood platelet count  354  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  134  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; multivitamins  5  ml ; senna  8.6  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; furosemide  80  mg ; polyethylene glycol  17  g ; 0.9% sodium chloride  50  bag ; 
 
unknown m 57 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  427  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  125  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; multivitamins  5  ml ; senna  8.6  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; polyethylene glycol  17  g ; potassium chloride (powder)  20  meq ; 
 
unknown m 57 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  433  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  119  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; multivitamins  5  ml ; senna  8.6  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; polyethylene glycol  17  g ; potassium chloride (powder)  20  meq ; fentanyl citrate  100-200  mcg ; 
 
unknown m 57 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  554  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  103  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; multivitamins  5  ml ; senna  8.6  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; polyethylene glycol  17  g ; fentanyl citrate  100-200  mcg ; levofloxacin  750  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  584  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  170  mg dl; chemistry blood glucose  124  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; multivitamins  5  ml ; senna  8.6  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; polyethylene glycol  17  g ; levofloxacin  750  mg ; senna  17.2  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  555  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  140  mg dl; chemistry blood lactate dehydrogenase (ld)  257  iu l; blood gas blood lactate  1.4  mmol l$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; multivitamins  5  ml ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; senna  17.2  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  464  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  138  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; multivitamins  5  ml ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; senna  17.2  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  436  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  127  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; multivitamins  5  ml ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; senna  17.2  mg ; artificial tear ointment  1  appl ; 
 
unknown m 57 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  455  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  120  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; phenobarbital  145.8  mg ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
 
unknown m 57 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  440  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood glucose  118  mg dl$heparin  5000  unit ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; artificial tears  1-2  drop ; phenobarbital  145.8  mg ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
 
unknown m 57 $nan$nan$heparin  5000  unit ; famotidine  20  mg ; folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
 
unknown m 57 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  152  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  137  mg dl$heparin  5000  unit ; famotidine  20  mg ; folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ibuprofen suspension  600  mg ; phytonadione  5  mg ; dextrose 5%  1000  ml ; ns  100  ml ; metronidazole  500  mg ; albuterol inhaler  6-10  puff ; 
 
unknown m 57 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  117  mg dl; chemistry blood lactate dehydrogenase (ld)  363  iu l; chemistry blood albumin  2.2  g dl$heparin  5000  unit ; famotidine  20  mg ; folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; ipratropium bromide neb  1  neb ; ibuprofen suspension  600  mg ; phytonadione  5  mg ; dextrose 5%  1000  ml ; ns  100  ml ; metronidazole  500  mg ; albuterol inhaler  6-10  puff ; 
 
unknown m 57 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  630  iu l; chemistry blood albumin  2.1  g dl; blood gas blood free calcium  1.03  mmol l$heparin  5000  unit ; famotidine  20  mg ; folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; phytonadione  5  mg ; albuterol inhaler  6-10  puff ; 
 
unknown m 57 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  118  mg dl; hematology blood bands  1  %$heparin  5000  unit ; famotidine  20  mg ; folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; phytonadione  5  mg ; albuterol inhaler  6-10  puff ; 
 
unknown m 57 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  2.5  g dl$heparin  5000  unit ; folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; albuterol inhaler  6-10  puff ; 
 
unknown m 57 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  99  mg dl$heparin  5000  unit ; folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; albuterol inhaler  6-10  puff ; lorazepam  1  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  128  mg dl$heparin  5000  unit ; folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; albuterol inhaler  6-10  puff ; lorazepam  1  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  137  mg dl; hematology blood bands  2  %$heparin  5000  unit ; folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; albuterol inhaler  6-10  puff ; nystatin oral suspension  5  ml ; 
 
unknown m 57 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  124  mg dl; chemistry blood lactate dehydrogenase (ld)  477  iu l; chemistry blood albumin  2.4  g dl$heparin  5000  unit ; folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; albuterol inhaler  6-10  puff ; nystatin oral suspension  5  ml ; 
 
unknown m 57 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  101  mg dl$folic acid  1  mg ; artificial tears  1-2  drop ; multivitamins  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; artificial tear ointment  1  appl ; albuterol inhaler  6-10  puff ; nystatin oral suspension  5  ml ; enoxaparin sodium  40  mg ; 
 
unknown m 56 $nan$hematology blood hematocrit  36.6  %; hematology blood hematocrit  34.5  %; hematology blood hematocrit  29.8  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  364  k ul; hematology blood platelet count  338  k ul; hematology blood platelet count  311  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  183  mg dl; chemistry blood glucose  231  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood chloride, whole blood  100  meq l; blood gas blood glucose  220  mg dl; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  10.7  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  132  meq l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; citalopram  20  mg ; omeprazole  20  mg ; insulin  0  unit ; levothyroxine sodium  200  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; trazodone  25  mg ; amlodipine  5  mg ; insulin  20  unit ; insulin  10  unit ; senna  8.6  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetaminophen  650  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.2-0.4  mg ; polyethylene glycol  17  g ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  25-100  mcg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 
 
unknown m 56 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry urine potassium, urine  27  meq l; chemistry urine urea nitrogen, urine  833  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  296  mg dl; chemistry blood lactate dehydrogenase (ld)  199  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; citalopram  20  mg ; omeprazole  20  mg ; levothyroxine sodium  200  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; trazodone  25  mg ; senna  8.6  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 5% dextrose  250  ml ; sodium phosphate  15  mmol ; 5% dextrose  500  ml ; sodium phosphate  15-30  mmol ; furosemide  40  mg ; levothyroxine sodium  224  mcg ; 
 
unknown m 56 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  226  mg dl; chemistry blood lactate dehydrogenase (ld)  213  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; citalopram  20  mg ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; trazodone  25  mg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; levothyroxine sodium  224  mcg ; insulin  30  unit ; insulin  15  unit ; insulin  25  unit ; 
 
unknown m 56 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  268  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; citalopram  20  mg ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; trazodone  25  mg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; levothyroxine sodium  224  mcg ; insulin  30  unit ; insulin  15  unit ; insulin  25  unit ; amlodipine  10  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; insulin  12  unit ; sodium chloride 0.9%  flush  10-20  ml ; furosemide  60  mg ; furosemide  80  mg ; oxycodone (immediate release)  5  mg ; 
 
unknown m 56 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  460  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  308  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; citalopram  20  mg ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; trazodone  25  mg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; levothyroxine sodium  224  mcg ; amlodipine  10  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; insulin  12  unit ; sodium chloride 0.9%  flush  10-20  ml ; furosemide  60  mg ; furosemide  80  mg ; oxycodone (immediate release)  5  mg ; torsemide  40  mg ; carvedilol  6.25  mg ; 
 
unknown m 56 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  469  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  233  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; citalopram  20  mg ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; trazodone  25  mg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; levothyroxine sodium  224  mcg ; amlodipine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; torsemide  40  mg ; carvedilol  6.25  mg ; carvedilol  12.5  mg ; enoxaparin sodium  30  mg ; 
 
unknown m 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; citalopram  20  mg ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; trazodone  25  mg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; levothyroxine sodium  224  mcg ; amlodipine  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; carvedilol  12.5  mg ; enoxaparin sodium  30  mg ; 
 
white m 72 $nan$nan$diltiazem extended-release  360  mg ; simvastatin  80  mg ; tiotropium bromide  1  cap ; aspirin  325  mg ; multivitamins  1  tab ; vitamin e  400  unit ; metoprolol tartrate  5  mg ; 
esophageal reflux anemia, unspecified atherosclerosis of native arteries of the extremities with intermittent claudication osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified glaucoma chronic total occlusion of artery of the extremities other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery unspecified glaucoma chronic airway obstruction, not elsewhere classified atherosclerosis of native arteries of the extremities with intermittent claudication anemia, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux other and unspecified hyperlipidemia peripheral vascular disease, unspecified 
white m 72 $nan$hematology blood hematocrit  33.0  %$diltiazem extended-release  360  mg ; simvastatin  80  mg ; tiotropium bromide  1  cap ; aspirin  325  mg ; multivitamins  1  tab ; vitamin e  400  unit ; metoprolol tartrate  5  mg ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; heparin  5000  unit ; albuterol inhaler  2  puff ; brimonidine tartrate 0.15% ophth.  1  drop ; ipratropium bromide neb  1  neb ; morphine sulfate  2-4  mg ; hydralazine  10  mg ; acetaminophen  500-1000  mg ; clopidogrel  75  mg ; furosemide  20  mg ; lisinopril  10  mg ; 
esophageal reflux anemia, unspecified atherosclerosis of native arteries of the extremities with intermittent claudication osteoarthrosis, unspecified whether generalized or localized, site unspecified unspecified glaucoma chronic total occlusion of artery of the extremities other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery unspecified glaucoma chronic airway obstruction, not elsewhere classified atherosclerosis of native arteries of the extremities with intermittent claudication anemia, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux other and unspecified hyperlipidemia peripheral vascular disease, unspecified 
hispanic latino f 34 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
postprocedural fever asthma, unspecified type, unspecified driver of pick-up truck or van injured in collision with other and unspecified motor vehicles in traffic accident kidney donors
hispanic latino f 34 $nan$hematology blood hematocrit  32.9  %$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; levothyroxine sodium  25  mcg ; 
postprocedural fever asthma, unspecified type, unspecified driver of pick-up truck or van injured in collision with other and unspecified motor vehicles in traffic accident kidney donors
hispanic latino f 34 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; levothyroxine sodium  25  mcg ; 
postprocedural fever asthma, unspecified type, unspecified driver of pick-up truck or van injured in collision with other and unspecified motor vehicles in traffic accident kidney donors
white f 57 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; cephalexin  500  mg ; diazepam  5  mg ; acetaminophen  650  mg ; 
 
white f 61 $nan$nan$acetaminophen  1000  mg ; pregabalin  75  mg ; heparin  5000  unit ; phenazopyridine  100  mg ; 
 
white f 61 $nan$nan$acetaminophen  1000  mg ; pregabalin  75  mg ; heparin  5000  unit ; phenazopyridine  100  mg ; 
 
white m 61 $temp  99.5  heartrate  105.0  resprate  15.0  o2sat  96.0  sbp  132.0  dbp  94.0  rhythm    pain  0  $hematology blood hematocrit  46.3  %; hematology blood hemoglobin  15.8  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  3  # hpf; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  118  mg dl; chemistry blood albumin  3.9  g dl; hematology urine glucose  70  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; omeprazole  20  mg ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5-2  mg ; heparin  5000  unit ; cilostazol  100  mg ; pravastatin  40  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1250  mg ; methadone  10  mg ; calcium carbonate  1000  mg ; nicotine patch  21  mg ; diazepam  5  mg ; ondansetron  4  mg ; 
cerebral artery occlusion, unspecified with cerebral infarction asthma, unspecified type, unspecified lumbago long-term (current) use of other medications other chronic pain grand mal status
white m 61 $nan$hematology blood hematocrit  41.3  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  154  mg dl$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; lorazepam  0.5-2  mg ; heparin  5000  unit ; cilostazol  100  mg ; pravastatin  40  mg ; calcium carbonate  1000  mg ; nicotine patch  21  mg ; diazepam  5  mg ; ondansetron  4  mg ; metoprolol tartrate  6.25  mg ; methadone  120  mg ; 
cerebral artery occlusion, unspecified with cerebral infarction asthma, unspecified type, unspecified lumbago long-term (current) use of other medications other chronic pain grand mal status
white m 61 $nan$nan$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; lorazepam  0.5-2  mg ; heparin  5000  unit ; cilostazol  100  mg ; pravastatin  40  mg ; calcium carbonate  1000  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; methadone  120  mg ; levetiracetam  1500  mg ; levetiracetam  1000  mg ; neutra-phos  2  pkt ; senna  1  tab ; 
cerebral artery occlusion, unspecified with cerebral infarction asthma, unspecified type, unspecified lumbago long-term (current) use of other medications other chronic pain grand mal status
white m 61 $nan$nan$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; lorazepam  0.5-2  mg ; heparin  5000  unit ; cilostazol  100  mg ; pravastatin  40  mg ; calcium carbonate  1000  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; methadone  120  mg ; levetiracetam  1500  mg ; levetiracetam  1000  mg ; neutra-phos  2  pkt ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; 
cerebral artery occlusion, unspecified with cerebral infarction asthma, unspecified type, unspecified lumbago long-term (current) use of other medications other chronic pain grand mal status
unknown m 50 $nan$nan$multivitamins  1  tab ; atenolol  50  mg ; simvastatin  40  mg ; valsartan  80  mg ; hydrochlorothiazide  25  mg ; benicar  40  mg ; 
 
unknown m 50 $nan$hematology blood hematocrit  35.6  %; hematology blood hematocrit  35.4  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  218  mg dl$multivitamins  1  tab ; atenolol  50  mg ; simvastatin  40  mg ; valsartan  80  mg ; hydrochlorothiazide  25  mg ; benicar  40  mg ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; docusate sodium  100  mg ; 
 
unknown m 50 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry urine creatinine, urine  72  mg dl; chemistry urine sodium, urine  106  meq l; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  238  mg dl; chemistry blood glucose  175  mg dl; chemistry urine protein creatinine ratio  0.1  ratio$multivitamins  1  tab ; atenolol  50  mg ; simvastatin  40  mg ; hydrochlorothiazide  25  mg ; benicar  40  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; insulin  6  unit ; 0.9% sodium chloride  500  ml ; 
 
unknown m 50 $nan$chemistry blood sodium  128  meq l$multivitamins  1  tab ; atenolol  50  mg ; simvastatin  40  mg ; benicar  40  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; insulin  6  unit ; 0.9% sodium chloride  500  ml ; 
 
other m 59 $nan$nan$calcium carbonate  1500  mg ; 
spontaneous bacterial peritonitis coagulation defect, unspecified acute kidney failure, unspecified portal hypertension nausea with vomiting, unspecified gastric varices esophageal varices without bleeding alcohol dependence, in remission other diseases of stomach and duodenum transient cerebral ischemic attack, unspecified alcoholic cirrhosis of liver with ascites hepatic failure, unspecified without coma other secondary thrombocytopenia alcoholic hepatic failure without coma other diseases of stomach and duodenum hematemesis awaiting organ transplant status acute kidney failure, unspecified essential (primary) hypertension portal hypertension gastric varices secondary esophageal varices without bleeding alcoholic cirrhosis of liver without ascites hypovolemia acute posthemorrhagic anemia hematemesis alcohol dependence, in remission awaiting organ transplant status hypovolemia esophageal varices without bleeding spontaneous bacterial peritonitis transient cerebral ischemic attack, unspecified pain in leg, unspecified hepatic failure, unspecified without coma nausea with vomiting, unspecified other diseases of stomach and duodenum cramp and spasm alcoholic cirrhosis of liver with ascites hypo-osmolality and hyponatremia portal hypertension hypotension, unspecified gastric varices acute kidney failure, unspecified dorsalgia, unspecified other secondary thrombocytopenia acute posthemorrhagic anemia coagulation defect, unspecified fever, unspecified
other m 59 $nan$hematology blood hematocrit  21.4  %; hematology blood hematocrit  18.7  %; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  6.4  g dl; hematology blood platelet count  50  k ul; hematology blood platelet count  46  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  3.1  ; chemistry urine potassium, urine  42  meq l; hematology urine wbc  11  # hpf; chemistry blood calcium, total  10.5  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood calcium, total  10.4  mg dl; chemistry blood bilirubin, indirect  3.9  mg dl; chemistry blood bilirubin, total  5.9  mg dl; chemistry blood bilirubin, total  5.2  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  135  iu l; chemistry blood albumin  4.5  g dl; chemistry blood albumin  4.5  g dl; hematology blood bands  0  %; chemistry blood bilirubin, direct  1.3  mg dl$calcium carbonate  1500  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; prochlorperazine  5  mg ; sucralfate  1  gm ; dicyclomine  20  mg ; midodrine  15  mg ; baclofen  5  mg ; docusate sodium  100  mg ; lactulose  30  ml ; magnesium oxide  400  mg ; rifaximin  550  mg ; omeprazole  20  mg ; albumin 25% (12.5g   50ml)  75  g ; vitamin d  1000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; 
spontaneous bacterial peritonitis coagulation defect, unspecified acute kidney failure, unspecified portal hypertension nausea with vomiting, unspecified gastric varices esophageal varices without bleeding alcohol dependence, in remission other diseases of stomach and duodenum transient cerebral ischemic attack, unspecified alcoholic cirrhosis of liver with ascites hepatic failure, unspecified without coma other secondary thrombocytopenia alcoholic hepatic failure without coma other diseases of stomach and duodenum hematemesis awaiting organ transplant status acute kidney failure, unspecified essential (primary) hypertension portal hypertension gastric varices secondary esophageal varices without bleeding alcoholic cirrhosis of liver without ascites hypovolemia acute posthemorrhagic anemia hematemesis alcohol dependence, in remission awaiting organ transplant status hypovolemia esophageal varices without bleeding spontaneous bacterial peritonitis transient cerebral ischemic attack, unspecified pain in leg, unspecified hepatic failure, unspecified without coma nausea with vomiting, unspecified other diseases of stomach and duodenum cramp and spasm alcoholic cirrhosis of liver with ascites hypo-osmolality and hyponatremia portal hypertension hypotension, unspecified gastric varices acute kidney failure, unspecified dorsalgia, unspecified other secondary thrombocytopenia acute posthemorrhagic anemia coagulation defect, unspecified fever, unspecified
other m 59 $nan$hematology blood hematocrit  23.7  %; hematology blood hematocrit  22.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  59  k ul; hematology blood platelet count  78  k ul; hematology blood platelet count  81  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  2.4  ; hematology urine wbc  5  # hpf; chemistry blood calcium, total  10.0  mg dl; chemistry blood bilirubin, total  8.6  mg dl; chemistry blood glucose  123  mg dl; chemistry blood lactate dehydrogenase (ld)  167  iu l$calcium carbonate  1500  mg ; sodium chloride 0.9%  flush  3  ml ; sucralfate  1  gm ; dicyclomine  20  mg ; midodrine  15  mg ; baclofen  5  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; rifaximin  550  mg ; albumin 25% (12.5g   50ml)  75  g ; vitamin d  1000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; vial  1  vial ; pantoprazole  40  mg ; phytonadione  10  mg ; albumin 25% (12.5g   50ml)  50  g ; phytonadione  5  mg ; 
spontaneous bacterial peritonitis coagulation defect, unspecified acute kidney failure, unspecified portal hypertension nausea with vomiting, unspecified gastric varices esophageal varices without bleeding alcohol dependence, in remission other diseases of stomach and duodenum transient cerebral ischemic attack, unspecified alcoholic cirrhosis of liver with ascites hepatic failure, unspecified without coma other secondary thrombocytopenia alcoholic hepatic failure without coma other diseases of stomach and duodenum hematemesis awaiting organ transplant status acute kidney failure, unspecified essential (primary) hypertension portal hypertension gastric varices secondary esophageal varices without bleeding alcoholic cirrhosis of liver without ascites hypovolemia acute posthemorrhagic anemia hematemesis alcohol dependence, in remission awaiting organ transplant status hypovolemia esophageal varices without bleeding spontaneous bacterial peritonitis transient cerebral ischemic attack, unspecified pain in leg, unspecified hepatic failure, unspecified without coma nausea with vomiting, unspecified other diseases of stomach and duodenum cramp and spasm alcoholic cirrhosis of liver with ascites hypo-osmolality and hyponatremia portal hypertension hypotension, unspecified gastric varices acute kidney failure, unspecified dorsalgia, unspecified other secondary thrombocytopenia acute posthemorrhagic anemia coagulation defect, unspecified fever, unspecified
other m 59 $nan$hematology blood hematocrit  21.7  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  74  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, indirect  7.4  mg dl; chemistry blood bilirubin, total  9.1  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  160  iu l; chemistry blood albumin  4.6  g dl; chemistry blood bilirubin, direct  1.7  mg dl$calcium carbonate  1500  mg ; sodium chloride 0.9%  flush  3  ml ; sucralfate  1  gm ; dicyclomine  20  mg ; midodrine  15  mg ; baclofen  5  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; rifaximin  550  mg ; vitamin d  1000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; vial  1  vial ; pantoprazole  40  mg ; phytonadione  10  mg ; albumin 25% (12.5g   50ml)  50  g ; phytonadione  5  mg ; ceftriaxone  2  gm ; 
spontaneous bacterial peritonitis coagulation defect, unspecified acute kidney failure, unspecified portal hypertension nausea with vomiting, unspecified gastric varices esophageal varices without bleeding alcohol dependence, in remission other diseases of stomach and duodenum transient cerebral ischemic attack, unspecified alcoholic cirrhosis of liver with ascites hepatic failure, unspecified without coma other secondary thrombocytopenia alcoholic hepatic failure without coma other diseases of stomach and duodenum hematemesis awaiting organ transplant status acute kidney failure, unspecified essential (primary) hypertension portal hypertension gastric varices secondary esophageal varices without bleeding alcoholic cirrhosis of liver without ascites hypovolemia acute posthemorrhagic anemia hematemesis alcohol dependence, in remission awaiting organ transplant status hypovolemia esophageal varices without bleeding spontaneous bacterial peritonitis transient cerebral ischemic attack, unspecified pain in leg, unspecified hepatic failure, unspecified without coma nausea with vomiting, unspecified other diseases of stomach and duodenum cramp and spasm alcoholic cirrhosis of liver with ascites hypo-osmolality and hyponatremia portal hypertension hypotension, unspecified gastric varices acute kidney failure, unspecified dorsalgia, unspecified other secondary thrombocytopenia acute posthemorrhagic anemia coagulation defect, unspecified fever, unspecified
other m 59 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  76  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.4  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  7.6  mg dl; chemistry blood glucose  121  mg dl; chemistry blood lactate dehydrogenase (ld)  189  iu l; chemistry blood albumin  4.7  g dl; hematology urine glucose  300  mg dl$calcium carbonate  1500  mg ; sodium chloride 0.9%  flush  3  ml ; sucralfate  1  gm ; dicyclomine  20  mg ; midodrine  15  mg ; baclofen  5  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; rifaximin  550  mg ; vitamin d  1000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; ceftriaxone  2  gm ; 
spontaneous bacterial peritonitis coagulation defect, unspecified acute kidney failure, unspecified portal hypertension nausea with vomiting, unspecified gastric varices esophageal varices without bleeding alcohol dependence, in remission other diseases of stomach and duodenum transient cerebral ischemic attack, unspecified alcoholic cirrhosis of liver with ascites hepatic failure, unspecified without coma other secondary thrombocytopenia alcoholic hepatic failure without coma other diseases of stomach and duodenum hematemesis awaiting organ transplant status acute kidney failure, unspecified essential (primary) hypertension portal hypertension gastric varices secondary esophageal varices without bleeding alcoholic cirrhosis of liver without ascites hypovolemia acute posthemorrhagic anemia hematemesis alcohol dependence, in remission awaiting organ transplant status hypovolemia esophageal varices without bleeding spontaneous bacterial peritonitis transient cerebral ischemic attack, unspecified pain in leg, unspecified hepatic failure, unspecified without coma nausea with vomiting, unspecified other diseases of stomach and duodenum cramp and spasm alcoholic cirrhosis of liver with ascites hypo-osmolality and hyponatremia portal hypertension hypotension, unspecified gastric varices acute kidney failure, unspecified dorsalgia, unspecified other secondary thrombocytopenia acute posthemorrhagic anemia coagulation defect, unspecified fever, unspecified
other m 59 $nan$hematology blood hematocrit  22.2  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  64  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  4.9  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  4.1  g dl$calcium carbonate  1500  mg ; sodium chloride 0.9%  flush  3  ml ; sucralfate  1  gm ; dicyclomine  20  mg ; midodrine  15  mg ; baclofen  5  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; rifaximin  550  mg ; vitamin d  1000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; ceftriaxone  2  gm ; phosphorus  500  mg ; ferrous sulfate  325  mg ; torsemide  20  mg ; 
spontaneous bacterial peritonitis coagulation defect, unspecified acute kidney failure, unspecified portal hypertension nausea with vomiting, unspecified gastric varices esophageal varices without bleeding alcohol dependence, in remission other diseases of stomach and duodenum transient cerebral ischemic attack, unspecified alcoholic cirrhosis of liver with ascites hepatic failure, unspecified without coma other secondary thrombocytopenia alcoholic hepatic failure without coma other diseases of stomach and duodenum hematemesis awaiting organ transplant status acute kidney failure, unspecified essential (primary) hypertension portal hypertension gastric varices secondary esophageal varices without bleeding alcoholic cirrhosis of liver without ascites hypovolemia acute posthemorrhagic anemia hematemesis alcohol dependence, in remission awaiting organ transplant status hypovolemia esophageal varices without bleeding spontaneous bacterial peritonitis transient cerebral ischemic attack, unspecified pain in leg, unspecified hepatic failure, unspecified without coma nausea with vomiting, unspecified other diseases of stomach and duodenum cramp and spasm alcoholic cirrhosis of liver with ascites hypo-osmolality and hyponatremia portal hypertension hypotension, unspecified gastric varices acute kidney failure, unspecified dorsalgia, unspecified other secondary thrombocytopenia acute posthemorrhagic anemia coagulation defect, unspecified fever, unspecified
other m 59 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  58  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  5.7  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  126  mg dl; chemistry blood albumin  4.2  g dl$calcium carbonate  1500  mg ; sodium chloride 0.9%  flush  3  ml ; sucralfate  1  gm ; dicyclomine  20  mg ; midodrine  15  mg ; baclofen  5  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; rifaximin  550  mg ; vitamin d  1000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; phosphorus  500  mg ; ferrous sulfate  325  mg ; potassium chloride  60  meq ; 
spontaneous bacterial peritonitis coagulation defect, unspecified acute kidney failure, unspecified portal hypertension nausea with vomiting, unspecified gastric varices esophageal varices without bleeding alcohol dependence, in remission other diseases of stomach and duodenum transient cerebral ischemic attack, unspecified alcoholic cirrhosis of liver with ascites hepatic failure, unspecified without coma other secondary thrombocytopenia alcoholic hepatic failure without coma other diseases of stomach and duodenum hematemesis awaiting organ transplant status acute kidney failure, unspecified essential (primary) hypertension portal hypertension gastric varices secondary esophageal varices without bleeding alcoholic cirrhosis of liver without ascites hypovolemia acute posthemorrhagic anemia hematemesis alcohol dependence, in remission awaiting organ transplant status hypovolemia esophageal varices without bleeding spontaneous bacterial peritonitis transient cerebral ischemic attack, unspecified pain in leg, unspecified hepatic failure, unspecified without coma nausea with vomiting, unspecified other diseases of stomach and duodenum cramp and spasm alcoholic cirrhosis of liver with ascites hypo-osmolality and hyponatremia portal hypertension hypotension, unspecified gastric varices acute kidney failure, unspecified dorsalgia, unspecified other secondary thrombocytopenia acute posthemorrhagic anemia coagulation defect, unspecified fever, unspecified
other m 59 $nan$nan$calcium carbonate  1500  mg ; sodium chloride 0.9%  flush  3  ml ; sucralfate  1  gm ; dicyclomine  20  mg ; midodrine  15  mg ; baclofen  5  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; rifaximin  550  mg ; vitamin d  1000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; ferrous sulfate  325  mg ; potassium chloride  60  meq ; 
spontaneous bacterial peritonitis coagulation defect, unspecified acute kidney failure, unspecified portal hypertension nausea with vomiting, unspecified gastric varices esophageal varices without bleeding alcohol dependence, in remission other diseases of stomach and duodenum transient cerebral ischemic attack, unspecified alcoholic cirrhosis of liver with ascites hepatic failure, unspecified without coma other secondary thrombocytopenia alcoholic hepatic failure without coma other diseases of stomach and duodenum hematemesis awaiting organ transplant status acute kidney failure, unspecified essential (primary) hypertension portal hypertension gastric varices secondary esophageal varices without bleeding alcoholic cirrhosis of liver without ascites hypovolemia acute posthemorrhagic anemia hematemesis alcohol dependence, in remission awaiting organ transplant status hypovolemia esophageal varices without bleeding spontaneous bacterial peritonitis transient cerebral ischemic attack, unspecified pain in leg, unspecified hepatic failure, unspecified without coma nausea with vomiting, unspecified other diseases of stomach and duodenum cramp and spasm alcoholic cirrhosis of liver with ascites hypo-osmolality and hyponatremia portal hypertension hypotension, unspecified gastric varices acute kidney failure, unspecified dorsalgia, unspecified other secondary thrombocytopenia acute posthemorrhagic anemia coagulation defect, unspecified fever, unspecified
other m 59 $nan$nan$calcium carbonate  1500  mg ; sodium chloride 0.9%  flush  3  ml ; sucralfate  1  gm ; dicyclomine  20  mg ; midodrine  15  mg ; baclofen  5  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; rifaximin  550  mg ; vitamin d  1000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; ferrous sulfate  325  mg ; 
spontaneous bacterial peritonitis coagulation defect, unspecified acute kidney failure, unspecified portal hypertension nausea with vomiting, unspecified gastric varices esophageal varices without bleeding alcohol dependence, in remission other diseases of stomach and duodenum transient cerebral ischemic attack, unspecified alcoholic cirrhosis of liver with ascites hepatic failure, unspecified without coma other secondary thrombocytopenia alcoholic hepatic failure without coma other diseases of stomach and duodenum hematemesis awaiting organ transplant status acute kidney failure, unspecified essential (primary) hypertension portal hypertension gastric varices secondary esophageal varices without bleeding alcoholic cirrhosis of liver without ascites hypovolemia acute posthemorrhagic anemia hematemesis alcohol dependence, in remission awaiting organ transplant status hypovolemia esophageal varices without bleeding spontaneous bacterial peritonitis transient cerebral ischemic attack, unspecified pain in leg, unspecified hepatic failure, unspecified without coma nausea with vomiting, unspecified other diseases of stomach and duodenum cramp and spasm alcoholic cirrhosis of liver with ascites hypo-osmolality and hyponatremia portal hypertension hypotension, unspecified gastric varices acute kidney failure, unspecified dorsalgia, unspecified other secondary thrombocytopenia acute posthemorrhagic anemia coagulation defect, unspecified fever, unspecified
unknown m 31 $temp  97.6  heartrate  125.0  resprate  16.0  o2sat  98.0  sbp  109.0  dbp  82.0  rhythm    pain    $hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  128  mg dl; blood gas blood lactate  2.4  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; lactated ringers  1000  ml ; ondansetron  4  mg ; lorazepam  1  mg ; tetanus-diphtox-acellular pertuss (tdap)  0.5  ml ; polyethylene glycol  17  g ; lactulose  15-30  ml ; 
 
unknown m 31 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  86  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; heparin  5000  unit ; lactated ringers  1000  ml ; ondansetron  4  mg ; tetanus-diphtox-acellular pertuss (tdap)  0.5  ml ; polyethylene glycol  17  g ; lactulose  15-30  ml ; diazepam - ciwa protocol  10  mg ; neutra-phos  2  pkt ; sodium chloride 0.9%  1000  ml ; 
 
unknown m 31 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  102  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; heparin  5000  unit ; tetanus-diphtox-acellular pertuss (tdap)  0.5  ml ; polyethylene glycol  17  g ; lactulose  15-30  ml ; diazepam - ciwa protocol  10  mg ; neutra-phos  2  pkt ; sodium chloride 0.9%  1000  ml ; ondansetron  4-8  mg ; metoclopramide  5  mg ; d5 1 2ns  1000  ml ; 
 
unknown m 31 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  101  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; heparin  5000  unit ; tetanus-diphtox-acellular pertuss (tdap)  0.5  ml ; polyethylene glycol  17  g ; lactulose  15-30  ml ; diazepam - ciwa protocol  10  mg ; ondansetron  4-8  mg ; metoclopramide  5  mg ; d5 1 2ns  1000  ml ; scopolamine patch  1  ptch ; bisacodyl  10  mg ; buprenorphine-naloxone tablet (8mg-2mg)  1  tab ; fleet enema (mineral oil)  1  enema ; bag  1  bag ; magnesium sulfate  4  gm ; docusate sodium  100  mg ; senna  8.6  mg ; 
 
unknown m 31 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; heparin  5000  unit ; tetanus-diphtox-acellular pertuss (tdap)  0.5  ml ; polyethylene glycol  17  g ; diazepam - ciwa protocol  10  mg ; ondansetron  4-8  mg ; scopolamine patch  1  ptch ; buprenorphine-naloxone tablet (8mg-2mg)  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; methylnaltrexone  12  mg ; 
 
unknown m 31 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; heparin  5000  unit ; tetanus-diphtox-acellular pertuss (tdap)  0.5  ml ; polyethylene glycol  17  g ; diazepam - ciwa protocol  10  mg ; ondansetron  4-8  mg ; scopolamine patch  1  ptch ; buprenorphine-naloxone tablet (8mg-2mg)  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; methylnaltrexone  12  mg ; nicotine patch  14  mg day ; 
 
black african american m 44 $temp  99.0  heartrate  68.0  resprate  20.0  o2sat  99.0  sbp  116.0  dbp  62.0  rhythm    pain  9  ; temp  98.6  heartrate  69.0  resprate  20.0  o2sat  100.0  sbp  143.0  dbp  71.0  rhythm    pain  9  ; temp    heartrate  56.0  resprate  17.0  o2sat  96.0  sbp  112.0  dbp  70.0  rhythm    pain  8  ; temp    heartrate  62.0  resprate  16.0  o2sat  96.0  sbp  121.0  dbp  75.0  rhythm    pain  0  $hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  65  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood bilirubin, indirect  1.6  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  111  mg dl; chemistry blood albumin  4.0  g dl; chemistry blood bilirubin, direct  0.3  mg dl$nan
noninfective gastroenteritis and colitis, unspecified lower abdominal pain, unspecified
black african american m 44 $temp  98.9  heartrate  61.0  resprate  16.0  o2sat  96.0  sbp  108.0  dbp  66.0  rhythm    pain  0  $hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  55  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l; chemistry blood albumin  3.1  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
noninfective gastroenteritis and colitis, unspecified lower abdominal pain, unspecified
black african american m 44 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  65  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l; chemistry blood albumin  3.5  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  40  meq ; ibuprofen  400-600  mg ; artificial tears  1-2  drop ; 
noninfective gastroenteritis and colitis, unspecified lower abdominal pain, unspecified
black african american m 44 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  193  iu l; chemistry blood albumin  3.4  g dl; chemistry blood % hemoglobin a1c  5.8  %$ceftriaxone  1  gm ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  40  meq ; ibuprofen  400-600  mg ; artificial tears  1-2  drop ; vial  1  vial ; 
noninfective gastroenteritis and colitis, unspecified lower abdominal pain, unspecified
white m 90 $nan$nan$clopidogrel  75  mg ; aspirin  325  mg ; diltiazem extended-release  180  mg ; levothyroxine  50  mcg ; pravastatin  40  mg ; fluticasone propionate nasal  1  spry ; 
other disease of nasal cavity and sinuses anemia, unspecified painful respiration personal history of malignant neoplasm of prostate unspecified essential hypertension unspecified acquired hypothyroidism esophageal reflux coronary atherosclerosis of native coronary artery pneumonia, organism unspecified obstructive chronic bronchitis with acute bronchitis percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism chronic airway obstruction, not elsewhere classified unspecified intestinal obstruction personal history of malignant neoplasm of other sites atherosclerosis of native arteries of the extremities, unspecified unspecified accident coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of other sites peripheral vascular disease, unspecified unspecified essential hypertension other thalassemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) contusion of lower leg osteoarthrosis, generalized, site unspecified coronary atherosclerosis of native coronary artery peripheral vascular disease, unspecified personal history of malignant neoplasm of prostate personal history of tobacco use malignant neoplasm of connective and other soft tissue of head, face, and neck other and unspecified angina pectoris pure hypercholesterolemia cataract extraction status atherosclerosis of aorta other diseases of lung, not elsewhere classified percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status malignant neoplasm of connective and other soft tissue of head, face, and neck pure hypercholesterolemia peripheral vascular disease, unspecified
white m 90 $nan$hematology blood hematocrit  27.8  %; hematology blood hematocrit  28.4  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  108  mg dl$clopidogrel  75  mg ; aspirin  325  mg ; diltiazem extended-release  180  mg ; levothyroxine  50  mcg ; pravastatin  40  mg ; fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; nitroglycerin sl  0.4  mg ; pantoprazole  40  mg ; albuterol inhaler  2  puff ; hydralazine  10  mg ; d5w  250  ml ; nitroglycerin  100  mg ; morphine sulfate  1-2  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; tamsulosin  0.8  mg ; 
other disease of nasal cavity and sinuses anemia, unspecified painful respiration personal history of malignant neoplasm of prostate unspecified essential hypertension unspecified acquired hypothyroidism esophageal reflux coronary atherosclerosis of native coronary artery pneumonia, organism unspecified obstructive chronic bronchitis with acute bronchitis percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism chronic airway obstruction, not elsewhere classified unspecified intestinal obstruction personal history of malignant neoplasm of other sites atherosclerosis of native arteries of the extremities, unspecified unspecified accident coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of other sites peripheral vascular disease, unspecified unspecified essential hypertension other thalassemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) contusion of lower leg osteoarthrosis, generalized, site unspecified coronary atherosclerosis of native coronary artery peripheral vascular disease, unspecified personal history of malignant neoplasm of prostate personal history of tobacco use malignant neoplasm of connective and other soft tissue of head, face, and neck other and unspecified angina pectoris pure hypercholesterolemia cataract extraction status atherosclerosis of aorta other diseases of lung, not elsewhere classified percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status malignant neoplasm of connective and other soft tissue of head, face, and neck pure hypercholesterolemia peripheral vascular disease, unspecified
white m 90 $nan$hematology blood hematocrit  29.6  %$clopidogrel  75  mg ; aspirin  325  mg ; diltiazem extended-release  180  mg ; levothyroxine  50  mcg ; pravastatin  40  mg ; fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; nitroglycerin sl  0.4  mg ; pantoprazole  40  mg ; albuterol inhaler  2  puff ; hydralazine  10  mg ; d5w  250  ml ; nitroglycerin  100  mg ; morphine sulfate  1-2  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; tamsulosin  0.8  mg ; lactated ringers  500  ml ; lisinopril  10  mg ; 
other disease of nasal cavity and sinuses anemia, unspecified painful respiration personal history of malignant neoplasm of prostate unspecified essential hypertension unspecified acquired hypothyroidism esophageal reflux coronary atherosclerosis of native coronary artery pneumonia, organism unspecified obstructive chronic bronchitis with acute bronchitis percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism chronic airway obstruction, not elsewhere classified unspecified intestinal obstruction personal history of malignant neoplasm of other sites atherosclerosis of native arteries of the extremities, unspecified unspecified accident coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of other sites peripheral vascular disease, unspecified unspecified essential hypertension other thalassemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) contusion of lower leg osteoarthrosis, generalized, site unspecified coronary atherosclerosis of native coronary artery peripheral vascular disease, unspecified personal history of malignant neoplasm of prostate personal history of tobacco use malignant neoplasm of connective and other soft tissue of head, face, and neck other and unspecified angina pectoris pure hypercholesterolemia cataract extraction status atherosclerosis of aorta other diseases of lung, not elsewhere classified percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status malignant neoplasm of connective and other soft tissue of head, face, and neck pure hypercholesterolemia peripheral vascular disease, unspecified
white f 61 $temp  102.4  heartrate  117.0  resprate  18.0  o2sat  95.0  sbp  113.0  dbp  59.0  rhythm    pain    ; temp  102.7  heartrate  120.0  resprate  18.0  o2sat  94.0  sbp  124.0  dbp  67.0  rhythm    pain  0  $nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; citalopram  10  mg ; hydrochlorothiazide  12.5  mg ; acetaminophen  325-650  mg ; doxycycline hyclate  100  mg ; potassium chloride  60  meq ; 
 
white f 61 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  22  k ul; chemistry blood chloride  106  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood bilirubin, total  0.4  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; citalopram  10  mg ; hydrochlorothiazide  12.5  mg ; acetaminophen  325-650  mg ; doxycycline hyclate  100  mg ; potassium chloride  60  meq ; levothyroxine sodium  100  mcg ; 
 
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxytocin  20  unit ; lr  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxytocin  20  unit ; lr  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; rubella virus vaccine  0.5  ml ; 
 
white m 74 $temp  97.8  heartrate  68.0  resprate  20.0  o2sat  99.0  sbp  130.0  dbp  82.0  rhythm    pain  0  $hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  120  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; enoxaparin (prophylaxis)  40  mg ; sodium chloride 0.9%  1000  ml ; 
 
white m 74 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  116  mg dl; chemistry blood lactate dehydrogenase (ld)  152  iu l; chemistry blood albumin  3.5  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; bisacodyl  10  mg ; enoxaparin (prophylaxis)  40  mg ; trazodone  50  mg ; 
 
white m 74 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; bisacodyl  10  mg ; enoxaparin (prophylaxis)  40  mg ; trazodone  50  mg ; 
 
white m 76 $temp  97.8  heartrate  81.0  resprate  21.0  o2sat  96.0  sbp  111.0  dbp  55.0  rhythm  normal sinus rhythm  pain  3  $hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  107  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; amiodarone  200  mg ; ondansetron  4  mg ; heparin  5000  unit ; aspirin  81  mg ; metoprolol tartrate  5  mg ; albuterol inhaler  2  puff ; 0.45% sodium chloride  1000  ml ; 
passenger of special construction vehicle injured in traffic accident unspecified protein-calorie malnutrition other and unspecified hyperlipidemia unspecified essential hypertension other colostomy and enterostomy complication body mass index between 19-24, adult vomiting alone constipation, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure personal history of malignant neoplasm of prostate malignant neoplasm of biliary tract, part unspecified site tobacco use disorder other and unspecified hyperlipidemia personal history of irradiation, presenting hazards to health personal history of malignant neoplasm of prostate malignant neoplasm of liver, secondary unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident disorder of bone and cartilage, unspecified person boarding or alighting a pick-up truck or van injured in collision with railway train or railway vehicle malignant neoplasm of extrahepatic bile ducts other digestive system complications coronary atherosclerosis of native coronary artery person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle macular degeneration (senile), unspecified peritoneal abscess attention to other artificial opening of digestive tract iron deficiency anemia, unspecified unspecified essential hypertension intestinal bypass or anastomosis status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other digestive system complications personal history of irradiation, presenting hazards to health status of other artificial opening of gastrointestinal tract personal history of malignant neoplasm of prostate unspecified protein-calorie malnutrition personal history of malignant neoplasm of other gastrointestinal tract body mass index between 19-24, adult anxiety state, unspecified person boarding or alighting a car injured in collision with heavy transport vehicle or bus passenger of special construction vehicle injured in traffic accident person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle peritoneal abscess surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other specified intestinal obstruction person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle accidents occurring in residential institution cardiac complications, not elsewhere classified acute kidney failure, unspecified
white m 76 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  75  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; amiodarone  200  mg ; ondansetron  4  mg ; heparin  5000  unit ; aspirin  81  mg ; metoprolol tartrate  5  mg ; albuterol inhaler  2  puff ; 0.45% sodium chloride  1000  ml ; 
passenger of special construction vehicle injured in traffic accident unspecified protein-calorie malnutrition other and unspecified hyperlipidemia unspecified essential hypertension other colostomy and enterostomy complication body mass index between 19-24, adult vomiting alone constipation, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure personal history of malignant neoplasm of prostate malignant neoplasm of biliary tract, part unspecified site tobacco use disorder other and unspecified hyperlipidemia personal history of irradiation, presenting hazards to health personal history of malignant neoplasm of prostate malignant neoplasm of liver, secondary unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident disorder of bone and cartilage, unspecified person boarding or alighting a pick-up truck or van injured in collision with railway train or railway vehicle malignant neoplasm of extrahepatic bile ducts other digestive system complications coronary atherosclerosis of native coronary artery person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle macular degeneration (senile), unspecified peritoneal abscess attention to other artificial opening of digestive tract iron deficiency anemia, unspecified unspecified essential hypertension intestinal bypass or anastomosis status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other digestive system complications personal history of irradiation, presenting hazards to health status of other artificial opening of gastrointestinal tract personal history of malignant neoplasm of prostate unspecified protein-calorie malnutrition personal history of malignant neoplasm of other gastrointestinal tract body mass index between 19-24, adult anxiety state, unspecified person boarding or alighting a car injured in collision with heavy transport vehicle or bus passenger of special construction vehicle injured in traffic accident person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle peritoneal abscess surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other specified intestinal obstruction person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle accidents occurring in residential institution cardiac complications, not elsewhere classified acute kidney failure, unspecified
white f 56 $nan$nan$acetaminophen  650  mg ; albuterol inhaler  2  puff ; bisacodyl  10  mg ; lorazepam  0.5  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; insulin  16  unit ; metoprolol tartrate  12.5  mg ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; metoprolol succinate xl  50  mg ; aspirin  325  mg ; lactulo  15  ml ; torsemide  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  4.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood glucose  169  mg dl$acetaminophen  650  mg ; albuterol inhaler  2  puff ; bisacodyl  10  mg ; lorazepam  0.5  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; insulin  16  unit ; metoprolol tartrate  12.5  mg ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; metoprolol succinate xl  50  mg ; aspirin  325  mg ; lactulo  15  ml ; torsemide  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; amlodipine  5  mg ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$nan$acetaminophen  650  mg ; albuterol inhaler  2  puff ; bisacodyl  10  mg ; lorazepam  0.5  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; insulin  16  unit ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; metoprolol succinate xl  50  mg ; aspirin  325  mg ; lactulo  15  ml ; torsemide  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; amlodipine  5  mg ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  69  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  118  # hpf; chemistry blood glucose  144  mg dl; blood gas blood lactate  1.1  mmol l; hematology urine glucose  70  mg dl$acetaminophen  650  mg ; albuterol inhaler  2  puff ; bisacodyl  10  mg ; lorazepam  0.5  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; insulin  16  unit ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; metoprolol succinate xl  50  mg ; aspirin  325  mg ; lactulo  15  ml ; torsemide  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; amlodipine  5  mg ; ciprofloxacin hcl  250  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  76  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  111  mg dl$albuterol inhaler  2  puff ; bisacodyl  10  mg ; lorazepam  0.5  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; insulin  16  unit ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; metoprolol succinate xl  50  mg ; aspirin  325  mg ; lactulo  15  ml ; torsemide  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; amlodipine  10  mg ; potassium chloride  20  meq ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  80  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  120  mg dl$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; insulin  16  unit ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; metoprolol succinate xl  50  mg ; aspirin  325  mg ; lactulo  15  ml ; torsemide  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; amlodipine  10  mg ; potassium chloride  20  meq ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$nan$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; insulin  16  unit ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; aspirin  325  mg ; lactulo  15  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  77  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  124  mg dl$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; insulin  16  unit ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; aspirin  325  mg ; lactulo  15  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; cephalexin  250  mg ; potassium chloride  40  meq ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$chemistry blood chloride  91  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; aspirin  325  mg ; lactulo  15  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; cephalexin  250  mg ; potassium chloride  40  meq ; benztropine mesylate  1  mg ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$nan$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; aspirin  325  mg ; lactulo  15  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; benztropine mesylate  1  mg ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  4.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  76  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  105  mg dl$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lamotrigine  50  mg ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; aspirin  325  mg ; lactulo  15  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; benztropine mesylate  1  mg ; mirtazapine  7.5  mg ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$nan$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; aspirin  325  mg ; lactulo  15  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; benztropine mesylate  1  mg ; mirtazapine  7.5  mg ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  4.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  81  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  128  mg dl$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; aspirin  325  mg ; lactulo  15  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; benztropine mesylate  1  mg ; mirtazapine  7.5  mg ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$nan$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium bicarbonate  1300  mg ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; aspirin  325  mg ; lactulo  15  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; benztropine mesylate  1  mg ; mirtazapine  7.5  mg ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  84  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  123  mg dl$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; aspirin  325  mg ; lactulo  15  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; benztropine mesylate  1  mg ; torsemide  60  mg ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
white f 56 $nan$nan$albuterol inhaler  2  puff ; bisacodyl  10  mg ; senna  17.2  mg ; cholestyramine  4  gm ; diphenoxylate-atropine  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; risperidone  3  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sevelamer carbonate  800  mg ; calcitriol  0.25  mcg ; levothyroxine sodium  100  mcg ; aspirin  325  mg ; lactulo  15  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; citalopram  10  mg ; heparin  5000  unit ; benztropine mesylate  1  mg ; torsemide  60  mg ; 
hyposmolality and/or hyponatremia conjunctivitis, unspecified renal dialysis status chronic kidney disease, stage v other and unspecified hyperlipidemia acute respiratory failure other convulsions bipolar i disorder, most recent episode (or current) depressed, unspecified congestive heart failure, unspecified acidosis atrial fibrillation hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified condition of brain diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polydipsia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism obstructive sleep apnea (adult)(pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic diastolic heart failure home accidents secondary hyperparathyroidism (of renal origin) diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism hyperosmolality and/or hypernatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status acute on chronic diastolic heart failure iron deficiency anemia, unspecified hyposmolality and/or hyponatremia other psychotropic agents causing adverse effects in therapeutic use atrial fibrillation bipolar disorder, unspecified acute kidney failure, unspecified congestive heart failure, unspecified home accidents chronic kidney disease, stage v hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage v or end stage renal disease atrial fibrillation grand mal status obesity, unspecified other and unspecified hyperlipidemia pneumonitis due to inhalation of food or vomitus hyposmolality and/or hyponatremia other specified hemiplegia and hemiparesis affecting unspecified side renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease
black african american f 73 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  142  mg dl$nan
 
white m 70 $nan$hematology blood hematocrit  30.9  %; hematology blood hematocrit  28.6  %; hematology blood hematocrit  28.3  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  110  k ul; hematology blood platelet count  124  k ul; hematology blood platelet count  89  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  118  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  167  mg dl; chemistry blood glucose  112  mg dl; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.22  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  0.94  mmol l; blood gas blood free calcium  0.95  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  4.9  mmol l; blood gas blood lactate  4.9  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  7.6  mmol l; blood gas blood lactate  6.4  mmol l; blood gas blood lactate  5.3  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood chloride, whole blood  115  meq l; blood gas blood chloride, whole blood  114  meq l; blood gas blood chloride, whole blood  118  meq l; blood gas blood chloride, whole blood  116  meq l; blood gas blood chloride, whole blood  113  meq l; blood gas blood glucose  111  mg dl; blood gas blood glucose  117  mg dl; blood gas blood glucose  358  mg dl; blood gas blood glucose  235  mg dl; blood gas blood glucose  175  mg dl; blood gas blood glucose  186  mg dl; blood gas blood glucose  146  mg dl; blood gas blood glucose  134  mg dl; blood gas blood glucose  167  mg dl; blood gas blood glucose  98  mg dl; blood gas blood hematocrit, calculated  41  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  41  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  13.5  g dl; blood gas blood hemoglobin  8.7  g dl; blood gas blood hemoglobin  10.9  g dl; blood gas blood hemoglobin  10.7  g dl; blood gas blood hemoglobin  13.6  g dl; blood gas blood hemoglobin  11.2  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  143  meq l; hematology urine glucose  neg  mg dl; blood gas blood carboxyhemoglobin  1.1  %; blood gas blood carboxyhemoglobin  1.0  %; blood gas blood methemoglobin  0  %; hematology urine bilirubin  neg  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; propofol  1000  mg ; fentanyl citrate  25-100  mcg ; ns  100  ml ; insulin human regular  100  unit ; d5w  250  ml ; nitroglycerin  100  mg ; metoprolol tartrate  5  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; metronidazole (flagyl)  500  mg ; lr  1000  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lr  500  ml ; calcium gluconate  2  gm ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 
pure hypercholesterolemia abdominal aneurysm without mention of rupture surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft anxiety state, unspecified abdominal pain, unspecified site personal history of colonic polyps other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure tobacco use disorder hypotension, unspecified gout, unspecified other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pure hypercholesterolemia persistent postoperative fistula peritoneal abscess unspecified essential hypertension abdominal aneurysm without mention of rupture other complications due to other vascular device, implant, and graft hemorrhage of gastrointestinal tract, unspecified anemia, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft
white m 70 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  91  k ul; hematology blood platelet count  83  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  103  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.21  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.27  mmol l; blood gas blood free calcium  0.97  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood glucose  85  mg dl; blood gas blood glucose  101  mg dl; blood gas blood glucose  93  mg dl; blood gas blood glucose  90  mg dl; blood gas blood glucose  98  mg dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.1  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.5  meq l$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; propofol  1000  mg ; fentanyl citrate  25-100  mcg ; ns  100  ml ; insulin human regular  100  unit ; d5w  250  ml ; nitroglycerin  100  mg ; metoprolol tartrate  5  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; metronidazole (flagyl)  500  mg ; lr  1000  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lr  500  ml ; calcium gluconate  2  gm ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; d5 1 2ns  1000  ml ; fluoxetine  20  mg ; simvastatin  40  mg ; aspirin  300  mg ; hydralazine  10  mg ; bupivacaine 0.5%  50  ml ; ns epidural bag  198.75  ml ; hydromorphone p.f.  2500  mcg ; diphenhydramine  12.5-25  mg ; metoclopramide  10  mg ; 
pure hypercholesterolemia abdominal aneurysm without mention of rupture surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft anxiety state, unspecified abdominal pain, unspecified site personal history of colonic polyps other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure tobacco use disorder hypotension, unspecified gout, unspecified other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pure hypercholesterolemia persistent postoperative fistula peritoneal abscess unspecified essential hypertension abdominal aneurysm without mention of rupture other complications due to other vascular device, implant, and graft hemorrhage of gastrointestinal tract, unspecified anemia, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft
white m 70 $nan$hematology blood hematocrit  27.5  %; hematology blood hematocrit  24.2  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  92  k ul; hematology blood platelet count  80  k ul; hematology blood platelet count  84  k ul; chemistry blood anion gap  3  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  115  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  654  mg dl; chemistry blood lactate dehydrogenase (ld)  218  iu l; chemistry blood albumin  2.1  g dl; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood glucose  96  mg dl; blood gas blood potassium, whole blood  4.3  meq l$sodium chloride 0.9%  flush  10  ml ; ns  100  ml ; insulin human regular  100  unit ; metoprolol tartrate  5  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; calcium gluconate  2  gm ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; d5 1 2ns  1000  ml ; fluoxetine  20  mg ; simvastatin  40  mg ; aspirin  300  mg ; hydralazine  10  mg ; bupivacaine 0.5%  50  ml ; ns epidural bag  198.75  ml ; hydromorphone p.f.  2500  mcg ; diphenhydramine  12.5-25  mg ; morphine sulfate  2-4  mg ; aspirin  81  mg ; midazolam  2  mg ; fentanyl citrate  100  mcg ; furosemide  20  mg ; heparin flush (10 units ml)  2  ml ; lorazepam  0.25  mg ; haloperidol  0.5  mg ; acetaminophen  325-650  mg ; 
pure hypercholesterolemia abdominal aneurysm without mention of rupture surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft anxiety state, unspecified abdominal pain, unspecified site personal history of colonic polyps other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure tobacco use disorder hypotension, unspecified gout, unspecified other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pure hypercholesterolemia persistent postoperative fistula peritoneal abscess unspecified essential hypertension abdominal aneurysm without mention of rupture other complications due to other vascular device, implant, and graft hemorrhage of gastrointestinal tract, unspecified anemia, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft
white m 70 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  10  ml ; ns  100  ml ; insulin human regular  100  unit ; metoprolol tartrate  5  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; calcium gluconate  2  gm ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; fluoxetine  20  mg ; simvastatin  40  mg ; hydralazine  10  mg ; morphine sulfate  2-4  mg ; aspirin  81  mg ; midazolam  2  mg ; fentanyl citrate  100  mcg ; furosemide  20  mg ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5  mg ; acetaminophen  325-650  mg ; diphenoxylate-atropine  1  tab ; tramadol (ultram)  50  mg ; pantoprazole  40  mg ; metoprolol tartrate  37.5  mg ; metoprolol tartrate  25  mg ; temazepam  30  mg ; 
pure hypercholesterolemia abdominal aneurysm without mention of rupture surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft anxiety state, unspecified abdominal pain, unspecified site personal history of colonic polyps other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure tobacco use disorder hypotension, unspecified gout, unspecified other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pure hypercholesterolemia persistent postoperative fistula peritoneal abscess unspecified essential hypertension abdominal aneurysm without mention of rupture other complications due to other vascular device, implant, and graft hemorrhage of gastrointestinal tract, unspecified anemia, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft
white m 70 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  125  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  102  mg dl$d5w  200  ml ; ciprofloxacin iv  400  mg ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; fluoxetine  20  mg ; simvastatin  40  mg ; hydralazine  10  mg ; aspirin  81  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; temazepam  30  mg ; miconazole powder 2%  1  appl ; 
pure hypercholesterolemia abdominal aneurysm without mention of rupture surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft anxiety state, unspecified abdominal pain, unspecified site personal history of colonic polyps other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure tobacco use disorder hypotension, unspecified gout, unspecified other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pure hypercholesterolemia persistent postoperative fistula peritoneal abscess unspecified essential hypertension abdominal aneurysm without mention of rupture other complications due to other vascular device, implant, and graft hemorrhage of gastrointestinal tract, unspecified anemia, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft
white m 70 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  91  mg dl$d5w  200  ml ; ciprofloxacin iv  400  mg ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; fluoxetine  20  mg ; simvastatin  40  mg ; hydralazine  10  mg ; aspirin  81  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; temazepam  30  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  500  mg ; furosemide  10  mg ; potassium chloride  40  meq ; ns  250  ml ; neutra-phos  2  pkt ; 
pure hypercholesterolemia abdominal aneurysm without mention of rupture surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft anxiety state, unspecified abdominal pain, unspecified site personal history of colonic polyps other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure tobacco use disorder hypotension, unspecified gout, unspecified other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pure hypercholesterolemia persistent postoperative fistula peritoneal abscess unspecified essential hypertension abdominal aneurysm without mention of rupture other complications due to other vascular device, implant, and graft hemorrhage of gastrointestinal tract, unspecified anemia, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft
white m 70 $nan$nan$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; fluoxetine  20  mg ; simvastatin  40  mg ; hydralazine  10  mg ; aspirin  81  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; temazepam  30  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  500  mg ; neutra-phos  2  pkt ; 
pure hypercholesterolemia abdominal aneurysm without mention of rupture surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft anxiety state, unspecified abdominal pain, unspecified site personal history of colonic polyps other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure tobacco use disorder hypotension, unspecified gout, unspecified other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pure hypercholesterolemia persistent postoperative fistula peritoneal abscess unspecified essential hypertension abdominal aneurysm without mention of rupture other complications due to other vascular device, implant, and graft hemorrhage of gastrointestinal tract, unspecified anemia, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft
white m 70 $nan$nan$fluoxetine  20  mg ; simvastatin  40  mg ; hydralazine  10  mg ; aspirin  81  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; temazepam  30  mg ; miconazole powder 2%  1  appl ; neutra-phos  2  pkt ; amoxicillin-clavulanic acid  500  mg ; 
pure hypercholesterolemia abdominal aneurysm without mention of rupture surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft anxiety state, unspecified abdominal pain, unspecified site personal history of colonic polyps other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure tobacco use disorder hypotension, unspecified gout, unspecified other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pure hypercholesterolemia persistent postoperative fistula peritoneal abscess unspecified essential hypertension abdominal aneurysm without mention of rupture other complications due to other vascular device, implant, and graft hemorrhage of gastrointestinal tract, unspecified anemia, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft
white m 70 $nan$nan$fluoxetine  20  mg ; simvastatin  40  mg ; hydralazine  10  mg ; aspirin  81  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; temazepam  30  mg ; miconazole powder 2%  1  appl ; neutra-phos  2  pkt ; amoxicillin-clavulanic acid  500  mg ; amoxicillin-clavulanic acid  875  mg ; 
pure hypercholesterolemia abdominal aneurysm without mention of rupture surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft anxiety state, unspecified abdominal pain, unspecified site personal history of colonic polyps other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure tobacco use disorder hypotension, unspecified gout, unspecified other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pure hypercholesterolemia persistent postoperative fistula peritoneal abscess unspecified essential hypertension abdominal aneurysm without mention of rupture other complications due to other vascular device, implant, and graft hemorrhage of gastrointestinal tract, unspecified anemia, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft
white m 70 $nan$nan$fluoxetine  20  mg ; simvastatin  40  mg ; aspirin  81  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; temazepam  30  mg ; miconazole powder 2%  1  appl ; neutra-phos  2  pkt ; amoxicillin-clavulanic acid  875  mg ; 
pure hypercholesterolemia abdominal aneurysm without mention of rupture surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft anxiety state, unspecified abdominal pain, unspecified site personal history of colonic polyps other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure tobacco use disorder hypotension, unspecified gout, unspecified other postoperative infection other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pure hypercholesterolemia persistent postoperative fistula peritoneal abscess unspecified essential hypertension abdominal aneurysm without mention of rupture other complications due to other vascular device, implant, and graft hemorrhage of gastrointestinal tract, unspecified anemia, unspecified infection and inflammatory reaction due to other vascular device, implant, and graft
black african american m 68 $nan$nan$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; 
 
black african american m 68 $nan$hematology blood hematocrit  33.1  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  353  k ul; hematology blood platelet count  394  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  7.7  mg dl; chemistry blood creatinine  7.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.9  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  185  mg dl; chemistry blood glucose  137  mg dl; hematology urine glucose  100  mg dl; hematology urine bilirubin  neg  mg dl$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; insulin  16  unit ; insulin  12  unit ; ns  250  ml ; potassium phosphate  15  mmol ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  250  mg ; sodium phosphate  15  mmol ; d5w  1000  ml ; sodium bicarbonate  150  meq ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; acetylcysteine 20%  1200  mg ; metoprolol  25  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; sevelamer  800  mg ; lisinopril  40  mg ; 
 
black african american m 68 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  433  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  7.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  116  mg dl$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  250  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; metoprolol  25  mg ; senna  1  tab ; sevelamer  800  mg ; lisinopril  40  mg ; 
 
black african american m 68 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  497  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  7.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  137  mg dl$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; ciprofloxacin hcl  250  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; senna  1  tab ; sevelamer  800  mg ; lisinopril  40  mg ; ondansetron  4  mg ; metoprolol  50  mg ; heparin   500  unit ; 1 2 ns  1000  ml ; 
 
black african american m 68 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  546  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  8.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  156  mg dl; blood gas blood free calcium  0.96  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood chloride, whole blood  93  meq l; blood gas blood glucose  154  mg dl; blood gas blood hematocrit, calculated  28  %; blood gas blood hemoglobin  9.2  g dl; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood calculated bicarbonate, whole blood  29  meq l$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; ciprofloxacin hcl  250  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; senna  1  tab ; sevelamer  800  mg ; lisinopril  40  mg ; ondansetron  4  mg ; heparin   500  unit ; 1 2 ns  1000  ml ; 
 
black african american m 68 $nan$hematology blood hematocrit  27.3  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  406  k ul; hematology blood platelet count  531  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  7.9  mg dl; chemistry blood creatinine  7.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  191  mg dl; chemistry blood glucose  273  mg dl; chemistry blood albumin  2.6  g dl; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  92  meq l; blood gas blood chloride, whole blood  94  meq l; blood gas blood glucose  157  mg dl; blood gas blood glucose  160  mg dl; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  10.5  g dl; blood gas blood hemoglobin  8.6  g dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood calculated bicarbonate, whole blood  29  meq l$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; ciprofloxacin hcl  250  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; senna  1  tab ; sevelamer  800  mg ; lisinopril  40  mg ; 1 2 ns  1000  ml ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sw  50  ml ; potassium chloride  20  meq ; magnesium sulfate  2  gm ; metoprolol  5  mg ; d5w  250  ml ; nitroglycerin  100  mg ; hydralazine  5  mg ; hydralazine  20  mg ; metoprolol  10  mg ; nicardipine iv  125  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  0.12  mg ; 
 
black african american m 68 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  419  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  8.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  160  mg dl$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; ciprofloxacin hcl  250  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; senna  1  tab ; sevelamer  800  mg ; lisinopril  40  mg ; heparin  5000  unit ; d5w  250  ml ; nitroglycerin  100  mg ; hydralazine  20  mg ; metoprolol  10  mg ; hydromorphone (dilaudid)  0.12  mg ; prochlorperazine  10  mg ; sevelamer  1600  mg ; 
 
black african american m 68 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  457  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  8.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  173  mg dl$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; ciprofloxacin hcl  250  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; senna  1  tab ; lisinopril  40  mg ; heparin  5000  unit ; d5w  250  ml ; nitroglycerin  100  mg ; hydralazine  20  mg ; metoprolol  10  mg ; prochlorperazine  10  mg ; sevelamer  1600  mg ; sodium chloride nasal  1-2  spry ; 
 
black african american m 68 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  443  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  7.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  170  mg dl$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; ciprofloxacin hcl  250  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; senna  1  tab ; lisinopril  40  mg ; heparin  5000  unit ; sevelamer  1600  mg ; sodium chloride nasal  1-2  spry ; pneumococcal vac polyvalent  0.5  ml ; 
 
black african american m 68 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  576  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  7.2  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  137  mg dl$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; ciprofloxacin hcl  250  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; senna  1  tab ; lisinopril  40  mg ; heparin  5000  unit ; sevelamer  1600  mg ; sodium chloride nasal  1-2  spry ; pneumococcal vac polyvalent  0.5  ml ; 
 
black african american m 68 $nan$nan$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; ciprofloxacin hcl  250  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; senna  1  tab ; lisinopril  40  mg ; heparin  5000  unit ; sevelamer  1600  mg ; sodium chloride nasal  1-2  spry ; pneumococcal vac polyvalent  0.5  ml ; 
 
black african american m 68 $nan$nan$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; ciprofloxacin hcl  250  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; metronidazole (flagyl)  500  mg ; senna  1  tab ; lisinopril  40  mg ; heparin  5000  unit ; sevelamer  1600  mg ; sodium chloride nasal  1-2  spry ; pneumococcal vac polyvalent  0.5  ml ; zolpidem tartrate  5-10  mg ; sulfameth trimethoprim ds  1  tab ; 
 
black african american m 68 $nan$nan$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; senna  1  tab ; lisinopril  40  mg ; heparin  5000  unit ; sevelamer  1600  mg ; sodium chloride nasal  1-2  spry ; pneumococcal vac polyvalent  0.5  ml ; zolpidem tartrate  5-10  mg ; sulfameth trimethoprim ds  1  tab ; ns  100  ml ; ferric gluconate  125  mg ; 
 
black african american m 68 $nan$nan$doxercalciferol  2.5  mcg ; ferrous sulfate  325  mg ; thiamine  100  mg ; atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel bisulfate  75  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; insulin  12  unit ; pantoprazole  40  mg ; bisacodyl  10  mg ; nitroglycerin sl  0.4  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; senna  1  tab ; lisinopril  40  mg ; heparin  5000  unit ; sevelamer  1600  mg ; sodium chloride nasal  1-2  spry ; pneumococcal vac polyvalent  0.5  ml ; zolpidem tartrate  5-10  mg ; sulfameth trimethoprim ds  1  tab ; 
 
hispanic latino f 36 $temp  100.0  heartrate  102.0  resprate  18.0  o2sat  100.0  sbp  114.0  dbp  62.0  rhythm    pain    ; temp  99.8  heartrate  100.0  resprate  18.0  o2sat  99.0  sbp  112.0  dbp  64.0  rhythm    pain    $hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  321  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  204  iu l; chemistry blood albumin  3.0  g dl$nafcillin  2  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; methadone (oral solution)  2 mg 1 ml  20  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; morphine sulfate  4  mg ; ibuprofen  600  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  96  mg dl$nafcillin  2  g ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; methadone (oral solution)  2 mg 1 ml  20  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; morphine sulfate  4  mg ; ibuprofen  600  mg ; methadone  20  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)  5-10  mg ; potassium chloride  40  meq ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  427  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  109  mg dl$nafcillin  2  g ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5-10  mg ; potassium chloride  40  meq ; ibuprofen  800  mg ; acetaminophen  1000  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  510  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  103  mg dl$nafcillin  2  g ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; oxycodone (immediate release)  5-10  mg ; ibuprofen  800  mg ; acetaminophen  1000  mg ; haloperidol  1  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  567  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  119  mg dl$nafcillin  2  g ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  250  ml ; ceftaroline  600  mg ; doxycycline hyclate  100  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  632  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  210  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  250  ml ; ceftaroline  600  mg ; doxycycline hyclate  100  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  732  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride  250  ml ; ceftaroline  600  mg ; doxycycline hyclate  100  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; ns syringe (intrapleural)  40  ml ; alteplase  10  mg ; syringe (sterile water)  30  ml ; dornase alfa  5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride  250  ml ; ceftaroline  600  mg ; ns syringe (intrapleural)  40  ml ; alteplase  10  mg ; syringe (sterile water)  30  ml ; dornase alfa  5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  10  mg ; bisacodyl  10  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  795  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  10  mg ; bisacodyl  10  mg ; lactated ringers  1000  ml ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  722  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  10  mg ; bisacodyl  10  mg ; lactated ringers  1000  ml ; morphine sulfate  4-6  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; morphine sulfate  2  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  812  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  10  mg ; bisacodyl  10  mg ; morphine sulfate  4-6  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; morphine sulfate  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  717  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  10  mg ; bisacodyl  10  mg ; morphine sulfate  4-6  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  955  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; methadone  5  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  939  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; methadone  5  mg ; ranitidine  75  mg ; oxycodone (immediate release)  10-20  mg ; morphine sulfate ir  15-30  mg ; morphine sulfate (concentrated oral solution) 20 mg ml  20-30  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
hispanic latino f 36 $nan$nan$heparin  5000  unit ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; nicotine patch  14  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; ranitidine  75  mg ; morphine sulfate (concentrated oral solution) 20 mg ml  20-30  mg ; methadone  10  mg ; 
bacteremia family history of other mental and behavioral disorders post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified nicotine dependence, cigarettes, uncomplicated opioid use, unspecified, uncomplicated carbuncle of left upper limb cutaneous abscess of right upper limb cocaine use, unspecified, uncomplicated unspecified viral hepatitis c without hepatic coma parking lot as the place of occurrence of the external cause opioid abuse, uncomplicated poisoning by heroin, accidental (unintentional), initial encounter accidental poisoning by heroin other alteration of consciousness driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident suicidal ideation accidents occurring in unspecified place depressive disorder, not elsewhere classified poisoning by heroin opioid type dependence, unspecified physical restraints status lack of housing 
white m 88 $nan$nan$acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; metoprolol tartrate  12.5  mg ; zolpidem tartrate  5  mg ; aspirin  325  mg ; 
 
white m 88 $nan$nan$acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; metoprolol tartrate  12.5  mg ; zolpidem tartrate  5  mg ; aspirin  325  mg ; 
 
white f 91 $temp  98.1  heartrate  88.0  resprate  18.0  o2sat  97.0  sbp  153.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  85  mg dl; chemistry blood albumin  2.7  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; tramadol  50  mg ; aspirin  81  mg ; bacitracin-polymyxin ointment  1  appl ; calcium carbonate  500  mg ; erythromycin 0.5% ophth oint  0.5  in ; furosemide  20  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% patch  2  ptch ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; apixaban  5  mg ; quetiapine fumarate  12.5  mg ; potassium chloride (powder)  40  meq ; magnesium citrate  300  ml ; vial  1  vial ; ceftriaxone  1  gm ; metronidazole  500  mg ; losartan potassium  50  mg ; mineral oil  30  ml ; ciprofloxacin hcl  500  mg ; bisacodyl  10  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; artificial tears  1-2  drop ; 
non-pressure chronic ulcer of unspecified part of right lower leg with unspecified severity chronic diastolic (congestive) heart failure presence of right artificial knee joint hypothyroidism, unspecified non-st elevation (nstemi) myocardial infarction morbid (severe) obesity due to excess calories other pulmonary embolism without acute cor pulmonale body mass index (bmi) 30.0-30.9, adult overexertion from prolonged static or awkward postures, initial encounter urinary tract infection, site not specified cervicalgia personal history of nicotine dependence periprosthetic fracture around internal prosthetic right knee joint, initial encounter hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acute posthemorrhagic anemia delirium due to known physiological condition unspecified protein-calorie malnutrition acute embolism and thrombosis of superficial veins of left upper extremity dysphagia, unspecified other retention of urine other fracture of lower end of right femur, initial encounter for closed fracture paroxysmal atrial fibrillation age-related osteoporosis without current pathological fracture enterocolitis due to clostridium difficile, not specified as recurrent presence of right artificial knee joint personal history of nicotine dependence unspecified asthma, uncomplicated sialoadenitis, unspecified hypothyroidism, unspecified essential (primary) hypertension personal history of in-situ neoplasm of breast allergy status to penicillin spinal stenosis, lumbar region, without neurogenic claudication other malaise and fatigue syncope and collapse unspecified acquired hypothyroidism personal history of tobacco use palpitations long-term (current) use of non-steroidal anti-inflammatories (nsaid) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast unspecified essential hypertension carcinoma in situ of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure 
white f 91 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; bacitracin-polymyxin ointment  1  appl ; calcium carbonate  500  mg ; erythromycin 0.5% ophth oint  0.5  in ; furosemide  20  mg ; levothyroxine sodium  75  mcg ; lidocaine 5% patch  2  ptch ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; apixaban  5  mg ; losartan potassium  50  mg ; mineral oil  30  ml ; bisacodyl  10  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; artificial tears  1-2  drop ; bag  1  bag ; magnesium sulfate  2  gm ; 
non-pressure chronic ulcer of unspecified part of right lower leg with unspecified severity chronic diastolic (congestive) heart failure presence of right artificial knee joint hypothyroidism, unspecified non-st elevation (nstemi) myocardial infarction morbid (severe) obesity due to excess calories other pulmonary embolism without acute cor pulmonale body mass index (bmi) 30.0-30.9, adult overexertion from prolonged static or awkward postures, initial encounter urinary tract infection, site not specified cervicalgia personal history of nicotine dependence periprosthetic fracture around internal prosthetic right knee joint, initial encounter hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acute posthemorrhagic anemia delirium due to known physiological condition unspecified protein-calorie malnutrition acute embolism and thrombosis of superficial veins of left upper extremity dysphagia, unspecified other retention of urine other fracture of lower end of right femur, initial encounter for closed fracture paroxysmal atrial fibrillation age-related osteoporosis without current pathological fracture enterocolitis due to clostridium difficile, not specified as recurrent presence of right artificial knee joint personal history of nicotine dependence unspecified asthma, uncomplicated sialoadenitis, unspecified hypothyroidism, unspecified essential (primary) hypertension personal history of in-situ neoplasm of breast allergy status to penicillin spinal stenosis, lumbar region, without neurogenic claudication other malaise and fatigue syncope and collapse unspecified acquired hypothyroidism personal history of tobacco use palpitations long-term (current) use of non-steroidal anti-inflammatories (nsaid) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast unspecified essential hypertension carcinoma in situ of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure 
white f 91 $nan$hematology blood hematocrit  33.1  %; hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  216  k ul; hematology blood platelet count  200  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  154  mg dl; blood gas blood lactate  2.8  mmol l$sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; bacitracin-polymyxin ointment  1  appl ; calcium carbonate  500  mg ; erythromycin 0.5% ophth oint  0.5  in ; levothyroxine sodium  75  mcg ; lidocaine 5% patch  2  ptch ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; apixaban  5  mg ; losartan potassium  50  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; artificial tears  1-2  drop ; glycerin supps  1  supp ; polyethylene glycol  17  g ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; 
non-pressure chronic ulcer of unspecified part of right lower leg with unspecified severity chronic diastolic (congestive) heart failure presence of right artificial knee joint hypothyroidism, unspecified non-st elevation (nstemi) myocardial infarction morbid (severe) obesity due to excess calories other pulmonary embolism without acute cor pulmonale body mass index (bmi) 30.0-30.9, adult overexertion from prolonged static or awkward postures, initial encounter urinary tract infection, site not specified cervicalgia personal history of nicotine dependence periprosthetic fracture around internal prosthetic right knee joint, initial encounter hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acute posthemorrhagic anemia delirium due to known physiological condition unspecified protein-calorie malnutrition acute embolism and thrombosis of superficial veins of left upper extremity dysphagia, unspecified other retention of urine other fracture of lower end of right femur, initial encounter for closed fracture paroxysmal atrial fibrillation age-related osteoporosis without current pathological fracture enterocolitis due to clostridium difficile, not specified as recurrent presence of right artificial knee joint personal history of nicotine dependence unspecified asthma, uncomplicated sialoadenitis, unspecified hypothyroidism, unspecified essential (primary) hypertension personal history of in-situ neoplasm of breast allergy status to penicillin spinal stenosis, lumbar region, without neurogenic claudication other malaise and fatigue syncope and collapse unspecified acquired hypothyroidism personal history of tobacco use palpitations long-term (current) use of non-steroidal anti-inflammatories (nsaid) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast unspecified essential hypertension carcinoma in situ of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure 
white f 91 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  87  mg dl; blood gas blood lactate  1.4  mmol l$sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; bacitracin-polymyxin ointment  1  appl ; calcium carbonate  500  mg ; erythromycin 0.5% ophth oint  0.5  in ; levothyroxine sodium  75  mcg ; lidocaine 5% patch  2  ptch ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; apixaban  5  mg ; losartan potassium  50  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; artificial tears  1-2  drop ; glycerin supps  1  supp ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; 
non-pressure chronic ulcer of unspecified part of right lower leg with unspecified severity chronic diastolic (congestive) heart failure presence of right artificial knee joint hypothyroidism, unspecified non-st elevation (nstemi) myocardial infarction morbid (severe) obesity due to excess calories other pulmonary embolism without acute cor pulmonale body mass index (bmi) 30.0-30.9, adult overexertion from prolonged static or awkward postures, initial encounter urinary tract infection, site not specified cervicalgia personal history of nicotine dependence periprosthetic fracture around internal prosthetic right knee joint, initial encounter hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acute posthemorrhagic anemia delirium due to known physiological condition unspecified protein-calorie malnutrition acute embolism and thrombosis of superficial veins of left upper extremity dysphagia, unspecified other retention of urine other fracture of lower end of right femur, initial encounter for closed fracture paroxysmal atrial fibrillation age-related osteoporosis without current pathological fracture enterocolitis due to clostridium difficile, not specified as recurrent presence of right artificial knee joint personal history of nicotine dependence unspecified asthma, uncomplicated sialoadenitis, unspecified hypothyroidism, unspecified essential (primary) hypertension personal history of in-situ neoplasm of breast allergy status to penicillin spinal stenosis, lumbar region, without neurogenic claudication other malaise and fatigue syncope and collapse unspecified acquired hypothyroidism personal history of tobacco use palpitations long-term (current) use of non-steroidal anti-inflammatories (nsaid) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast unspecified essential hypertension carcinoma in situ of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure 
white f 91 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; bacitracin-polymyxin ointment  1  appl ; calcium carbonate  500  mg ; erythromycin 0.5% ophth oint  0.5  in ; levothyroxine sodium  75  mcg ; lidocaine 5% patch  2  ptch ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; apixaban  5  mg ; losartan potassium  50  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; artificial tears  1-2  drop ; glycerin supps  1  supp ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; tramadol  25  mg ; potassium chloride  60  meq ; 
non-pressure chronic ulcer of unspecified part of right lower leg with unspecified severity chronic diastolic (congestive) heart failure presence of right artificial knee joint hypothyroidism, unspecified non-st elevation (nstemi) myocardial infarction morbid (severe) obesity due to excess calories other pulmonary embolism without acute cor pulmonale body mass index (bmi) 30.0-30.9, adult overexertion from prolonged static or awkward postures, initial encounter urinary tract infection, site not specified cervicalgia personal history of nicotine dependence periprosthetic fracture around internal prosthetic right knee joint, initial encounter hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acute posthemorrhagic anemia delirium due to known physiological condition unspecified protein-calorie malnutrition acute embolism and thrombosis of superficial veins of left upper extremity dysphagia, unspecified other retention of urine other fracture of lower end of right femur, initial encounter for closed fracture paroxysmal atrial fibrillation age-related osteoporosis without current pathological fracture enterocolitis due to clostridium difficile, not specified as recurrent presence of right artificial knee joint personal history of nicotine dependence unspecified asthma, uncomplicated sialoadenitis, unspecified hypothyroidism, unspecified essential (primary) hypertension personal history of in-situ neoplasm of breast allergy status to penicillin spinal stenosis, lumbar region, without neurogenic claudication other malaise and fatigue syncope and collapse unspecified acquired hypothyroidism personal history of tobacco use palpitations long-term (current) use of non-steroidal anti-inflammatories (nsaid) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast unspecified essential hypertension carcinoma in situ of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure 
white f 91 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; bacitracin-polymyxin ointment  1  appl ; calcium carbonate  500  mg ; erythromycin 0.5% ophth oint  0.5  in ; levothyroxine sodium  75  mcg ; lidocaine 5% patch  2  ptch ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; apixaban  5  mg ; losartan potassium  50  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; artificial tears  1-2  drop ; glycerin supps  1  supp ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; tramadol  25  mg ; potassium chloride  60  meq ; lactulose  15  ml ; 
non-pressure chronic ulcer of unspecified part of right lower leg with unspecified severity chronic diastolic (congestive) heart failure presence of right artificial knee joint hypothyroidism, unspecified non-st elevation (nstemi) myocardial infarction morbid (severe) obesity due to excess calories other pulmonary embolism without acute cor pulmonale body mass index (bmi) 30.0-30.9, adult overexertion from prolonged static or awkward postures, initial encounter urinary tract infection, site not specified cervicalgia personal history of nicotine dependence periprosthetic fracture around internal prosthetic right knee joint, initial encounter hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acute posthemorrhagic anemia delirium due to known physiological condition unspecified protein-calorie malnutrition acute embolism and thrombosis of superficial veins of left upper extremity dysphagia, unspecified other retention of urine other fracture of lower end of right femur, initial encounter for closed fracture paroxysmal atrial fibrillation age-related osteoporosis without current pathological fracture enterocolitis due to clostridium difficile, not specified as recurrent presence of right artificial knee joint personal history of nicotine dependence unspecified asthma, uncomplicated sialoadenitis, unspecified hypothyroidism, unspecified essential (primary) hypertension personal history of in-situ neoplasm of breast allergy status to penicillin spinal stenosis, lumbar region, without neurogenic claudication other malaise and fatigue syncope and collapse unspecified acquired hypothyroidism personal history of tobacco use palpitations long-term (current) use of non-steroidal anti-inflammatories (nsaid) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast unspecified essential hypertension carcinoma in situ of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure 
white f 91 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; bacitracin-polymyxin ointment  1  appl ; calcium carbonate  500  mg ; erythromycin 0.5% ophth oint  0.5  in ; levothyroxine sodium  75  mcg ; lidocaine 5% patch  2  ptch ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; apixaban  5  mg ; losartan potassium  50  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; artificial tears  1-2  drop ; glycerin supps  1  supp ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; potassium chloride  60  meq ; 
non-pressure chronic ulcer of unspecified part of right lower leg with unspecified severity chronic diastolic (congestive) heart failure presence of right artificial knee joint hypothyroidism, unspecified non-st elevation (nstemi) myocardial infarction morbid (severe) obesity due to excess calories other pulmonary embolism without acute cor pulmonale body mass index (bmi) 30.0-30.9, adult overexertion from prolonged static or awkward postures, initial encounter urinary tract infection, site not specified cervicalgia personal history of nicotine dependence periprosthetic fracture around internal prosthetic right knee joint, initial encounter hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acute posthemorrhagic anemia delirium due to known physiological condition unspecified protein-calorie malnutrition acute embolism and thrombosis of superficial veins of left upper extremity dysphagia, unspecified other retention of urine other fracture of lower end of right femur, initial encounter for closed fracture paroxysmal atrial fibrillation age-related osteoporosis without current pathological fracture enterocolitis due to clostridium difficile, not specified as recurrent presence of right artificial knee joint personal history of nicotine dependence unspecified asthma, uncomplicated sialoadenitis, unspecified hypothyroidism, unspecified essential (primary) hypertension personal history of in-situ neoplasm of breast allergy status to penicillin spinal stenosis, lumbar region, without neurogenic claudication other malaise and fatigue syncope and collapse unspecified acquired hypothyroidism personal history of tobacco use palpitations long-term (current) use of non-steroidal anti-inflammatories (nsaid) person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast unspecified essential hypertension carcinoma in situ of breast other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure 
asian f 47 $nan$hematology blood hematocrit  32.9  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  339  k ul; hematology blood platelet count  272  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  118  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  1.9  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  152  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  173  mg dl; chemistry blood glucose  128  mg dl; chemistry blood albumin  4.1  g dl; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood sodium, whole blood  143  meq l$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; senna  8.6  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  25-50  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lactated ringers  1000  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; 
 
asian f 47 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  448  iu l$sodium chloride 0.9%  flush  3  ml ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ondansetron  4  mg ; senna  8.6  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  25-50  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lactated ringers  1000  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; heparin  5000  unit ; phosphorus  500  mg ; levetiracetam  500  mg ; hydralazine  10  mg ; labetalol  5-10  mg ; acetaminophen iv  1000  mg ; labetalol  10-20  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  142  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; fentanyl citrate  25-50  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; docusate sodium  100  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; heparin  5000  unit ; phosphorus  500  mg ; levetiracetam  500  mg ; acetaminophen iv  1000  mg ; labetalol  10-20  mg ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; labetalol  100  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  263  k ul$acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; fentanyl citrate  25-50  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; heparin  5000  unit ; levetiracetam  500  mg ; labetalol  150  mg ; oxycodone liquid  2.5-5  mg ; labetalol  200  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  23  # hpf; chemistry blood glucose  147  mg dl$acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; heparin  5000  unit ; oxycodone liquid  2.5-5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
 
asian f 47 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  125  mg dl$acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; heparin  5000  unit ; oxycodone liquid  2.5-5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; ferrous sulfate  325  mg ; 0.9% sodium chloride  50  ml ; iron dextran (test dose)  25  mg ; iron dextran complex  500  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  354  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  133  mg dl$acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; heparin  5000  unit ; oxycodone liquid  2.5-5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; ferrous sulfate  325  mg ; 0.9% sodium chloride  50  ml ; iron dextran (test dose)  25  mg ; iron dextran complex  500  mg ; ampicillin sodium  500  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  416  k ul$acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; heparin  5000  unit ; oxycodone liquid  2.5-5  mg ; ferrous sulfate  325  mg ; ampicillin sodium  500  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  415  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  91  mg dl$acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; heparin  5000  unit ; oxycodone liquid  2.5-5  mg ; ferrous sulfate  325  mg ; ampicillin sodium  500  mg ; aspirin  81  mg ; d5ns  1000  ml ; 
 
asian f 47 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  406  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  124  mg dl$acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; heparin  5000  unit ; oxycodone liquid  2.5-5  mg ; ferrous sulfate  325  mg ; ampicillin sodium  500  mg ; aspirin  81  mg ; d5ns  1000  ml ; captopril  6.25  mg ; 
 
asian f 47 $nan$chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  116  mg dl$acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; oxycodone liquid  2.5-5  mg ; ferrous sulfate  325  mg ; aspirin  81  mg ; captopril  6.25  mg ; captopril  12.5  mg ; lidocaine 5% patch  1  ptch ; 
 
asian f 47 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  491  k ul$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; oxycodone liquid  2.5-5  mg ; ferrous sulfate  325  mg ; aspirin  81  mg ; captopril  12.5  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  536  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  88  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; 
 
asian f 47 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  506  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  98  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; 
 
asian f 47 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  425  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  107  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; 
 
asian f 47 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  392  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  96  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; 
 
asian f 47 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  364  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  102  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; baclofen  5  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  94  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; baclofen  5  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  93  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; baclofen  5  mg ; baclofen  10  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; baclofen  10  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  92  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; baclofen  10  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; baclofen  10  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  87  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; d5lr  1000  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; ranitidine (liquid)  150  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; maalox diphenhydramine lidocaine  15  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  87  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  128  mg dl; chemistry blood albumin  4.7  g dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lidocaine 5% patch  1  ptch ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  83  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  80  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  79  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  80  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; 
 
asian f 47 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  78  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  143  mg dl; chemistry blood lactate dehydrogenase (ld)  209  iu l; chemistry blood albumin  4.4  g dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  78  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  82  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  123  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  84  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; lisinopril  5  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  86  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; acyclovir  400  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; acyclovir  400  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; gabapentin  200  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; baclofen  2.5  mg ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
asian f 47 $nan$nan$bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; guaifenesin  5-10  ml ; cepacol (sore throat lozenge)  1  loz ; clopidogrel  75  mg ; multivitamins  1  tab ; gabapentin  300  mg ; 
 
white f 51 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  412  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  108  mg dl; blood gas blood lactate  1.2  mmol l$nan
postmastectomy lymphedema syndrome cellulitis and abscess of upper arm and forearm staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus bacteremia malignant neoplasm of breast (female), unspecified malignant neoplasm of liver, secondary depressive disorder, not elsewhere classified secondary malignant neoplasm of lung
white f 51 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  366  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  100  mg dl$lorazepam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; acetaminophen  500-1000  mg ; senna  1  tab ; enoxaparin sodium  120  mg ; heparin flush port (10 units ml)  5  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sertraline  50  mg ; multivitamins  1  cap ; lisinopril  5  mg ; heparin flush (100 units ml)  5  ml ; 
postmastectomy lymphedema syndrome cellulitis and abscess of upper arm and forearm staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus bacteremia malignant neoplasm of breast (female), unspecified malignant neoplasm of liver, secondary depressive disorder, not elsewhere classified secondary malignant neoplasm of lung
white f 51 $nan$nan$lorazepam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; acetaminophen  500-1000  mg ; senna  1  tab ; enoxaparin sodium  120  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sertraline  50  mg ; multivitamins  1  cap ; lisinopril  5  mg ; heparin flush (100 units ml)  5  ml ; 
postmastectomy lymphedema syndrome cellulitis and abscess of upper arm and forearm staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus bacteremia malignant neoplasm of breast (female), unspecified malignant neoplasm of liver, secondary depressive disorder, not elsewhere classified secondary malignant neoplasm of lung
white m 58 $temp  97.8  heartrate  109.0  resprate  22.0  o2sat  99.0  sbp  163.0  dbp  86.0  rhythm    pain  10  ; temp  98.7  heartrate  94.0  resprate  16.0  o2sat  98.0  sbp  121.0  dbp  68.0  rhythm    pain    ; temp    heartrate  90.0  resprate  18.0  o2sat  100.0  sbp  142.0  dbp  81.0  rhythm    pain  6  ; temp  98.8  heartrate  93.0  resprate  20.0  o2sat  98.0  sbp  120.0  dbp  74.0  rhythm    pain  8  ; temp    heartrate  87.0  resprate  20.0  o2sat  100.0  sbp  120.0  dbp  65.0  rhythm    pain  8  ; temp    heartrate  93.0  resprate  18.0  o2sat  100.0  sbp  121.0  dbp  56.0  rhythm    pain  sleep  $hematology blood hematocrit  40.6  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  4.3  g dl$nan
unspecified mood [affective] disorder other chronic pain anxiety disorder, unspecified pain in right shoulder major depressive disorder, single episode, unspecified epilepsy, unspecified, not intractable, without status epilepticus foot drop, right foot radiculopathy, site unspecified cervicalgia dorsalgia, unspecified
white m 58 $temp  98.7  heartrate  81.0  resprate  20.0  o2sat  95.0  sbp  124.0  dbp  58.0  rhythm    pain  sleep  $hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  90  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; heparin  2100-4200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; neutra-phos  2  pkt ; carbamazepine  400  mg ; docusate sodium  100  mg ; vitamin d  1000  unit ; calcium carbonate  500  mg ; enoxaparin sodium  100  mg ; carbamazepine  300  mg ; 
unspecified mood [affective] disorder other chronic pain anxiety disorder, unspecified pain in right shoulder major depressive disorder, single episode, unspecified epilepsy, unspecified, not intractable, without status epilepticus foot drop, right foot radiculopathy, site unspecified cervicalgia dorsalgia, unspecified
white f 79 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; morphine sulfate  1-2  mg ; acetaminophen w codeine  1  tab ; morphine sulfate  1-5  mg ; meperidine  12.5  mg ; promethazine hcl  6.25-12.5  mg ; prochlorperazine  2.5-5  mg ; haloperidol  0.25-0.5  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; docusate sodium  100  mg ; erythromycin 0.5% ophth oint  0.5  in ; 
 
asian f 60 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  125  mg dl$senna  1  tab ; prochlorperazine  10  mg ; oxycodone-acetaminophen  1-2  tab ; polyvinyl   1-2  drop ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; morphine sulfate  2-4  mg ; 5% dextrose  100  ml ; acyclovir  400  mg ; heparin  5000  unit ; erythromycin 0.5% ophth oint  0.5  in ; prednisolone acetate 1% ophth. susp.  1  drop ; gabapentin  300  mg ; morphine sulfate ir  7.5-15  mg ; docusate sodium  100  mg ; nortriptyline  25  mg ; scopolamine 0.25% ophth soln  1  drop ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta herpes zoster dermatitis of eyelid herpes zoster with unspecified nervous system complication herpes zoster keratoconjunctivitis
asian f 60 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood glucose  98  mg dl$senna  1  tab ; prochlorperazine  10  mg ; oxycodone-acetaminophen  1-2  tab ; 0.9% sodium chloride  1000  ml ; 5% dextrose  100  ml ; acyclovir  400  mg ; heparin  5000  unit ; gabapentin  300  mg ; morphine sulfate ir  7.5-15  mg ; docusate sodium  100  mg ; nortriptyline  25  mg ; potassium chloride  60  meq ; artificial tears  1-2  drop ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta herpes zoster dermatitis of eyelid herpes zoster with unspecified nervous system complication herpes zoster keratoconjunctivitis
asian f 60 $nan$nan$senna  1  tab ; prochlorperazine  10  mg ; 5% dextrose  100  ml ; acyclovir  400  mg ; heparin  5000  unit ; docusate sodium  100  mg ; nortriptyline  25  mg ; potassium chloride  60  meq ; artificial tears  1-2  drop ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta herpes zoster dermatitis of eyelid herpes zoster with unspecified nervous system complication herpes zoster keratoconjunctivitis
white m 64 $nan$nan$heparin  5000  unit ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  37.1  %; hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  479  k ul; hematology blood platelet count  419  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.7  ; chemistry urine chloride, urine  60  meq l; chemistry urine creatinine, urine  195  mg dl; chemistry urine potassium, urine  62  meq l; chemistry urine sodium, urine  24  meq l; chemistry urine urea nitrogen, urine  418  mg dl; hematology urine wbc  18  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  187  mg dl; chemistry blood glucose  216  mg dl; chemistry blood glucose  220  mg dl; chemistry blood lactate dehydrogenase (ld)  229  iu l; chemistry blood albumin  2.2  g dl; hematology blood bands  3  %; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  1.1  mmol l; hematology urine glucose  100  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; aztreonam  2000  mg ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; aspirin  300  mg ; sterile water  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; phytonadione  5  mg ; colistin  75  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  199  mg dl; chemistry blood glucose  228  mg dl; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  1.5  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; soln  50  ml ; lr  1000  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; aztreonam  2000  mg ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; aspirin  300  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; phytonadione  5  mg ; colistin  75  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  340  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  204  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood glucose  188  mg dl; blood gas blood potassium, whole blood  4.1  meq l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; soln  50  ml ; lr  1000  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; phytonadione  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  180  mg dl; blood gas blood potassium, whole blood  3.6  meq l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  100  ml ; vasopressin  40  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; phytonadione  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; potassium chloride  40  meq ; potassium chloride  80  meq ; docusate sodium (liquid)  100  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  182  mg dl; chemistry blood glucose  186  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.5  mmol l; hematology urine glucose  150  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; potassium chloride  40  meq ; potassium chloride  80  meq ; docusate sodium (liquid)  100  mg ; colistin  150  mg ; albumin 5% (12.5g   250ml)  12.5  g ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  355  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.6  ; hematology urine wbc  5  # hpf; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  190  mg dl; chemistry blood glucose  147  mg dl; chemistry blood lactate dehydrogenase (ld)  127  iu l; chemistry blood albumin  2.5  g dl; hematology blood bands  3  %; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.4  mmol l; hematology urine glucose  300  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; colistin  150  mg ; albumin 5% (12.5g   250ml)  12.5  g ; 0.9% sodium chloride  1000  ml ; diphenhydramine  25  mg ; albumin 25% (12.5g   50ml)  50  g ; acetylcysteine 20%  600  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  21.6  %; hematology blood hematocrit  27.7  %; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  350  k ul; hematology blood platelet count  376  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  181  mg dl; chemistry blood glucose  173  mg dl; chemistry blood lactate dehydrogenase (ld)  167  iu l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.6  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; 0.9% sodium chloride  1000  ml ; diphenhydramine  25  mg ; albumin 25% (12.5g   50ml)  50  g ; acetylcysteine 20%  600  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; gastroview (diatrizoate meglumine & sodium)  30  ml ; vancomycin oral liquid  125  mg ; amikacin  700  mg ; nystatin oral suspension  5  ml ; furosemide  100  mg ; clobetasol propionate 0.05% cream  1  appl ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  416  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  165  mg dl; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.8  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; acetylcysteine 20%  600  mg ; amikacin  700  mg ; nystatin oral suspension  5  ml ; furosemide  100  mg ; clobetasol propionate 0.05% cream  1  appl ; 5% dextrose  50  ml ; cefepime desensitization  0.0002  mg ; cefepime desensitization  0.002  mg ; cefepime desensitization  0.02  mg ; cefepime desensitization  0.2  mg ; cefepime desensitization  2  mg ; cefepime desensitization  20  mg ; cefepime desensitization  200  mg ; acetaminophen  650  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  456  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.5  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  173  mg dl; chemistry blood lactate dehydrogenase (ld)  213  iu l; chemistry blood albumin  1.8  g dl; blood gas blood lactate  1.7  mmol l; hematology urine glucose  300  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; amikacin  700  mg ; nystatin oral suspension  5  ml ; furosemide  100  mg ; clobetasol propionate 0.05% cream  1  appl ; acetaminophen  650  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  488  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.5  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  212  mg dl; chemistry blood glucose  209  mg dl; chemistry blood lactate dehydrogenase (ld)  225  iu l; chemistry blood albumin  1.8  g dl; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.8  mmol l; hematology urine glucose  150  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; furosemide  100  mg ; clobetasol propionate 0.05% cream  1  appl ; metoprolol tartrate  5  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  26.2  %; hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  520  k ul; hematology blood platelet count  449  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  258  mg dl; chemistry blood glucose  246  mg dl; chemistry blood lactate dehydrogenase (ld)  210  iu l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; furosemide  100  mg ; clobetasol propionate 0.05% cream  1  appl ; metoprolol tartrate  5  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  25.0  %; hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  527  k ul; hematology blood platelet count  422  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  163  mg dl; chemistry blood glucose  215  mg dl; chemistry blood lactate dehydrogenase (ld)  185  iu l; chemistry blood albumin  1.8  g dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.6  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; furosemide  100  mg ; clobetasol propionate 0.05% cream  1  appl ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  22.6  %; hematology blood hematocrit  29.6  %; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  473  k ul; hematology blood platelet count  441  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  120  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  177  iu l; chemistry blood lactate dehydrogenase (ld)  213  iu l; blood gas blood lactate  1.6  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; furosemide  100  mg ; clobetasol propionate 0.05% cream  1  appl ; adenosine  6  mg ; fentanyl citrate  50  mcg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  28.3  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  498  k ul; hematology blood platelet count  497  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  192  iu l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.9  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; furosemide  100  mg ; clobetasol propionate 0.05% cream  1  appl ; adenosine  6  mg ; fentanyl citrate  50  mcg ; propofol  1000  mg ; propofol  200  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  25.4  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  547  k ul; hematology blood platelet count  531  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  117  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  126  mg dl; chemistry blood albumin  2.0  g dl; blood gas blood lactate  0.8  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  325  mg ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; furosemide  100  mg ; clobetasol propionate 0.05% cream  1  appl ; propofol  1000  mg ; propofol  200  mg ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  10  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  27.8  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  558  k ul; hematology blood platelet count  612  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  201  mg dl; chemistry blood glucose  273  mg dl; chemistry blood lactate dehydrogenase (ld)  166  iu l; chemistry blood albumin  2.0  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  1.2  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  10  mg ; enalaprilat  1.25  mg ; enalaprilat  0.625  mg ; metoprolol tartrate  15  mg ; labetalol  10  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  642  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  210  mg dl; chemistry blood glucose  235  mg dl; hematology blood bands  6  %; hematology urine glucose  300  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; enalaprilat  0.625  mg ; metoprolol tartrate  15  mg ; labetalol  10  mg ; lorazepam  1  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  663  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  251  mg dl; chemistry blood glucose  231  mg dl; hematology blood bands  0  %; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  2.2  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  15  mg ; lorazepam  1  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  630  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  2.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  214  mg dl; blood gas blood free calcium  1.02  mmol l; blood gas blood lactate  1.5  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  15  mg ; lorazepam  1  mg ; lorazepam  1-2  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  646  k ul; hematology blood platelet count  582  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  133  mg dl; blood gas blood free calcium  1.00  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.4  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  15  mg ; lorazepam  1-2  mg ; lorazepam  2  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  558  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  149  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  15  mg ; lorazepam  1-2  mg ; daptomycin  770  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  628  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  161  mg dl; chemistry blood glucose  180  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l; hematology urine glucose  300  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  15  mg ; lorazepam  1-2  mg ; daptomycin  770  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  624  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  186  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; chemistry blood albumin  2.4  g dl; blood gas blood free calcium  1.06  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  15  mg ; lorazepam  1-2  mg ; daptomycin  770  mg ; fentanyl citrate  25-50  mcg ; midazolam  4  mg ; fentanyl citrate  200  mcg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  520  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  79  mg dl; chemistry blood lactate dehydrogenase (ld)  214  iu l; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.0  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  15  mg ; lorazepam  1-2  mg ; daptomycin  770  mg ; fentanyl citrate  25-50  mcg ; midazolam  4  mg ; fentanyl citrate  200  mcg ; fentanyl citrate  100  mcg ; hydromorphone (dilaudid)  2  mg ; midazolam  2  mg ; miconazole powder 2%  1  appl ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  464  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  137  mg dl; blood gas blood free calcium  1.10  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  15  mg ; lorazepam  1-2  mg ; daptomycin  770  mg ; fentanyl citrate  25-50  mcg ; fentanyl citrate  100  mcg ; hydromorphone (dilaudid)  2  mg ; midazolam  2  mg ; miconazole powder 2%  1  appl ; hydromorphone (dilaudid)  0.5  mg ; olanzapine (disintegrating tablet)  5  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  137  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  15  mg ; lorazepam  1-2  mg ; daptomycin  770  mg ; fentanyl citrate  25-50  mcg ; miconazole powder 2%  1  appl ; hydromorphone (dilaudid)  0.5  mg ; olanzapine (disintegrating tablet)  5  mg ; enalapril maleate  5  mg ; metoprolol tartrate  50  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  173  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; lorazepam  1-2  mg ; daptomycin  770  mg ; miconazole powder 2%  1  appl ; olanzapine (disintegrating tablet)  5  mg ; enalapril maleate  5  mg ; metoprolol tartrate  50  mg ; heparin flush (10 units ml)  2  ml ; lorazepam  4  mg ; amino acids 4.25% w  dextrose 5%  1000  ml ; multivitamin iv  10  ml ; haloperidol  2.5  mg ; lidocaine viscous 2%  20  ml ; midazolam  1  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  24.1  %; hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  329  k ul; hematology blood platelet count  281  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  160  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; lorazepam  1-2  mg ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; lorazepam  4  mg ; haloperidol  2.5  mg ; lidocaine viscous 2%  20  ml ; midazolam  1  mg ; olanzapine (disintegrating tablet)  10  mg ; furosemide  20  mg ; furosemide  40  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  22.8  %; hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  279  k ul; hematology blood platelet count  285  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  156  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; diphenhydramine  25  mg ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; lorazepam  1-2  mg ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; haloperidol  2.5  mg ; olanzapine (disintegrating tablet)  10  mg ; furosemide  20  mg ; furosemide  40  mg ; metoprolol tartrate  75  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  153  mg dl; chemistry blood glucose  86  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; olanzapine (disintegrating tablet)  10  mg ; metoprolol tartrate  75  mg ; insulin  10  unit ; metoprolol tartrate  100  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  146  mg dl; chemistry blood glucose  128  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; olanzapine (disintegrating tablet)  10  mg ; insulin  10  unit ; metoprolol tartrate  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; olanzapine  5  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  155  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; olanzapine (disintegrating tablet)  10  mg ; insulin  10  unit ; metoprolol tartrate  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; olanzapine  5  mg ; haloperidol  1-2  mg ; insulin  20  unit ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  166  mg dl; chemistry blood glucose  115  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; haloperidol  1-2  mg ; insulin  20  unit ; insulin  30  unit ; clonazepam  0.5  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  3.0  g dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; vial  1  vial ; pantoprazole  40  mg ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; insulin  30  unit ; clonazepam  0.5  mg ; trazodone  25  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  35  mg dl; hematology urine wbc  42  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  104  mg dl; hematology urine glucose  150  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; insulin  30  unit ; clonazepam  0.5  mg ; trazodone  25  mg ; trazodone  50  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  103  mg dl; hematology blood bands  0  %$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  500  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; insulin  30  unit ; clonazepam  0.5  mg ; trazodone  50  mg ; diltiazem  30  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology urine wbc  68  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  156  mg dl; hematology urine glucose  150  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  500  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; insulin  30  unit ; clonazepam  0.5  mg ; diltiazem  30  mg ; diltiazem  60  mg ; torsemide  20  mg ; diltiazem  90  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  82  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  500  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; insulin  30  unit ; clonazepam  0.5  mg ; torsemide  20  mg ; diltiazem  90  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  116  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  500  ml ; nystatin oral suspension  5  ml ; albuterol inhaler  4-6  puff ; miconazole powder 2%  1  appl ; heparin flush (10 units ml)  2  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; clonazepam  0.5  mg ; torsemide  20  mg ; diltiazem  90  mg ; insulin  45  unit ; diltiazem  120  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white m 64 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  500  ml ; albuterol inhaler  4-6  puff ; heparin flush (10 units ml)  2  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; clonazepam  0.5  mg ; torsemide  20  mg ; insulin  45  unit ; diltiazem  120  mg ; torsemide  30  mg ; 
congestive heart failure, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute pancreatitis aortocoronary bypass status bacteremia delirium due to conditions classified elsewhere acute respiratory failure paralytic ileus penicillins causing adverse effects in therapeutic use unspecified essential hypertension chronic systolic heart failure long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes dermatitis due to drugs and medicines taken internally staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled shock, unspecified acute kidney failure, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms congestive heart failure, unspecified atrial fibrillation personal history of tobacco use coronary atherosclerosis of native coronary artery acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled family history of ischemic heart disease osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh pure hypercholesterolemia unspecified essential hypertension anemia, unspecified polyneuropathy in diabetes person boarding or alighting a pedal cycle injured in collision with fixed or stationary object acute on chronic systolic heart failure subendocardial infarction, initial episode of care 
white f 40 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  1000  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; 
 
white m 78 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  167  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; vial  1  vial ; cefepime  2  g ; ns  100  ml ; metronidazole  500  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; furosemide  20  mg ; levothyroxine sodium  75  mcg ; metoprolol succinate xl  50  mg ; pregabalin  75  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lactated ringers  1000  ml ; 
family history of diabetes mellitus dysphagia, unspecified chronic systolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease hypothyroidism, unspecified non-pressure chronic ulcer of other part of right foot with unspecified severity encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm presence of aortocoronary bypass graft presence of cardiac pacemaker infection of amputation stump, right lower extremity retention of urine, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with other specified complication hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acquired absence of right great toe left bundle-branch block, unspecified presence of xenogenic heart valve chronic kidney disease, unspecified acquired absence of other left toe(s) cellulitis of right lower limb type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair atherosclerosis of native arteries of extremities with gangrene, right leg type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic polyneuropathy acute posthemorrhagic anemia long term (current) use of insulin personal history of nicotine dependence other hyperlipidemia long term (current) use of antithrombotics/antiplatelets other acute osteomyelitis, right ankle and foot presence of cardiac pacemaker type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene personal history of nicotine dependence gangrene, not elsewhere classified hypertensive heart disease with heart failure venous insufficiency (chronic) (peripheral) presence of xenogenic heart valve atherosclerotic heart disease of native coronary artery without angina pectoris other osteomyelitis, ankle and foot presence of coronary angioplasty implant and graft type 2 diabetes mellitus with other specified complication cellulitis of left toe old myocardial infarction chronic systolic (congestive) heart failure hypothyroidism, unspecified cellulitis of left lower limb hyperlipidemia, unspecified
white m 78 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; vial  1  vial ; cefepime  2  g ; ns  100  ml ; metronidazole  500  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; furosemide  20  mg ; levothyroxine sodium  75  mcg ; metoprolol succinate xl  50  mg ; pregabalin  75  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lactated ringers  1000  ml ; 
family history of diabetes mellitus dysphagia, unspecified chronic systolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease hypothyroidism, unspecified non-pressure chronic ulcer of other part of right foot with unspecified severity encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm presence of aortocoronary bypass graft presence of cardiac pacemaker infection of amputation stump, right lower extremity retention of urine, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with other specified complication hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acquired absence of right great toe left bundle-branch block, unspecified presence of xenogenic heart valve chronic kidney disease, unspecified acquired absence of other left toe(s) cellulitis of right lower limb type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair atherosclerosis of native arteries of extremities with gangrene, right leg type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic polyneuropathy acute posthemorrhagic anemia long term (current) use of insulin personal history of nicotine dependence other hyperlipidemia long term (current) use of antithrombotics/antiplatelets other acute osteomyelitis, right ankle and foot presence of cardiac pacemaker type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene personal history of nicotine dependence gangrene, not elsewhere classified hypertensive heart disease with heart failure venous insufficiency (chronic) (peripheral) presence of xenogenic heart valve atherosclerotic heart disease of native coronary artery without angina pectoris other osteomyelitis, ankle and foot presence of coronary angioplasty implant and graft type 2 diabetes mellitus with other specified complication cellulitis of left toe old myocardial infarction chronic systolic (congestive) heart failure hypothyroidism, unspecified cellulitis of left lower limb hyperlipidemia, unspecified
white m 78 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  217  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole  500  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; furosemide  20  mg ; levothyroxine sodium  75  mcg ; metoprolol succinate xl  50  mg ; pregabalin  75  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; ondansetron  4  mg ; 
family history of diabetes mellitus dysphagia, unspecified chronic systolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease hypothyroidism, unspecified non-pressure chronic ulcer of other part of right foot with unspecified severity encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm presence of aortocoronary bypass graft presence of cardiac pacemaker infection of amputation stump, right lower extremity retention of urine, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with other specified complication hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acquired absence of right great toe left bundle-branch block, unspecified presence of xenogenic heart valve chronic kidney disease, unspecified acquired absence of other left toe(s) cellulitis of right lower limb type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair atherosclerosis of native arteries of extremities with gangrene, right leg type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic polyneuropathy acute posthemorrhagic anemia long term (current) use of insulin personal history of nicotine dependence other hyperlipidemia long term (current) use of antithrombotics/antiplatelets other acute osteomyelitis, right ankle and foot presence of cardiac pacemaker type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene personal history of nicotine dependence gangrene, not elsewhere classified hypertensive heart disease with heart failure venous insufficiency (chronic) (peripheral) presence of xenogenic heart valve atherosclerotic heart disease of native coronary artery without angina pectoris other osteomyelitis, ankle and foot presence of coronary angioplasty implant and graft type 2 diabetes mellitus with other specified complication cellulitis of left toe old myocardial infarction chronic systolic (congestive) heart failure hypothyroidism, unspecified cellulitis of left lower limb hyperlipidemia, unspecified
white m 78 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  133  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole  500  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; furosemide  20  mg ; levothyroxine sodium  75  mcg ; metoprolol succinate xl  50  mg ; pregabalin  75  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; ondansetron  4  mg ; 
family history of diabetes mellitus dysphagia, unspecified chronic systolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease hypothyroidism, unspecified non-pressure chronic ulcer of other part of right foot with unspecified severity encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm presence of aortocoronary bypass graft presence of cardiac pacemaker infection of amputation stump, right lower extremity retention of urine, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with other specified complication hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acquired absence of right great toe left bundle-branch block, unspecified presence of xenogenic heart valve chronic kidney disease, unspecified acquired absence of other left toe(s) cellulitis of right lower limb type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair atherosclerosis of native arteries of extremities with gangrene, right leg type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic polyneuropathy acute posthemorrhagic anemia long term (current) use of insulin personal history of nicotine dependence other hyperlipidemia long term (current) use of antithrombotics/antiplatelets other acute osteomyelitis, right ankle and foot presence of cardiac pacemaker type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene personal history of nicotine dependence gangrene, not elsewhere classified hypertensive heart disease with heart failure venous insufficiency (chronic) (peripheral) presence of xenogenic heart valve atherosclerotic heart disease of native coronary artery without angina pectoris other osteomyelitis, ankle and foot presence of coronary angioplasty implant and graft type 2 diabetes mellitus with other specified complication cellulitis of left toe old myocardial infarction chronic systolic (congestive) heart failure hypothyroidism, unspecified cellulitis of left lower limb hyperlipidemia, unspecified
white m 78 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  141  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole  500  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; furosemide  20  mg ; levothyroxine sodium  75  mcg ; metoprolol succinate xl  50  mg ; pregabalin  75  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium citrate  20  meq ; bag  1  bag ; 
family history of diabetes mellitus dysphagia, unspecified chronic systolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease hypothyroidism, unspecified non-pressure chronic ulcer of other part of right foot with unspecified severity encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm presence of aortocoronary bypass graft presence of cardiac pacemaker infection of amputation stump, right lower extremity retention of urine, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with other specified complication hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acquired absence of right great toe left bundle-branch block, unspecified presence of xenogenic heart valve chronic kidney disease, unspecified acquired absence of other left toe(s) cellulitis of right lower limb type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair atherosclerosis of native arteries of extremities with gangrene, right leg type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic polyneuropathy acute posthemorrhagic anemia long term (current) use of insulin personal history of nicotine dependence other hyperlipidemia long term (current) use of antithrombotics/antiplatelets other acute osteomyelitis, right ankle and foot presence of cardiac pacemaker type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene personal history of nicotine dependence gangrene, not elsewhere classified hypertensive heart disease with heart failure venous insufficiency (chronic) (peripheral) presence of xenogenic heart valve atherosclerotic heart disease of native coronary artery without angina pectoris other osteomyelitis, ankle and foot presence of coronary angioplasty implant and graft type 2 diabetes mellitus with other specified complication cellulitis of left toe old myocardial infarction chronic systolic (congestive) heart failure hypothyroidism, unspecified cellulitis of left lower limb hyperlipidemia, unspecified
white m 78 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  142  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; furosemide  20  mg ; levothyroxine sodium  75  mcg ; metoprolol succinate xl  50  mg ; pregabalin  75  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sulfameth trimethoprim ds  1  tab ; 
family history of diabetes mellitus dysphagia, unspecified chronic systolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease hypothyroidism, unspecified non-pressure chronic ulcer of other part of right foot with unspecified severity encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm presence of aortocoronary bypass graft presence of cardiac pacemaker infection of amputation stump, right lower extremity retention of urine, unspecified acute kidney failure, unspecified type 2 diabetes mellitus with other specified complication hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acquired absence of right great toe left bundle-branch block, unspecified presence of xenogenic heart valve chronic kidney disease, unspecified acquired absence of other left toe(s) cellulitis of right lower limb type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair atherosclerosis of native arteries of extremities with gangrene, right leg type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic polyneuropathy acute posthemorrhagic anemia long term (current) use of insulin personal history of nicotine dependence other hyperlipidemia long term (current) use of antithrombotics/antiplatelets other acute osteomyelitis, right ankle and foot presence of cardiac pacemaker type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene personal history of nicotine dependence gangrene, not elsewhere classified hypertensive heart disease with heart failure venous insufficiency (chronic) (peripheral) presence of xenogenic heart valve atherosclerotic heart disease of native coronary artery without angina pectoris other osteomyelitis, ankle and foot presence of coronary angioplasty implant and graft type 2 diabetes mellitus with other specified complication cellulitis of left toe old myocardial infarction chronic systolic (congestive) heart failure hypothyroidism, unspecified cellulitis of left lower limb hyperlipidemia, unspecified
white m 75 $temp    heartrate  66.0  resprate    o2sat    sbp  85.0  dbp  37.0  rhythm    pain  0  ; temp  97.4  heartrate  64.0  resprate  19.0  o2sat  100.0  sbp  83.0  dbp  35.0  rhythm    pain  0  ; temp  974.0  heartrate  65.0  resprate  15.0  o2sat  100.0  sbp  81.0  dbp  36.0  rhythm    pain    $hematology blood hematocrit  18.1  %; hematology blood hematocrit  22.4  %; hematology blood hemoglobin  6.0  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  36  k ul; hematology blood platelet count  33  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  92  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  251  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  194  mg dl; blood gas blood potassium, whole blood  5.2  meq l; blood gas blood sodium, whole blood  124  meq l$bisacodyl  10  mg ; senna  8.6  mg ; esomeprazole sodium  40  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; midazolam  1  mg ; fentanyl citrate  50  mcg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; 
long term (current) use of insulin adverse effect of antineoplastic and immunosuppressive drugs, initial encounter personal history of malignant neoplasm of prostate hypothyroidism, unspecified acute kidney failure, unspecified essential (primary) hypertension anemia in neoplastic disease antineoplastic chemotherapy induced pancytopenia chronic obstructive pulmonary disease, unspecified ischemic cardiomyopathy family history of malignant neoplasm of other organs or systems hypo-osmolality and hyponatremia radiation proctitis alcohol dependence, in remission secondary esophageal varices without bleeding nonrheumatic aortic (valve) stenosis hyperlipidemia, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure old myocardial infarction presence of aortocoronary bypass graft secondary malignant neoplasm of unspecified site patient room in hospital as the place of occurrence of the external cause liver cell carcinoma personal history of nicotine dependence malignant (primary) neoplasm, unspecified type 2 diabetes mellitus without complications portal vein thrombosis acute posthemorrhagic anemia dieulafoy lesion (hemorrhagic) of stomach and duodenum hypotension, unspecified hypovolemia bathroom of single-family (private) house as the place of occurrence of the external cause obstructive sleep apnea (adult) (pediatric) personal history of irradiation arteriovenous malformation of digestive system vessel alcoholic cirrhosis of liver without ascites anemia, unspecified presence of aortocoronary bypass graft personal history of nicotine dependence type 2 diabetes mellitus without complications secondary esophageal varices without bleeding alcoholic cirrhosis of liver with ascites atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive heart disease with heart failure hypothyroidism, unspecified emphysema, unspecified presence of coronary angioplasty implant and graft personal history of malignant neoplasm of prostate
white m 75 $nan$nan$esomeprazole sodium  40  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; 
long term (current) use of insulin adverse effect of antineoplastic and immunosuppressive drugs, initial encounter personal history of malignant neoplasm of prostate hypothyroidism, unspecified acute kidney failure, unspecified essential (primary) hypertension anemia in neoplastic disease antineoplastic chemotherapy induced pancytopenia chronic obstructive pulmonary disease, unspecified ischemic cardiomyopathy family history of malignant neoplasm of other organs or systems hypo-osmolality and hyponatremia radiation proctitis alcohol dependence, in remission secondary esophageal varices without bleeding nonrheumatic aortic (valve) stenosis hyperlipidemia, unspecified radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure old myocardial infarction presence of aortocoronary bypass graft secondary malignant neoplasm of unspecified site patient room in hospital as the place of occurrence of the external cause liver cell carcinoma personal history of nicotine dependence malignant (primary) neoplasm, unspecified type 2 diabetes mellitus without complications portal vein thrombosis acute posthemorrhagic anemia dieulafoy lesion (hemorrhagic) of stomach and duodenum hypotension, unspecified hypovolemia bathroom of single-family (private) house as the place of occurrence of the external cause obstructive sleep apnea (adult) (pediatric) personal history of irradiation arteriovenous malformation of digestive system vessel alcoholic cirrhosis of liver without ascites anemia, unspecified presence of aortocoronary bypass graft personal history of nicotine dependence type 2 diabetes mellitus without complications secondary esophageal varices without bleeding alcoholic cirrhosis of liver with ascites atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive heart disease with heart failure hypothyroidism, unspecified emphysema, unspecified presence of coronary angioplasty implant and graft personal history of malignant neoplasm of prostate
black african american f 55 $temp    heartrate  118.0  resprate  25.0  o2sat  99.0  sbp  103.0  dbp  60.0  rhythm    pain  0  ; temp  98.1  heartrate  111.0  resprate  18.0  o2sat  99.0  sbp  118.0  dbp  79.0  rhythm    pain  0  ; temp  97.1  heartrate  111.0  resprate  19.0  o2sat  100.0  sbp  107.0  dbp  57.0  rhythm    pain  0  ; temp    heartrate  118.0  resprate  29.0  o2sat  99.0  sbp  104.0  dbp  57.0  rhythm    pain  0  ; temp  97.0  heartrate  115.0  resprate  20.0  o2sat  99.0  sbp  101.0  dbp  59.0  rhythm    pain  0  ; temp    heartrate  114.0  resprate  22.0  o2sat  98.0  sbp  122.0  dbp  100.0  rhythm    pain  0  ; temp    heartrate  97.0  resprate  22.0  o2sat  100.0  sbp  119.0  dbp  74.0  rhythm    pain    ; temp  98.5  heartrate  114.0  resprate  18.0  o2sat  100.0  sbp  94.0  dbp  52.0  rhythm    pain  0  $hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  24  # hpf; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  134  mg dl; chemistry blood albumin  3.9  g dl; blood gas blood lactate  3.6  mmol l$nan
 
black african american f 55 $temp    heartrate  112.0  resprate  16.0  o2sat  98.0  sbp  115.0  dbp  68.0  rhythm    pain    ; temp  98.0  heartrate  118.0  resprate  16.0  o2sat  98.0  sbp  110.0  dbp  72.0  rhythm    pain  0  ; temp    heartrate  120.0  resprate  18.0  o2sat  98.0  sbp  111.0  dbp  84.0  rhythm    pain  0  $hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  731  iu l; chemistry blood albumin  3.2  g dl; blood gas blood lactate  1.6  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; heparin  1400-2700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lactated ringers  1000  ml ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
black african american f 55 $nan$hematology blood hematocrit  30.5  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  254  k ul; hematology blood platelet count  254  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  132  mg dl; blood gas blood lactate  2.6  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; heparin  5000  unit ; potassium chloride  40  meq ; ipratropium bromide neb  1  neb ; lidocaine 1%  1  ml ; acetaminophen  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; phosphorus  250  mg ; 
 
black african american f 55 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  246  k ul; hematology blood platelet count  215  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  36  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  140  mg dl$yellow cadd cassette  1  cadd ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; phosphorus  250  mg ; sodium chloride 0.9%  flush  10-20  ml ; bupivacaine 0.1%  250  ml ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
black african american f 55 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  123  mg dl; hematology blood bands  0  %$yellow cadd cassette  1  cadd ; bag  1  bag ; magnesium sulfate  2  gm ; diphenhydramine  25  mg ; naloxone  0.1-0.2  mg ; 
 
black african american f 55 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  95  mg dl; hematology blood bands  2  %$yellow cadd cassette  1  cadd ; diphenhydramine  25  mg ; naloxone  0.1-0.2  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; ibuprofen  400  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; furosemide  10  mg ; docusate sodium  100  mg ; 
 
black african american f 55 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  313  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  106  mg dl; hematology blood bands  0  %$ibuprofen  400  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; furosemide  10  mg ; docusate sodium  100  mg ; 
 
black african american f 55 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  333  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  95  mg dl; hematology blood bands  0  %$ibuprofen  400  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; 
 
white f 32 $nan$hematology blood hematocrit  27.1  %; hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  185  k ul$naloxone  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; ondansetron  4  mg ; lactated ringers  1000  ml ; ibuprofen  600  mg ; bisacodyl  10  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; docusate sodium  100  mg ; milk of magnesia  30  ml ; enoxaparin sodium  40  mg ; cyclobenzaprine  10  mg ; levothyroxine sodium  175  mcg ; 
endocrine, nutritional and metabolic diseases complicating pregnancy, third trimester diseases of the respiratory system complicating pregnancy, third trimester removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure gastro-esophageal reflux disease without esophagitis other specified diseases and conditions complicating pregnancy, childbirth and the puerperium postprocedural hypothyroidism personal history of nicotine dependence personal history of malignant neoplasm of thyroid dental caries, unspecified diseases of the digestive system complicating pregnancy, third trimester anemia complicating pregnancy, third trimester spondylosis, unspecified personal history of malignant neoplasm of breast 34 weeks gestation of pregnancy other asthma bilateral primary osteoarthritis of knee diseases of the respiratory system complicating pregnancy, second trimester endocrine, nutritional and metabolic diseases complicating pregnancy, second trimester estrogen receptor positive status [er+] personal history of malignant neoplasm of thyroid spotting complicating pregnancy, second trimester personal history of nicotine dependence malignant neoplasm of upper-outer quadrant of left female breast unspecified asthma, uncomplicated malignant neoplasm complicating pregnancy, second trimester 14 weeks gestation of pregnancy removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure postprocedural hypothyroidism
white f 32 $nan$nan$naloxone  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; lactated ringers  1000  ml ; ibuprofen  600  mg ; bisacodyl  10  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; docusate sodium  100  mg ; milk of magnesia  30  ml ; enoxaparin sodium  40  mg ; cyclobenzaprine  10  mg ; levothyroxine sodium  175  mcg ; ketorolac  30  mg ; hydromorphone (dilaudid)  2  mg ; oxycodone (immediate release)  5  mg ; 
endocrine, nutritional and metabolic diseases complicating pregnancy, third trimester diseases of the respiratory system complicating pregnancy, third trimester removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure gastro-esophageal reflux disease without esophagitis other specified diseases and conditions complicating pregnancy, childbirth and the puerperium postprocedural hypothyroidism personal history of nicotine dependence personal history of malignant neoplasm of thyroid dental caries, unspecified diseases of the digestive system complicating pregnancy, third trimester anemia complicating pregnancy, third trimester spondylosis, unspecified personal history of malignant neoplasm of breast 34 weeks gestation of pregnancy other asthma bilateral primary osteoarthritis of knee diseases of the respiratory system complicating pregnancy, second trimester endocrine, nutritional and metabolic diseases complicating pregnancy, second trimester estrogen receptor positive status [er+] personal history of malignant neoplasm of thyroid spotting complicating pregnancy, second trimester personal history of nicotine dependence malignant neoplasm of upper-outer quadrant of left female breast unspecified asthma, uncomplicated malignant neoplasm complicating pregnancy, second trimester 14 weeks gestation of pregnancy removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure postprocedural hypothyroidism
white f 32 $nan$nan$naloxone  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; docusate sodium  100  mg ; milk of magnesia  30  ml ; enoxaparin sodium  40  mg ; levothyroxine sodium  175  mcg ; hydromorphone (dilaudid)  2  mg ; oxycodone (immediate release)  5  mg ; 
endocrine, nutritional and metabolic diseases complicating pregnancy, third trimester diseases of the respiratory system complicating pregnancy, third trimester removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure gastro-esophageal reflux disease without esophagitis other specified diseases and conditions complicating pregnancy, childbirth and the puerperium postprocedural hypothyroidism personal history of nicotine dependence personal history of malignant neoplasm of thyroid dental caries, unspecified diseases of the digestive system complicating pregnancy, third trimester anemia complicating pregnancy, third trimester spondylosis, unspecified personal history of malignant neoplasm of breast 34 weeks gestation of pregnancy other asthma bilateral primary osteoarthritis of knee diseases of the respiratory system complicating pregnancy, second trimester endocrine, nutritional and metabolic diseases complicating pregnancy, second trimester estrogen receptor positive status [er+] personal history of malignant neoplasm of thyroid spotting complicating pregnancy, second trimester personal history of nicotine dependence malignant neoplasm of upper-outer quadrant of left female breast unspecified asthma, uncomplicated malignant neoplasm complicating pregnancy, second trimester 14 weeks gestation of pregnancy removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure postprocedural hypothyroidism
white f 43 $nan$nan$acetaminophen  1000  mg ; heparin  5000  unit ; 
 
white f 43 $nan$nan$acetaminophen  1000  mg ; heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; morphine sulfate  100  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  gm ; aspirin  121.5  mg ; docusate sodium  100  mg ; acetaminophen iv  1000  mg ; 
 
white f 43 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  gm ; aspirin  121.5  mg ; docusate sodium  100  mg ; acetaminophen iv  1000  mg ; oxycodone (immediate release)  5-10  mg ; lorazepam  0.5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; 
 
white f 43 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  gm ; aspirin  121.5  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; lorazepam  0.5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; mupirocin ointment 2%  1  appl ; 
 
white f 43 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  gm ; aspirin  121.5  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; lorazepam  0.5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; mupirocin ointment 2%  1  appl ; 
 
white m 89 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  99  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; heparin  5000  unit ; atenolol  50  mg ; lisinopril  20  mg ; simvastatin  20  mg ; aspirin  81  mg ; cyanocobalamin  1000  mcg ; 
 
white m 89 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; heparin  5000  unit ; atenolol  50  mg ; lisinopril  20  mg ; simvastatin  20  mg ; aspirin  81  mg ; cyanocobalamin  1000  mcg ; 
 
other m 60 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  100  mg dl; chemistry blood % hemoglobin a1c  5.5  %$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; labetalol  5  mg ; insulin  0  unit ; 5% dextrose  50  ml ; fosphenytoin  150  mg pe ; fosphenytoin  500  mg pe ; sw  100  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; morphine sulfate     ; fosphenytoin  100  mg pe ; morphine sulfate  0.5-1  mg ; ondansetron     ; ondansetron  4  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  25  mg ; docusate sodium  100  mg ; gabapentin  600  mg ; senna  1  tab ; fluphenazine  2.5  mg ; 
 
other m 60 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  100  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; labetalol  5  mg ; insulin  0  unit ; 5% dextrose  50  ml ; fosphenytoin  150  mg pe ; sw  100  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; fosphenytoin  100  mg pe ; morphine sulfate  0.5-1  mg ; ondansetron  4  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; metoprolol tartrate  25  mg ; docusate sodium  100  mg ; gabapentin  600  mg ; senna  1  tab ; fluphenazine  2.5  mg ; aspirin  325  mg ; simvastatin  10  mg ; furosemide  40  mg ; fluphenazine  10  mg ; hydralazine  10  mg ; heparin  5000  unit ; metoprolol tartrate  12.5  mg ; phenytoin infatab  150  mg ; metoprolol tartrate  37.5  mg ; 
 
other m 60 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  190  iu l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; fluphenazine  10  mg ; hydralazine  10  mg ; metoprolol tartrate  12.5  mg ; phenytoin infatab  150  mg ; metoprolol tartrate  37.5  mg ; potassium chloride  40  meq ; fosphenytoin  200  mg pe ; 
 
other m 60 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  111  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; fluphenazine  10  mg ; hydralazine  10  mg ; phenytoin infatab  150  mg ; metoprolol tartrate  37.5  mg ; potassium chloride  40  meq ; fosphenytoin  200  mg pe ; lorazepam  2  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; 
 
other m 60 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  121  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; fluphenazine  10  mg ; hydralazine  10  mg ; phenytoin infatab  150  mg ; metoprolol tartrate  37.5  mg ; lorazepam  2  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; 
 
other m 60 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; fluphenazine  10  mg ; hydralazine  10  mg ; phenytoin infatab  150  mg ; metoprolol tartrate  37.5  mg ; 
 
white f 36 $nan$hematology blood hematocrit  33.6  %; hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  220  k ul; hematology blood platelet count  225  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  103  mg dl; chemistry blood albumin  3.5  g dl; blood gas blood lactate  0.6  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; dextrose 5%  100  ml ; levofloxacin  500  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; fluoxetine  40  mg ; ranitidine  150  mg ; bag  1  bag ; magnesium sulfate  2  gm ; lamotrigine  25  mg ; lamotrigine  100  mg ; furosemide  10  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; sw  200  ml ; potassium chloride  20  meq ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; oxycodone (immediate release)   5  mg ; acetaminophen  1000  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, indirect  0.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  115  mg dl; chemistry blood bilirubin, direct  0.2  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; dextrose 5%  100  ml ; levofloxacin  500  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ranitidine  150  mg ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  10  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; oxycodone (immediate release)   5  mg ; acetaminophen  1000  mg ; clonazepam  0.5  mg ; furosemide  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; cefepime  2  g ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; metoprolol tartrate  12.5  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  408  iu l; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ranitidine  150  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; acetaminophen  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; cefepime  2  g ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; metoprolol tartrate  12.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lidocaine 1%  2.5  ml ; benzocaine 20% spray  1  spry ; midazolam  1-5  mg ; fentanyl citrate  25-100  mcg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  108  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ranitidine  150  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; acetaminophen  1000  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; metoprolol tartrate  12.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lidocaine 1%  2.5  ml ; benzocaine 20% spray  1  spry ; midazolam  1-5  mg ; fentanyl citrate  25-100  mcg ; sumatriptan succinate  25  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; acetaminophen-caff-butalbital  1-2  tab ; captopril  6.25  mg ; azithromycin  500  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ranitidine  150  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; metoprolol tartrate  12.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; fentanyl citrate  25-100  mcg ; sumatriptan succinate  25  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; acetaminophen-caff-butalbital  1-2  tab ; captopril  6.25  mg ; azithromycin  500  mg ; benzonatate  100  mg ; guaifenesin  15  ml ; guaifenesin-codeine phosphate  10-15  ml ; tramadol (ultram)  50  mg ; azithromycin  250  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  328  k ul; hematology blood inr(pt)  1.5  $sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; ranitidine  150  mg ; metoprolol tartrate  12.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; captopril  6.25  mg ; benzonatate  100  mg ; guaifenesin-codeine phosphate  10-15  ml ; tramadol (ultram)  50  mg ; azithromycin  250  mg ; ketorolac  30  mg ; fluticasone propionate nasal  1  spry ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  484  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; ranitidine  150  mg ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; ketorolac  30  mg ; fluticasone propionate nasal  1  spry ; clonazepam  0.25  mg ; guaifenesin-codeine phosphate  15  ml ; oxymetazoline  1  spry ; dextromethorphan polistirex  30  mg ; codeine sulfate  15  mg ; pantoprazole  40  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; ketorolac  30  mg ; fluticasone propionate nasal  1  spry ; oxymetazoline  1  spry ; dextromethorphan polistirex  30  mg ; codeine sulfate  15  mg ; pantoprazole  40  mg ; morphine sulfate  2  mg ; metoprolol succinate xl  12.5  mg ; prednisone  20  mg ; codeine sulfate  30  mg ; guaifenesin-dextromethorphan  10  ml ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  565  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  80  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; ketorolac  30  mg ; fluticasone propionate nasal  1  spry ; oxymetazoline  1  spry ; pantoprazole  40  mg ; morphine sulfate  2  mg ; metoprolol succinate xl  12.5  mg ; prednisone  20  mg ; codeine sulfate  30  mg ; guaifenesin-dextromethorphan  10  ml ; trazodone  50  mg ; bisacodyl  10  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  654  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  366  iu l$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; oxymetazoline  1  spry ; pantoprazole  40  mg ; metoprolol succinate xl  12.5  mg ; prednisone  20  mg ; codeine sulfate  30  mg ; guaifenesin-dextromethorphan  10  ml ; trazodone  50  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; guaifenesin-dextromethorphan  5  ml ; lisinopril  2.5  mg ; guaifenesin-codeine phosphate  10  ml ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  762  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  93  mg dl; blood gas blood lactate  1.4  mmol l$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; pantoprazole  40  mg ; metoprolol succinate xl  12.5  mg ; guaifenesin-dextromethorphan  10  ml ; guaifenesin-dextromethorphan  5  ml ; lisinopril  2.5  mg ; guaifenesin-codeine phosphate  10  ml ; lorazepam  0.25  mg ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; midazolam  0.5-2  mg ; docusate sodium (liquid)  100  mg ; midazolam  2-4  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  789  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  90  mg dl; blood gas blood lactate  0.7  mmol l$ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; pantoprazole  40  mg ; metoprolol succinate xl  12.5  mg ; guaifenesin-dextromethorphan  10  ml ; guaifenesin-dextromethorphan  5  ml ; lisinopril  2.5  mg ; guaifenesin-codeine phosphate  10  ml ; propofol  1000  mg ; midazolam  0.5-2  mg ; docusate sodium (liquid)  100  mg ; midazolam  2-4  mg ; quetiapine fumarate  25  mg ; vial  1  vial ; metoprolol tartrate  6.25  mg ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  753  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  96  mg dl$ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; guaifenesin-dextromethorphan  10  ml ; guaifenesin-dextromethorphan  5  ml ; guaifenesin-codeine phosphate  10  ml ; propofol  1000  mg ; docusate sodium (liquid)  100  mg ; quetiapine fumarate  25  mg ; vial  1  vial ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  810  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  122  mg dl$ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; guaifenesin-dextromethorphan  10  ml ; guaifenesin-dextromethorphan  5  ml ; guaifenesin-codeine phosphate  10  ml ; docusate sodium (liquid)  100  mg ; quetiapine fumarate  25  mg ; vial  1  vial ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; aspirin  325  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; atropine sulfate  1  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  791  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  80  mg dl; chemistry blood lactate dehydrogenase (ld)  223  iu l; chemistry blood albumin  2.5  g dl; blood gas blood lactate  0.7  mmol l$ondansetron  4  mg ; heparin  5000  unit ; senna  8.6  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; docusate sodium (liquid)  100  mg ; quetiapine fumarate  25  mg ; vial  1  vial ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; aspirin  325  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; atropine sulfate  1  mg ; midazolam  0.5-1  mg ; lorazepam  1  mg ; methylprednisolone sodium succ  40  mg ; propofol  200  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  887  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  132  mg dl$ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; docusate sodium (liquid)  100  mg ; quetiapine fumarate  25  mg ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; aspirin  325  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; lorazepam  1  mg ; methylprednisolone sodium succ  40  mg ; propofol  200  mg ; lansoprazole oral disintegrating tab  30  mg ; polyethylene glycol  17  g ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  28.0  %; hematology blood hematocrit  29.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  820  k ul; hematology blood platelet count  785  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  97  mg dl$ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; docusate sodium (liquid)  100  mg ; quetiapine fumarate  25  mg ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; aspirin  325  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; lorazepam  1  mg ; propofol  200  mg ; lansoprazole oral disintegrating tab  30  mg ; polyethylene glycol  17  g ; clonazepam  1  mg ; acetaminophen iv  1000  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  29.7  %; hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  807  k ul; hematology blood platelet count  737  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  91  mg dl$ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; docusate sodium (liquid)  100  mg ; quetiapine fumarate  25  mg ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; lorazepam  1  mg ; propofol  200  mg ; lansoprazole oral disintegrating tab  30  mg ; polyethylene glycol  17  g ; clonazepam  1  mg ; acetaminophen iv  1000  mg ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  795  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  108  mg dl$ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; docusate sodium (liquid)  100  mg ; quetiapine fumarate  25  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; lorazepam  1  mg ; polyethylene glycol  17  g ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  833  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  106  mg dl$ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; quetiapine fumarate  25  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; lorazepam  1  mg ; polyethylene glycol  17  g ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; lisinopril  10  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$hematology blood hematocrit  39.6  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  842  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  171  mg dl$ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; quetiapine fumarate  25  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; lorazepam  1  mg ; polyethylene glycol  17  g ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; lisinopril  10  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  130  mg dl$ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; quetiapine fumarate  25  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; lisinopril  10  mg ; dextroamphetamine  5  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$nan$heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; quetiapine fumarate  25  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; lisinopril  10  mg ; dextroamphetamine  5  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ketorolac  15  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$nan$heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; tramadol (ultram)  50  mg ; fluticasone propionate nasal  1  spry ; quetiapine fumarate  25  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10-20  ml ; lisinopril  10  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ketorolac  15  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 36 $nan$nan$heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; fluticasone propionate nasal  1  spry ; quetiapine fumarate  25  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10-20  ml ; lisinopril  10  mg ; 
excessive or frequent menstruation primary thrombocytopenia,unspecified acute posthemorrhagic anemia bipolar disorder, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified attention deficit disorder with hyperactivity migraine, unspecified, without mention of intractable migraine without mention of status migrainosus anxiety state, unspecified acute upper respiratory infections of unspecified site bipolar disorder, unspecified immune thrombocytopenic purpura severe sepsis unspecified septicemia septic shock anxiety state, unspecified influenza due to identified novel influenza a virus with other respiratory manifestations attention deficit disorder without mention of hyperactivity tobacco use disorder acute kidney failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus swelling of limb thrombotic microangiopathy pain in limb
white f 63 $temp  98.0  heartrate  89.0  resprate  19.0  o2sat  100.0  sbp  165.0  dbp  87.0  rhythm    pain  0  ; temp  97.9  heartrate  78.0  resprate  18.0  o2sat  100.0  sbp  152.0  dbp  80.0  rhythm    pain  0  ; temp  97.8  heartrate  76.0  resprate  18.0  o2sat  100.0  sbp  144.0  dbp  78.0  rhythm    pain  0  ; temp  97.8  heartrate  101.0  resprate  18.0  o2sat  96.0  sbp  139.0  dbp  76.0  rhythm    pain    $hematology urine wbc  2  # hpf$nan
other accidental fall from one level to another accidents occurring in other specified places open wound of tooth (broken) (fractured) (due to trauma), without mention of complication other mitochondrial metabolism disorders driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing abrasion or friction burn of face, neck, and scalp except eye, without mention of infection 
black african american f 29 $temp  97.6  heartrate  111.0  resprate  11.0  o2sat    sbp  107.0  dbp  74.0  rhythm    pain    $hematology blood hematocrit  31.6  %; hematology blood hematocrit  28.5  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  148  k ul; hematology blood platelet count  160  k ul; hematology blood platelet count  162  k ul; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  $sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; simethicone  40-80  mg ; levetiracetam  1000  mg ; ferrous sulfate  325  mg ; 
puerperal endometritis, postpartum condition or complication pelvic hematoma, postpartum condition or complication unspecified inflammatory disease of uterus delayed and secondary postpartum hemorrhage, postpartum condition or complication delayed and secondary postpartum hemorrhage, postpartum condition or complication other complications of obstetrical surgical wounds, postpartum condition or complication anemia of mother, delivered, with or without mention of antepartum condition abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition epilepsy complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia post term pregnancy, delivered, with or without mention of antepartum condition secondary uterine inertia, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn dizziness and giddiness epilepsy, unspecified, without mention of intractable epilepsy abnormality in fetal heart rate or rhythm, antepartum condition or complication anemia, unspecified anemia of mother, antepartum condition or complication other current conditions classifiable elsewhere of mother, antepartum condition or complication 
black african american f 29 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  164  k ul; hematology blood platelet count  176  k ul$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; simethicone  40-80  mg ; levetiracetam  1000  mg ; ferrous sulfate  325  mg ; 
puerperal endometritis, postpartum condition or complication pelvic hematoma, postpartum condition or complication unspecified inflammatory disease of uterus delayed and secondary postpartum hemorrhage, postpartum condition or complication delayed and secondary postpartum hemorrhage, postpartum condition or complication other complications of obstetrical surgical wounds, postpartum condition or complication anemia of mother, delivered, with or without mention of antepartum condition abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition epilepsy complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia post term pregnancy, delivered, with or without mention of antepartum condition secondary uterine inertia, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn dizziness and giddiness epilepsy, unspecified, without mention of intractable epilepsy abnormality in fetal heart rate or rhythm, antepartum condition or complication anemia, unspecified anemia of mother, antepartum condition or complication other current conditions classifiable elsewhere of mother, antepartum condition or complication 
black african american f 29 $nan$hematology blood hematocrit  25.1  %; hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  178  k ul; hematology blood platelet count  178  k ul; hematology blood inr(pt)  0.9  $sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; simethicone  40-80  mg ; levetiracetam  1000  mg ; ferrous sulfate  325  mg ; 
puerperal endometritis, postpartum condition or complication pelvic hematoma, postpartum condition or complication unspecified inflammatory disease of uterus delayed and secondary postpartum hemorrhage, postpartum condition or complication delayed and secondary postpartum hemorrhage, postpartum condition or complication other complications of obstetrical surgical wounds, postpartum condition or complication anemia of mother, delivered, with or without mention of antepartum condition abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition epilepsy complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia post term pregnancy, delivered, with or without mention of antepartum condition secondary uterine inertia, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn dizziness and giddiness epilepsy, unspecified, without mention of intractable epilepsy abnormality in fetal heart rate or rhythm, antepartum condition or complication anemia, unspecified anemia of mother, antepartum condition or complication other current conditions classifiable elsewhere of mother, antepartum condition or complication 
black african american f 29 $nan$hematology blood hematocrit  25.9  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  195  k ul; hematology blood platelet count  228  k ul$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; simethicone  40-80  mg ; levetiracetam  1000  mg ; ferrous sulfate  325  mg ; 
puerperal endometritis, postpartum condition or complication pelvic hematoma, postpartum condition or complication unspecified inflammatory disease of uterus delayed and secondary postpartum hemorrhage, postpartum condition or complication delayed and secondary postpartum hemorrhage, postpartum condition or complication other complications of obstetrical surgical wounds, postpartum condition or complication anemia of mother, delivered, with or without mention of antepartum condition abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition epilepsy complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia post term pregnancy, delivered, with or without mention of antepartum condition secondary uterine inertia, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn dizziness and giddiness epilepsy, unspecified, without mention of intractable epilepsy abnormality in fetal heart rate or rhythm, antepartum condition or complication anemia, unspecified anemia of mother, antepartum condition or complication other current conditions classifiable elsewhere of mother, antepartum condition or complication 
white f 64 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  22  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  94  mg dl$nan
 
white f 64 $nan$nan$0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; clonazepam  0.5-1  mg ; fluoxetine  60  mg ; lorazepam  0.5-1  mg ; gabapentin  200  mg ; hydrocodone-acetaminophen  1-2  tab ; omeprazole  40  mg ; ondansetron  4  mg ; famotidine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; carbamazepine  200  mg ; sucralfate  1  gm ; cepacol (menthol)  1  loz ; quetiapine fumarate  50  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; doxepin hcl  100  mg ; 
 
white f 64 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  97  mg dl$0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; clonazepam  0.5-1  mg ; fluoxetine  60  mg ; lorazepam  0.5-1  mg ; gabapentin  200  mg ; hydrocodone-acetaminophen  1-2  tab ; ondansetron  4  mg ; famotidine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; carbamazepine  200  mg ; sucralfate  1  gm ; cepacol (menthol)  1  loz ; quetiapine fumarate  50  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; doxepin hcl  100  mg ; bisacodyl  10  mg ; 
 
white m 55 $nan$nan$iso-osmotic dextrose  50  ml ; cefazolin  2  g ; allopurinol  150  mg ; influenza vaccine quadrivalent  0.5  ml ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.12  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; bupropion  300  mg ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; senna  8.6  mg ; hydromorphone (dilaudid)  20  mg ; 
hip joint replacement depressive disorder, not elsewhere classified other abnormal blood chemistry car passenger injured in collision with van in traffic accident barrett's esophagus syncope and collapse epilepsy, unspecified, without mention of intractable epilepsy 
white m 55 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  115  mg dl$iso-osmotic dextrose  50  ml ; cefazolin  2  g ; allopurinol  150  mg ; influenza vaccine quadrivalent  0.5  ml ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; bupropion  300  mg ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; senna  8.6  mg ; hydromorphone (dilaudid)  20  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  1000  ml ; lorazepam  0.25  mg ; calcium carbonate  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
hip joint replacement depressive disorder, not elsewhere classified other abnormal blood chemistry car passenger injured in collision with van in traffic accident barrett's esophagus syncope and collapse epilepsy, unspecified, without mention of intractable epilepsy 
white m 55 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  205  k ul$allopurinol  150  mg ; influenza vaccine quadrivalent  0.5  ml ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; bupropion  300  mg ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; senna  8.6  mg ; enoxaparin sodium  40  mg ; lorazepam  0.25  mg ; calcium carbonate  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; oxycodone (immediate release)   5-15  mg ; 
hip joint replacement depressive disorder, not elsewhere classified other abnormal blood chemistry car passenger injured in collision with van in traffic accident barrett's esophagus syncope and collapse epilepsy, unspecified, without mention of intractable epilepsy 
white m 55 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  223  k ul$allopurinol  150  mg ; influenza vaccine quadrivalent  0.5  ml ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; bupropion  300  mg ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; senna  8.6  mg ; enoxaparin sodium  40  mg ; lorazepam  0.25  mg ; calcium carbonate  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; oxycodone (immediate release)   5-15  mg ; 
hip joint replacement depressive disorder, not elsewhere classified other abnormal blood chemistry car passenger injured in collision with van in traffic accident barrett's esophagus syncope and collapse epilepsy, unspecified, without mention of intractable epilepsy 
white m 38 $temp  98.2  heartrate  69.0  resprate  16.0  o2sat  98.0  sbp  135.0  dbp  73.0  rhythm    pain  8  $nan$0.9% sodium chloride  1000  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; nicotine patch  21  mg ; hydroxyzine  50  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; propranolol  10  mg ; omeprazole  20  mg ; duloxetine  60  mg ; heparin  5000  unit ; d5ns  1000  ml ; polyethylene glycol  17  g ; morphine sulfate  100  mg ; 
 
white m 38 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  75  mg dl; chemistry blood lactate dehydrogenase (ld)  130  iu l; chemistry blood albumin  3.7  g dl$ondansetron  4  mg ; bisacodyl  10  mg ; nicotine patch  21  mg ; hydroxyzine  50  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; propranolol  10  mg ; omeprazole  20  mg ; duloxetine  60  mg ; heparin  5000  unit ; d5ns  1000  ml ; polyethylene glycol  17  g ; morphine sulfate  100  mg ; cyclobenzaprine  10  mg ; sodium chloride nasal  1-2  spry ; 
 
white m 38 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  45  mg dl$ondansetron  4  mg ; bisacodyl  10  mg ; nicotine patch  21  mg ; hydroxyzine  50  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; propranolol  10  mg ; omeprazole  20  mg ; duloxetine  60  mg ; heparin  5000  unit ; polyethylene glycol  17  g ; cyclobenzaprine  10  mg ; sodium chloride nasal  1-2  spry ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; morphine sulfate  500  mg ; omeprazole  40  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; tamsulosin  0.4  mg ; 
 
white m 38 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  100  mg dl$ondansetron  4  mg ; bisacodyl  10  mg ; nicotine patch  21  mg ; hydroxyzine  50  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; propranolol  10  mg ; duloxetine  60  mg ; polyethylene glycol  17  g ; cyclobenzaprine  10  mg ; sodium chloride nasal  1-2  spry ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; morphine sulfate  500  mg ; omeprazole  40  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; tamsulosin  0.4  mg ; metoclopramide  10  mg ; 
 
white m 38 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  80  mg dl; chemistry blood lactate dehydrogenase (ld)  179  iu l; chemistry blood bilirubin, direct  0.1  mg dl$ondansetron  4  mg ; bisacodyl  10  mg ; nicotine patch  21  mg ; hydroxyzine  50  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; propranolol  10  mg ; duloxetine  60  mg ; polyethylene glycol  17  g ; cyclobenzaprine  10  mg ; sodium chloride nasal  1-2  spry ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; morphine sulfate  500  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; metoclopramide  10  mg ; gabapentin  600  mg ; 
 
white m 38 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  163  iu l$ondansetron  4  mg ; bisacodyl  10  mg ; nicotine patch  21  mg ; hydroxyzine  50  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; propranolol  10  mg ; duloxetine  60  mg ; polyethylene glycol  17  g ; cyclobenzaprine  10  mg ; sodium chloride nasal  1-2  spry ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; morphine sulfate  500  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; metoclopramide  10  mg ; gabapentin  600  mg ; lidocaine jelly 2% (urojet)  1  appl ; finasteride  5  mg ; promethazine  6.25  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; morphine sr (ms contin)  15  mg ; morphine sulfate ir  15  mg ; mirtazapine  7.5  mg ; 
 
white m 38 $nan$nan$bisacodyl  10  mg ; nicotine patch  21  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; propranolol  10  mg ; duloxetine  60  mg ; polyethylene glycol  17  g ; cyclobenzaprine  10  mg ; sodium chloride nasal  1-2  spry ; d5 1 2ns  1000  ml ; omeprazole  40  mg ; tamsulosin  0.4  mg ; metoclopramide  10  mg ; gabapentin  600  mg ; lidocaine jelly 2% (urojet)  1  appl ; finasteride  5  mg ; promethazine  6.25  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; morphine sr (ms contin)  15  mg ; morphine sulfate ir  15  mg ; mirtazapine  7.5  mg ; tramadol (ultram)  50  mg ; gabapentin  300  mg ; 
 
white m 38 $nan$nan$bisacodyl  10  mg ; nicotine patch  21  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; propranolol  10  mg ; duloxetine  60  mg ; polyethylene glycol  17  g ; cyclobenzaprine  10  mg ; sodium chloride nasal  1-2  spry ; omeprazole  40  mg ; tamsulosin  0.4  mg ; metoclopramide  10  mg ; finasteride  5  mg ; promethazine  6.25  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; morphine sulfate ir  15  mg ; mirtazapine  7.5  mg ; tramadol (ultram)  50  mg ; gabapentin  300  mg ; 
 
black african american m 52 $nan$nan$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; aspirin  81  mg ; lisinopril  40  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled arthropathy associated with neurological disorders ulcer of heel and midfoot other and unspecified hyperlipidemia 
black african american m 52 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  153  mg dl; chemistry blood % hemoglobin a1c  12.1  %$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; aspirin  81  mg ; lisinopril  40  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; metronidazole (flagyl)  500  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ciprofloxacin hcl  500  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; insulin  35  unit ; insulin  25  unit ; 
unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled arthropathy associated with neurological disorders ulcer of heel and midfoot other and unspecified hyperlipidemia 
black african american m 52 $nan$hematology blood hematocrit  36.4  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  94  mg dl$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; aspirin  81  mg ; lisinopril  40  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ciprofloxacin hcl  500  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; insulin  35  unit ; insulin  25  unit ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 
unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled arthropathy associated with neurological disorders ulcer of heel and midfoot other and unspecified hyperlipidemia 
black african american m 52 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  206  mg dl$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; aspirin  81  mg ; lisinopril  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ciprofloxacin hcl  500  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; insulin  35  unit ; insulin  25  unit ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 
unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled arthropathy associated with neurological disorders ulcer of heel and midfoot other and unspecified hyperlipidemia 
black african american m 52 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  325  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  231  mg dl$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; aspirin  81  mg ; lisinopril  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ciprofloxacin hcl  500  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; insulin  35  unit ; insulin  25  unit ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lr  1000  ml ; 
unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled arthropathy associated with neurological disorders ulcer of heel and midfoot other and unspecified hyperlipidemia 
black african american m 52 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  242  mg dl$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; aspirin  81  mg ; lisinopril  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ciprofloxacin hcl  500  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; insulin  35  unit ; insulin  25  unit ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lr  1000  ml ; 
unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled arthropathy associated with neurological disorders ulcer of heel and midfoot other and unspecified hyperlipidemia 
black african american m 52 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  185  mg dl$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; aspirin  81  mg ; lisinopril  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ciprofloxacin hcl  500  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; insulin  35  unit ; insulin  25  unit ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lr  1000  ml ; heparin flush (10 units ml)  2  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 
unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled arthropathy associated with neurological disorders ulcer of heel and midfoot other and unspecified hyperlipidemia 
black african american m 52 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  198  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$amlodipine  10  mg ; hydrochlorothiazide  25  mg ; aspirin  81  mg ; lisinopril  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ciprofloxacin hcl  500  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; insulin  35  unit ; insulin  25  unit ; lr  1000  ml ; heparin flush (10 units ml)  2  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 
unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled arthropathy associated with neurological disorders ulcer of heel and midfoot other and unspecified hyperlipidemia 
white f 93 $nan$nan$insulin  14  unit ; hydrochlorothiazide  25  mg ; lisinopril  40  mg ; omeprazole  20  mg ; simvastatin  20  mg ; 
personal history of tobacco use personal history of methicillin resistant staphylococcus aureus congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status disorders of bursae and tendons in shoulder region, unspecified chronic systolic heart failure coronary atherosclerosis of native coronary artery old myocardial infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast other and unspecified hyperlipidemia peripheral angiopathy in diseases classified elsewhere kyphosis (acquired) (postural) unspecified essential hypertension unspecified disorder of kidney and ureter mitral valve disorders diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status long-term (current) use of insulin personal history of malignant neoplasm of breast peripheral angiopathy in diseases classified elsewhere personal history of methicillin resistant staphylococcus aureus person boarding or alighting a pedal cycle injured in collision with pedestrian or animal chronic combined systolic and diastolic heart failure atherosclerosis of native arteries of the extremities, unspecified mitral valve insufficiency and aortic valve insufficiency diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled anemia, unspecified congestive heart failure, unspecified other kyphosis (acquired) first degree atrioventricular block other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other specified cardiac dysrhythmias peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin hyperpotassemia coronary atherosclerosis of native coronary artery peripheral angiopathy in diseases classified elsewhere pain in limb kyphosis (acquired) (postural)
white f 93 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  114  mg dl$insulin  14  unit ; hydrochlorothiazide  25  mg ; lisinopril  40  mg ; omeprazole  20  mg ; simvastatin  20  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; letrozole  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; hydralazine  25  mg ; 
personal history of tobacco use personal history of methicillin resistant staphylococcus aureus congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status disorders of bursae and tendons in shoulder region, unspecified chronic systolic heart failure coronary atherosclerosis of native coronary artery old myocardial infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast other and unspecified hyperlipidemia peripheral angiopathy in diseases classified elsewhere kyphosis (acquired) (postural) unspecified essential hypertension unspecified disorder of kidney and ureter mitral valve disorders diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status long-term (current) use of insulin personal history of malignant neoplasm of breast peripheral angiopathy in diseases classified elsewhere personal history of methicillin resistant staphylococcus aureus person boarding or alighting a pedal cycle injured in collision with pedestrian or animal chronic combined systolic and diastolic heart failure atherosclerosis of native arteries of the extremities, unspecified mitral valve insufficiency and aortic valve insufficiency diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled anemia, unspecified congestive heart failure, unspecified other kyphosis (acquired) first degree atrioventricular block other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other specified cardiac dysrhythmias peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin hyperpotassemia coronary atherosclerosis of native coronary artery peripheral angiopathy in diseases classified elsewhere pain in limb kyphosis (acquired) (postural)
white f 93 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  84  mg dl$insulin  14  unit ; hydrochlorothiazide  25  mg ; lisinopril  40  mg ; omeprazole  20  mg ; simvastatin  20  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; letrozole  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; hydralazine  25  mg ; 
personal history of tobacco use personal history of methicillin resistant staphylococcus aureus congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status disorders of bursae and tendons in shoulder region, unspecified chronic systolic heart failure coronary atherosclerosis of native coronary artery old myocardial infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast other and unspecified hyperlipidemia peripheral angiopathy in diseases classified elsewhere kyphosis (acquired) (postural) unspecified essential hypertension unspecified disorder of kidney and ureter mitral valve disorders diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status long-term (current) use of insulin personal history of malignant neoplasm of breast peripheral angiopathy in diseases classified elsewhere personal history of methicillin resistant staphylococcus aureus person boarding or alighting a pedal cycle injured in collision with pedestrian or animal chronic combined systolic and diastolic heart failure atherosclerosis of native arteries of the extremities, unspecified mitral valve insufficiency and aortic valve insufficiency diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled anemia, unspecified congestive heart failure, unspecified other kyphosis (acquired) first degree atrioventricular block other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other specified cardiac dysrhythmias peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin hyperpotassemia coronary atherosclerosis of native coronary artery peripheral angiopathy in diseases classified elsewhere pain in limb kyphosis (acquired) (postural)
white f 93 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  95  mg dl$insulin  14  unit ; hydrochlorothiazide  25  mg ; lisinopril  40  mg ; omeprazole  20  mg ; simvastatin  20  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; letrozole  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; 
personal history of tobacco use personal history of methicillin resistant staphylococcus aureus congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status disorders of bursae and tendons in shoulder region, unspecified chronic systolic heart failure coronary atherosclerosis of native coronary artery old myocardial infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast other and unspecified hyperlipidemia peripheral angiopathy in diseases classified elsewhere kyphosis (acquired) (postural) unspecified essential hypertension unspecified disorder of kidney and ureter mitral valve disorders diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status long-term (current) use of insulin personal history of malignant neoplasm of breast peripheral angiopathy in diseases classified elsewhere personal history of methicillin resistant staphylococcus aureus person boarding or alighting a pedal cycle injured in collision with pedestrian or animal chronic combined systolic and diastolic heart failure atherosclerosis of native arteries of the extremities, unspecified mitral valve insufficiency and aortic valve insufficiency diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled anemia, unspecified congestive heart failure, unspecified other kyphosis (acquired) first degree atrioventricular block other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other specified cardiac dysrhythmias peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin hyperpotassemia coronary atherosclerosis of native coronary artery peripheral angiopathy in diseases classified elsewhere pain in limb kyphosis (acquired) (postural)
white f 93 $nan$nan$insulin  14  unit ; hydrochlorothiazide  25  mg ; lisinopril  40  mg ; omeprazole  20  mg ; simvastatin  20  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; letrozole  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; 
personal history of tobacco use personal history of methicillin resistant staphylococcus aureus congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status disorders of bursae and tendons in shoulder region, unspecified chronic systolic heart failure coronary atherosclerosis of native coronary artery old myocardial infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast other and unspecified hyperlipidemia peripheral angiopathy in diseases classified elsewhere kyphosis (acquired) (postural) unspecified essential hypertension unspecified disorder of kidney and ureter mitral valve disorders diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status long-term (current) use of insulin personal history of malignant neoplasm of breast peripheral angiopathy in diseases classified elsewhere personal history of methicillin resistant staphylococcus aureus person boarding or alighting a pedal cycle injured in collision with pedestrian or animal chronic combined systolic and diastolic heart failure atherosclerosis of native arteries of the extremities, unspecified mitral valve insufficiency and aortic valve insufficiency diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled anemia, unspecified congestive heart failure, unspecified other kyphosis (acquired) first degree atrioventricular block other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other specified cardiac dysrhythmias peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin hyperpotassemia coronary atherosclerosis of native coronary artery peripheral angiopathy in diseases classified elsewhere pain in limb kyphosis (acquired) (postural)
white f 93 $nan$nan$insulin  14  unit ; hydrochlorothiazide  25  mg ; lisinopril  40  mg ; omeprazole  20  mg ; simvastatin  20  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; letrozole  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; 
personal history of tobacco use personal history of methicillin resistant staphylococcus aureus congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status disorders of bursae and tendons in shoulder region, unspecified chronic systolic heart failure coronary atherosclerosis of native coronary artery old myocardial infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast other and unspecified hyperlipidemia peripheral angiopathy in diseases classified elsewhere kyphosis (acquired) (postural) unspecified essential hypertension unspecified disorder of kidney and ureter mitral valve disorders diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status long-term (current) use of insulin personal history of malignant neoplasm of breast peripheral angiopathy in diseases classified elsewhere personal history of methicillin resistant staphylococcus aureus person boarding or alighting a pedal cycle injured in collision with pedestrian or animal chronic combined systolic and diastolic heart failure atherosclerosis of native arteries of the extremities, unspecified mitral valve insufficiency and aortic valve insufficiency diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled anemia, unspecified congestive heart failure, unspecified other kyphosis (acquired) first degree atrioventricular block other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other specified cardiac dysrhythmias peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction long-term (current) use of insulin hyperpotassemia coronary atherosclerosis of native coronary artery peripheral angiopathy in diseases classified elsewhere pain in limb kyphosis (acquired) (postural)
hispanic latino f 24 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  93  mg dl$hydromorphone (dilaudid)  0.5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; d5ns  1000  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; trazodone  200  mg ; insulin  0  unit ; diphenhydramine  50  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; tramadol (ultram)  200  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; diazepam  10  mg ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage gastroparesis other colostomy and enterostomy complication diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis influenza due to identified novel h1n1 influenza virus other chronic pain chronic pancreatitis unspecified gastritis and gastroduodenitis, without mention of hemorrhage constipation, unspecified gastroparesis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled abdominal pain, unspecified site unspecified personality disorder personal history of peptic ulcer disease chronic pancreatitis gastroparesis abnormal weight gain car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled acute inflammatory diseases of uterus, except cervix asthma, unspecified type, unspecified iron deficiency anemia, unspecified dysthymic disorder galactorrhea not associated with childbirth asthma, unspecified type, with (acute) exacerbation acute upper respiratory infections of unspecified site borderline personality disorder unspecified gastritis and gastroduodenitis, without mention of hemorrhage acute upper respiratory infections of unspecified site gastrostomy status asthma, unspecified type, unspecified iron deficiency anemia, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastroparesis chronic pancreatitis retention of urine, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin depressive disorder, not elsewhere classified borderline personality disorder retention of urine, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation retention of urine, unspecified
hispanic latino f 24 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  159  mg dl$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; trazodone  200  mg ; diphenhydramine  50  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; tramadol (ultram)  200  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; diazepam  10  mg ; fluticasone-salmeterol diskus (250 50)   2  inh ; quetiapine fumarate  400  mg ; insulin  15  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sarna lotion  1  appl ; insulin  20  unit ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage gastroparesis other colostomy and enterostomy complication diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis influenza due to identified novel h1n1 influenza virus other chronic pain chronic pancreatitis unspecified gastritis and gastroduodenitis, without mention of hemorrhage constipation, unspecified gastroparesis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled abdominal pain, unspecified site unspecified personality disorder personal history of peptic ulcer disease chronic pancreatitis gastroparesis abnormal weight gain car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled acute inflammatory diseases of uterus, except cervix asthma, unspecified type, unspecified iron deficiency anemia, unspecified dysthymic disorder galactorrhea not associated with childbirth asthma, unspecified type, with (acute) exacerbation acute upper respiratory infections of unspecified site borderline personality disorder unspecified gastritis and gastroduodenitis, without mention of hemorrhage acute upper respiratory infections of unspecified site gastrostomy status asthma, unspecified type, unspecified iron deficiency anemia, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastroparesis chronic pancreatitis retention of urine, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin depressive disorder, not elsewhere classified borderline personality disorder retention of urine, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation retention of urine, unspecified
hispanic latino f 24 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  300  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  120  mg dl$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; trazodone  200  mg ; tramadol (ultram)  200  mg ; diazepam  10  mg ; fluticasone-salmeterol diskus (250 50)   2  inh ; quetiapine fumarate  400  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sarna lotion  1  appl ; insulin  20  unit ; magnesium oxide  400  mg ; d5 1 2ns  1000  ml ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage gastroparesis other colostomy and enterostomy complication diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis influenza due to identified novel h1n1 influenza virus other chronic pain chronic pancreatitis unspecified gastritis and gastroduodenitis, without mention of hemorrhage constipation, unspecified gastroparesis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled abdominal pain, unspecified site unspecified personality disorder personal history of peptic ulcer disease chronic pancreatitis gastroparesis abnormal weight gain car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled acute inflammatory diseases of uterus, except cervix asthma, unspecified type, unspecified iron deficiency anemia, unspecified dysthymic disorder galactorrhea not associated with childbirth asthma, unspecified type, with (acute) exacerbation acute upper respiratory infections of unspecified site borderline personality disorder unspecified gastritis and gastroduodenitis, without mention of hemorrhage acute upper respiratory infections of unspecified site gastrostomy status asthma, unspecified type, unspecified iron deficiency anemia, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastroparesis chronic pancreatitis retention of urine, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin depressive disorder, not elsewhere classified borderline personality disorder retention of urine, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation retention of urine, unspecified
hispanic latino f 24 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  224  mg dl$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; trazodone  200  mg ; tramadol (ultram)  200  mg ; diazepam  10  mg ; fluticasone-salmeterol diskus (250 50)   2  inh ; quetiapine fumarate  400  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sarna lotion  1  appl ; magnesium oxide  400  mg ; insulin  30  unit ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage gastroparesis other colostomy and enterostomy complication diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis influenza due to identified novel h1n1 influenza virus other chronic pain chronic pancreatitis unspecified gastritis and gastroduodenitis, without mention of hemorrhage constipation, unspecified gastroparesis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled abdominal pain, unspecified site unspecified personality disorder personal history of peptic ulcer disease chronic pancreatitis gastroparesis abnormal weight gain car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled acute inflammatory diseases of uterus, except cervix asthma, unspecified type, unspecified iron deficiency anemia, unspecified dysthymic disorder galactorrhea not associated with childbirth asthma, unspecified type, with (acute) exacerbation acute upper respiratory infections of unspecified site borderline personality disorder unspecified gastritis and gastroduodenitis, without mention of hemorrhage acute upper respiratory infections of unspecified site gastrostomy status asthma, unspecified type, unspecified iron deficiency anemia, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastroparesis chronic pancreatitis retention of urine, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin depressive disorder, not elsewhere classified borderline personality disorder retention of urine, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation retention of urine, unspecified
hispanic latino f 24 $nan$nan$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; trazodone  200  mg ; tramadol (ultram)  200  mg ; diazepam  10  mg ; fluticasone-salmeterol diskus (250 50)   2  inh ; quetiapine fumarate  400  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sarna lotion  1  appl ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; heparin  5000  unit ; insulin  5  unit ; fluconazole  200  mg ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage gastroparesis other colostomy and enterostomy complication diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis influenza due to identified novel h1n1 influenza virus other chronic pain chronic pancreatitis unspecified gastritis and gastroduodenitis, without mention of hemorrhage constipation, unspecified gastroparesis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled abdominal pain, unspecified site unspecified personality disorder personal history of peptic ulcer disease chronic pancreatitis gastroparesis abnormal weight gain car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled acute inflammatory diseases of uterus, except cervix asthma, unspecified type, unspecified iron deficiency anemia, unspecified dysthymic disorder galactorrhea not associated with childbirth asthma, unspecified type, with (acute) exacerbation acute upper respiratory infections of unspecified site borderline personality disorder unspecified gastritis and gastroduodenitis, without mention of hemorrhage acute upper respiratory infections of unspecified site gastrostomy status asthma, unspecified type, unspecified iron deficiency anemia, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastroparesis chronic pancreatitis retention of urine, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin depressive disorder, not elsewhere classified borderline personality disorder retention of urine, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation retention of urine, unspecified
hispanic latino f 24 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  93  mg dl$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; trazodone  200  mg ; tramadol (ultram)  200  mg ; diazepam  10  mg ; fluticasone-salmeterol diskus (250 50)   2  inh ; quetiapine fumarate  400  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sarna lotion  1  appl ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; heparin  5000  unit ; insulin  5  unit ; fluconazole  200  mg ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage gastroparesis other colostomy and enterostomy complication diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis influenza due to identified novel h1n1 influenza virus other chronic pain chronic pancreatitis unspecified gastritis and gastroduodenitis, without mention of hemorrhage constipation, unspecified gastroparesis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled abdominal pain, unspecified site unspecified personality disorder personal history of peptic ulcer disease chronic pancreatitis gastroparesis abnormal weight gain car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled acute inflammatory diseases of uterus, except cervix asthma, unspecified type, unspecified iron deficiency anemia, unspecified dysthymic disorder galactorrhea not associated with childbirth asthma, unspecified type, with (acute) exacerbation acute upper respiratory infections of unspecified site borderline personality disorder unspecified gastritis and gastroduodenitis, without mention of hemorrhage acute upper respiratory infections of unspecified site gastrostomy status asthma, unspecified type, unspecified iron deficiency anemia, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastroparesis chronic pancreatitis retention of urine, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin depressive disorder, not elsewhere classified borderline personality disorder retention of urine, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation retention of urine, unspecified
hispanic latino f 24 $nan$nan$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; trazodone  200  mg ; tramadol (ultram)  200  mg ; diazepam  10  mg ; fluticasone-salmeterol diskus (250 50)   2  inh ; quetiapine fumarate  400  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sarna lotion  1  appl ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; heparin  5000  unit ; 
unspecified gastritis and gastroduodenitis, without mention of hemorrhage gastroparesis other colostomy and enterostomy complication diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis influenza due to identified novel h1n1 influenza virus other chronic pain chronic pancreatitis unspecified gastritis and gastroduodenitis, without mention of hemorrhage constipation, unspecified gastroparesis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled abdominal pain, unspecified site unspecified personality disorder personal history of peptic ulcer disease chronic pancreatitis gastroparesis abnormal weight gain car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled acute inflammatory diseases of uterus, except cervix asthma, unspecified type, unspecified iron deficiency anemia, unspecified dysthymic disorder galactorrhea not associated with childbirth asthma, unspecified type, with (acute) exacerbation acute upper respiratory infections of unspecified site borderline personality disorder unspecified gastritis and gastroduodenitis, without mention of hemorrhage acute upper respiratory infections of unspecified site gastrostomy status asthma, unspecified type, unspecified iron deficiency anemia, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastroparesis chronic pancreatitis retention of urine, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin depressive disorder, not elsewhere classified borderline personality disorder retention of urine, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation retention of urine, unspecified
white m 56 $nan$nan$atorvastatin  10  mg ; multivitamins  1  tab ; 
 
white m 56 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  97  mg dl$atorvastatin  10  mg ; multivitamins  1  tab ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; diphenhydramine  12.5-50  mg ; ondansetron  4  mg ; ketorolac  15  mg ; ketorolac  30  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; enoxaparin sodium  40  mg ; 
 
white m 56 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  114  mg dl$atorvastatin  10  mg ; multivitamins  1  tab ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; diphenhydramine  12.5-50  mg ; ondansetron  4  mg ; ketorolac  15  mg ; ketorolac  30  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; enoxaparin sodium  40  mg ; 
 
white m 56 $nan$nan$atorvastatin  10  mg ; multivitamins  1  tab ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; diphenhydramine  12.5-50  mg ; ondansetron  4  mg ; enoxaparin sodium  40  mg ; 
 
hispanic latino m 42 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; oxycodone-acetaminophen elixir  5-10  ml ; prochlorperazine  10  mg ; ondansetron  8  mg ; heparin  5000  unit ; 
other and unspecified hyperlipidemia unspecified essential hypertension chest pain, unspecified 
hispanic latino m 42 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; oxycodone-acetaminophen elixir  5-10  ml ; prochlorperazine  10  mg ; heparin  5000  unit ; docusate sodium (liquid)  100  mg ; multivitamins  5  ml ; ranitidine (liquid)  150  mg ; 
other and unspecified hyperlipidemia unspecified essential hypertension chest pain, unspecified 
white m 91 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  97  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; debrox 6.5%  5-10  drop ; 
 
white m 91 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  98  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; debrox 6.5%  5-10  drop ; ns  500  ml ; 
 
white m 91 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; debrox 6.5%  5-10  drop ; ns  500  ml ; 
 
white m 91 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  129  mg dl; chemistry blood glucose  99  mg dl; chemistry blood albumin  3.7  g dl; chemistry urine protein creatinine ratio  0.2  ratio$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; debrox 6.5%  5-10  drop ; ns  1000  ml ; vitamin d  400  unit ; pneumococcal vac polyvalent  0.5  ml ; 
 
white m 91 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; debrox 6.5%  5-10  drop ; vitamin d  400  unit ; pneumococcal vac polyvalent  0.5  ml ; vitamin d  800  unit ; calcium carbonate  500  mg ; senna  1  tab ; 
 
white m 91 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; pneumococcal vac polyvalent  0.5  ml ; vitamin d  800  unit ; calcium carbonate  500  mg ; senna  1  tab ; milk of magnesia  30  ml ; 
 
white m 91 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood bilirubin, indirect  0.7  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  113  mg dl; chemistry blood albumin  4.7  g dl; chemistry blood bilirubin, direct  0.2  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; pneumococcal vac polyvalent  0.5  ml ; vitamin d  800  unit ; calcium carbonate  500  mg ; senna  1  tab ; milk of magnesia  30  ml ; 
 
white m 91 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  141  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; pneumococcal vac polyvalent  0.5  ml ; vitamin d  800  unit ; calcium carbonate  500  mg ; prochlorperazine  5-10  mg ; 
 
white m 91 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; pneumococcal vac polyvalent  0.5  ml ; vitamin d  800  unit ; calcium carbonate  500  mg ; prochlorperazine  5-10  mg ; 
 
white m 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; pneumococcal vac polyvalent  0.5  ml ; vitamin d  800  unit ; calcium carbonate  500  mg ; prochlorperazine  5-10  mg ; 
 
white m 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; pneumococcal vac polyvalent  0.5  ml ; vitamin d  800  unit ; calcium carbonate  500  mg ; prochlorperazine  5-10  mg ; 
 
white m 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; pneumococcal vac polyvalent  0.5  ml ; vitamin d  800  unit ; calcium carbonate  500  mg ; prochlorperazine  5-10  mg ; 
 
black african american f 75 $nan$nan$losartan potassium  100  mg ; hydrochlorothiazide  12.5  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  40  mg ; docusate sodium  100  mg ; 
 
black african american f 75 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  2.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  150  mg dl$losartan potassium  100  mg ; hydrochlorothiazide  12.5  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  40  mg ; docusate sodium  100  mg ; heparin  7800  unit ; heparin  2000-3900  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; senna  1  tab ; morphine sulfate ir  15  mg ; 1 2 ns  1000  ml ; heparin  2000  unit ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chloride  60  meq ; sw  100  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; fluticasone-salmeterol diskus (100 50)  1  inh ; 
 
black african american f 75 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  125  mg dl$losartan potassium  100  mg ; hydrochlorothiazide  12.5  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  40  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; senna  1  tab ; morphine sulfate ir  15  mg ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chloride  60  meq ; 0.9% sodium chloride  500  ml ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; heparin  1800-3600  unit ; warfarin  5  mg ; 
 
black african american f 75 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  109  mg dl$losartan potassium  100  mg ; hydrochlorothiazide  12.5  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  40  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; senna  1  tab ; morphine sulfate ir  15  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; heparin  1800-3600  unit ; warfarin  5  mg ; bisacodyl  10  mg ; hydrochlorothiazide  25  mg ; enoxaparin sodium  90  mg ; metoprolol tartrate  37.5  mg ; 
 
black african american f 75 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  163  mg dl$losartan potassium  100  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  40  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; senna  1  tab ; morphine sulfate ir  15  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; warfarin  5  mg ; bisacodyl  10  mg ; hydrochlorothiazide  25  mg ; metoprolol tartrate  37.5  mg ; enoxaparin sodium  80  mg ; cepacol (menthol)  1  loz ; oxycodone-acetaminophen  1-2  tab ; 
 
black african american f 75 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  109  mg dl$losartan potassium  100  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  40  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; senna  1  tab ; fluticasone-salmeterol diskus (100 50)  1  inh ; warfarin  5  mg ; bisacodyl  10  mg ; hydrochlorothiazide  25  mg ; metoprolol tartrate  37.5  mg ; cepacol (menthol)  1  loz ; oxycodone-acetaminophen  1-2  tab ; guaifenesin-dextromethorphan  5-10  ml ; 
 
black african american f 75 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  351  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  107  mg dl$losartan potassium  100  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  40  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; senna  1  tab ; fluticasone-salmeterol diskus (100 50)  1  inh ; warfarin  5  mg ; bisacodyl  10  mg ; hydrochlorothiazide  25  mg ; metoprolol tartrate  37.5  mg ; cepacol (menthol)  1  loz ; oxycodone-acetaminophen  1-2  tab ; guaifenesin-dextromethorphan  5-10  ml ; 
 
white m 81 $nan$hematology blood hematocrit  40.8  %; hematology blood hematocrit  32.5  %; hematology blood hemoglobin  13.0  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  142  k ul; hematology blood platelet count  101  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; hematology urine wbc  40  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  71  mg dl; chemistry blood albumin  4.6  g dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood chloride, whole blood  94  meq l; blood gas blood chloride, whole blood  93  meq l; blood gas blood glucose  85  mg dl; blood gas blood glucose  117  mg dl; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hemoglobin  11.7  g dl; blood gas blood hemoglobin  11.6  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  135  meq l; chemistry blood % hemoglobin a1c  4.8  %$docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; fluticasone propionate nasal  1  spry ; senna  8.6  mg ; atorvastatin  10  mg ; ipratropium-albuterol neb  1  neb ; clopidogrel  300  mg ; mirtazapine  15  mg ; heparin  1200-2400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; ciprofloxacin hcl  500  mg ; multivitamins  1  tab ; aspirin  325  mg ; tiotropium bromide  1  cap ; venlafaxine xr  75  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; sterile water  50  ml ; potassium chloride  20  meq ; 
other specified abnormal findings of blood chemistry stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter unspecified place or not applicable hypertensive heart disease with heart failure unspecified severe protein-calorie malnutrition nicotine dependence, cigarettes, uncomplicated encounter for adjustment and management of automatic implantable cardiac defibrillator major depressive disorder, single episode, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants abnormal coagulation profile hyperlipidemia, unspecified nonrheumatic mitral (valve) stenosis anxiety disorder, unspecified unspecified atrial fibrillation chronic systolic (congestive) heart failure unspecified dementia without behavioral disturbance dependence on supplemental oxygen body mass index (bmi) 19.9 or less, adult bed confinement status cachexia
white m 81 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  122  k ul; hematology blood platelet count  107  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  238  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  3.3  g dl; chemistry blood albumin  3.4  g dl; blood gas blood lactate  1.4  mmol l$sodium chloride 0.9%  flush  10  ml ; sw  200  ml ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; propofol  1000  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  1000  ml ; hydrocortisone na succ.  50  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; furosemide  40  mg ; 
other specified abnormal findings of blood chemistry stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter unspecified place or not applicable hypertensive heart disease with heart failure unspecified severe protein-calorie malnutrition nicotine dependence, cigarettes, uncomplicated encounter for adjustment and management of automatic implantable cardiac defibrillator major depressive disorder, single episode, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants abnormal coagulation profile hyperlipidemia, unspecified nonrheumatic mitral (valve) stenosis anxiety disorder, unspecified unspecified atrial fibrillation chronic systolic (congestive) heart failure unspecified dementia without behavioral disturbance dependence on supplemental oxygen body mass index (bmi) 19.9 or less, adult bed confinement status cachexia
white m 81 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  78  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  176  mg dl$sodium chloride 0.9%  flush  10  ml ; bag  2  bag ; magnesium sulfate  4  gm ; propofol  1000  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  1000  ml ; hydrocortisone na succ.  50  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; furosemide  40  mg ; warfarin  2  mg ; metoprolol tartrate  6.25  mg ; 
other specified abnormal findings of blood chemistry stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter unspecified place or not applicable hypertensive heart disease with heart failure unspecified severe protein-calorie malnutrition nicotine dependence, cigarettes, uncomplicated encounter for adjustment and management of automatic implantable cardiac defibrillator major depressive disorder, single episode, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants abnormal coagulation profile hyperlipidemia, unspecified nonrheumatic mitral (valve) stenosis anxiety disorder, unspecified unspecified atrial fibrillation chronic systolic (congestive) heart failure unspecified dementia without behavioral disturbance dependence on supplemental oxygen body mass index (bmi) 19.9 or less, adult bed confinement status cachexia
white m 81 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  96  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  10  ml ; bag  2  bag ; magnesium sulfate  4  gm ; propofol  1000  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; warfarin  2  mg ; metoprolol tartrate  6.25  mg ; prednisone  10  mg ; metoprolol succinate xl  12.5  mg ; warfarin  3  mg ; 
other specified abnormal findings of blood chemistry stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter unspecified place or not applicable hypertensive heart disease with heart failure unspecified severe protein-calorie malnutrition nicotine dependence, cigarettes, uncomplicated encounter for adjustment and management of automatic implantable cardiac defibrillator major depressive disorder, single episode, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants abnormal coagulation profile hyperlipidemia, unspecified nonrheumatic mitral (valve) stenosis anxiety disorder, unspecified unspecified atrial fibrillation chronic systolic (congestive) heart failure unspecified dementia without behavioral disturbance dependence on supplemental oxygen body mass index (bmi) 19.9 or less, adult bed confinement status cachexia
white m 81 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  97  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  91  mg dl$prednisone  10  mg ; enoxaparin sodium  60  mg ; metoprolol succinate xl  25  mg ; warfarin  1  mg ; warfarin  1  dose ; 
other specified abnormal findings of blood chemistry stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter unspecified place or not applicable hypertensive heart disease with heart failure unspecified severe protein-calorie malnutrition nicotine dependence, cigarettes, uncomplicated encounter for adjustment and management of automatic implantable cardiac defibrillator major depressive disorder, single episode, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants abnormal coagulation profile hyperlipidemia, unspecified nonrheumatic mitral (valve) stenosis anxiety disorder, unspecified unspecified atrial fibrillation chronic systolic (congestive) heart failure unspecified dementia without behavioral disturbance dependence on supplemental oxygen body mass index (bmi) 19.9 or less, adult bed confinement status cachexia
white m 81 $nan$nan$prednisone  10  mg ; enoxaparin sodium  60  mg ; metoprolol succinate xl  25  mg ; warfarin  1  mg ; warfarin  1  dose ; 
other specified abnormal findings of blood chemistry stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter unspecified place or not applicable hypertensive heart disease with heart failure unspecified severe protein-calorie malnutrition nicotine dependence, cigarettes, uncomplicated encounter for adjustment and management of automatic implantable cardiac defibrillator major depressive disorder, single episode, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants abnormal coagulation profile hyperlipidemia, unspecified nonrheumatic mitral (valve) stenosis anxiety disorder, unspecified unspecified atrial fibrillation chronic systolic (congestive) heart failure unspecified dementia without behavioral disturbance dependence on supplemental oxygen body mass index (bmi) 19.9 or less, adult bed confinement status cachexia
white m 81 $nan$nan$prednisone  10  mg ; enoxaparin sodium  60  mg ; metoprolol succinate xl  25  mg ; warfarin  1  dose ; 
other specified abnormal findings of blood chemistry stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter unspecified place or not applicable hypertensive heart disease with heart failure unspecified severe protein-calorie malnutrition nicotine dependence, cigarettes, uncomplicated encounter for adjustment and management of automatic implantable cardiac defibrillator major depressive disorder, single episode, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants abnormal coagulation profile hyperlipidemia, unspecified nonrheumatic mitral (valve) stenosis anxiety disorder, unspecified unspecified atrial fibrillation chronic systolic (congestive) heart failure unspecified dementia without behavioral disturbance dependence on supplemental oxygen body mass index (bmi) 19.9 or less, adult bed confinement status cachexia
black african american m 48 $nan$nan$amlodipine  10  mg ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; prednisone  120  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; doxorubicin  23  mg ; vincristine (oncovin)  0.5  mg ; etoposide  115  mg ; sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; bisacodyl  5  mg ; oseltamivir  75  mg ; senna  1  tab ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; docusate sodium  100  mg ; 
nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites compression of vein encounter for antineoplastic chemotherapy unspecified essential hypertension other malignant lymphomas, unspecified site, extranodal and solid organ sites long-term (current) use of other medications unspecified essential hypertension benign neoplasm of mediastinum enlargement of lymph nodes
black african american m 48 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  146  mg dl; chemistry blood lactate dehydrogenase (ld)  188  iu l$amlodipine  10  mg ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; prednisone  120  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; doxorubicin  23  mg ; vincristine (oncovin)  0.5  mg ; etoposide  115  mg ; sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; bisacodyl  5  mg ; oseltamivir  75  mg ; senna  1  tab ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; docusate sodium  100  mg ; heparin  5000  unit ; 
nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites compression of vein encounter for antineoplastic chemotherapy unspecified essential hypertension other malignant lymphomas, unspecified site, extranodal and solid organ sites long-term (current) use of other medications unspecified essential hypertension benign neoplasm of mediastinum enlargement of lymph nodes
black african american m 48 $nan$hematology blood hematocrit  31.7  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  307  k ul; hematology blood platelet count  300  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  173  iu l$amlodipine  10  mg ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; prednisone  120  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; doxorubicin  23  mg ; vincristine (oncovin)  0.5  mg ; etoposide  115  mg ; acyclovir  400  mg ; bisacodyl  5  mg ; oseltamivir  75  mg ; senna  1  tab ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; docusate sodium  100  mg ; prednisone  20  mg ; prednisone  100  mg ; 
nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites compression of vein encounter for antineoplastic chemotherapy unspecified essential hypertension other malignant lymphomas, unspecified site, extranodal and solid organ sites long-term (current) use of other medications unspecified essential hypertension benign neoplasm of mediastinum enlargement of lymph nodes
black african american m 48 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  88  mg dl$amlodipine  10  mg ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; doxorubicin  23  mg ; vincristine (oncovin)  0.5  mg ; etoposide  115  mg ; acyclovir  400  mg ; bisacodyl  5  mg ; oseltamivir  75  mg ; senna  1  tab ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; docusate sodium  100  mg ; prednisone  20  mg ; prednisone  100  mg ; 
nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites compression of vein encounter for antineoplastic chemotherapy unspecified essential hypertension other malignant lymphomas, unspecified site, extranodal and solid organ sites long-term (current) use of other medications unspecified essential hypertension benign neoplasm of mediastinum enlargement of lymph nodes
black african american m 48 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  91  mg dl$amlodipine  10  mg ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; doxorubicin  23  mg ; vincristine (oncovin)  0.5  mg ; etoposide  115  mg ; acyclovir  400  mg ; bisacodyl  5  mg ; oseltamivir  75  mg ; senna  1  tab ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; docusate sodium  100  mg ; prednisone  20  mg ; prednisone  100  mg ; 0.9% sodium chloride  250  ml ; cyclophosphamide  1720  mg ; 
nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites compression of vein encounter for antineoplastic chemotherapy unspecified essential hypertension other malignant lymphomas, unspecified site, extranodal and solid organ sites long-term (current) use of other medications unspecified essential hypertension benign neoplasm of mediastinum enlargement of lymph nodes
black african american m 48 $nan$nan$amlodipine  10  mg ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; acyclovir  400  mg ; bisacodyl  5  mg ; oseltamivir  75  mg ; senna  1  tab ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; docusate sodium  100  mg ; prednisone  20  mg ; prednisone  100  mg ; 0.9% sodium chloride  250  ml ; cyclophosphamide  1720  mg ; 
nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites compression of vein encounter for antineoplastic chemotherapy unspecified essential hypertension other malignant lymphomas, unspecified site, extranodal and solid organ sites long-term (current) use of other medications unspecified essential hypertension benign neoplasm of mediastinum enlargement of lymph nodes
white f 63 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; acetaminophen  325-650  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; diphenhydramine  25  mg ; morphine sulfate  1-4  mg ; 
 
white f 63 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; diphenhydramine  25  mg ; oxycodone-acetaminophen  1-2  tab ; metformin (glucophage)  1500  mg ; glyburide  2.5  mg ; atorvastatin  80  mg ; moexipril  15  mg ; fluoxetine  20  mg ; oxycodone (immediate release)   5-10  mg ; d5 1 2ns  1000  ml ; metformin (glucophage)  1000  mg ; 
 
white f 63 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  191  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; metformin (glucophage)  1500  mg ; glyburide  2.5  mg ; atorvastatin  80  mg ; moexipril  15  mg ; fluoxetine  20  mg ; oxycodone (immediate release)   5-10  mg ; d5 1 2ns  1000  ml ; metformin (glucophage)  1000  mg ; 
 
white f 63 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; metformin (glucophage)  1500  mg ; glyburide  2.5  mg ; atorvastatin  80  mg ; moexipril  15  mg ; fluoxetine  20  mg ; oxycodone (immediate release)   5-10  mg ; metformin (glucophage)  1000  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; 
 
white f 63 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; metformin (glucophage)  1500  mg ; glyburide  2.5  mg ; atorvastatin  80  mg ; moexipril  15  mg ; fluoxetine  20  mg ; oxycodone (immediate release)   5-10  mg ; metformin (glucophage)  1000  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; 
 
white m 50 $temp  99.4  heartrate  107.0  resprate  16.0  o2sat  100.0  sbp  130.0  dbp  84.0  rhythm    pain  0  $nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; amlodipine  5  mg ; gabapentin  600  mg ; levothyroxine sodium  125  mcg ; pregabalin  100  mg ; omeprazole  20  mg ; 
hypothyroidism, unspecified other disturbances of skin sensation gastro-esophageal reflux disease without esophagitis acute gastroenteropathy due to norwalk agent essential (primary) hypertension guillain-barre syndrome gastro-esophageal reflux disease without esophagitis guillain-barre syndrome hypothyroidism, unspecified vitamin b12 deficiency anemia, unspecified other place in hospital as the place of occurrence of the external cause guillain-barre syndrome gastro-esophageal reflux disease without esophagitis aspiration of fluid as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other reaction to spinal and lumbar puncture 
white m 50 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  123  iu l; chemistry blood albumin  3.3  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; amlodipine  5  mg ; gabapentin  600  mg ; levothyroxine sodium  125  mcg ; pregabalin  100  mg ; omeprazole  20  mg ; gabapentin  900  mg ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lidocaine 5% ointment  1  appl ; vitamin d  1000  unit ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; pregabalin  25  mg ; pregabalin  75  mg ; 
hypothyroidism, unspecified other disturbances of skin sensation gastro-esophageal reflux disease without esophagitis acute gastroenteropathy due to norwalk agent essential (primary) hypertension guillain-barre syndrome gastro-esophageal reflux disease without esophagitis guillain-barre syndrome hypothyroidism, unspecified vitamin b12 deficiency anemia, unspecified other place in hospital as the place of occurrence of the external cause guillain-barre syndrome gastro-esophageal reflux disease without esophagitis aspiration of fluid as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other reaction to spinal and lumbar puncture 
white m 50 $nan$hematology blood hematocrit  42.8  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  155  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; amlodipine  5  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lidocaine 5% ointment  1  appl ; vitamin d  1000  unit ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
hypothyroidism, unspecified other disturbances of skin sensation gastro-esophageal reflux disease without esophagitis acute gastroenteropathy due to norwalk agent essential (primary) hypertension guillain-barre syndrome gastro-esophageal reflux disease without esophagitis guillain-barre syndrome hypothyroidism, unspecified vitamin b12 deficiency anemia, unspecified other place in hospital as the place of occurrence of the external cause guillain-barre syndrome gastro-esophageal reflux disease without esophagitis aspiration of fluid as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other reaction to spinal and lumbar puncture 
white m 50 $nan$hematology blood hematocrit  41.9  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  381  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  146  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; amlodipine  5  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; lidocaine 5% ointment  1  appl ; vitamin d  1000  unit ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
hypothyroidism, unspecified other disturbances of skin sensation gastro-esophageal reflux disease without esophagitis acute gastroenteropathy due to norwalk agent essential (primary) hypertension guillain-barre syndrome gastro-esophageal reflux disease without esophagitis guillain-barre syndrome hypothyroidism, unspecified vitamin b12 deficiency anemia, unspecified other place in hospital as the place of occurrence of the external cause guillain-barre syndrome gastro-esophageal reflux disease without esophagitis aspiration of fluid as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other reaction to spinal and lumbar puncture 
white m 50 $nan$hematology blood hematocrit  43.1  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  133  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; amlodipine  5  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; lidocaine 5% ointment  1  appl ; vitamin d  1000  unit ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; gabapentin  300  mg ; gabapentin  800  mg ; pregabalin  150  mg ; 
hypothyroidism, unspecified other disturbances of skin sensation gastro-esophageal reflux disease without esophagitis acute gastroenteropathy due to norwalk agent essential (primary) hypertension guillain-barre syndrome gastro-esophageal reflux disease without esophagitis guillain-barre syndrome hypothyroidism, unspecified vitamin b12 deficiency anemia, unspecified other place in hospital as the place of occurrence of the external cause guillain-barre syndrome gastro-esophageal reflux disease without esophagitis aspiration of fluid as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other reaction to spinal and lumbar puncture 
white m 50 $nan$hematology blood hematocrit  44.0  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  357  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  88  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; amlodipine  5  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lidocaine 5% ointment  1  appl ; vitamin d  1000  unit ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; gabapentin  800  mg ; pregabalin  150  mg ; prednisone  60  mg ; 
hypothyroidism, unspecified other disturbances of skin sensation gastro-esophageal reflux disease without esophagitis acute gastroenteropathy due to norwalk agent essential (primary) hypertension guillain-barre syndrome gastro-esophageal reflux disease without esophagitis guillain-barre syndrome hypothyroidism, unspecified vitamin b12 deficiency anemia, unspecified other place in hospital as the place of occurrence of the external cause guillain-barre syndrome gastro-esophageal reflux disease without esophagitis aspiration of fluid as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other reaction to spinal and lumbar puncture 
white m 50 $nan$hematology blood hematocrit  45.8  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  80  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; amlodipine  5  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lidocaine 5% ointment  1  appl ; vitamin d  1000  unit ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; gabapentin  800  mg ; pregabalin  150  mg ; prednisone  60  mg ; 
hypothyroidism, unspecified other disturbances of skin sensation gastro-esophageal reflux disease without esophagitis acute gastroenteropathy due to norwalk agent essential (primary) hypertension guillain-barre syndrome gastro-esophageal reflux disease without esophagitis guillain-barre syndrome hypothyroidism, unspecified vitamin b12 deficiency anemia, unspecified other place in hospital as the place of occurrence of the external cause guillain-barre syndrome gastro-esophageal reflux disease without esophagitis aspiration of fluid as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other reaction to spinal and lumbar puncture 
white m 50 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; amlodipine  5  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lidocaine 5% ointment  1  appl ; vitamin d  1000  unit ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; gabapentin  800  mg ; pregabalin  150  mg ; prednisone  60  mg ; 
hypothyroidism, unspecified other disturbances of skin sensation gastro-esophageal reflux disease without esophagitis acute gastroenteropathy due to norwalk agent essential (primary) hypertension guillain-barre syndrome gastro-esophageal reflux disease without esophagitis guillain-barre syndrome hypothyroidism, unspecified vitamin b12 deficiency anemia, unspecified other place in hospital as the place of occurrence of the external cause guillain-barre syndrome gastro-esophageal reflux disease without esophagitis aspiration of fluid as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other reaction to spinal and lumbar puncture 
white m 91 $nan$hematology blood hematocrit  30.2  %; hematology blood hematocrit  24.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  326  k ul; hematology blood platelet count  230  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  169  mg dl; chemistry blood albumin  2.7  g dl$multivitamins  1  cap ; ferrous sulfate  325  mg ; allopurinol  100  mg ; felodipine  10  mg ; spironolactone  25  mg ; glipizide  25  mg ; clopidogrel  75  mg ; pneumococcal vac polyvalent  0.5  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; furosemide  40  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; 0.9% sodium chloride  250  ml ; oxycodone (immediate release)   2.5-5  mg ; 0.9% sodium chloride  500  ml ; metoprolol tartrate  5  mg ; docusate sodium  100  mg ; senna  1  tab ; propranolol  20  mg ; bag  50  ml ; magnesium sulfate  2  gm ; sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  100  ml ; magnesium sulfate  4  gm ; 
 
white m 91 $nan$hematology blood hematocrit  22.5  %; hematology blood hematocrit  28.4  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  127  mg dl$multivitamins  1  cap ; ferrous sulfate  325  mg ; allopurinol  100  mg ; spironolactone  25  mg ; glipizide  25  mg ; clopidogrel  75  mg ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  100  ml ; magnesium sulfate  4  gm ; enoxaparin sodium  30  mg ; spironolactone  12.5  mg ; oxycodone (immediate release)   2.5  mg ; propranolol  10  mg ; 
 
white m 91 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  75  mg dl$multivitamins  1  cap ; ferrous sulfate  325  mg ; allopurinol  100  mg ; glipizide  25  mg ; clopidogrel  75  mg ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  30  mg ; oxycodone (immediate release)   2.5  mg ; propranolol  10  mg ; aspirin  81  mg ; diltiazem  15  mg ; acetaminophen  1000  mg ; 
 
white m 91 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood glucose  76  mg dl$multivitamins  1  cap ; ferrous sulfate  325  mg ; allopurinol  100  mg ; glipizide  25  mg ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  30  mg ; oxycodone (immediate release)   2.5  mg ; aspirin  81  mg ; diltiazem  15  mg ; acetaminophen  1000  mg ; 
 
white m 91 $nan$nan$multivitamins  1  cap ; ferrous sulfate  325  mg ; allopurinol  100  mg ; glipizide  25  mg ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  30  mg ; oxycodone (immediate release)   2.5  mg ; aspirin  81  mg ; diltiazem  15  mg ; acetaminophen  1000  mg ; 
 
white f 60 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  1000  ml ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; aspirin  325  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; gabapentin  600  mg ; senna  17.2  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ranitidine  150  mg ; loratadine  10  mg ; fluoxetine  20  mg ; 
 
white f 60 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  1000  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5-10  mg ; aspirin  325  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; gabapentin  600  mg ; senna  17.2  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ranitidine  150  mg ; loratadine  10  mg ; fluoxetine  20  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
white f 60 $nan$nan$ondansetron  4  mg ; bisacodyl  10  mg ; oxycodone (immediate release)   5-10  mg ; aspirin  325  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; gabapentin  600  mg ; senna  17.2  mg ; ranitidine  150  mg ; loratadine  10  mg ; fluoxetine  20  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
other f 41 $nan$nan$ibuprofen  600  mg ; acetaminophen  1000  mg ; labetalol  20  mg ; hydralazine  10  mg ; labetalol  10  mg ; levothyroxine sodium  50  mcg ; nifedipine cr  30  mg ; 
unspecified acquired hypothyroidism unspecified motorcycle rider injured in collision with fixed or stationary object in nontraffic accident thyroid dysfunction of mother, delivered, with or without mention of antepartum condition poor fetal growth, affecting management of mother, delivered, with or without mention of antepartum condition multiple gestation with malpresentation of one fetus or more, delivered, with or without mention of antepartum condition anemia, unspecified twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) burn due to other powered watercraft on fire twin pregnancy, delivered, with or without mention of antepartum condition anemia of mother, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition outcome of delivery, twins, both liveborn transient hypertension of pregnancy, delivered , with or without mention of antepartum condition endometriosis of uterus other specified complications of pregnancy, delivered, with or without mention of antepartum condition epistaxis twin pregnancy, antepartum condition or complication transient hypertension of pregnancy, antepartum condition or complication burn due to other powered watercraft on fire twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) threatened premature labor, antepartum condition or complication twin pregnancy, antepartum condition or complication twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) burn due to other powered watercraft on fire anemia of mother, antepartum condition or complication unspecified acquired hypothyroidism threatened premature labor, antepartum condition or complication cervical shortening, antepartum condition or complication twin pregnancy, antepartum condition or complication thyroid dysfunction of mother, antepartum condition or complication anemia, unspecified burn due to other powered watercraft on fire polyhydramnios, antepartum condition or complication twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) elderly primigravida, antepartum condition or complication other postprocedural status other noninflammatory disorders of ovary, fallopian tube, and broad ligament abnormal coagulation profile other chronic pain pulmonary collapse other and unspecified ovarian cyst lumbago unspecified acquired hypothyroidism unspecified pleural effusion fever, unspecified 
other f 41 $nan$nan$ibuprofen  600  mg ; acetaminophen  1000  mg ; labetalol  20  mg ; hydralazine  10  mg ; labetalol  10  mg ; levothyroxine sodium  50  mcg ; nifedipine cr  30  mg ; levothyroxine sodium  75  mcg ; 
unspecified acquired hypothyroidism unspecified motorcycle rider injured in collision with fixed or stationary object in nontraffic accident thyroid dysfunction of mother, delivered, with or without mention of antepartum condition poor fetal growth, affecting management of mother, delivered, with or without mention of antepartum condition multiple gestation with malpresentation of one fetus or more, delivered, with or without mention of antepartum condition anemia, unspecified twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) burn due to other powered watercraft on fire twin pregnancy, delivered, with or without mention of antepartum condition anemia of mother, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition outcome of delivery, twins, both liveborn transient hypertension of pregnancy, delivered , with or without mention of antepartum condition endometriosis of uterus other specified complications of pregnancy, delivered, with or without mention of antepartum condition epistaxis twin pregnancy, antepartum condition or complication transient hypertension of pregnancy, antepartum condition or complication burn due to other powered watercraft on fire twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) threatened premature labor, antepartum condition or complication twin pregnancy, antepartum condition or complication twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) burn due to other powered watercraft on fire anemia of mother, antepartum condition or complication unspecified acquired hypothyroidism threatened premature labor, antepartum condition or complication cervical shortening, antepartum condition or complication twin pregnancy, antepartum condition or complication thyroid dysfunction of mother, antepartum condition or complication anemia, unspecified burn due to other powered watercraft on fire polyhydramnios, antepartum condition or complication twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) elderly primigravida, antepartum condition or complication other postprocedural status other noninflammatory disorders of ovary, fallopian tube, and broad ligament abnormal coagulation profile other chronic pain pulmonary collapse other and unspecified ovarian cyst lumbago unspecified acquired hypothyroidism unspecified pleural effusion fever, unspecified 
black african american f 71 $temp    heartrate  79.0  resprate  16.0  o2sat  100.0  sbp  134.0  dbp  65.0  rhythm    pain  "95"  ; temp  98.4  heartrate  89.0  resprate  16.0  o2sat  100.0  sbp  124.0  dbp  57.0  rhythm    pain    $hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  87  mg dl$diazepam  2  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  325  mg ; bisacodyl  10  mg ; cyanocobalamin  1000  mcg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; losartan potassium  100  mg ; metformin xr (glucophage xr)  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; polyethylene glycol  17  g ; senna  8.6  mg ; tramadol (ultram)  50  mg ; acyclovir  400  mg ; sulfameth trimethoprim ss  1  tab ; trazodone  25  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; tramadol (ultram)  50-100  mg ; 
multiple myeloma, without mention of having achieved remission other and unspecified disc disorder, lumbar region pneumonia, organism unspecified pneumococcal septicemia [streptococcus pneumoniae septicemia] acute kidney failure, unspecified unspecified essential hypertension osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh lumbosacral spondylosis without myelopathy septic shock intraspinal abscess diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled person on outside of bus injured in collision with pedestrian or animal in traffic accident obesity, unspecified obstructive sleep apnea (adult)(pediatric) examination of participant in clinical trial anemia in neoplastic disease long-term (current) use of other medications acute osteomyelitis, other specified sites unspecified acquired hypothyroidism severe sepsis personal history of tobacco use knee joint replacement obesity, unspecified personal history of tobacco use unspecified acquired hypothyroidism unspecified essential hypertension retention of urine, unspecified mild cognitive impairment, so stated intervertebral disc disorder with myelopathy, thoracic region full incontinence of feces cerebral aneurysm, nonruptured obstructive sleep apnea (adult)(pediatric) syringomyelia and syringobulbia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled body mass index 36.0-36.9, adult other psoriasis monoclonal paraproteinemia knee joint replacement knee joint replacement obesity, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled arthropathy, unspecified, site unspecified esophageal reflux cerebral aneurysm, nonruptured anemia, unspecified unspecified essential hypertension headache obstructive sleep apnea (adult)(pediatric)
black african american f 71 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  325  mg ; bisacodyl  10  mg ; cyanocobalamin  1000  mcg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; losartan potassium  100  mg ; metformin xr (glucophage xr)  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; polyethylene glycol  17  g ; senna  8.6  mg ; acyclovir  400  mg ; sulfameth trimethoprim ss  1  tab ; trazodone  25  mg ; tramadol (ultram)  50-100  mg ; 
multiple myeloma, without mention of having achieved remission other and unspecified disc disorder, lumbar region pneumonia, organism unspecified pneumococcal septicemia [streptococcus pneumoniae septicemia] acute kidney failure, unspecified unspecified essential hypertension osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh lumbosacral spondylosis without myelopathy septic shock intraspinal abscess diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled person on outside of bus injured in collision with pedestrian or animal in traffic accident obesity, unspecified obstructive sleep apnea (adult)(pediatric) examination of participant in clinical trial anemia in neoplastic disease long-term (current) use of other medications acute osteomyelitis, other specified sites unspecified acquired hypothyroidism severe sepsis personal history of tobacco use knee joint replacement obesity, unspecified personal history of tobacco use unspecified acquired hypothyroidism unspecified essential hypertension retention of urine, unspecified mild cognitive impairment, so stated intervertebral disc disorder with myelopathy, thoracic region full incontinence of feces cerebral aneurysm, nonruptured obstructive sleep apnea (adult)(pediatric) syringomyelia and syringobulbia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled body mass index 36.0-36.9, adult other psoriasis monoclonal paraproteinemia knee joint replacement knee joint replacement obesity, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled arthropathy, unspecified, site unspecified esophageal reflux cerebral aneurysm, nonruptured anemia, unspecified unspecified essential hypertension headache obstructive sleep apnea (adult)(pediatric)
white f 66 $temp  98.3  heartrate  82.0  resprate  16.0  o2sat  98.0  sbp  112.0  dbp  64.0  rhythm    pain  5  $hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; clonazepam  1  mg ; gabapentin  600  mg ; morphine sr (ms contin)  60  mg ; prochlorperazine  5-10  mg ; hydromorphone (dilaudid)  4  mg ; hydromorphone (dilaudid)  4-8  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
essential (primary) hypertension family history of malignant neoplasm of other organs or systems personal history of malignant melanoma of skin compression of vein long term (current) use of non-steroidal anti-inflammatories (nsaid) secondary malignant neoplasm of other specified sites cellulitis of right lower limb lymphedema, not elsewhere classified disruption of wound, unspecified, initial encounter obesity, unspecified body mass index (bmi) 40.0-44.9, adult anxiety disorder, unspecified chronic embolism and thrombosis of unspecified deep veins of right distal lower extremity other postoperative infection long-term (current) use of anticoagulants anxiety state, unspecified personal history of malignant melanoma of skin personal history of venous thrombosis and embolism secondary malignant neoplasm of other specified sites methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation family history of other specified malignant neoplasm acute venous embolism and thrombosis of deep vessels of proximal lower extremity body mass index 29.0-29.9, adult obesity, unspecified constipation, unspecified peripheral vascular complications, not elsewhere classified long-term (current) use of anticoagulants other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified venous embolism and thrombosis of superficial vessels of lower extremity secondary and unspecified malignant neoplasm of intrapelvic lymph nodes personal history of malignant melanoma of skin family history of other specified malignant neoplasm other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site infected postoperative seroma cellulitis and abscess of trunk body mass index 31.0-31.9, adult obesity, unspecified secondary and unspecified malignant neoplasm of intrapelvic lymph nodes personal history of malignant melanoma of skin unspecified occupant of heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident procedure not carried out for other reasons family history of other lymphatic and hematopoietic neoplasms family history of other specified malignant neoplasm body mass index 31.0-31.9, adult morbid obesity
white f 66 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; clonazepam  1  mg ; gabapentin  600  mg ; morphine sr (ms contin)  60  mg ; prochlorperazine  5-10  mg ; hydromorphone (dilaudid)  4-8  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
essential (primary) hypertension family history of malignant neoplasm of other organs or systems personal history of malignant melanoma of skin compression of vein long term (current) use of non-steroidal anti-inflammatories (nsaid) secondary malignant neoplasm of other specified sites cellulitis of right lower limb lymphedema, not elsewhere classified disruption of wound, unspecified, initial encounter obesity, unspecified body mass index (bmi) 40.0-44.9, adult anxiety disorder, unspecified chronic embolism and thrombosis of unspecified deep veins of right distal lower extremity other postoperative infection long-term (current) use of anticoagulants anxiety state, unspecified personal history of malignant melanoma of skin personal history of venous thrombosis and embolism secondary malignant neoplasm of other specified sites methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation family history of other specified malignant neoplasm acute venous embolism and thrombosis of deep vessels of proximal lower extremity body mass index 29.0-29.9, adult obesity, unspecified constipation, unspecified peripheral vascular complications, not elsewhere classified long-term (current) use of anticoagulants other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified venous embolism and thrombosis of superficial vessels of lower extremity secondary and unspecified malignant neoplasm of intrapelvic lymph nodes personal history of malignant melanoma of skin family history of other specified malignant neoplasm other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site infected postoperative seroma cellulitis and abscess of trunk body mass index 31.0-31.9, adult obesity, unspecified secondary and unspecified malignant neoplasm of intrapelvic lymph nodes personal history of malignant melanoma of skin unspecified occupant of heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident procedure not carried out for other reasons family history of other lymphatic and hematopoietic neoplasms family history of other specified malignant neoplasm body mass index 31.0-31.9, adult morbid obesity
white f 66 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; clonazepam  1  mg ; gabapentin  600  mg ; morphine sr (ms contin)  60  mg ; prochlorperazine  5-10  mg ; hydromorphone (dilaudid)  4-8  mg ; cephalexin  500  mg ; capsaicin 0.025%  1  appl ; lidocaine 5% patch  2  ptch ; 
essential (primary) hypertension family history of malignant neoplasm of other organs or systems personal history of malignant melanoma of skin compression of vein long term (current) use of non-steroidal anti-inflammatories (nsaid) secondary malignant neoplasm of other specified sites cellulitis of right lower limb lymphedema, not elsewhere classified disruption of wound, unspecified, initial encounter obesity, unspecified body mass index (bmi) 40.0-44.9, adult anxiety disorder, unspecified chronic embolism and thrombosis of unspecified deep veins of right distal lower extremity other postoperative infection long-term (current) use of anticoagulants anxiety state, unspecified personal history of malignant melanoma of skin personal history of venous thrombosis and embolism secondary malignant neoplasm of other specified sites methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation family history of other specified malignant neoplasm acute venous embolism and thrombosis of deep vessels of proximal lower extremity body mass index 29.0-29.9, adult obesity, unspecified constipation, unspecified peripheral vascular complications, not elsewhere classified long-term (current) use of anticoagulants other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation anxiety state, unspecified venous embolism and thrombosis of superficial vessels of lower extremity secondary and unspecified malignant neoplasm of intrapelvic lymph nodes personal history of malignant melanoma of skin family history of other specified malignant neoplasm other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site infected postoperative seroma cellulitis and abscess of trunk body mass index 31.0-31.9, adult obesity, unspecified secondary and unspecified malignant neoplasm of intrapelvic lymph nodes personal history of malignant melanoma of skin unspecified occupant of heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident procedure not carried out for other reasons family history of other lymphatic and hematopoietic neoplasms family history of other specified malignant neoplasm body mass index 31.0-31.9, adult morbid obesity
white m 59 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; lisinopril  20  mg ; 
 
white m 59 $nan$hematology blood hematocrit  39.7  %; hematology blood hematocrit  40.2  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  303  k ul; hematology blood platelet count  313  k ul; hematology blood platelet count  293  k ul; hematology blood platelet count  302  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  273  iu l; chemistry blood albumin  4.3  g dl$aspirin ec  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; lisinopril  20  mg ; 1 2 ns  1000  ml ; atropine sulfate  0.5  mg ; sw  100  ml ; eptifibatide  75  mg ; sodium chloride 0.9%  flush  3  ml ; lisinopril  10  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; metoprolol tartrate  12.5  mg ; acetylcysteine 20%  600  mg ; docusate sodium  100  mg ; hydrochlorothiazide  37.5  mg ; lisinopril  30  mg ; 
 
white m 59 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  129  mg dl$aspirin ec  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; atropine sulfate  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; lisinopril  10  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; acetylcysteine 20%  600  mg ; docusate sodium  100  mg ; hydrochlorothiazide  37.5  mg ; lisinopril  30  mg ; heparin  5000  unit ; 
 
white m 59 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; atropine sulfate  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; docusate sodium  100  mg ; hydrochlorothiazide  37.5  mg ; lisinopril  30  mg ; heparin  5000  unit ; 
 
white f 74 $temp  97.9  heartrate  97.0  resprate  22.0  o2sat  93.0  sbp  149.0  dbp  79.0  rhythm    pain    $hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  171  iu l; chemistry blood albumin  3.6  g dl$lactated ringers  1000  ml ; levofloxacin  500  mg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; divalproex (delayed release)  250  mg ; clonazepam  0.25  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; carbidopa-levodopa (25-100)  1  tab ; omeprazole  20  mg ; folic acid  2  mg ; metoprolol succinate xl  200  mg ; lisinopril  2.5  mg ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  1000  mg ; quetiapine fumarate  50  mg ; 
unspecified essential hypertension bronchitis, not specified as acute or chronic mycosis fungoides, unspecified site, extranodal and solid organ sites acute upper respiratory infections of unspecified site urinary tract infection, site not specified paralysis agitans chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, in remission other late effects of cerebrovascular disease pulmonary collapse esophageal reflux muscle weakness (generalized) benign essential hypertension pneumonia, organism unspecified bipolar disorder, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified paralysis agitans delirium due to conditions classified elsewhere mycosis fungoides, unspecified site, extranodal and solid organ sites other malignant lymphomas, unspecified site, extranodal and solid organ sites urinary frequency esophageal reflux urinary tract infection, site not specified bacteremia paralysis agitans escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site congestive heart failure, unspecified benign essential hypertension bipolar disorder, unspecified chronic lymphoid leukemia, without mention of having achieved remission encephalopathy, unspecified dysthymic disorder chronic systolic heart failure 
white f 74 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  107  mg dl$miconazole powder 2%  1  appl ; heparin  5000  unit ; divalproex (delayed release)  250  mg ; clonazepam  0.25  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; carbidopa-levodopa (25-100)  1  tab ; omeprazole  20  mg ; folic acid  2  mg ; metoprolol succinate xl  200  mg ; lisinopril  2.5  mg ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  1000  mg ; quetiapine fumarate  50  mg ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; pramipexole  0.125  mg ; heparin flush (10 units ml)  2  ml ; clobetasol propionate 0.05% cream  1  appl ; 
unspecified essential hypertension bronchitis, not specified as acute or chronic mycosis fungoides, unspecified site, extranodal and solid organ sites acute upper respiratory infections of unspecified site urinary tract infection, site not specified paralysis agitans chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, in remission other late effects of cerebrovascular disease pulmonary collapse esophageal reflux muscle weakness (generalized) benign essential hypertension pneumonia, organism unspecified bipolar disorder, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified paralysis agitans delirium due to conditions classified elsewhere mycosis fungoides, unspecified site, extranodal and solid organ sites other malignant lymphomas, unspecified site, extranodal and solid organ sites urinary frequency esophageal reflux urinary tract infection, site not specified bacteremia paralysis agitans escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site congestive heart failure, unspecified benign essential hypertension bipolar disorder, unspecified chronic lymphoid leukemia, without mention of having achieved remission encephalopathy, unspecified dysthymic disorder chronic systolic heart failure 
white f 74 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  133  mg dl$miconazole powder 2%  1  appl ; heparin  5000  unit ; divalproex (delayed release)  250  mg ; clonazepam  0.25  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; carbidopa-levodopa (25-100)  1  tab ; omeprazole  20  mg ; folic acid  2  mg ; metoprolol succinate xl  200  mg ; lisinopril  2.5  mg ; senna  1  tab ; docusate sodium  100  mg ; quetiapine fumarate  50  mg ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; pramipexole  0.125  mg ; heparin flush (10 units ml)  2  ml ; clobetasol propionate 0.05% cream  1  appl ; 
unspecified essential hypertension bronchitis, not specified as acute or chronic mycosis fungoides, unspecified site, extranodal and solid organ sites acute upper respiratory infections of unspecified site urinary tract infection, site not specified paralysis agitans chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, in remission other late effects of cerebrovascular disease pulmonary collapse esophageal reflux muscle weakness (generalized) benign essential hypertension pneumonia, organism unspecified bipolar disorder, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified paralysis agitans delirium due to conditions classified elsewhere mycosis fungoides, unspecified site, extranodal and solid organ sites other malignant lymphomas, unspecified site, extranodal and solid organ sites urinary frequency esophageal reflux urinary tract infection, site not specified bacteremia paralysis agitans escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site congestive heart failure, unspecified benign essential hypertension bipolar disorder, unspecified chronic lymphoid leukemia, without mention of having achieved remission encephalopathy, unspecified dysthymic disorder chronic systolic heart failure 
white m 58 $nan$nan$dexamethasone  10  mg ; 
fever presenting with conditions classified elsewhere neutropenia, unspecified nodular lymphoma, unspecified site, extranodal and solid organ sites other specified cardiac dysrhythmias personal history of venous thrombosis and embolism diarrhea other and unspecified diseases of the oral soft tissues 
white m 58 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  171  iu l; chemistry blood albumin  3.8  g dl$dexamethasone  10  mg ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  250  ml ; cyclophosphamide  2140  mg ; 0.9% sodium chloride  50  ml ; mesna  1280  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; ondansetron  8  mg ; lorazepam  0.5-2  mg ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; 
fever presenting with conditions classified elsewhere neutropenia, unspecified nodular lymphoma, unspecified site, extranodal and solid organ sites other specified cardiac dysrhythmias personal history of venous thrombosis and embolism diarrhea other and unspecified diseases of the oral soft tissues 
white m 58 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  250  ml ; cyclophosphamide  2140  mg ; 0.9% sodium chloride  50  ml ; mesna  1280  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; ondansetron  8  mg ; lorazepam  0.5-2  mg ; 0.9% sodium chloride  1000  ml ; 
fever presenting with conditions classified elsewhere neutropenia, unspecified nodular lymphoma, unspecified site, extranodal and solid organ sites other specified cardiac dysrhythmias personal history of venous thrombosis and embolism diarrhea other and unspecified diseases of the oral soft tissues 
black african american m 54 $nan$nan$omeprazole  20  mg ; furosemide  40  mg ; multivitamins  1  tab ; 
hiccough mechanical complication due to other implant and internal device, not elsewhere classified thrombocytopenia, unspecified other pancytopenia leukocytopenia, unspecified unspecified pruritic disorder unspecified essential hypertension anxiety state, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) complications of transplanted liver cholangitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation jaundice, unspecified, not of newborn hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified other ascites chronic congestive splenomegaly awaiting organ transplant status unspecified essential hypertension personal history of venous thrombosis and embolism fever, unspecified other secondary thrombocytopenia leukocytopenia, unspecified complications of transplanted liver cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding neutropenia, unspecified portal vein thrombosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified viral hepatitis c without hepatic coma other ascites rash and other nonspecific skin eruption spontaneous bacterial peritonitis fever, unspecified unspecified essential hypertension esophageal varices without mention of bleeding awaiting organ transplant status chronic hepatitis c without mention of hepatic coma personal history of venous thrombosis and embolism hyposmolality and/or hyponatremia acute kidney failure, unspecified spontaneous bacterial peritonitis chronic hepatitis c without mention of hepatic coma esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified deficiency anemia streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group g hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
black african american m 54 $nan$hematology blood hematocrit  31.5  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  74  k ul; hematology blood platelet count  93  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  40.2  mg dl; chemistry blood bilirubin, total  40.2  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.4  g dl$omeprazole  20  mg ; furosemide  40  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; vitamin d  400  unit ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; lactulose  30  ml ; cyclosporine (neoral) modified  100  mg ; cyclosporine (neoral) modified  25  mg ; cyclosporine (neoral) modified  50  mg ; olanzapine  10  mg ; valganciclovir  900  mg ; 0.9% sodium chloride  50  ml ; daptomycin  500  mg ; ursodiol  300  mg ; heparin  5000  unit ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; tamsulosin  0.4  mg ; hydroxyzine  25  mg ; potassium chloride  40  meq ; heparin flush (10 units ml)  2  ml ; 0.9% sodium chloride  250  ml ; 
hiccough mechanical complication due to other implant and internal device, not elsewhere classified thrombocytopenia, unspecified other pancytopenia leukocytopenia, unspecified unspecified pruritic disorder unspecified essential hypertension anxiety state, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) complications of transplanted liver cholangitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation jaundice, unspecified, not of newborn hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified other ascites chronic congestive splenomegaly awaiting organ transplant status unspecified essential hypertension personal history of venous thrombosis and embolism fever, unspecified other secondary thrombocytopenia leukocytopenia, unspecified complications of transplanted liver cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding neutropenia, unspecified portal vein thrombosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified viral hepatitis c without hepatic coma other ascites rash and other nonspecific skin eruption spontaneous bacterial peritonitis fever, unspecified unspecified essential hypertension esophageal varices without mention of bleeding awaiting organ transplant status chronic hepatitis c without mention of hepatic coma personal history of venous thrombosis and embolism hyposmolality and/or hyponatremia acute kidney failure, unspecified spontaneous bacterial peritonitis chronic hepatitis c without mention of hepatic coma esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified deficiency anemia streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group g hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
black african american m 54 $nan$nan$omeprazole  20  mg ; furosemide  40  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; vitamin d  400  unit ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; lactulose  30  ml ; valganciclovir  900  mg ; 0.9% sodium chloride  50  ml ; daptomycin  500  mg ; ursodiol  300  mg ; heparin  5000  unit ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; tamsulosin  0.4  mg ; hydroxyzine  25  mg ; potassium chloride  40  meq ; heparin flush (10 units ml)  2  ml ; 
hiccough mechanical complication due to other implant and internal device, not elsewhere classified thrombocytopenia, unspecified other pancytopenia leukocytopenia, unspecified unspecified pruritic disorder unspecified essential hypertension anxiety state, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) complications of transplanted liver cholangitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation jaundice, unspecified, not of newborn hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified other ascites chronic congestive splenomegaly awaiting organ transplant status unspecified essential hypertension personal history of venous thrombosis and embolism fever, unspecified other secondary thrombocytopenia leukocytopenia, unspecified complications of transplanted liver cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding neutropenia, unspecified portal vein thrombosis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified viral hepatitis c without hepatic coma other ascites rash and other nonspecific skin eruption spontaneous bacterial peritonitis fever, unspecified unspecified essential hypertension esophageal varices without mention of bleeding awaiting organ transplant status chronic hepatitis c without mention of hepatic coma personal history of venous thrombosis and embolism hyposmolality and/or hyponatremia acute kidney failure, unspecified spontaneous bacterial peritonitis chronic hepatitis c without mention of hepatic coma esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified deficiency anemia streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group g hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
other f 60 $nan$hematology blood hematocrit  36.6  %; hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  235  k ul; hematology blood platelet count  222  k ul; hematology blood platelet count  223  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3-10  ml ; nitroglycerin sl  0.3  mg ; sodium chloride 0.9%  1000  ml ; omeprazole  20  mg ; vitamin d  1000  unit ; potassium chloride  20  meq ; senna  8.6  mg ; heparin  1000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  6.25  mg ; aspirin  81  mg ; clopidogrel  75  mg ; ramipril  10  mg ; atorvastatin  80  mg ; 
 
other f 60 $nan$hematology blood hematocrit  36.4  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  238  k ul; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  $sodium chloride 0.9%  flush  3-10  ml ; nitroglycerin sl  0.3  mg ; omeprazole  20  mg ; vitamin d  1000  unit ; potassium chloride  20  meq ; senna  8.6  mg ; metoprolol tartrate  6.25  mg ; aspirin  81  mg ; clopidogrel  75  mg ; ramipril  10  mg ; atorvastatin  80  mg ; potassium chloride  40  meq ; metoprolol succinate xl  12.5  mg ; 
 
white m 76 $temp  102.9  heartrate  86.0  resprate  28.0  o2sat  97.0  sbp  114.0  dbp  48.0  rhythm    pain  sleeping  $hematology blood hematocrit  35.4  %; hematology blood hematocrit  37.2  %; hematology blood hematocrit  38.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  152  k ul; hematology blood platelet count  139  k ul; hematology blood platelet count  174  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.3  ; hematology urine wbc  20  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  173  iu l; blood gas blood lactate  1.4  mmol l$sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; tiotropium bromide  2  puff ; sulfameth trimethoprim ss  1  tab ; ranitidine  75  mg ; psyllium powder  1  pkt ; prednisone  5  mg ; nitroglycerin sl  0.3  mg ; montelukast  10  mg ; metoprolol succinate xl  12.5  mg ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; bag  1  bag ; magnesium sulfate  2  gm ; metoclopramide  5  mg ; lactated ringers  1000  ml ; tacrolimus  0.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; lidocaine jelly 2% (glydo)  1  appl ; mycophenolate mofetil  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; metoclopramide  10  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; lorazepam  0.25  mg ; azithromycin  500  mg ; hydrocortisone na succ.  50  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; tacrolimus  1  mg ; loratadine  10  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 
esophageal reflux kidney replaced by transplant other diseases of lung, not elsewhere classified other emphysema percutaneous transluminal coronary angioplasty status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias chronic kidney disease, unspecified coronary atherosclerosis of native coronary artery contusion of abdominal wall acute kidney failure, unspecified accidents occurring in unspecified place end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other respiratory abnormalities kidney replaced by transplant volume depletion, unspecified dizziness and giddiness esophageal reflux unspecified accident nausea alone end stage renal disease shortness of breath hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident esophageal reflux coronary atherosclerosis of native coronary artery end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza other and unspecified angina pectoris kidney replaced by transplant reflux esophagitis end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant unspecified gastritis and gastroduodenitis, without mention of hemorrhage nausea alone
white m 76 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  244  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; heparin  5000  unit ; tiotropium bromide  2  puff ; sulfameth trimethoprim ss  1  tab ; ranitidine  75  mg ; psyllium powder  1  pkt ; prednisone  5  mg ; nitroglycerin sl  0.3  mg ; montelukast  10  mg ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; metoclopramide  10  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; azithromycin  500  mg ; hydrocortisone na succ.  50  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; tacrolimus  1  mg ; loratadine  10  mg ; azithromycin  250  mg ; phosphorus  250  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
esophageal reflux kidney replaced by transplant other diseases of lung, not elsewhere classified other emphysema percutaneous transluminal coronary angioplasty status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias chronic kidney disease, unspecified coronary atherosclerosis of native coronary artery contusion of abdominal wall acute kidney failure, unspecified accidents occurring in unspecified place end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other respiratory abnormalities kidney replaced by transplant volume depletion, unspecified dizziness and giddiness esophageal reflux unspecified accident nausea alone end stage renal disease shortness of breath hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident esophageal reflux coronary atherosclerosis of native coronary artery end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza other and unspecified angina pectoris kidney replaced by transplant reflux esophagitis end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant unspecified gastritis and gastroduodenitis, without mention of hemorrhage nausea alone
white m 76 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  169  mg dl; chemistry blood glucose  265  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; heparin  5000  unit ; tiotropium bromide  2  puff ; sulfameth trimethoprim ss  1  tab ; ranitidine  75  mg ; psyllium powder  1  pkt ; nitroglycerin sl  0.3  mg ; montelukast  10  mg ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; metoclopramide  10  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; hydrocortisone na succ.  50  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; tacrolimus  1  mg ; loratadine  10  mg ; azithromycin  250  mg ; phosphorus  250  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; neutra-phos  2  pkt ; 5% dextrose  250  ml ; sodium phosphate  30  mmol ; sodium chloride 0.9%  flush  10  ml ; 
esophageal reflux kidney replaced by transplant other diseases of lung, not elsewhere classified other emphysema percutaneous transluminal coronary angioplasty status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias chronic kidney disease, unspecified coronary atherosclerosis of native coronary artery contusion of abdominal wall acute kidney failure, unspecified accidents occurring in unspecified place end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other respiratory abnormalities kidney replaced by transplant volume depletion, unspecified dizziness and giddiness esophageal reflux unspecified accident nausea alone end stage renal disease shortness of breath hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident esophageal reflux coronary atherosclerosis of native coronary artery end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza other and unspecified angina pectoris kidney replaced by transplant reflux esophagitis end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant unspecified gastritis and gastroduodenitis, without mention of hemorrhage nausea alone
white m 76 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; heparin  5000  unit ; tiotropium bromide  2  puff ; sulfameth trimethoprim ss  1  tab ; ranitidine  75  mg ; psyllium powder  1  pkt ; nitroglycerin sl  0.3  mg ; montelukast  10  mg ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; metoclopramide  10  mg ; tacrolimus  1  mg ; loratadine  10  mg ; azithromycin  250  mg ; phosphorus  250  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 5% dextrose  250  ml ; sodium phosphate  30  mmol ; mycophenolate mofetil  500  mg ; levofloxacin  750  mg ; 
esophageal reflux kidney replaced by transplant other diseases of lung, not elsewhere classified other emphysema percutaneous transluminal coronary angioplasty status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias chronic kidney disease, unspecified coronary atherosclerosis of native coronary artery contusion of abdominal wall acute kidney failure, unspecified accidents occurring in unspecified place end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other respiratory abnormalities kidney replaced by transplant volume depletion, unspecified dizziness and giddiness esophageal reflux unspecified accident nausea alone end stage renal disease shortness of breath hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident esophageal reflux coronary atherosclerosis of native coronary artery end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza other and unspecified angina pectoris kidney replaced by transplant reflux esophagitis end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant unspecified gastritis and gastroduodenitis, without mention of hemorrhage nausea alone
white m 76 $nan$hematology blood hematocrit  44.8  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; heparin  5000  unit ; tiotropium bromide  2  puff ; sulfameth trimethoprim ss  1  tab ; ranitidine  75  mg ; psyllium powder  1  pkt ; nitroglycerin sl  0.3  mg ; montelukast  10  mg ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; metoclopramide  10  mg ; tacrolimus  1  mg ; loratadine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; mycophenolate mofetil  500  mg ; levofloxacin  750  mg ; 
esophageal reflux kidney replaced by transplant other diseases of lung, not elsewhere classified other emphysema percutaneous transluminal coronary angioplasty status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias chronic kidney disease, unspecified coronary atherosclerosis of native coronary artery contusion of abdominal wall acute kidney failure, unspecified accidents occurring in unspecified place end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other respiratory abnormalities kidney replaced by transplant volume depletion, unspecified dizziness and giddiness esophageal reflux unspecified accident nausea alone end stage renal disease shortness of breath hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident esophageal reflux coronary atherosclerosis of native coronary artery end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza other and unspecified angina pectoris kidney replaced by transplant reflux esophagitis end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant unspecified gastritis and gastroduodenitis, without mention of hemorrhage nausea alone
white m 76 $nan$hematology blood hematocrit  45.2  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; heparin  5000  unit ; tiotropium bromide  2  puff ; sulfameth trimethoprim ss  1  tab ; ranitidine  75  mg ; psyllium powder  1  pkt ; nitroglycerin sl  0.3  mg ; montelukast  10  mg ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; metoclopramide  10  mg ; tacrolimus  1  mg ; loratadine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; mycophenolate mofetil  500  mg ; levofloxacin  750  mg ; 
esophageal reflux kidney replaced by transplant other diseases of lung, not elsewhere classified other emphysema percutaneous transluminal coronary angioplasty status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias chronic kidney disease, unspecified coronary atherosclerosis of native coronary artery contusion of abdominal wall acute kidney failure, unspecified accidents occurring in unspecified place end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other respiratory abnormalities kidney replaced by transplant volume depletion, unspecified dizziness and giddiness esophageal reflux unspecified accident nausea alone end stage renal disease shortness of breath hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident esophageal reflux coronary atherosclerosis of native coronary artery end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza other and unspecified angina pectoris kidney replaced by transplant reflux esophagitis end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant unspecified gastritis and gastroduodenitis, without mention of hemorrhage nausea alone
white m 76 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; heparin  5000  unit ; tiotropium bromide  2  puff ; sulfameth trimethoprim ss  1  tab ; ranitidine  75  mg ; psyllium powder  1  pkt ; nitroglycerin sl  0.3  mg ; montelukast  10  mg ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; metoclopramide  10  mg ; tacrolimus  1  mg ; loratadine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; mycophenolate mofetil  500  mg ; levofloxacin  750  mg ; 
esophageal reflux kidney replaced by transplant other diseases of lung, not elsewhere classified other emphysema percutaneous transluminal coronary angioplasty status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias chronic kidney disease, unspecified coronary atherosclerosis of native coronary artery contusion of abdominal wall acute kidney failure, unspecified accidents occurring in unspecified place end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other respiratory abnormalities kidney replaced by transplant volume depletion, unspecified dizziness and giddiness esophageal reflux unspecified accident nausea alone end stage renal disease shortness of breath hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident esophageal reflux coronary atherosclerosis of native coronary artery end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hemorrhage complicating a procedure coronary atherosclerosis of native coronary artery need for prophylactic vaccination and inoculation against influenza other and unspecified angina pectoris kidney replaced by transplant reflux esophagitis end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant unspecified gastritis and gastroduodenitis, without mention of hemorrhage nausea alone
asian f 68 $temp    heartrate  84.0  resprate  14.0  o2sat  100.0  sbp  117.0  dbp  60.0  rhythm    pain  5 10  ; temp  98.4  heartrate  90.0  resprate  15.0  o2sat  100.0  sbp  119.0  dbp  53.0  rhythm    pain  5 10  $hematology blood hematocrit  31.5  %; hematology blood hematocrit  29.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  145  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  89  meq l; chemistry urine creatinine, urine  48  mg dl; chemistry urine potassium, urine  24  meq l; chemistry urine sodium, urine  48  meq l; chemistry urine urea nitrogen, urine  889  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  54  mg dl; chemistry blood glucose  61  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hemoglobin  11.9  g dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; glucose tab  2-4  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; budesonide  3  mg ; omeprazole  20  mg ; lactated ringers  1000  ml ; sodium bicarbonate  650  mg ; azathioprine  100  mg ; hydroxychloroquine sulfate  200  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  1250  mg ; vitamin d  400  unit ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride (powder)  60  meq ; 
esophageal reflux autoimmune hepatitis systemic lupus erythematosus adrenal cortical steroids causing adverse effects in therapeutic use personal history of pathologic fracture depressive disorder, not elsewhere classified other osteoporosis other and unspecified coagulation defects unspecified cataract pneumonia, organism unspecified enlargement of lymph nodes other pancytopenia person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of malignant neoplasm of large intestine sicca syndrome headache personal history of tuberculosis hypotension, unspecified ileostomy status acquired absence of intestine (large) (small) osteoporosis, unspecified pathologic fracture of vertebrae autoimmune hepatitis ileostomy status pneumonia, organism unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident sialoadenitis other chronic pain nausea with vomiting headache bacteremia other specified disorders of skin other specified antibiotics causing adverse effects in therapeutic use esophageal reflux personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident depressive disorder, not elsewhere classified osteoporosis, unspecified pathologic fracture of vertebrae autoimmune hepatitis chest pain, unspecified acute upper respiratory infections of unspecified site ileostomy status esophageal reflux other acute pain pathologic fracture of vertebrae other chronic hepatitis
asian f 68 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  94  mg dl$glucose tab  2-4  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; budesonide  3  mg ; omeprazole  20  mg ; lactated ringers  1000  ml ; azathioprine  100  mg ; hydroxychloroquine sulfate  200  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  1250  mg ; vitamin d  400  unit ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride (powder)  60  meq ; phosphorus  500  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; acetaminophen  650  mg ; bupropion (sustained release)  100  mg ; 
esophageal reflux autoimmune hepatitis systemic lupus erythematosus adrenal cortical steroids causing adverse effects in therapeutic use personal history of pathologic fracture depressive disorder, not elsewhere classified other osteoporosis other and unspecified coagulation defects unspecified cataract pneumonia, organism unspecified enlargement of lymph nodes other pancytopenia person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of malignant neoplasm of large intestine sicca syndrome headache personal history of tuberculosis hypotension, unspecified ileostomy status acquired absence of intestine (large) (small) osteoporosis, unspecified pathologic fracture of vertebrae autoimmune hepatitis ileostomy status pneumonia, organism unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident sialoadenitis other chronic pain nausea with vomiting headache bacteremia other specified disorders of skin other specified antibiotics causing adverse effects in therapeutic use esophageal reflux personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident depressive disorder, not elsewhere classified osteoporosis, unspecified pathologic fracture of vertebrae autoimmune hepatitis chest pain, unspecified acute upper respiratory infections of unspecified site ileostomy status esophageal reflux other acute pain pathologic fracture of vertebrae other chronic hepatitis
asian f 68 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  89  mg dl$glucose tab  2-4  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; budesonide  3  mg ; omeprazole  20  mg ; azathioprine  100  mg ; hydroxychloroquine sulfate  200  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  1250  mg ; vitamin d  400  unit ; phosphorus  500  mg ; acetaminophen  650  mg ; bupropion (sustained release)  100  mg ; 
esophageal reflux autoimmune hepatitis systemic lupus erythematosus adrenal cortical steroids causing adverse effects in therapeutic use personal history of pathologic fracture depressive disorder, not elsewhere classified other osteoporosis other and unspecified coagulation defects unspecified cataract pneumonia, organism unspecified enlargement of lymph nodes other pancytopenia person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of malignant neoplasm of large intestine sicca syndrome headache personal history of tuberculosis hypotension, unspecified ileostomy status acquired absence of intestine (large) (small) osteoporosis, unspecified pathologic fracture of vertebrae autoimmune hepatitis ileostomy status pneumonia, organism unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident sialoadenitis other chronic pain nausea with vomiting headache bacteremia other specified disorders of skin other specified antibiotics causing adverse effects in therapeutic use esophageal reflux personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident depressive disorder, not elsewhere classified osteoporosis, unspecified pathologic fracture of vertebrae autoimmune hepatitis chest pain, unspecified acute upper respiratory infections of unspecified site ileostomy status esophageal reflux other acute pain pathologic fracture of vertebrae other chronic hepatitis
asian f 68 $nan$nan$glucose tab  2-4  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; budesonide  3  mg ; omeprazole  20  mg ; azathioprine  100  mg ; hydroxychloroquine sulfate  200  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  1250  mg ; vitamin d  400  unit ; phosphorus  500  mg ; acetaminophen  650  mg ; bupropion (sustained release)  100  mg ; 
esophageal reflux autoimmune hepatitis systemic lupus erythematosus adrenal cortical steroids causing adverse effects in therapeutic use personal history of pathologic fracture depressive disorder, not elsewhere classified other osteoporosis other and unspecified coagulation defects unspecified cataract pneumonia, organism unspecified enlargement of lymph nodes other pancytopenia person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of malignant neoplasm of large intestine sicca syndrome headache personal history of tuberculosis hypotension, unspecified ileostomy status acquired absence of intestine (large) (small) osteoporosis, unspecified pathologic fracture of vertebrae autoimmune hepatitis ileostomy status pneumonia, organism unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident sialoadenitis other chronic pain nausea with vomiting headache bacteremia other specified disorders of skin other specified antibiotics causing adverse effects in therapeutic use esophageal reflux personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident depressive disorder, not elsewhere classified osteoporosis, unspecified pathologic fracture of vertebrae autoimmune hepatitis chest pain, unspecified acute upper respiratory infections of unspecified site ileostomy status esophageal reflux other acute pain pathologic fracture of vertebrae other chronic hepatitis
white m 56 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  380  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  145  mg dl$sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; azathioprine  150  mg ; tiotropium bromide  1  cap ; duloxetine  60  mg ; aspirin  325  mg ; thiamine  100  mg ; prednisone  40  mg ; simvastatin  20  mg ; pantoprazole  40  mg ; senna  1  tab ; bisacodyl  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; azithromycin  250  mg ; morphine sr (ms contin)  15  mg ; clonazepam  0.5  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; haloperidol  0.5  mg ; gabapentin  300  mg ; zolpidem tartrate  5  mg ; 
hyposmolality and/or hyponatremia congestive heart failure, unspecified sedative, hypnotic or anxiolytic dependence, unspecified chronic hepatitis c without mention of hepatic coma drug withdrawal lung involvement in other diseases classified elsewhere acute bronchitis impotence of organic origin obstructive sleep apnea (adult)(pediatric) osteoporosis, unspecified spinal stenosis, lumbar region, without neurogenic claudication pneumonia, organism unspecified sarcoidosis anxiety state, unspecified
white m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; azathioprine  150  mg ; tiotropium bromide  1  cap ; duloxetine  60  mg ; aspirin  325  mg ; thiamine  100  mg ; prednisone  40  mg ; simvastatin  20  mg ; pantoprazole  40  mg ; senna  1  tab ; bisacodyl  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; azithromycin  250  mg ; morphine sr (ms contin)  15  mg ; clonazepam  0.5  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; haloperidol  0.5  mg ; gabapentin  300  mg ; zolpidem tartrate  5  mg ; duloxetine  90  mg ; ibuprofen  400  mg ; albuterol 0.083% neb soln  1  neb ; 
hyposmolality and/or hyponatremia congestive heart failure, unspecified sedative, hypnotic or anxiolytic dependence, unspecified chronic hepatitis c without mention of hepatic coma drug withdrawal lung involvement in other diseases classified elsewhere acute bronchitis impotence of organic origin obstructive sleep apnea (adult)(pediatric) osteoporosis, unspecified spinal stenosis, lumbar region, without neurogenic claudication pneumonia, organism unspecified sarcoidosis anxiety state, unspecified
white m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; azathioprine  150  mg ; tiotropium bromide  1  cap ; aspirin  325  mg ; thiamine  100  mg ; prednisone  40  mg ; simvastatin  20  mg ; pantoprazole  40  mg ; senna  1  tab ; bisacodyl  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; azithromycin  250  mg ; morphine sr (ms contin)  15  mg ; clonazepam  0.5  mg ; heparin  5000  unit ; haloperidol  0.5  mg ; zolpidem tartrate  5  mg ; duloxetine  90  mg ; ibuprofen  400  mg ; albuterol 0.083% neb soln  1  neb ; advair diskus  1  puff ; sulfameth trimethoprim ds  1  tab ; 
hyposmolality and/or hyponatremia congestive heart failure, unspecified sedative, hypnotic or anxiolytic dependence, unspecified chronic hepatitis c without mention of hepatic coma drug withdrawal lung involvement in other diseases classified elsewhere acute bronchitis impotence of organic origin obstructive sleep apnea (adult)(pediatric) osteoporosis, unspecified spinal stenosis, lumbar region, without neurogenic claudication pneumonia, organism unspecified sarcoidosis anxiety state, unspecified
white m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; azathioprine  150  mg ; tiotropium bromide  1  cap ; aspirin  325  mg ; thiamine  100  mg ; prednisone  40  mg ; simvastatin  20  mg ; pantoprazole  40  mg ; senna  1  tab ; bisacodyl  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; azithromycin  250  mg ; clonazepam  0.5  mg ; heparin  5000  unit ; haloperidol  0.5  mg ; zolpidem tartrate  5  mg ; duloxetine  90  mg ; ibuprofen  400  mg ; albuterol 0.083% neb soln  1  neb ; advair diskus  1  puff ; sulfameth trimethoprim ds  1  tab ; 
hyposmolality and/or hyponatremia congestive heart failure, unspecified sedative, hypnotic or anxiolytic dependence, unspecified chronic hepatitis c without mention of hepatic coma drug withdrawal lung involvement in other diseases classified elsewhere acute bronchitis impotence of organic origin obstructive sleep apnea (adult)(pediatric) osteoporosis, unspecified spinal stenosis, lumbar region, without neurogenic claudication pneumonia, organism unspecified sarcoidosis anxiety state, unspecified
white m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; azathioprine  150  mg ; tiotropium bromide  1  cap ; aspirin  325  mg ; thiamine  100  mg ; prednisone  40  mg ; simvastatin  20  mg ; pantoprazole  40  mg ; senna  1  tab ; bisacodyl  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; azithromycin  250  mg ; clonazepam  0.5  mg ; heparin  5000  unit ; haloperidol  0.5  mg ; zolpidem tartrate  5  mg ; duloxetine  90  mg ; ibuprofen  400  mg ; albuterol 0.083% neb soln  1  neb ; advair diskus  1  puff ; sulfameth trimethoprim ds  1  tab ; 
hyposmolality and/or hyponatremia congestive heart failure, unspecified sedative, hypnotic or anxiolytic dependence, unspecified chronic hepatitis c without mention of hepatic coma drug withdrawal lung involvement in other diseases classified elsewhere acute bronchitis impotence of organic origin obstructive sleep apnea (adult)(pediatric) osteoporosis, unspecified spinal stenosis, lumbar region, without neurogenic claudication pneumonia, organism unspecified sarcoidosis anxiety state, unspecified
white m 65 $temp  98.0  heartrate  84.0  resprate  16.0  o2sat  96.0  sbp  113.0  dbp  73.0  rhythm    pain  3  $hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  106  mg dl; hematology blood wbc count  2.9  k ul$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; albuterol inhaler  2  puff ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ss  1  tab ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dolutegravir  50  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  1  puff ; 
thrombocytopenia, unspecified cellulitis of right lower limb fall on stairs or ladders in water transport injuring unspecified person unspecified asthma, uncomplicated other disorders of phosphorus metabolism human immunodeficiency virus [hiv] disease other problems related to lifestyle anemia in other chronic diseases classified elsewhere sepsis, unspecified organism pneumonia due to streptococcus pneumoniae streptococcus pneumoniae as the cause of diseases classified elsewhere unspecified asthma, uncomplicated bacteremia human immunodeficiency virus [hiv] disease personal history of other malignant neoplasm of skin diarrhea, unspecified unspecified viral hepatitis c without hepatic coma nicotine dependence, cigarettes, uncomplicated hairy leukoplakia unspecified asthma, uncomplicated cellulitis of right lower limb kaposi's sarcoma of soft tissue alcohol abuse, unspecified unspecified psychosis physical restraints status 
white m 65 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry urine creatinine, urine  63  mg dl; chemistry urine sodium, urine  34  meq l; chemistry blood glucose  103  mg dl$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; albuterol inhaler  2  puff ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ss  1  tab ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dolutegravir  50  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  1  puff ; 
thrombocytopenia, unspecified cellulitis of right lower limb fall on stairs or ladders in water transport injuring unspecified person unspecified asthma, uncomplicated other disorders of phosphorus metabolism human immunodeficiency virus [hiv] disease other problems related to lifestyle anemia in other chronic diseases classified elsewhere sepsis, unspecified organism pneumonia due to streptococcus pneumoniae streptococcus pneumoniae as the cause of diseases classified elsewhere unspecified asthma, uncomplicated bacteremia human immunodeficiency virus [hiv] disease personal history of other malignant neoplasm of skin diarrhea, unspecified unspecified viral hepatitis c without hepatic coma nicotine dependence, cigarettes, uncomplicated hairy leukoplakia unspecified asthma, uncomplicated cellulitis of right lower limb kaposi's sarcoma of soft tissue alcohol abuse, unspecified unspecified psychosis physical restraints status 
white m 65 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  102  mg dl$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ss  1  tab ; dolutegravir  50  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  1  puff ; hydromorphone (dilaudid)  0.5  mg ; 
thrombocytopenia, unspecified cellulitis of right lower limb fall on stairs or ladders in water transport injuring unspecified person unspecified asthma, uncomplicated other disorders of phosphorus metabolism human immunodeficiency virus [hiv] disease other problems related to lifestyle anemia in other chronic diseases classified elsewhere sepsis, unspecified organism pneumonia due to streptococcus pneumoniae streptococcus pneumoniae as the cause of diseases classified elsewhere unspecified asthma, uncomplicated bacteremia human immunodeficiency virus [hiv] disease personal history of other malignant neoplasm of skin diarrhea, unspecified unspecified viral hepatitis c without hepatic coma nicotine dependence, cigarettes, uncomplicated hairy leukoplakia unspecified asthma, uncomplicated cellulitis of right lower limb kaposi's sarcoma of soft tissue alcohol abuse, unspecified unspecified psychosis physical restraints status 
white m 65 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  98  mg dl$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ss  1  tab ; dolutegravir  50  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  1  puff ; hydromorphone (dilaudid)  0.5  mg ; magnesium oxide  400  mg ; 
thrombocytopenia, unspecified cellulitis of right lower limb fall on stairs or ladders in water transport injuring unspecified person unspecified asthma, uncomplicated other disorders of phosphorus metabolism human immunodeficiency virus [hiv] disease other problems related to lifestyle anemia in other chronic diseases classified elsewhere sepsis, unspecified organism pneumonia due to streptococcus pneumoniae streptococcus pneumoniae as the cause of diseases classified elsewhere unspecified asthma, uncomplicated bacteremia human immunodeficiency virus [hiv] disease personal history of other malignant neoplasm of skin diarrhea, unspecified unspecified viral hepatitis c without hepatic coma nicotine dependence, cigarettes, uncomplicated hairy leukoplakia unspecified asthma, uncomplicated cellulitis of right lower limb kaposi's sarcoma of soft tissue alcohol abuse, unspecified unspecified psychosis physical restraints status 
white m 65 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  105  mg dl$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ss  1  tab ; dolutegravir  50  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  1  puff ; magnesium oxide  400  mg ; oxycodone (immediate release)  2.5  mg ; 
thrombocytopenia, unspecified cellulitis of right lower limb fall on stairs or ladders in water transport injuring unspecified person unspecified asthma, uncomplicated other disorders of phosphorus metabolism human immunodeficiency virus [hiv] disease other problems related to lifestyle anemia in other chronic diseases classified elsewhere sepsis, unspecified organism pneumonia due to streptococcus pneumoniae streptococcus pneumoniae as the cause of diseases classified elsewhere unspecified asthma, uncomplicated bacteremia human immunodeficiency virus [hiv] disease personal history of other malignant neoplasm of skin diarrhea, unspecified unspecified viral hepatitis c without hepatic coma nicotine dependence, cigarettes, uncomplicated hairy leukoplakia unspecified asthma, uncomplicated cellulitis of right lower limb kaposi's sarcoma of soft tissue alcohol abuse, unspecified unspecified psychosis physical restraints status 
white m 65 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  112  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ss  1  tab ; dolutegravir  50  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  1  puff ; oxycodone (immediate release)  2.5  mg ; 
thrombocytopenia, unspecified cellulitis of right lower limb fall on stairs or ladders in water transport injuring unspecified person unspecified asthma, uncomplicated other disorders of phosphorus metabolism human immunodeficiency virus [hiv] disease other problems related to lifestyle anemia in other chronic diseases classified elsewhere sepsis, unspecified organism pneumonia due to streptococcus pneumoniae streptococcus pneumoniae as the cause of diseases classified elsewhere unspecified asthma, uncomplicated bacteremia human immunodeficiency virus [hiv] disease personal history of other malignant neoplasm of skin diarrhea, unspecified unspecified viral hepatitis c without hepatic coma nicotine dependence, cigarettes, uncomplicated hairy leukoplakia unspecified asthma, uncomplicated cellulitis of right lower limb kaposi's sarcoma of soft tissue alcohol abuse, unspecified unspecified psychosis physical restraints status 
white m 65 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  104  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ss  1  tab ; dolutegravir  50  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  1  puff ; 
thrombocytopenia, unspecified cellulitis of right lower limb fall on stairs or ladders in water transport injuring unspecified person unspecified asthma, uncomplicated other disorders of phosphorus metabolism human immunodeficiency virus [hiv] disease other problems related to lifestyle anemia in other chronic diseases classified elsewhere sepsis, unspecified organism pneumonia due to streptococcus pneumoniae streptococcus pneumoniae as the cause of diseases classified elsewhere unspecified asthma, uncomplicated bacteremia human immunodeficiency virus [hiv] disease personal history of other malignant neoplasm of skin diarrhea, unspecified unspecified viral hepatitis c without hepatic coma nicotine dependence, cigarettes, uncomplicated hairy leukoplakia unspecified asthma, uncomplicated cellulitis of right lower limb kaposi's sarcoma of soft tissue alcohol abuse, unspecified unspecified psychosis physical restraints status 
white m 65 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  102  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ss  1  tab ; dolutegravir  50  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  1  puff ; linezolid  600  mg ; 
thrombocytopenia, unspecified cellulitis of right lower limb fall on stairs or ladders in water transport injuring unspecified person unspecified asthma, uncomplicated other disorders of phosphorus metabolism human immunodeficiency virus [hiv] disease other problems related to lifestyle anemia in other chronic diseases classified elsewhere sepsis, unspecified organism pneumonia due to streptococcus pneumoniae streptococcus pneumoniae as the cause of diseases classified elsewhere unspecified asthma, uncomplicated bacteremia human immunodeficiency virus [hiv] disease personal history of other malignant neoplasm of skin diarrhea, unspecified unspecified viral hepatitis c without hepatic coma nicotine dependence, cigarettes, uncomplicated hairy leukoplakia unspecified asthma, uncomplicated cellulitis of right lower limb kaposi's sarcoma of soft tissue alcohol abuse, unspecified unspecified psychosis physical restraints status 
white m 65 $nan$nan$senna  8.6  mg ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; heparin  5000  unit ; docusate sodium  100  mg ; sulfameth trimethoprim ss  1  tab ; dolutegravir  50  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  1  puff ; linezolid  600  mg ; 
thrombocytopenia, unspecified cellulitis of right lower limb fall on stairs or ladders in water transport injuring unspecified person unspecified asthma, uncomplicated other disorders of phosphorus metabolism human immunodeficiency virus [hiv] disease other problems related to lifestyle anemia in other chronic diseases classified elsewhere sepsis, unspecified organism pneumonia due to streptococcus pneumoniae streptococcus pneumoniae as the cause of diseases classified elsewhere unspecified asthma, uncomplicated bacteremia human immunodeficiency virus [hiv] disease personal history of other malignant neoplasm of skin diarrhea, unspecified unspecified viral hepatitis c without hepatic coma nicotine dependence, cigarettes, uncomplicated hairy leukoplakia unspecified asthma, uncomplicated cellulitis of right lower limb kaposi's sarcoma of soft tissue alcohol abuse, unspecified unspecified psychosis physical restraints status 
white f 47 $nan$hematology blood inr(pt)  4.5  $allopurinol  300  mg ; folic acid  1  mg ; vitamin d  800  unit ; folic acid  5  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ns  1000  ml ; albuterol mdi  1-2  puff ; gabapentin  600  mg ; oxycodone sr (oxycontin)  20  mg ; hydromorphone (dilaudid)  4  mg ; ondansetron  4  mg ; senna  1  tab ; miconazole powder 2%  1  appl ; lorazepam  0.5  mg ; bisacodyl  10  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; lactulose  30  ml ; vial  1  vial ; filgrastim  300  mcg ; filgrastim  480  mcg ; zolpidem tartrate  5  mg ; diphenhydramine  25  mg ; warfarin  4  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; 
asthma, unspecified type, unspecified carpal tunnel syndrome long-term (current) use of other medications other and unspecified nonspecific immunological findings immune thrombocytopenic purpura autoimmune hemolytic anemias encounter for antineoplastic chemotherapy other malignant lymphomas, unspecified site, extranodal and solid organ sites unspecified essential hypertension sicca syndrome personal history of venous thrombosis and embolism long-term (current) use of anticoagulants obstructive sleep apnea (adult)(pediatric) immune thrombocytopenic purpura other malignant lymphomas, unspecified site, extranodal and solid organ sites long-term (current) use of anticoagulants infected postoperative seroma unspecified essential hypertension bacteremia sicca syndrome obstructive sleep apnea (adult)(pediatric) methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other and unspecified nonspecific immunological findings acute venous embolism and thrombosis of deep vessels of proximal lower extremity morbid obesity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dermatophytosis of the body pseudomonas infection in conditions classified elsewhere and of unspecified site autoimmune hemolytic anemias cellulitis and abscess of trunk swelling of limb long-term (current) use of anticoagulants unspecified essential hypertension dermatophytosis of groin and perianal area neoplasm related pain (acute) (chronic) pulmonary collapse morbid obesity other acute postoperative pain compression of vein acute venous embolism and thrombosis of deep vessels of proximal lower extremity other malignant lymphomas, intrapelvic lymph nodes immune thrombocytopenic purpura obstructive sleep apnea (adult)(pediatric) primary hypercoagulable state systemic lupus erythematosus urinary tract infection, site not specified
white f 47 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  161  mg dl; hematology blood bands  19  %$allopurinol  300  mg ; vitamin d  800  unit ; folic acid  5  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; albuterol mdi  1-2  puff ; gabapentin  600  mg ; oxycodone sr (oxycontin)  20  mg ; hydromorphone (dilaudid)  4  mg ; ondansetron  4  mg ; senna  1  tab ; miconazole powder 2%  1  appl ; lorazepam  0.5  mg ; bisacodyl  10  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; lactulose  30  ml ; vial  1  vial ; filgrastim  300  mcg ; filgrastim  480  mcg ; zolpidem tartrate  5  mg ; diphenhydramine  25  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; vial  2  vial ; filgrastim  600  mcg ; 
asthma, unspecified type, unspecified carpal tunnel syndrome long-term (current) use of other medications other and unspecified nonspecific immunological findings immune thrombocytopenic purpura autoimmune hemolytic anemias encounter for antineoplastic chemotherapy other malignant lymphomas, unspecified site, extranodal and solid organ sites unspecified essential hypertension sicca syndrome personal history of venous thrombosis and embolism long-term (current) use of anticoagulants obstructive sleep apnea (adult)(pediatric) immune thrombocytopenic purpura other malignant lymphomas, unspecified site, extranodal and solid organ sites long-term (current) use of anticoagulants infected postoperative seroma unspecified essential hypertension bacteremia sicca syndrome obstructive sleep apnea (adult)(pediatric) methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other and unspecified nonspecific immunological findings acute venous embolism and thrombosis of deep vessels of proximal lower extremity morbid obesity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dermatophytosis of the body pseudomonas infection in conditions classified elsewhere and of unspecified site autoimmune hemolytic anemias cellulitis and abscess of trunk swelling of limb long-term (current) use of anticoagulants unspecified essential hypertension dermatophytosis of groin and perianal area neoplasm related pain (acute) (chronic) pulmonary collapse morbid obesity other acute postoperative pain compression of vein acute venous embolism and thrombosis of deep vessels of proximal lower extremity other malignant lymphomas, intrapelvic lymph nodes immune thrombocytopenic purpura obstructive sleep apnea (adult)(pediatric) primary hypercoagulable state systemic lupus erythematosus urinary tract infection, site not specified
white f 47 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  63  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  142  mg dl; hematology blood bands  4.7  %$allopurinol  300  mg ; vitamin d  800  unit ; folic acid  5  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; albuterol mdi  1-2  puff ; gabapentin  600  mg ; oxycodone sr (oxycontin)  20  mg ; hydromorphone (dilaudid)  4  mg ; ondansetron  4  mg ; senna  1  tab ; miconazole powder 2%  1  appl ; lorazepam  0.5  mg ; bisacodyl  10  mg ; lactulose  30  ml ; zolpidem tartrate  5  mg ; diphenhydramine  25  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; amlodipine  5  mg ; 
asthma, unspecified type, unspecified carpal tunnel syndrome long-term (current) use of other medications other and unspecified nonspecific immunological findings immune thrombocytopenic purpura autoimmune hemolytic anemias encounter for antineoplastic chemotherapy other malignant lymphomas, unspecified site, extranodal and solid organ sites unspecified essential hypertension sicca syndrome personal history of venous thrombosis and embolism long-term (current) use of anticoagulants obstructive sleep apnea (adult)(pediatric) immune thrombocytopenic purpura other malignant lymphomas, unspecified site, extranodal and solid organ sites long-term (current) use of anticoagulants infected postoperative seroma unspecified essential hypertension bacteremia sicca syndrome obstructive sleep apnea (adult)(pediatric) methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other and unspecified nonspecific immunological findings acute venous embolism and thrombosis of deep vessels of proximal lower extremity morbid obesity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dermatophytosis of the body pseudomonas infection in conditions classified elsewhere and of unspecified site autoimmune hemolytic anemias cellulitis and abscess of trunk swelling of limb long-term (current) use of anticoagulants unspecified essential hypertension dermatophytosis of groin and perianal area neoplasm related pain (acute) (chronic) pulmonary collapse morbid obesity other acute postoperative pain compression of vein acute venous embolism and thrombosis of deep vessels of proximal lower extremity other malignant lymphomas, intrapelvic lymph nodes immune thrombocytopenic purpura obstructive sleep apnea (adult)(pediatric) primary hypercoagulable state systemic lupus erythematosus urinary tract infection, site not specified
hispanic latino m 35 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  3.0  mg dl; chemistry blood glucose  69  mg dl; chemistry blood albumin  4.0  g dl$folic acid  1  mg ; thiamine  100  mg ; montelukast sodium  10  mg ; omeprazole  20  mg ; 0.45% sodium chloride  1000  ml ; hydromorphone (dilaudid)  0.5-1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  1  mg ; albuterol 0.083% neb soln  1  neb ; lorazepam  1  mg ; loratadine  10  mg ; lactulose  30  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; sarna lotion  1  appl ; hydroxyzine  50  mg ; diphenhydramine  25  mg ; 
acidosis acute alcoholic hepatitis portal hypertension alcohol withdrawal opioid type dependence, unspecified acute alcoholic intoxication in alcoholism, unspecified alcohol abuse, continuous alcohol withdrawal alcoholic gastritis, without mention of hemorrhage acute alcoholic hepatitis asthma, unspecified type, unspecified alcoholic cirrhosis of liver opioid type dependence, unspecified tobacco use disorder alcohol abuse, unspecified acute alcoholic intoxication in alcoholism, continuous acute pancreatitis alcohol withdrawal alcoholic cirrhosis of liver other pancytopenia thrombocytopenia, unspecified acute alcoholic hepatitis opioid type dependence, unspecified opioid type dependence, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver other and unspecified alcohol dependence, continuous asthma, unspecified type, unspecified other hemoptysis portal hypertension alcohol withdrawal abdominal pain, generalized unspecified gastritis and gastroduodenitis, without mention of hemorrhage alcoholic cirrhosis of liver asthma, unspecified type, with (acute) exacerbation alcohol withdrawal opioid type dependence, continuous thrombocytopenia, unspecified abdominal pain, unspecified site other chest pain asthma, unspecified type, unspecified alcoholic cirrhosis of liver alcohol withdrawal thrombocytopenia, unspecified alcoholic gastritis, without mention of hemorrhage unspecified essential hypertension other and unspecified alcohol dependence, episodic alcoholic cirrhosis of liver
hispanic latino m 35 $nan$nan$folic acid  1  mg ; thiamine  100  mg ; montelukast sodium  10  mg ; loratadine  10  mg ; lactulose  30  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; sarna lotion  1  appl ; hydroxyzine  50  mg ; diphenhydramine  25  mg ; lactated ringers  1000  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 
acidosis acute alcoholic hepatitis portal hypertension alcohol withdrawal opioid type dependence, unspecified acute alcoholic intoxication in alcoholism, unspecified alcohol abuse, continuous alcohol withdrawal alcoholic gastritis, without mention of hemorrhage acute alcoholic hepatitis asthma, unspecified type, unspecified alcoholic cirrhosis of liver opioid type dependence, unspecified tobacco use disorder alcohol abuse, unspecified acute alcoholic intoxication in alcoholism, continuous acute pancreatitis alcohol withdrawal alcoholic cirrhosis of liver other pancytopenia thrombocytopenia, unspecified acute alcoholic hepatitis opioid type dependence, unspecified opioid type dependence, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver other and unspecified alcohol dependence, continuous asthma, unspecified type, unspecified other hemoptysis portal hypertension alcohol withdrawal abdominal pain, generalized unspecified gastritis and gastroduodenitis, without mention of hemorrhage alcoholic cirrhosis of liver asthma, unspecified type, with (acute) exacerbation alcohol withdrawal opioid type dependence, continuous thrombocytopenia, unspecified abdominal pain, unspecified site other chest pain asthma, unspecified type, unspecified alcoholic cirrhosis of liver alcohol withdrawal thrombocytopenia, unspecified alcoholic gastritis, without mention of hemorrhage unspecified essential hypertension other and unspecified alcohol dependence, episodic alcoholic cirrhosis of liver
hispanic latino m 35 $nan$hematology blood hematocrit  40.1  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  99  mg dl$folic acid  1  mg ; thiamine  100  mg ; montelukast sodium  10  mg ; loratadine  10  mg ; lactulose  30  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; sarna lotion  1  appl ; hydroxyzine  50  mg ; bag  100  ml ; magnesium sulfate  4  gm ; oxycodone (immediate release)   10  mg ; 
acidosis acute alcoholic hepatitis portal hypertension alcohol withdrawal opioid type dependence, unspecified acute alcoholic intoxication in alcoholism, unspecified alcohol abuse, continuous alcohol withdrawal alcoholic gastritis, without mention of hemorrhage acute alcoholic hepatitis asthma, unspecified type, unspecified alcoholic cirrhosis of liver opioid type dependence, unspecified tobacco use disorder alcohol abuse, unspecified acute alcoholic intoxication in alcoholism, continuous acute pancreatitis alcohol withdrawal alcoholic cirrhosis of liver other pancytopenia thrombocytopenia, unspecified acute alcoholic hepatitis opioid type dependence, unspecified opioid type dependence, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver other and unspecified alcohol dependence, continuous asthma, unspecified type, unspecified other hemoptysis portal hypertension alcohol withdrawal abdominal pain, generalized unspecified gastritis and gastroduodenitis, without mention of hemorrhage alcoholic cirrhosis of liver asthma, unspecified type, with (acute) exacerbation alcohol withdrawal opioid type dependence, continuous thrombocytopenia, unspecified abdominal pain, unspecified site other chest pain asthma, unspecified type, unspecified alcoholic cirrhosis of liver alcohol withdrawal thrombocytopenia, unspecified alcoholic gastritis, without mention of hemorrhage unspecified essential hypertension other and unspecified alcohol dependence, episodic alcoholic cirrhosis of liver
hispanic latino m 35 $nan$nan$folic acid  1  mg ; thiamine  100  mg ; montelukast sodium  10  mg ; loratadine  10  mg ; lactulose  30  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; sarna lotion  1  appl ; hydroxyzine  50  mg ; oxycodone (immediate release)   10  mg ; 
acidosis acute alcoholic hepatitis portal hypertension alcohol withdrawal opioid type dependence, unspecified acute alcoholic intoxication in alcoholism, unspecified alcohol abuse, continuous alcohol withdrawal alcoholic gastritis, without mention of hemorrhage acute alcoholic hepatitis asthma, unspecified type, unspecified alcoholic cirrhosis of liver opioid type dependence, unspecified tobacco use disorder alcohol abuse, unspecified acute alcoholic intoxication in alcoholism, continuous acute pancreatitis alcohol withdrawal alcoholic cirrhosis of liver other pancytopenia thrombocytopenia, unspecified acute alcoholic hepatitis opioid type dependence, unspecified opioid type dependence, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver other and unspecified alcohol dependence, continuous asthma, unspecified type, unspecified other hemoptysis portal hypertension alcohol withdrawal abdominal pain, generalized unspecified gastritis and gastroduodenitis, without mention of hemorrhage alcoholic cirrhosis of liver asthma, unspecified type, with (acute) exacerbation alcohol withdrawal opioid type dependence, continuous thrombocytopenia, unspecified abdominal pain, unspecified site other chest pain asthma, unspecified type, unspecified alcoholic cirrhosis of liver alcohol withdrawal thrombocytopenia, unspecified alcoholic gastritis, without mention of hemorrhage unspecified essential hypertension other and unspecified alcohol dependence, episodic alcoholic cirrhosis of liver
hispanic latino m 35 $nan$nan$folic acid  1  mg ; thiamine  100  mg ; montelukast sodium  10  mg ; loratadine  10  mg ; heparin  5000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; sarna lotion  1  appl ; hydroxyzine  50  mg ; oxycodone (immediate release)   10  mg ; 
acidosis acute alcoholic hepatitis portal hypertension alcohol withdrawal opioid type dependence, unspecified acute alcoholic intoxication in alcoholism, unspecified alcohol abuse, continuous alcohol withdrawal alcoholic gastritis, without mention of hemorrhage acute alcoholic hepatitis asthma, unspecified type, unspecified alcoholic cirrhosis of liver opioid type dependence, unspecified tobacco use disorder alcohol abuse, unspecified acute alcoholic intoxication in alcoholism, continuous acute pancreatitis alcohol withdrawal alcoholic cirrhosis of liver other pancytopenia thrombocytopenia, unspecified acute alcoholic hepatitis opioid type dependence, unspecified opioid type dependence, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver other and unspecified alcohol dependence, continuous asthma, unspecified type, unspecified other hemoptysis portal hypertension alcohol withdrawal abdominal pain, generalized unspecified gastritis and gastroduodenitis, without mention of hemorrhage alcoholic cirrhosis of liver asthma, unspecified type, with (acute) exacerbation alcohol withdrawal opioid type dependence, continuous thrombocytopenia, unspecified abdominal pain, unspecified site other chest pain asthma, unspecified type, unspecified alcoholic cirrhosis of liver alcohol withdrawal thrombocytopenia, unspecified alcoholic gastritis, without mention of hemorrhage unspecified essential hypertension other and unspecified alcohol dependence, episodic alcoholic cirrhosis of liver
hispanic latino m 35 $nan$nan$folic acid  1  mg ; thiamine  100  mg ; montelukast sodium  10  mg ; loratadine  10  mg ; heparin  5000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; sarna lotion  1  appl ; hydroxyzine  50  mg ; oxycodone (immediate release)   10  mg ; 
acidosis acute alcoholic hepatitis portal hypertension alcohol withdrawal opioid type dependence, unspecified acute alcoholic intoxication in alcoholism, unspecified alcohol abuse, continuous alcohol withdrawal alcoholic gastritis, without mention of hemorrhage acute alcoholic hepatitis asthma, unspecified type, unspecified alcoholic cirrhosis of liver opioid type dependence, unspecified tobacco use disorder alcohol abuse, unspecified acute alcoholic intoxication in alcoholism, continuous acute pancreatitis alcohol withdrawal alcoholic cirrhosis of liver other pancytopenia thrombocytopenia, unspecified acute alcoholic hepatitis opioid type dependence, unspecified opioid type dependence, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver other and unspecified alcohol dependence, continuous asthma, unspecified type, unspecified other hemoptysis portal hypertension alcohol withdrawal abdominal pain, generalized unspecified gastritis and gastroduodenitis, without mention of hemorrhage alcoholic cirrhosis of liver asthma, unspecified type, with (acute) exacerbation alcohol withdrawal opioid type dependence, continuous thrombocytopenia, unspecified abdominal pain, unspecified site other chest pain asthma, unspecified type, unspecified alcoholic cirrhosis of liver alcohol withdrawal thrombocytopenia, unspecified alcoholic gastritis, without mention of hemorrhage unspecified essential hypertension other and unspecified alcohol dependence, episodic alcoholic cirrhosis of liver
white f 52 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  188  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; pantoprazole  40  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; dextroamphetamine  10  mg ; clonazepam  1  mg ; docusate sodium  100  mg ; topiramate (topamax)  25  mg ; lamotrigine  200  mg ; lubiprostone  24  mcg ; insulin  6  unit ; hydromorphone (dilaudid)  0.25  mg ; fluoxetine  60  mg ; levothyroxine sodium  50  mcg ; modafinil  300  mg ; modafinil  200  mg ; sodium chloride 0.9%  1000  ml ; lidocaine 1%  1  ml ; hydrocodone-acetaminophen (5mg-325mg)  2  tab ; 
shortness of breath orthostatic hypotension obstructive sleep apnea (adult)(pediatric) peripheral autonomic neuropathy in disorders classified elsewhere anxiety state, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus depressive disorder, not elsewhere classified long-term (current) use of aspirin end stage renal disease other malaise and fatigue diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled long-term (current) use of insulin other and unspecified hyperlipidemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease paroxysmal ventricular tachycardia gastroparesis nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of noncompliance with medical treatment, presenting hazards to health pure hypercholesterolemia bipolar i disorder, most recent episode (or current) depressed, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled orthostatic hypotension acute kidney failure, unspecified long-term (current) use of insulin hyposmolality and/or hyponatremia constipation, unspecified anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus gastroparesis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) anxiety state, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy depressive disorder, not elsewhere classified dysphonia gastroparesis other respiratory abnormalities polyneuropathy in diabetes acute kidney failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled pure hypercholesterolemia chest pain, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified chronic fatigue syndrome
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; pantoprazole  40  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; dextroamphetamine  10  mg ; docusate sodium  100  mg ; topiramate (topamax)  25  mg ; lamotrigine  200  mg ; lubiprostone  24  mcg ; insulin  6  unit ; hydromorphone (dilaudid)  0.25  mg ; fluoxetine  60  mg ; levothyroxine sodium  50  mcg ; modafinil  300  mg ; modafinil  200  mg ; sodium chloride 0.9%  1000  ml ; lidocaine 1%  1  ml ; hydrocodone-acetaminophen (5mg-325mg)  2  tab ; prochlorperazine  10  mg ; 
shortness of breath orthostatic hypotension obstructive sleep apnea (adult)(pediatric) peripheral autonomic neuropathy in disorders classified elsewhere anxiety state, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus depressive disorder, not elsewhere classified long-term (current) use of aspirin end stage renal disease other malaise and fatigue diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled long-term (current) use of insulin other and unspecified hyperlipidemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease paroxysmal ventricular tachycardia gastroparesis nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of noncompliance with medical treatment, presenting hazards to health pure hypercholesterolemia bipolar i disorder, most recent episode (or current) depressed, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled orthostatic hypotension acute kidney failure, unspecified long-term (current) use of insulin hyposmolality and/or hyponatremia constipation, unspecified anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus gastroparesis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) anxiety state, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy depressive disorder, not elsewhere classified dysphonia gastroparesis other respiratory abnormalities polyneuropathy in diabetes acute kidney failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled pure hypercholesterolemia chest pain, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified chronic fatigue syndrome
white f 71 $temp    heartrate  130.0  resprate  23.0  o2sat  97.0  sbp  132.0  dbp  56.0  rhythm    pain  2  $hematology blood hematocrit  37.0  %; hematology blood hematocrit  35.9  %; hematology blood hematocrit  34.3  %; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  300  k ul; hematology blood platelet count  244  k ul; hematology blood platelet count  255  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  136  meq l; chemistry urine creatinine, urine  6  mg dl; chemistry urine potassium, urine  18  meq l; chemistry urine sodium, urine  116  meq l; chemistry urine urea nitrogen, urine  79  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  132  mg dl; chemistry blood lactate dehydrogenase (ld)  169  iu l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  130  mg dl; blood gas blood hematocrit, calculated  37  %; blood gas blood hemoglobin  12.2  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  136  meq l$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; furosemide  20  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; trazodone  25  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fentanyl citrate  12.5-25  mcg ; heparin flush (10 units ml)  1  ml ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  1000  ml ; soln  100  ml ; acetaminophen iv  1000  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  111  mg dl; chemistry blood albumin  2.8  g dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; furosemide  20  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; anastrozole  1  mg ; trazodone  25  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fentanyl citrate  12.5-25  mcg ; heparin flush (10 units ml)  1  ml ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  1000  ml ; soln  100  ml ; acetaminophen iv  1000  mg ; 0.9% sodium chloride  500  ml ; fentanyl citrate  25  mcg ; mupirocin nasal ointment 2%  1  appl ; fentanyl citrate  25-50  mcg ; famotidine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  118  mg dl; chemistry blood albumin  3.0  g dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; trazodone  25  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; mupirocin nasal ointment 2%  1  appl ; fentanyl citrate  25-50  mcg ; famotidine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; metoprolol tartrate  5  mg ; 0.9% sodium chloride  250  ml ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; lorazepam  1  mg ; neutra-phos  1  pkt ; furosemide  10  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  120  mg dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; trazodone  25  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; mupirocin nasal ointment 2%  1  appl ; famotidine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; metoprolol tartrate  5  mg ; 0.9% sodium chloride  250  ml ; amiodarone  150  mg ; lorazepam  1  mg ; neutra-phos  1  pkt ; furosemide  10  mg ; amiodarone  200  mg ; acetaminophen (liquid)  650  mg ; trazodone  50  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; ketorolac  15  mg ; furosemide  40  mg ; heparin  5700  unit ; heparin  1400-2900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  350  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  228  iu l$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; mupirocin nasal ointment 2%  1  appl ; famotidine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; trazodone  50  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; ketorolac  15  mg ; furosemide  40  mg ; lorazepam  0.5-2  mg ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  340  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  6.9  meq l; chemistry blood potassium  6.4  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  14  meq l; chemistry urine creatinine, urine  111  mg dl; chemistry urine potassium, urine  33  meq l; chemistry urine urea nitrogen, urine  994  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  111  mg dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; mupirocin nasal ointment 2%  1  appl ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; trazodone  50  mg ; ketorolac  15  mg ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  353  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  117  mg dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; mupirocin nasal ointment 2%  1  appl ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; trazodone  50  mg ; ketorolac  15  mg ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; diltiazem  15  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  400  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  7.9  meq l; chemistry blood potassium  8.3  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine chloride, urine  91  meq l; chemistry urine sodium, urine  23  meq l; hematology urine wbc  73  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  109  mg dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; trazodone  50  mg ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; diltiazem  15  mg ; lorazepam  0.5  mg ; diltiazem  5  mg ; sarna lotion  1  appl ; ns  100  ml ; esmolol  2000  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  413  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  21  mg dl; hematology urine wbc  25  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  109  mg dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; trazodone  50  mg ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; lorazepam  0.5  mg ; sarna lotion  1  appl ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; morphine sulfate ir  15  mg ; enoxaparin sodium  30  mg ; multivitamins  1  tab ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; metoprolol tartrate  12.5  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  505  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  102  meq l; chemistry urine chloride, urine  105  meq l; chemistry urine creatinine, urine  59  mg dl; chemistry urine creatinine, urine  55  mg dl; chemistry urine potassium, urine  43  meq l; chemistry urine potassium, urine  41  meq l; chemistry urine sodium, urine  52  meq l; chemistry urine sodium, urine  65  meq l; chemistry urine urea nitrogen, urine  513  mg dl; chemistry urine urea nitrogen, urine  414  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  103  mg dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; trazodone  50  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; lorazepam  0.5  mg ; sarna lotion  1  appl ; morphine sulfate ir  15  mg ; multivitamins  1  tab ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; enoxaparin sodium  60  mg ; metoprolol tartrate  2.5  mg ; ondansetron  4  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  517  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.2  meq l; chemistry blood potassium  6.2  meq l; chemistry blood potassium  5.9  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  121  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  68  meq l; chemistry urine chloride, urine  17  meq l; chemistry urine chloride, urine  13  meq l; chemistry urine creatinine, urine  106  mg dl; chemistry urine creatinine, urine  183  mg dl; chemistry urine creatinine, urine  184  mg dl; chemistry urine potassium, urine  63  meq l; chemistry urine potassium, urine  70  meq l; chemistry urine potassium, urine  67  meq l; chemistry urine sodium, urine  22  meq l; chemistry urine urea nitrogen, urine  751  mg dl; chemistry urine urea nitrogen, urine  980  mg dl; chemistry urine urea nitrogen, urine  1118  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  104  mg dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; trazodone  50  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; lorazepam  0.5  mg ; sarna lotion  1  appl ; morphine sulfate ir  15  mg ; multivitamins  1  tab ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; enoxaparin sodium  60  mg ; metoprolol tartrate  2.5  mg ; ondansetron  4  mg ; ondansetron  8  mg ; 0.9% sodium chloride (excel bag)  250  ml ; paclitaxel (taxol)  150  mg ; dexamethasone  20  mg ; diphenhydramine  25-50  mg ; iso-osmotic sodium chloride  50  ml ; prochlorperazine  10  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  461  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  8.3  meq l; chemistry blood potassium  7.0  meq l; chemistry blood potassium  6.8  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  127  mg dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; trazodone  50  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; lorazepam  0.5  mg ; sarna lotion  1  appl ; morphine sulfate ir  15  mg ; multivitamins  1  tab ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; ondansetron  8  mg ; 0.9% sodium chloride (excel bag)  250  ml ; paclitaxel (taxol)  150  mg ; dexamethasone  20  mg ; diphenhydramine  25-50  mg ; iso-osmotic sodium chloride  50  ml ; prochlorperazine  10  mg ; lidocaine viscous 2%  20  ml ; nystat  500,000  unit ; olanzapine (disintegrating tablet)  2.5  mg ; sodium polystyrene sulfonate  30  gm ; sodium polystyrene sulfonate  15  gm ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  461  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.8  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  110  mg dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; sarna lotion  1  appl ; morphine sulfate ir  15  mg ; multivitamins  1  tab ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; ondansetron  8  mg ; 0.9% sodium chloride (excel bag)  250  ml ; paclitaxel (taxol)  150  mg ; dexamethasone  20  mg ; diphenhydramine  25-50  mg ; iso-osmotic sodium chloride  50  ml ; prochlorperazine  10  mg ; lidocaine viscous 2%  20  ml ; nystat  500,000  unit ; olanzapine (disintegrating tablet)  2.5  mg ; sodium polystyrene sulfonate  15  gm ; olanzapine (disintegrating tablet)  5  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  429  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  29  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  105  mg dl; chemistry blood albumin  2.3  g dl$docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; sarna lotion  1  appl ; morphine sulfate ir  15  mg ; multivitamins  1  tab ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; ondansetron  8  mg ; 0.9% sodium chloride (excel bag)  250  ml ; paclitaxel (taxol)  150  mg ; dexamethasone  20  mg ; diphenhydramine  25-50  mg ; iso-osmotic sodium chloride  50  ml ; prochlorperazine  10  mg ; lidocaine viscous 2%  20  ml ; nystat  500,000  unit ; olanzapine (disintegrating tablet)  5  mg ; docusate sodium (liquid)  100  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  371  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  96  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; sarna lotion  1  appl ; morphine sulfate ir  15  mg ; multivitamins  1  tab ; bisacodyl  10  mg ; ondansetron  8  mg ; 0.9% sodium chloride (excel bag)  250  ml ; paclitaxel (taxol)  150  mg ; dexamethasone  20  mg ; diphenhydramine  25-50  mg ; iso-osmotic sodium chloride  50  ml ; prochlorperazine  10  mg ; lidocaine viscous 2%  20  ml ; nystat  500,000  unit ; olanzapine (disintegrating tablet)  5  mg ; docusate sodium (liquid)  100  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  96  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; sarna lotion  1  appl ; morphine sulfate ir  15  mg ; multivitamins  1  tab ; bisacodyl  10  mg ; ondansetron  8  mg ; 0.9% sodium chloride (excel bag)  250  ml ; paclitaxel (taxol)  150  mg ; dexamethasone  20  mg ; diphenhydramine  25-50  mg ; iso-osmotic sodium chloride  50  ml ; prochlorperazine  10  mg ; lidocaine viscous 2%  20  ml ; nystat  500,000  unit ; olanzapine (disintegrating tablet)  5  mg ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  353  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  106  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; sarna lotion  1  appl ; morphine sulfate ir  15  mg ; multivitamins  1  tab ; bisacodyl  10  mg ; ondansetron  8  mg ; 0.9% sodium chloride (excel bag)  250  ml ; paclitaxel (taxol)  150  mg ; dexamethasone  20  mg ; diphenhydramine  25-50  mg ; iso-osmotic sodium chloride  50  ml ; prochlorperazine  10  mg ; lidocaine viscous 2%  20  ml ; nystat  500,000  unit ; olanzapine (disintegrating tablet)  5  mg ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; lidocaine 1%  20  ml ; metoprolol tartrate  6.25  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  28.8  %; hematology blood hematocrit  28.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  352  k ul; hematology blood platelet count  337  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  1.9  g dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; sarna lotion  1  appl ; morphine sulfate ir  15  mg ; multivitamins  1  tab ; bisacodyl  10  mg ; ondansetron  8  mg ; 0.9% sodium chloride (excel bag)  250  ml ; paclitaxel (taxol)  150  mg ; dexamethasone  20  mg ; diphenhydramine  25-50  mg ; iso-osmotic sodium chloride  50  ml ; prochlorperazine  10  mg ; lidocaine viscous 2%  20  ml ; olanzapine (disintegrating tablet)  5  mg ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; lidocaine 1%  20  ml ; metoprolol tartrate  6.25  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lidocaine 5% patch  1  ptch ; levofloxacin  750  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; hydrocortisone na succ.  100  mg ; acetaminophen  325-650  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
white f 71 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  344  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  8.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  142  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; sarna lotion  1  appl ; morphine sulfate ir  15  mg ; multivitamins  1  tab ; bisacodyl  10  mg ; ondansetron  8  mg ; 0.9% sodium chloride (excel bag)  250  ml ; paclitaxel (taxol)  150  mg ; dexamethasone  20  mg ; diphenhydramine  25-50  mg ; iso-osmotic sodium chloride  50  ml ; prochlorperazine  10  mg ; lidocaine viscous 2%  20  ml ; olanzapine (disintegrating tablet)  5  mg ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; metoprolol tartrate  6.25  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lidocaine 5% patch  1  ptch ; levofloxacin  750  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; hydrocortisone na succ.  100  mg ; acetaminophen  325-650  mg ; 
estrogen receptor positive status [er+] goiter, unspecified osteoporosis, unspecified malignant neoplasm of lower-inner quadrant of female breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident driver of special all-terrain or other off-road motor vehicle injured in traffic accident family history of malignant neoplasm of breast malignant neoplasm of lower-outer quadrant of female breast
black african american m 73 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  110  mg dl; chemistry blood urea nitrogen  109  mg dl; chemistry urine creatinine, urine  89  mg dl; chemistry urine sodium, urine  42  meq l; chemistry urine urea nitrogen, urine  367  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  107  mg dl; chemistry urine protein creatinine ratio  0.2  ratio; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$heparin  5000  unit ; mycophenolate mofetil  1000  mg ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; insulin  0  unit ; tacrolimus  2  mg ; sodium polystyrene sulfonate  30  gm ; prazosin hcl  1  mg ; aspirin ec  81  mg ; 
 
black african american m 73 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  112  mg dl; chemistry blood urea nitrogen  112  mg dl; hematology blood inr(pt)  1.6  ; chemistry urine creatinine, urine  148  mg dl; chemistry urine sodium, urine  11  meq l; chemistry urine urea nitrogen, urine  497  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  162  mg dl; chemistry blood glucose  100  mg dl$heparin  5000  unit ; mycophenolate mofetil  1000  mg ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; tacrolimus  2  mg ; sodium polystyrene sulfonate  30  gm ; prazosin hcl  1  mg ; aspirin ec  81  mg ; prazosin hcl  2  mg ; sevelamer  800  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
 
black african american m 73 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  113  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  120  mg dl$heparin  5000  unit ; mycophenolate mofetil  1000  mg ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; tacrolimus  2  mg ; prazosin hcl  1  mg ; aspirin ec  81  mg ; prazosin hcl  2  mg ; sevelamer  800  mg ; ipratropium bromide neb  1  neb ; heparin flush cvl  (100 units ml)  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; furosemide  40  mg ; hydralazine  50  mg ; tacrolimus  3  mg ; 
 
black african american m 73 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  113  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  106  mg dl$heparin  5000  unit ; mycophenolate mofetil  1000  mg ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; tacrolimus  2  mg ; prazosin hcl  1  mg ; aspirin ec  81  mg ; prazosin hcl  2  mg ; sevelamer  800  mg ; ipratropium bromide neb  1  neb ; heparin flush cvl  (100 units ml)  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; furosemide  40  mg ; hydralazine  50  mg ; tacrolimus  3  mg ; senna  2  tab ; docusate sodium  100  mg ; tacrolimus  1  mg ; torsemide  100  mg ; 
 
black african american m 73 $nan$hematology blood hematocrit  24.0  %; hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  109  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  91  mg dl$heparin  5000  unit ; mycophenolate mofetil  1000  mg ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; prazosin hcl  1  mg ; aspirin ec  81  mg ; prazosin hcl  2  mg ; sevelamer  800  mg ; ipratropium bromide neb  1  neb ; heparin flush cvl  (100 units ml)  1  ml ; hydralazine  50  mg ; tacrolimus  3  mg ; senna  2  tab ; docusate sodium  100  mg ; tacrolimus  1  mg ; torsemide  100  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; cephalexin  250  mg ; 
 
black african american m 73 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  108  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  118  mg dl$heparin  5000  unit ; mycophenolate mofetil  1000  mg ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; prazosin hcl  1  mg ; aspirin ec  81  mg ; prazosin hcl  2  mg ; sevelamer  800  mg ; ipratropium bromide neb  1  neb ; heparin flush cvl  (100 units ml)  1  ml ; hydralazine  50  mg ; tacrolimus  3  mg ; senna  2  tab ; docusate sodium  100  mg ; torsemide  100  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; cephalexin  250  mg ; carvedilol  3.125  mg ; 
 
black african american m 73 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  108  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  108  mg dl$heparin  5000  unit ; mycophenolate mofetil  1000  mg ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; prazosin hcl  1  mg ; aspirin ec  81  mg ; prazosin hcl  2  mg ; sevelamer  800  mg ; ipratropium bromide neb  1  neb ; heparin flush cvl  (100 units ml)  1  ml ; hydralazine  50  mg ; senna  2  tab ; docusate sodium  100  mg ; torsemide  100  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; cephalexin  250  mg ; carvedilol  3.125  mg ; 
 
black african american m 73 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  109  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  108  mg dl$heparin  5000  unit ; mycophenolate mofetil  1000  mg ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; prazosin hcl  1  mg ; aspirin ec  81  mg ; prazosin hcl  2  mg ; sevelamer  800  mg ; ipratropium bromide neb  1  neb ; heparin flush cvl  (100 units ml)  1  ml ; hydralazine  50  mg ; senna  2  tab ; docusate sodium  100  mg ; torsemide  100  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; cephalexin  250  mg ; carvedilol  3.125  mg ; metolazone  5  mg ; bisacodyl  10  mg ; 
 
black african american m 73 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  108  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  114  mg dl$heparin  5000  unit ; mycophenolate mofetil  1000  mg ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; prazosin hcl  1  mg ; aspirin ec  81  mg ; prazosin hcl  2  mg ; sevelamer  800  mg ; ipratropium bromide neb  1  neb ; heparin flush cvl  (100 units ml)  1  ml ; hydralazine  50  mg ; senna  2  tab ; docusate sodium  100  mg ; torsemide  100  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; carvedilol  3.125  mg ; metolazone  5  mg ; bisacodyl  10  mg ; 
 
white f 69 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  112  mg dl$aspirin ec  325  mg ; clopidogrel  75  mg ; metoprolol succinate xl  25  mg ; paroxetine  20  mg ; levothyroxine sodium  88  mcg ; fluticasone propionate nasal  1  spry ; rosuvastatin calcium  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; pantoprazole  40  mg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2  mg ; ondansetron  4  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; insulin  0  unit ; docusate sodium  100  mg ; fexofenadine  60  mg ; 
cerebral aneurysm, nonruptured unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled epistaxis pure hypercholesterolemia esophageal reflux occlusion and stenosis of multiple and bilateral precerebral arteries without mention of cerebral infarction 
white f 69 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; metoprolol succinate xl  25  mg ; paroxetine  20  mg ; levothyroxine sodium  88  mcg ; fluticasone propionate nasal  1  spry ; rosuvastatin calcium  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; pantoprazole  40  mg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2  mg ; ondansetron  4  mg ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; insulin  0  unit ; docusate sodium  100  mg ; fexofenadine  60  mg ; 
cerebral aneurysm, nonruptured unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled epistaxis pure hypercholesterolemia esophageal reflux occlusion and stenosis of multiple and bilateral precerebral arteries without mention of cerebral infarction 
white f 86 $temp  97.8  heartrate  107.0  resprate  22.0  o2sat  100.0  sbp  91.0  dbp  64.0  rhythm    pain  0  $hematology blood hematocrit  24.9  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  187  k ul; hematology blood platelet count  186  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  4.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  213  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; polyethylene glycol  17  g ; metoprolol succinate xl  25  mg ; senna  8.6  mg ; warfarin  1  dose ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; potassium chloride  60  meq ; vial  1  vial ; cefepime  1  g ; potassium chloride  80  meq ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  4.3  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; polyethylene glycol  17  g ; metoprolol succinate xl  25  mg ; senna  8.6  mg ; warfarin  1  dose ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; potassium chloride  60  meq ; vial  1  vial ; cefepime  1  g ; potassium chloride  80  meq ; furosemide  100  mg ; metoprolol tartrate  12.5  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; magnesium oxide  400  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; miconazole powder 2%  1  appl ; ceftriaxone  1  gm ; azithromycin  250  mg ; furosemide  20  mg ; furosemide  80  mg ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  2.9  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  2.7  ; chemistry urine creatinine, urine  31  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  81  mg dl; chemistry urine protein creatinine ratio  0.8  mg mg$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; polyethylene glycol  17  g ; senna  8.6  mg ; warfarin  1  dose ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; furosemide  100  mg ; metoprolol tartrate  12.5  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; magnesium oxide  400  mg ; miconazole powder 2%  1  appl ; furosemide  20  mg ; furosemide  80  mg ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  52  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; polyethylene glycol  17  g ; senna  8.6  mg ; warfarin  1  dose ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; metoprolol tartrate  12.5  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  54  mg dl; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; polyethylene glycol  17  g ; senna  8.6  mg ; warfarin  1  dose ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; metoprolol tartrate  12.5  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; furosemide  120  mg ; metolazone  2.5  mg ; ipratropium-albuterol neb  1  neb ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  2.0  ; hematology urine wbc  57  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; warfarin  1  dose ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  12.5  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; furosemide  120  mg ; metolazone  2.5  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  3  puff ; fluticasone propionate nasal  2  spry ; warfarin  5  mg ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  12.5  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  3  puff ; fluticasone propionate nasal  2  spry ; warfarin  5  mg ; acetaminophen  1000  mg ; lorazepam  0.5  mg ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  12.5  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  3  puff ; fluticasone propionate nasal  2  spry ; acetaminophen  1000  mg ; lorazepam  0.5  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  52  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  3  puff ; fluticasone propionate nasal  2  spry ; metoprolol tartrate  25  mg ; acetaminophen  650  mg ; aquaphor ointment  1  appl ; sodium chloride 3% inhalation soln  15  ml ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  3  puff ; fluticasone propionate nasal  2  spry ; metoprolol tartrate  25  mg ; aquaphor ointment  1  appl ; sodium chloride 3% inhalation soln  15  ml ; lorazepam  0.25  mg ; bumetanide  3  mg ; ondansetron  4  mg ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  3  puff ; fluticasone propionate nasal  2  spry ; metoprolol tartrate  25  mg ; aquaphor ointment  1  appl ; bumetanide  3  mg ; ondansetron  4  mg ; ramelteon  8  mg ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  3  puff ; fluticasone propionate nasal  2  spry ; metoprolol tartrate  25  mg ; aquaphor ointment  1  appl ; bumetanide  3  mg ; ondansetron  4  mg ; ramelteon  8  mg ; trazodone  25  mg ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  3  puff ; fluticasone propionate nasal  2  spry ; aquaphor ointment  1  appl ; bumetanide  3  mg ; ondansetron  4  mg ; ramelteon  8  mg ; trazodone  25  mg ; metoprolol succinate xl  100  mg ; potassium chloride  20  meq ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
white f 86 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  100  mg ; guaifenesin  5-10  ml ; miconazole powder 2%  1  appl ; ipratropium-albuterol neb  1  neb ; fluticasone propionate 110mcg  3  puff ; fluticasone propionate nasal  2  spry ; aquaphor ointment  1  appl ; bumetanide  3  mg ; ondansetron  4  mg ; ramelteon  8  mg ; trazodone  25  mg ; metoprolol succinate xl  100  mg ; 
pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere infection and inflammatory reaction due to indwelling urethral catheter, initial encounter long term (current) use of anticoagulants urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other secondary pulmonary hypertension personal history of malignant neoplasm of other parts of uterus rheumatic disorders of both mitral and aortic valves hyperlipidemia, unspecified paroxysmal atrial fibrillation contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) hyperkalemia body mass index (bmi) 40.0-44.9, adult hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in nursing home as the place of occurrence of the external cause chronic kidney disease, stage 3 (moderate) acute on chronic systolic (congestive) heart failure presence of cardiac pacemaker urinary tract infection, site not specified chronic obstructive pulmonary disease, unspecified pericarditis in diseases classified elsewhere other specified bacterial agents as the cause of diseases classified elsewhere acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale obesity, unspecified rheumatic heart failure fecal impaction abnormal uterine and vaginal bleeding, unspecified hyperlipidemia, unspecified other pulmonary embolism without acute cor pulmonale acute respiratory failure with hypoxia unspecified diastolic (congestive) heart failure chronic kidney disease, stage 3 (moderate) fever, unspecified body mass index (bmi) 50.0-59.9, adult presence of cardiac pacemaker chronic atrial fibrillation long term (current) use of anticoagulants unspecified asthma, uncomplicated obesity, unspecified venous insufficiency (chronic) (peripheral) acute embolism and thrombosis of left femoral vein unspecified fracture of lower end of left femur, initial encounter for closed fracture combined rheumatic disorders of mitral, aortic and tricuspid valves mixed hyperlipidemia acute posthemorrhagic anemia combined rheumatic disorders of mitral, aortic and tricuspid valves hypotension, unspecified body mass index (bmi) 45.0-49.9, adult
hispanic latino f 65 $temp  98.6  heartrate  88.0  resprate  14.0  o2sat  93.0  sbp  124.0  dbp  65.0  rhythm    pain  0  $hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  24  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, indirect  0.9  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  199  mg dl; chemistry blood glucose  198  mg dl; chemistry blood lactate dehydrogenase (ld)  146  iu l; chemistry blood albumin  3.2  g dl; chemistry blood bilirubin, direct  0.7  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  100  mg ; bupropion (sustained release)  150  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  2  spry ; guaifenesin  5-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; loratadine  10  mg ; montelukast  10  mg ; multivitamins  1  tab ; ondansetron  4  mg ; rifaximin  550  mg ; spironolactone  100  mg ; ursodiol  300  mg ; insulin  0  unit ; insulin  10  unit ; insulin  15  unit ; tolvaptan  30  mg ; senna  8.6  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; furosemide  20  mg ; 
other specified pleural conditions long term (current) use of insulin type 2 diabetes mellitus without complications unspecified cirrhosis of liver nontoxic single thyroid nodule psoriasis, unspecified other pancytopenia umbilical hernia without obstruction or gangrene bipolar disorder, unspecified hypo-osmolality and hyponatremia secondary esophageal varices without bleeding nonalcoholic steatohepatitis (nash) unspecified asthma, uncomplicated hypovolemia acute kidney failure, unspecified liver cell carcinoma schizophrenia, unspecified other pulmonary collapse unspecified asthma, uncomplicated schizophrenia, unspecified nontoxic single thyroid nodule long term (current) use of insulin unspecified cirrhosis of liver type 2 diabetes mellitus without complications hypo-osmolality and hyponatremia secondary esophageal varices without bleeding umbilical hernia without obstruction or gangrene other ascites body mass index (bmi) 24.0-24.9, adult other specified pleural conditions other secondary thrombocytopenia unspecified protein-calorie malnutrition acute kidney failure, unspecified bipolar disorder, unspecified liver cell carcinoma benign neoplasm of ascending colon secondary esophageal varices without bleeding other diseases of stomach and duodenum awaiting organ transplant status long term (current) use of insulin other specified pleural conditions other ascites other pancytopenia portal hypertension nonalcoholic steatohepatitis (nash) body mass index (bmi) 26.0-26.9, adult angiodysplasia of colon without hemorrhage unspecified asthma, uncomplicated
hispanic latino f 65 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  22  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  100  mg ; bupropion (sustained release)  150  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  2  spry ; guaifenesin  5-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; loratadine  10  mg ; montelukast  10  mg ; multivitamins  1  tab ; ondansetron  4  mg ; rifaximin  550  mg ; spironolactone  100  mg ; ursodiol  300  mg ; insulin  0  unit ; insulin  10  unit ; insulin  15  unit ; tolvaptan  30  mg ; senna  8.6  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; furosemide  20  mg ; sarna lotion  1  appl ; insulin  6  unit ; 
other specified pleural conditions long term (current) use of insulin type 2 diabetes mellitus without complications unspecified cirrhosis of liver nontoxic single thyroid nodule psoriasis, unspecified other pancytopenia umbilical hernia without obstruction or gangrene bipolar disorder, unspecified hypo-osmolality and hyponatremia secondary esophageal varices without bleeding nonalcoholic steatohepatitis (nash) unspecified asthma, uncomplicated hypovolemia acute kidney failure, unspecified liver cell carcinoma schizophrenia, unspecified other pulmonary collapse unspecified asthma, uncomplicated schizophrenia, unspecified nontoxic single thyroid nodule long term (current) use of insulin unspecified cirrhosis of liver type 2 diabetes mellitus without complications hypo-osmolality and hyponatremia secondary esophageal varices without bleeding umbilical hernia without obstruction or gangrene other ascites body mass index (bmi) 24.0-24.9, adult other specified pleural conditions other secondary thrombocytopenia unspecified protein-calorie malnutrition acute kidney failure, unspecified bipolar disorder, unspecified liver cell carcinoma benign neoplasm of ascending colon secondary esophageal varices without bleeding other diseases of stomach and duodenum awaiting organ transplant status long term (current) use of insulin other specified pleural conditions other ascites other pancytopenia portal hypertension nonalcoholic steatohepatitis (nash) body mass index (bmi) 26.0-26.9, adult angiodysplasia of colon without hemorrhage unspecified asthma, uncomplicated
hispanic latino f 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  100  mg ; bupropion (sustained release)  150  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  2  spry ; guaifenesin  5-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; loratadine  10  mg ; montelukast  10  mg ; multivitamins  1  tab ; ondansetron  4  mg ; rifaximin  550  mg ; spironolactone  100  mg ; ursodiol  300  mg ; insulin  0  unit ; insulin  10  unit ; insulin  15  unit ; tolvaptan  30  mg ; senna  8.6  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; furosemide  20  mg ; sarna lotion  1  appl ; insulin  6  unit ; 
other specified pleural conditions long term (current) use of insulin type 2 diabetes mellitus without complications unspecified cirrhosis of liver nontoxic single thyroid nodule psoriasis, unspecified other pancytopenia umbilical hernia without obstruction or gangrene bipolar disorder, unspecified hypo-osmolality and hyponatremia secondary esophageal varices without bleeding nonalcoholic steatohepatitis (nash) unspecified asthma, uncomplicated hypovolemia acute kidney failure, unspecified liver cell carcinoma schizophrenia, unspecified other pulmonary collapse unspecified asthma, uncomplicated schizophrenia, unspecified nontoxic single thyroid nodule long term (current) use of insulin unspecified cirrhosis of liver type 2 diabetes mellitus without complications hypo-osmolality and hyponatremia secondary esophageal varices without bleeding umbilical hernia without obstruction or gangrene other ascites body mass index (bmi) 24.0-24.9, adult other specified pleural conditions other secondary thrombocytopenia unspecified protein-calorie malnutrition acute kidney failure, unspecified bipolar disorder, unspecified liver cell carcinoma benign neoplasm of ascending colon secondary esophageal varices without bleeding other diseases of stomach and duodenum awaiting organ transplant status long term (current) use of insulin other specified pleural conditions other ascites other pancytopenia portal hypertension nonalcoholic steatohepatitis (nash) body mass index (bmi) 26.0-26.9, adult angiodysplasia of colon without hemorrhage unspecified asthma, uncomplicated
white m 65 $temp    heartrate  72.0  resprate  16.0  o2sat  99.0  sbp    dbp    rhythm    pain  0  ; temp    heartrate  76.0  resprate  19.0  o2sat  96.0  sbp  104.0  dbp  62.0  rhythm    pain  0  $hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  136  mg dl; blood gas blood lactate  1.8  mmol l$nan
 
white m 65 $temp  97.7  heartrate  70.0  resprate  17.0  o2sat  100.0  sbp  129.0  dbp  66.0  rhythm    pain  5  $hematology blood hematocrit  30.7  %; hematology blood hematocrit  29.6  %; hematology blood hematocrit  30.2  %; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  1000  ml ; 0.45% sodium chloride  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; ascorbic acid  500  mg ; atorvastatin  40  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; potassium chloride  40  meq ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol tartrate  12.5  mg ; golytely  2  l ; d5lr  1000  ml ; metoprolol tartrate  25  mg ; 
 
white m 65 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  1000  ml ; 0.45% sodium chloride  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; ascorbic acid  500  mg ; atorvastatin  40  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; potassium chloride  40  meq ; bag  2  bag ; magnesium sulfate  4  gm ; golytely  2  l ; d5lr  1000  ml ; metoprolol tartrate  25  mg ; 
 
black african american f 39 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  201  mg dl; blood gas blood glucose  193  mg dl; blood gas blood hematocrit, calculated  39  %; blood gas blood hemoglobin  13.0  g dl; blood gas blood potassium, whole blood  3.7  meq l$nan
outcome of delivery, single liveborn abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition previous cesarean delivery, delivered, with or without mention of antepartum condition diabetes mellitus of mother, complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident early onset of delivery, delivered, with or without mention of antepartum condition mental disorders of mother, delivered, with or without mention of antepartum condition depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled supervision of unspecified high-risk pregnancy cocaine abuse, continuous unspecified schizophrenia, unspecified elderly multigravida, delivered with or without mention of antepartum condition unspecified motorcycle rider injured in collision with car, pick-up truck or van in traffic accident other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition 
black african american f 39 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; misoprostol  800  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
outcome of delivery, single liveborn abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition previous cesarean delivery, delivered, with or without mention of antepartum condition diabetes mellitus of mother, complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident early onset of delivery, delivered, with or without mention of antepartum condition mental disorders of mother, delivered, with or without mention of antepartum condition depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled supervision of unspecified high-risk pregnancy cocaine abuse, continuous unspecified schizophrenia, unspecified elderly multigravida, delivered with or without mention of antepartum condition unspecified motorcycle rider injured in collision with car, pick-up truck or van in traffic accident other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition 
black african american m 47 $nan$nan$folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; 
other alteration of consciousness alcohol abuse, unspecified cocaine abuse, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tobacco use disorder unspecified essential hypertension other and unspecified alcohol dependence, continuous alcohol withdrawal other convulsions 
black african american m 47 $nan$hematology blood hematocrit  42.3  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  89  mg dl$folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; 0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; diazepam  10  mg ; heparin  5000  unit ; labetalol  100  mg ; sodium chloride 0.9%  flush  3  ml ; 
other alteration of consciousness alcohol abuse, unspecified cocaine abuse, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tobacco use disorder unspecified essential hypertension other and unspecified alcohol dependence, continuous alcohol withdrawal other convulsions 
black african american m 47 $nan$nan$folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; heparin  5000  unit ; labetalol  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; 
other alteration of consciousness alcohol abuse, unspecified cocaine abuse, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tobacco use disorder unspecified essential hypertension other and unspecified alcohol dependence, continuous alcohol withdrawal other convulsions 
black african american m 47 $nan$nan$folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; heparin  5000  unit ; labetalol  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; 
other alteration of consciousness alcohol abuse, unspecified cocaine abuse, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tobacco use disorder unspecified essential hypertension other and unspecified alcohol dependence, continuous alcohol withdrawal other convulsions 
white m 86 $temp  97.4  heartrate  63.0  resprate  18.0  o2sat  96.0  sbp  104.0  dbp  45.0  rhythm    pain  0  $hematology blood hematocrit  28.6  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  164  k ul; hematology blood platelet count  170  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  98  mg dl$acetaminophen  1000  mg ; atorvastatin  40  mg ; cetirizine  10  mg ; duloxetine  60  mg ; folic acid  1  mg ; gabapentin  100  mg ; lorazepam  0.5-1  mg ; pregabalin  25  mg ; sodium chloride 0.9%  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
 
white m 86 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  94  mg dl$acetaminophen  1000  mg ; atorvastatin  40  mg ; cetirizine  10  mg ; duloxetine  60  mg ; folic acid  1  mg ; gabapentin  100  mg ; lorazepam  0.5-1  mg ; pregabalin  25  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  3  ml ; warfarin  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; warfarin  4  mg ; 
 
white m 86 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  183  k ul; hematology blood inr(pt)  2.3  $acetaminophen  1000  mg ; atorvastatin  40  mg ; cetirizine  10  mg ; duloxetine  60  mg ; folic acid  1  mg ; gabapentin  100  mg ; lorazepam  0.5-1  mg ; sodium chloride 0.9%  flush  3  ml ; warfarin  5  mg ; omeprazole  40  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; warfarin  4  mg ; fluticasone propionate nasal  2  spry ; aspirin  325  mg ; warfarin  3  mg ; 
 
white m 86 $nan$nan$acetaminophen  1000  mg ; atorvastatin  40  mg ; cetirizine  10  mg ; duloxetine  60  mg ; folic acid  1  mg ; gabapentin  100  mg ; lorazepam  0.5-1  mg ; sodium chloride 0.9%  flush  3  ml ; omeprazole  40  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; warfarin  4  mg ; fluticasone propionate nasal  2  spry ; aspirin  325  mg ; warfarin  3  mg ; 
 
white f 42 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate  2-4  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; influenza virus vaccine  0.5  ml ; 
 
white f 42 $nan$nan$ondansetron  4  mg ; acetaminophen  650  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; diphenhydramine  25-50  mg ; hydromorphone (dilaudid)  12.5  mg ; oxycodone (immediate release)   5-15  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; diazepam  5  mg ; dexamethasone  4  mg ; 
 
white f 42 $nan$nan$ondansetron  4  mg ; acetaminophen  650  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; diphenhydramine  25-50  mg ; oxycodone (immediate release)   5-15  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; diazepam  5  mg ; dexamethasone  4  mg ; cepacol (menthol)  1  loz ; 
 
white f 42 $nan$nan$ondansetron  4  mg ; acetaminophen  650  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; diphenhydramine  25-50  mg ; oxycodone (immediate release)   5-15  mg ; docusate sodium  100  mg ; diazepam  5  mg ; cepacol (menthol)  1  loz ; 
 
white f 42 $nan$nan$ondansetron  4  mg ; acetaminophen  650  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; diphenhydramine  25-50  mg ; oxycodone (immediate release)   5-15  mg ; docusate sodium  100  mg ; diazepam  5  mg ; cepacol (menthol)  1  loz ; 
 
white m 68 $temp  100.1  heartrate  89.0  resprate  18.0  o2sat  96.0  sbp  129.0  dbp  75.0  rhythm    pain    $hematology blood hematocrit  32.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  490  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  204  mg dl$nan
atrial fibrillation end stage renal disease leukocytosis, unspecified ulcer of other part of foot coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyposmolality and/or hyponatremia painful respiration diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified diastolic heart failure, unspecified other symptoms involving cardiovascular system renal dialysis status personal history of tobacco use gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction ulcer of heel and midfoot other and unspecified hyperlipidemia acute pericarditis, unspecified body mass index 34.0-34.9, adult fever, unspecified polyneuropathy in diabetes end stage renal disease chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation hypocalcemia other transfusion reaction congestive heart failure, unspecified unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic diastolic heart failure acute posthemorrhagic anemia diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled disorders of phosphorus metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease subendocardial infarction, initial episode of care other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obesity, unspecified long-term (current) use of insulin atrial fibrillation unspecified glaucoma depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) ulcer of other part of foot
white m 68 $temp  98.6  heartrate  95.0  resprate  16.0  o2sat  98.0  sbp  134.0  dbp  74.0  rhythm    pain  0  $chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  6.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  157  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; atorvastatin  20  mg ; finasteride  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; morphine sulfate  2-4  mg ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; sertraline  50  mg ; tamsulosin  0.4  mg ; insulin  0  unit ; clopidogrel  75  mg ; aspirin  325  mg ; insulin  8  unit ; insulin  5  unit ; calcium acetate  1334  mg ; latanoprost 0.005% ophth. soln.  1  drop ; nephrocaps  1  cap ; senna  8.6  mg ; insulin  6  unit ; heparin  5000  unit ; docusate sodium  100  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  25  unit ; insulin  35  unit ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; calcium carbonate  500-1000  mg ; 
atrial fibrillation end stage renal disease leukocytosis, unspecified ulcer of other part of foot coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyposmolality and/or hyponatremia painful respiration diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified diastolic heart failure, unspecified other symptoms involving cardiovascular system renal dialysis status personal history of tobacco use gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction ulcer of heel and midfoot other and unspecified hyperlipidemia acute pericarditis, unspecified body mass index 34.0-34.9, adult fever, unspecified polyneuropathy in diabetes end stage renal disease chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation hypocalcemia other transfusion reaction congestive heart failure, unspecified unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic diastolic heart failure acute posthemorrhagic anemia diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled disorders of phosphorus metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease subendocardial infarction, initial episode of care other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obesity, unspecified long-term (current) use of insulin atrial fibrillation unspecified glaucoma depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) ulcer of other part of foot
white m 68 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  477  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  7.8  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  71  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  76  mg dl; chemistry blood albumin  2.9  g dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; finasteride  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; morphine sulfate  2-4  mg ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; sertraline  50  mg ; tamsulosin  0.4  mg ; clopidogrel  75  mg ; aspirin  325  mg ; calcium acetate  1334  mg ; latanoprost 0.005% ophth. soln.  1  drop ; nephrocaps  1  cap ; senna  8.6  mg ; heparin  5000  unit ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  35  unit ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; calcium carbonate  500-1000  mg ; lidocaine 1%  1  ml ; epoetin alfa  9000  unit ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  2-4  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
atrial fibrillation end stage renal disease leukocytosis, unspecified ulcer of other part of foot coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyposmolality and/or hyponatremia painful respiration diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified diastolic heart failure, unspecified other symptoms involving cardiovascular system renal dialysis status personal history of tobacco use gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction ulcer of heel and midfoot other and unspecified hyperlipidemia acute pericarditis, unspecified body mass index 34.0-34.9, adult fever, unspecified polyneuropathy in diabetes end stage renal disease chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation hypocalcemia other transfusion reaction congestive heart failure, unspecified unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic diastolic heart failure acute posthemorrhagic anemia diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled disorders of phosphorus metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease subendocardial infarction, initial episode of care other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obesity, unspecified long-term (current) use of insulin atrial fibrillation unspecified glaucoma depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) ulcer of other part of foot
white m 68 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  529  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; finasteride  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; sertraline  50  mg ; tamsulosin  0.4  mg ; clopidogrel  75  mg ; aspirin  325  mg ; calcium acetate  1334  mg ; latanoprost 0.005% ophth. soln.  1  drop ; nephrocaps  1  cap ; senna  8.6  mg ; heparin  5000  unit ; docusate sodium  100  mg ; calcium carbonate  500-1000  mg ; hydromorphone (dilaudid)  2-4  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; famotidine  20  mg ; 
atrial fibrillation end stage renal disease leukocytosis, unspecified ulcer of other part of foot coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyposmolality and/or hyponatremia painful respiration diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified diastolic heart failure, unspecified other symptoms involving cardiovascular system renal dialysis status personal history of tobacco use gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction ulcer of heel and midfoot other and unspecified hyperlipidemia acute pericarditis, unspecified body mass index 34.0-34.9, adult fever, unspecified polyneuropathy in diabetes end stage renal disease chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation hypocalcemia other transfusion reaction congestive heart failure, unspecified unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic diastolic heart failure acute posthemorrhagic anemia diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled disorders of phosphorus metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease subendocardial infarction, initial episode of care other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obesity, unspecified long-term (current) use of insulin atrial fibrillation unspecified glaucoma depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) ulcer of other part of foot
white m 68 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  589  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  8.0  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  57  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; finasteride  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; sertraline  50  mg ; tamsulosin  0.4  mg ; clopidogrel  75  mg ; aspirin  325  mg ; calcium acetate  1334  mg ; latanoprost 0.005% ophth. soln.  1  drop ; nephrocaps  1  cap ; heparin  5000  unit ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; famotidine  20  mg ; polyethylene glycol  17  g ; insulin  30  unit ; calcium carbonate  500  mg ; 
atrial fibrillation end stage renal disease leukocytosis, unspecified ulcer of other part of foot coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyposmolality and/or hyponatremia painful respiration diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified diastolic heart failure, unspecified other symptoms involving cardiovascular system renal dialysis status personal history of tobacco use gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction ulcer of heel and midfoot other and unspecified hyperlipidemia acute pericarditis, unspecified body mass index 34.0-34.9, adult fever, unspecified polyneuropathy in diabetes end stage renal disease chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation hypocalcemia other transfusion reaction congestive heart failure, unspecified unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic diastolic heart failure acute posthemorrhagic anemia diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled disorders of phosphorus metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease subendocardial infarction, initial episode of care other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obesity, unspecified long-term (current) use of insulin atrial fibrillation unspecified glaucoma depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) ulcer of other part of foot
white m 68 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  564  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  9.7  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; finasteride  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; sertraline  50  mg ; tamsulosin  0.4  mg ; clopidogrel  75  mg ; aspirin  325  mg ; calcium acetate  1334  mg ; latanoprost 0.005% ophth. soln.  1  drop ; nephrocaps  1  cap ; heparin  5000  unit ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; famotidine  20  mg ; polyethylene glycol  17  g ; insulin  30  unit ; calcium carbonate  500  mg ; heparin (hemodialysis)  6000  unit ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; bisacodyl  10  mg ; 
atrial fibrillation end stage renal disease leukocytosis, unspecified ulcer of other part of foot coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyposmolality and/or hyponatremia painful respiration diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified diastolic heart failure, unspecified other symptoms involving cardiovascular system renal dialysis status personal history of tobacco use gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction ulcer of heel and midfoot other and unspecified hyperlipidemia acute pericarditis, unspecified body mass index 34.0-34.9, adult fever, unspecified polyneuropathy in diabetes end stage renal disease chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation hypocalcemia other transfusion reaction congestive heart failure, unspecified unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic diastolic heart failure acute posthemorrhagic anemia diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled disorders of phosphorus metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease subendocardial infarction, initial episode of care other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obesity, unspecified long-term (current) use of insulin atrial fibrillation unspecified glaucoma depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) ulcer of other part of foot
white m 68 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  528  k ul; hematology blood platelet count  528  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  6.1  mg dl; chemistry blood creatinine  6.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  81  mg dl; chemistry blood glucose  80  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; finasteride  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; sertraline  50  mg ; tamsulosin  0.4  mg ; clopidogrel  75  mg ; aspirin  325  mg ; calcium acetate  1334  mg ; latanoprost 0.005% ophth. soln.  1  drop ; nephrocaps  1  cap ; heparin  5000  unit ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; famotidine  20  mg ; polyethylene glycol  17  g ; insulin  30  unit ; bisacodyl  10  mg ; milk of magnesia  30  ml ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; hydromorphone (dilaudid)  0.5  mg ; insulin  15  unit ; 
atrial fibrillation end stage renal disease leukocytosis, unspecified ulcer of other part of foot coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyposmolality and/or hyponatremia painful respiration diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified diastolic heart failure, unspecified other symptoms involving cardiovascular system renal dialysis status personal history of tobacco use gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction ulcer of heel and midfoot other and unspecified hyperlipidemia acute pericarditis, unspecified body mass index 34.0-34.9, adult fever, unspecified polyneuropathy in diabetes end stage renal disease chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation hypocalcemia other transfusion reaction congestive heart failure, unspecified unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic diastolic heart failure acute posthemorrhagic anemia diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled disorders of phosphorus metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease subendocardial infarction, initial episode of care other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obesity, unspecified long-term (current) use of insulin atrial fibrillation unspecified glaucoma depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) ulcer of other part of foot
white m 68 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  585  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; finasteride  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; sertraline  50  mg ; tamsulosin  0.4  mg ; clopidogrel  75  mg ; aspirin  325  mg ; calcium acetate  1334  mg ; latanoprost 0.005% ophth. soln.  1  drop ; nephrocaps  1  cap ; heparin  5000  unit ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; famotidine  20  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; milk of magnesia  30  ml ; insulin  15  unit ; oxycodone sr (oxycontin)  10  mg ; 
atrial fibrillation end stage renal disease leukocytosis, unspecified ulcer of other part of foot coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyposmolality and/or hyponatremia painful respiration diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified diastolic heart failure, unspecified other symptoms involving cardiovascular system renal dialysis status personal history of tobacco use gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction ulcer of heel and midfoot other and unspecified hyperlipidemia acute pericarditis, unspecified body mass index 34.0-34.9, adult fever, unspecified polyneuropathy in diabetes end stage renal disease chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation hypocalcemia other transfusion reaction congestive heart failure, unspecified unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic diastolic heart failure acute posthemorrhagic anemia diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled disorders of phosphorus metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease subendocardial infarction, initial episode of care other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obesity, unspecified long-term (current) use of insulin atrial fibrillation unspecified glaucoma depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) ulcer of other part of foot
white m 68 $nan$hematology blood hematocrit  32.6  %; hematology blood hematocrit  31.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  589  k ul; hematology blood platelet count  525  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  6.4  mg dl; chemistry blood creatinine  6.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  200  mg dl; chemistry blood glucose  224  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; finasteride  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; sertraline  50  mg ; tamsulosin  0.4  mg ; clopidogrel  75  mg ; aspirin  325  mg ; calcium acetate  1334  mg ; latanoprost 0.005% ophth. soln.  1  drop ; nephrocaps  1  cap ; heparin  5000  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; famotidine  20  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; milk of magnesia  30  ml ; insulin  15  unit ; oxycodone sr (oxycontin)  10  mg ; 
atrial fibrillation end stage renal disease leukocytosis, unspecified ulcer of other part of foot coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyposmolality and/or hyponatremia painful respiration diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified diastolic heart failure, unspecified other symptoms involving cardiovascular system renal dialysis status personal history of tobacco use gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction ulcer of heel and midfoot other and unspecified hyperlipidemia acute pericarditis, unspecified body mass index 34.0-34.9, adult fever, unspecified polyneuropathy in diabetes end stage renal disease chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation hypocalcemia other transfusion reaction congestive heart failure, unspecified unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic diastolic heart failure acute posthemorrhagic anemia diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled disorders of phosphorus metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease subendocardial infarction, initial episode of care other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obesity, unspecified long-term (current) use of insulin atrial fibrillation unspecified glaucoma depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) ulcer of other part of foot
white m 68 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  583  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  169  mg dl$atorvastatin  20  mg ; finasteride  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; omeprazole  20  mg ; sertraline  50  mg ; tamsulosin  0.4  mg ; clopidogrel  75  mg ; aspirin  325  mg ; calcium acetate  1334  mg ; latanoprost 0.005% ophth. soln.  1  drop ; nephrocaps  1  cap ; heparin  5000  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; famotidine  20  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; milk of magnesia  30  ml ; insulin  15  unit ; oxycodone sr (oxycontin)  10  mg ; 
atrial fibrillation end stage renal disease leukocytosis, unspecified ulcer of other part of foot coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyposmolality and/or hyponatremia painful respiration diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified diastolic heart failure, unspecified other symptoms involving cardiovascular system renal dialysis status personal history of tobacco use gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction ulcer of heel and midfoot other and unspecified hyperlipidemia acute pericarditis, unspecified body mass index 34.0-34.9, adult fever, unspecified polyneuropathy in diabetes end stage renal disease chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation hypocalcemia other transfusion reaction congestive heart failure, unspecified unspecified analgesic and antipyretic causing adverse effects in therapeutic use chronic diastolic heart failure acute posthemorrhagic anemia diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled disorders of phosphorus metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease subendocardial infarction, initial episode of care other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obesity, unspecified long-term (current) use of insulin atrial fibrillation unspecified glaucoma depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) ulcer of other part of foot
white m 23 $nan$chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  76  mg dl; chemistry blood glucose  433  mg dl$insulin  20  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  1000  ml ; magnesium oxide  400  mg ; insulin  18  unit ; insulin  4  unit ; potassium chloride  40  meq ; 
 
white m 23 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  74  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; magnesium oxide  400  mg ; insulin  4  unit ; potassium chloride  40  meq ; 
 
white m 23 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 
 
white f 75 $temp  97.6  heartrate  72.0  resprate  18.0  o2sat  97.0  sbp  170.0  dbp  73.0  rhythm    pain  4  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  4  ; temp  97.9  heartrate  83.0  resprate  16.0  o2sat  97.0  sbp  133.0  dbp  64.0  rhythm    pain  5  ; temp  97.7  heartrate  90.0  resprate  16.0  o2sat  98.0  sbp  116.0  dbp  76.0  rhythm    pain  0  $hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  115  mg dl$nan
 
white m 51 $nan$nan$olanzapine  5  mg ; 
major depressive affective disorder, single episode, unspecified other occupational circumstances or maladjustment delusional disorder dysthymic disorder
white m 51 $nan$nan$olanzapine  5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nicotine polacrilex  1  stck ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; olanzapine  15  mg ; fluoxetine  20  mg ; 
major depressive affective disorder, single episode, unspecified other occupational circumstances or maladjustment delusional disorder dysthymic disorder
white m 51 $nan$nan$nicotine polacrilex  1  stck ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; olanzapine  15  mg ; fluoxetine  20  mg ; 
major depressive affective disorder, single episode, unspecified other occupational circumstances or maladjustment delusional disorder dysthymic disorder
white m 51 $nan$nan$nicotine polacrilex  1  stck ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; olanzapine  15  mg ; fluoxetine  20  mg ; diphenhydramine  50  mg ; olanzapine  10  mg ; zolpidem tartrate  5  mg ; 
major depressive affective disorder, single episode, unspecified other occupational circumstances or maladjustment delusional disorder dysthymic disorder
white m 51 $nan$nan$nicotine polacrilex  1  stck ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; fluoxetine  20  mg ; olanzapine  10  mg ; zolpidem tartrate  5  mg ; 
major depressive affective disorder, single episode, unspecified other occupational circumstances or maladjustment delusional disorder dysthymic disorder
white m 51 $nan$nan$nicotine polacrilex  1  stck ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; fluoxetine  20  mg ; olanzapine  10  mg ; zolpidem tartrate  5  mg ; 
major depressive affective disorder, single episode, unspecified other occupational circumstances or maladjustment delusional disorder dysthymic disorder
white m 51 $nan$nan$nicotine polacrilex  1  stck ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; fluoxetine  20  mg ; olanzapine  10  mg ; zolpidem tartrate  5  mg ; 
major depressive affective disorder, single episode, unspecified other occupational circumstances or maladjustment delusional disorder dysthymic disorder
white m 51 $nan$nan$nicotine polacrilex  1  stck ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; fluoxetine  20  mg ; olanzapine  10  mg ; zolpidem tartrate  5  mg ; 
major depressive affective disorder, single episode, unspecified other occupational circumstances or maladjustment delusional disorder dysthymic disorder
white f 39 $nan$hematology blood hematocrit  28.2  %; hematology blood hematocrit  30.1  %; hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  152  k ul; hematology blood platelet count  144  k ul; hematology blood platelet count  181  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  5.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood bilirubin, total  4.1  mg dl; chemistry blood glucose  77  mg dl; chemistry blood glucose  137  mg dl; chemistry blood albumin  3.3  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.29  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  0.83  mmol l; blood gas blood free calcium  0.83  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  3.7  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood chloride, whole blood  106  meq l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  109  mg dl; blood gas blood glucose  219  mg dl; blood gas blood glucose  191  mg dl; blood gas blood glucose  127  mg dl; blood gas blood glucose  94  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  31  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hemoglobin  12.8  g dl; blood gas blood hemoglobin  10.1  g dl; blood gas blood hemoglobin  12.5  g dl; blood gas blood hemoglobin  10.2  g dl; blood gas blood hemoglobin  10.1  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  5.5  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  130  meq l; blood gas blood sodium, whole blood  129  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  136  meq l$ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; heparin flush (10 units ml)  1  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; morphine sulfate  2-6  mg ; promethazine  12.5  mg ; metoprolol tartrate  5  mg ; lorazepam  0.5  mg ; d5 1 2ns  1000  ml ; calcium gluconate  2  gm ; insulin  0  unit ; syringe  1  ml ; heparin sodium  5000  unit ; 
 
white f 39 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  131  mg dl; chemistry blood albumin  2.9  g dl$heparin flush (10 units ml)  1  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; morphine sulfate  2-6  mg ; promethazine  12.5  mg ; metoprolol tartrate  5  mg ; lorazepam  0.5  mg ; calcium gluconate  2  gm ; insulin  0  unit ; syringe  1  ml ; heparin sodium  5000  unit ; alprazolam  0.5  mg ; 
 
white f 39 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  99  mg dl; chemistry blood albumin  2.7  g dl$heparin flush (10 units ml)  1  ml ; lorazepam  0.5  mg ; insulin  0  unit ; syringe  1  ml ; heparin sodium  5000  unit ; alprazolam  0.5  mg ; metoprolol tartrate  25  mg ; amlodipine  5  mg ; escitalopram oxalate  30  mg ; lisinopril  10  mg ; lithium carbonate  600  mg ; sodium chloride 0.9%  flush  3  ml ; bupropion  150  mg ; nortriptyline  25  mg ; bisacodyl  10  mg ; 
 
white f 39 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  67  mg dl; chemistry blood albumin  3.0  g dl$heparin flush (10 units ml)  1  ml ; lorazepam  0.5  mg ; insulin  0  unit ; syringe  1  ml ; heparin sodium  5000  unit ; alprazolam  0.5  mg ; metoprolol tartrate  25  mg ; escitalopram oxalate  30  mg ; lithium carbonate  600  mg ; sodium chloride 0.9%  flush  3  ml ; bupropion  150  mg ; nortriptyline  25  mg ; bisacodyl  10  mg ; potassium chloride  40  meq ; neutra-phos  1  pkt ; oxycodone-acetaminophen  1-2  tab ; 
 
white f 39 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  78  mg dl; chemistry blood albumin  2.8  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$heparin flush (10 units ml)  1  ml ; lorazepam  0.5  mg ; syringe  1  ml ; heparin sodium  5000  unit ; alprazolam  0.5  mg ; metoprolol tartrate  25  mg ; escitalopram oxalate  30  mg ; lithium carbonate  600  mg ; sodium chloride 0.9%  flush  3  ml ; bupropion  150  mg ; nortriptyline  25  mg ; potassium chloride  40  meq ; neutra-phos  1  pkt ; oxycodone-acetaminophen  1-2  tab ; 
 
white f 39 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  364  k ul$heparin flush (10 units ml)  1  ml ; lorazepam  0.5  mg ; syringe  1  ml ; heparin sodium  5000  unit ; alprazolam  0.5  mg ; metoprolol tartrate  25  mg ; escitalopram oxalate  30  mg ; lithium carbonate  600  mg ; sodium chloride 0.9%  flush  3  ml ; bupropion  150  mg ; nortriptyline  25  mg ; oxycodone-acetaminophen  1-2  tab ; 
 
white f 39 $nan$nan$heparin flush (10 units ml)  1  ml ; lorazepam  0.5  mg ; syringe  1  ml ; heparin sodium  5000  unit ; alprazolam  0.5  mg ; metoprolol tartrate  25  mg ; escitalopram oxalate  30  mg ; lithium carbonate  600  mg ; sodium chloride 0.9%  flush  3  ml ; bupropion  150  mg ; nortriptyline  25  mg ; oxycodone-acetaminophen  1-2  tab ; furosemide  20  mg ; 
 
white m 61 $temp  97.2  heartrate  85.0  resprate  18.0  o2sat  98.0  sbp  150.0  dbp  97.0  rhythm    pain  uta  ; temp    heartrate  86.0  resprate  26.0  o2sat  98.0  sbp  123.0  dbp  84.0  rhythm    pain  02  ; temp    heartrate  80.0  resprate  18.0  o2sat  95.0  sbp  127.0  dbp  95.0  rhythm    pain  0  ; temp    heartrate  62.0  resprate  18.0  o2sat  95.0  sbp  121.0  dbp  102.0  rhythm    pain  0  ; temp    heartrate  69.0  resprate  20.0  o2sat  96.0  sbp  127.0  dbp  84.0  rhythm    pain    ; temp  99.1  heartrate  73.0  resprate  18.0  o2sat  96.0  sbp  121.0  dbp  88.0  rhythm    pain  2  $hematology blood hematocrit  38.1  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  4.3  g dl; blood gas blood lactate  1.2  mmol l; hematology blood wbc count  6.3  k ul$nan
tremor, unspecified body mass index (bmi) 28.0-28.9, adult major depressive disorder, single episode, unspecified hypoxemia pain in left knee obesity, unspecified cocaine abuse, in remission pain in right knee asymptomatic human immunodeficiency virus [hiv] infection status alcohol dependence with withdrawal, unspecified fatty (change of) liver, not elsewhere classified localized enlarged lymph nodes other seizures other stimulant abuse, in remission acute pharyngitis, unspecified anxiety disorder, unspecified essential tremor changes in skin texture major depressive disorder, single episode, unspecified other seizures asymptomatic human immunodeficiency virus [hiv] infection status acidosis other pancytopenia nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] hypovolemia alcohol dependence with withdrawal, unspecified generalized anxiety disorder asymptomatic human immunodeficiency virus [hiv] infection status major depressive disorder, single episode, unspecified family history of alcohol abuse and dependence alcohol dependence with withdrawal, unspecified anxiety disorder, unspecified epilepsy, unspecified, not intractable, without status epilepticus acute respiratory failure with hypoxia nausea anxiety disorder, unspecified alcohol dependence with withdrawal, unspecified epilepsy, unspecified, not intractable, without status epilepticus essential tremor major depressive disorder, single episode, unspecified headache asymptomatic human immunodeficiency virus [hiv] infection status unspecified abdominal pain major depressive disorder, recurrent, unspecified essential tremor anxiety disorder, unspecified asymptomatic human immunodeficiency virus [hiv] infection status alcohol dependence with withdrawal, unspecified
white m 61 $temp    heartrate  73.0  resprate  20.0  o2sat  97.0  sbp  128.0  dbp  92.0  rhythm    pain  0  ; temp  98.9  heartrate  60.0  resprate  16.0  o2sat  95.0  sbp  121.0  dbp  84.0  rhythm    pain  0  $hematology blood hematocrit  39.3  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  141  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; diazepam - ciwa protocol  20  mg ; diazepam - ciwa protocol  10  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; cyanocobalamin  1000  mcg ; fluoxetine  60  mg ; folic acid  1  mg ; levetiracetam  1000  mg ; mirtazapine  45  mg ; multivitamins  1  tab ; propranolol  20  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; darunavir  800  mg ; cobicistat  150  mg ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  4  gm ; ibuprofen  400  mg ; 
tremor, unspecified body mass index (bmi) 28.0-28.9, adult major depressive disorder, single episode, unspecified hypoxemia pain in left knee obesity, unspecified cocaine abuse, in remission pain in right knee asymptomatic human immunodeficiency virus [hiv] infection status alcohol dependence with withdrawal, unspecified fatty (change of) liver, not elsewhere classified localized enlarged lymph nodes other seizures other stimulant abuse, in remission acute pharyngitis, unspecified anxiety disorder, unspecified essential tremor changes in skin texture major depressive disorder, single episode, unspecified other seizures asymptomatic human immunodeficiency virus [hiv] infection status acidosis other pancytopenia nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] hypovolemia alcohol dependence with withdrawal, unspecified generalized anxiety disorder asymptomatic human immunodeficiency virus [hiv] infection status major depressive disorder, single episode, unspecified family history of alcohol abuse and dependence alcohol dependence with withdrawal, unspecified anxiety disorder, unspecified epilepsy, unspecified, not intractable, without status epilepticus acute respiratory failure with hypoxia nausea anxiety disorder, unspecified alcohol dependence with withdrawal, unspecified epilepsy, unspecified, not intractable, without status epilepticus essential tremor major depressive disorder, single episode, unspecified headache asymptomatic human immunodeficiency virus [hiv] infection status unspecified abdominal pain major depressive disorder, recurrent, unspecified essential tremor anxiety disorder, unspecified asymptomatic human immunodeficiency virus [hiv] infection status alcohol dependence with withdrawal, unspecified
white m 61 $nan$hematology blood hematocrit  44.8  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  85  mg dl; chemistry blood albumin  4.6  g dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; cyanocobalamin  1000  mcg ; fluoxetine  60  mg ; folic acid  1  mg ; levetiracetam  1000  mg ; mirtazapine  45  mg ; multivitamins  1  tab ; propranolol  20  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; darunavir  800  mg ; cobicistat  150  mg ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  4  gm ; ibuprofen  400  mg ; lactated ringers  1000  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
tremor, unspecified body mass index (bmi) 28.0-28.9, adult major depressive disorder, single episode, unspecified hypoxemia pain in left knee obesity, unspecified cocaine abuse, in remission pain in right knee asymptomatic human immunodeficiency virus [hiv] infection status alcohol dependence with withdrawal, unspecified fatty (change of) liver, not elsewhere classified localized enlarged lymph nodes other seizures other stimulant abuse, in remission acute pharyngitis, unspecified anxiety disorder, unspecified essential tremor changes in skin texture major depressive disorder, single episode, unspecified other seizures asymptomatic human immunodeficiency virus [hiv] infection status acidosis other pancytopenia nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] hypovolemia alcohol dependence with withdrawal, unspecified generalized anxiety disorder asymptomatic human immunodeficiency virus [hiv] infection status major depressive disorder, single episode, unspecified family history of alcohol abuse and dependence alcohol dependence with withdrawal, unspecified anxiety disorder, unspecified epilepsy, unspecified, not intractable, without status epilepticus acute respiratory failure with hypoxia nausea anxiety disorder, unspecified alcohol dependence with withdrawal, unspecified epilepsy, unspecified, not intractable, without status epilepticus essential tremor major depressive disorder, single episode, unspecified headache asymptomatic human immunodeficiency virus [hiv] infection status unspecified abdominal pain major depressive disorder, recurrent, unspecified essential tremor anxiety disorder, unspecified asymptomatic human immunodeficiency virus [hiv] infection status alcohol dependence with withdrawal, unspecified
white m 61 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  93  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; cyanocobalamin  1000  mcg ; fluoxetine  60  mg ; folic acid  1  mg ; levetiracetam  1000  mg ; mirtazapine  45  mg ; multivitamins  1  tab ; propranolol  20  mg ; emtricitabine-tenofovir alafen (200mg-25mg) *descovy*  1  tab ; darunavir  800  mg ; cobicistat  150  mg ; ibuprofen  400  mg ; 
tremor, unspecified body mass index (bmi) 28.0-28.9, adult major depressive disorder, single episode, unspecified hypoxemia pain in left knee obesity, unspecified cocaine abuse, in remission pain in right knee asymptomatic human immunodeficiency virus [hiv] infection status alcohol dependence with withdrawal, unspecified fatty (change of) liver, not elsewhere classified localized enlarged lymph nodes other seizures other stimulant abuse, in remission acute pharyngitis, unspecified anxiety disorder, unspecified essential tremor changes in skin texture major depressive disorder, single episode, unspecified other seizures asymptomatic human immunodeficiency virus [hiv] infection status acidosis other pancytopenia nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] hypovolemia alcohol dependence with withdrawal, unspecified generalized anxiety disorder asymptomatic human immunodeficiency virus [hiv] infection status major depressive disorder, single episode, unspecified family history of alcohol abuse and dependence alcohol dependence with withdrawal, unspecified anxiety disorder, unspecified epilepsy, unspecified, not intractable, without status epilepticus acute respiratory failure with hypoxia nausea anxiety disorder, unspecified alcohol dependence with withdrawal, unspecified epilepsy, unspecified, not intractable, without status epilepticus essential tremor major depressive disorder, single episode, unspecified headache asymptomatic human immunodeficiency virus [hiv] infection status unspecified abdominal pain major depressive disorder, recurrent, unspecified essential tremor anxiety disorder, unspecified asymptomatic human immunodeficiency virus [hiv] infection status alcohol dependence with withdrawal, unspecified
other m 75 $nan$nan$iso-osmotic dextrose  50  ml ; amlodipine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; levothyroxine sodium  200  mcg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; cefazolin  2  g ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  2-4  mg ; lactated ringers  1000  ml ; senna  8.6  mg ; morphine sr (ms contin)  30  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; acetaminophen  1000  mg ; gabapentin  400  mg ; docusate sodium  100  mg ; isosorbide mononitrate (extended release)  60  mg ; sodium chloride 0.9%  1000  ml ; 
personal history of nicotine dependence hyperlipidemia, unspecified other chest pain nutritional anemia, unspecified presence of unspecified artificial knee joint essential (primary) hypertension obesity, unspecified unspecified fracture of lower end of right femur, subsequent encounter for closed fracture with nonunion other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft hypothyroidism, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction infection and inflammatory reaction due to internal fixation device of right femur, initial encounter unspecified place or not applicable exposure to other specified factors, subsequent encounter body mass index (bmi) 36.0-36.9, adult other staphylococcus as the cause of diseases classified elsewhere pain in leg, unspecified 
other m 75 $nan$nan$iso-osmotic dextrose  50  ml ; amlodipine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; levothyroxine sodium  200  mcg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; cefazolin  2  g ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  2-4  mg ; lactated ringers  1000  ml ; senna  8.6  mg ; morphine sr (ms contin)  30  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; acetaminophen  1000  mg ; gabapentin  400  mg ; docusate sodium  100  mg ; isosorbide mononitrate (extended release)  60  mg ; sodium chloride 0.9%  1000  ml ; clopidogrel  75  mg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; 
personal history of nicotine dependence hyperlipidemia, unspecified other chest pain nutritional anemia, unspecified presence of unspecified artificial knee joint essential (primary) hypertension obesity, unspecified unspecified fracture of lower end of right femur, subsequent encounter for closed fracture with nonunion other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft hypothyroidism, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction infection and inflammatory reaction due to internal fixation device of right femur, initial encounter unspecified place or not applicable exposure to other specified factors, subsequent encounter body mass index (bmi) 36.0-36.9, adult other staphylococcus as the cause of diseases classified elsewhere pain in leg, unspecified 
other m 75 $nan$nan$amlodipine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; levothyroxine sodium  200  mcg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  2-4  mg ; lactated ringers  1000  ml ; senna  8.6  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  1000  mg ; gabapentin  400  mg ; docusate sodium  100  mg ; isosorbide mononitrate (extended release)  60  mg ; clopidogrel  75  mg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; 
personal history of nicotine dependence hyperlipidemia, unspecified other chest pain nutritional anemia, unspecified presence of unspecified artificial knee joint essential (primary) hypertension obesity, unspecified unspecified fracture of lower end of right femur, subsequent encounter for closed fracture with nonunion other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft hypothyroidism, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction infection and inflammatory reaction due to internal fixation device of right femur, initial encounter unspecified place or not applicable exposure to other specified factors, subsequent encounter body mass index (bmi) 36.0-36.9, adult other staphylococcus as the cause of diseases classified elsewhere pain in leg, unspecified 
other m 75 $nan$nan$amlodipine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; levothyroxine sodium  200  mcg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  2-4  mg ; lactated ringers  1000  ml ; senna  8.6  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  1000  mg ; gabapentin  400  mg ; docusate sodium  100  mg ; isosorbide mononitrate (extended release)  60  mg ; clopidogrel  75  mg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; 
personal history of nicotine dependence hyperlipidemia, unspecified other chest pain nutritional anemia, unspecified presence of unspecified artificial knee joint essential (primary) hypertension obesity, unspecified unspecified fracture of lower end of right femur, subsequent encounter for closed fracture with nonunion other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft hypothyroidism, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction infection and inflammatory reaction due to internal fixation device of right femur, initial encounter unspecified place or not applicable exposure to other specified factors, subsequent encounter body mass index (bmi) 36.0-36.9, adult other staphylococcus as the cause of diseases classified elsewhere pain in leg, unspecified 
other m 75 $nan$nan$amlodipine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; levothyroxine sodium  200  mcg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  2-4  mg ; senna  8.6  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  1000  mg ; gabapentin  400  mg ; docusate sodium  100  mg ; isosorbide mononitrate (extended release)  60  mg ; clopidogrel  75  mg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; 
personal history of nicotine dependence hyperlipidemia, unspecified other chest pain nutritional anemia, unspecified presence of unspecified artificial knee joint essential (primary) hypertension obesity, unspecified unspecified fracture of lower end of right femur, subsequent encounter for closed fracture with nonunion other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft hypothyroidism, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction infection and inflammatory reaction due to internal fixation device of right femur, initial encounter unspecified place or not applicable exposure to other specified factors, subsequent encounter body mass index (bmi) 36.0-36.9, adult other staphylococcus as the cause of diseases classified elsewhere pain in leg, unspecified 
other m 75 $nan$nan$amlodipine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; levothyroxine sodium  200  mcg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  2-4  mg ; senna  8.6  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  1000  mg ; gabapentin  400  mg ; docusate sodium  100  mg ; isosorbide mononitrate (extended release)  60  mg ; clopidogrel  75  mg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; morphine sr (ms contin)  15-30  mg ; vancomycin  1750  mg ; morphine sulfate ir  15-30  mg ; 
personal history of nicotine dependence hyperlipidemia, unspecified other chest pain nutritional anemia, unspecified presence of unspecified artificial knee joint essential (primary) hypertension obesity, unspecified unspecified fracture of lower end of right femur, subsequent encounter for closed fracture with nonunion other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft hypothyroidism, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction infection and inflammatory reaction due to internal fixation device of right femur, initial encounter unspecified place or not applicable exposure to other specified factors, subsequent encounter body mass index (bmi) 36.0-36.9, adult other staphylococcus as the cause of diseases classified elsewhere pain in leg, unspecified 
other m 75 $nan$nan$amlodipine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; levothyroxine sodium  200  mcg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; senna  8.6  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  1000  mg ; gabapentin  400  mg ; docusate sodium  100  mg ; isosorbide mononitrate (extended release)  60  mg ; clopidogrel  75  mg ; atorvastatin  40  mg ; enoxaparin sodium  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10-20  ml ; vancomycin  1750  mg ; morphine sulfate ir  15-30  mg ; 
personal history of nicotine dependence hyperlipidemia, unspecified other chest pain nutritional anemia, unspecified presence of unspecified artificial knee joint essential (primary) hypertension obesity, unspecified unspecified fracture of lower end of right femur, subsequent encounter for closed fracture with nonunion other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft hypothyroidism, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction infection and inflammatory reaction due to internal fixation device of right femur, initial encounter unspecified place or not applicable exposure to other specified factors, subsequent encounter body mass index (bmi) 36.0-36.9, adult other staphylococcus as the cause of diseases classified elsewhere pain in leg, unspecified 
white m 76 $nan$nan$clopidogrel  75  mg ; aspirin  81  mg ; ramipril  10  mg ; 
 
white m 76 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  160  mg dl$clopidogrel  75  mg ; aspirin  81  mg ; ramipril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; quetiapine fumarate  12.5  mg ; insulin  0  unit ; hydralazine  10  mg ; docusate sodium  100  mg ; bystolic  5  mg ; 
 
white m 76 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  161  mg dl$clopidogrel  75  mg ; aspirin  81  mg ; ramipril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; quetiapine fumarate  12.5  mg ; insulin  0  unit ; hydralazine  10  mg ; docusate sodium  100  mg ; bystolic  5  mg ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-1  mg ; 
 
white m 76 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  149  mg dl$clopidogrel  75  mg ; aspirin  81  mg ; ramipril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; quetiapine fumarate  12.5  mg ; insulin  0  unit ; docusate sodium  100  mg ; bystolic  5  mg ; lorazepam  0.5-1  mg ; 
 
white m 76 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  158  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$clopidogrel  75  mg ; aspirin  81  mg ; ramipril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; quetiapine fumarate  12.5  mg ; insulin  0  unit ; docusate sodium  100  mg ; bystolic  5  mg ; 
 
white m 76 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  150  mg dl$clopidogrel  75  mg ; aspirin  81  mg ; ramipril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; quetiapine fumarate  12.5  mg ; insulin  0  unit ; docusate sodium  100  mg ; bystolic  5  mg ; heparin  5000  unit ; 
 
white m 76 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  155  mg dl$clopidogrel  75  mg ; aspirin  81  mg ; ramipril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; quetiapine fumarate  12.5  mg ; insulin  0  unit ; docusate sodium  100  mg ; bystolic  5  mg ; heparin  5000  unit ; 
 
white m 76 $nan$nan$clopidogrel  75  mg ; aspirin  81  mg ; ramipril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; quetiapine fumarate  12.5  mg ; insulin  0  unit ; docusate sodium  100  mg ; bystolic  5  mg ; heparin  5000  unit ; 
 
white m 76 $nan$nan$clopidogrel  75  mg ; aspirin  81  mg ; ramipril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; quetiapine fumarate  12.5  mg ; insulin  0  unit ; docusate sodium  100  mg ; bystolic  5  mg ; heparin  5000  unit ; 
 
white m 68 $nan$nan$aspirin  325  mg ; ezetimibe  10  mg ; paroxetine  20  mg ; clopidogrel  75  mg ; 
 
white m 68 $nan$hematology blood hematocrit  37.5  %; hematology blood hematocrit  35.8  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  428  k ul; hematology blood platelet count  435  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  117  mg dl; chemistry blood lactate dehydrogenase (ld)  444  iu l$aspirin  325  mg ; ezetimibe  10  mg ; paroxetine  20  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  100  mg ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; diphenhydramine  25  mg ; phytonadione  5  mg ; methylprednisolone sodium succ  60  mg ; ranitidine  150  mg ; pneumococcal vac polyvalent  0.5  ml ; oxycodone (immediate release)   5-10  mg ; 
 
white m 68 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  383  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood glucose  90  mg dl$aspirin  325  mg ; ezetimibe  10  mg ; paroxetine  20  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; phytonadione  5  mg ; ranitidine  150  mg ; pneumococcal vac polyvalent  0.5  ml ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
white m 68 $nan$hematology blood hematocrit  33.6  %; hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  385  k ul; hematology blood platelet count  380  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.5  ; chemistry blood bilirubin, indirect  0.6  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  138  mg dl; chemistry blood albumin  3.5  g dl; chemistry blood bilirubin, direct  0.4  mg dl; chemistry blood % hemoglobin a1c  5.6  %$aspirin  325  mg ; ezetimibe  10  mg ; paroxetine  20  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sw  50  ml ; magnesium sulfate  2  gm ; 1 2 ns  1000  ml ; atropine sulfate  0.5  mg ; 
 
white m 68 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  367  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  94  mg dl$aspirin  325  mg ; ezetimibe  10  mg ; paroxetine  20  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; pneumococcal vac polyvalent  0.5  ml ; 1 2 ns  1000  ml ; atropine sulfate  0.5  mg ; zolpidem tartrate  5  mg ; enalapril maleate  10  mg ; enoxaparin sodium  30  mg ; 
 
white m 68 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  325  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  80  mg dl$aspirin  325  mg ; ezetimibe  10  mg ; paroxetine  20  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  100  mg ; pantoprazole  40  mg ; pneumococcal vac polyvalent  0.5  ml ; atropine sulfate  0.5  mg ; zolpidem tartrate  5  mg ; enalapril maleate  10  mg ; enoxaparin sodium  30  mg ; magnesium oxide  400  mg ; 
 
white m 68 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  89  mg dl$aspirin  325  mg ; ezetimibe  10  mg ; paroxetine  20  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  100  mg ; pantoprazole  40  mg ; pneumococcal vac polyvalent  0.5  ml ; atropine sulfate  0.5  mg ; zolpidem tartrate  5  mg ; enalapril maleate  10  mg ; enoxaparin sodium  30  mg ; magnesium oxide  400  mg ; lactulose  30  ml ; 
 
white m 68 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  86  mg dl$aspirin  325  mg ; ezetimibe  10  mg ; paroxetine  20  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  100  mg ; pantoprazole  40  mg ; pneumococcal vac polyvalent  0.5  ml ; atropine sulfate  0.5  mg ; zolpidem tartrate  5  mg ; enalapril maleate  10  mg ; enoxaparin sodium  30  mg ; lactulose  30  ml ; senna  1  tab ; docusate sodium  100  mg ; 
 
white m 68 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  94  mg dl$aspirin  325  mg ; ezetimibe  10  mg ; paroxetine  20  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  100  mg ; pantoprazole  40  mg ; pneumococcal vac polyvalent  0.5  ml ; atropine sulfate  0.5  mg ; zolpidem tartrate  5  mg ; enalapril maleate  10  mg ; lactulose  30  ml ; senna  1  tab ; docusate sodium  100  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
 
white m 68 $nan$hematology blood hematocrit  32.5  %; hematology blood hematocrit  22.8  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  258  k ul; hematology blood platelet count  299  k ul; hematology blood platelet count  253  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; chemistry blood glucose  82  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood chloride, whole blood  99  meq l; blood gas blood chloride, whole blood  106  meq l; blood gas blood glucose  104  mg dl; blood gas blood glucose  115  mg dl; blood gas blood glucose  136  mg dl; blood gas blood glucose  171  mg dl; blood gas blood glucose  160  mg dl; blood gas blood glucose  122  mg dl; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  23  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hematocrit, calculated  23  %; blood gas blood hematocrit, calculated  23  %; blood gas blood hemoglobin  11.0  g dl; blood gas blood hemoglobin  7.8  g dl; blood gas blood hemoglobin  8.2  g dl; blood gas blood hemoglobin  7.5  g dl; blood gas blood hemoglobin  7.8  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  5.6  meq l; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  6.1  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  135  meq l$d5w  250  ml ; aspirin  325  mg ; ezetimibe  10  mg ; paroxetine  20  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  100  mg ; pantoprazole  40  mg ; pneumococcal vac polyvalent  0.5  ml ; atropine sulfate  0.5  mg ; zolpidem tartrate  5  mg ; enalapril maleate  10  mg ; lactulose  30  ml ; senna  1  tab ; docusate sodium  100  mg ; sw  100  ml ; magnesium sulfate  4  gm ; aspirin ec  81  mg ; aspirin  81  mg ; ns  100  ml ; insulin human regular  100  unit ; lr  1000  ml ; propofol  1000  mg ; propofol  200  mg ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; potassium chloride  20  meq ; calcium gluconate  2  gm ; meperidine  12.5  mg ; metoclopramide  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sucralfate  1  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; epinephrine  2  mg ; 
 
white m 68 $nan$hematology blood hematocrit  28.8  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  152  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood glucose  161  mg dl; blood gas blood glucose  176  mg dl; blood gas blood glucose  135  mg dl; blood gas blood glucose  137  mg dl; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  3.9  meq l$d5w  250  ml ; aspirin ec  81  mg ; aspirin  81  mg ; ns  100  ml ; insulin human regular  100  unit ; lr  1000  ml ; propofol  1000  mg ; propofol  200  mg ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; potassium chloride  20  meq ; calcium gluconate  2  gm ; meperidine  12.5  mg ; metoclopramide  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sucralfate  1  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; epinephrine  2  mg ; fentanyl citrate  25-100  mcg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; ketorolac  30  mg ; ns  500  ml ; ketorolac  15  mg ; potassium chloride  40  meq ; 
 
white m 68 $nan$hematology blood hematocrit  22.0  %; hematology blood hematocrit  29.3  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  120  mg dl$furosemide  20  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; insulin  0  unit ; ibuprofen  400  mg ; 
 
white m 68 $nan$hematology blood hematocrit  26.2  %$furosemide  20  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; insulin  0  unit ; ibuprofen  400  mg ; ferrous gluconate  325  mg ; 
 
white m 68 $nan$hematology blood hematocrit  27.9  %; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood urea nitrogen  15  mg dl$furosemide  20  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; insulin  0  unit ; ibuprofen  400  mg ; ferrous gluconate  325  mg ; ascorbic acid  500  mg ; warfarin  5  mg ; warfarin  1  dose ; 
 
white m 68 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  116  mg dl$furosemide  20  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; insulin  0  unit ; ibuprofen  400  mg ; ferrous gluconate  325  mg ; ascorbic acid  500  mg ; warfarin  5  mg ; warfarin  1  dose ; furosemide  40  mg ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; metoprolol succinate xl  50  mg ; cephalexin  500  mg ; 
 
white m 68 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  128  mg dl$milk of magnesia  30  ml ; bisacodyl  10  mg ; insulin  0  unit ; ferrous gluconate  325  mg ; ascorbic acid  500  mg ; warfarin  1  dose ; lisinopril  2.5  mg ; metoprolol succinate xl  50  mg ; cephalexin  500  mg ; warfarin  7.5  mg ; aspirin ec  325  mg ; atorvastatin  20  mg ; potassium chloride  60  meq ; 
 
white m 68 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; insulin  0  unit ; ferrous gluconate  325  mg ; ascorbic acid  500  mg ; warfarin  1  dose ; lisinopril  2.5  mg ; cephalexin  500  mg ; aspirin ec  325  mg ; atorvastatin  20  mg ; potassium chloride  60  meq ; 
 
white m 47 $nan$hematology urine wbc  0  # hpf$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; acetaminophen  325-650  mg ; 
 
white m 47 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; acetaminophen  325-650  mg ; cepastat (phenol) lozenge  1  loz ; 
 
black african american m 68 $nan$hematology urine wbc  1  # hpf; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood potassium, whole blood  4.4  meq l$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; methylprednisolone sodium succ  80  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; verapamil sr  120  mg ; pantoprazole  40  mg ; senna  1  tab ; lactulose  30  ml ; finasteride  5  mg ; sertraline  50  mg ; pravastatin  20  mg ; aspirin  81  mg ; vitamin d  400  unit ; multivitamins  1  cap ; prednisone  60  mg ; tiotropium bromide  1  cap ; insulin  0  unit ; calcium carbonate  500  mg ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol (250 50)   1  inh ; docusate sodium  100  mg ; oxycodone-acetaminophen  2  tab ; 
other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery obstructive chronic bronchitis with acute bronchitis old myocardial infarction unspecified essential hypertension 
black african american m 68 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood glucose  72  mg dl$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; verapamil sr  120  mg ; pantoprazole  40  mg ; finasteride  5  mg ; sertraline  50  mg ; pravastatin  20  mg ; aspirin  81  mg ; vitamin d  400  unit ; multivitamins  1  cap ; prednisone  60  mg ; tiotropium bromide  1  cap ; insulin  0  unit ; calcium carbonate  500  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol (250 50)   1  inh ; docusate sodium  100  mg ; oxycodone-acetaminophen  2  tab ; alendronate sodium  70  mg ; sarna lotion  1  appl ; 
other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery obstructive chronic bronchitis with acute bronchitis old myocardial infarction unspecified essential hypertension 
black african american m 68 $nan$nan$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; verapamil sr  120  mg ; pantoprazole  40  mg ; finasteride  5  mg ; sertraline  50  mg ; pravastatin  20  mg ; aspirin  81  mg ; vitamin d  400  unit ; multivitamins  1  cap ; prednisone  60  mg ; tiotropium bromide  1  cap ; insulin  0  unit ; calcium carbonate  500  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol (250 50)   1  inh ; docusate sodium  100  mg ; oxycodone-acetaminophen  2  tab ; alendronate sodium  70  mg ; sarna lotion  1  appl ; lorazepam  0.5  mg ; 
other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery obstructive chronic bronchitis with acute bronchitis old myocardial infarction unspecified essential hypertension 
unknown m 50 $temp    heartrate  51.0  resprate  16.0  o2sat  98.0  sbp  111.0  dbp  65.0  rhythm    pain    $hematology blood hematocrit  33.3  %; hematology blood hematocrit  32.8  %; hematology blood hematocrit  31.5  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  160  k ul; hematology blood platelet count  157  k ul; hematology blood platelet count  162  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  108  mg dl; blood gas blood lactate  1.0  mmol l$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; morphine sulfate  2  mg ; morphine sulfate  2-4  mg ; heparin  1500-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; morphine sulfate  4  mg ; morphine sulfate  5  mg ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  500-1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; vial  1  vial ; pantoprazole  40  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  50  ml ; alteplase  50  mg ; hydromorphone (dilaudid)  0.125  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; hydromorphone (dilaudid)  0.25  mg ; enoxaparin sodium  80  mg ; hydromorphone (dilaudid)  1  mg ; lorazepam  0.5-2  mg ; docusate sodium  100  mg ; oxymetazoline  1  spry ; sodium chloride nasal  1-2  spry ; oxycodone (immediate release)   5-10  mg ; 
 
unknown m 50 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  31.3  %; hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  153  k ul; hematology blood platelet count  171  k ul; hematology blood platelet count  199  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  86  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; vial  1  vial ; pantoprazole  40  mg ; bag  50  ml ; alteplase  50  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; enoxaparin sodium  80  mg ; lorazepam  0.5-2  mg ; docusate sodium  100  mg ; oxymetazoline  1  spry ; sodium chloride nasal  1-2  spry ; oxycodone (immediate release)   5-10  mg ; polyethylene glycol  17  g ; 
 
unknown m 50 $nan$hematology blood hematocrit  31.2  %; hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  103  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; vial  1  vial ; pantoprazole  40  mg ; bag  50  ml ; alteplase  50  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; docusate sodium  100  mg ; oxymetazoline  1  spry ; sodium chloride nasal  1-2  spry ; oxycodone (immediate release)   5-10  mg ; polyethylene glycol  17  g ; enoxaparin sodium  110  mg ; rivaroxaban  15  mg ; 
 
unknown m 50 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  102  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; vial  1  vial ; pantoprazole  40  mg ; docusate sodium  100  mg ; oxymetazoline  1  spry ; sodium chloride nasal  1-2  spry ; oxycodone (immediate release)   5-10  mg ; polyethylene glycol  17  g ; rivaroxaban  15  mg ; 
 
white m 74 $nan$nan$bisacodyl  10  mg ; sertraline  100  mg ; aspirin  81  mg ; metoprolol succinate xl  12.5  mg ; 
 
white m 74 $nan$nan$trazodone  50  mg ; bisacodyl  10  mg ; sertraline  100  mg ; aspirin  81  mg ; metoprolol succinate xl  12.5  mg ; acetaminophen  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; lactated ringers  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; cyclobenzaprine  10  mg ; diazepam  2-5  mg ; docusate sodium  100  mg ; famotidine  20  mg ; simvastatin  10  mg ; senna  8.6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white m 74 $nan$nan$trazodone  50  mg ; bisacodyl  10  mg ; sertraline  100  mg ; aspirin  81  mg ; metoprolol succinate xl  12.5  mg ; acetaminophen  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; lactated ringers  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; cyclobenzaprine  10  mg ; diazepam  2-5  mg ; docusate sodium  100  mg ; famotidine  20  mg ; simvastatin  10  mg ; senna  8.6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; tamsulosin  0.4  mg ; lidocaine jelly 2% (urojet)  1  appl ; diazepam  5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; 
 
white m 74 $nan$nan$trazodone  50  mg ; bisacodyl  10  mg ; sertraline  100  mg ; aspirin  81  mg ; metoprolol succinate xl  12.5  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; famotidine  20  mg ; simvastatin  10  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; diazepam  5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; sodium chloride 0.9%  1000  ml ; sulfameth trimethoprim ds  1  tab ; 
 
white m 74 $nan$nan$trazodone  50  mg ; bisacodyl  10  mg ; sertraline  100  mg ; aspirin  81  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; famotidine  20  mg ; simvastatin  10  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; diazepam  5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; sodium chloride 0.9%  1000  ml ; sulfameth trimethoprim ds  1  tab ; oxycodone (immediate release)   5  mg ; 
 
white m 74 $nan$nan$trazodone  50  mg ; bisacodyl  10  mg ; sertraline  100  mg ; aspirin  81  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; famotidine  20  mg ; simvastatin  10  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; diazepam  5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; sulfameth trimethoprim ds  1  tab ; oxycodone (immediate release)   5  mg ; 
 
white m 74 $nan$nan$trazodone  50  mg ; bisacodyl  10  mg ; sertraline  100  mg ; aspirin  81  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; famotidine  20  mg ; simvastatin  10  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; diazepam  5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; sulfameth trimethoprim ds  1  tab ; hydromorphone (dilaudid)  2-4  mg ; 
 
white m 74 $nan$nan$trazodone  50  mg ; bisacodyl  10  mg ; sertraline  100  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; famotidine  20  mg ; simvastatin  10  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; diazepam  5  mg ; acetaminophen  650  mg ; sulfameth trimethoprim ds  1  tab ; 
 
white f 61 $nan$hematology blood hematocrit  42.8  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  763  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  194  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; gabapentin  600  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; terbinafine 1% cream  1  appl ; methadone  30  mg ; tizanidine  4  mg ; multivitamins  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; enoxaparin sodium  40  mg ; 
chronic pain syndrome esophageal reflux dermatophytosis of nail polycythemia vera cellulitis and abscess of leg, except foot venous (peripheral) insufficiency, unspecified accidents occurring in unspecified place disruption of internal operation (surgical) wound digestive-genital tract fistula, female polycythemia vera other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation prolapse of vaginal vault after hysterectomy unspecified essential hypertension polycythemia vera degeneration of intervertebral disc, site unspecified esophageal reflux other inflammatory disease of cervix, vagina and vulva hemorrhage complicating a procedure other chronic pain other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation body mass index 40.0-44.9, adult obesity, unspecified other acute postoperative pain polycythemia vera history of fall personal history of tobacco use degeneration of intervertebral disc, site unspecified other iatrogenic hypotension other specified erythematous conditions hyperpotassemia long-term (current) use of other medications unspecified essential hypertension acute kidney failure, unspecified other signs and symptoms in breast other chronic pain cellulitis and abscess of leg, except foot hyposmolality and/or hyponatremia other specified cardiac dysrhythmias degeneration of intervertebral disc, site unspecified polycythemia vera abdominal pain, right upper quadrant other chronic nonalcoholic liver disease accidents occurring in residential institution splenomegaly other chronic pain other antihypertensive agents causing adverse effects in therapeutic use physical restraints status benign essential hypertension
white f 61 $nan$hematology blood hematocrit  49.8  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  827  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  123  mg dl; chemistry blood % hemoglobin a1c  7.9  %$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; gabapentin  600  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; terbinafine 1% cream  1  appl ; methadone  30  mg ; tizanidine  4  mg ; multivitamins  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; enoxaparin sodium  40  mg ; linezolid  600  mg ; 
chronic pain syndrome esophageal reflux dermatophytosis of nail polycythemia vera cellulitis and abscess of leg, except foot venous (peripheral) insufficiency, unspecified accidents occurring in unspecified place disruption of internal operation (surgical) wound digestive-genital tract fistula, female polycythemia vera other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation prolapse of vaginal vault after hysterectomy unspecified essential hypertension polycythemia vera degeneration of intervertebral disc, site unspecified esophageal reflux other inflammatory disease of cervix, vagina and vulva hemorrhage complicating a procedure other chronic pain other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation body mass index 40.0-44.9, adult obesity, unspecified other acute postoperative pain polycythemia vera history of fall personal history of tobacco use degeneration of intervertebral disc, site unspecified other iatrogenic hypotension other specified erythematous conditions hyperpotassemia long-term (current) use of other medications unspecified essential hypertension acute kidney failure, unspecified other signs and symptoms in breast other chronic pain cellulitis and abscess of leg, except foot hyposmolality and/or hyponatremia other specified cardiac dysrhythmias degeneration of intervertebral disc, site unspecified polycythemia vera abdominal pain, right upper quadrant other chronic nonalcoholic liver disease accidents occurring in residential institution splenomegaly other chronic pain other antihypertensive agents causing adverse effects in therapeutic use physical restraints status benign essential hypertension
white m 58 $nan$hematology blood hematocrit  40.8  %; hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.1  g dl; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  352  k ul; hematology blood platelet count  346  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  155  mg dl; chemistry blood glucose  162  mg dl; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.00  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood chloride, whole blood  113  meq l; blood gas blood glucose  104  mg dl; blood gas blood glucose  108  mg dl; blood gas blood hematocrit, calculated  37  %; blood gas blood hematocrit, calculated  37  %; blood gas blood hemoglobin  12.4  g dl; blood gas blood hemoglobin  12.3  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  140  meq l$heparin  5000  unit ; lithium carbonate  300  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; d5w  250  ml ; nitroglycerin  100  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; ondansetron  4  mg ; yellow cadd cassette  1  cadd ; bupivacaine 0.1%  250  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; lorazepam  0.5  mg ; acetaminophen iv  1000  mg ; venlafaxine xr  150  mg ; 
 
white m 58 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  131  mg dl$heparin  5000  unit ; lithium carbonate  300  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5w  250  ml ; nitroglycerin  100  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; ondansetron  4  mg ; yellow cadd cassette  1  cadd ; bupivacaine 0.1%  250  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; lorazepam  0.5  mg ; venlafaxine xr  150  mg ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; metoprolol tartrate  5  mg ; 
 
white m 58 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  344  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  109  mg dl$lithium carbonate  300  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5w  250  ml ; nitroglycerin  100  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; ondansetron  4  mg ; yellow cadd cassette  1  cadd ; bupivacaine 0.1%  250  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; lorazepam  0.5  mg ; venlafaxine xr  150  mg ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; metoprolol tartrate  5  mg ; hydralazine  10  mg ; 
 
white m 58 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  91  mg dl$lithium carbonate  300  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5w  250  ml ; nitroglycerin  100  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; ondansetron  4  mg ; yellow cadd cassette  1  cadd ; bupivacaine 0.1%  250  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; lorazepam  0.5  mg ; venlafaxine xr  150  mg ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; metoprolol tartrate  5  mg ; hydralazine  10  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; neutra-phos  2  pkt ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white m 58 $nan$nan$lithium carbonate  300  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; venlafaxine xr  150  mg ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone (immediate release)   5-10  mg ; potassium chloride (powder)  20  meq ; 
 
white m 58 $nan$nan$lithium carbonate  300  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; venlafaxine xr  150  mg ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white f 42 $nan$hematology blood hematocrit  40.6  %; hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.6  g dl; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  245  k ul; hematology blood platelet count  228  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  8  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; insulin  10  unit ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  0.5-1  mg ; senna  8.6  mg ; docusate sodium  100  mg ; promethazine  12.5  mg ; 
follow-up examination, following other surgery nausea with vomiting abdominal pain, unspecified site chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified digestive system complications, not elsewhere classified friedländer's bacillus infection in conditions classified elsewhere and of unspecified site other iatrogenic hypotension peritoneal adhesions (postoperative) (postinfection) chronic pancreatitis accidents occurring in other specified places keloid scar surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstruction of bile duct digestive system complications, not elsewhere classified calculus of bile duct without mention of cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction nausea alone personal history of noncompliance with medical treatment, presenting hazards to health diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled calculus of bile duct without mention of cholecystitis, with obstruction calculus of bile duct without mention of cholecystitis, with obstruction digestive system complications, not elsewhere classified personal history of tuberculosis cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic pancreatitis calculus of bile duct without mention of cholecystitis, without mention of obstruction chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled dehydration peritoneal adhesions (postoperative) (postinfection) other specified diseases of pancreas hyperpotassemia chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 42 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; insulin  10  unit ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  0.5-1  mg ; senna  8.6  mg ; docusate sodium  100  mg ; promethazine  12.5  mg ; insulin  5  unit ; 0.45% sodium chloride  1000  ml ; potassium chloride  20  meq ; 
follow-up examination, following other surgery nausea with vomiting abdominal pain, unspecified site chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified digestive system complications, not elsewhere classified friedländer's bacillus infection in conditions classified elsewhere and of unspecified site other iatrogenic hypotension peritoneal adhesions (postoperative) (postinfection) chronic pancreatitis accidents occurring in other specified places keloid scar surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstruction of bile duct digestive system complications, not elsewhere classified calculus of bile duct without mention of cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction nausea alone personal history of noncompliance with medical treatment, presenting hazards to health diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled calculus of bile duct without mention of cholecystitis, with obstruction calculus of bile duct without mention of cholecystitis, with obstruction digestive system complications, not elsewhere classified personal history of tuberculosis cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic pancreatitis calculus of bile duct without mention of cholecystitis, without mention of obstruction chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled dehydration peritoneal adhesions (postoperative) (postinfection) other specified diseases of pancreas hyperpotassemia chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 42 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  0.5-1  mg ; senna  8.6  mg ; docusate sodium  100  mg ; promethazine  12.5  mg ; 0.45% sodium chloride  1000  ml ; potassium chloride  20  meq ; 
follow-up examination, following other surgery nausea with vomiting abdominal pain, unspecified site chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified digestive system complications, not elsewhere classified friedländer's bacillus infection in conditions classified elsewhere and of unspecified site other iatrogenic hypotension peritoneal adhesions (postoperative) (postinfection) chronic pancreatitis accidents occurring in other specified places keloid scar surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstruction of bile duct digestive system complications, not elsewhere classified calculus of bile duct without mention of cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction nausea alone personal history of noncompliance with medical treatment, presenting hazards to health diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled calculus of bile duct without mention of cholecystitis, with obstruction calculus of bile duct without mention of cholecystitis, with obstruction digestive system complications, not elsewhere classified personal history of tuberculosis cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic pancreatitis calculus of bile duct without mention of cholecystitis, without mention of obstruction chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled dehydration peritoneal adhesions (postoperative) (postinfection) other specified diseases of pancreas hyperpotassemia chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 42 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  0.5-1  mg ; senna  8.6  mg ; docusate sodium  100  mg ; promethazine  12.5  mg ; 
follow-up examination, following other surgery nausea with vomiting abdominal pain, unspecified site chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified digestive system complications, not elsewhere classified friedländer's bacillus infection in conditions classified elsewhere and of unspecified site other iatrogenic hypotension peritoneal adhesions (postoperative) (postinfection) chronic pancreatitis accidents occurring in other specified places keloid scar surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstruction of bile duct digestive system complications, not elsewhere classified calculus of bile duct without mention of cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled gastric ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction nausea alone personal history of noncompliance with medical treatment, presenting hazards to health diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled calculus of bile duct without mention of cholecystitis, with obstruction calculus of bile duct without mention of cholecystitis, with obstruction digestive system complications, not elsewhere classified personal history of tuberculosis cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic pancreatitis calculus of bile duct without mention of cholecystitis, without mention of obstruction chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled dehydration peritoneal adhesions (postoperative) (postinfection) other specified diseases of pancreas hyperpotassemia chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
black african american f 45 $nan$nan$lacosamide  100  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; bisacodyl  10  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; hydralazine  10-20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1  puff ; acetaminophen-caff-butalbital  1-2  tab ; pantoprazole  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; insulin  0  unit ; gabapentin  300  mg ; 
major depressive disorder, single episode, unspecified neoplasm of uncertain behavior of craniopharyngeal duct pure hypercholesterolemia, unspecified postprocedural hypothyroidism essential (primary) hypertension hypocalcemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew anxiety disorder, unspecified nausea with vomiting, unspecified other and unspecified fall in water transport injuring occupant of small boat, powered hypomagnesemia type 2 diabetes mellitus without complications hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side hypopituitarism unspecified adrenocortical insufficiency neoplasm related pain (acute) (chronic) unspecified asthma, uncomplicated diabetes insipidus epilepsy, unspecified, not intractable, without status epilepticus long term (current) use of insulin asymptomatic human immunodeficiency virus [hiv] infection status unspecified visual loss other herpesviral infection facial weakness personal history of benign neoplasm of the brain anxiety disorder, unspecified hypopituitarism asymptomatic human immunodeficiency virus [hiv] infection status long term (current) use of insulin type 2 diabetes mellitus without complications nausea with vomiting, unspecified major depressive disorder, single episode, unspecified other specified postprocedural states dysarthria and anarthria essential (primary) hypertension diarrhea, unspecified dysplasia of cervix uteri, unspecified unspecified asthma, uncomplicated personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits headache visual discomfort, right eye unspecified adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] long term (current) use of insulin acute kidney failure, unspecified other specified postprocedural states type 2 diabetes mellitus without complications hypokalemia
black african american f 45 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  260  mg dl; hematology urine glucose  150  mg dl$lacosamide  100  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; bisacodyl  10  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; hydralazine  10-20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1  puff ; acetaminophen-caff-butalbital  1-2  tab ; pantoprazole  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; insulin  0  unit ; gabapentin  300  mg ; desmopressin nasal  2  spry ; genvoya  1  tab ; tradjenta  5  mg ; docusate sodium  100  mg ; hydrocortisone  10  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; desmopressin nasal  1  spry ; insulin  20  unit ; ondansetron  4  mg ; heparin  5000  unit ; hydrocortisone  5  mg ; 
major depressive disorder, single episode, unspecified neoplasm of uncertain behavior of craniopharyngeal duct pure hypercholesterolemia, unspecified postprocedural hypothyroidism essential (primary) hypertension hypocalcemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew anxiety disorder, unspecified nausea with vomiting, unspecified other and unspecified fall in water transport injuring occupant of small boat, powered hypomagnesemia type 2 diabetes mellitus without complications hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side hypopituitarism unspecified adrenocortical insufficiency neoplasm related pain (acute) (chronic) unspecified asthma, uncomplicated diabetes insipidus epilepsy, unspecified, not intractable, without status epilepticus long term (current) use of insulin asymptomatic human immunodeficiency virus [hiv] infection status unspecified visual loss other herpesviral infection facial weakness personal history of benign neoplasm of the brain anxiety disorder, unspecified hypopituitarism asymptomatic human immunodeficiency virus [hiv] infection status long term (current) use of insulin type 2 diabetes mellitus without complications nausea with vomiting, unspecified major depressive disorder, single episode, unspecified other specified postprocedural states dysarthria and anarthria essential (primary) hypertension diarrhea, unspecified dysplasia of cervix uteri, unspecified unspecified asthma, uncomplicated personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits headache visual discomfort, right eye unspecified adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] long term (current) use of insulin acute kidney failure, unspecified other specified postprocedural states type 2 diabetes mellitus without complications hypokalemia
black african american f 45 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  359  mg dl$lacosamide  100  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; bisacodyl  10  mg ; hydralazine  10-20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1  puff ; acetaminophen-caff-butalbital  1-2  tab ; pantoprazole  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; gabapentin  300  mg ; desmopressin nasal  2  spry ; genvoya  1  tab ; tradjenta  5  mg ; docusate sodium  100  mg ; hydrocortisone  10  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; desmopressin nasal  1  spry ; ondansetron  4  mg ; heparin  5000  unit ; hydrocortisone  5  mg ; insulin  30  unit ; neutra-phos  1  pkt ; 
major depressive disorder, single episode, unspecified neoplasm of uncertain behavior of craniopharyngeal duct pure hypercholesterolemia, unspecified postprocedural hypothyroidism essential (primary) hypertension hypocalcemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew anxiety disorder, unspecified nausea with vomiting, unspecified other and unspecified fall in water transport injuring occupant of small boat, powered hypomagnesemia type 2 diabetes mellitus without complications hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side hypopituitarism unspecified adrenocortical insufficiency neoplasm related pain (acute) (chronic) unspecified asthma, uncomplicated diabetes insipidus epilepsy, unspecified, not intractable, without status epilepticus long term (current) use of insulin asymptomatic human immunodeficiency virus [hiv] infection status unspecified visual loss other herpesviral infection facial weakness personal history of benign neoplasm of the brain anxiety disorder, unspecified hypopituitarism asymptomatic human immunodeficiency virus [hiv] infection status long term (current) use of insulin type 2 diabetes mellitus without complications nausea with vomiting, unspecified major depressive disorder, single episode, unspecified other specified postprocedural states dysarthria and anarthria essential (primary) hypertension diarrhea, unspecified dysplasia of cervix uteri, unspecified unspecified asthma, uncomplicated personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits headache visual discomfort, right eye unspecified adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] long term (current) use of insulin acute kidney failure, unspecified other specified postprocedural states type 2 diabetes mellitus without complications hypokalemia
black african american f 45 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  327  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  256  mg dl$lacosamide  100  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1  puff ; acetaminophen-caff-butalbital  1-2  tab ; pantoprazole  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; gabapentin  300  mg ; desmopressin nasal  2  spry ; genvoya  1  tab ; tradjenta  5  mg ; docusate sodium  100  mg ; hydrocortisone  10  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; desmopressin nasal  1  spry ; ondansetron  4  mg ; heparin  5000  unit ; hydrocortisone  5  mg ; insulin  30  unit ; neutra-phos  1  pkt ; neutra-phos  2  pkt ; 
major depressive disorder, single episode, unspecified neoplasm of uncertain behavior of craniopharyngeal duct pure hypercholesterolemia, unspecified postprocedural hypothyroidism essential (primary) hypertension hypocalcemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew anxiety disorder, unspecified nausea with vomiting, unspecified other and unspecified fall in water transport injuring occupant of small boat, powered hypomagnesemia type 2 diabetes mellitus without complications hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side hypopituitarism unspecified adrenocortical insufficiency neoplasm related pain (acute) (chronic) unspecified asthma, uncomplicated diabetes insipidus epilepsy, unspecified, not intractable, without status epilepticus long term (current) use of insulin asymptomatic human immunodeficiency virus [hiv] infection status unspecified visual loss other herpesviral infection facial weakness personal history of benign neoplasm of the brain anxiety disorder, unspecified hypopituitarism asymptomatic human immunodeficiency virus [hiv] infection status long term (current) use of insulin type 2 diabetes mellitus without complications nausea with vomiting, unspecified major depressive disorder, single episode, unspecified other specified postprocedural states dysarthria and anarthria essential (primary) hypertension diarrhea, unspecified dysplasia of cervix uteri, unspecified unspecified asthma, uncomplicated personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits headache visual discomfort, right eye unspecified adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] long term (current) use of insulin acute kidney failure, unspecified other specified postprocedural states type 2 diabetes mellitus without complications hypokalemia
black african american f 45 $nan$nan$lacosamide  100  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1  puff ; acetaminophen-caff-butalbital  1-2  tab ; pantoprazole  40  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; gabapentin  300  mg ; desmopressin nasal  2  spry ; genvoya  1  tab ; tradjenta  5  mg ; docusate sodium  100  mg ; hydrocortisone  10  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; desmopressin nasal  1  spry ; ondansetron  4  mg ; heparin  5000  unit ; hydrocortisone  5  mg ; insulin  30  unit ; neutra-phos  2  pkt ; stribild  1  tab ; 
major depressive disorder, single episode, unspecified neoplasm of uncertain behavior of craniopharyngeal duct pure hypercholesterolemia, unspecified postprocedural hypothyroidism essential (primary) hypertension hypocalcemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew anxiety disorder, unspecified nausea with vomiting, unspecified other and unspecified fall in water transport injuring occupant of small boat, powered hypomagnesemia type 2 diabetes mellitus without complications hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side hypopituitarism unspecified adrenocortical insufficiency neoplasm related pain (acute) (chronic) unspecified asthma, uncomplicated diabetes insipidus epilepsy, unspecified, not intractable, without status epilepticus long term (current) use of insulin asymptomatic human immunodeficiency virus [hiv] infection status unspecified visual loss other herpesviral infection facial weakness personal history of benign neoplasm of the brain anxiety disorder, unspecified hypopituitarism asymptomatic human immunodeficiency virus [hiv] infection status long term (current) use of insulin type 2 diabetes mellitus without complications nausea with vomiting, unspecified major depressive disorder, single episode, unspecified other specified postprocedural states dysarthria and anarthria essential (primary) hypertension diarrhea, unspecified dysplasia of cervix uteri, unspecified unspecified asthma, uncomplicated personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits headache visual discomfort, right eye unspecified adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] long term (current) use of insulin acute kidney failure, unspecified other specified postprocedural states type 2 diabetes mellitus without complications hypokalemia
white m 72 $temp    heartrate  86.0  resprate  20.0  o2sat  98.0  sbp  150.0  dbp  69.0  rhythm    pain  2  ; temp    heartrate  85.0  resprate  16.0  o2sat  98.0  sbp  146.0  dbp  65.0  rhythm    pain    $hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  245  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; tamsulosin  0.4  mg ; metoprolol succinate xl  25  mg ; atorvastatin  40  mg ; gemfibrozil  600  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; hydralazine  10-20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; isosorbide mononitrate (extended release)  45  mg ; 
occlusion and stenosis of right carotid artery presence of prosthetic heart valve personal history of nicotine dependence type 2 diabetes mellitus without complications peripheral vascular disease, unspecified gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants hyperlipidemia, unspecified acquired absence of right leg below knee essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere cellulitis of right lower limb hyperlipidemia, unspecified long term (current) use of anticoagulants essential (primary) hypertension encounter for immunization presence of prosthetic heart valve personal history of nicotine dependence non-pressure chronic ulcer of other part of right foot with unspecified severity presence of prosthetic heart valve hyperlipidemia, unspecified essential (primary) hypertension acute posthemorrhagic anemia long term (current) use of anticoagulants non-pressure chronic ulcer of other part of right foot with unspecified severity type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity essential (primary) hypertension 
white m 72 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  204  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  17.2  mg ; tamsulosin  0.4  mg ; metoprolol succinate xl  25  mg ; atorvastatin  40  mg ; gemfibrozil  600  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; hydralazine  10-20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; isosorbide mononitrate (extended release)  45  mg ; ondansetron  4  mg ; heparin  5000  unit ; ramelteon  8  mg ; 5% dextrose  50  ml ; phytonadione  10  mg ; 
occlusion and stenosis of right carotid artery presence of prosthetic heart valve personal history of nicotine dependence type 2 diabetes mellitus without complications peripheral vascular disease, unspecified gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants hyperlipidemia, unspecified acquired absence of right leg below knee essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere cellulitis of right lower limb hyperlipidemia, unspecified long term (current) use of anticoagulants essential (primary) hypertension encounter for immunization presence of prosthetic heart valve personal history of nicotine dependence non-pressure chronic ulcer of other part of right foot with unspecified severity presence of prosthetic heart valve hyperlipidemia, unspecified essential (primary) hypertension acute posthemorrhagic anemia long term (current) use of anticoagulants non-pressure chronic ulcer of other part of right foot with unspecified severity type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity essential (primary) hypertension 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  17.2  mg ; tamsulosin  0.4  mg ; metoprolol succinate xl  25  mg ; atorvastatin  40  mg ; gemfibrozil  600  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; hydralazine  10-20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; isosorbide mononitrate (extended release)  45  mg ; heparin  5000  unit ; ramelteon  8  mg ; metformin (glucophage)  500  mg ; amoxicillin-clavulanic acid  875  mg ; 
occlusion and stenosis of right carotid artery presence of prosthetic heart valve personal history of nicotine dependence type 2 diabetes mellitus without complications peripheral vascular disease, unspecified gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants hyperlipidemia, unspecified acquired absence of right leg below knee essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere cellulitis of right lower limb hyperlipidemia, unspecified long term (current) use of anticoagulants essential (primary) hypertension encounter for immunization presence of prosthetic heart valve personal history of nicotine dependence non-pressure chronic ulcer of other part of right foot with unspecified severity presence of prosthetic heart valve hyperlipidemia, unspecified essential (primary) hypertension acute posthemorrhagic anemia long term (current) use of anticoagulants non-pressure chronic ulcer of other part of right foot with unspecified severity type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity essential (primary) hypertension 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  17.2  mg ; tamsulosin  0.4  mg ; metoprolol succinate xl  25  mg ; atorvastatin  40  mg ; gemfibrozil  600  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; isosorbide mononitrate (extended release)  45  mg ; heparin  5000  unit ; ramelteon  8  mg ; metformin (glucophage)  500  mg ; amoxicillin-clavulanic acid  875  mg ; lidocaine 5% patch  1  ptch ; 
occlusion and stenosis of right carotid artery presence of prosthetic heart valve personal history of nicotine dependence type 2 diabetes mellitus without complications peripheral vascular disease, unspecified gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants hyperlipidemia, unspecified acquired absence of right leg below knee essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere cellulitis of right lower limb hyperlipidemia, unspecified long term (current) use of anticoagulants essential (primary) hypertension encounter for immunization presence of prosthetic heart valve personal history of nicotine dependence non-pressure chronic ulcer of other part of right foot with unspecified severity presence of prosthetic heart valve hyperlipidemia, unspecified essential (primary) hypertension acute posthemorrhagic anemia long term (current) use of anticoagulants non-pressure chronic ulcer of other part of right foot with unspecified severity type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity essential (primary) hypertension 
white f 89 $temp  98.2  heartrate  57.0  resprate  18.0  o2sat  100.0  sbp  149.0  dbp  93.0  rhythm    pain    $hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  79  mg dl; chemistry blood lactate dehydrogenase (ld)  240  iu l$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  325  mg ; amlodipine  10  mg ; ascorbic acid  500  mg ; bisacodyl  10  mg ; carvedilol  12.5  mg ; chlorthalidone  12.5  mg ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; omeprazole  20  mg ; phenobarbital  32.4  mg ; simvastatin  10  mg ; thiamine  100  mg ; apixaban  5  mg ; heparin  5000  unit ; phenytoin sodium extended  60  mg ; phenytoin infatab  60  mg ; vial  1  vial ; ceftriaxone  1  gm ; phenytoin sodium extended  100  mg ; oseltamivir  30  mg ; 
 
white f 89 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  325  mg ; amlodipine  10  mg ; ascorbic acid  500  mg ; bisacodyl  10  mg ; carvedilol  12.5  mg ; chlorthalidone  12.5  mg ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; omeprazole  20  mg ; phenobarbital  32.4  mg ; simvastatin  10  mg ; thiamine  100  mg ; heparin  5000  unit ; phenytoin infatab  60  mg ; vial  1  vial ; ceftriaxone  1  gm ; oseltamivir  30  mg ; 
 
white f 89 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  325  mg ; amlodipine  10  mg ; ascorbic acid  500  mg ; bisacodyl  10  mg ; carvedilol  12.5  mg ; chlorthalidone  12.5  mg ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; omeprazole  20  mg ; phenobarbital  32.4  mg ; simvastatin  10  mg ; thiamine  100  mg ; heparin  5000  unit ; phenytoin infatab  60  mg ; oseltamivir  30  mg ; 
 
white f 89 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  325  mg ; amlodipine  10  mg ; ascorbic acid  500  mg ; bisacodyl  10  mg ; carvedilol  12.5  mg ; chlorthalidone  12.5  mg ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; losartan potassium  50  mg ; omeprazole  20  mg ; phenobarbital  32.4  mg ; simvastatin  10  mg ; thiamine  100  mg ; heparin  5000  unit ; phenytoin infatab  60  mg ; oseltamivir  30  mg ; 
 
white m 79 $temp  98.6  heartrate  88.0  resprate  20.0  o2sat  96.0  sbp  95.0  dbp  54.0  rhythm    pain  0  $hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry urine chloride, urine  10  meq l; chemistry urine creatinine, urine  211  mg dl; chemistry urine potassium, urine  96  meq l; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  115  mg dl; chemistry urine protein creatinine ratio  10.4  ratio; chemistry urine albumin, urine  1678  mg dl; chemistry urine albumin creatinine, urine  7952.6  mg g$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; carvedilol  3.125  mg ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; aspirin  325  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; lorazepam  0.25  mg ; heparin  5000  unit ; 
 
white m 79 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  108  mg dl; chemistry blood albumin  2.3  g dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; aspirin  325  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; lorazepam  0.25  mg ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; nitroglycerin sl  0.3  mg ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; 
 
white m 79 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  8.2  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; aspirin  325  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; nitroglycerin sl  0.3  mg ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; furosemide  20  mg ; 
 
white m 79 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  7.8  mg dl$aspirin  81  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; aspirin  325  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; furosemide  20  mg ; lisinopril  2.5  mg ; midodrine  2.5  mg ; furosemide  40  mg ; furosemide  60  mg ; 
 
white m 79 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  93  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; lisinopril  2.5  mg ; midodrine  2.5  mg ; furosemide  40  mg ; furosemide  60  mg ; 
 
white m 79 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  355  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  103  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; lisinopril  2.5  mg ; midodrine  2.5  mg ; 
 
white m 79 $nan$hematology blood hematocrit  36.4  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  340  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  94  mg dl; blood gas blood free calcium  1.12  mmol l$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; lisinopril  2.5  mg ; midodrine  2.5  mg ; 
 
white m 79 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  8.0  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; lisinopril  2.5  mg ; midodrine  2.5  mg ; lisinopril  5  mg ; midodrine  5  mg ; lidocaine 2%  20  ml ; 
 
white m 79 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  354  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  36  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; lisinopril  5  mg ; midodrine  5  mg ; lidocaine 2%  20  ml ; 
 
white m 79 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  39  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; lisinopril  5  mg ; midodrine  5  mg ; 
 
white m 79 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  86  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; lisinopril  5  mg ; midodrine  5  mg ; 
 
white m 79 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  306  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  233  iu l; chemistry blood albumin  1.9  g dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; atorvastatin  40  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; lisinopril  5  mg ; midodrine  5  mg ; 
 
white m 79 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  309  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine chloride, urine  39  meq l; chemistry urine creatinine, urine  132  mg dl; chemistry urine potassium, urine  54  meq l; chemistry urine sodium, urine  43  meq l; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  88  mg dl; chemistry blood lactate dehydrogenase (ld)  255  iu l; chemistry urine protein creatinine ratio  13.6  ratio$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; lisinopril  5  mg ; midodrine  5  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  20  mg ; acyclovir  400  mg ; melphalan  12  mg ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; syringe (chemo)  2.1  ml ; bortezomib  2.1  mg ; 
 
white m 79 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  0.9  ; chemistry urine chloride, urine  20  meq l; chemistry urine creatinine, urine  158  mg dl; chemistry urine potassium, urine  60  meq l; chemistry urine sodium, urine  28  meq l; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  273  iu l$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; midodrine  5  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  20  mg ; melphalan  12  mg ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; syringe (chemo)  2.1  ml ; bortezomib  2.1  mg ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  250  ml ; 
 
white m 79 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  116  mg dl; chemistry blood lactate dehydrogenase (ld)  226  iu l$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; midodrine  5  mg ; dexamethasone  20  mg ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; syringe (chemo)  2.1  ml ; bortezomib  2.1  mg ; 0.9% sodium chloride  250  ml ; sodium polystyrene sulfonate  30  gm ; bumetanide  1  mg ; dexamethasone  10  mg ; 
 
white m 79 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; midodrine  5  mg ; dexamethasone  20  mg ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; dexamethasone  10  mg ; 
 
white m 79 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood urea nitrogen  57  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; midodrine  5  mg ; dexamethasone  20  mg ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; potassium chloride  30  meq ; 
 
white m 79 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  58  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; midodrine  5  mg ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; potassium chloride  30  meq ; 
 
white m 79 $nan$chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  60  mg dl; chemistry urine chloride, urine  123  meq l; chemistry urine creatinine, urine  27  mg dl; chemistry urine potassium, urine  20  meq l; chemistry urine sodium, urine  119  meq l; chemistry urine urea nitrogen, urine  257  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; midodrine  5  mg ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; 
 
white m 79 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood urea nitrogen  58  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; 
 
white m 79 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  122  mg dl; chemistry blood albumin  2.4  g dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; metolazone  2.5  mg ; 
 
white m 79 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  61  mg dl; chemistry blood urea nitrogen  61  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; metolazone  2.5  mg ; potassium chloride  60  meq ; 
 
white m 79 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; potassium chloride  60  meq ; torsemide  40  mg ; potassium chloride  40  meq ; 
 
white m 79 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  61  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; fluticasone propionate nasal  1  spry ; docusate sodium  100  mg ; fluoxetine  20  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; miconazole powder 2%  1  appl ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; torsemide  40  mg ; potassium chloride  40  meq ; 
 
white m 82 $nan$hematology blood hematocrit  24.1  %; hematology blood hematocrit  30.8  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  107  k ul; hematology blood platelet count  131  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  0.95  mmol l; blood gas blood free calcium  0.98  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood chloride, whole blood  100  meq l; blood gas blood chloride, whole blood  111  meq l; blood gas blood glucose  96  mg dl; blood gas blood glucose  105  mg dl; blood gas blood glucose  119  mg dl; blood gas blood glucose  128  mg dl; blood gas blood glucose  131  mg dl; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  23  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hemoglobin  10.6  g dl; blood gas blood hemoglobin  7.8  g dl; blood gas blood hemoglobin  8.0  g dl; blood gas blood hemoglobin  8.2  g dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  135  meq l$sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; 
nonrheumatic aortic (valve) stenosis esophageal obstruction unspecified place or not applicable generalized hyperhidrosis unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence cardiac catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for preprocedural cardiovascular examination injury of conjunctiva and corneal abrasion without foreign body, right eye, initial encounter gastro-esophageal reflux disease without esophagitis postprocedural hemorrhage of skin and subcutaneous tissue following other procedure exposure to other specified factors, initial encounter rheumatoid arthritis, unspecified ulcerative colitis, unspecified, without complications
white m 82 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  71  mg dl; chemistry blood glucose  157  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.03  mmol l; blood gas blood glucose  117  mg dl; blood gas blood glucose  68  mg dl; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.3  meq l$sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; albumin 5% (25g   500ml)  25  g ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; sucralfate  1  gm ; mesalamine dr  1600  mg ; arava  20  mg ; furosemide  20  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; metoprolol tartrate  5  mg ; clevidipine  25  mg ; 
nonrheumatic aortic (valve) stenosis esophageal obstruction unspecified place or not applicable generalized hyperhidrosis unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence cardiac catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for preprocedural cardiovascular examination injury of conjunctiva and corneal abrasion without foreign body, right eye, initial encounter gastro-esophageal reflux disease without esophagitis postprocedural hemorrhage of skin and subcutaneous tissue following other procedure exposure to other specified factors, initial encounter rheumatoid arthritis, unspecified ulcerative colitis, unspecified, without complications
white m 82 $nan$hematology blood hematocrit  23.0  %; hematology blood hematocrit  24.9  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  108  k ul; hematology blood platelet count  100  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  111  mg dl; blood gas blood free calcium  1.02  mmol l; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood glucose  112  mg dl; blood gas blood glucose  92  mg dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.4  meq l$sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 5%  1000  ml ; d5w  250  ml ; nitroglycerin  100  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; aspirin ec  81  mg ; milk of magnesia  30  ml ; sucralfate  1  gm ; mesalamine dr  1600  mg ; arava  20  mg ; furosemide  20  mg ; insulin  0  unit ; clevidipine  25  mg ; hydralazine  10  mg ; hydralazine  25  mg ; lisinopril  5  mg ; muro 128  1  in ; tamsulosin  0.4  mg ; furosemide  40  mg ; 
nonrheumatic aortic (valve) stenosis esophageal obstruction unspecified place or not applicable generalized hyperhidrosis unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence cardiac catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for preprocedural cardiovascular examination injury of conjunctiva and corneal abrasion without foreign body, right eye, initial encounter gastro-esophageal reflux disease without esophagitis postprocedural hemorrhage of skin and subcutaneous tissue following other procedure exposure to other specified factors, initial encounter rheumatoid arthritis, unspecified ulcerative colitis, unspecified, without complications
white m 82 $nan$hematology blood hematocrit  24.2  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  110  k ul; chemistry blood creatinine  1.6  mg dl; chemistry blood urea nitrogen  31  mg dl$sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 5%  1000  ml ; d5w  250  ml ; nitroglycerin  100  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; aspirin ec  81  mg ; milk of magnesia  30  ml ; sucralfate  1  gm ; mesalamine dr  1600  mg ; arava  20  mg ; furosemide  20  mg ; insulin  0  unit ; clevidipine  25  mg ; hydralazine  10  mg ; hydralazine  25  mg ; lisinopril  5  mg ; muro 128  1  in ; tamsulosin  0.4  mg ; furosemide  40  mg ; acetaminophen iv  1000  mg ; 
nonrheumatic aortic (valve) stenosis esophageal obstruction unspecified place or not applicable generalized hyperhidrosis unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence cardiac catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for preprocedural cardiovascular examination injury of conjunctiva and corneal abrasion without foreign body, right eye, initial encounter gastro-esophageal reflux disease without esophagitis postprocedural hemorrhage of skin and subcutaneous tissue following other procedure exposure to other specified factors, initial encounter rheumatoid arthritis, unspecified ulcerative colitis, unspecified, without complications
white m 82 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; aspirin ec  81  mg ; milk of magnesia  30  ml ; sucralfate  1  gm ; mesalamine dr  1600  mg ; arava  20  mg ; insulin  0  unit ; muro 128  1  in ; tamsulosin  0.4  mg ; potassium chloride  40  meq ; 
nonrheumatic aortic (valve) stenosis esophageal obstruction unspecified place or not applicable generalized hyperhidrosis unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence cardiac catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for preprocedural cardiovascular examination injury of conjunctiva and corneal abrasion without foreign body, right eye, initial encounter gastro-esophageal reflux disease without esophagitis postprocedural hemorrhage of skin and subcutaneous tissue following other procedure exposure to other specified factors, initial encounter rheumatoid arthritis, unspecified ulcerative colitis, unspecified, without complications
white m 82 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; aspirin ec  81  mg ; milk of magnesia  30  ml ; sucralfate  1  gm ; mesalamine dr  1600  mg ; arava  20  mg ; insulin  0  unit ; muro 128  1  in ; tamsulosin  0.4  mg ; potassium chloride  40  meq ; warfarin  2  mg ; 
nonrheumatic aortic (valve) stenosis esophageal obstruction unspecified place or not applicable generalized hyperhidrosis unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence cardiac catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for preprocedural cardiovascular examination injury of conjunctiva and corneal abrasion without foreign body, right eye, initial encounter gastro-esophageal reflux disease without esophagitis postprocedural hemorrhage of skin and subcutaneous tissue following other procedure exposure to other specified factors, initial encounter rheumatoid arthritis, unspecified ulcerative colitis, unspecified, without complications
white m 82 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; aspirin ec  81  mg ; milk of magnesia  30  ml ; sucralfate  1  gm ; mesalamine dr  1600  mg ; arava  20  mg ; insulin  0  unit ; muro 128  1  in ; tamsulosin  0.4  mg ; warfarin  2  mg ; bag  1  bag ; warfarin  4  mg ; warfarin  1  dose ; 
nonrheumatic aortic (valve) stenosis esophageal obstruction unspecified place or not applicable generalized hyperhidrosis unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence cardiac catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for preprocedural cardiovascular examination injury of conjunctiva and corneal abrasion without foreign body, right eye, initial encounter gastro-esophageal reflux disease without esophagitis postprocedural hemorrhage of skin and subcutaneous tissue following other procedure exposure to other specified factors, initial encounter rheumatoid arthritis, unspecified ulcerative colitis, unspecified, without complications
white m 82 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; aspirin ec  81  mg ; milk of magnesia  30  ml ; sucralfate  1  gm ; mesalamine dr  1600  mg ; arava  20  mg ; insulin  0  unit ; muro 128  1  in ; tamsulosin  0.4  mg ; bag  1  bag ; warfarin  4  mg ; warfarin  1  dose ; 
nonrheumatic aortic (valve) stenosis esophageal obstruction unspecified place or not applicable generalized hyperhidrosis unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence cardiac catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for preprocedural cardiovascular examination injury of conjunctiva and corneal abrasion without foreign body, right eye, initial encounter gastro-esophageal reflux disease without esophagitis postprocedural hemorrhage of skin and subcutaneous tissue following other procedure exposure to other specified factors, initial encounter rheumatoid arthritis, unspecified ulcerative colitis, unspecified, without complications
white f 33 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  194  k ul$naloxone  40-80  mcg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white f 33 $nan$nan$naloxone  40-80  mcg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white f 33 $nan$nan$naloxone  40-80  mcg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; hydrocortisone cream 2.5%  1  appl ; 
 
white f 33 $nan$nan$naloxone  40-80  mcg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; hydrocortisone cream 2.5%  1  appl ; sarna lotion  1  appl ; 
 
white f 33 $nan$nan$naloxone  40-80  mcg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; hydrocortisone cream 2.5%  1  appl ; sarna lotion  1  appl ; 
 
white f 80 $temp    heartrate  68.0  resprate  16.0  o2sat  98.0  sbp  158.0  dbp  68.0  rhythm    pain  0  $nan$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; senna  2  tab ; 
 
white f 49 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  314  k ul; hematology blood inr(pt)  1.0  $nan
 
white f 49 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  268  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; ketorolac  15-30  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.25  mg ; sertraline  100  mg ; 
 
white f 49 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; ketorolac  15-30  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25  mg ; sertraline  100  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white f 49 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ketorolac  15-30  mg ; ibuprofen  600  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; sertraline  100  mg ; hydromorphone (dilaudid)  2-4  mg ; lorazepam  0.5  mg ; 
 
white f 49 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ketorolac  15-30  mg ; ibuprofen  600  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; sertraline  100  mg ; hydromorphone (dilaudid)  2-4  mg ; lorazepam  0.5  mg ; 
 
unknown m 69 $nan$hematology blood hematocrit  41.0  %; hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.6  g dl; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  224  k ul; hematology blood platelet count  204  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  10.4  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  107  mg dl; chemistry blood albumin  4.7  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; aspirin  325  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; diltiazem extended-release  240  mg ; valsartan  160  mg ; allopurinol  300  mg ; fluoxetine  20  mg ; sodium chloride 0.9%  1000  ml ; 
 
unknown m 69 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  101  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; aspirin  325  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; diltiazem extended-release  240  mg ; valsartan  160  mg ; allopurinol  300  mg ; fluoxetine  20  mg ; sodium chloride 0.9%  1000  ml ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; hydralazine  10  mg ; 
 
unknown m 69 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; aspirin  325  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; diltiazem extended-release  240  mg ; valsartan  160  mg ; allopurinol  300  mg ; fluoxetine  20  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; metoprolol tartrate  5  mg ; lorazepam  1  mg ; 
 
unknown m 69 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; aspirin  325  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; diltiazem extended-release  240  mg ; valsartan  160  mg ; allopurinol  300  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; metoprolol tartrate  5  mg ; lorazepam  1  mg ; 
 
unknown m 69 $nan$hematology blood hematocrit  41.0  %; hematology blood hematocrit  43.7  %; hematology blood hemoglobin  13.6  g dl; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  192  k ul; hematology blood platelet count  207  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  145  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; aspirin  325  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; diltiazem extended-release  240  mg ; valsartan  160  mg ; allopurinol  300  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; metoprolol tartrate  5  mg ; morphine sulfate  2-4  mg ; labetalol  10-20  mg ; clevidipine  25  mg ; ondansetron  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; diltiazem  60  mg ; 
 
unknown m 69 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; diltiazem  60  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; glycopyrrolate  0.2  mg ; propofol  1000  mg ; 
 
unknown m 69 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  122  mg dl; blood gas blood free calcium  1.36  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; diltiazem  60  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; glycopyrrolate  0.2  mg ; propofol  1000  mg ; levetiracetam  750  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
unknown m 69 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  138  mg dl; blood gas blood free calcium  1.34  mmol l; blood gas blood lactate  1.4  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; diltiazem  60  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; propofol  1000  mg ; levetiracetam  750  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; phosphorus  500  mg ; 
 
unknown m 69 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; diltiazem  60  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; phosphorus  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 
 
unknown m 69 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; diltiazem  60  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; phosphorus  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 
 
unknown m 69 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  148  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; diltiazem  60  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
unknown m 69 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; ropinirole  1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; diltiazem  60  mg ; furosemide  10  mg ; 
 
unknown m 69 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  300  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; diltiazem  60  mg ; furosemide  10  mg ; 
 
unknown m 69 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  10.5  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  140  mg dl; chemistry blood glucose  141  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam oral solution  500  mg ; 
 
unknown m 69 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; lorazepam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
unknown m 69 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  123  mg dl; chemistry blood % hemoglobin a1c  5.5  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; lorazepam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
unknown m 69 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  10  # hpf; chemistry blood calcium, total  10.7  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  195  iu l; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; d5 1 2ns  1000  ml ; 
 
unknown m 69 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  9  # hpf; chemistry blood calcium, total  10.9  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; d5 1 2ns  1000  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
 
unknown m 69 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  305  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  11.1  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; labetalol  200  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
unknown m 69 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  10.8  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; labetalol  400  mg ; lidocaine jelly 2% (urojet)  1  appl ; potassium chloride (powder)  40  meq ; 
 
unknown m 69 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.8  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; labetalol  400  mg ; lidocaine jelly 2% (urojet)  1  appl ; potassium chloride (powder)  40  meq ; 
 
unknown m 69 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  154  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; labetalol  400  mg ; acetaminophen iv  1000  mg ; 
 
unknown m 69 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; labetalol  400  mg ; acetaminophen iv  1000  mg ; 
 
unknown m 69 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; labetalol  400  mg ; 
 
unknown m 69 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  50  mg ; senna  8.6  mg ; clonidine  0.1  mg ; sertraline  100  mg ; bicalutamide  50  mg ; valsartan  160  mg ; allopurinol  300  mg ; thiamine  100  mg ; folic acid  1  mg ; morphine sulfate  2-4  mg ; ondansetron  8  mg ; diltiazem  60  mg ; levetiracetam  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; labetalol  400  mg ; 
 
white m 89 $nan$nan$omeprazole  40  mg ; vitamin d  400  unit ; 
atrial fibrillation acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified do not resuscitate status other malaise and fatigue other and unspecified noninfectious gastroenteritis and colitis percutaneous transluminal coronary angioplasty status personal history of venous thrombosis and embolism esophageal reflux coronary atherosclerosis of native coronary artery difficulty in walking chronic airway obstruction, not elsewhere classified dyskinesia of esophagus lumbago depressive disorder, not elsewhere classified chronic kidney disease, unspecified diverticulosis of colon (without mention of hemorrhage) peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction chronic airway obstruction, not elsewhere classified urinary tract infection, site not specified acute kidney failure, unspecified other and unspecified hyperlipidemia acute pancreatitis chronic pancreatitis personal history of venous thrombosis and embolism adult failure to thrive depressive disorder, not elsewhere classified unspecified essential hypertension personal history of tobacco use do not resuscitate status atrial fibrillation percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified personal history of tobacco use hypoglycemia, unspecified hyperpotassemia intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) pain in joint, pelvic region and thigh coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified personal history of venous thrombosis and embolism atrial fibrillation insomnia, unspecified chronic airway obstruction, not elsewhere classified acidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia other chronic pain
white m 89 $temp  98.7  heartrate  97.0  resprate  15.0  o2sat    sbp  165.0  dbp  79.0  rhythm    pain  0  $hematology blood hematocrit  38.9  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  102  mg dl$omeprazole  40  mg ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; senna  2  tab ; alprazolam  0.25  mg ; oxycodone-acetaminophen  1  tab ; nitroglycerin sl  0.4  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; heparin  5000  unit ; amlodipine  2.5  mg ; venlafaxine xr  150  mg ; metoprolol tartrate  25  mg ; simvastatin  10  mg ; lisinopril  2.5  mg ; 
atrial fibrillation acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified do not resuscitate status other malaise and fatigue other and unspecified noninfectious gastroenteritis and colitis percutaneous transluminal coronary angioplasty status personal history of venous thrombosis and embolism esophageal reflux coronary atherosclerosis of native coronary artery difficulty in walking chronic airway obstruction, not elsewhere classified dyskinesia of esophagus lumbago depressive disorder, not elsewhere classified chronic kidney disease, unspecified diverticulosis of colon (without mention of hemorrhage) peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction chronic airway obstruction, not elsewhere classified urinary tract infection, site not specified acute kidney failure, unspecified other and unspecified hyperlipidemia acute pancreatitis chronic pancreatitis personal history of venous thrombosis and embolism adult failure to thrive depressive disorder, not elsewhere classified unspecified essential hypertension personal history of tobacco use do not resuscitate status atrial fibrillation percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified personal history of tobacco use hypoglycemia, unspecified hyperpotassemia intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) pain in joint, pelvic region and thigh coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified personal history of venous thrombosis and embolism atrial fibrillation insomnia, unspecified chronic airway obstruction, not elsewhere classified acidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia other chronic pain
white m 89 $nan$nan$omeprazole  40  mg ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; senna  2  tab ; alprazolam  0.25  mg ; oxycodone-acetaminophen  1  tab ; nitroglycerin sl  0.4  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; heparin  5000  unit ; amlodipine  2.5  mg ; venlafaxine xr  150  mg ; metoprolol tartrate  25  mg ; simvastatin  10  mg ; lisinopril  2.5  mg ; 
atrial fibrillation acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified do not resuscitate status other malaise and fatigue other and unspecified noninfectious gastroenteritis and colitis percutaneous transluminal coronary angioplasty status personal history of venous thrombosis and embolism esophageal reflux coronary atherosclerosis of native coronary artery difficulty in walking chronic airway obstruction, not elsewhere classified dyskinesia of esophagus lumbago depressive disorder, not elsewhere classified chronic kidney disease, unspecified diverticulosis of colon (without mention of hemorrhage) peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction chronic airway obstruction, not elsewhere classified urinary tract infection, site not specified acute kidney failure, unspecified other and unspecified hyperlipidemia acute pancreatitis chronic pancreatitis personal history of venous thrombosis and embolism adult failure to thrive depressive disorder, not elsewhere classified unspecified essential hypertension personal history of tobacco use do not resuscitate status atrial fibrillation percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified personal history of tobacco use hypoglycemia, unspecified hyperpotassemia intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) pain in joint, pelvic region and thigh coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified personal history of venous thrombosis and embolism atrial fibrillation insomnia, unspecified chronic airway obstruction, not elsewhere classified acidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia other chronic pain
other m 73 $nan$hematology blood hematocrit  30.9  %; hematology blood hematocrit  33.0  %; hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  156  k ul; hematology blood platelet count  134  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.5  ; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood chloride, whole blood  109  meq l; blood gas blood chloride, whole blood  110  meq l; blood gas blood glucose  147  mg dl; blood gas blood glucose  165  mg dl; blood gas blood glucose  196  mg dl; blood gas blood glucose  208  mg dl; blood gas blood glucose  143  mg dl; blood gas blood glucose  128  mg dl; blood gas blood glucose  132  mg dl; blood gas blood glucose  155  mg dl; blood gas blood glucose  92  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  12.1  g dl; blood gas blood hemoglobin  11.1  g dl; blood gas blood hemoglobin  11.0  g dl; blood gas blood hemoglobin  10.8  g dl; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  6.2  meq l; blood gas blood potassium, whole blood  6.8  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  136  meq l$syringe (iso-osmotic dextrose)  20  ml ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; influenza vaccine quadrivalent  0.5  ml ; lidocaine jelly 2% (glydo)  1  appl ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; 0.9% sodium chloride  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; d5w  250  ml ; nitroglycerin  100  mg ; hydromorphone (dilaudid)  2-4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; 
percutaneous transluminal coronary angioplasty status coronary atherosclerosis of unspecified type of vessel, native or graft pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) accidents occurring in other specified places cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft other chronic nonalcoholic liver disease unspecified essential hypertension urinary tract infection, site not specified esophageal varices in diseases classified elsewhere, without mention of bleeding abdominal pain, unspecified site percutaneous transluminal coronary angioplasty status other abnormal glucose other and unspecified hyperlipidemia diarrhea nontoxic uninodular goiter other specified vaccinations against streptococcus pneumoniae [pneumococcus] obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) percutaneous transluminal coronary angioplasty status other chest pain other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery
other m 73 $nan$hematology blood hematocrit  33.4  %; hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology urine wbc  12  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  160  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood sodium, whole blood  131  meq l; hematology urine glucose  70  mg dl$tramadol  25  mg ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 5%  1000  ml ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; 0.9% sodium chloride  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; d5w  250  ml ; nitroglycerin  100  mg ; hydromorphone (dilaudid)  2-4  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; aspirin ec  81  mg ; metoprolol tartrate  6.25  mg ; furosemide  20  mg ; insulin  0  unit ; insulin  30  unit ; lisinopril  2.5  mg ; bisacodyl  10  mg ; metoprolol tartrate  12.5  mg ; 
percutaneous transluminal coronary angioplasty status coronary atherosclerosis of unspecified type of vessel, native or graft pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) accidents occurring in other specified places cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft other chronic nonalcoholic liver disease unspecified essential hypertension urinary tract infection, site not specified esophageal varices in diseases classified elsewhere, without mention of bleeding abdominal pain, unspecified site percutaneous transluminal coronary angioplasty status other abnormal glucose other and unspecified hyperlipidemia diarrhea nontoxic uninodular goiter other specified vaccinations against streptococcus pneumoniae [pneumococcus] obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) percutaneous transluminal coronary angioplasty status other chest pain other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery
other m 73 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood glucose  169  mg dl$tramadol  25  mg ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; aspirin ec  81  mg ; furosemide  20  mg ; insulin  0  unit ; insulin  30  unit ; bisacodyl  10  mg ; hydralazine  10  mg ; labetalol  10  mg ; senna  17.2  mg ; metoprolol tartrate  25  mg ; 
percutaneous transluminal coronary angioplasty status coronary atherosclerosis of unspecified type of vessel, native or graft pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) accidents occurring in other specified places cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft other chronic nonalcoholic liver disease unspecified essential hypertension urinary tract infection, site not specified esophageal varices in diseases classified elsewhere, without mention of bleeding abdominal pain, unspecified site percutaneous transluminal coronary angioplasty status other abnormal glucose other and unspecified hyperlipidemia diarrhea nontoxic uninodular goiter other specified vaccinations against streptococcus pneumoniae [pneumococcus] obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) percutaneous transluminal coronary angioplasty status other chest pain other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery
other m 73 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  145  mg dl$tramadol  25  mg ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; aspirin ec  81  mg ; furosemide  20  mg ; insulin  0  unit ; insulin  30  unit ; bisacodyl  10  mg ; hydralazine  10  mg ; labetalol  10  mg ; senna  17.2  mg ; metoprolol tartrate  25  mg ; tramadol  50  mg ; metoprolol tartrate  37.5  mg ; 
percutaneous transluminal coronary angioplasty status coronary atherosclerosis of unspecified type of vessel, native or graft pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) accidents occurring in other specified places cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft other chronic nonalcoholic liver disease unspecified essential hypertension urinary tract infection, site not specified esophageal varices in diseases classified elsewhere, without mention of bleeding abdominal pain, unspecified site percutaneous transluminal coronary angioplasty status other abnormal glucose other and unspecified hyperlipidemia diarrhea nontoxic uninodular goiter other specified vaccinations against streptococcus pneumoniae [pneumococcus] obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) percutaneous transluminal coronary angioplasty status other chest pain other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery
other m 73 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  154  mg dl$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; aspirin ec  81  mg ; furosemide  20  mg ; insulin  0  unit ; insulin  30  unit ; bisacodyl  10  mg ; hydralazine  10  mg ; senna  17.2  mg ; tramadol  50  mg ; metoprolol tartrate  37.5  mg ; bag  1  bag ; lisinopril  5  mg ; 
percutaneous transluminal coronary angioplasty status coronary atherosclerosis of unspecified type of vessel, native or graft pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) accidents occurring in other specified places cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft other chronic nonalcoholic liver disease unspecified essential hypertension urinary tract infection, site not specified esophageal varices in diseases classified elsewhere, without mention of bleeding abdominal pain, unspecified site percutaneous transluminal coronary angioplasty status other abnormal glucose other and unspecified hyperlipidemia diarrhea nontoxic uninodular goiter other specified vaccinations against streptococcus pneumoniae [pneumococcus] obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) percutaneous transluminal coronary angioplasty status other chest pain other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery
other m 73 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  154  mg dl$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; aspirin ec  81  mg ; furosemide  20  mg ; insulin  0  unit ; insulin  30  unit ; bisacodyl  10  mg ; hydralazine  10  mg ; senna  17.2  mg ; tramadol  50  mg ; bag  1  bag ; lisinopril  5  mg ; potassium chloride  40  meq ; 
percutaneous transluminal coronary angioplasty status coronary atherosclerosis of unspecified type of vessel, native or graft pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) accidents occurring in other specified places cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft other chronic nonalcoholic liver disease unspecified essential hypertension urinary tract infection, site not specified esophageal varices in diseases classified elsewhere, without mention of bleeding abdominal pain, unspecified site percutaneous transluminal coronary angioplasty status other abnormal glucose other and unspecified hyperlipidemia diarrhea nontoxic uninodular goiter other specified vaccinations against streptococcus pneumoniae [pneumococcus] obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) percutaneous transluminal coronary angioplasty status other chest pain other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery
black african american m 73 $nan$hematology blood hematocrit  33.4  %; hematology blood hematocrit  34.9  %; hematology blood hematocrit  31.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  166  k ul; hematology blood platelet count  168  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine chloride, urine  94  meq l; chemistry urine chloride, urine  95  meq l; chemistry urine creatinine, urine  49  mg dl; chemistry urine creatinine, urine  40  mg dl; chemistry urine potassium, urine  31  meq l; chemistry urine potassium, urine  37  meq l; chemistry urine sodium, urine  93  meq l; chemistry urine sodium, urine  90  meq l; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  70  mg dl; chemistry blood glucose  66  mg dl; chemistry blood glucose  72  mg dl; chemistry blood lactate dehydrogenase (ld)  307  iu l; chemistry blood lactate dehydrogenase (ld)  338  iu l; chemistry blood albumin  2.5  g dl; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood calculated bicarbonate, whole blood  20  meq l$iso-osmotic dextrose  50  ml ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  100  ml ; pantoprazole  80  mg ; nystatin oral suspension  5  ml ; ipratropium bromide neb  1  neb ; acetaminophen  325-650  mg ; fluconazole  100  mg ; albuterol 0.083% neb soln  1  neb ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; piperacillin-tazobactam  2.25  g ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 5% dextrose  50  ml ; levofloxacin  250  mg ; raltegravir  400  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; diltiazem  30  mg ; 
chronic pain syndrome tobacco use disorder cachexia chronic kidney disease, unspecified depressive disorder, not elsewhere classified sinoatrial node dysfunction fever, unspecified candidiasis of mouth spinal stenosis, lumbar region, without neurogenic claudication chondrocalcinosis, unspecified, lower leg esophageal reflux other disorders of calcium metabolism personal history of malignant neoplasm of prostate anemia, unspecified other chest pain aneurysm of renal artery personal history of noncompliance with medical treatment, presenting hazards to health antiviral drugs causing adverse effects in therapeutic use abdominal pain, other specified site acidosis atrial fibrillation human immunodeficiency virus [hiv] disease adult failure to thrive chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction chronic vascular insufficiency of intestine chronic kidney disease, unspecified leukocytopenia, unspecified bacteremia other diseases of lung, not elsewhere classified tobacco use disorder personal history of malignant neoplasm of prostate chondrocalcinosis, due to pyrophosphate crystals, lower leg other emphysema abdominal pain, left lower quadrant abdominal aneurysm without mention of rupture atrial fibrillation anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus other chronic pain major depressive affective disorder, single episode, unspecified human immunodeficiency virus [hiv] disease other disorders of calcium metabolism antiviral drugs causing adverse effects in therapeutic use esophageal reflux human immunodeficiency virus [hiv] disease tobacco use disorder unspecified protein-calorie malnutrition chronic kidney disease, unspecified
black african american m 73 $nan$hematology blood hematocrit  35.1  %; hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; nystatin oral suspension  5  ml ; ipratropium bromide neb  1  neb ; acetaminophen  325-650  mg ; fluconazole  100  mg ; albuterol 0.083% neb soln  1  neb ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 5% dextrose  50  ml ; levofloxacin  250  mg ; raltegravir  400  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; diltiazem  30  mg ; oxycodone (immediate release)   5  mg ; atazanavir  400  mg ; lamivudine  300  mg ; abacavir sulfate  600  mg ; omeprazole  20  mg ; potassium chloride  40  meq ; ranitidine  150  mg ; oxycodone sr (oxycontin)  30  mg ; lorazepam  1  mg ; 
chronic pain syndrome tobacco use disorder cachexia chronic kidney disease, unspecified depressive disorder, not elsewhere classified sinoatrial node dysfunction fever, unspecified candidiasis of mouth spinal stenosis, lumbar region, without neurogenic claudication chondrocalcinosis, unspecified, lower leg esophageal reflux other disorders of calcium metabolism personal history of malignant neoplasm of prostate anemia, unspecified other chest pain aneurysm of renal artery personal history of noncompliance with medical treatment, presenting hazards to health antiviral drugs causing adverse effects in therapeutic use abdominal pain, other specified site acidosis atrial fibrillation human immunodeficiency virus [hiv] disease adult failure to thrive chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction chronic vascular insufficiency of intestine chronic kidney disease, unspecified leukocytopenia, unspecified bacteremia other diseases of lung, not elsewhere classified tobacco use disorder personal history of malignant neoplasm of prostate chondrocalcinosis, due to pyrophosphate crystals, lower leg other emphysema abdominal pain, left lower quadrant abdominal aneurysm without mention of rupture atrial fibrillation anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus other chronic pain major depressive affective disorder, single episode, unspecified human immunodeficiency virus [hiv] disease other disorders of calcium metabolism antiviral drugs causing adverse effects in therapeutic use esophageal reflux human immunodeficiency virus [hiv] disease tobacco use disorder unspecified protein-calorie malnutrition chronic kidney disease, unspecified
black african american m 73 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  265  iu l$sodium chloride 0.9%  flush  3  ml ; nystatin oral suspension  5  ml ; ipratropium bromide neb  1  neb ; acetaminophen  325-650  mg ; fluconazole  100  mg ; albuterol 0.083% neb soln  1  neb ; 5% dextrose  50  ml ; levofloxacin  250  mg ; raltegravir  400  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; diltiazem  30  mg ; oxycodone (immediate release)   5  mg ; atazanavir  400  mg ; lamivudine  300  mg ; abacavir sulfate  600  mg ; potassium chloride  40  meq ; ranitidine  150  mg ; oxycodone sr (oxycontin)  30  mg ; 
chronic pain syndrome tobacco use disorder cachexia chronic kidney disease, unspecified depressive disorder, not elsewhere classified sinoatrial node dysfunction fever, unspecified candidiasis of mouth spinal stenosis, lumbar region, without neurogenic claudication chondrocalcinosis, unspecified, lower leg esophageal reflux other disorders of calcium metabolism personal history of malignant neoplasm of prostate anemia, unspecified other chest pain aneurysm of renal artery personal history of noncompliance with medical treatment, presenting hazards to health antiviral drugs causing adverse effects in therapeutic use abdominal pain, other specified site acidosis atrial fibrillation human immunodeficiency virus [hiv] disease adult failure to thrive chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction chronic vascular insufficiency of intestine chronic kidney disease, unspecified leukocytopenia, unspecified bacteremia other diseases of lung, not elsewhere classified tobacco use disorder personal history of malignant neoplasm of prostate chondrocalcinosis, due to pyrophosphate crystals, lower leg other emphysema abdominal pain, left lower quadrant abdominal aneurysm without mention of rupture atrial fibrillation anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus other chronic pain major depressive affective disorder, single episode, unspecified human immunodeficiency virus [hiv] disease other disorders of calcium metabolism antiviral drugs causing adverse effects in therapeutic use esophageal reflux human immunodeficiency virus [hiv] disease tobacco use disorder unspecified protein-calorie malnutrition chronic kidney disease, unspecified
black african american m 73 $nan$hematology blood hematocrit  39.3  %; hematology blood hematocrit  32.8  %; hematology blood hemoglobin  12.3  g dl; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; nystatin oral suspension  5  ml ; ipratropium bromide neb  1  neb ; acetaminophen  325-650  mg ; fluconazole  100  mg ; albuterol 0.083% neb soln  1  neb ; raltegravir  400  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; diltiazem  30  mg ; oxycodone (immediate release)   5  mg ; atazanavir  400  mg ; lamivudine  300  mg ; abacavir sulfate  600  mg ; ranitidine  150  mg ; oxycodone sr (oxycontin)  30  mg ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; sulfameth trimethoprim ss  1  tab ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; golytely  4  l ; 
chronic pain syndrome tobacco use disorder cachexia chronic kidney disease, unspecified depressive disorder, not elsewhere classified sinoatrial node dysfunction fever, unspecified candidiasis of mouth spinal stenosis, lumbar region, without neurogenic claudication chondrocalcinosis, unspecified, lower leg esophageal reflux other disorders of calcium metabolism personal history of malignant neoplasm of prostate anemia, unspecified other chest pain aneurysm of renal artery personal history of noncompliance with medical treatment, presenting hazards to health antiviral drugs causing adverse effects in therapeutic use abdominal pain, other specified site acidosis atrial fibrillation human immunodeficiency virus [hiv] disease adult failure to thrive chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction chronic vascular insufficiency of intestine chronic kidney disease, unspecified leukocytopenia, unspecified bacteremia other diseases of lung, not elsewhere classified tobacco use disorder personal history of malignant neoplasm of prostate chondrocalcinosis, due to pyrophosphate crystals, lower leg other emphysema abdominal pain, left lower quadrant abdominal aneurysm without mention of rupture atrial fibrillation anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus other chronic pain major depressive affective disorder, single episode, unspecified human immunodeficiency virus [hiv] disease other disorders of calcium metabolism antiviral drugs causing adverse effects in therapeutic use esophageal reflux human immunodeficiency virus [hiv] disease tobacco use disorder unspecified protein-calorie malnutrition chronic kidney disease, unspecified
black african american m 73 $nan$hematology blood hematocrit  31.8  %; hematology blood hematocrit  33.8  %; hematology blood hematocrit  31.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  85  mg dl$sw  50  ml ; sodium chloride 0.9%  flush  3  ml ; nystatin oral suspension  5  ml ; ipratropium bromide neb  1  neb ; acetaminophen  325-650  mg ; fluconazole  100  mg ; albuterol 0.083% neb soln  1  neb ; raltegravir  400  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; diltiazem  30  mg ; oxycodone (immediate release)   5  mg ; atazanavir  400  mg ; lamivudine  300  mg ; abacavir sulfate  600  mg ; oxycodone sr (oxycontin)  30  mg ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; sulfameth trimethoprim ss  1  tab ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; diltiazem extended-release  120  mg ; 
chronic pain syndrome tobacco use disorder cachexia chronic kidney disease, unspecified depressive disorder, not elsewhere classified sinoatrial node dysfunction fever, unspecified candidiasis of mouth spinal stenosis, lumbar region, without neurogenic claudication chondrocalcinosis, unspecified, lower leg esophageal reflux other disorders of calcium metabolism personal history of malignant neoplasm of prostate anemia, unspecified other chest pain aneurysm of renal artery personal history of noncompliance with medical treatment, presenting hazards to health antiviral drugs causing adverse effects in therapeutic use abdominal pain, other specified site acidosis atrial fibrillation human immunodeficiency virus [hiv] disease adult failure to thrive chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction chronic vascular insufficiency of intestine chronic kidney disease, unspecified leukocytopenia, unspecified bacteremia other diseases of lung, not elsewhere classified tobacco use disorder personal history of malignant neoplasm of prostate chondrocalcinosis, due to pyrophosphate crystals, lower leg other emphysema abdominal pain, left lower quadrant abdominal aneurysm without mention of rupture atrial fibrillation anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus other chronic pain major depressive affective disorder, single episode, unspecified human immunodeficiency virus [hiv] disease other disorders of calcium metabolism antiviral drugs causing adverse effects in therapeutic use esophageal reflux human immunodeficiency virus [hiv] disease tobacco use disorder unspecified protein-calorie malnutrition chronic kidney disease, unspecified
black african american m 73 $nan$nan$sw  50  ml ; nystatin oral suspension  5  ml ; ipratropium bromide neb  1  neb ; acetaminophen  325-650  mg ; fluconazole  100  mg ; albuterol 0.083% neb soln  1  neb ; raltegravir  400  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; oxycodone (immediate release)   5  mg ; atazanavir  400  mg ; lamivudine  300  mg ; abacavir sulfate  600  mg ; oxycodone sr (oxycontin)  30  mg ; sulfameth trimethoprim ss  1  tab ; 
chronic pain syndrome tobacco use disorder cachexia chronic kidney disease, unspecified depressive disorder, not elsewhere classified sinoatrial node dysfunction fever, unspecified candidiasis of mouth spinal stenosis, lumbar region, without neurogenic claudication chondrocalcinosis, unspecified, lower leg esophageal reflux other disorders of calcium metabolism personal history of malignant neoplasm of prostate anemia, unspecified other chest pain aneurysm of renal artery personal history of noncompliance with medical treatment, presenting hazards to health antiviral drugs causing adverse effects in therapeutic use abdominal pain, other specified site acidosis atrial fibrillation human immunodeficiency virus [hiv] disease adult failure to thrive chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction chronic vascular insufficiency of intestine chronic kidney disease, unspecified leukocytopenia, unspecified bacteremia other diseases of lung, not elsewhere classified tobacco use disorder personal history of malignant neoplasm of prostate chondrocalcinosis, due to pyrophosphate crystals, lower leg other emphysema abdominal pain, left lower quadrant abdominal aneurysm without mention of rupture atrial fibrillation anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus other chronic pain major depressive affective disorder, single episode, unspecified human immunodeficiency virus [hiv] disease other disorders of calcium metabolism antiviral drugs causing adverse effects in therapeutic use esophageal reflux human immunodeficiency virus [hiv] disease tobacco use disorder unspecified protein-calorie malnutrition chronic kidney disease, unspecified
white m 80 $temp  98.4  heartrate  85.0  resprate  16.0  o2sat  97.0  sbp  140.0  dbp  50.0  rhythm    pain  0  ; temp    heartrate  78.0  resprate  16.0  o2sat  98.0  sbp  136.0  dbp  51.0  rhythm    pain  0  ; temp  97.9  heartrate  83.0  resprate  16.0  o2sat  97.0  sbp  132.0  dbp  64.0  rhythm    pain  0  $hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry urine chloride, urine  37  meq l; chemistry urine creatinine, urine  43  mg dl; chemistry urine potassium, urine  17  meq l; chemistry urine sodium, urine  48  meq l; hematology urine wbc  4  # hpf; chemistry blood glucose  192  mg dl; blood gas blood lactate  1.4  mmol l$nan
obstructive sleep apnea (adult) (pediatric) toxic encephalopathy chronic kidney disease, stage 3 (moderate) orthostatic hypotension chronic obstructive pulmonary disease, unspecified unspecified street and highway as the place of occurrence of the external cause syncope and collapse abrasion, right knee, initial encounter atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of antithrombotics/antiplatelets hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease occlusion and stenosis of bilateral carotid arteries mild cognitive impairment, so stated benign prostatic hyperplasia without lower urinary tract symptoms car driver injured in collision with fixed or stationary object in nontraffic accident, initial encounter type 2 diabetes mellitus with diabetic chronic kidney disease presence of coronary angioplasty implant and graft personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nonrheumatic aortic (valve) insufficiency hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve insufficiency and aortic valve insufficiency other and unspecified hyperlipidemia chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of aspirin peripheral vascular disease, unspecified other and unspecified angina pectoris occlusion and stenosis of carotid artery without mention of cerebral infarction 
white m 80 $temp    heartrate  84.0  resprate  16.0  o2sat  98.0  sbp  127.0  dbp  86.0  rhythm    pain  0  $hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  5.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  124  iu l; blood gas blood potassium, whole blood  4.8  meq l$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; vial  1  vial ; ceftriaxone  1  gm ; azithromycin  250  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  1000  ml ; metoprolol succinate xl  25  mg ; atorvastatin  40  mg ; tamsulosin  0.4  mg ; baclofen  5  mg ; 
obstructive sleep apnea (adult) (pediatric) toxic encephalopathy chronic kidney disease, stage 3 (moderate) orthostatic hypotension chronic obstructive pulmonary disease, unspecified unspecified street and highway as the place of occurrence of the external cause syncope and collapse abrasion, right knee, initial encounter atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of antithrombotics/antiplatelets hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease occlusion and stenosis of bilateral carotid arteries mild cognitive impairment, so stated benign prostatic hyperplasia without lower urinary tract symptoms car driver injured in collision with fixed or stationary object in nontraffic accident, initial encounter type 2 diabetes mellitus with diabetic chronic kidney disease presence of coronary angioplasty implant and graft personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nonrheumatic aortic (valve) insufficiency hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve insufficiency and aortic valve insufficiency other and unspecified hyperlipidemia chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of aspirin peripheral vascular disease, unspecified other and unspecified angina pectoris occlusion and stenosis of carotid artery without mention of cerebral infarction 
white m 80 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry urine creatinine, urine  72  mg dl; hematology urine wbc  12  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  99  mg dl; chemistry urine protein creatinine ratio  0.8  mg mg$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  1000  ml ; metoprolol succinate xl  25  mg ; atorvastatin  40  mg ; tamsulosin  0.4  mg ; baclofen  5  mg ; vitamin d  5000  unit ; lactated ringers  1000  ml ; 
obstructive sleep apnea (adult) (pediatric) toxic encephalopathy chronic kidney disease, stage 3 (moderate) orthostatic hypotension chronic obstructive pulmonary disease, unspecified unspecified street and highway as the place of occurrence of the external cause syncope and collapse abrasion, right knee, initial encounter atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of antithrombotics/antiplatelets hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease occlusion and stenosis of bilateral carotid arteries mild cognitive impairment, so stated benign prostatic hyperplasia without lower urinary tract symptoms car driver injured in collision with fixed or stationary object in nontraffic accident, initial encounter type 2 diabetes mellitus with diabetic chronic kidney disease presence of coronary angioplasty implant and graft personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nonrheumatic aortic (valve) insufficiency hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve insufficiency and aortic valve insufficiency other and unspecified hyperlipidemia chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of aspirin peripheral vascular disease, unspecified other and unspecified angina pectoris occlusion and stenosis of carotid artery without mention of cerebral infarction 
white m 80 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; metoprolol succinate xl  25  mg ; atorvastatin  40  mg ; tamsulosin  0.4  mg ; vitamin d  5000  unit ; lactated ringers  1000  ml ; magnesium oxide  400  mg ; 
obstructive sleep apnea (adult) (pediatric) toxic encephalopathy chronic kidney disease, stage 3 (moderate) orthostatic hypotension chronic obstructive pulmonary disease, unspecified unspecified street and highway as the place of occurrence of the external cause syncope and collapse abrasion, right knee, initial encounter atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of antithrombotics/antiplatelets hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease occlusion and stenosis of bilateral carotid arteries mild cognitive impairment, so stated benign prostatic hyperplasia without lower urinary tract symptoms car driver injured in collision with fixed or stationary object in nontraffic accident, initial encounter type 2 diabetes mellitus with diabetic chronic kidney disease presence of coronary angioplasty implant and graft personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nonrheumatic aortic (valve) insufficiency hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve insufficiency and aortic valve insufficiency other and unspecified hyperlipidemia chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of aspirin peripheral vascular disease, unspecified other and unspecified angina pectoris occlusion and stenosis of carotid artery without mention of cerebral infarction 
white m 80 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry urine creatinine, urine  37  mg dl; chemistry blood glucose  88  mg dl; chemistry urine protein creatinine ratio  0.8  mg mg; chemistry urine 24 hr creatinine  740  mg 24hr$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; metoprolol succinate xl  25  mg ; atorvastatin  40  mg ; tamsulosin  0.4  mg ; vitamin d  5000  unit ; magnesium oxide  400  mg ; 
obstructive sleep apnea (adult) (pediatric) toxic encephalopathy chronic kidney disease, stage 3 (moderate) orthostatic hypotension chronic obstructive pulmonary disease, unspecified unspecified street and highway as the place of occurrence of the external cause syncope and collapse abrasion, right knee, initial encounter atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of antithrombotics/antiplatelets hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease occlusion and stenosis of bilateral carotid arteries mild cognitive impairment, so stated benign prostatic hyperplasia without lower urinary tract symptoms car driver injured in collision with fixed or stationary object in nontraffic accident, initial encounter type 2 diabetes mellitus with diabetic chronic kidney disease presence of coronary angioplasty implant and graft personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nonrheumatic aortic (valve) insufficiency hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified mitral valve insufficiency and aortic valve insufficiency other and unspecified hyperlipidemia chronic kidney disease, stage iv (severe) coronary atherosclerosis of native coronary artery personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long-term (current) use of aspirin peripheral vascular disease, unspecified other and unspecified angina pectoris occlusion and stenosis of carotid artery without mention of cerebral infarction 
white f 71 $temp  97.9  heartrate  97.0  resprate  18.0  o2sat  100.0  sbp  154.0  dbp  69.0  rhythm    pain  10  ; temp  98.8  heartrate  88.0  resprate  17.0  o2sat  99.0  sbp  137.0  dbp  80.0  rhythm    pain  10  ; temp  99.6  heartrate  93.0  resprate  17.0  o2sat  97.0  sbp  137.0  dbp  82.0  rhythm    pain  6  ; temp  98.9  heartrate  89.0  resprate  16.0  o2sat  98.0  sbp  131.0  dbp  79.0  rhythm    pain    ; temp  98.8  heartrate  84.0  resprate  16.0  o2sat  99.0  sbp  111.0  dbp  52.0  rhythm    pain    $hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  305  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  72  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  90  mg dl; blood gas blood lactate  1.7  mmol l$nan
 
white f 71 $temp  98.9  heartrate  86.0  resprate  18.0  o2sat  99.0  sbp  143.0  dbp  82.0  rhythm    pain    $hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  93  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; chlorthalidone  12.5  mg ; folic acid  1  mg ; ciprofloxacin hcl  250  mg ; sterile water  50  ml ; potassium chloride  20  meq ; potassium chloride  60  meq ; oxybutynin  5  mg ; phenazopyridine  100  mg ; tamsulosin  0.4  mg ; 
 
white f 71 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; chlorthalidone  12.5  mg ; folic acid  1  mg ; potassium chloride  60  meq ; oxybutynin  5  mg ; phenazopyridine  100  mg ; tamsulosin  0.4  mg ; 
 
white f 81 $temp  98.7  heartrate  66.0  resprate  21.0  o2sat  99.0  sbp  101.0  dbp  45.0  rhythm    pain  0  $hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.6  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry urine chloride, urine  86  meq l; chemistry urine creatinine, urine  33  mg dl; chemistry urine potassium, urine  25  meq l; chemistry urine sodium, urine  82  meq l; chemistry blood glucose  271  mg dl; chemistry blood glucose  121  mg dl$heparin  5000  unit ; docusate sodium  100  mg ; furosemide  20  mg ; insulin  10  unit ; dextrose 50%  12.5  gm ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; calcium carbonate  500  mg ; aspirin  81  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; budesonide  3  mg ; budesonide  9  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
 
white f 81 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  202  mg dl; chemistry blood glucose  183  mg dl$heparin  5000  unit ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; calcium carbonate  500  mg ; aspirin  81  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; budesonide  9  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; lisinopril  10  mg ; insulin  12  unit ; 
 
white f 81 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  300  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  206  mg dl$heparin  5000  unit ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; calcium carbonate  500  mg ; aspirin  81  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; budesonide  9  mg ; 0.9% sodium chloride  500  ml ; insulin  12  unit ; atovaquone suspension  1500  mg ; 
 
white f 81 $nan$nan$heparin  5000  unit ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; calcium carbonate  500  mg ; aspirin  81  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; budesonide  9  mg ; atovaquone suspension  1500  mg ; 
 
black african american f 37 $nan$nan$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 37 $nan$nan$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 37 $nan$nan$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 37 $nan$nan$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white m 54 $temp    heartrate  76.0  resprate  18.0  o2sat  95.0  sbp  90.0  dbp  66.0  rhythm    pain  6  ; temp    heartrate  74.0  resprate  16.0  o2sat  95.0  sbp  83.0  dbp  57.0  rhythm    pain  6  ; temp    heartrate  83.0  resprate  15.0  o2sat  95.0  sbp  91.0  dbp  62.0  rhythm    pain  4  ; temp  98.2  heartrate  73.0  resprate  16.0  o2sat  96.0  sbp  95.0  dbp  60.0  rhythm  sinus rhythm  pain  4  ; temp    heartrate  71.0  resprate  16.0  o2sat  97.0  sbp  93.0  dbp  62.0  rhythm    pain    ; temp    heartrate  68.0  resprate  18.0  o2sat  95.0  sbp  100.0  dbp  70.0  rhythm    pain    $blood gas blood lactate  2.0  mmol l$multivitamins  1  tab ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; sodium chloride 0.9%  flush  3  ml ; verapamil  40  mg ; morphine sulfate (oral soln.)  10  mg ; hydrocodone-acetaminophen (5mg-500mg  1  tab ; heparin  5000  unit ; morphine sulfate (oral soln.)  10-15  mg ; senna  1  tab ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; verapamil sr  180  mg ; 0.9% sodium chloride  500  ml ; 
chest pain, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of pulmonary embolism automatic implantable cardiac defibrillator in situ unspecified essential hypertension chest pain, unspecified automatic implantable cardiac defibrillator in situ hypertrophic obstructive cardiomyopathy other chest pain tobacco use disorder other and unspecified hyperlipidemia alcohol abuse, unspecified ostium secundum type atrial septal defect tobacco use disorder automatic implantable cardiac defibrillator in situ other and unspecified alcohol dependence, unspecified hemiplegia, unspecified, affecting unspecified side personal history of malignant neoplasm of testis alcohol withdrawal other convulsions other specified diseases of blood and blood-forming organs hypertrophic obstructive cardiomyopathy alcohol abuse, unspecified automatic implantable cardiac defibrillator in situ chest pain, unspecified backache, unspecified automatic implantable cardiac defibrillator in situ hypertrophic obstructive cardiomyopathy other chest pain other chest pain lumbago other chronic pain esophageal reflux automatic implantable cardiac defibrillator in situ lumbago other and unspecified hyperlipidemia dehydration ostium secundum type atrial septal defect automatic implantable cardiac defibrillator in situ hypertrophic obstructive cardiomyopathy other chronic pain acute kidney failure, unspecified other and unspecified hyperlipidemia tobacco use disorder automatic implantable cardiac defibrillator in situ lumbago family history of sudden cardiac death (scd) personal history of malignant neoplasm of testis
white m 54 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  94  mg dl$multivitamins  1  tab ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen (5mg-500mg  1  tab ; heparin  5000  unit ; morphine sulfate (oral soln.)  10-15  mg ; senna  1  tab ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; verapamil sr  180  mg ; 0.9% sodium chloride  500  ml ; 
chest pain, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of pulmonary embolism automatic implantable cardiac defibrillator in situ unspecified essential hypertension chest pain, unspecified automatic implantable cardiac defibrillator in situ hypertrophic obstructive cardiomyopathy other chest pain tobacco use disorder other and unspecified hyperlipidemia alcohol abuse, unspecified ostium secundum type atrial septal defect tobacco use disorder automatic implantable cardiac defibrillator in situ other and unspecified alcohol dependence, unspecified hemiplegia, unspecified, affecting unspecified side personal history of malignant neoplasm of testis alcohol withdrawal other convulsions other specified diseases of blood and blood-forming organs hypertrophic obstructive cardiomyopathy alcohol abuse, unspecified automatic implantable cardiac defibrillator in situ chest pain, unspecified backache, unspecified automatic implantable cardiac defibrillator in situ hypertrophic obstructive cardiomyopathy other chest pain other chest pain lumbago other chronic pain esophageal reflux automatic implantable cardiac defibrillator in situ lumbago other and unspecified hyperlipidemia dehydration ostium secundum type atrial septal defect automatic implantable cardiac defibrillator in situ hypertrophic obstructive cardiomyopathy other chronic pain acute kidney failure, unspecified other and unspecified hyperlipidemia tobacco use disorder automatic implantable cardiac defibrillator in situ lumbago family history of sudden cardiac death (scd) personal history of malignant neoplasm of testis
white f 36 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  255  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; multivitamins  1  tab ; omeprazole  40  mg ; paroxetine  20  mg ; simvastatin  20  mg ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  8  mg ; lactated ringers  1000  ml ; gabapentin  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (10 units ml)  2  ml ; acetaminophen  1000  mg ; insulin  0  unit ; mirtazapine  30  mg ; insulin  14  unit ; 
diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled congestive heart failure, unspecified esophageal reflux background diabetic retinopathy chronic systolic heart failure dehydration hyperpotassemia peripheral angiopathy in diseases classified elsewhere polyneuropathy in diabetes gastroparesis acute kidney failure, unspecified diarrhea other bone involvement in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypotension, unspecified unspecified osteomyelitis, ankle and foot atherosclerosis of autologous vein bypass graft of the extremities diabetes with other specified manifestations, type i [juvenile type], uncontrolled esophageal reflux acute kidney failure, unspecified diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled acute on chronic systolic heart failure methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site polyneuropathy in diabetes other nonspecific abnormal serum enzyme levels congestive heart failure, unspecified acquired coagulation factor deficiency atherosclerosis of native arteries of the extremities with ulceration acute osteomyelitis, ankle and foot ulcer of ankle gastroparesis other bone involvement in diseases classified elsewhere persistent vomiting diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin ulcer of heel and midfoot unspecified protein-calorie malnutrition iron deficiency anemia, unspecified tobacco use disorder cellulitis and abscess of foot, except toes esophageal reflux anxiety state, unspecified pneumonia, organism unspecified diarrhea polyneuropathy in diabetes gastroparesis background diabetic retinopathy
white f 36 $nan$nan$aspirin  325  mg ; clopidogrel  75  mg ; multivitamins  1  tab ; omeprazole  40  mg ; paroxetine  20  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ondansetron  8  mg ; lactated ringers  1000  ml ; gabapentin  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (10 units ml)  2  ml ; acetaminophen  1000  mg ; insulin  0  unit ; mirtazapine  30  mg ; insulin  14  unit ; senna  1  tab ; 
diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled congestive heart failure, unspecified esophageal reflux background diabetic retinopathy chronic systolic heart failure dehydration hyperpotassemia peripheral angiopathy in diseases classified elsewhere polyneuropathy in diabetes gastroparesis acute kidney failure, unspecified diarrhea other bone involvement in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled hypotension, unspecified unspecified osteomyelitis, ankle and foot atherosclerosis of autologous vein bypass graft of the extremities diabetes with other specified manifestations, type i [juvenile type], uncontrolled esophageal reflux acute kidney failure, unspecified diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled acute on chronic systolic heart failure methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site polyneuropathy in diabetes other nonspecific abnormal serum enzyme levels congestive heart failure, unspecified acquired coagulation factor deficiency atherosclerosis of native arteries of the extremities with ulceration acute osteomyelitis, ankle and foot ulcer of ankle gastroparesis other bone involvement in diseases classified elsewhere persistent vomiting diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin ulcer of heel and midfoot unspecified protein-calorie malnutrition iron deficiency anemia, unspecified tobacco use disorder cellulitis and abscess of foot, except toes esophageal reflux anxiety state, unspecified pneumonia, organism unspecified diarrhea polyneuropathy in diabetes gastroparesis background diabetic retinopathy
white m 64 $temp    heartrate  96.0  resprate  18.0  o2sat  96.0  sbp  115.0  dbp  66.0  rhythm    pain    ; temp    heartrate  93.0  resprate  18.0  o2sat  96.0  sbp  100.0  dbp  81.0  rhythm    pain    $hematology blood hematocrit  34.0  %; hematology blood hematocrit  35.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  280  k ul; hematology blood platelet count  264  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  104  mg dl$heparin  5000  unit ; acarbose  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; citalopram  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; vial  1  vial ; ceftazidime  2  g ; morphine sr (ms contin)  15  mg ; venlafaxine  100  mg ; methylprednisolone  40  mg ; acarbose  50  mg ; morphine sr (ms contin)  30  mg ; omeprazole  40  mg ; 0.9% sodium chloride  250  ml ; azithromycin   250  mg ; aspirin  81  mg ; 
type 2 diabetes mellitus with other specified complication spondylolisthesis, cervical region acquired absence of other left toe(s) gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified bariatric surgery status gout, unspecified iron deficiency anemia, unspecified cellulitis of left lower limb delirium due to known physiological condition anxiety disorder, unspecified attention-deficit hyperactivity disorder, unspecified type personal history of nicotine dependence chronic diastolic (congestive) heart failure solitary pulmonary nodule streptococcus, group a, as the cause of diseases classified elsewhere acquired absence of left great toe chronic pain syndrome osteomyelitis of vertebra, cervical region hypertensive heart disease with heart failure nutritional anemia, unspecified 
white m 64 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  94  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; citalopram  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; vial  1  vial ; ceftazidime  2  g ; venlafaxine  100  mg ; acarbose  50  mg ; morphine sr (ms contin)  30  mg ; omeprazole  40  mg ; 0.9% sodium chloride  250  ml ; azithromycin   250  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; bupropion xl (once daily)  150  mg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; 
type 2 diabetes mellitus with other specified complication spondylolisthesis, cervical region acquired absence of other left toe(s) gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified bariatric surgery status gout, unspecified iron deficiency anemia, unspecified cellulitis of left lower limb delirium due to known physiological condition anxiety disorder, unspecified attention-deficit hyperactivity disorder, unspecified type personal history of nicotine dependence chronic diastolic (congestive) heart failure solitary pulmonary nodule streptococcus, group a, as the cause of diseases classified elsewhere acquired absence of left great toe chronic pain syndrome osteomyelitis of vertebra, cervical region hypertensive heart disease with heart failure nutritional anemia, unspecified 
white m 64 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  88  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; citalopram  20  mg ; venlafaxine  100  mg ; acarbose  50  mg ; omeprazole  40  mg ; 0.9% sodium chloride  250  ml ; azithromycin   250  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; bupropion xl (once daily)  150  mg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lactated ringers  1000  ml ; 
type 2 diabetes mellitus with other specified complication spondylolisthesis, cervical region acquired absence of other left toe(s) gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified bariatric surgery status gout, unspecified iron deficiency anemia, unspecified cellulitis of left lower limb delirium due to known physiological condition anxiety disorder, unspecified attention-deficit hyperactivity disorder, unspecified type personal history of nicotine dependence chronic diastolic (congestive) heart failure solitary pulmonary nodule streptococcus, group a, as the cause of diseases classified elsewhere acquired absence of left great toe chronic pain syndrome osteomyelitis of vertebra, cervical region hypertensive heart disease with heart failure nutritional anemia, unspecified 
white m 64 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  90  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; citalopram  20  mg ; venlafaxine  100  mg ; acarbose  50  mg ; omeprazole  40  mg ; 0.9% sodium chloride  250  ml ; azithromycin   250  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; bupropion xl (once daily)  150  mg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lactated ringers  1000  ml ; hydrocodone-acetaminophen (5mg-325mg)  2  tab ; clonazepam  0.5  mg ; metoclopramide  10  mg ; diphenhydramine  50  mg ; 
type 2 diabetes mellitus with other specified complication spondylolisthesis, cervical region acquired absence of other left toe(s) gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified bariatric surgery status gout, unspecified iron deficiency anemia, unspecified cellulitis of left lower limb delirium due to known physiological condition anxiety disorder, unspecified attention-deficit hyperactivity disorder, unspecified type personal history of nicotine dependence chronic diastolic (congestive) heart failure solitary pulmonary nodule streptococcus, group a, as the cause of diseases classified elsewhere acquired absence of left great toe chronic pain syndrome osteomyelitis of vertebra, cervical region hypertensive heart disease with heart failure nutritional anemia, unspecified 
white m 64 $nan$nan$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; citalopram  20  mg ; venlafaxine  100  mg ; acarbose  50  mg ; omeprazole  40  mg ; 0.9% sodium chloride  250  ml ; azithromycin   250  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; bupropion xl (once daily)  150  mg ; hydrocodone-acetaminophen (5mg-325mg)  2  tab ; clonazepam  0.5  mg ; metoclopramide  10  mg ; diphenhydramine  50  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
type 2 diabetes mellitus with other specified complication spondylolisthesis, cervical region acquired absence of other left toe(s) gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified bariatric surgery status gout, unspecified iron deficiency anemia, unspecified cellulitis of left lower limb delirium due to known physiological condition anxiety disorder, unspecified attention-deficit hyperactivity disorder, unspecified type personal history of nicotine dependence chronic diastolic (congestive) heart failure solitary pulmonary nodule streptococcus, group a, as the cause of diseases classified elsewhere acquired absence of left great toe chronic pain syndrome osteomyelitis of vertebra, cervical region hypertensive heart disease with heart failure nutritional anemia, unspecified 
white m 64 $nan$nan$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; citalopram  20  mg ; venlafaxine  100  mg ; acarbose  50  mg ; omeprazole  40  mg ; 0.9% sodium chloride  250  ml ; azithromycin   250  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; bupropion xl (once daily)  150  mg ; hydrocodone-acetaminophen (5mg-325mg)  2  tab ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
type 2 diabetes mellitus with other specified complication spondylolisthesis, cervical region acquired absence of other left toe(s) gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified bariatric surgery status gout, unspecified iron deficiency anemia, unspecified cellulitis of left lower limb delirium due to known physiological condition anxiety disorder, unspecified attention-deficit hyperactivity disorder, unspecified type personal history of nicotine dependence chronic diastolic (congestive) heart failure solitary pulmonary nodule streptococcus, group a, as the cause of diseases classified elsewhere acquired absence of left great toe chronic pain syndrome osteomyelitis of vertebra, cervical region hypertensive heart disease with heart failure nutritional anemia, unspecified 
white m 64 $nan$nan$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; citalopram  20  mg ; venlafaxine  100  mg ; acarbose  50  mg ; omeprazole  40  mg ; 0.9% sodium chloride  250  ml ; azithromycin   250  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; bupropion xl (once daily)  150  mg ; hydrocodone-acetaminophen (5mg-325mg)  2  tab ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
type 2 diabetes mellitus with other specified complication spondylolisthesis, cervical region acquired absence of other left toe(s) gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified bariatric surgery status gout, unspecified iron deficiency anemia, unspecified cellulitis of left lower limb delirium due to known physiological condition anxiety disorder, unspecified attention-deficit hyperactivity disorder, unspecified type personal history of nicotine dependence chronic diastolic (congestive) heart failure solitary pulmonary nodule streptococcus, group a, as the cause of diseases classified elsewhere acquired absence of left great toe chronic pain syndrome osteomyelitis of vertebra, cervical region hypertensive heart disease with heart failure nutritional anemia, unspecified 
white f 75 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  130  mg dl$docusate sodium  100  mg ; atorvastatin  20  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; hydromorphone (dilaudid)  20  mg ; pantoprazole  40  mg ; latanoprost 0.005% ophth. soln.  1  drop ; 
 
white f 75 $nan$nan$docusate sodium  100  mg ; atorvastatin  20  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; hydromorphone (dilaudid)  20  mg ; pantoprazole  40  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lactulose  30  ml ; bisacodyl  10  mg ; propafenone hcl  225  mg ; ketorolac  15  mg ; lactated ringers  1000  ml ; 
 
white f 75 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  92  mg dl$docusate sodium  100  mg ; atorvastatin  20  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; pantoprazole  40  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lactulose  30  ml ; bisacodyl  10  mg ; propafenone hcl  225  mg ; ketorolac  15  mg ; lactated ringers  1000  ml ; sodium chloride 0.9%  1000  ml ; 
 
white f 75 $nan$nan$docusate sodium  100  mg ; atorvastatin  20  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; pantoprazole  40  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lactulose  30  ml ; bisacodyl  10  mg ; propafenone hcl  225  mg ; sodium chloride 0.9%  1000  ml ; 
 
white m 89 $temp  98.6  heartrate  91.0  resprate  28.0  o2sat  91.0  sbp  130.0  dbp  71.0  rhythm    pain  0  ; temp  98.4  heartrate  88.0  resprate  20.0  o2sat  93.0  sbp  122.0  dbp  70.0  rhythm    pain  0  ; temp  98.4  heartrate  86.0  resprate  18.0  o2sat  94.0  sbp  126.0  dbp  74.0  rhythm    pain  0  $hematology blood hematocrit  38.4  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  7.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  115  mg dl; blood gas blood lactate  2.1  mmol l; blood gas blood potassium, whole blood  5.7  meq l$nan
hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity pneumonitis due to inhalation of food and vomit atherosclerotic heart disease of native coronary artery without angina pectoris unspecified atrial fibrillation anemia in chronic kidney disease major depressive disorder, single episode, unspecified other pulmonary embolism without acute cor pulmonale end stage renal disease acute respiratory failure with hypoxia other secondary thrombocytopenia acidosis old myocardial infarction sepsis, unspecified organism severe sepsis with septic shock iron deficiency anemia, unspecified hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side chronic systolic (congestive) heart failure do not resuscitate dependence on renal dialysis gastro-esophageal reflux disease without esophagitis toxic encephalopathy chronic obstructive pulmonary disease, unspecified acute respiratory failure with hypercapnia major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following cerebral infarction affecting right dominant side end stage renal disease hypoxemia iron deficiency anemia, unspecified hypotension, unspecified unspecified atrial fibrillation obstructive sleep apnea (adult) (pediatric) dependence on renal dialysis patient's noncompliance with renal dialysis fluid overload, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction cellulitis of right toe chronic diastolic (congestive) heart failure thrombocytopenia, unspecified gastro-esophageal reflux disease without esophagitis chronic obstructive pulmonary disease, unspecified dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis anemia in chronic kidney disease hemiplegia and hemiparesis following cerebral infarction affecting right dominant side
white m 89 $temp  98.4  heartrate  82.0  resprate  18.0  o2sat  96.0  sbp  122.0  dbp  70.0  rhythm    pain  0  ; temp  98.4  heartrate  84.0  resprate  18.0  o2sat  95.0  sbp  116.0  dbp  63.0  rhythm    pain  0  ; temp  98.4  heartrate  88.0  resprate  18.0  o2sat  91.0  sbp  70.0  dbp  45.0  rhythm    pain  0  ; temp  98.4  heartrate  89.0  resprate  18.0  o2sat  92.0  sbp  76.0  dbp  51.0  rhythm    pain  0  ; temp  98.4  heartrate  91.0  resprate  18.0  o2sat  93.0  sbp  80.0  dbp  48.0  rhythm    pain  0  ; temp  98.4  heartrate  90.0  resprate  18.0  o2sat  93.0  sbp  89.0  dbp  48.0  rhythm    pain  0  ; temp  98.4  heartrate  83.0  resprate  18.0  o2sat  92.0  sbp  86.0  dbp  50.0  rhythm    pain  0  ; temp  98.4  heartrate  84.0  resprate  18.0  o2sat  98.0  sbp  88.0  dbp  45.0  rhythm    pain  0  ; temp  98.4  heartrate  86.0  resprate  18.0  o2sat  99.0  sbp  109.0  dbp  81.0  rhythm    pain  0  $blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; heparin  5000  unit ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; bisacodyl  10  mg ; calcium carbonate  1250  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; multivitamins  1  tab ; nephrocaps  1  cap ; omeprazole  20  mg ; ondansetron  4  mg ; senna  8.6  mg ; sevelamer carbonate  2400  mg ; simvastatin  20  mg ; fluoxetine  20  mg ; mirtazapine  7.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  bag ; vancomycin  0  md to order daily dose ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ceftazidime  2  g ; 
hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity pneumonitis due to inhalation of food and vomit atherosclerotic heart disease of native coronary artery without angina pectoris unspecified atrial fibrillation anemia in chronic kidney disease major depressive disorder, single episode, unspecified other pulmonary embolism without acute cor pulmonale end stage renal disease acute respiratory failure with hypoxia other secondary thrombocytopenia acidosis old myocardial infarction sepsis, unspecified organism severe sepsis with septic shock iron deficiency anemia, unspecified hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side chronic systolic (congestive) heart failure do not resuscitate dependence on renal dialysis gastro-esophageal reflux disease without esophagitis toxic encephalopathy chronic obstructive pulmonary disease, unspecified acute respiratory failure with hypercapnia major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following cerebral infarction affecting right dominant side end stage renal disease hypoxemia iron deficiency anemia, unspecified hypotension, unspecified unspecified atrial fibrillation obstructive sleep apnea (adult) (pediatric) dependence on renal dialysis patient's noncompliance with renal dialysis fluid overload, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction cellulitis of right toe chronic diastolic (congestive) heart failure thrombocytopenia, unspecified gastro-esophageal reflux disease without esophagitis chronic obstructive pulmonary disease, unspecified dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis anemia in chronic kidney disease hemiplegia and hemiparesis following cerebral infarction affecting right dominant side
white m 89 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; heparin  5000  unit ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; bisacodyl  10  mg ; calcium carbonate  1250  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; multivitamins  1  tab ; nephrocaps  1  cap ; omeprazole  20  mg ; ondansetron  4  mg ; senna  8.6  mg ; sevelamer carbonate  2400  mg ; simvastatin  20  mg ; fluoxetine  20  mg ; mirtazapine  7.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  bag ; vancomycin  0  md to order daily dose ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ceftazidime  2  g ; phenylephrine  60  mg ; magnesium sulfate  2  gm ; calcitriol  0.5  mcg ; midodrine  10  mg ; haloperidol  1  mg ; 
hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity pneumonitis due to inhalation of food and vomit atherosclerotic heart disease of native coronary artery without angina pectoris unspecified atrial fibrillation anemia in chronic kidney disease major depressive disorder, single episode, unspecified other pulmonary embolism without acute cor pulmonale end stage renal disease acute respiratory failure with hypoxia other secondary thrombocytopenia acidosis old myocardial infarction sepsis, unspecified organism severe sepsis with septic shock iron deficiency anemia, unspecified hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side chronic systolic (congestive) heart failure do not resuscitate dependence on renal dialysis gastro-esophageal reflux disease without esophagitis toxic encephalopathy chronic obstructive pulmonary disease, unspecified acute respiratory failure with hypercapnia major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following cerebral infarction affecting right dominant side end stage renal disease hypoxemia iron deficiency anemia, unspecified hypotension, unspecified unspecified atrial fibrillation obstructive sleep apnea (adult) (pediatric) dependence on renal dialysis patient's noncompliance with renal dialysis fluid overload, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction cellulitis of right toe chronic diastolic (congestive) heart failure thrombocytopenia, unspecified gastro-esophageal reflux disease without esophagitis chronic obstructive pulmonary disease, unspecified dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis anemia in chronic kidney disease hemiplegia and hemiparesis following cerebral infarction affecting right dominant side
white m 89 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  123  k ul; hematology blood platelet count  116  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  4.7  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  10.6  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  76  mg dl; chemistry blood glucose  69  mg dl; blood gas blood lactate  1.3  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; bisacodyl  10  mg ; milk of magnesia  30  ml ; nephrocaps  1  cap ; ondansetron  4  mg ; senna  8.6  mg ; sevelamer carbonate  2400  mg ; mirtazapine  7.5  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  bag ; vancomycin  0  md to order daily dose ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; phenylephrine  60  mg ; calcitriol  0.5  mcg ; midodrine  10  mg ; haloperidol  1  mg ; olanzapine (disintegrating tablet)  5  mg ; heparin dwell (1000 units ml)  2000-8000  unit ; sodium chloride 0.9%  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midodrine  15  mg ; 
hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity pneumonitis due to inhalation of food and vomit atherosclerotic heart disease of native coronary artery without angina pectoris unspecified atrial fibrillation anemia in chronic kidney disease major depressive disorder, single episode, unspecified other pulmonary embolism without acute cor pulmonale end stage renal disease acute respiratory failure with hypoxia other secondary thrombocytopenia acidosis old myocardial infarction sepsis, unspecified organism severe sepsis with septic shock iron deficiency anemia, unspecified hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side chronic systolic (congestive) heart failure do not resuscitate dependence on renal dialysis gastro-esophageal reflux disease without esophagitis toxic encephalopathy chronic obstructive pulmonary disease, unspecified acute respiratory failure with hypercapnia major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following cerebral infarction affecting right dominant side end stage renal disease hypoxemia iron deficiency anemia, unspecified hypotension, unspecified unspecified atrial fibrillation obstructive sleep apnea (adult) (pediatric) dependence on renal dialysis patient's noncompliance with renal dialysis fluid overload, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction cellulitis of right toe chronic diastolic (congestive) heart failure thrombocytopenia, unspecified gastro-esophageal reflux disease without esophagitis chronic obstructive pulmonary disease, unspecified dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis anemia in chronic kidney disease hemiplegia and hemiparesis following cerebral infarction affecting right dominant side
white m 89 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; bisacodyl  10  mg ; milk of magnesia  30  ml ; nephrocaps  1  cap ; ondansetron  4  mg ; senna  8.6  mg ; sevelamer carbonate  2400  mg ; mirtazapine  7.5  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  bag ; vancomycin  0  md to order daily dose ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; phenylephrine  60  mg ; calcitriol  0.5  mcg ; heparin dwell (1000 units ml)  2000-8000  unit ; sodium chloride 0.9%  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; sodium chloride 0.9%  flush  10  ml ; haloperidol  2.5  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; 
hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity pneumonitis due to inhalation of food and vomit atherosclerotic heart disease of native coronary artery without angina pectoris unspecified atrial fibrillation anemia in chronic kidney disease major depressive disorder, single episode, unspecified other pulmonary embolism without acute cor pulmonale end stage renal disease acute respiratory failure with hypoxia other secondary thrombocytopenia acidosis old myocardial infarction sepsis, unspecified organism severe sepsis with septic shock iron deficiency anemia, unspecified hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side chronic systolic (congestive) heart failure do not resuscitate dependence on renal dialysis gastro-esophageal reflux disease without esophagitis toxic encephalopathy chronic obstructive pulmonary disease, unspecified acute respiratory failure with hypercapnia major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following cerebral infarction affecting right dominant side end stage renal disease hypoxemia iron deficiency anemia, unspecified hypotension, unspecified unspecified atrial fibrillation obstructive sleep apnea (adult) (pediatric) dependence on renal dialysis patient's noncompliance with renal dialysis fluid overload, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction cellulitis of right toe chronic diastolic (congestive) heart failure thrombocytopenia, unspecified gastro-esophageal reflux disease without esophagitis chronic obstructive pulmonary disease, unspecified dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis anemia in chronic kidney disease hemiplegia and hemiparesis following cerebral infarction affecting right dominant side
white m 89 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; senna  8.6  mg ; mirtazapine  7.5  mg ; bag  1  bag ; vancomycin  0  md to order daily dose ; heparin dwell (1000 units ml)  2000-8000  unit ; sodium chloride 0.9%  flush  10  ml ; haloperidol  2.5  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; glycopyrrolate  0.1  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity pneumonitis due to inhalation of food and vomit atherosclerotic heart disease of native coronary artery without angina pectoris unspecified atrial fibrillation anemia in chronic kidney disease major depressive disorder, single episode, unspecified other pulmonary embolism without acute cor pulmonale end stage renal disease acute respiratory failure with hypoxia other secondary thrombocytopenia acidosis old myocardial infarction sepsis, unspecified organism severe sepsis with septic shock iron deficiency anemia, unspecified hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side chronic systolic (congestive) heart failure do not resuscitate dependence on renal dialysis gastro-esophageal reflux disease without esophagitis toxic encephalopathy chronic obstructive pulmonary disease, unspecified acute respiratory failure with hypercapnia major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following cerebral infarction affecting right dominant side end stage renal disease hypoxemia iron deficiency anemia, unspecified hypotension, unspecified unspecified atrial fibrillation obstructive sleep apnea (adult) (pediatric) dependence on renal dialysis patient's noncompliance with renal dialysis fluid overload, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction cellulitis of right toe chronic diastolic (congestive) heart failure thrombocytopenia, unspecified gastro-esophageal reflux disease without esophagitis chronic obstructive pulmonary disease, unspecified dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis anemia in chronic kidney disease hemiplegia and hemiparesis following cerebral infarction affecting right dominant side
white m 89 $nan$nan$sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; senna  8.6  mg ; mirtazapine  7.5  mg ; heparin dwell (1000 units ml)  2000-8000  unit ; sodium chloride 0.9%  flush  10  ml ; glycopyrrolate  0.1  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity pneumonitis due to inhalation of food and vomit atherosclerotic heart disease of native coronary artery without angina pectoris unspecified atrial fibrillation anemia in chronic kidney disease major depressive disorder, single episode, unspecified other pulmonary embolism without acute cor pulmonale end stage renal disease acute respiratory failure with hypoxia other secondary thrombocytopenia acidosis old myocardial infarction sepsis, unspecified organism severe sepsis with septic shock iron deficiency anemia, unspecified hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side chronic systolic (congestive) heart failure do not resuscitate dependence on renal dialysis gastro-esophageal reflux disease without esophagitis toxic encephalopathy chronic obstructive pulmonary disease, unspecified acute respiratory failure with hypercapnia major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following cerebral infarction affecting right dominant side end stage renal disease hypoxemia iron deficiency anemia, unspecified hypotension, unspecified unspecified atrial fibrillation obstructive sleep apnea (adult) (pediatric) dependence on renal dialysis patient's noncompliance with renal dialysis fluid overload, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction cellulitis of right toe chronic diastolic (congestive) heart failure thrombocytopenia, unspecified gastro-esophageal reflux disease without esophagitis chronic obstructive pulmonary disease, unspecified dependence on renal dialysis end stage renal disease major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis anemia in chronic kidney disease hemiplegia and hemiparesis following cerebral infarction affecting right dominant side
white f 58 $nan$nan$bupropion (sustained release)  100  mg ; 
 
white f 58 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  165  mg dl$bupropion (sustained release)  100  mg ; multivitamins  1  cap ; vitamin d  400  unit ; aspirin  325  mg ; citalopram  20  mg ; amlodipine  5  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; lorazepam  0.5-1  mg ; diphenhydramine  12.5-50  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; ketorolac  15  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; morphine sr (ms contin)  15  mg ; docusate sodium  100  mg ; senna  1  tab ; amitriptyline  10  mg ; sarna lotion  1  appl ; 
 
white f 58 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  226  k ul$bupropion (sustained release)  100  mg ; multivitamins  1  cap ; vitamin d  400  unit ; aspirin  325  mg ; citalopram  20  mg ; amlodipine  5  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; lorazepam  0.5-1  mg ; diphenhydramine  12.5-50  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; ketorolac  15  mg ; morphine sr (ms contin)  15  mg ; docusate sodium  100  mg ; senna  1  tab ; amitriptyline  10  mg ; sarna lotion  1  appl ; triamterene-hydrochlorothiazide  1  cap ; methylphenidate (ritalin)  15  mg ; 
 
white f 58 $nan$nan$bupropion (sustained release)  100  mg ; multivitamins  1  cap ; vitamin d  400  unit ; aspirin  325  mg ; amlodipine  5  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; lorazepam  0.5-1  mg ; diphenhydramine  12.5-50  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; ketorolac  15  mg ; morphine sr (ms contin)  15  mg ; docusate sodium  100  mg ; senna  1  tab ; sarna lotion  1  appl ; triamterene-hydrochlorothiazide  1  cap ; methylphenidate (ritalin)  15  mg ; 
 
white m 27 $temp  97.8  heartrate  95.0  resprate  18.0  o2sat  94.0  sbp  122.0  dbp  79.0  rhythm    pain  8  $hematology blood hematocrit  45.6  %; hematology blood hemoglobin  16.0  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  107  mg dl; chemistry blood albumin  4.7  g dl$nan
 
white m 27 $temp  98.0  heartrate  90.0  resprate  18.0  o2sat  90.0  sbp  120.0  dbp  80.0  rhythm    pain  8  ; temp  99.0  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $hematology blood hematocrit  40.7  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  127  mg dl$prochlorperazine  10  mg ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; bag  2  bag ; magnesium sulfate  4  gm ; ondansetron  8  mg ; ketorolac  15  mg ; clonazepam  0.5  mg ; escitalopram oxalate  10  mg ; zolpidem tartrate  5  mg ; hydromorphone (dilaudid)  0.25  mg ; 
 
white m 27 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  85  mg dl$prochlorperazine  10  mg ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; bag  2  bag ; magnesium sulfate  4  gm ; ondansetron  8  mg ; ketorolac  15  mg ; escitalopram oxalate  10  mg ; zolpidem tartrate  5  mg ; hydromorphone (dilaudid)  0.25  mg ; paliperidone er  6  mg ; multivitamins  1  tab ; thiamine  100  mg ; phosphorus  500  mg ; 
 
white m 27 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  72  mg dl$prochlorperazine  10  mg ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; ketorolac  15  mg ; escitalopram oxalate  10  mg ; zolpidem tartrate  5  mg ; paliperidone er  6  mg ; multivitamins  1  tab ; thiamine  100  mg ; phosphorus  500  mg ; 
 
white f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; oxycodone-acetaminophen  2  tab ; hydromorphone (dilaudid)  12.5  mg ; heparin  5000  unit ; 
 
white f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; oxycodone-acetaminophen  2  tab ; hydromorphone (dilaudid)  12.5  mg ; heparin  5000  unit ; 
 
white m 79 $nan$nan$midodrine  10  mg ; levothyroxine sodium  25  mcg ; 
urinary frequency unspecified acquired hypothyroidism unspecified disorder of autonomic nervous system sepsis urinary tract infection, site not specified other septicemia due to gram-negative organisms osteoporosis, unspecified orthostatic hypotension hematuria esophageal reflux obstructive sleep apnea (adult)(pediatric) infection and inflammatory reaction due to indwelling urinary catheter pancytopenia 
white m 79 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  98  mg dl$midodrine  10  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; d5w  200  ml ; ciprofloxacin iv  400  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; lr  1000  ml ; midodrine  5  mg ; heparin  5000  unit ; ns  500  ml ; ns  1000  ml ; 
urinary frequency unspecified acquired hypothyroidism unspecified disorder of autonomic nervous system sepsis urinary tract infection, site not specified other septicemia due to gram-negative organisms osteoporosis, unspecified orthostatic hypotension hematuria esophageal reflux obstructive sleep apnea (adult)(pediatric) infection and inflammatory reaction due to indwelling urinary catheter pancytopenia 
white m 79 $nan$nan$midodrine  10  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; d5w  200  ml ; ciprofloxacin iv  400  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; midodrine  5  mg ; heparin  5000  unit ; ns  500  ml ; ns  1000  ml ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; 
urinary frequency unspecified acquired hypothyroidism unspecified disorder of autonomic nervous system sepsis urinary tract infection, site not specified other septicemia due to gram-negative organisms osteoporosis, unspecified orthostatic hypotension hematuria esophageal reflux obstructive sleep apnea (adult)(pediatric) infection and inflammatory reaction due to indwelling urinary catheter pancytopenia 
white m 79 $nan$nan$midodrine  10  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; d5w  200  ml ; ciprofloxacin iv  400  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; midodrine  5  mg ; heparin  5000  unit ; ns  1000  ml ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; citalopram hydrobromide  20  mg ; oxybutynin  5  mg ; pantoprazole  40  mg ; 
urinary frequency unspecified acquired hypothyroidism unspecified disorder of autonomic nervous system sepsis urinary tract infection, site not specified other septicemia due to gram-negative organisms osteoporosis, unspecified orthostatic hypotension hematuria esophageal reflux obstructive sleep apnea (adult)(pediatric) infection and inflammatory reaction due to indwelling urinary catheter pancytopenia 
white m 79 $nan$nan$midodrine  10  mg ; sodium chloride 0.9%  flush  3  ml ; d5w  200  ml ; ciprofloxacin iv  400  mg ; midodrine  5  mg ; heparin  5000  unit ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; citalopram hydrobromide  20  mg ; oxybutynin  5  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; 
urinary frequency unspecified acquired hypothyroidism unspecified disorder of autonomic nervous system sepsis urinary tract infection, site not specified other septicemia due to gram-negative organisms osteoporosis, unspecified orthostatic hypotension hematuria esophageal reflux obstructive sleep apnea (adult)(pediatric) infection and inflammatory reaction due to indwelling urinary catheter pancytopenia 
white m 79 $nan$nan$midodrine  10  mg ; sodium chloride 0.9%  flush  3  ml ; midodrine  5  mg ; heparin  5000  unit ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; levothyroxine sodium  50  mcg ; citalopram hydrobromide  20  mg ; oxybutynin  5  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; 
urinary frequency unspecified acquired hypothyroidism unspecified disorder of autonomic nervous system sepsis urinary tract infection, site not specified other septicemia due to gram-negative organisms osteoporosis, unspecified orthostatic hypotension hematuria esophageal reflux obstructive sleep apnea (adult)(pediatric) infection and inflammatory reaction due to indwelling urinary catheter pancytopenia 
white f 62 $nan$chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood albumin  3.8  g dl; chemistry blood albumin  4.2  g dl; chemistry blood albumin  3.8  g dl$citalopram  60  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; gabapentin  600  mg ; sumatriptan succinate  50-100  mg ; trazodone  200  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  2-4  mg ; clonazepam  0.5  mg ; lorazepam  0.5-2  mg ; 
dysthymic disorder other motor vehicle traffic accident involving collision on the highway injuring driver of motor vehicle other than motorcycle abrasion or friction burn of other, multiple, and unspecified sites, without mention of infection closed fracture of acetabulum
white f 62 $nan$chemistry blood calcium, total  8.2  mg dl; chemistry blood albumin  3.7  g dl$citalopram  60  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; gabapentin  600  mg ; sumatriptan succinate  50-100  mg ; trazodone  200  mg ; hydromorphone (dilaudid)  2-4  mg ; clonazepam  0.5  mg ; lorazepam  0.5-2  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; oxycodone (immediate release)   5  mg ; sodium chloride 3% inhalation soln  3  ml ; 
dysthymic disorder other motor vehicle traffic accident involving collision on the highway injuring driver of motor vehicle other than motorcycle abrasion or friction burn of other, multiple, and unspecified sites, without mention of infection closed fracture of acetabulum
white f 62 $nan$nan$citalopram  60  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; gabapentin  600  mg ; trazodone  200  mg ; clonazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; sodium chloride 3% inhalation soln  3  ml ; fluticasone propionate nasal  2  spry ; acetylcysteine 20%  1-10  ml ; acetaminophen  650  mg ; 
dysthymic disorder other motor vehicle traffic accident involving collision on the highway injuring driver of motor vehicle other than motorcycle abrasion or friction burn of other, multiple, and unspecified sites, without mention of infection closed fracture of acetabulum
white f 62 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  104  mg dl; chemistry blood albumin  3.5  g dl$citalopram  60  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; gabapentin  600  mg ; trazodone  200  mg ; clonazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; sodium chloride 3% inhalation soln  3  ml ; fluticasone propionate nasal  2  spry ; acetylcysteine 20%  1-10  ml ; acetaminophen  650  mg ; ascorbic acid  500  mg ; furosemide  20  mg ; sumatriptan succinate  50  mg ; 
dysthymic disorder other motor vehicle traffic accident involving collision on the highway injuring driver of motor vehicle other than motorcycle abrasion or friction burn of other, multiple, and unspecified sites, without mention of infection closed fracture of acetabulum
white f 62 $nan$hematology blood hematocrit  38.3  %; hematology blood hematocrit  34.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  168  k ul; hematology blood platelet count  175  k ul; hematology blood bands  6  %$citalopram  60  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; gabapentin  600  mg ; trazodone  200  mg ; clonazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; sodium chloride 3% inhalation soln  3  ml ; fluticasone propionate nasal  2  spry ; acetylcysteine 20%  1-10  ml ; acetaminophen  650  mg ; ascorbic acid  500  mg ; furosemide  20  mg ; sumatriptan succinate  50  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
dysthymic disorder other motor vehicle traffic accident involving collision on the highway injuring driver of motor vehicle other than motorcycle abrasion or friction burn of other, multiple, and unspecified sites, without mention of infection closed fracture of acetabulum
white f 62 $nan$nan$citalopram  60  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; gabapentin  600  mg ; trazodone  200  mg ; clonazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; sodium chloride 3% inhalation soln  3  ml ; fluticasone propionate nasal  2  spry ; acetylcysteine 20%  1-10  ml ; acetaminophen  650  mg ; ascorbic acid  500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diazepam  5-10  mg ; senna  1  tab ; 
dysthymic disorder other motor vehicle traffic accident involving collision on the highway injuring driver of motor vehicle other than motorcycle abrasion or friction burn of other, multiple, and unspecified sites, without mention of infection closed fracture of acetabulum
white f 62 $nan$hematology blood hematocrit  37.1  %; hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  190  k ul; hematology blood platelet count  214  k ul; hematology blood bands  0  %$citalopram  60  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; gabapentin  600  mg ; trazodone  200  mg ; clonazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; sodium chloride 3% inhalation soln  3  ml ; fluticasone propionate nasal  2  spry ; acetylcysteine 20%  1-10  ml ; acetaminophen  650  mg ; ascorbic acid  500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diazepam  5-10  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 
dysthymic disorder other motor vehicle traffic accident involving collision on the highway injuring driver of motor vehicle other than motorcycle abrasion or friction burn of other, multiple, and unspecified sites, without mention of infection closed fracture of acetabulum
white f 62 $nan$nan$citalopram  60  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; gabapentin  600  mg ; trazodone  200  mg ; clonazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; fluticasone propionate nasal  2  spry ; acetylcysteine 20%  1-10  ml ; acetaminophen  650  mg ; ascorbic acid  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diazepam  5-10  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; loperamide  2  mg ; 
dysthymic disorder other motor vehicle traffic accident involving collision on the highway injuring driver of motor vehicle other than motorcycle abrasion or friction burn of other, multiple, and unspecified sites, without mention of infection closed fracture of acetabulum
white f 62 $nan$nan$citalopram  60  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; gabapentin  600  mg ; trazodone  200  mg ; clonazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; fluticasone propionate nasal  2  spry ; acetylcysteine 20%  1-10  ml ; acetaminophen  650  mg ; ascorbic acid  500  mg ; diazepam  5-10  mg ; senna  1  tab ; loperamide  2  mg ; 
dysthymic disorder other motor vehicle traffic accident involving collision on the highway injuring driver of motor vehicle other than motorcycle abrasion or friction burn of other, multiple, and unspecified sites, without mention of infection closed fracture of acetabulum
white m 53 $temp  98.4  heartrate  120.0  resprate  20.0  o2sat  96.0  sbp  100.0  dbp  46.0  rhythm    pain  uta  $hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  193  iu l; blood gas blood lactate  2.3  mmol l; hematology blood wbc count  3.4  k ul$senna  8.6  mg ; bisacodyl  10  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; lactated ringers  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aluminum-magnesium hydrox.-simethicone  30  ml ; hyoscyamine  0.125  mg ; ipratropium bromide neb  1  neb ; lorazepam  0.25  mg ; ns  100  ml ; metronidazole  500  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; bacitracin ointment  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; atovaquone suspension  1500  mg ; calcium acetate  1334  mg ; citalopram  10  mg ; darunavir  800  mg ; emtricitabine-tenofovir (truvada)  1  tab ; levetiracetam oral solution  1250  mg ; ritonavir  100  mg ; vancomycin oral liquid  125  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ondansetron  4  mg ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 53 $nan$hematology blood hematocrit  32.3  %; hematology blood hematocrit  35.2  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  106  k ul; hematology blood platelet count  109  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  91  mg dl; blood gas blood lactate  1.0  mmol l$senna  8.6  mg ; bisacodyl  10  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aluminum-magnesium hydrox.-simethicone  30  ml ; hyoscyamine  0.125  mg ; ipratropium bromide neb  1  neb ; lorazepam  0.25  mg ; bacitracin ointment  1  appl ; atovaquone suspension  1500  mg ; calcium acetate  1334  mg ; citalopram  10  mg ; darunavir  800  mg ; emtricitabine-tenofovir (truvada)  1  tab ; levetiracetam oral solution  1250  mg ; ritonavir  100  mg ; vancomycin oral liquid  125  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  1000  ml ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 53 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  126  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry urine creatinine, urine  53  mg dl; chemistry urine sodium, urine  154  meq l; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  110  mg dl$senna  8.6  mg ; bisacodyl  10  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aluminum-magnesium hydrox.-simethicone  30  ml ; hyoscyamine  0.125  mg ; ipratropium bromide neb  1  neb ; lorazepam  0.25  mg ; bacitracin ointment  1  appl ; atovaquone suspension  1500  mg ; calcium acetate  1334  mg ; citalopram  10  mg ; darunavir  800  mg ; emtricitabine-tenofovir (truvada)  1  tab ; levetiracetam oral solution  1250  mg ; ritonavir  100  mg ; vancomycin oral liquid  125  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10  ml ; cefepime  2  g ; azithromycin  1200  mg ; phosphorus  500  mg ; furosemide  10  mg ; furosemide  20  mg ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 53 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  18  mg dl; hematology urine wbc  10  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  556  iu l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  1.3  mmol l$senna  8.6  mg ; bisacodyl  10  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; hyoscyamine  0.125  mg ; lorazepam  0.25  mg ; bacitracin ointment  1  appl ; atovaquone suspension  1500  mg ; calcium acetate  1334  mg ; citalopram  10  mg ; darunavir  800  mg ; emtricitabine-tenofovir (truvada)  1  tab ; levetiracetam oral solution  1250  mg ; ritonavir  100  mg ; vancomycin oral liquid  125  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10  ml ; cefepime  2  g ; azithromycin  1200  mg ; phosphorus  500  mg ; ipratropium-albuterol neb  1  neb ; sodium chloride 3% inhalation soln  15  ml ; potassium chloride (powder)  60  meq ; 0.9% sodium chloride  100  ml ; tobramycin sulfate  440  mg ; levetiracetam  1250  mg ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; atovaquone suspension  750  mg ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 53 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  128  mg dl; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.2  mmol l$cefepime  2  g ; 0.9% sodium chloride  100  ml ; tobramycin sulfate  440  mg ; levetiracetam  1250  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; atovaquone suspension  750  mg ; acetaminophen (liquid)  650  mg ; dexmedetomidine  0.4  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; meropenem  500  mg ; prednisone  40  mg ; primaquine phosphate  30  mg ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 53 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  340  iu l$0.9% sodium chloride  100  ml ; tobramycin sulfate  440  mg ; levetiracetam  1250  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; atovaquone suspension  750  mg ; acetaminophen (liquid)  650  mg ; dexmedetomidine  0.4  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; meropenem  500  mg ; prednisone  40  mg ; primaquine phosphate  30  mg ; fentanyl citrate  50  mcg ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 53 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  140  mg dl; chemistry blood lactate dehydrogenase (ld)  313  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %$levetiracetam  1250  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; atovaquone suspension  750  mg ; acetaminophen (liquid)  650  mg ; dexmedetomidine  0.4  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; meropenem  500  mg ; prednisone  40  mg ; primaquine phosphate  30  mg ; fentanyl citrate  50  mcg ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 53 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  104  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  280  iu l; chemistry blood albumin  2.8  g dl; blood gas blood lactate  1.5  mmol l$levetiracetam  1250  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; atovaquone suspension  750  mg ; acetaminophen (liquid)  650  mg ; dexmedetomidine  0.4  mg ; neutra-phos  2  pkt ; sodium phosphate  30  mmol ; quetiapine fumarate  25  mg ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 53 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  280  iu l; chemistry blood albumin  2.7  g dl; blood gas blood lactate  1.3  mmol l$levetiracetam  1250  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; acetaminophen (liquid)  650  mg ; dexmedetomidine  0.4  mg ; quetiapine fumarate  25  mg ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 53 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  258  iu l; chemistry blood albumin  3.1  g dl$soln  50  ml ; fentanyl citrate  2.5  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; acetaminophen (liquid)  650  mg ; quetiapine fumarate  25  mg ; meropenem  1000  mg ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 53 $nan$nan$soln  50  ml ; fentanyl citrate  2.5  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; acetaminophen (liquid)  650  mg ; quetiapine fumarate  25  mg ; meropenem  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
osteonecrosis, unspecified dependence on supplemental oxygen unspecified abdominal pain calculus of kidney with calculus of ureter human immunodeficiency virus [hiv] disease noninfective gastroenteritis and colitis, unspecified tracheostomy status resistance to multiple antibiotics pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere encounter for attention to other artificial openings of digestive tract unspecified convulsions chronic respiratory failure with hypoxia major depressive disorder, single episode, unspecified urinary tract infection, site not specified other chronic pain personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified anxiety disorder, unspecified insomnia, unspecified sepsis, unspecified organism dependence on supplemental oxygen urinary tract infection, site not specified human immunodeficiency virus [hiv] disease acute kidney failure, unspecified resistance to quinolones and fluoroquinolones unspecified abdominal pain epilepsy, unspecified, not intractable, without status epilepticus osteonecrosis, unspecified personal history of urinary (tract) infections acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia malfunction of tracheostomy stoma pneumonitis due to inhalation of food and vomit personal history of nicotine dependence anxiety disorder, unspecified pneumonia due to escherichia coli personal history of pneumonia (recurrent) acidosis pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere gastrostomy status severe sepsis without septic shock enterocolitis due to clostridium difficile insomnia, unspecified dysphagia, unspecified chronic ulcer of other specified sites pneumonitis due to inhalation of food or vomitus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gastrostomy status
white m 79 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  2-4  mg ; ketorolac  15  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; zolpidem tartrate  5  mg ; hydrocodone-acetaminophen  1-2  tab ; phenazopyridine  100  mg ; tamsulosin  0.4  mg ; 
 
white m 79 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  2-4  mg ; ketorolac  15  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; zolpidem tartrate  5  mg ; hydrocodone-acetaminophen  1-2  tab ; phenazopyridine  100  mg ; tamsulosin  0.4  mg ; 
 
white m 77 $nan$nan$warfarin  5  mg ; 
personal history of venous thrombosis and embolism other and unspecified hyperlipidemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants asthma, unspecified type, unspecified esophageal reflux anemia, unspecified atrial fibrillation anal fissure old myocardial infarction coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia acute kidney failure, unspecified other iatrogenic hypotension coronary atherosclerosis of native coronary artery unspecified essential hypertension long-term (current) use of anticoagulants personal history of venous thrombosis and embolism hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other and unspecified hyperlipidemia long-term (current) use of anticoagulants unspecified essential hypertension coronary atherosclerosis of native coronary artery personal history of venous thrombosis and embolism atrial fibrillation acute kidney failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) asthma, unspecified type, unspecified esophageal reflux intermediate coronary syndrome unspecified viral infection local anti-infectives and anti-inflammatory drugs causing adverse effects in therapeutic use atrial fibrillation other disorders of plasma protein metabolism other pulmonary embolism and infarction toxic myopathy coronary atherosclerosis of native coronary artery thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm pancytopenia old myocardial infarction constipation, unspecified
white m 77 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  88  mg dl; chemistry blood % hemoglobin a1c  5.7  %$warfarin  5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; bisacodyl  10  mg ; hydralazine  10  mg ; niacin sr  500  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; metoprolol tartrate  50  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; aspirin  325  mg ; ferrous sulfate  325  mg ; finasteride  5  mg ; terazosin  5  mg ; 
personal history of venous thrombosis and embolism other and unspecified hyperlipidemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants asthma, unspecified type, unspecified esophageal reflux anemia, unspecified atrial fibrillation anal fissure old myocardial infarction coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia acute kidney failure, unspecified other iatrogenic hypotension coronary atherosclerosis of native coronary artery unspecified essential hypertension long-term (current) use of anticoagulants personal history of venous thrombosis and embolism hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other and unspecified hyperlipidemia long-term (current) use of anticoagulants unspecified essential hypertension coronary atherosclerosis of native coronary artery personal history of venous thrombosis and embolism atrial fibrillation acute kidney failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) asthma, unspecified type, unspecified esophageal reflux intermediate coronary syndrome unspecified viral infection local anti-infectives and anti-inflammatory drugs causing adverse effects in therapeutic use atrial fibrillation other disorders of plasma protein metabolism other pulmonary embolism and infarction toxic myopathy coronary atherosclerosis of native coronary artery thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm pancytopenia old myocardial infarction constipation, unspecified
hispanic latino m 19 $nan$hematology blood inr(pt)  1.1  $heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen (liquid)  650  mg ; hydromorphone (dilaudid)  0.25  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; morphine sulfate  1-2  mg ; oxycodone-acetaminophen elixir  5-10  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; 
 
hispanic latino m 19 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  230  k ul; hematology blood bands  0  %$heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; morphine sulfate  1-2  mg ; oxycodone-acetaminophen elixir  5-10  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; cephalexin  500  mg ; 
 
white m 62 $nan$hematology blood hematocrit  36.8  %; hematology blood hematocrit  33.3  %; hematology blood hematocrit  31.2  %; hematology blood hematocrit  26.7  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  12.2  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  236  k ul; hematology blood platelet count  213  k ul; hematology blood platelet count  252  k ul; hematology blood platelet count  216  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  120  mg dl; chemistry blood glucose  118  mg dl; blood gas blood free calcium  1.29  mmol l; blood gas blood free calcium  1.25  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood glucose  148  mg dl; blood gas blood glucose  118  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  38  %; blood gas blood hemoglobin  12.8  g dl; blood gas blood hemoglobin  12.5  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  142  meq l$tacrolimus  0.5  mg ; tacrolimus  1  mg ; omeprazole  20  mg ; pravastatin  20  mg ; aspirin  325  mg ; clopidogrel  75  mg ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident atherosclerosis of native arteries of the extremities with intermittent claudication liver replaced by transplant other and unspecified hyperlipidemia unspecified essential hypertension benign neoplasm of bladder unspecified essential hypertension pure hypercholesterolemia person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obstructive sleep apnea (adult)(pediatric) incisional hernia without mention of obstruction or gangrene personal history of malignant neoplasm of prostate liver replaced by transplant unspecified essential hypertension unspecified essential hypertension person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute pancreatitis personal history of malignant neoplasm of prostate liver replaced by transplant other and unspecified hyperlipidemia acute kidney failure, unspecified unspecified essential hypertension altered mental status personal history of malignant neoplasm of prostate liver replaced by transplant iron deficiency anemia secondary to blood loss (chronic) urinary tract infection, site not specified dehydration unspecified otitis media disorder of bone and cartilage, unspecified person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute mastoiditis without complications 
white m 62 $nan$hematology blood hematocrit  28.3  %; hematology blood hematocrit  28.5  %; hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  118  mg dl$tacrolimus  0.5  mg ; tacrolimus  1  mg ; omeprazole  20  mg ; pravastatin  20  mg ; aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; d5w  250  ml ; nitroglycerin  100  mg ; nitroglycerin ointment  2%  1  in ; magnesium sulfate  4  gm ; lr  1000  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; warfarin  5  mg ; hydromorphone (dilaudid)  12.5  mg ; heparin sodium  25,000  unit ; warfarin  1  dose ; docusate sodium  100  mg ; sw  100  ml ; potassium chloride  40  meq ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident atherosclerosis of native arteries of the extremities with intermittent claudication liver replaced by transplant other and unspecified hyperlipidemia unspecified essential hypertension benign neoplasm of bladder unspecified essential hypertension pure hypercholesterolemia person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obstructive sleep apnea (adult)(pediatric) incisional hernia without mention of obstruction or gangrene personal history of malignant neoplasm of prostate liver replaced by transplant unspecified essential hypertension unspecified essential hypertension person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute pancreatitis personal history of malignant neoplasm of prostate liver replaced by transplant other and unspecified hyperlipidemia acute kidney failure, unspecified unspecified essential hypertension altered mental status personal history of malignant neoplasm of prostate liver replaced by transplant iron deficiency anemia secondary to blood loss (chronic) urinary tract infection, site not specified dehydration unspecified otitis media disorder of bone and cartilage, unspecified person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute mastoiditis without complications 
white m 62 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  110  mg dl$omeprazole  20  mg ; pravastatin  20  mg ; aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; d5w  250  ml ; nitroglycerin  100  mg ; nitroglycerin ointment  2%  1  in ; magnesium sulfate  4  gm ; lr  1000  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; warfarin  5  mg ; hydromorphone (dilaudid)  12.5  mg ; warfarin  1  dose ; docusate sodium  100  mg ; sw  100  ml ; potassium chloride  40  meq ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; sw  50  ml ; magnesium sulfate  2  gm ; oxycodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.125  mg ; neutra-phos  2  pkt ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident atherosclerosis of native arteries of the extremities with intermittent claudication liver replaced by transplant other and unspecified hyperlipidemia unspecified essential hypertension benign neoplasm of bladder unspecified essential hypertension pure hypercholesterolemia person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obstructive sleep apnea (adult)(pediatric) incisional hernia without mention of obstruction or gangrene personal history of malignant neoplasm of prostate liver replaced by transplant unspecified essential hypertension unspecified essential hypertension person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute pancreatitis personal history of malignant neoplasm of prostate liver replaced by transplant other and unspecified hyperlipidemia acute kidney failure, unspecified unspecified essential hypertension altered mental status personal history of malignant neoplasm of prostate liver replaced by transplant iron deficiency anemia secondary to blood loss (chronic) urinary tract infection, site not specified dehydration unspecified otitis media disorder of bone and cartilage, unspecified person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute mastoiditis without complications 
white m 62 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  106  mg dl$omeprazole  20  mg ; pravastatin  20  mg ; aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; warfarin  1  dose ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; sw  50  ml ; magnesium sulfate  2  gm ; oxycodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.125  mg ; neutra-phos  2  pkt ; metoprolol tartrate  50  mg ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident atherosclerosis of native arteries of the extremities with intermittent claudication liver replaced by transplant other and unspecified hyperlipidemia unspecified essential hypertension benign neoplasm of bladder unspecified essential hypertension pure hypercholesterolemia person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obstructive sleep apnea (adult)(pediatric) incisional hernia without mention of obstruction or gangrene personal history of malignant neoplasm of prostate liver replaced by transplant unspecified essential hypertension unspecified essential hypertension person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute pancreatitis personal history of malignant neoplasm of prostate liver replaced by transplant other and unspecified hyperlipidemia acute kidney failure, unspecified unspecified essential hypertension altered mental status personal history of malignant neoplasm of prostate liver replaced by transplant iron deficiency anemia secondary to blood loss (chronic) urinary tract infection, site not specified dehydration unspecified otitis media disorder of bone and cartilage, unspecified person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute mastoiditis without complications 
white m 62 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  92  mg dl$omeprazole  20  mg ; pravastatin  20  mg ; aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; warfarin  1  dose ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.125  mg ; metoprolol tartrate  50  mg ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident atherosclerosis of native arteries of the extremities with intermittent claudication liver replaced by transplant other and unspecified hyperlipidemia unspecified essential hypertension benign neoplasm of bladder unspecified essential hypertension pure hypercholesterolemia person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obstructive sleep apnea (adult)(pediatric) incisional hernia without mention of obstruction or gangrene personal history of malignant neoplasm of prostate liver replaced by transplant unspecified essential hypertension unspecified essential hypertension person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute pancreatitis personal history of malignant neoplasm of prostate liver replaced by transplant other and unspecified hyperlipidemia acute kidney failure, unspecified unspecified essential hypertension altered mental status personal history of malignant neoplasm of prostate liver replaced by transplant iron deficiency anemia secondary to blood loss (chronic) urinary tract infection, site not specified dehydration unspecified otitis media disorder of bone and cartilage, unspecified person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute mastoiditis without complications 
white m 62 $nan$nan$omeprazole  20  mg ; pravastatin  20  mg ; aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; warfarin  1  dose ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.125  mg ; metoprolol tartrate  50  mg ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident atherosclerosis of native arteries of the extremities with intermittent claudication liver replaced by transplant other and unspecified hyperlipidemia unspecified essential hypertension benign neoplasm of bladder unspecified essential hypertension pure hypercholesterolemia person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obstructive sleep apnea (adult)(pediatric) incisional hernia without mention of obstruction or gangrene personal history of malignant neoplasm of prostate liver replaced by transplant unspecified essential hypertension unspecified essential hypertension person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute pancreatitis personal history of malignant neoplasm of prostate liver replaced by transplant other and unspecified hyperlipidemia acute kidney failure, unspecified unspecified essential hypertension altered mental status personal history of malignant neoplasm of prostate liver replaced by transplant iron deficiency anemia secondary to blood loss (chronic) urinary tract infection, site not specified dehydration unspecified otitis media disorder of bone and cartilage, unspecified person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident acute mastoiditis without complications 
white m 56 $nan$nan$amlodipine  10  mg ; citalopram hydrobromide  20  mg ; glyburide  5  mg ; isosorbide mononitrate (extended release)  30  mg ; omeprazole  40  mg ; rosuvastatin calcium  10  mg ; valsartan  160  mg ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; nitroglycerin sl  0.4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; insulin  0  unit ; furosemide  20  mg ; metformin (glucophage)  1000  mg ; metoprolol tartrate  50  mg ; glyburide  10  mg ; diphenhydramine  25-50  mg ; heparin  5000  unit ; 
 
white m 56 $nan$nan$amlodipine  10  mg ; citalopram hydrobromide  20  mg ; omeprazole  40  mg ; rosuvastatin calcium  10  mg ; valsartan  160  mg ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; nitroglycerin sl  0.4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; insulin  0  unit ; furosemide  20  mg ; metformin (glucophage)  1000  mg ; metoprolol tartrate  50  mg ; glyburide  10  mg ; diphenhydramine  25-50  mg ; heparin  5000  unit ; 
 
hispanic latino m 65 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.125  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; diphenhydramine  12.5-25  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; ketorolac  15  mg ; amlodipine  10  mg ; atorvastatin  20  mg ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
acute kidney failure, unspecified viral intestinal infection, unspecified dehydration nicotine dependence, cigarettes, uncomplicated other disorders of electrolyte and fluid balance, not elsewhere classified essential (primary) hypertension acidosis 
hispanic latino m 65 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.4  g dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.125  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; diphenhydramine  12.5-25  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; ketorolac  15  mg ; amlodipine  10  mg ; atorvastatin  20  mg ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; enoxaparin sodium  40  mg ; 
acute kidney failure, unspecified viral intestinal infection, unspecified dehydration nicotine dependence, cigarettes, uncomplicated other disorders of electrolyte and fluid balance, not elsewhere classified essential (primary) hypertension acidosis 
white f 37 $temp  103.2  heartrate  129.0  resprate  23.0  o2sat    sbp  89.0  dbp  44.0  rhythm    pain    ; temp  100.8  heartrate  115.0  resprate  26.0  o2sat  97.0  sbp  97.0  dbp  43.0  rhythm  sinus tachycardia  pain  0  ; temp  99.3  heartrate  125.0  resprate  32.0  o2sat  100.0  sbp  89.0  dbp  45.0  rhythm  sinus tachycardia  pain  0  ; temp  99.8  heartrate  117.0  resprate  31.0  o2sat    sbp  89.0  dbp  56.0  rhythm  sinus tachycardia  pain    $nan$dasatinib  100  mg ; 
cough personal history of antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] encounter for antineoplastic chemotherapy candidiasis of skin and nails calculus of kidney acute lymphoid leukemia, without mention of having achieved remission dehydration hypotension, unspecified anxiety state, unspecified encounter for antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] neutropenia, unspecified fever presenting with conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tachycardia, unspecified hypovolemia anemia, unspecified acute lymphoid leukemia, without mention of having achieved remission candidiasis of mouth tumor lysis syndrome anxiety state, unspecified other disorders of muscle, ligament, and fascia acute lymphoid leukemia, without mention of having achieved remission thrombocytopenia, unspecified disorders of soft tissue, unspecified neutropenia, unspecified stomatitis and mucositis, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus anemia, unspecified
white f 37 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp  99.6  heartrate  110.0  resprate  33.0  o2sat    sbp  121.0  dbp  56.0  rhythm  sinus tachycardia  pain    $hematology blood hematocrit  20.2  %; hematology blood hematocrit  20.7  %; hematology blood hematocrit  22.1  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  9  k ul; hematology blood platelet count  8  k ul; hematology blood platelet count  30  k ul; hematology blood platelet count  7  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  2.7  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  6.7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, indirect  4.1  mg dl; chemistry blood bilirubin, total  5.3  mg dl; chemistry blood bilirubin, total  6.5  mg dl; chemistry blood glucose  211  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  200  iu l; hematology blood bands  0  %; blood gas blood lactate  1.3  mmol l; chemistry blood bilirubin, direct  2.4  mg dl$vial  1  vial ; dasatinib  100  mg ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  100  ml ; acyclovir  400  mg ; clonazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; filgrastim  480  mcg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ursodiol  300  mg ; docusate sodium  100  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; potassium chloride (powder)  60  meq ; acetaminophen  650  mg ; diphenhydramine  25  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; nystatin  500,000  unit ; neutra-phos  2  pkt ; 
cough personal history of antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] encounter for antineoplastic chemotherapy candidiasis of skin and nails calculus of kidney acute lymphoid leukemia, without mention of having achieved remission dehydration hypotension, unspecified anxiety state, unspecified encounter for antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] neutropenia, unspecified fever presenting with conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tachycardia, unspecified hypovolemia anemia, unspecified acute lymphoid leukemia, without mention of having achieved remission candidiasis of mouth tumor lysis syndrome anxiety state, unspecified other disorders of muscle, ligament, and fascia acute lymphoid leukemia, without mention of having achieved remission thrombocytopenia, unspecified disorders of soft tissue, unspecified neutropenia, unspecified stomatitis and mucositis, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus anemia, unspecified
white f 37 $nan$hematology blood hematocrit  18.6  %; hematology blood hematocrit  25.5  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  34  k ul; hematology blood platelet count  15  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  5.5  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; chemistry blood albumin  3.5  g dl$vial  1  vial ; dasatinib  100  mg ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  100  ml ; acyclovir  400  mg ; clonazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; filgrastim  480  mcg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ursodiol  300  mg ; docusate sodium  100  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; potassium chloride (powder)  60  meq ; acetaminophen  650  mg ; diphenhydramine  25  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; nystatin  500,000  unit ; neutra-phos  2  pkt ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; cepacol (menthol)  1  loz ; lorazepam  0.5  mg ; ondansetron  4-8  mg ; 
cough personal history of antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] encounter for antineoplastic chemotherapy candidiasis of skin and nails calculus of kidney acute lymphoid leukemia, without mention of having achieved remission dehydration hypotension, unspecified anxiety state, unspecified encounter for antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] neutropenia, unspecified fever presenting with conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tachycardia, unspecified hypovolemia anemia, unspecified acute lymphoid leukemia, without mention of having achieved remission candidiasis of mouth tumor lysis syndrome anxiety state, unspecified other disorders of muscle, ligament, and fascia acute lymphoid leukemia, without mention of having achieved remission thrombocytopenia, unspecified disorders of soft tissue, unspecified neutropenia, unspecified stomatitis and mucositis, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus anemia, unspecified
white f 37 $nan$hematology blood hematocrit  21.2  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  16  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, indirect  1.8  mg dl; chemistry blood bilirubin, total  3.7  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  190  iu l; hematology blood bands  0  %; chemistry blood bilirubin, direct  1.9  mg dl$vial  1  vial ; dasatinib  100  mg ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  100  ml ; acyclovir  400  mg ; clonazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; filgrastim  480  mcg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ursodiol  300  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; nystatin  500,000  unit ; ipratropium bromide neb  1  neb ; cepacol (menthol)  1  loz ; lorazepam  0.5  mg ; ondansetron  4-8  mg ; meropenem  500  mg ; nystatin oral suspension  5  ml ; calcium replacement (oncology)  1  g ; calcium gluconate  3  g ; lorazepam  1  mg ; 
cough personal history of antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] encounter for antineoplastic chemotherapy candidiasis of skin and nails calculus of kidney acute lymphoid leukemia, without mention of having achieved remission dehydration hypotension, unspecified anxiety state, unspecified encounter for antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] neutropenia, unspecified fever presenting with conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tachycardia, unspecified hypovolemia anemia, unspecified acute lymphoid leukemia, without mention of having achieved remission candidiasis of mouth tumor lysis syndrome anxiety state, unspecified other disorders of muscle, ligament, and fascia acute lymphoid leukemia, without mention of having achieved remission thrombocytopenia, unspecified disorders of soft tissue, unspecified neutropenia, unspecified stomatitis and mucositis, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus anemia, unspecified
white f 37 $nan$hematology blood hematocrit  21.1  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  6  k ul; hematology blood platelet count  33  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, indirect  1.2  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  199  iu l; hematology blood bands  6  %; chemistry blood bilirubin, direct  0.9  mg dl$vial  1  vial ; dasatinib  100  mg ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  100  ml ; acyclovir  400  mg ; oxycodone (immediate release)   5  mg ; filgrastim  480  mcg ; ursodiol  300  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; cepacol (menthol)  1  loz ; lorazepam  0.5  mg ; ondansetron  4-8  mg ; meropenem  500  mg ; nystatin oral suspension  5  ml ; calcium replacement (oncology)  1  g ; calcium gluconate  3  g ; 
cough personal history of antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] encounter for antineoplastic chemotherapy candidiasis of skin and nails calculus of kidney acute lymphoid leukemia, without mention of having achieved remission dehydration hypotension, unspecified anxiety state, unspecified encounter for antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] neutropenia, unspecified fever presenting with conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tachycardia, unspecified hypovolemia anemia, unspecified acute lymphoid leukemia, without mention of having achieved remission candidiasis of mouth tumor lysis syndrome anxiety state, unspecified other disorders of muscle, ligament, and fascia acute lymphoid leukemia, without mention of having achieved remission thrombocytopenia, unspecified disorders of soft tissue, unspecified neutropenia, unspecified stomatitis and mucositis, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus anemia, unspecified
white f 37 $nan$hematology blood hematocrit  19.3  %; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  42  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  111  mg dl; chemistry blood lactate dehydrogenase (ld)  212  iu l; hematology blood bands  6  %$vial  1  vial ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5  mg ; filgrastim  480  mcg ; ursodiol  300  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; cepacol (menthol)  1  loz ; lorazepam  0.5  mg ; ondansetron  4-8  mg ; nystatin oral suspension  5  ml ; calcium replacement (oncology)  1  g ; calcium gluconate  3  g ; ciprofloxacin hcl  500  mg ; 
cough personal history of antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] encounter for antineoplastic chemotherapy candidiasis of skin and nails calculus of kidney acute lymphoid leukemia, without mention of having achieved remission dehydration hypotension, unspecified anxiety state, unspecified encounter for antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] neutropenia, unspecified fever presenting with conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tachycardia, unspecified hypovolemia anemia, unspecified acute lymphoid leukemia, without mention of having achieved remission candidiasis of mouth tumor lysis syndrome anxiety state, unspecified other disorders of muscle, ligament, and fascia acute lymphoid leukemia, without mention of having achieved remission thrombocytopenia, unspecified disorders of soft tissue, unspecified neutropenia, unspecified stomatitis and mucositis, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus anemia, unspecified
white f 37 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  64  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  92  mg dl; hematology blood bands  6  %$sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5  mg ; ursodiol  300  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; cepacol (menthol)  1  loz ; ondansetron  4-8  mg ; nystatin oral suspension  5  ml ; calcium replacement (oncology)  1  g ; calcium gluconate  3  g ; ciprofloxacin hcl  500  mg ; micafungin  100  mg ; 
cough personal history of antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] encounter for antineoplastic chemotherapy candidiasis of skin and nails calculus of kidney acute lymphoid leukemia, without mention of having achieved remission dehydration hypotension, unspecified anxiety state, unspecified encounter for antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] neutropenia, unspecified fever presenting with conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tachycardia, unspecified hypovolemia anemia, unspecified acute lymphoid leukemia, without mention of having achieved remission candidiasis of mouth tumor lysis syndrome anxiety state, unspecified other disorders of muscle, ligament, and fascia acute lymphoid leukemia, without mention of having achieved remission thrombocytopenia, unspecified disorders of soft tissue, unspecified neutropenia, unspecified stomatitis and mucositis, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus anemia, unspecified
white f 37 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  93  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  101  mg dl; hematology blood bands  6  %$sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5  mg ; ursodiol  300  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; cepacol (menthol)  1  loz ; ondansetron  4-8  mg ; nystatin oral suspension  5  ml ; calcium replacement (oncology)  1  g ; calcium gluconate  3  g ; micafungin  100  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; *nf* ertapenem sodium  1  gm ; 
cough personal history of antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] encounter for antineoplastic chemotherapy candidiasis of skin and nails calculus of kidney acute lymphoid leukemia, without mention of having achieved remission dehydration hypotension, unspecified anxiety state, unspecified encounter for antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] neutropenia, unspecified fever presenting with conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tachycardia, unspecified hypovolemia anemia, unspecified acute lymphoid leukemia, without mention of having achieved remission candidiasis of mouth tumor lysis syndrome anxiety state, unspecified other disorders of muscle, ligament, and fascia acute lymphoid leukemia, without mention of having achieved remission thrombocytopenia, unspecified disorders of soft tissue, unspecified neutropenia, unspecified stomatitis and mucositis, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus anemia, unspecified
white f 37 $nan$nan$sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5  mg ; ursodiol  300  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; cepacol (menthol)  1  loz ; ondansetron  4-8  mg ; nystatin oral suspension  5  ml ; calcium replacement (oncology)  1  g ; calcium gluconate  3  g ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; *nf* ertapenem sodium  1  gm ; 
cough personal history of antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] encounter for antineoplastic chemotherapy candidiasis of skin and nails calculus of kidney acute lymphoid leukemia, without mention of having achieved remission dehydration hypotension, unspecified anxiety state, unspecified encounter for antineoplastic chemotherapy acute lymphoid leukemia, without mention of having achieved remission nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] neutropenia, unspecified fever presenting with conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] tachycardia, unspecified hypovolemia anemia, unspecified acute lymphoid leukemia, without mention of having achieved remission candidiasis of mouth tumor lysis syndrome anxiety state, unspecified other disorders of muscle, ligament, and fascia acute lymphoid leukemia, without mention of having achieved remission thrombocytopenia, unspecified disorders of soft tissue, unspecified neutropenia, unspecified stomatitis and mucositis, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus anemia, unspecified
other m 85 $nan$hematology blood hematocrit  37.0  %; hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  152  k ul; hematology blood platelet count  154  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  103  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  174  mg dl; blood gas blood hematocrit, calculated  50  %; blood gas blood hemoglobin  16.6  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  135  meq l$escitalopram oxalate  10  mg ; levothyroxine sodium  50  mcg ; rosuvastatin calcium  20  mg ; warfarin  2.5  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin flush (10 units ml)  1  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen iv  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; insulin  0  unit ; bag  100  ml ; magnesium sulfate  4  gm ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; cefazolin  2  g ; hydralazine  10  mg ; 
 
other m 85 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  104  mg dl$bag  50  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  50  mcg ; rosuvastatin calcium  20  mg ; warfarin  2.5  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin flush (10 units ml)  1  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen iv  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; insulin  0  unit ; bag  100  ml ; magnesium sulfate  4  gm ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; cefazolin  2  g ; hydralazine  10  mg ; cepacol (menthol)  1  loz ; magnesium sulfate  2  gm ; 
 
other m 85 $nan$nan$bag  50  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  50  mcg ; rosuvastatin calcium  20  mg ; warfarin  2.5  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin flush (10 units ml)  1  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen iv  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; insulin  0  unit ; heparin  5000  unit ; cepacol (menthol)  1  loz ; magnesium sulfate  2  gm ; losartan potassium  50  mg ; aspirin  325  mg ; tramadol (ultram)  25  mg ; nitroglycerin sl  0.4  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; calcium carbonate  500  mg ; 
 
other m 85 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  163  mg dl; chemistry blood glucose  97  mg dl$escitalopram oxalate  10  mg ; levothyroxine sodium  50  mcg ; rosuvastatin calcium  20  mg ; warfarin  2.5  mg ; 0.45% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; cepacol (menthol)  1  loz ; losartan potassium  50  mg ; aspirin  325  mg ; tramadol (ultram)  25  mg ; nitroglycerin sl  0.4  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; calcium carbonate  500  mg ; metoprolol succinate xl  25  mg ; potassium chloride  40  meq ; 
 
other m 85 $nan$nan$escitalopram oxalate  10  mg ; levothyroxine sodium  50  mcg ; rosuvastatin calcium  20  mg ; warfarin  2.5  mg ; 0.45% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; cepacol (menthol)  1  loz ; losartan potassium  50  mg ; aspirin  325  mg ; tramadol (ultram)  25  mg ; nitroglycerin sl  0.4  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; metoprolol succinate xl  25  mg ; potassium chloride  40  meq ; losartan potassium  100  mg ; 
 
other m 85 $nan$nan$escitalopram oxalate  10  mg ; levothyroxine sodium  50  mcg ; rosuvastatin calcium  20  mg ; warfarin  2.5  mg ; 0.45% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; cepacol (menthol)  1  loz ; aspirin  325  mg ; tramadol (ultram)  25  mg ; nitroglycerin sl  0.4  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; metoprolol succinate xl  25  mg ; losartan potassium  100  mg ; 
 
unknown f 91 $nan$nan$aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; ranitidine  150  mg ; 
 
unknown f 91 $nan$hematology blood hematocrit  39.0  %; hematology blood hematocrit  38.2  %; hematology blood hemoglobin  13.7  g dl; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  238  k ul; hematology blood platelet count  201  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  97  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; ranitidine  150  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; potassium chloride  60  meq ; clopidogrel  300  mg ; metoprolol tartrate  75  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; docusate sodium  100  mg ; senna  1  tab ; trazodone  12.5  mg ; metoprolol tartrate  50  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; 
 
unknown f 91 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  110  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; ranitidine  150  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; potassium chloride  60  meq ; clopidogrel  300  mg ; docusate sodium  100  mg ; senna  1  tab ; trazodone  12.5  mg ; metoprolol tartrate  50  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; atropine sulfate  0.5  mg ; furosemide  40  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; 
 
unknown f 91 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  104  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; ranitidine  150  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; trazodone  12.5  mg ; metoprolol tartrate  50  mg ; atropine sulfate  0.5  mg ; furosemide  40  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; warfarin  5  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
unknown f 91 $nan$hematology blood hematocrit  32.9  %; hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  143  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; ranitidine  150  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; trazodone  12.5  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; warfarin  5  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
unknown f 91 $nan$nan$aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; ranitidine  150  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; trazodone  12.5  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; warfarin  5  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
white f 91 $nan$hematology blood hematocrit  41.2  %; hematology blood hematocrit  38.2  %; hematology blood hemoglobin  13.1  g dl; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  206  k ul; hematology blood platelet count  193  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  107  mg dl$atorvastatin  40  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; simethicone  40-80  mg ; oxycodone (immediate release)  2.5  mg ; aspirin  81  mg ; metoprolol succinate xl  25  mg ; sertraline  50  mg ; 
major depressive disorder, single episode, unspecified essential (primary) hypertension acidosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris unspecified osteoarthritis, unspecified site unspecified atrioventricular block unspecified place or not applicable other mechanical complication of cardiac electrode, initial encounter orthostatic hypotension adverse effect of beta-adrenoreceptor antagonists, initial encounter long term (current) use of aspirin migraine without aura, not intractable, without status migrainosus personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension anxiety disorder, unspecified occlusion and stenosis of right carotid artery encounter for immunization constipation, unspecified major depressive disorder, single episode, unspecified encounter for adjustment and management of other part of cardiac pacemaker unspecified atrial fibrillation bradycardia, unspecified adverse effect of calcium-channel blockers, initial encounter orthostatic hypotension other chronic pulmonary heart diseases passenger of special construction vehicle injured in traffic accident mobitz (type) ii atrioventricular block unspecified essential hypertension history of fall body mass index between 19-24, adult loss of weight migraine, unspecified, without mention of intractable migraine without mention of status migrainosus
white f 91 $nan$nan$atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; simethicone  40-80  mg ; oxycodone (immediate release)  2.5  mg ; aspirin  81  mg ; metoprolol succinate xl  25  mg ; sertraline  50  mg ; 
major depressive disorder, single episode, unspecified essential (primary) hypertension acidosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris unspecified osteoarthritis, unspecified site unspecified atrioventricular block unspecified place or not applicable other mechanical complication of cardiac electrode, initial encounter orthostatic hypotension adverse effect of beta-adrenoreceptor antagonists, initial encounter long term (current) use of aspirin migraine without aura, not intractable, without status migrainosus personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension anxiety disorder, unspecified occlusion and stenosis of right carotid artery encounter for immunization constipation, unspecified major depressive disorder, single episode, unspecified encounter for adjustment and management of other part of cardiac pacemaker unspecified atrial fibrillation bradycardia, unspecified adverse effect of calcium-channel blockers, initial encounter orthostatic hypotension other chronic pulmonary heart diseases passenger of special construction vehicle injured in traffic accident mobitz (type) ii atrioventricular block unspecified essential hypertension history of fall body mass index between 19-24, adult loss of weight migraine, unspecified, without mention of intractable migraine without mention of status migrainosus
asian m 68 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  598  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; pravastatin  20  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; ranitidine  150  mg ; potassium chloride  20  meq ; furosemide  20  mg ; albuterol inhaler  2  puff ; metoprolol tartrate  50  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
long-term (current) use of aspirin intermediate coronary syndrome lesion of ulnar nerve other iatrogenic hypotension occlusion and stenosis of carotid artery without mention of cerebral infarction other and unspecified hyperlipidemia occlusion and stenosis of multiple and bilateral precerebral arteries without mention of cerebral infarction esophageal reflux person boarding or alighting a pedal cycle injured in collision with fixed or stationary object family history of ischemic heart disease unspecified essential hypertension coronary atherosclerosis of native coronary artery
black african american f 26 $nan$nan$d5lr  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; famotidine  20  mg ; ondansetron  4  mg ; prenatal vitamins  1  tab ; bisacodyl  10  mg ; metoclopramide  10  mg ; pyridoxine  50  mg ; lactated ringers  1000  ml ; 
toxic shock syndrome asthma, unspecified type, unspecified acidosis anemia, unspecified esophageal reflux 
black african american f 26 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; famotidine  20  mg ; ondansetron  4  mg ; prenatal vitamins  1  tab ; bisacodyl  10  mg ; metoclopramide  10  mg ; pyridoxine  50  mg ; 
toxic shock syndrome asthma, unspecified type, unspecified acidosis anemia, unspecified esophageal reflux 
black african american m 59 $nan$hematology blood hematocrit  43.5  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  108  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; prednisone  60  mg ; aspirin  325  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; isoniazid  300  mg ; pyridoxine  200  mg ; sulfameth trimethoprim ds  1  tab ; 
 
black african american m 59 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; prednisone  60  mg ; aspirin  325  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; isoniazid  300  mg ; pyridoxine  200  mg ; sulfameth trimethoprim ds  1  tab ; prednisone  40  mg ; 
 
black african american m 59 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; aspirin  325  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; isoniazid  300  mg ; pyridoxine  200  mg ; sulfameth trimethoprim ds  1  tab ; prednisone  40  mg ; 
 
white f 70 $nan$hematology blood hematocrit  28.2  %; hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  319  k ul; hematology blood platelet count  275  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  174  mg dl$bupivacaine 0.1%  250  ml ; epidural bag  1  bag ; hydromorphone p.f.  2500  mcg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; amp  1  amp ; octreotide acetate  100  mcg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; insulin  0  unit ; cepacol (menthol)  1  loz ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; sw  100  ml ; potassium chloride  40  meq ; bupivacaine 0.05%  250  ml ; 
 
white f 70 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; amp  1  amp ; octreotide acetate  100  mcg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; insulin  0  unit ; cepacol (menthol)  1  loz ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; sw  100  ml ; potassium chloride  40  meq ; bupivacaine 0.05%  250  ml ; lr  1000  ml ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; 
 
white f 70 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  116  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; amp  1  amp ; octreotide acetate  100  mcg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; insulin  0  unit ; cepacol (menthol)  1  loz ; metoclopramide  10  mg ; bupivacaine 0.05%  250  ml ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; 
 
white f 70 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  104  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; amp  1  amp ; octreotide acetate  100  mcg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; ondansetron  4  mg ; insulin  0  unit ; cepacol (menthol)  1  loz ; metoclopramide  10  mg ; bupivacaine 0.05%  250  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; d5 1 2ns  500  ml ; heparin flush (10 units ml)  1  ml ; 
 
white f 70 $nan$hematology blood hematocrit  25.3  %$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; amp  1  amp ; octreotide acetate  100  mcg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; metoclopramide  10  mg ; bupivacaine 0.05%  250  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; heparin flush (10 units ml)  1  ml ; hydromorphone (dilaudid)  12.5  mg ; potassium phosphate  30  mmol ; sw  50  ml ; potassium chloride  20  meq ; 
 
white f 70 $nan$hematology blood hematocrit  28.6  %; hematology blood hematocrit  25.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  334  k ul; hematology blood platelet count  354  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  104  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; amp  1  amp ; octreotide acetate  100  mcg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; metoclopramide  10  mg ; heparin flush (10 units ml)  1  ml ; hydromorphone (dilaudid)  12.5  mg ; potassium phosphate  30  mmol ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white f 70 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; amp  1  amp ; octreotide acetate  100  mcg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; metoclopramide  10  mg ; heparin flush (10 units ml)  1  ml ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; 
 
white f 70 $nan$nan$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; acetaminophen  650  mg ; diphenhydramine  25  mg ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; metoclopramide  10  mg ; heparin flush (10 units ml)  1  ml ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; 
 
white f 70 $nan$nan$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; acetaminophen  650  mg ; diphenhydramine  25  mg ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; metoclopramide  10  mg ; heparin flush (10 units ml)  1  ml ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; 
 
white m 84 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood glucose  140  mg dl$fluticasone-salmeterol diskus (250 50)   1  inh ; sodium chloride 0.9%  flush  3  ml ; sulfameth trimethoprim ss  1  tab ; diltiazem extended-release  240  mg ; lisinopril  10  mg ; prednisone  10  mg ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; azithromycin  250  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; warfarin  3  mg ; prednisone  40  mg ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$nan$fluticasone-salmeterol diskus (250 50)   1  inh ; sodium chloride 0.9%  flush  3  ml ; sulfameth trimethoprim ss  1  tab ; diltiazem extended-release  240  mg ; lisinopril  10  mg ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; warfarin  3  mg ; prednisone  40  mg ; levofloxacin  750  mg ; morphine sulfate  0.5  mg ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$hematology blood hematocrit  39.5  %; hematology blood hematocrit  36.0  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  268  k ul; hematology blood platelet count  205  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  3.7  ; hematology blood inr(pt)  3.9  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  159  mg dl; chemistry blood glucose  147  mg dl; blood gas blood lactate  1.6  mmol l$fluticasone-salmeterol diskus (250 50)   1  inh ; sodium chloride 0.9%  flush  3  ml ; sulfameth trimethoprim ss  1  tab ; diltiazem extended-release  240  mg ; lisinopril  10  mg ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; warfarin  3  mg ; levofloxacin  750  mg ; morphine sulfate  0.5  mg ; hydralazine  10  mg ; methylprednisolone sodium succ  100  mg ; *nf* levalbuterol soln  0.63  mg ; prednisone  60  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; levalbuterol tartrate  0.63  mg ; furosemide  40  mg ; diltiazem  10  mg ; morphine sulfate  1  mg ; ipratropium bromide neb  1  neb ; warfarin  1  dose ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  3.9  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  133  mg dl; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.2  mmol l$fluticasone-salmeterol diskus (250 50)   1  inh ; sodium chloride 0.9%  flush  3  ml ; sulfameth trimethoprim ss  1  tab ; lisinopril  10  mg ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; *nf* levalbuterol soln  0.63  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; levalbuterol tartrate  0.63  mg ; furosemide  40  mg ; diltiazem  10  mg ; morphine sulfate  1  mg ; ipratropium bromide neb  1  neb ; warfarin  1  dose ; diltiazem  30  mg ; diltiazem  60  mg ; morphine sulfate  2  mg ; lorazepam  0.5  mg ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  3.6  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  140  mg dl; chemistry blood glucose  127  mg dl; blood gas blood lactate  1.3  mmol l$fluticasone-salmeterol diskus (250 50)   1  inh ; sodium chloride 0.9%  flush  3  ml ; sulfameth trimethoprim ss  1  tab ; lisinopril  10  mg ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; levalbuterol tartrate  0.63  mg ; ipratropium bromide neb  1  neb ; warfarin  1  dose ; diltiazem  60  mg ; morphine sulfate  2  mg ; lorazepam  0.5  mg ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood glucose  155  mg dl$fluticasone-salmeterol diskus (250 50)   1  inh ; sulfameth trimethoprim ss  1  tab ; lisinopril  10  mg ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; warfarin  1  dose ; diltiazem  60  mg ; methylprednisolone sodium succ  125  mg ; diltiazem  90  mg ; diltiazem  5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$hematology blood inr(pt)  3.4  $sulfameth trimethoprim ss  1  tab ; lisinopril  10  mg ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; warfarin  1  dose ; methylprednisolone sodium succ  125  mg ; diltiazem  90  mg ; diltiazem  5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  2.8  ; hematology urine wbc  6-10  # hpf; chemistry blood glucose  141  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sulfameth trimethoprim ss  1  tab ; lisinopril  10  mg ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; warfarin  1  dose ; methylprednisolone sodium succ  125  mg ; diltiazem  90  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; olanzapine  2.5  mg ; 0.9% sodium chloride  250  ml ; haloperidol  0.5  mg ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$hematology blood hematocrit  38.5  %; hematology blood hematocrit  33.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  265  k ul; hematology blood platelet count  207  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  2.4  ; hematology urine wbc  0  # hpf; chemistry blood glucose  125  mg dl; chemistry blood glucose  118  mg dl$sulfameth trimethoprim ss  1  tab ; lisinopril  10  mg ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; diltiazem  90  mg ; olanzapine  2.5  mg ; 0.9% sodium chloride  250  ml ; haloperidol  0.5  mg ; 0.9% sodium chloride  500  ml ; methylprednisolone sodium succ  20  mg ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  3.6  ; chemistry blood glucose  117  mg dl$sulfameth trimethoprim ss  1  tab ; lisinopril  10  mg ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; diltiazem  90  mg ; 0.9% sodium chloride  500  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; lisinopril  20  mg ; doxazosin  2  mg ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  4.5  ; chemistry blood glucose  111  mg dl; chemistry blood albumin  3.1  g dl$sulfameth trimethoprim ss  1  tab ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; diltiazem  90  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; doxazosin  2  mg ; multivitamins  1  tab ; folic acid  1  mg ; dorzolamide 2% ophth. soln.  1  drop ; latanoprost 0.005% ophth. soln.  1  drop ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
white m 84 $nan$nan$sulfameth trimethoprim ss  1  tab ; atorvastatin  10  mg ; aspirin  325  mg ; finasteride  5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; omeprazole  20  mg ; diltiazem  90  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; doxazosin  2  mg ; multivitamins  1  tab ; folic acid  1  mg ; dorzolamide 2% ophth. soln.  1  drop ; latanoprost 0.005% ophth. soln.  1  drop ; 
atrial fibrillation chronic obstructive asthma with (acute) exacerbation coronary atherosclerosis of native coronary artery unspecified essential hypertension obstructive chronic bronchitis with (acute) exacerbation leukocytosis, unspecified diastolic heart failure, unspecified adrenal cortical steroids causing adverse effects in therapeutic use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) long-term (current) use of steroids hip joint replacement long-term (current) use of anticoagulants congestive heart failure, unspecified coronary atherosclerosis of native coronary artery hypoxemia atrial fibrillation car passenger injured in collision with van in traffic accident car passenger injured in collision with van in traffic accident atrial fibrillation coronary atherosclerosis of native coronary artery hip joint replacement chronic obstructive asthma with (acute) exacerbation personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension long-term (current) use of anticoagulants femoral hernia with obstruction, unilateral or unspecified (not specified as recurrent) chronic airway obstruction, not elsewhere classified other specified personal history presenting hazards to health long-term (current) use of anticoagulants car passenger injured in collision with van in traffic accident hip joint replacement coronary atherosclerosis of native coronary artery atrial fibrillation retention of urine, unspecified unspecified essential hypertension personal history of tobacco use 
black african american f 78 $temp  97.9  heartrate  64.0  resprate  16.0  o2sat  99.0  sbp  116.0  dbp  77.0  rhythm    pain  0  $nan$enalapril maleate  20  mg ; amlodipine  5  mg ; memantine  10  mg ; calcium carbonate  1250  mg ; vitamin d  800  unit ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; 
 
black african american f 78 $temp  98.2  heartrate  65.0  resprate  18.0  o2sat  100.0  sbp  122.0  dbp  74.0  rhythm    pain  0  $hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  103  mg dl$enalapril maleate  20  mg ; amlodipine  5  mg ; memantine  10  mg ; calcium carbonate  1250  mg ; vitamin d  800  unit ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; enalapril maleate  10  mg ; amitriptyline  10  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; lorazepam  1  mg ; 
 
black african american f 78 $nan$nan$enalapril maleate  20  mg ; amlodipine  5  mg ; memantine  10  mg ; calcium carbonate  1250  mg ; vitamin d  800  unit ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; enalapril maleate  10  mg ; amitriptyline  10  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; lorazepam  1  mg ; 
 
white m 70 $temp  100.1  heartrate  98.0  resprate  18.0  o2sat  98.0  sbp  118.0  dbp  70.0  rhythm    pain    $hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  109  mg dl$heparin  5000  unit ; acetaminophen  650  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; oxycodone (immediate release)  5  mg ; vial  1  vial ; meropenem  500  mg ; d5 1 2ns  1000  ml ; omeprazole  20  mg ; aspirin  81  mg ; heparin flush (100 units ml)  5  ml ; 
pleural effusion, not elsewhere classified anemia, unspecified secondary carcinoid tumors of liver gastro-esophageal reflux disease without esophagitis other acute postprocedural pain secondary carcinoid tumors of bone personal history of nicotine dependence patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified place or not applicable personal history of malignant carcinoid tumor of small intestine atelectasis infection following a procedure, other surgical site, initial encounter abscess of liver other specified diseases of biliary tract abnormal levels of other serum enzymes other thrombophilia acute respiratory failure with hypoxia cellulitis of back [any part except buttock] essential (primary) hypertension unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere infection following a procedure, organ and space surgical site, initial encounter resistance to multiple antibiotics ventral hernia without obstruction or gangrene personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of other organs and systems essential (primary) hypertension hyperlipidemia, unspecified laparoscopic surgical procedure converted to open procedure other secondary neuroendocrine tumors other secondary thrombocytopenia other fall from one level to another in water transport injuring occupant of other watercraft -- crew malignant poorly differentiated neuroendocrine tumors hypomagnesemia fall on stairs or ladders in water transport injuring unspecified person acquired coagulation factor deficiency cholangitis hyperlipidemia, unspecified other gram-negative sepsis acute cholecystitis with chronic cholecystitis other disorders of phosphorus metabolism essential (primary) hypertension hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis infection following a procedure, initial encounter ileus, unspecified
white m 70 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  111  mg dl$heparin  5000  unit ; acetaminophen  650  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; oxycodone (immediate release)  5  mg ; omeprazole  20  mg ; aspirin  81  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ciprofloxacin hcl  500  mg ; amoxicillin-clavulanic acid  875  mg ; 
pleural effusion, not elsewhere classified anemia, unspecified secondary carcinoid tumors of liver gastro-esophageal reflux disease without esophagitis other acute postprocedural pain secondary carcinoid tumors of bone personal history of nicotine dependence patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified place or not applicable personal history of malignant carcinoid tumor of small intestine atelectasis infection following a procedure, other surgical site, initial encounter abscess of liver other specified diseases of biliary tract abnormal levels of other serum enzymes other thrombophilia acute respiratory failure with hypoxia cellulitis of back [any part except buttock] essential (primary) hypertension unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere infection following a procedure, organ and space surgical site, initial encounter resistance to multiple antibiotics ventral hernia without obstruction or gangrene personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of other organs and systems essential (primary) hypertension hyperlipidemia, unspecified laparoscopic surgical procedure converted to open procedure other secondary neuroendocrine tumors other secondary thrombocytopenia other fall from one level to another in water transport injuring occupant of other watercraft -- crew malignant poorly differentiated neuroendocrine tumors hypomagnesemia fall on stairs or ladders in water transport injuring unspecified person acquired coagulation factor deficiency cholangitis hyperlipidemia, unspecified other gram-negative sepsis acute cholecystitis with chronic cholecystitis other disorders of phosphorus metabolism essential (primary) hypertension hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis infection following a procedure, initial encounter ileus, unspecified
white m 70 $nan$nan$acetaminophen  650  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; oxycodone (immediate release)  5  mg ; omeprazole  20  mg ; aspirin  81  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ciprofloxacin hcl  500  mg ; amoxicillin-clavulanic acid  875  mg ; 
pleural effusion, not elsewhere classified anemia, unspecified secondary carcinoid tumors of liver gastro-esophageal reflux disease without esophagitis other acute postprocedural pain secondary carcinoid tumors of bone personal history of nicotine dependence patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified place or not applicable personal history of malignant carcinoid tumor of small intestine atelectasis infection following a procedure, other surgical site, initial encounter abscess of liver other specified diseases of biliary tract abnormal levels of other serum enzymes other thrombophilia acute respiratory failure with hypoxia cellulitis of back [any part except buttock] essential (primary) hypertension unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere infection following a procedure, organ and space surgical site, initial encounter resistance to multiple antibiotics ventral hernia without obstruction or gangrene personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of other organs and systems essential (primary) hypertension hyperlipidemia, unspecified laparoscopic surgical procedure converted to open procedure other secondary neuroendocrine tumors other secondary thrombocytopenia other fall from one level to another in water transport injuring occupant of other watercraft -- crew malignant poorly differentiated neuroendocrine tumors hypomagnesemia fall on stairs or ladders in water transport injuring unspecified person acquired coagulation factor deficiency cholangitis hyperlipidemia, unspecified other gram-negative sepsis acute cholecystitis with chronic cholecystitis other disorders of phosphorus metabolism essential (primary) hypertension hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis infection following a procedure, initial encounter ileus, unspecified
black african american f 63 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  520  k ul; hematology blood platelet count  511  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  197  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; furosemide  20  mg ; losartan potassium  100  mg ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  650  mg ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; pregabalin  75  mg ; simvastatin  20  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  22.8  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  494  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  9  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  163  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; furosemide  20  mg ; losartan potassium  100  mg ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  650  mg ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; pregabalin  75  mg ; simvastatin  20  mg ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)  5  mg ; senna  8.6  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)  10  mg ; docusate sodium  100  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  459  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  129  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; furosemide  20  mg ; losartan potassium  100  mg ; hydromorphone (dilaudid)  0.5-1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; pregabalin  75  mg ; simvastatin  20  mg ; oxycodone (immediate release)  5  mg ; senna  8.6  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)  10  mg ; docusate sodium  100  mg ; magnesium oxide  280  mg ; bag  1  bag ; magnesium sulfate  2  gm ; sulfameth trimethoprim ds  1  tab ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  451  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  160  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; furosemide  20  mg ; hydromorphone (dilaudid)  0.5-1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; pregabalin  75  mg ; simvastatin  20  mg ; senna  8.6  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)  10  mg ; docusate sodium  100  mg ; bag  1  bag ; magnesium sulfate  2  gm ; sulfameth trimethoprim ds  1  tab ; metformin xr (glucophage xr)  750  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  119  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; furosemide  20  mg ; hydromorphone (dilaudid)  0.5-1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; pregabalin  75  mg ; simvastatin  20  mg ; senna  8.6  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)  10  mg ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; metformin xr (glucophage xr)  750  mg ; baclofen  5  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$nan$aspirin ec  81  mg ; clopidogrel  75  mg ; furosemide  20  mg ; hydromorphone (dilaudid)  0.5-1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; pregabalin  75  mg ; simvastatin  20  mg ; senna  8.6  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; metformin xr (glucophage xr)  750  mg ; baclofen  5  mg ; sodium chloride 0.9%  flush  3  ml ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  593  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  143  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; pregabalin  75  mg ; simvastatin  20  mg ; senna  8.6  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; metformin xr (glucophage xr)  750  mg ; baclofen  5  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  4  mg ; hydromorphone (dilaudid)  0.5  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  661  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  148  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; pregabalin  75  mg ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  4  mg ; hydromorphone (dilaudid)  0.5  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$nan$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; pregabalin  75  mg ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; sulfameth trimethoprim ds  1  tab ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole  500  mg ; oxycodone sr (oxycontin)  10  mg ; dakins 1 4 strength  1  appl ; pregabalin  100  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  812  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  6.6  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  109  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole  500  mg ; oxycodone sr (oxycontin)  10  mg ; dakins 1 4 strength  1  appl ; pregabalin  100  mg ; sodium polystyrene sulfonate  30  gm ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  820  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  128  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole  500  mg ; oxycodone sr (oxycontin)  10  mg ; dakins 1 4 strength  1  appl ; pregabalin  100  mg ; sodium polystyrene sulfonate  30  gm ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  815  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  143  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole  500  mg ; oxycodone sr (oxycontin)  10  mg ; dakins 1 4 strength  1  appl ; pregabalin  100  mg ; sodium chloride  1  gm ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  812  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  162  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; oxycodone sr (oxycontin)  10  mg ; dakins 1 4 strength  1  appl ; pregabalin  100  mg ; sodium chloride  1  gm ; lidocaine 5% patch  1  ptch ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  854  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  131  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; oxycodone sr (oxycontin)  10  mg ; pregabalin  100  mg ; sodium chloride  1  gm ; lidocaine 5% patch  1  ptch ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  1  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  822  k ul$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; oxycodone sr (oxycontin)  10  mg ; pregabalin  100  mg ; lidocaine 5% patch  1  ptch ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  1  mg ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  911  k ul$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; oxycodone sr (oxycontin)  10  mg ; pregabalin  100  mg ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; tamsulosin  0.4  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  20.3  %; hematology blood hematocrit  18.8  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  6.2  g dl; hematology blood hemoglobin  6.0  g dl; hematology blood platelet count  788  k ul; hematology blood platelet count  733  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry urine creatinine, urine  65  mg dl; chemistry urine sodium, urine  21  meq l; chemistry urine urea nitrogen, urine  386  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  153  mg dl; chemistry blood glucose  111  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; oxycodone sr (oxycontin)  10  mg ; pregabalin  100  mg ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; dextrose 50%  25  gm ; insulin  10  unit ; sodium polystyrene sulfonate  15  gm ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  706  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  128  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; oxycodone sr (oxycontin)  10  mg ; pregabalin  100  mg ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; dextrose 50%  25  gm ; insulin  10  unit ; sodium polystyrene sulfonate  15  gm ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  103  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; pregabalin  100  mg ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; hydromorphone (dilaudid)  4-6  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  702  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  119  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; pregabalin  100  mg ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; hydromorphone (dilaudid)  4-6  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; multivitamins w minerals  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; ascorbic acid  500  mg ; oxycodone sr (oxycontin)  20  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  719  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  139  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; pregabalin  100  mg ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; hydromorphone (dilaudid)  4-6  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; multivitamins w minerals  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; ascorbic acid  500  mg ; oxycodone sr (oxycontin)  20  mg ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
black african american f 63 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  136  mg dl$aspirin ec  81  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; simvastatin  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  750  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; pregabalin  100  mg ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; hydromorphone (dilaudid)  4-6  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; multivitamins w minerals  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; ascorbic acid  500  mg ; oxycodone sr (oxycontin)  20  mg ; sodium chloride nasal  1-2  spry ; 
gastro-esophageal reflux disease with esophagitis obstructive sleep apnea (adult) (pediatric) frequency of micturition atherosclerosis of native arteries of right leg with ulceration of other part of foot type 2 diabetes mellitus without complications cellulitis of right lower limb hypo-osmolality and hyponatremia non-pressure chronic ulcer of right ankle with unspecified severity obesity, unspecified chronic obstructive pulmonary disease, unspecified gout, unspecified presence of coronary angioplasty implant and graft hyperlipidemia, unspecified long term (current) use of oral hypoglycemic drugs major depressive disorder, single episode, unspecified unspecified sensorineural hearing loss personal history of nicotine dependence body mass index (bmi) 26.0-26.9, adult anxiety disorder, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right lower leg with unspecified severity chronic obstructive pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, unspecified, uncomplicated personal history of peptic ulcer disease presence of coronary angioplasty implant and graft hyperlipidemia, unspecified type 2 diabetes mellitus with other skin ulcer chronic obstructive pulmonary disease, unspecified personal history of peptic ulcer disease gastro-esophageal reflux disease without esophagitis essential (primary) hypertension non-pressure chronic ulcer of other part of right lower leg with unspecified severity nicotine dependence, cigarettes, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene obesity, unspecified long term (current) use of antithrombotics/antiplatelets obstructive sleep apnea (adult) (pediatric) presence of coronary angioplasty implant and graft non-pressure chronic ulcer of right calf with unspecified severity
white m 57 $temp  98.7  heartrate  72.0  resprate  16.0  o2sat  99.0  sbp  157.0  dbp  120.0  rhythm    pain  0  ; temp  97.8  heartrate  92.0  resprate  16.0  o2sat  98.0  sbp  182.0  dbp  130.0  rhythm    pain  0  ; temp    heartrate  93.0  resprate  18.0  o2sat  95.0  sbp  206.0  dbp  136.0  rhythm    pain  0  ; temp    heartrate  80.0  resprate  18.0  o2sat  97.0  sbp  168.0  dbp  106.0  rhythm    pain  0  ; temp    heartrate  85.0  resprate  20.0  o2sat  99.0  sbp  157.0  dbp  98.0  rhythm    pain  sleeping  ; temp    heartrate  88.0  resprate  15.0  o2sat  97.0  sbp    dbp    rhythm    pain  sleeping  $hematology blood hematocrit  45.9  %; hematology blood hemoglobin  15.8  g dl; hematology blood platelet count  371  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  94  mg dl$nan
 
white m 57 $temp  97.9  heartrate  82.0  resprate  15.0  o2sat  96.0  sbp  167.0  dbp  102.0  rhythm    pain  0  ; temp    heartrate  81.0  resprate  16.0  o2sat  97.0  sbp  156.0  dbp  81.0  rhythm    pain  0  ; temp  97.5  heartrate  84.0  resprate  15.0  o2sat  97.0  sbp  194.0  dbp  130.0  rhythm    pain  3  ; temp  98.1  heartrate  74.0  resprate  16.0  o2sat  98.0  sbp  154.0  dbp  97.0  rhythm    pain  6  ; temp  98.3  heartrate  77.0  resprate  18.0  o2sat  93.0  sbp  154.0  dbp  101.0  rhythm    pain    ; temp  99.0  heartrate  74.0  resprate  18.0  o2sat  94.0  sbp  164.0  dbp  119.0  rhythm    pain  0  $hematology blood hematocrit  45.7  %; hematology blood hemoglobin  15.4  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  104  mg dl$nan
 
asian m 79 $temp    heartrate  82.0  resprate  19.0  o2sat  100.0  sbp  131.0  dbp  48.0  rhythm  sinus rhythm  pain  0  ; temp  101.8  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate  82.0  resprate  20.0  o2sat  98.0  sbp  133.0  dbp  52.0  rhythm  sinus rhythm  pain  0  ; temp  98.2  heartrate  79.0  resprate  18.0  o2sat  100.0  sbp  127.0  dbp  45.0  rhythm    pain  0  $hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  67  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; colchicine  0.6  mg ; dipyridamole-aspirin  1  cap ; fish oil (omega 3)  1000  mg ; loratadine  10  mg ; losartan potassium  25  mg ; omeprazole  20  mg ; pravastatin  40  mg ; sodium bicarbonate  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; verapamil  80  mg ; 
intestinal infection due to other organism, not elsewhere classified acidosis hyperpotassemia renal sclerosis, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic diastolic heart failure aortic valve disorders coronary atherosclerosis of native coronary artery congestive heart failure, unspecified chronic kidney disease, stage iv (severe) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
asian m 79 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; colchicine  0.6  mg ; dipyridamole-aspirin  1  cap ; fish oil (omega 3)  1000  mg ; loratadine  10  mg ; losartan potassium  25  mg ; omeprazole  20  mg ; pravastatin  40  mg ; sodium bicarbonate  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; verapamil  80  mg ; furosemide  20  mg ; levofloxacin  500  mg ; 
intestinal infection due to other organism, not elsewhere classified acidosis hyperpotassemia renal sclerosis, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic diastolic heart failure aortic valve disorders coronary atherosclerosis of native coronary artery congestive heart failure, unspecified chronic kidney disease, stage iv (severe) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
asian m 79 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; colchicine  0.6  mg ; dipyridamole-aspirin  1  cap ; fish oil (omega 3)  1000  mg ; loratadine  10  mg ; omeprazole  20  mg ; pravastatin  40  mg ; sodium bicarbonate  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; verapamil  80  mg ; furosemide  20  mg ; levofloxacin  500  mg ; losartan potassium  50  mg ; 
intestinal infection due to other organism, not elsewhere classified acidosis hyperpotassemia renal sclerosis, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic diastolic heart failure aortic valve disorders coronary atherosclerosis of native coronary artery congestive heart failure, unspecified chronic kidney disease, stage iv (severe) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia in chronic kidney disease diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified
white f 43 $nan$nan$docusate sodium  100  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; acyclovir  400  mg ; nephrocaps  1  cap ; nifedipine cr  30  mg ; 
pre-eclampsia or eclampsia superimposed on pre-existing hypertension, antepartum condition or complication elderly primigravida, antepartum condition or complication unspecified essential hypertension elderly primigravida, antepartum condition or complication benign essential hypertension complicating pregnancy, childbirth, and the puerperium, antepartum condition or complication 
white f 43 $nan$chemistry urine creatinine, urine  90  mg dl; chemistry urine protein creatinine ratio  0.1  ratio; chemistry urine 24 hr creatinine  1080  mg 24hr$docusate sodium  100  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; acyclovir  400  mg ; nephrocaps  1  cap ; nifedipine cr  30  mg ; 
pre-eclampsia or eclampsia superimposed on pre-existing hypertension, antepartum condition or complication elderly primigravida, antepartum condition or complication unspecified essential hypertension elderly primigravida, antepartum condition or complication benign essential hypertension complicating pregnancy, childbirth, and the puerperium, antepartum condition or complication 
white f 43 $nan$nan$docusate sodium  100  mg ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; acyclovir  400  mg ; nephrocaps  1  cap ; nifedipine cr  30  mg ; 
pre-eclampsia or eclampsia superimposed on pre-existing hypertension, antepartum condition or complication elderly primigravida, antepartum condition or complication unspecified essential hypertension elderly primigravida, antepartum condition or complication benign essential hypertension complicating pregnancy, childbirth, and the puerperium, antepartum condition or complication 
white m 78 $nan$nan$acetaminophen  1000  mg ; levothyroxine sodium  50  mcg ; citalopram  60  mg ; aspirin  325  mg ; clopidogrel  75  mg ; allopurinol  100  mg ; 
coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism chronic systolic heart failure abdominal pain, right upper quadrant percutaneous transluminal coronary angioplasty status mitral valve disorders other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension home accidents depressive disorder, not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) congestive heart failure, unspecified eosinophilia esophageal reflux gout, unspecified car passenger injured in collision with van in traffic accident hip joint replacement percutaneous transluminal coronary angioplasty status acute cholecystitis congestive heart failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified acquired hypothyroidism unspecified essential hypertension mitral valve disorders systolic heart failure, unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension hyposmolality and/or hyponatremia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery fever, unspecified gout, unspecified esophageal reflux anemia, unspecified mitral valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cardiogenic shock car passenger injured in collision with van in traffic accident depressive disorder, not elsewhere classified hip joint replacement acute kidney failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) subendocardial infarction, initial episode of care
white m 78 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine chloride, urine  17  meq l; chemistry urine creatinine, urine  105  mg dl; chemistry urine potassium, urine  31  meq l; chemistry urine sodium, urine  17  meq l; chemistry urine urea nitrogen, urine  542  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  93  mg dl$acetaminophen  1000  mg ; levothyroxine sodium  50  mcg ; citalopram  60  mg ; aspirin  325  mg ; clopidogrel  75  mg ; allopurinol  100  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; tamsulosin  0.4  mg ; ranitidine  300  mg ; oxycodone (immediate release)   10  mg ; 
coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism chronic systolic heart failure abdominal pain, right upper quadrant percutaneous transluminal coronary angioplasty status mitral valve disorders other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension home accidents depressive disorder, not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) congestive heart failure, unspecified eosinophilia esophageal reflux gout, unspecified car passenger injured in collision with van in traffic accident hip joint replacement percutaneous transluminal coronary angioplasty status acute cholecystitis congestive heart failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified acquired hypothyroidism unspecified essential hypertension mitral valve disorders systolic heart failure, unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension hyposmolality and/or hyponatremia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery fever, unspecified gout, unspecified esophageal reflux anemia, unspecified mitral valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cardiogenic shock car passenger injured in collision with van in traffic accident depressive disorder, not elsewhere classified hip joint replacement acute kidney failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) subendocardial infarction, initial episode of care
white m 78 $nan$nan$acetaminophen  1000  mg ; levothyroxine sodium  50  mcg ; citalopram  60  mg ; aspirin  325  mg ; clopidogrel  75  mg ; allopurinol  100  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; tamsulosin  0.4  mg ; ranitidine  300  mg ; oxycodone (immediate release)   10  mg ; 
coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism chronic systolic heart failure abdominal pain, right upper quadrant percutaneous transluminal coronary angioplasty status mitral valve disorders other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension home accidents depressive disorder, not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) congestive heart failure, unspecified eosinophilia esophageal reflux gout, unspecified car passenger injured in collision with van in traffic accident hip joint replacement percutaneous transluminal coronary angioplasty status acute cholecystitis congestive heart failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified acquired hypothyroidism unspecified essential hypertension mitral valve disorders systolic heart failure, unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension hyposmolality and/or hyponatremia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery fever, unspecified gout, unspecified esophageal reflux anemia, unspecified mitral valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cardiogenic shock car passenger injured in collision with van in traffic accident depressive disorder, not elsewhere classified hip joint replacement acute kidney failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) subendocardial infarction, initial episode of care
white m 22 $nan$nan$acetaminophen  325-650  mg ; risperidone  2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; lorazepam  0.5  mg ; risperidone  1  mg ; bupropion (sustained release)  150  mg ; 
 
white f 90 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  106  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  179  mg dl; blood gas blood potassium, whole blood  4.4  meq l$insulin  19  unit ; vitamin b complex  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; pravastatin  40  mg ; torsemide  80  mg ; sevelamer carbonate  800  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; tramadol (ultram)  25  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; hydralazine  25  mg ; insulin  0  unit ; calcium carbonate  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; acetaminophen  650  mg ; carvedilol  25  mg ; fluticasone propionate 110mcg  2  puff ; isosorbide dinitrate  20  mg ; 
long-term (current) use of insulin methicillin resistant staphylococcus aureus septicemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia chronic systolic heart failure esophageal reflux congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status anemia in chronic kidney disease background diabetic retinopathy peripheral vascular disease, unspecified do not resuscitate status backache, unspecified bloodstream infection due to central venous catheter coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled vitreous hemorrhage end stage renal disease other encephalopathy urinary tract infection, site not specified other and unspecified hyperlipidemia renal dialysis status acute kidney failure, unspecified long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site end stage renal disease acute on chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other alteration of consciousness diarrhea diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled merrf syndrome congestive heart failure, unspecified chronic combined systolic and diastolic heart failure other specified disorders of circulatory system contusion of face, scalp, and neck except eye(s) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified gout, unspecified coronary atherosclerosis of native coronary artery long-term (current) use of insulin other agents affecting blood constituents causing adverse effects in therapeutic use hypopotassemia
white f 90 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  104  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  130  mg dl$insulin  19  unit ; vitamin b complex  1  cap ; amlodipine  10  mg ; aspirin  81  mg ; clopidogrel  75  mg ; pravastatin  40  mg ; torsemide  80  mg ; sevelamer carbonate  800  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; tramadol (ultram)  25  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; hydralazine  25  mg ; insulin  0  unit ; calcium carbonate  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; acetaminophen  650  mg ; carvedilol  25  mg ; fluticasone propionate 110mcg  2  puff ; isosorbide dinitrate  20  mg ; oxycodone (immediate release)   2.5  mg ; oxycodone-acetaminophen  1  tab ; 
long-term (current) use of insulin methicillin resistant staphylococcus aureus septicemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia chronic systolic heart failure esophageal reflux congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status anemia in chronic kidney disease background diabetic retinopathy peripheral vascular disease, unspecified do not resuscitate status backache, unspecified bloodstream infection due to central venous catheter coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled vitreous hemorrhage end stage renal disease other encephalopathy urinary tract infection, site not specified other and unspecified hyperlipidemia renal dialysis status acute kidney failure, unspecified long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site end stage renal disease acute on chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other alteration of consciousness diarrhea diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled merrf syndrome congestive heart failure, unspecified chronic combined systolic and diastolic heart failure other specified disorders of circulatory system contusion of face, scalp, and neck except eye(s) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified gout, unspecified coronary atherosclerosis of native coronary artery long-term (current) use of insulin other agents affecting blood constituents causing adverse effects in therapeutic use hypopotassemia
white f 49 $temp  99.3  heartrate  88.0  resprate  18.0  o2sat  95.0  sbp  118.0  dbp  50.0  rhythm    pain  0  $hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  54  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  7.6  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; albumin 25% (12.5g   50ml)  100  g ; midodrine  15  mg ; lactulose  30  ml ; trazodone  50  mg ; rifaximin  550  mg ; vial  1  vial ; ceftriaxone  2  gm ; ondansetron  4  mg ; 
 
white f 49 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  7.9  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; albumin 25% (12.5g   50ml)  100  g ; midodrine  15  mg ; lactulose  30  ml ; trazodone  50  mg ; rifaximin  550  mg ; vial  1  vial ; ceftriaxone  2  gm ; ondansetron  4  mg ; albumin 25% (12.5g   50ml)  75  g ; lidocaine 1%  10  ml ; 
 
white f 49 $nan$hematology blood inr(pt)  2.9  ; chemistry blood bilirubin, total  6.2  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; midodrine  15  mg ; lactulose  30  ml ; trazodone  50  mg ; rifaximin  550  mg ; vial  1  vial ; ceftriaxone  2  gm ; albumin 25% (12.5g   50ml)  75  g ; lidocaine 1%  10  ml ; spironolactone  100  mg ; furosemide  60  mg ; furosemide  30  mg ; 
 
white f 49 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  58  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  5.9  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.6  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; midodrine  15  mg ; lactulose  30  ml ; trazodone  50  mg ; rifaximin  550  mg ; vial  1  vial ; ceftriaxone  2  gm ; furosemide  30  mg ; 
 
white f 49 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; midodrine  15  mg ; lactulose  30  ml ; trazodone  50  mg ; rifaximin  550  mg ; furosemide  30  mg ; 
 
black african american m 62 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry urine creatinine, urine  42  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  140  mg dl; chemistry urine protein creatinine ratio  0.2  mg mg$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; tacrolimus  3  mg ; mycophenolate mofetil  1000  mg ; prednisone  20  mg ; valganciclovir  450  mg ; sulfameth trimethoprim ss  1  tab ; lamivudine  25  mg ; methadone  10  mg ; omeprazole  20  mg ; nystatin oral suspension  5  ml ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  80  mg ; 
dependence on renal dialysis old myocardial infarction adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperglycemia, unspecified unspecified place in hospital as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated hyperkalemia thrombocytopenia, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris dorsalgia, unspecified end stage renal disease chronic viral hepatitis c chronic hepatitis c without mention of hepatic coma other pancytopenia coronary atherosclerosis of native coronary artery old myocardial infarction awaiting organ transplant status street and highway accidents motor vehicle traffic accident involving collision with pedestrian injuring pedestrian hyperpotassemia tobacco use disorder end stage renal disease subarachnoid hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease 
black african american m 62 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  6  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; tacrolimus  3  mg ; mycophenolate mofetil  1000  mg ; prednisone  20  mg ; valganciclovir  450  mg ; sulfameth trimethoprim ss  1  tab ; lamivudine  25  mg ; methadone  10  mg ; omeprazole  20  mg ; nystatin oral suspension  5  ml ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  80  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; 
dependence on renal dialysis old myocardial infarction adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperglycemia, unspecified unspecified place in hospital as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated hyperkalemia thrombocytopenia, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris dorsalgia, unspecified end stage renal disease chronic viral hepatitis c chronic hepatitis c without mention of hepatic coma other pancytopenia coronary atherosclerosis of native coronary artery old myocardial infarction awaiting organ transplant status street and highway accidents motor vehicle traffic accident involving collision with pedestrian injuring pedestrian hyperpotassemia tobacco use disorder end stage renal disease subarachnoid hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease 
black african american m 62 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; tacrolimus  3  mg ; mycophenolate mofetil  1000  mg ; prednisone  20  mg ; valganciclovir  450  mg ; sulfameth trimethoprim ss  1  tab ; lamivudine  25  mg ; methadone  10  mg ; omeprazole  20  mg ; nystatin oral suspension  5  ml ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; 
dependence on renal dialysis old myocardial infarction adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperglycemia, unspecified unspecified place in hospital as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated hyperkalemia thrombocytopenia, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris dorsalgia, unspecified end stage renal disease chronic viral hepatitis c chronic hepatitis c without mention of hepatic coma other pancytopenia coronary atherosclerosis of native coronary artery old myocardial infarction awaiting organ transplant status street and highway accidents motor vehicle traffic accident involving collision with pedestrian injuring pedestrian hyperpotassemia tobacco use disorder end stage renal disease subarachnoid hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease 
black african american m 62 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  172  iu l; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; tacrolimus  3  mg ; mycophenolate mofetil  1000  mg ; prednisone  20  mg ; valganciclovir  450  mg ; sulfameth trimethoprim ss  1  tab ; lamivudine  25  mg ; methadone  10  mg ; omeprazole  20  mg ; nystatin oral suspension  5  ml ; ciprofloxacin hcl  500  mg ; 
dependence on renal dialysis old myocardial infarction adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperglycemia, unspecified unspecified place in hospital as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated hyperkalemia thrombocytopenia, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris dorsalgia, unspecified end stage renal disease chronic viral hepatitis c chronic hepatitis c without mention of hepatic coma other pancytopenia coronary atherosclerosis of native coronary artery old myocardial infarction awaiting organ transplant status street and highway accidents motor vehicle traffic accident involving collision with pedestrian injuring pedestrian hyperpotassemia tobacco use disorder end stage renal disease subarachnoid hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease 
black african american m 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; tacrolimus  3  mg ; mycophenolate mofetil  1000  mg ; prednisone  20  mg ; valganciclovir  450  mg ; sulfameth trimethoprim ss  1  tab ; lamivudine  25  mg ; methadone  10  mg ; omeprazole  20  mg ; nystatin oral suspension  5  ml ; ciprofloxacin hcl  500  mg ; tacrolimus  2  mg ; 
dependence on renal dialysis old myocardial infarction adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperglycemia, unspecified unspecified place in hospital as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated hyperkalemia thrombocytopenia, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris dorsalgia, unspecified end stage renal disease chronic viral hepatitis c chronic hepatitis c without mention of hepatic coma other pancytopenia coronary atherosclerosis of native coronary artery old myocardial infarction awaiting organ transplant status street and highway accidents motor vehicle traffic accident involving collision with pedestrian injuring pedestrian hyperpotassemia tobacco use disorder end stage renal disease subarachnoid hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease 
white f 64 $nan$nan$clopidogrel  75  mg ; folic acid  1  mg ; hydroxychloroquine sulfate  400  mg ; lisinopril  20  mg ; simvastatin  20  mg ; 
personal history of tobacco use rheumatoid arthritis atherosclerosis of native arteries of the extremities with intermittent claudication unspecified essential hypertension chronic total occlusion of artery of the extremities other and unspecified hyperlipidemia embolism and thrombosis of abdominal aorta spinal stenosis, unspecified region personal history of malignant neoplasm of tongue 
white f 64 $nan$hematology blood hematocrit  34.8  %; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood urea nitrogen  13  mg dl$clopidogrel  75  mg ; folic acid  1  mg ; hydroxychloroquine sulfate  400  mg ; lisinopril  20  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; pantoprazole  40  mg ; oxycodone-acetaminophen  1  tab ; amitriptyline  50  mg ; gabapentin  900  mg ; mirapex  0.125  mg ; warfarin  2  mg ; 
personal history of tobacco use rheumatoid arthritis atherosclerosis of native arteries of the extremities with intermittent claudication unspecified essential hypertension chronic total occlusion of artery of the extremities other and unspecified hyperlipidemia embolism and thrombosis of abdominal aorta spinal stenosis, unspecified region personal history of malignant neoplasm of tongue 
asian f 86 $temp    heartrate  70.0  resprate  18.0  o2sat  96.0  sbp  109.0  dbp  72.0  rhythm    pain    ; temp    heartrate  72.0  resprate  18.0  o2sat    sbp  110.0  dbp  78.0  rhythm    pain    $nan$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; folic acid  1  mg ; cyanocobalamin  250  mcg ; 
 
asian f 86 $temp  97.3  heartrate  72.0  resprate  18.0  o2sat  96.0  sbp  128.0  dbp  78.0  rhythm    pain    $hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  111  mg dl; blood gas blood lactate  2.9  mmol l$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; folic acid  1  mg ; cyanocobalamin  250  mcg ; calcium carbonate  500  mg ; heparin  5000  unit ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  2  tab ; nitrofurantoin monohyd (macrobid)  100  mg ; 0.9% sodium chloride  1000  ml ; amlodipine  5  mg ; isosorbide mononitrate (extended release)  30  mg ; 
 
asian f 86 $nan$nan$vitamin d  800  unit ; multivitamins  1  tab ; aspirin  81  mg ; folic acid  1  mg ; cyanocobalamin  250  mcg ; calcium carbonate  500  mg ; heparin  5000  unit ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  2  tab ; nitrofurantoin monohyd (macrobid)  100  mg ; amlodipine  5  mg ; isosorbide mononitrate (extended release)  30  mg ; 
 
white f 72 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  8 10  ; temp  98.0  heartrate  90.0  resprate  20.0  o2sat  99.0  sbp  105.0  dbp  64.0  rhythm    pain  5 10  $nan$prednisone  7.5  mg ; 
spondylosis of unspecified site, without mention of myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified pure hypercholesterolemia stress incontinence, female long-term (current) use of steroids other dependence on machines, supplemental oxygen chronic kidney disease, stage iii (moderate) esophageal reflux pulmonary collapse tobacco use disorder personal history of colonic polyps other chest pain hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident depressive disorder, not elsewhere classified dysphagia, unspecified polymyalgia rheumatica atherosclerosis of native arteries of the extremities with rest pain chronic diastolic heart failure obstructive chronic bronchitis with (acute) exacerbation other and unspecified hyperlipidemia hyperpotassemia abdominal pain, right upper quadrant acute kidney failure with lesion of tubular necrosis other acute and subacute forms of ischemic heart disease, other other respiratory abnormalities dehydration other specified hypotension dysphagia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified cardiac dysrhythmias lumbosacral spondylosis without myelopathy other opiates and related narcotics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia acidosis obstructive chronic bronchitis with (acute) exacerbation esophageal reflux tobacco use disorder depressive disorder, not elsewhere classified stress incontinence, female personal history of colonic polyps other alteration of consciousness unspecified hypertensive heart disease without heart failure atherosclerosis of native arteries of the extremities with intermittent claudication polymyalgia rheumatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 72 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  83  mg dl$prednisone  7.5  mg ; 0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; bupropion (sustained release)  100  mg ; cepastat (phenol) lozenge  1  loz ; divalproex (delayed release)  250  mg ; fluoxetine  40  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; furosemide  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin  5-10  ml ; omeprazole  20  mg ; oxycodone (immediate release)   15  mg ; polyethylene glycol  17  g ; propranolol  20  mg ; simvastatin  40  mg ; trazodone  150  mg ; vitamin d  1000  unit ; cilostazol  100  mg ; insulin  0  unit ; nicotine lozenge  4  mg ; calcium carbonate  500  mg ; lidocaine 5% patch  2  ptch ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; nicotine patch  14  mg ; prednisone  10  mg ; magnesium oxide  800  mg ; amoxicillin-clavulanic acid  875  mg ; azithromycin  500  mg ; 
spondylosis of unspecified site, without mention of myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified pure hypercholesterolemia stress incontinence, female long-term (current) use of steroids other dependence on machines, supplemental oxygen chronic kidney disease, stage iii (moderate) esophageal reflux pulmonary collapse tobacco use disorder personal history of colonic polyps other chest pain hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident depressive disorder, not elsewhere classified dysphagia, unspecified polymyalgia rheumatica atherosclerosis of native arteries of the extremities with rest pain chronic diastolic heart failure obstructive chronic bronchitis with (acute) exacerbation other and unspecified hyperlipidemia hyperpotassemia abdominal pain, right upper quadrant acute kidney failure with lesion of tubular necrosis other acute and subacute forms of ischemic heart disease, other other respiratory abnormalities dehydration other specified hypotension dysphagia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified cardiac dysrhythmias lumbosacral spondylosis without myelopathy other opiates and related narcotics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia acidosis obstructive chronic bronchitis with (acute) exacerbation esophageal reflux tobacco use disorder depressive disorder, not elsewhere classified stress incontinence, female personal history of colonic polyps other alteration of consciousness unspecified hypertensive heart disease without heart failure atherosclerosis of native arteries of the extremities with intermittent claudication polymyalgia rheumatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 72 $nan$nan$prednisone  7.5  mg ; 0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; bupropion (sustained release)  100  mg ; cepastat (phenol) lozenge  1  loz ; divalproex (delayed release)  250  mg ; fluoxetine  40  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; furosemide  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin  5-10  ml ; omeprazole  20  mg ; polyethylene glycol  17  g ; propranolol  20  mg ; simvastatin  40  mg ; trazodone  150  mg ; vitamin d  1000  unit ; cilostazol  100  mg ; insulin  0  unit ; nicotine lozenge  4  mg ; calcium carbonate  500  mg ; lidocaine 5% patch  2  ptch ; nicotine patch  14  mg ; prednisone  10  mg ; magnesium oxide  800  mg ; azithromycin  500  mg ; 
spondylosis of unspecified site, without mention of myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified pure hypercholesterolemia stress incontinence, female long-term (current) use of steroids other dependence on machines, supplemental oxygen chronic kidney disease, stage iii (moderate) esophageal reflux pulmonary collapse tobacco use disorder personal history of colonic polyps other chest pain hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident depressive disorder, not elsewhere classified dysphagia, unspecified polymyalgia rheumatica atherosclerosis of native arteries of the extremities with rest pain chronic diastolic heart failure obstructive chronic bronchitis with (acute) exacerbation other and unspecified hyperlipidemia hyperpotassemia abdominal pain, right upper quadrant acute kidney failure with lesion of tubular necrosis other acute and subacute forms of ischemic heart disease, other other respiratory abnormalities dehydration other specified hypotension dysphagia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified cardiac dysrhythmias lumbosacral spondylosis without myelopathy other opiates and related narcotics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia acidosis obstructive chronic bronchitis with (acute) exacerbation esophageal reflux tobacco use disorder depressive disorder, not elsewhere classified stress incontinence, female personal history of colonic polyps other alteration of consciousness unspecified hypertensive heart disease without heart failure atherosclerosis of native arteries of the extremities with intermittent claudication polymyalgia rheumatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 56 $temp    heartrate  64.0  resprate  16.0  o2sat  96.0  sbp  121.0  dbp  71.0  rhythm    pain  0  $hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  98  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  135  mg dl$sodium chloride 0.9%  flush  3-10  ml ; d5 1 2ns  1000  ml ; heparin  5000  unit ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; 0.9% sodium chloride  50  ml ; daptomycin  450  mg ; acetaminophen  500  mg ; aspirin  81  mg ; escitalopram oxalate  30  mg ; magnesium oxide  800  mg ; omeprazole  20  mg ; valganciclovir  900  mg ; prednisone  12.5  mg ; tacrolimus  2  mg ; tacrolimus  3  mg ; mycophenolate mofetil  1500  mg ; mycophenolate mofetil  1000  mg ; calcium carbonate  1000  mg ; vitamin d  1000  unit ; 
inflammatory disorders of breast awaiting organ transplant status fever, unspecified cough autoimmune hepatitis unspecified cirrhosis of liver cellulitis of right lower limb systemic involvement of connective tissue, unspecified nicotine dependence, cigarettes, uncomplicated hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified autoimmune hepatitis encephalopathy, unspecified awaiting organ transplant status cellulitis of right lower limb unspecified cirrhosis of liver long term (current) use of systemic steroids esophageal varices in diseases classified elsewhere, without mention of bleeding hepatic encephalopathy cirrhosis of liver without mention of alcohol autoimmune hepatitis portal hypertension long-term (current) use of steroids other ascites autoimmune hepatitis calculus of gallbladder with other cholecystitis, without mention of obstruction thrombocytopenia, unspecified long-term (current) use of steroids cirrhosis of liver without mention of alcohol portal hypertension calculus of gallbladder with other cholecystitis, without mention of obstruction osteoarthrosis, localized, not specified whether primary or secondary, shoulder region other specified disorders of stomach and duodenum portal hypertension autoimmune hepatitis thrombocytopenia, unspecified cirrhosis of liver without mention of alcohol autoimmune hepatitis cirrhosis of liver without mention of alcohol cellulitis and abscess of foot, except toes long-term (current) use of steroids edema cellulitis and abscess of hand, except fingers and thumb cirrhosis of liver without mention of alcohol synovitis and tenosynovitis, unspecified other ascites autoimmune hepatitis myalgia and myositis, unspecified
white f 56 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  251  iu l$sodium chloride 0.9%  flush  3-10  ml ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; 0.9% sodium chloride  50  ml ; daptomycin  450  mg ; acetaminophen  500  mg ; aspirin  81  mg ; omeprazole  20  mg ; valganciclovir  900  mg ; prednisone  12.5  mg ; mycophenolate mofetil  1500  mg ; mycophenolate mofetil  1000  mg ; calcium carbonate  1000  mg ; vitamin d  1000  unit ; escitalopram oxalate  10  mg ; amoxicillin-clavulanic acid  875  mg ; tacrolimus  0.5  mg ; tacrolimus  1  mg ; 
inflammatory disorders of breast awaiting organ transplant status fever, unspecified cough autoimmune hepatitis unspecified cirrhosis of liver cellulitis of right lower limb systemic involvement of connective tissue, unspecified nicotine dependence, cigarettes, uncomplicated hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified autoimmune hepatitis encephalopathy, unspecified awaiting organ transplant status cellulitis of right lower limb unspecified cirrhosis of liver long term (current) use of systemic steroids esophageal varices in diseases classified elsewhere, without mention of bleeding hepatic encephalopathy cirrhosis of liver without mention of alcohol autoimmune hepatitis portal hypertension long-term (current) use of steroids other ascites autoimmune hepatitis calculus of gallbladder with other cholecystitis, without mention of obstruction thrombocytopenia, unspecified long-term (current) use of steroids cirrhosis of liver without mention of alcohol portal hypertension calculus of gallbladder with other cholecystitis, without mention of obstruction osteoarthrosis, localized, not specified whether primary or secondary, shoulder region other specified disorders of stomach and duodenum portal hypertension autoimmune hepatitis thrombocytopenia, unspecified cirrhosis of liver without mention of alcohol autoimmune hepatitis cirrhosis of liver without mention of alcohol cellulitis and abscess of foot, except toes long-term (current) use of steroids edema cellulitis and abscess of hand, except fingers and thumb cirrhosis of liver without mention of alcohol synovitis and tenosynovitis, unspecified other ascites autoimmune hepatitis myalgia and myositis, unspecified
white f 56 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  103  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  253  iu l$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; aspirin  81  mg ; omeprazole  20  mg ; valganciclovir  900  mg ; prednisone  12.5  mg ; mycophenolate mofetil  1500  mg ; mycophenolate mofetil  1000  mg ; calcium carbonate  1000  mg ; vitamin d  1000  unit ; escitalopram oxalate  10  mg ; amoxicillin-clavulanic acid  875  mg ; tacrolimus  0.5  mg ; tacrolimus  1  mg ; 
inflammatory disorders of breast awaiting organ transplant status fever, unspecified cough autoimmune hepatitis unspecified cirrhosis of liver cellulitis of right lower limb systemic involvement of connective tissue, unspecified nicotine dependence, cigarettes, uncomplicated hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified autoimmune hepatitis encephalopathy, unspecified awaiting organ transplant status cellulitis of right lower limb unspecified cirrhosis of liver long term (current) use of systemic steroids esophageal varices in diseases classified elsewhere, without mention of bleeding hepatic encephalopathy cirrhosis of liver without mention of alcohol autoimmune hepatitis portal hypertension long-term (current) use of steroids other ascites autoimmune hepatitis calculus of gallbladder with other cholecystitis, without mention of obstruction thrombocytopenia, unspecified long-term (current) use of steroids cirrhosis of liver without mention of alcohol portal hypertension calculus of gallbladder with other cholecystitis, without mention of obstruction osteoarthrosis, localized, not specified whether primary or secondary, shoulder region other specified disorders of stomach and duodenum portal hypertension autoimmune hepatitis thrombocytopenia, unspecified cirrhosis of liver without mention of alcohol autoimmune hepatitis cirrhosis of liver without mention of alcohol cellulitis and abscess of foot, except toes long-term (current) use of steroids edema cellulitis and abscess of hand, except fingers and thumb cirrhosis of liver without mention of alcohol synovitis and tenosynovitis, unspecified other ascites autoimmune hepatitis myalgia and myositis, unspecified
black african american m 65 $nan$blood gas blood lactate  1.4  mmol l$sodium chloride 0.9%  flush  3  ml ; ascorbic acid  500  mg ; aspirin  81  mg ; bisacodyl  10  mg ; cepacol (sore throat lozenge)  1  loz ; cyclobenzaprine  10  mg ; docusate sodium  100  mg ; famotidine  20  mg ; ferrous sulfate  325  mg ; gabapentin  300  mg ; ipratropium-albuterol neb  1  neb ; levetiracetam  250  mg ; levetiracetam  1000  mg ; multivitamins  1  tab ; oxycodone--acetaminophen (5mg-325mg)  2  tab ; polyethylene glycol  17  g ; senna  8.6  mg ; simethicone  80  mg ; trazodone  50  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; acetaminophen  650  mg ; enoxaparin sodium  40  mg ; 
 
black african american m 65 $nan$hematology blood hematocrit  27.2  %; hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  490  k ul; hematology blood platelet count  501  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  179  mg dl$sodium chloride 0.9%  flush  3  ml ; ascorbic acid  500  mg ; aspirin  81  mg ; bisacodyl  10  mg ; cepacol (sore throat lozenge)  1  loz ; cyclobenzaprine  10  mg ; docusate sodium  100  mg ; famotidine  20  mg ; ferrous sulfate  325  mg ; gabapentin  300  mg ; levetiracetam  250  mg ; levetiracetam  1000  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; senna  8.6  mg ; simethicone  80  mg ; trazodone  50  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; acetaminophen  650  mg ; enoxaparin sodium  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
 
black african american m 65 $nan$nan$ascorbic acid  500  mg ; aspirin  81  mg ; bisacodyl  10  mg ; cepacol (sore throat lozenge)  1  loz ; cyclobenzaprine  10  mg ; docusate sodium  100  mg ; famotidine  20  mg ; ferrous sulfate  325  mg ; gabapentin  300  mg ; levetiracetam  250  mg ; levetiracetam  1000  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; senna  8.6  mg ; simethicone  80  mg ; trazodone  50  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; acetaminophen  650  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
 
white m 54 $nan$nan$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; levetiracetam  1500  mg ; zonisamide  500  mg ; minocycline  100  mg ; clindamycin 1% solution  1  appl ; lidocaine 5% patch  2  ptch ; loratadine  10  mg ; pyridoxine  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; tegretol xr  600  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; tegretol  600  mg ; mysoline  250  mg ; travatan z  1  drop ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
unspecified essential hypertension unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg late effects of injury, undetermined whether accidentally or purposely inflicted personal history of malignant neoplasm of brain personal history of tobacco use unspecified acquired deformity of head late effect of intracranial injury without mention of skull fracture generalized nonconvulsive epilepsy, without mention of intractable epilepsy other and unspecified hyperlipidemia body mass index 29.0-29.9, adult infection and inflammatory reaction due to other internal prosthetic device, implant, and graft obesity, unspecified unspecified essential hypertension epilepsy, unspecified, without mention of intractable epilepsy personal history of tobacco use methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site personal history of traumatic brain injury surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chest pain, unspecified other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) other specified acquired deformity of head unspecified essential hypertension tachycardia, unspecified other and unspecified hyperlipidemia unspecified glaucoma personal history of malignant neoplasm of brain obstructive sleep apnea (adult)(pediatric) personal history of traumatic brain injury other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy unspecified essential hypertension other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms intracranial abscess obesity, unspecified epilepsy, unspecified, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia personal history of traumatic fracture other postoperative infection personal history of tobacco use personal history of malignant neoplasm of brain dysarthria hemiplegia, unspecified, affecting unspecified side unspecified glaucoma facial weakness other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation body mass index 29.0-29.9, adult
white m 54 $nan$hematology blood hematocrit  41.3  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  90  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; levetiracetam  1500  mg ; zonisamide  500  mg ; minocycline  100  mg ; clindamycin 1% solution  1  appl ; lidocaine 5% patch  2  ptch ; loratadine  10  mg ; pyridoxine  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; tegretol  600  mg ; mysoline  250  mg ; travatan z  1  drop ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
unspecified essential hypertension unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg late effects of injury, undetermined whether accidentally or purposely inflicted personal history of malignant neoplasm of brain personal history of tobacco use unspecified acquired deformity of head late effect of intracranial injury without mention of skull fracture generalized nonconvulsive epilepsy, without mention of intractable epilepsy other and unspecified hyperlipidemia body mass index 29.0-29.9, adult infection and inflammatory reaction due to other internal prosthetic device, implant, and graft obesity, unspecified unspecified essential hypertension epilepsy, unspecified, without mention of intractable epilepsy personal history of tobacco use methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site personal history of traumatic brain injury surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chest pain, unspecified other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) other specified acquired deformity of head unspecified essential hypertension tachycardia, unspecified other and unspecified hyperlipidemia unspecified glaucoma personal history of malignant neoplasm of brain obstructive sleep apnea (adult)(pediatric) personal history of traumatic brain injury other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy unspecified essential hypertension other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms intracranial abscess obesity, unspecified epilepsy, unspecified, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia personal history of traumatic fracture other postoperative infection personal history of tobacco use personal history of malignant neoplasm of brain dysarthria hemiplegia, unspecified, affecting unspecified side unspecified glaucoma facial weakness other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation body mass index 29.0-29.9, adult
white m 54 $nan$nan$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; levetiracetam  1500  mg ; zonisamide  500  mg ; minocycline  100  mg ; clindamycin 1% solution  1  appl ; lidocaine 5% patch  2  ptch ; loratadine  10  mg ; pyridoxine  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; tegretol  600  mg ; mysoline  250  mg ; travatan z  1  drop ; 
unspecified essential hypertension unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg late effects of injury, undetermined whether accidentally or purposely inflicted personal history of malignant neoplasm of brain personal history of tobacco use unspecified acquired deformity of head late effect of intracranial injury without mention of skull fracture generalized nonconvulsive epilepsy, without mention of intractable epilepsy other and unspecified hyperlipidemia body mass index 29.0-29.9, adult infection and inflammatory reaction due to other internal prosthetic device, implant, and graft obesity, unspecified unspecified essential hypertension epilepsy, unspecified, without mention of intractable epilepsy personal history of tobacco use methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site personal history of traumatic brain injury surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chest pain, unspecified other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) other specified acquired deformity of head unspecified essential hypertension tachycardia, unspecified other and unspecified hyperlipidemia unspecified glaucoma personal history of malignant neoplasm of brain obstructive sleep apnea (adult)(pediatric) personal history of traumatic brain injury other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy unspecified essential hypertension other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms intracranial abscess obesity, unspecified epilepsy, unspecified, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia personal history of traumatic fracture other postoperative infection personal history of tobacco use personal history of malignant neoplasm of brain dysarthria hemiplegia, unspecified, affecting unspecified side unspecified glaucoma facial weakness other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation body mass index 29.0-29.9, adult
white m 63 $nan$nan$paroxetine  20  mg ; montelukast sodium  10  mg ; 
 
white m 63 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  359  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  146  mg dl; chemistry blood albumin  3.3  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$paroxetine  20  mg ; montelukast sodium  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; albuterol  1-2  puff ; vial  1  vial ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; amp  1  amp ; octreotide acetate  100  mcg ; fluticasone-salmeterol (250 50)   1  inh ; heparin  5000  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  gm ; 
 
white m 63 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  159  mg dl$paroxetine  20  mg ; montelukast sodium  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; albuterol  1-2  puff ; vial  1  vial ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; amp  1  amp ; octreotide acetate  100  mcg ; fluticasone-salmeterol (250 50)   1  inh ; heparin  5000  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  gm ; pantoprazole  40  mg ; ns  500  ml ; potassium chloride  40  meq ; neutra-phos  2  pkt ; calcium carbonate  1500  mg ; 
 
white m 63 $nan$nan$paroxetine  20  mg ; montelukast sodium  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol  1-2  puff ; acetaminophen  325-650  mg ; fluticasone-salmeterol (250 50)   1  inh ; heparin  5000  unit ; pantoprazole  40  mg ; ns  500  ml ; potassium chloride  40  meq ; neutra-phos  2  pkt ; calcium carbonate  1500  mg ; amoxicillin-clavulanic acid  500  mg ; 
 
white f 42 $nan$nan$fluoxetine  10  mg ; aspirin  121.5  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; diphenhydramine  25  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  gm ; heparin  5000  unit ; docusate sodium  100  mg ; sarna lotion  1  appl ; 
 
white f 42 $nan$nan$fluoxetine  10  mg ; aspirin  121.5  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  gm ; heparin  5000  unit ; docusate sodium  100  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; oxycodone (immediate release)   5-10  mg ; metoclopramide  10  mg ; ondansetron  4-8  mg ; scopolamine patch  1  ptch ; d5ns  1000  ml ; lorazepam  0.5  mg ; 
 
white f 42 $nan$nan$fluoxetine  10  mg ; aspirin  121.5  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  gm ; heparin  5000  unit ; docusate sodium  100  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; oxycodone (immediate release)   5-10  mg ; metoclopramide  10  mg ; ondansetron  4-8  mg ; scopolamine patch  1  ptch ; d5ns  1000  ml ; lorazepam  0.5  mg ; 
 
white f 42 $nan$nan$fluoxetine  10  mg ; aspirin  121.5  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  gm ; heparin  5000  unit ; docusate sodium  100  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; oxycodone (immediate release)   5-10  mg ; metoclopramide  10  mg ; ondansetron  4-8  mg ; scopolamine patch  1  ptch ; lorazepam  0.5  mg ; 
 
white m 90 $nan$nan$clopidogrel  75  mg ; levothyroxine sodium  25  mcg ; simvastatin  20  mg ; aspirin  325  mg ; polyethylene glycol  17  g ; 
chronic total occlusion of artery of the extremities unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism below knee amputation status long-term (current) use of insulin congestive heart failure, unspecified ulcer of other part of foot diastolic heart failure, unspecified atherosclerosis of native arteries of the extremities with ulceration aortic valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with rest pain diastolic heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities ulcer of other part of foot heart valve replaced by other means long-term (current) use of insulin unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified atherosclerosis of native arteries of the extremities with gangrene aortocoronary bypass status below knee amputation status unspecified acquired hypothyroidism diastolic heart failure, unspecified cellulitis and abscess of foot, except toes unspecified acquired hypothyroidism cellulitis and abscess of leg, except foot aortocoronary bypass status heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified chronic total occlusion of artery of the extremities acidosis subendocardial infarction, initial episode of care atherosclerosis of native arteries of the extremities with gangrene hematemesis unspecified essential hypertension
white m 90 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  156  mg dl$clopidogrel  75  mg ; levothyroxine sodium  25  mcg ; simvastatin  20  mg ; aspirin  325  mg ; polyethylene glycol  17  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; furosemide  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; insulin  6  unit ; lisinopril  2.5  mg ; furosemide  10  mg ; 
chronic total occlusion of artery of the extremities unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism below knee amputation status long-term (current) use of insulin congestive heart failure, unspecified ulcer of other part of foot diastolic heart failure, unspecified atherosclerosis of native arteries of the extremities with ulceration aortic valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with rest pain diastolic heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities ulcer of other part of foot heart valve replaced by other means long-term (current) use of insulin unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified atherosclerosis of native arteries of the extremities with gangrene aortocoronary bypass status below knee amputation status unspecified acquired hypothyroidism diastolic heart failure, unspecified cellulitis and abscess of foot, except toes unspecified acquired hypothyroidism cellulitis and abscess of leg, except foot aortocoronary bypass status heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified chronic total occlusion of artery of the extremities acidosis subendocardial infarction, initial episode of care atherosclerosis of native arteries of the extremities with gangrene hematemesis unspecified essential hypertension
white m 90 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  95  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  95  mg dl$clopidogrel  75  mg ; levothyroxine sodium  25  mcg ; simvastatin  20  mg ; polyethylene glycol  17  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; furosemide  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; insulin  6  unit ; lisinopril  2.5  mg ; furosemide  10  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; 
chronic total occlusion of artery of the extremities unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism below knee amputation status long-term (current) use of insulin congestive heart failure, unspecified ulcer of other part of foot diastolic heart failure, unspecified atherosclerosis of native arteries of the extremities with ulceration aortic valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with rest pain diastolic heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities ulcer of other part of foot heart valve replaced by other means long-term (current) use of insulin unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified atherosclerosis of native arteries of the extremities with gangrene aortocoronary bypass status below knee amputation status unspecified acquired hypothyroidism diastolic heart failure, unspecified cellulitis and abscess of foot, except toes unspecified acquired hypothyroidism cellulitis and abscess of leg, except foot aortocoronary bypass status heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified chronic total occlusion of artery of the extremities acidosis subendocardial infarction, initial episode of care atherosclerosis of native arteries of the extremities with gangrene hematemesis unspecified essential hypertension
white m 90 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  76  mg dl$clopidogrel  75  mg ; levothyroxine sodium  25  mcg ; simvastatin  20  mg ; polyethylene glycol  17  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; insulin  6  unit ; lisinopril  2.5  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; 
chronic total occlusion of artery of the extremities unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism below knee amputation status long-term (current) use of insulin congestive heart failure, unspecified ulcer of other part of foot diastolic heart failure, unspecified atherosclerosis of native arteries of the extremities with ulceration aortic valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with rest pain diastolic heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities ulcer of other part of foot heart valve replaced by other means long-term (current) use of insulin unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified atherosclerosis of native arteries of the extremities with gangrene aortocoronary bypass status below knee amputation status unspecified acquired hypothyroidism diastolic heart failure, unspecified cellulitis and abscess of foot, except toes unspecified acquired hypothyroidism cellulitis and abscess of leg, except foot aortocoronary bypass status heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified chronic total occlusion of artery of the extremities acidosis subendocardial infarction, initial episode of care atherosclerosis of native arteries of the extremities with gangrene hematemesis unspecified essential hypertension
white m 90 $nan$nan$clopidogrel  75  mg ; levothyroxine sodium  25  mcg ; simvastatin  20  mg ; polyethylene glycol  17  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; insulin  6  unit ; lisinopril  2.5  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; 
chronic total occlusion of artery of the extremities unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism below knee amputation status long-term (current) use of insulin congestive heart failure, unspecified ulcer of other part of foot diastolic heart failure, unspecified atherosclerosis of native arteries of the extremities with ulceration aortic valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with rest pain diastolic heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities ulcer of other part of foot heart valve replaced by other means long-term (current) use of insulin unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified atherosclerosis of native arteries of the extremities with gangrene aortocoronary bypass status below knee amputation status unspecified acquired hypothyroidism diastolic heart failure, unspecified cellulitis and abscess of foot, except toes unspecified acquired hypothyroidism cellulitis and abscess of leg, except foot aortocoronary bypass status heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified chronic total occlusion of artery of the extremities acidosis subendocardial infarction, initial episode of care atherosclerosis of native arteries of the extremities with gangrene hematemesis unspecified essential hypertension
white m 90 $nan$nan$clopidogrel  75  mg ; levothyroxine sodium  25  mcg ; simvastatin  20  mg ; polyethylene glycol  17  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; insulin  6  unit ; lisinopril  2.5  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; 
chronic total occlusion of artery of the extremities unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism below knee amputation status long-term (current) use of insulin congestive heart failure, unspecified ulcer of other part of foot diastolic heart failure, unspecified atherosclerosis of native arteries of the extremities with ulceration aortic valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with rest pain diastolic heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities ulcer of other part of foot heart valve replaced by other means long-term (current) use of insulin unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified atherosclerosis of native arteries of the extremities with gangrene aortocoronary bypass status below knee amputation status unspecified acquired hypothyroidism diastolic heart failure, unspecified cellulitis and abscess of foot, except toes unspecified acquired hypothyroidism cellulitis and abscess of leg, except foot aortocoronary bypass status heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified chronic total occlusion of artery of the extremities acidosis subendocardial infarction, initial episode of care atherosclerosis of native arteries of the extremities with gangrene hematemesis unspecified essential hypertension
white m 90 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  99  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  87  mg dl$clopidogrel  75  mg ; levothyroxine sodium  25  mcg ; simvastatin  20  mg ; polyethylene glycol  17  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; insulin  6  unit ; lisinopril  2.5  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; 
chronic total occlusion of artery of the extremities unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism below knee amputation status long-term (current) use of insulin congestive heart failure, unspecified ulcer of other part of foot diastolic heart failure, unspecified atherosclerosis of native arteries of the extremities with ulceration aortic valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with rest pain diastolic heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities ulcer of other part of foot heart valve replaced by other means long-term (current) use of insulin unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified atherosclerosis of native arteries of the extremities with gangrene aortocoronary bypass status below knee amputation status unspecified acquired hypothyroidism diastolic heart failure, unspecified cellulitis and abscess of foot, except toes unspecified acquired hypothyroidism cellulitis and abscess of leg, except foot aortocoronary bypass status heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified chronic total occlusion of artery of the extremities acidosis subendocardial infarction, initial episode of care atherosclerosis of native arteries of the extremities with gangrene hematemesis unspecified essential hypertension
white m 90 $nan$nan$clopidogrel  75  mg ; levothyroxine sodium  25  mcg ; simvastatin  20  mg ; polyethylene glycol  17  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; insulin  6  unit ; lisinopril  2.5  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; 
chronic total occlusion of artery of the extremities unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism below knee amputation status long-term (current) use of insulin congestive heart failure, unspecified ulcer of other part of foot diastolic heart failure, unspecified atherosclerosis of native arteries of the extremities with ulceration aortic valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with rest pain diastolic heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities ulcer of other part of foot heart valve replaced by other means long-term (current) use of insulin unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified atherosclerosis of native arteries of the extremities with gangrene aortocoronary bypass status below knee amputation status unspecified acquired hypothyroidism diastolic heart failure, unspecified cellulitis and abscess of foot, except toes unspecified acquired hypothyroidism cellulitis and abscess of leg, except foot aortocoronary bypass status heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified chronic total occlusion of artery of the extremities acidosis subendocardial infarction, initial episode of care atherosclerosis of native arteries of the extremities with gangrene hematemesis unspecified essential hypertension
white m 90 $nan$nan$clopidogrel  75  mg ; levothyroxine sodium  25  mcg ; simvastatin  20  mg ; polyethylene glycol  17  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; insulin  6  unit ; lisinopril  2.5  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; 
chronic total occlusion of artery of the extremities unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism below knee amputation status long-term (current) use of insulin congestive heart failure, unspecified ulcer of other part of foot diastolic heart failure, unspecified atherosclerosis of native arteries of the extremities with ulceration aortic valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with rest pain diastolic heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities ulcer of other part of foot heart valve replaced by other means long-term (current) use of insulin unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia congestive heart failure, unspecified atherosclerosis of native arteries of the extremities with gangrene aortocoronary bypass status below knee amputation status unspecified acquired hypothyroidism diastolic heart failure, unspecified cellulitis and abscess of foot, except toes unspecified acquired hypothyroidism cellulitis and abscess of leg, except foot aortocoronary bypass status heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified chronic total occlusion of artery of the extremities acidosis subendocardial infarction, initial episode of care atherosclerosis of native arteries of the extremities with gangrene hematemesis unspecified essential hypertension
black african american m 52 $nan$nan$citalopram  20  mg ; lisinopril  20  mg ; simvastatin  80  mg ; lisinopril  10  mg ; citalopram  40  mg ; 
long-term (current) use of insulin diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension anemia of other chronic disease other and unspecified hyperlipidemia urinary tract infection, site not specified ulcer of other part of foot polyneuropathy in diabetes
black african american m 52 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood glucose  90  mg dl$citalopram  20  mg ; lisinopril  20  mg ; simvastatin  80  mg ; lisinopril  10  mg ; citalopram  40  mg ; sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; golytely  4  l ; gabapentin  300  mg ; hydrochlorothiazide  12.5  mg ; hydralazine  25  mg ; 
long-term (current) use of insulin diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension anemia of other chronic disease other and unspecified hyperlipidemia urinary tract infection, site not specified ulcer of other part of foot polyneuropathy in diabetes
black african american m 52 $nan$nan$citalopram  40  mg ; gabapentin  300  mg ; hydrochlorothiazide  12.5  mg ; hydralazine  25  mg ; 
long-term (current) use of insulin diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension anemia of other chronic disease other and unspecified hyperlipidemia urinary tract infection, site not specified ulcer of other part of foot polyneuropathy in diabetes
black african american m 52 $nan$nan$citalopram  40  mg ; gabapentin  300  mg ; hydrochlorothiazide  12.5  mg ; hydralazine  25  mg ; 
long-term (current) use of insulin diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension anemia of other chronic disease other and unspecified hyperlipidemia urinary tract infection, site not specified ulcer of other part of foot polyneuropathy in diabetes
white f 42 $temp  97.2  heartrate  72.0  resprate  18.0  o2sat  100.0  sbp  142.0  dbp  94.0  rhythm    pain  6  ; temp    heartrate  84.0  resprate  18.0  o2sat  100.0  sbp  156.0  dbp  76.0  rhythm    pain    ; temp    heartrate  57.0  resprate  15.0  o2sat  100.0  sbp  106.0  dbp  63.0  rhythm    pain  sleeping  $hematology blood hematocrit  41.0  %; hematology blood hematocrit  36.9  %; hematology blood hemoglobin  13.5  g dl; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  261  k ul; hematology blood platelet count  232  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  3.8  g dl; hematology blood bands  5  %; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  92  mg dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood calculated bicarbonate, whole blood  24  meq l$nan
second degree perineal laceration during delivery 38 weeks gestation of pregnancy labor and delivery complicated by cord around neck, without compression, not applicable or unspecified other specified complications of labor and delivery abnormality in fetal heart rate and rhythm complicating labor and delivery hyperprolactinemia spinal stenosis, cervical region single live birth second-degree perineal laceration, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn anxiety state, unspecified infection of amniotic cavity, delivered, with or without mention of antepartum condition
white f 42 $temp    heartrate  55.0  resprate  16.0  o2sat  100.0  sbp  101.0  dbp  50.0  rhythm    pain  0  $hematology blood hematocrit  37.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  104  mg dl; chemistry blood % hemoglobin a1c  5.1  %$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin ec  81  mg ; bupropion  100  mg ; 
second degree perineal laceration during delivery 38 weeks gestation of pregnancy labor and delivery complicated by cord around neck, without compression, not applicable or unspecified other specified complications of labor and delivery abnormality in fetal heart rate and rhythm complicating labor and delivery hyperprolactinemia spinal stenosis, cervical region single live birth second-degree perineal laceration, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn anxiety state, unspecified infection of amniotic cavity, delivered, with or without mention of antepartum condition
white m 48 $temp  99.0  heartrate  90.0  resprate  18.0  o2sat    sbp  113.0  dbp  85.0  rhythm    pain  3  ; temp    heartrate  92.0  resprate  18.0  o2sat  97.0  sbp  117.0  dbp  79.0  rhythm    pain  2  ; temp  98.1  heartrate  80.0  resprate  18.0  o2sat  97.0  sbp  116.0  dbp  73.0  rhythm    pain  2  $hematology urine wbc  44  # hpf$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  800  mg ; albuterol inhaler  2  puff ; amitriptyline  25  mg ; aspirin  81  mg ; citalopram  40  mg ; colchicine  0.6  mg ; dapsone  100  mg ; darunavir  800  mg ; emtricitabine-tenofovir (truvada)  1  tab ; lidocaine 5% patch  1  ptch ; lisinopril  10  mg ; ritonavir  100  mg ; dolutegravir  50  mg ; pantoprazole  40  mg ; 
posttraumatic stress disorder human immunodeficiency virus [hiv] disease visual discomfort toxic encephalopathy attention deficit disorder with hyperactivity other late effects of cerebrovascular disease other musculoskeletal symptoms referable to limbs unspecified persistent mental disorders due to conditions classified elsewhere acute alcoholic intoxication in alcoholism, unspecified anxiety state, unspecified generalized anxiety disorder ostium secundum type atrial septal defect posttraumatic stress disorder intraspinal abscess altered mental status unspecified condition of brain cervical spondylosis without myelopathy attention deficit disorder with hyperactivity human immunodeficiency virus [hiv] disease late effects of cerebrovascular disease, alterations of sensations major depressive affective disorder, single episode, unspecified 
white m 48 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  98  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; amitriptyline  25  mg ; aspirin  81  mg ; citalopram  40  mg ; colchicine  0.6  mg ; darunavir  800  mg ; emtricitabine-tenofovir (truvada)  1  tab ; lidocaine 5% patch  1  ptch ; lisinopril  10  mg ; ritonavir  100  mg ; dolutegravir  50  mg ; pantoprazole  40  mg ; morphine sulfate  1  mg ; acetaminophen  650  mg ; potassium chloride  40  meq ; ibuprofen  400  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; 
posttraumatic stress disorder human immunodeficiency virus [hiv] disease visual discomfort toxic encephalopathy attention deficit disorder with hyperactivity other late effects of cerebrovascular disease other musculoskeletal symptoms referable to limbs unspecified persistent mental disorders due to conditions classified elsewhere acute alcoholic intoxication in alcoholism, unspecified anxiety state, unspecified generalized anxiety disorder ostium secundum type atrial septal defect posttraumatic stress disorder intraspinal abscess altered mental status unspecified condition of brain cervical spondylosis without myelopathy attention deficit disorder with hyperactivity human immunodeficiency virus [hiv] disease late effects of cerebrovascular disease, alterations of sensations major depressive affective disorder, single episode, unspecified 
white m 48 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  358  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  91  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; amitriptyline  25  mg ; aspirin  81  mg ; citalopram  40  mg ; colchicine  0.6  mg ; darunavir  800  mg ; emtricitabine-tenofovir (truvada)  1  tab ; lidocaine 5% patch  1  ptch ; lisinopril  10  mg ; ritonavir  100  mg ; dolutegravir  50  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; potassium chloride  40  meq ; ibuprofen  400  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
posttraumatic stress disorder human immunodeficiency virus [hiv] disease visual discomfort toxic encephalopathy attention deficit disorder with hyperactivity other late effects of cerebrovascular disease other musculoskeletal symptoms referable to limbs unspecified persistent mental disorders due to conditions classified elsewhere acute alcoholic intoxication in alcoholism, unspecified anxiety state, unspecified generalized anxiety disorder ostium secundum type atrial septal defect posttraumatic stress disorder intraspinal abscess altered mental status unspecified condition of brain cervical spondylosis without myelopathy attention deficit disorder with hyperactivity human immunodeficiency virus [hiv] disease late effects of cerebrovascular disease, alterations of sensations major depressive affective disorder, single episode, unspecified 
white m 48 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  347  k ul$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; amitriptyline  25  mg ; aspirin  81  mg ; citalopram  40  mg ; colchicine  0.6  mg ; darunavir  800  mg ; emtricitabine-tenofovir (truvada)  1  tab ; lidocaine 5% patch  1  ptch ; lisinopril  10  mg ; ritonavir  100  mg ; dolutegravir  50  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; ibuprofen  400  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
posttraumatic stress disorder human immunodeficiency virus [hiv] disease visual discomfort toxic encephalopathy attention deficit disorder with hyperactivity other late effects of cerebrovascular disease other musculoskeletal symptoms referable to limbs unspecified persistent mental disorders due to conditions classified elsewhere acute alcoholic intoxication in alcoholism, unspecified anxiety state, unspecified generalized anxiety disorder ostium secundum type atrial septal defect posttraumatic stress disorder intraspinal abscess altered mental status unspecified condition of brain cervical spondylosis without myelopathy attention deficit disorder with hyperactivity human immunodeficiency virus [hiv] disease late effects of cerebrovascular disease, alterations of sensations major depressive affective disorder, single episode, unspecified 
white m 71 $nan$nan$amlodipine  5  mg ; aspirin  81  mg ; clopidogrel  75  mg ; 
 
white m 71 $nan$hematology blood hematocrit  36.9  %; hematology blood hematocrit  33.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  139  mg dl; blood gas blood free calcium  0.94  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood chloride, whole blood  100  meq l; blood gas blood glucose  137  mg dl; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  10.9  g dl; blood gas blood potassium, whole blood  2.6  meq l; blood gas blood sodium, whole blood  126  meq l$amlodipine  5  mg ; aspirin  81  mg ; clopidogrel  75  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; albuterol-ipratropium  1-2  puff ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; hydralazine  10  mg ; atenolol  50  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4-8  mg ; aspirin  325  mg ; 
 
white m 71 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  136  mg dl; chemistry urine sodium, urine  56  meq l; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  139  mg dl; hematology urine glucose  tr  mg dl; hematology urine bilirubin  neg  mg dl$amlodipine  5  mg ; aspirin  81  mg ; clopidogrel  75  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; albuterol-ipratropium  1-2  puff ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; atenolol  50  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4-8  mg ; aspirin  325  mg ; potassium chloride  40  meq ; d5w  250  ml ; nitroglycerin  100  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)   5-10  mg ; prochlorperazine  10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; promethazine  6.25  mg ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; simvastatin  20  mg ; 
 
white m 71 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry urine chloride, urine  60  meq l; chemistry urine creatinine, urine  106  mg dl; chemistry urine potassium, urine  48  meq l; chemistry urine sodium, urine  41  meq l; chemistry urine urea nitrogen, urine  689  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  138  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$amlodipine  5  mg ; clopidogrel  75  mg ; pneumococcal vac polyvalent  0.5  ml ; albuterol-ipratropium  1-2  puff ; atenolol  50  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  325  mg ; potassium chloride  40  meq ; oxycodone (immediate release)   5-10  mg ; prochlorperazine  10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; promethazine  6.25  mg ; 0.9% sodium chloride  500  ml ; simvastatin  20  mg ; bisacodyl  10  mg ; senna  1  tab ; 
 
white m 71 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  172  k ul; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry urine chloride, urine  55  meq l; chemistry urine potassium, urine  33  meq l; chemistry urine sodium, urine  36  meq l; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  117  mg dl$amlodipine  5  mg ; clopidogrel  75  mg ; pneumococcal vac polyvalent  0.5  ml ; albuterol-ipratropium  1-2  puff ; atenolol  50  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  325  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; promethazine  6.25  mg ; simvastatin  20  mg ; bisacodyl  10  mg ; senna  1  tab ; neutra-phos  2  pkt ; 
 
white m 71 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  98  mg dl$amlodipine  5  mg ; clopidogrel  75  mg ; pneumococcal vac polyvalent  0.5  ml ; albuterol-ipratropium  1-2  puff ; atenolol  50  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  325  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; promethazine  6.25  mg ; simvastatin  20  mg ; bisacodyl  10  mg ; senna  1  tab ; neutra-phos  2  pkt ; 
 
white m 71 $nan$nan$amlodipine  5  mg ; clopidogrel  75  mg ; pneumococcal vac polyvalent  0.5  ml ; albuterol-ipratropium  1-2  puff ; atenolol  50  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  325  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; promethazine  6.25  mg ; simvastatin  20  mg ; bisacodyl  10  mg ; senna  1  tab ; 
 
white m 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; milk of magnesia  30  ml ; diazepam  2-5  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; hydromorphone (dilaudid)  0.5  mg ; oxycodone (immediate release)   5-15  mg ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; 
 
white m 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; milk of magnesia  30  ml ; diazepam  2-5  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; hydromorphone (dilaudid)  0.5  mg ; oxycodone (immediate release)   5-15  mg ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; docusate sodium  100  mg ; clonazepam  1  mg ; bisacodyl  10  mg ; aripiprazole  20  mg ; citalopram  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; senna  1  tab ; 
 
white m 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; clonazepam  1  mg ; bisacodyl  10  mg ; aripiprazole  20  mg ; citalopram  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; senna  1  tab ; hydromorphone (dilaudid)  4-8  mg ; diazepam  5-10  mg ; 
 
white m 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; clonazepam  1  mg ; bisacodyl  10  mg ; aripiprazole  20  mg ; citalopram  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; senna  1  tab ; hydromorphone (dilaudid)  4-8  mg ; diazepam  5-10  mg ; gabapentin  300  mg ; tizanidine  4  mg ; 
 
black african american m 67 $temp  98.1  heartrate  62.0  resprate  16.0  o2sat  98.0  sbp  223.0  dbp  92.0  rhythm    pain  0  $hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  52  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  115  mg dl$nan
superficial mycosis, unspecified chronic kidney disease, stage 3 (moderate) cerebral edema acute kidney failure with tubular necrosis dysarthria and anarthria type 2 diabetes mellitus with diabetic chronic kidney disease chronic systolic (congestive) heart failure cerebral infarction, unspecified left bundle-branch block, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema occlusion and stenosis of left carotid artery long term (current) use of insulin type 2 diabetes mellitus with hypoglycemia without coma hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cardiomyopathy, unspecified hyperlipidemia, unspecified disorder of brain, unspecified type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene presence of coronary angioplasty implant and graft diarrhea, unspecified aphasia legal blindness, as defined in usa atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene atherosclerotic heart disease of native coronary artery without angina pectoris pure hypercholesterolemia, unspecified legal blindness, as defined in usa stenosis of coronary artery stent, initial encounter chronic kidney disease, unspecified unspecified place or not applicable long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease left bundle-branch block, unspecified 
black african american m 67 $temp  97.6  heartrate  57.0  resprate  16.0  o2sat  100.0  sbp  198.0  dbp  78.0  rhythm    pain  0  ; temp    heartrate  57.0  resprate  16.0  o2sat  100.0  sbp  211.0  dbp  88.0  rhythm    pain  0  ; temp  97.6  heartrate  59.0  resprate  16.0  o2sat  100.0  sbp  186.0  dbp  92.0  rhythm    pain    ; temp    heartrate  60.0  resprate  17.0  o2sat  98.0  sbp  143.0  dbp  62.0  rhythm    pain  sleeping  ; temp  97.4  heartrate  64.0  resprate  17.0  o2sat  98.0  sbp  156.0  dbp  69.0  rhythm    pain  0  ; temp  97.8  heartrate  60.0  resprate  16.0  o2sat  100.0  sbp  146.0  dbp  59.0  rhythm    pain    ; temp    heartrate  61.0  resprate  21.0  o2sat  100.0  sbp  169.0  dbp  73.0  rhythm    pain    ; temp    heartrate  57.0  resprate  16.0  o2sat  99.0  sbp  137.0  dbp  62.0  rhythm    pain    ; temp    heartrate  68.0  resprate  17.0  o2sat  100.0  sbp  177.0  dbp  73.0  rhythm    pain    ; temp    heartrate  57.0  resprate  15.0  o2sat  100.0  sbp  163.0  dbp  67.0  rhythm    pain    ; temp  97.8  heartrate  54.0  resprate  13.0  o2sat  99.0  sbp  160.0  dbp  65.0  rhythm    pain    ; temp    heartrate  57.0  resprate  14.0  o2sat  100.0  sbp  172.0  dbp  57.0  rhythm    pain  utr  ; temp    heartrate  54.0  resprate  12.0  o2sat  99.0  sbp  195.0  dbp  80.0  rhythm    pain  utr  ; temp    heartrate  74.0  resprate  16.0  o2sat  100.0  sbp  199.0  dbp  79.0  rhythm    pain  utr  ; temp    heartrate  57.0  resprate  16.0  o2sat  95.0  sbp  216.0  dbp  81.0  rhythm    pain  utr  ; temp    heartrate  53.0  resprate  14.0  o2sat  100.0  sbp  188.0  dbp  75.0  rhythm    pain  utr  ; temp    heartrate  56.0  resprate  12.0  o2sat  100.0  sbp  200.0  dbp  86.0  rhythm    pain  utr  $hematology urine wbc  1  # hpf$nan
superficial mycosis, unspecified chronic kidney disease, stage 3 (moderate) cerebral edema acute kidney failure with tubular necrosis dysarthria and anarthria type 2 diabetes mellitus with diabetic chronic kidney disease chronic systolic (congestive) heart failure cerebral infarction, unspecified left bundle-branch block, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema occlusion and stenosis of left carotid artery long term (current) use of insulin type 2 diabetes mellitus with hypoglycemia without coma hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cardiomyopathy, unspecified hyperlipidemia, unspecified disorder of brain, unspecified type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene presence of coronary angioplasty implant and graft diarrhea, unspecified aphasia legal blindness, as defined in usa atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene atherosclerotic heart disease of native coronary artery without angina pectoris pure hypercholesterolemia, unspecified legal blindness, as defined in usa stenosis of coronary artery stent, initial encounter chronic kidney disease, unspecified unspecified place or not applicable long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease left bundle-branch block, unspecified 
black african american m 67 $temp    heartrate  56.0  resprate  12.0  o2sat  99.0  sbp  205.0  dbp  86.0  rhythm    pain  utr  $hematology blood hematocrit  45.8  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  72  mg dl$docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; lorazepam  2  mg ; vitamin d  2000  unit ; multivitamins  1  tab ; levetiracetam  500  mg ; hydralazine  10  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexamethasone  4  mg ; acetaminophen  325-650  mg ; atorvastatin  80  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
superficial mycosis, unspecified chronic kidney disease, stage 3 (moderate) cerebral edema acute kidney failure with tubular necrosis dysarthria and anarthria type 2 diabetes mellitus with diabetic chronic kidney disease chronic systolic (congestive) heart failure cerebral infarction, unspecified left bundle-branch block, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema occlusion and stenosis of left carotid artery long term (current) use of insulin type 2 diabetes mellitus with hypoglycemia without coma hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cardiomyopathy, unspecified hyperlipidemia, unspecified disorder of brain, unspecified type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene presence of coronary angioplasty implant and graft diarrhea, unspecified aphasia legal blindness, as defined in usa atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene atherosclerotic heart disease of native coronary artery without angina pectoris pure hypercholesterolemia, unspecified legal blindness, as defined in usa stenosis of coronary artery stent, initial encounter chronic kidney disease, unspecified unspecified place or not applicable long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease left bundle-branch block, unspecified 
black african american m 67 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  76  mg dl$hydralazine  10  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexamethasone  4  mg ; acetaminophen  325-650  mg ; atorvastatin  80  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; 
superficial mycosis, unspecified chronic kidney disease, stage 3 (moderate) cerebral edema acute kidney failure with tubular necrosis dysarthria and anarthria type 2 diabetes mellitus with diabetic chronic kidney disease chronic systolic (congestive) heart failure cerebral infarction, unspecified left bundle-branch block, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema occlusion and stenosis of left carotid artery long term (current) use of insulin type 2 diabetes mellitus with hypoglycemia without coma hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cardiomyopathy, unspecified hyperlipidemia, unspecified disorder of brain, unspecified type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene presence of coronary angioplasty implant and graft diarrhea, unspecified aphasia legal blindness, as defined in usa atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene atherosclerotic heart disease of native coronary artery without angina pectoris pure hypercholesterolemia, unspecified legal blindness, as defined in usa stenosis of coronary artery stent, initial encounter chronic kidney disease, unspecified unspecified place or not applicable long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease left bundle-branch block, unspecified 
black african american m 67 $nan$hematology blood hematocrit  41.4  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  118  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  123  mg dl$hydralazine  10  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexamethasone  4  mg ; acetaminophen  325-650  mg ; atorvastatin  80  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; lactated ringers  1000  ml ; 
superficial mycosis, unspecified chronic kidney disease, stage 3 (moderate) cerebral edema acute kidney failure with tubular necrosis dysarthria and anarthria type 2 diabetes mellitus with diabetic chronic kidney disease chronic systolic (congestive) heart failure cerebral infarction, unspecified left bundle-branch block, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema occlusion and stenosis of left carotid artery long term (current) use of insulin type 2 diabetes mellitus with hypoglycemia without coma hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cardiomyopathy, unspecified hyperlipidemia, unspecified disorder of brain, unspecified type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene presence of coronary angioplasty implant and graft diarrhea, unspecified aphasia legal blindness, as defined in usa atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene atherosclerotic heart disease of native coronary artery without angina pectoris pure hypercholesterolemia, unspecified legal blindness, as defined in usa stenosis of coronary artery stent, initial encounter chronic kidney disease, unspecified unspecified place or not applicable long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease left bundle-branch block, unspecified 
black african american m 67 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  118  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  66  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  172  mg dl$hydralazine  10  mg ; 0.9% sodium chloride  100  ml ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexamethasone  4  mg ; acetaminophen  325-650  mg ; atorvastatin  80  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; lactated ringers  1000  ml ; labetalol  150  mg ; 
superficial mycosis, unspecified chronic kidney disease, stage 3 (moderate) cerebral edema acute kidney failure with tubular necrosis dysarthria and anarthria type 2 diabetes mellitus with diabetic chronic kidney disease chronic systolic (congestive) heart failure cerebral infarction, unspecified left bundle-branch block, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema occlusion and stenosis of left carotid artery long term (current) use of insulin type 2 diabetes mellitus with hypoglycemia without coma hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cardiomyopathy, unspecified hyperlipidemia, unspecified disorder of brain, unspecified type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene presence of coronary angioplasty implant and graft diarrhea, unspecified aphasia legal blindness, as defined in usa atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene atherosclerotic heart disease of native coronary artery without angina pectoris pure hypercholesterolemia, unspecified legal blindness, as defined in usa stenosis of coronary artery stent, initial encounter chronic kidney disease, unspecified unspecified place or not applicable long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease left bundle-branch block, unspecified 
black african american m 67 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  119  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  191  mg dl$hydralazine  10  mg ; 0.9% sodium chloride  100  ml ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexamethasone  4  mg ; acetaminophen  325-650  mg ; atorvastatin  80  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; lactated ringers  1000  ml ; labetalol  150  mg ; warfarin  2  mg ; labetalol  100  mg ; 
superficial mycosis, unspecified chronic kidney disease, stage 3 (moderate) cerebral edema acute kidney failure with tubular necrosis dysarthria and anarthria type 2 diabetes mellitus with diabetic chronic kidney disease chronic systolic (congestive) heart failure cerebral infarction, unspecified left bundle-branch block, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema occlusion and stenosis of left carotid artery long term (current) use of insulin type 2 diabetes mellitus with hypoglycemia without coma hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cardiomyopathy, unspecified hyperlipidemia, unspecified disorder of brain, unspecified type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene presence of coronary angioplasty implant and graft diarrhea, unspecified aphasia legal blindness, as defined in usa atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene atherosclerotic heart disease of native coronary artery without angina pectoris pure hypercholesterolemia, unspecified legal blindness, as defined in usa stenosis of coronary artery stent, initial encounter chronic kidney disease, unspecified unspecified place or not applicable long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease left bundle-branch block, unspecified 
black african american m 67 $nan$hematology blood hematocrit  37.9  %; hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.4  g dl; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  73  k ul; hematology blood platelet count  93  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  117  meq l; chemistry blood chloride  119  meq l; chemistry blood chloride  121  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.8  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  152  meq l; chemistry blood sodium  152  meq l; chemistry blood urea nitrogen  81  mg dl; chemistry blood urea nitrogen  86  mg dl; chemistry blood urea nitrogen  86  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  240  mg dl; chemistry blood glucose  230  mg dl; chemistry blood glucose  244  mg dl; blood gas blood free calcium  1.25  mmol l; blood gas blood free calcium  0.99  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.8  mmol l; blood gas blood glucose  224  mg dl; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  5.5  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.9  meq l$hydralazine  10  mg ; 0.9% sodium chloride  100  ml ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexamethasone  4  mg ; acetaminophen  325-650  mg ; atorvastatin  80  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; warfarin  2  mg ; labetalol  100  mg ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; labetalol  10  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; midazolam  2  mg ; bag  50  ml ; fentanyl citrate  2.5  mg ; vasopressin  40  unit ; midazolam  100  mg ; 0.9% sodium chloride  250  ml ; cisatracurium besylate  100  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; lidocaine jelly 2% (glydo)  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; insulin (regular) for hyperkalemia  10  unit ; albumin 25% (12.5g   50ml)  25  g ; argatroban  250  mg ; dextrose 50%  25  gm ; epinephrine  8  mg ; norepinephrine  8  mg ; epinephrine  2  mg ; 
superficial mycosis, unspecified chronic kidney disease, stage 3 (moderate) cerebral edema acute kidney failure with tubular necrosis dysarthria and anarthria type 2 diabetes mellitus with diabetic chronic kidney disease chronic systolic (congestive) heart failure cerebral infarction, unspecified left bundle-branch block, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema occlusion and stenosis of left carotid artery long term (current) use of insulin type 2 diabetes mellitus with hypoglycemia without coma hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cardiomyopathy, unspecified hyperlipidemia, unspecified disorder of brain, unspecified type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene presence of coronary angioplasty implant and graft diarrhea, unspecified aphasia legal blindness, as defined in usa atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene atherosclerotic heart disease of native coronary artery without angina pectoris pure hypercholesterolemia, unspecified legal blindness, as defined in usa stenosis of coronary artery stent, initial encounter chronic kidney disease, unspecified unspecified place or not applicable long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease left bundle-branch block, unspecified 
black african american m 67 $nan$hematology blood hematocrit  26.0  %; hematology blood hematocrit  21.7  %; hematology blood hematocrit  21.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  44  k ul; hematology blood platelet count  35  k ul; hematology blood platelet count  22  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  118  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  89  mg dl; chemistry blood urea nitrogen  74  mg dl; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  4.1  ; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  2.6  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  307  mg dl; chemistry blood glucose  252  mg dl; chemistry blood glucose  204  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.21  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.1  meq l$hydralazine  10  mg ; 0.9% sodium chloride  100  ml ; acetaminophen  325-650  mg ; atorvastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; vial  1  vial ; pantoprazole  40  mg ; labetalol  10  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; midazolam  2  mg ; bag  50  ml ; fentanyl citrate  2.5  mg ; vasopressin  40  unit ; midazolam  100  mg ; 0.9% sodium chloride  250  ml ; cisatracurium besylate  100  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine jelly 2% (glydo)  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; insulin (regular) for hyperkalemia  10  unit ; albumin 25% (12.5g   50ml)  25  g ; argatroban  250  mg ; dextrose 50%  25  gm ; norepinephrine  8  mg ; epinephrine  2  mg ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; sodium chloride 0.9%  flush for crrt  100-200  ml ; sodium citrate 4%  4  ml ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sw  100  ml ; potassium chloride  10  meq ; neomycin-polymyxin-bacitracin  1  appl ; artificial tear ointment  1  appl ; heparin flush (1000 units ml)  2000-8000  unit ; artificial tears  1-2  drop ; 
superficial mycosis, unspecified chronic kidney disease, stage 3 (moderate) cerebral edema acute kidney failure with tubular necrosis dysarthria and anarthria type 2 diabetes mellitus with diabetic chronic kidney disease chronic systolic (congestive) heart failure cerebral infarction, unspecified left bundle-branch block, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema occlusion and stenosis of left carotid artery long term (current) use of insulin type 2 diabetes mellitus with hypoglycemia without coma hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cardiomyopathy, unspecified hyperlipidemia, unspecified disorder of brain, unspecified type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene presence of coronary angioplasty implant and graft diarrhea, unspecified aphasia legal blindness, as defined in usa atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene atherosclerotic heart disease of native coronary artery without angina pectoris pure hypercholesterolemia, unspecified legal blindness, as defined in usa stenosis of coronary artery stent, initial encounter chronic kidney disease, unspecified unspecified place or not applicable long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease left bundle-branch block, unspecified 
black african american m 67 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  23  k ul; blood gas blood free calcium  1.20  mmol l; blood gas blood potassium, whole blood  4.1  meq l$hydralazine  10  mg ; 0.9% sodium chloride  100  ml ; acetaminophen  325-650  mg ; atorvastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; vial  1  vial ; pantoprazole  40  mg ; labetalol  10  mg ; 0.9% sodium chloride  250  ml ; cisatracurium besylate  100  mg ; sodium chloride 0.9%  flush  10  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albumin 25% (12.5g   50ml)  25  g ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; sodium chloride 0.9%  flush for crrt  100-200  ml ; sodium citrate 4%  4  ml ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sw  100  ml ; potassium chloride  10  meq ; neomycin-polymyxin-bacitracin  1  appl ; artificial tear ointment  1  appl ; heparin flush (1000 units ml)  2000-8000  unit ; artificial tears  1-2  drop ; propofol  1000  mg ; propofol  200  mg ; glycopyrrolate  0.1  mg ; lorazepam  0.5-2  mg ; ondansetron  4-8  mg ; heparin flush (10 units ml)  1  ml ; vancomycin  0  md to order daily dose ; 
superficial mycosis, unspecified chronic kidney disease, stage 3 (moderate) cerebral edema acute kidney failure with tubular necrosis dysarthria and anarthria type 2 diabetes mellitus with diabetic chronic kidney disease chronic systolic (congestive) heart failure cerebral infarction, unspecified left bundle-branch block, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema occlusion and stenosis of left carotid artery long term (current) use of insulin type 2 diabetes mellitus with hypoglycemia without coma hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease cardiomyopathy, unspecified hyperlipidemia, unspecified disorder of brain, unspecified type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene presence of coronary angioplasty implant and graft diarrhea, unspecified aphasia legal blindness, as defined in usa atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene atherosclerotic heart disease of native coronary artery without angina pectoris pure hypercholesterolemia, unspecified legal blindness, as defined in usa stenosis of coronary artery stent, initial encounter chronic kidney disease, unspecified unspecified place or not applicable long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease left bundle-branch block, unspecified 
white f 47 $nan$nan$prednisone  5  mg ; folic acid  1  mg ; 
 
white f 47 $nan$hematology blood hematocrit  34.9  %; hematology blood hematocrit  31.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  197  k ul; hematology blood platelet count  188  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  78  mg dl$prednisone  5  mg ; folic acid  1  mg ; ns  1000  ml ; ketorolac  30  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.12  mg ; docusate sodium  100  mg ; senna  1  tab ; ibuprofen  800  mg ; oxycodone (immediate release)   5  mg ; 
 
white f 47 $nan$nan$prednisone  5  mg ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; ibuprofen  800  mg ; oxycodone (immediate release)   5  mg ; 
 
white m 82 $temp  98.0  heartrate  87.0  resprate  16.0  o2sat  98.0  sbp  123.0  dbp  56.0  rhythm    pain  0  $hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  56  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  152  mg dl; chemistry blood glucose  159  mg dl; chemistry blood albumin  3.0  g dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  2  tab ; furosemide  40  mg ; heparin  5000  unit ; ascorbic acid  500  mg ; aspirin  81  mg ; ciprofloxacin hcl  250  mg ; ferrous gluconate  324  mg ; lactulose  30  ml ; multivitamins  1  tab ; nadolol  10  mg ; omeprazole  20  mg ; rifaximin  550  mg ; vitamin e  400  unit ; spironolactone  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albumin 25% (12.5g   50ml)  50  g ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia, unspecified peripheral vascular disease, unspecified essential and other specified forms of tremor percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes atrial fibrillation other chronic nonalcoholic liver disease esophageal varices without mention of bleeding portal hypertension hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of liver unspecified essential hypertension coronary atherosclerosis of native coronary artery thrombocytopenia, unspecified other specified disorders of stomach and duodenum unspecified hereditary and idiopathic peripheral neuropathy esophageal varices in diseases classified elsewhere, without mention of bleeding iron deficiency anemia, unspecified edema percutaneous transluminal coronary angioplasty status atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cirrhosis of liver without mention of alcohol coronary atherosclerosis of native coronary artery other specified disorders of stomach and duodenum other ascites personal history of malignant neoplasm of liver benign neoplasm of colon acute kidney failure, unspecified portal hypertension hemorrhage of gastrointestinal tract, unspecified angiodysplasia of intestine (without mention of hemorrhage) peripheral vascular disease, unspecified other chronic nonalcoholic liver disease internal hemorrhoids without mention of complication closed fracture of intertrochanteric section of neck of femur diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled essential and other specified forms of tremor peripheral vascular disease, unspecified other chronic nonalcoholic liver disease malignant neoplasm of liver, primary polyneuropathy in diabetes percutaneous transluminal coronary angioplasty status cirrhosis of liver without mention of alcohol fall from other slipping, tripping, or stumbling coronary atherosclerosis of native coronary artery other ascites
white m 82 $nan$hematology blood hematocrit  27.9  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  50  k ul; hematology blood platelet count  50  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  329  mg dl; chemistry blood glucose  134  mg dl; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  2  tab ; furosemide  40  mg ; heparin  5000  unit ; ascorbic acid  500  mg ; aspirin  81  mg ; ciprofloxacin hcl  250  mg ; ferrous gluconate  324  mg ; lactulose  30  ml ; multivitamins  1  tab ; nadolol  10  mg ; omeprazole  20  mg ; rifaximin  550  mg ; vitamin e  400  unit ; spironolactone  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albumin 25% (12.5g   50ml)  50  g ; furosemide  20  mg ; insulin  12  unit ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia, unspecified peripheral vascular disease, unspecified essential and other specified forms of tremor percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes atrial fibrillation other chronic nonalcoholic liver disease esophageal varices without mention of bleeding portal hypertension hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of liver unspecified essential hypertension coronary atherosclerosis of native coronary artery thrombocytopenia, unspecified other specified disorders of stomach and duodenum unspecified hereditary and idiopathic peripheral neuropathy esophageal varices in diseases classified elsewhere, without mention of bleeding iron deficiency anemia, unspecified edema percutaneous transluminal coronary angioplasty status atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cirrhosis of liver without mention of alcohol coronary atherosclerosis of native coronary artery other specified disorders of stomach and duodenum other ascites personal history of malignant neoplasm of liver benign neoplasm of colon acute kidney failure, unspecified portal hypertension hemorrhage of gastrointestinal tract, unspecified angiodysplasia of intestine (without mention of hemorrhage) peripheral vascular disease, unspecified other chronic nonalcoholic liver disease internal hemorrhoids without mention of complication closed fracture of intertrochanteric section of neck of femur diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled essential and other specified forms of tremor peripheral vascular disease, unspecified other chronic nonalcoholic liver disease malignant neoplasm of liver, primary polyneuropathy in diabetes percutaneous transluminal coronary angioplasty status cirrhosis of liver without mention of alcohol fall from other slipping, tripping, or stumbling coronary atherosclerosis of native coronary artery other ascites
white m 82 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  46  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  121  mg dl; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  2  tab ; heparin  5000  unit ; ascorbic acid  500  mg ; aspirin  81  mg ; ciprofloxacin hcl  250  mg ; ferrous gluconate  324  mg ; lactulose  30  ml ; multivitamins  1  tab ; nadolol  10  mg ; omeprazole  20  mg ; rifaximin  550  mg ; vitamin e  400  unit ; spironolactone  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; furosemide  20  mg ; insulin  12  unit ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia, unspecified peripheral vascular disease, unspecified essential and other specified forms of tremor percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes atrial fibrillation other chronic nonalcoholic liver disease esophageal varices without mention of bleeding portal hypertension hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of liver unspecified essential hypertension coronary atherosclerosis of native coronary artery thrombocytopenia, unspecified other specified disorders of stomach and duodenum unspecified hereditary and idiopathic peripheral neuropathy esophageal varices in diseases classified elsewhere, without mention of bleeding iron deficiency anemia, unspecified edema percutaneous transluminal coronary angioplasty status atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cirrhosis of liver without mention of alcohol coronary atherosclerosis of native coronary artery other specified disorders of stomach and duodenum other ascites personal history of malignant neoplasm of liver benign neoplasm of colon acute kidney failure, unspecified portal hypertension hemorrhage of gastrointestinal tract, unspecified angiodysplasia of intestine (without mention of hemorrhage) peripheral vascular disease, unspecified other chronic nonalcoholic liver disease internal hemorrhoids without mention of complication closed fracture of intertrochanteric section of neck of femur diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled essential and other specified forms of tremor peripheral vascular disease, unspecified other chronic nonalcoholic liver disease malignant neoplasm of liver, primary polyneuropathy in diabetes percutaneous transluminal coronary angioplasty status cirrhosis of liver without mention of alcohol fall from other slipping, tripping, or stumbling coronary atherosclerosis of native coronary artery other ascites
white m 82 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  42  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  214  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  2  tab ; ascorbic acid  500  mg ; aspirin  81  mg ; ciprofloxacin hcl  250  mg ; ferrous gluconate  324  mg ; lactulose  30  ml ; multivitamins  1  tab ; nadolol  10  mg ; omeprazole  20  mg ; rifaximin  550  mg ; vitamin e  400  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; spironolactone  100  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia, unspecified peripheral vascular disease, unspecified essential and other specified forms of tremor percutaneous transluminal coronary angioplasty status polyneuropathy in diabetes atrial fibrillation other chronic nonalcoholic liver disease esophageal varices without mention of bleeding portal hypertension hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of liver unspecified essential hypertension coronary atherosclerosis of native coronary artery thrombocytopenia, unspecified other specified disorders of stomach and duodenum unspecified hereditary and idiopathic peripheral neuropathy esophageal varices in diseases classified elsewhere, without mention of bleeding iron deficiency anemia, unspecified edema percutaneous transluminal coronary angioplasty status atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cirrhosis of liver without mention of alcohol coronary atherosclerosis of native coronary artery other specified disorders of stomach and duodenum other ascites personal history of malignant neoplasm of liver benign neoplasm of colon acute kidney failure, unspecified portal hypertension hemorrhage of gastrointestinal tract, unspecified angiodysplasia of intestine (without mention of hemorrhage) peripheral vascular disease, unspecified other chronic nonalcoholic liver disease internal hemorrhoids without mention of complication closed fracture of intertrochanteric section of neck of femur diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled essential and other specified forms of tremor peripheral vascular disease, unspecified other chronic nonalcoholic liver disease malignant neoplasm of liver, primary polyneuropathy in diabetes percutaneous transluminal coronary angioplasty status cirrhosis of liver without mention of alcohol fall from other slipping, tripping, or stumbling coronary atherosclerosis of native coronary artery other ascites
white m 54 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  286  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; insulin  0  unit ; insulin  36  unit ; carvedilol  3.125  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; insulin  18  unit ; insulin  8  unit ; 
secondary carcinoid tumors of liver secondary carcinoid tumors of distant lymph nodes other gram-negative sepsis toxic gastroenteritis and colitis secondary carcinoid tumors of peritoneum essential (primary) hypertension personal history of nicotine dependence other obstructive and reflux uropathy type 1 diabetes mellitus with hyperglycemia tubulo-interstitial nephritis, not specified as acute or chronic long term (current) use of insulin other specified noninfective gastroenteritis and colitis other artificial openings of urinary tract status unspecified place or not applicable malignant carcinoid tumor of the small intestine, unspecified portion atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified adverse effect of unspecified systemic antibiotic, initial encounter presence of insulin pump (external) (internal) personal history of nicotine dependence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 1 diabetes mellitus without complications long term (current) use of insulin hyperlipidemia, unspecified hydronephrosis with ureteral stricture, not elsewhere classified essential (primary) hypertension malfunction of incontinent external stoma of urinary tract malignant carcinoid tumor of unspecified site urinary tract infection, site not specified sepsis due to enterococcus diarrhea, unspecified pyonephrosis presence of insulin pump (external) (internal) extravasation of other vesicant agent, initial encounter severe sepsis without septic shock secondary carcinoid tumors of liver other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure secondary carcinoid tumors of other sites secondary carcinoid tumors of distant lymph nodes acute kidney failure, unspecified carcinoid syndrome atherosclerotic heart disease of native coronary artery without angina pectoris urticaria, unspecified long term (current) use of insulin personal history of nicotine dependence hyperlipidemia, unspecified type 1 diabetes mellitus with hyperglycemia tubulo-interstitial nephritis, not specified as acute or chronic
white m 32 $nan$nan$sirolimus  1  mg ; pravastatin  10  mg ; prednisone  7.5  mg ; azathioprine  100  mg ; 
other and unspecified hyperlipidemia chronic glomerulonephritis in diseases classified elsewhere systemic lupus erythematosus candidal esophagitis kidney replaced by transplant chronic kidney disease, unspecified abnormal coagulation profile diarrhea car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified acidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified other postprocedural status hyperpotassemia kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other and unspecified hyperlipidemia unspecified essential hypertension acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified systemic lupus erythematosus chronic glomerulonephritis in diseases classified elsewhere dehydration
white m 32 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry urine chloride, urine  25  meq l; chemistry urine creatinine, urine  464  mg dl; chemistry urine potassium, urine  34  meq l; chemistry urine sodium, urine  41  meq l; chemistry urine urea nitrogen, urine  406  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  108  mg dl$sirolimus  1  mg ; pravastatin  10  mg ; prednisone  7.5  mg ; azathioprine  100  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; clotrimazole  1  troc ; heparin  5000  unit ; labetalol  50  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; 
other and unspecified hyperlipidemia chronic glomerulonephritis in diseases classified elsewhere systemic lupus erythematosus candidal esophagitis kidney replaced by transplant chronic kidney disease, unspecified abnormal coagulation profile diarrhea car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified acidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified other postprocedural status hyperpotassemia kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other and unspecified hyperlipidemia unspecified essential hypertension acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified systemic lupus erythematosus chronic glomerulonephritis in diseases classified elsewhere dehydration
white m 32 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  89  mg dl$sirolimus  1  mg ; pravastatin  10  mg ; prednisone  7.5  mg ; azathioprine  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; clotrimazole  1  troc ; heparin  5000  unit ; labetalol  50  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; 
other and unspecified hyperlipidemia chronic glomerulonephritis in diseases classified elsewhere systemic lupus erythematosus candidal esophagitis kidney replaced by transplant chronic kidney disease, unspecified abnormal coagulation profile diarrhea car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified acidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified other postprocedural status hyperpotassemia kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other and unspecified hyperlipidemia unspecified essential hypertension acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified systemic lupus erythematosus chronic glomerulonephritis in diseases classified elsewhere dehydration
white m 32 $nan$nan$sirolimus  1  mg ; pravastatin  10  mg ; prednisone  7.5  mg ; azathioprine  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; clotrimazole  1  troc ; heparin  5000  unit ; labetalol  50  mg ; 
other and unspecified hyperlipidemia chronic glomerulonephritis in diseases classified elsewhere systemic lupus erythematosus candidal esophagitis kidney replaced by transplant chronic kidney disease, unspecified abnormal coagulation profile diarrhea car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident acute kidney failure, unspecified acidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified other postprocedural status hyperpotassemia kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other and unspecified hyperlipidemia unspecified essential hypertension acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified systemic lupus erythematosus chronic glomerulonephritis in diseases classified elsewhere dehydration
white m 85 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  86  mg dl; hematology blood bands  4  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; vial  1  vial ; heparin sodium  1100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; clopidogrel  75  mg ; levothyroxine sodium  50  mcg ; morphine sulfate ir  15  mg ; prednisone  10  mg ; ranitidine  300  mg ; ferrous sulfate  325  mg ; polyethylene glycol  17  g ; atorvastatin  80  mg ; finasteride  5  mg ; aspirin  325  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; 
do not resuscitate status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) prinzmetal angina long-term (current) use of aspirin coronary atherosclerosis of autologous vein bypass graft secondary malignant neoplasm of lung hypovolemia malignant melanoma of skin of lower limb, including hip unspecified hearing loss percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia esophageal reflux personal history of antineoplastic chemotherapy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified essential hypertension glucocorticoid deficiency personal history of irradiation, presenting hazards to health chronic total occlusion of coronary artery intermediate coronary syndrome accidents occurring in residential institution other chronic pulmonary heart diseases unspecified essential hypertension neutropenia, unspecified malignant melanoma of skin of lower limb, including hip unspecified acquired hypothyroidism antineoplastic chemotherapy induced anemia secondary malignant neoplasm of lung hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of unspecified type of vessel, native or graft do not resuscitate status anemia in neoplastic disease percutaneous transluminal coronary angioplasty status fever presenting with conditions classified elsewhere hypotension, unspecified glucocorticoid deficiency other specified cardiac dysrhythmias prinzmetal angina aortocoronary bypass status other and unspecified hyperlipidemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white m 85 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  118  mg dl; hematology blood bands  6  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; vial  1  vial ; heparin sodium  1100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; clopidogrel  75  mg ; levothyroxine sodium  50  mcg ; morphine sulfate ir  15  mg ; prednisone  10  mg ; ranitidine  300  mg ; ferrous sulfate  325  mg ; polyethylene glycol  17  g ; atorvastatin  80  mg ; finasteride  5  mg ; aspirin  325  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; nitroglycerin sl  0.3  mg ; potassium chloride  60  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; 0.9% sodium chloride  500  ml ; 
do not resuscitate status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) prinzmetal angina long-term (current) use of aspirin coronary atherosclerosis of autologous vein bypass graft secondary malignant neoplasm of lung hypovolemia malignant melanoma of skin of lower limb, including hip unspecified hearing loss percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia esophageal reflux personal history of antineoplastic chemotherapy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified essential hypertension glucocorticoid deficiency personal history of irradiation, presenting hazards to health chronic total occlusion of coronary artery intermediate coronary syndrome accidents occurring in residential institution other chronic pulmonary heart diseases unspecified essential hypertension neutropenia, unspecified malignant melanoma of skin of lower limb, including hip unspecified acquired hypothyroidism antineoplastic chemotherapy induced anemia secondary malignant neoplasm of lung hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of unspecified type of vessel, native or graft do not resuscitate status anemia in neoplastic disease percutaneous transluminal coronary angioplasty status fever presenting with conditions classified elsewhere hypotension, unspecified glucocorticoid deficiency other specified cardiac dysrhythmias prinzmetal angina aortocoronary bypass status other and unspecified hyperlipidemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white m 85 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; vial  1  vial ; heparin sodium  1100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; clopidogrel  75  mg ; levothyroxine sodium  50  mcg ; morphine sulfate ir  15  mg ; prednisone  10  mg ; ranitidine  300  mg ; ferrous sulfate  325  mg ; polyethylene glycol  17  g ; atorvastatin  80  mg ; finasteride  5  mg ; aspirin  325  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; nitroglycerin sl  0.3  mg ; potassium chloride  60  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; 0.9% sodium chloride  500  ml ; potassium chloride replacement (oncology)  10  meq ; potassium chloride replacement (oncology)  20  meq ; neutra-phos  1  pkt ; potassium chl 40 meq   1000 ml d5w  1000  ml ; 
do not resuscitate status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) prinzmetal angina long-term (current) use of aspirin coronary atherosclerosis of autologous vein bypass graft secondary malignant neoplasm of lung hypovolemia malignant melanoma of skin of lower limb, including hip unspecified hearing loss percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia esophageal reflux personal history of antineoplastic chemotherapy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified essential hypertension glucocorticoid deficiency personal history of irradiation, presenting hazards to health chronic total occlusion of coronary artery intermediate coronary syndrome accidents occurring in residential institution other chronic pulmonary heart diseases unspecified essential hypertension neutropenia, unspecified malignant melanoma of skin of lower limb, including hip unspecified acquired hypothyroidism antineoplastic chemotherapy induced anemia secondary malignant neoplasm of lung hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of unspecified type of vessel, native or graft do not resuscitate status anemia in neoplastic disease percutaneous transluminal coronary angioplasty status fever presenting with conditions classified elsewhere hypotension, unspecified glucocorticoid deficiency other specified cardiac dysrhythmias prinzmetal angina aortocoronary bypass status other and unspecified hyperlipidemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white m 85 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  149  mg dl; hematology blood bands  4  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; vial  1  vial ; heparin sodium  1100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; clopidogrel  75  mg ; levothyroxine sodium  50  mcg ; morphine sulfate ir  15  mg ; prednisone  10  mg ; ranitidine  300  mg ; ferrous sulfate  325  mg ; polyethylene glycol  17  g ; atorvastatin  80  mg ; finasteride  5  mg ; aspirin  325  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  10  meq ; neutra-phos  1  pkt ; potassium chl 40 meq   1000 ml d5w  1000  ml ; amlodipine  2.5  mg ; 
do not resuscitate status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) prinzmetal angina long-term (current) use of aspirin coronary atherosclerosis of autologous vein bypass graft secondary malignant neoplasm of lung hypovolemia malignant melanoma of skin of lower limb, including hip unspecified hearing loss percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia esophageal reflux personal history of antineoplastic chemotherapy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified essential hypertension glucocorticoid deficiency personal history of irradiation, presenting hazards to health chronic total occlusion of coronary artery intermediate coronary syndrome accidents occurring in residential institution other chronic pulmonary heart diseases unspecified essential hypertension neutropenia, unspecified malignant melanoma of skin of lower limb, including hip unspecified acquired hypothyroidism antineoplastic chemotherapy induced anemia secondary malignant neoplasm of lung hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of unspecified type of vessel, native or graft do not resuscitate status anemia in neoplastic disease percutaneous transluminal coronary angioplasty status fever presenting with conditions classified elsewhere hypotension, unspecified glucocorticoid deficiency other specified cardiac dysrhythmias prinzmetal angina aortocoronary bypass status other and unspecified hyperlipidemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white m 85 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; clopidogrel  75  mg ; levothyroxine sodium  50  mcg ; morphine sulfate ir  15  mg ; prednisone  10  mg ; ranitidine  300  mg ; ferrous sulfate  325  mg ; polyethylene glycol  17  g ; atorvastatin  80  mg ; finasteride  5  mg ; aspirin  325  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  10  meq ; amlodipine  2.5  mg ; trazodone  25  mg ; 
do not resuscitate status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) prinzmetal angina long-term (current) use of aspirin coronary atherosclerosis of autologous vein bypass graft secondary malignant neoplasm of lung hypovolemia malignant melanoma of skin of lower limb, including hip unspecified hearing loss percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia esophageal reflux personal history of antineoplastic chemotherapy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism iron deficiency anemia, unspecified unspecified essential hypertension glucocorticoid deficiency personal history of irradiation, presenting hazards to health chronic total occlusion of coronary artery intermediate coronary syndrome accidents occurring in residential institution other chronic pulmonary heart diseases unspecified essential hypertension neutropenia, unspecified malignant melanoma of skin of lower limb, including hip unspecified acquired hypothyroidism antineoplastic chemotherapy induced anemia secondary malignant neoplasm of lung hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of unspecified type of vessel, native or graft do not resuscitate status anemia in neoplastic disease percutaneous transluminal coronary angioplasty status fever presenting with conditions classified elsewhere hypotension, unspecified glucocorticoid deficiency other specified cardiac dysrhythmias prinzmetal angina aortocoronary bypass status other and unspecified hyperlipidemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 77 $nan$nan$ondansetron  8  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; prednisone  100  mg ; 
unspecified hydronephrosis anxiety disorder, unspecified localized edema unspecified osteoarthritis, unspecified site personal history of irradiation encounter for antineoplastic chemotherapy polyneuropathy, unspecified anemia due to antineoplastic chemotherapy diffuse large b-cell lymphoma, lymph nodes of multiple sites fluid overload, unspecified hyperlipidemia, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter obesity, unspecified family history of malignant neoplasm, unspecified unspecified asthma, uncomplicated drug induced constipation other viral infections of unspecified site unspecified place in hospital as the place of occurrence of the external cause gastro-esophageal reflux disease without esophagitis essential (primary) hypertension abdominal aortic aneurysm, without rupture body mass index (bmi) 35.0-35.9, adult hyperlipidemia, unspecified unspecified place or not applicable encounter for antineoplastic chemotherapy adverse effect of antineoplastic and immunosuppressive drugs, initial encounter abdominal aortic aneurysm, without rupture anxiety disorder, unspecified localized edema essential (primary) hypertension unspecified place in hospital as the place of occurrence of the external cause drug-induced polyneuropathy anemia due to antineoplastic chemotherapy unspecified b-cell lymphoma, lymph nodes of multiple sites drug induced constipation postprocedural hemorrhage of skin and subcutaneous tissue following other procedure other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other insomnia compression of vein lymphedema, not elsewhere classified anxiety disorder, unspecified encounter for antineoplastic chemotherapy essential (primary) hypertension anemia in neoplastic disease hypo-osmolality and hyponatremia patient room in hospital as the place of occurrence of the external cause body mass index (bmi) 38.0-38.9, adult unspecified b-cell lymphoma, extranodal and solid organ sites
white f 77 $nan$hematology blood hematocrit  24.9  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  160  k ul; hematology blood platelet count  162  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  198  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  203  iu l; chemistry blood lactate dehydrogenase (ld)  204  iu l; chemistry blood albumin  3.5  g dl; chemistry blood albumin  3.6  g dl$ondansetron  8  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; prednisone  100  mg ; acyclovir  400  mg ; enoxaparin sodium  90  mg ; furosemide  20  mg ; omeprazole  20  mg ; heparin flush (100 units ml)  5  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; doxorubicin  29  mg ; 0.9% sodium chloride  1000  ml ; etoposide  140  mg ; losartan potassium  25  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
unspecified hydronephrosis anxiety disorder, unspecified localized edema unspecified osteoarthritis, unspecified site personal history of irradiation encounter for antineoplastic chemotherapy polyneuropathy, unspecified anemia due to antineoplastic chemotherapy diffuse large b-cell lymphoma, lymph nodes of multiple sites fluid overload, unspecified hyperlipidemia, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter obesity, unspecified family history of malignant neoplasm, unspecified unspecified asthma, uncomplicated drug induced constipation other viral infections of unspecified site unspecified place in hospital as the place of occurrence of the external cause gastro-esophageal reflux disease without esophagitis essential (primary) hypertension abdominal aortic aneurysm, without rupture body mass index (bmi) 35.0-35.9, adult hyperlipidemia, unspecified unspecified place or not applicable encounter for antineoplastic chemotherapy adverse effect of antineoplastic and immunosuppressive drugs, initial encounter abdominal aortic aneurysm, without rupture anxiety disorder, unspecified localized edema essential (primary) hypertension unspecified place in hospital as the place of occurrence of the external cause drug-induced polyneuropathy anemia due to antineoplastic chemotherapy unspecified b-cell lymphoma, lymph nodes of multiple sites drug induced constipation postprocedural hemorrhage of skin and subcutaneous tissue following other procedure other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other insomnia compression of vein lymphedema, not elsewhere classified anxiety disorder, unspecified encounter for antineoplastic chemotherapy essential (primary) hypertension anemia in neoplastic disease hypo-osmolality and hyponatremia patient room in hospital as the place of occurrence of the external cause body mass index (bmi) 38.0-38.9, adult unspecified b-cell lymphoma, extranodal and solid organ sites
white f 77 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  149  mg dl; chemistry blood lactate dehydrogenase (ld)  213  iu l; chemistry blood albumin  3.8  g dl$ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisone  100  mg ; acyclovir  400  mg ; enoxaparin sodium  90  mg ; furosemide  20  mg ; omeprazole  20  mg ; heparin flush (100 units ml)  5  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; doxorubicin  29  mg ; 0.9% sodium chloride  1000  ml ; etoposide  140  mg ; losartan potassium  25  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
unspecified hydronephrosis anxiety disorder, unspecified localized edema unspecified osteoarthritis, unspecified site personal history of irradiation encounter for antineoplastic chemotherapy polyneuropathy, unspecified anemia due to antineoplastic chemotherapy diffuse large b-cell lymphoma, lymph nodes of multiple sites fluid overload, unspecified hyperlipidemia, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter obesity, unspecified family history of malignant neoplasm, unspecified unspecified asthma, uncomplicated drug induced constipation other viral infections of unspecified site unspecified place in hospital as the place of occurrence of the external cause gastro-esophageal reflux disease without esophagitis essential (primary) hypertension abdominal aortic aneurysm, without rupture body mass index (bmi) 35.0-35.9, adult hyperlipidemia, unspecified unspecified place or not applicable encounter for antineoplastic chemotherapy adverse effect of antineoplastic and immunosuppressive drugs, initial encounter abdominal aortic aneurysm, without rupture anxiety disorder, unspecified localized edema essential (primary) hypertension unspecified place in hospital as the place of occurrence of the external cause drug-induced polyneuropathy anemia due to antineoplastic chemotherapy unspecified b-cell lymphoma, lymph nodes of multiple sites drug induced constipation postprocedural hemorrhage of skin and subcutaneous tissue following other procedure other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other insomnia compression of vein lymphedema, not elsewhere classified anxiety disorder, unspecified encounter for antineoplastic chemotherapy essential (primary) hypertension anemia in neoplastic disease hypo-osmolality and hyponatremia patient room in hospital as the place of occurrence of the external cause body mass index (bmi) 38.0-38.9, adult unspecified b-cell lymphoma, extranodal and solid organ sites
white f 77 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  150  mg dl; chemistry blood lactate dehydrogenase (ld)  211  iu l; chemistry blood albumin  3.3  g dl$ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisone  100  mg ; acyclovir  400  mg ; enoxaparin sodium  90  mg ; omeprazole  20  mg ; heparin flush (100 units ml)  5  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; doxorubicin  29  mg ; 0.9% sodium chloride  1000  ml ; etoposide  140  mg ; losartan potassium  25  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
unspecified hydronephrosis anxiety disorder, unspecified localized edema unspecified osteoarthritis, unspecified site personal history of irradiation encounter for antineoplastic chemotherapy polyneuropathy, unspecified anemia due to antineoplastic chemotherapy diffuse large b-cell lymphoma, lymph nodes of multiple sites fluid overload, unspecified hyperlipidemia, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter obesity, unspecified family history of malignant neoplasm, unspecified unspecified asthma, uncomplicated drug induced constipation other viral infections of unspecified site unspecified place in hospital as the place of occurrence of the external cause gastro-esophageal reflux disease without esophagitis essential (primary) hypertension abdominal aortic aneurysm, without rupture body mass index (bmi) 35.0-35.9, adult hyperlipidemia, unspecified unspecified place or not applicable encounter for antineoplastic chemotherapy adverse effect of antineoplastic and immunosuppressive drugs, initial encounter abdominal aortic aneurysm, without rupture anxiety disorder, unspecified localized edema essential (primary) hypertension unspecified place in hospital as the place of occurrence of the external cause drug-induced polyneuropathy anemia due to antineoplastic chemotherapy unspecified b-cell lymphoma, lymph nodes of multiple sites drug induced constipation postprocedural hemorrhage of skin and subcutaneous tissue following other procedure other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other insomnia compression of vein lymphedema, not elsewhere classified anxiety disorder, unspecified encounter for antineoplastic chemotherapy essential (primary) hypertension anemia in neoplastic disease hypo-osmolality and hyponatremia patient room in hospital as the place of occurrence of the external cause body mass index (bmi) 38.0-38.9, adult unspecified b-cell lymphoma, extranodal and solid organ sites
white f 77 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  148  mg dl; chemistry blood lactate dehydrogenase (ld)  187  iu l; chemistry blood albumin  3.4  g dl$ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisone  100  mg ; acyclovir  400  mg ; enoxaparin sodium  90  mg ; omeprazole  20  mg ; heparin flush (100 units ml)  5  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; doxorubicin  29  mg ; 0.9% sodium chloride  1000  ml ; etoposide  140  mg ; losartan potassium  25  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
unspecified hydronephrosis anxiety disorder, unspecified localized edema unspecified osteoarthritis, unspecified site personal history of irradiation encounter for antineoplastic chemotherapy polyneuropathy, unspecified anemia due to antineoplastic chemotherapy diffuse large b-cell lymphoma, lymph nodes of multiple sites fluid overload, unspecified hyperlipidemia, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter obesity, unspecified family history of malignant neoplasm, unspecified unspecified asthma, uncomplicated drug induced constipation other viral infections of unspecified site unspecified place in hospital as the place of occurrence of the external cause gastro-esophageal reflux disease without esophagitis essential (primary) hypertension abdominal aortic aneurysm, without rupture body mass index (bmi) 35.0-35.9, adult hyperlipidemia, unspecified unspecified place or not applicable encounter for antineoplastic chemotherapy adverse effect of antineoplastic and immunosuppressive drugs, initial encounter abdominal aortic aneurysm, without rupture anxiety disorder, unspecified localized edema essential (primary) hypertension unspecified place in hospital as the place of occurrence of the external cause drug-induced polyneuropathy anemia due to antineoplastic chemotherapy unspecified b-cell lymphoma, lymph nodes of multiple sites drug induced constipation postprocedural hemorrhage of skin and subcutaneous tissue following other procedure other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other insomnia compression of vein lymphedema, not elsewhere classified anxiety disorder, unspecified encounter for antineoplastic chemotherapy essential (primary) hypertension anemia in neoplastic disease hypo-osmolality and hyponatremia patient room in hospital as the place of occurrence of the external cause body mass index (bmi) 38.0-38.9, adult unspecified b-cell lymphoma, extranodal and solid organ sites
white f 77 $nan$nan$ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisone  100  mg ; acyclovir  400  mg ; enoxaparin sodium  90  mg ; omeprazole  20  mg ; heparin flush (100 units ml)  5  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; doxorubicin  29  mg ; 0.9% sodium chloride  1000  ml ; etoposide  140  mg ; losartan potassium  25  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; cyclophosphamide  2160  mg ; 
unspecified hydronephrosis anxiety disorder, unspecified localized edema unspecified osteoarthritis, unspecified site personal history of irradiation encounter for antineoplastic chemotherapy polyneuropathy, unspecified anemia due to antineoplastic chemotherapy diffuse large b-cell lymphoma, lymph nodes of multiple sites fluid overload, unspecified hyperlipidemia, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter obesity, unspecified family history of malignant neoplasm, unspecified unspecified asthma, uncomplicated drug induced constipation other viral infections of unspecified site unspecified place in hospital as the place of occurrence of the external cause gastro-esophageal reflux disease without esophagitis essential (primary) hypertension abdominal aortic aneurysm, without rupture body mass index (bmi) 35.0-35.9, adult hyperlipidemia, unspecified unspecified place or not applicable encounter for antineoplastic chemotherapy adverse effect of antineoplastic and immunosuppressive drugs, initial encounter abdominal aortic aneurysm, without rupture anxiety disorder, unspecified localized edema essential (primary) hypertension unspecified place in hospital as the place of occurrence of the external cause drug-induced polyneuropathy anemia due to antineoplastic chemotherapy unspecified b-cell lymphoma, lymph nodes of multiple sites drug induced constipation postprocedural hemorrhage of skin and subcutaneous tissue following other procedure other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other insomnia compression of vein lymphedema, not elsewhere classified anxiety disorder, unspecified encounter for antineoplastic chemotherapy essential (primary) hypertension anemia in neoplastic disease hypo-osmolality and hyponatremia patient room in hospital as the place of occurrence of the external cause body mass index (bmi) 38.0-38.9, adult unspecified b-cell lymphoma, extranodal and solid organ sites
white m 77 $temp  97.3  heartrate  69.0  resprate  15.0  o2sat  100.0  sbp  129.0  dbp  61.0  rhythm    pain  0  $hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  111  mg dl$aspirin  300  mg ; carbidopa-levodopa (25-100)  1  tab ; ropinirole  4  mg ; lactated ringers  1000  ml ; selegiline hcl  5  mg ; heparin  5000  unit ; aspirin  81  mg ; cyanocobalamin  50  mcg ; senna  5  ml ; senna  1  tab ; vitamin d  1000  unit ; carbidopa-levodopa (25-100)  2  tab ; tasmar  50  mg ; levothyroxine sodium  88  mcg ; levothyroxine sodium  75  mcg ; ropinirole  3  mg ; fludrocortisone acetate  0.2  mg ; d5 1 2ns  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; levothyroxine sodium  100  mcg ; ropinirole  12  mg ; 
paralysis agitans open wound of knee, leg [except thigh], and ankle, without mention of complication long-term (current) use of aspirin open wound of forehead, without mention of complication unspecified acquired hypothyroidism conjunctival hemorrhage head injury, unspecified history of fall superficial injury of eyelids and periocular area fall from other slipping, tripping, or stumbling home accidents other orchitis, epididymitis, and epididymo-orchitis, without mention of abscess unspecified acquired hypothyroidism paralysis agitans
white m 77 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  141  mg dl$influenza virus vaccine  0.5  ml ; levothyroxine sodium  100  mcg ; ropinirole  12  mg ; 
paralysis agitans open wound of knee, leg [except thigh], and ankle, without mention of complication long-term (current) use of aspirin open wound of forehead, without mention of complication unspecified acquired hypothyroidism conjunctival hemorrhage head injury, unspecified history of fall superficial injury of eyelids and periocular area fall from other slipping, tripping, or stumbling home accidents other orchitis, epididymitis, and epididymo-orchitis, without mention of abscess unspecified acquired hypothyroidism paralysis agitans
white m 77 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  122  mg dl$influenza virus vaccine  0.5  ml ; levothyroxine sodium  100  mcg ; ropinirole  12  mg ; carbidopa-levodopa (25-100)  4  tab ; potassium chloride (powder)  40  meq ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 5% dextrose  250  ml ; 
paralysis agitans open wound of knee, leg [except thigh], and ankle, without mention of complication long-term (current) use of aspirin open wound of forehead, without mention of complication unspecified acquired hypothyroidism conjunctival hemorrhage head injury, unspecified history of fall superficial injury of eyelids and periocular area fall from other slipping, tripping, or stumbling home accidents other orchitis, epididymitis, and epididymo-orchitis, without mention of abscess unspecified acquired hypothyroidism paralysis agitans
white m 77 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  127  mg dl$levothyroxine sodium  100  mcg ; ropinirole  12  mg ; carbidopa-levodopa (25-100)  4  tab ; 5% dextrose  250  ml ; 
paralysis agitans open wound of knee, leg [except thigh], and ankle, without mention of complication long-term (current) use of aspirin open wound of forehead, without mention of complication unspecified acquired hypothyroidism conjunctival hemorrhage head injury, unspecified history of fall superficial injury of eyelids and periocular area fall from other slipping, tripping, or stumbling home accidents other orchitis, epididymitis, and epididymo-orchitis, without mention of abscess unspecified acquired hypothyroidism paralysis agitans
white m 77 $nan$nan$levothyroxine sodium  100  mcg ; ropinirole  12  mg ; carbidopa-levodopa (25-100)  4  tab ; ropinirole  2  mg ; ropinirole  10  mg ; 
paralysis agitans open wound of knee, leg [except thigh], and ankle, without mention of complication long-term (current) use of aspirin open wound of forehead, without mention of complication unspecified acquired hypothyroidism conjunctival hemorrhage head injury, unspecified history of fall superficial injury of eyelids and periocular area fall from other slipping, tripping, or stumbling home accidents other orchitis, epididymitis, and epididymo-orchitis, without mention of abscess unspecified acquired hypothyroidism paralysis agitans
asian m 55 $temp  100.0  heartrate  102.0  resprate  22.0  o2sat  98.0  sbp  119.0  dbp  67.0  rhythm    pain  0  ; temp    heartrate  101.0  resprate  22.0  o2sat  98.0  sbp  120.0  dbp  60.0  rhythm    pain  0  ; temp  103.2  heartrate  135.0  resprate  17.0  o2sat  99.0  sbp  193.0  dbp  94.0  rhythm    pain   2  ; temp  103.1  heartrate  127.0  resprate  28.0  o2sat  99.0  sbp  195.0  dbp  89.0  rhythm    pain  2  ; temp  100.4  heartrate  115.0  resprate  26.0  o2sat  98.0  sbp  175.0  dbp  80.0  rhythm    pain  1  ; temp  102.0  heartrate  117.0  resprate  24.0  o2sat  97.0  sbp  178.0  dbp  93.0  rhythm    pain  0  ; temp  102.7  heartrate  119.0  resprate  26.0  o2sat  98.0  sbp  164.0  dbp  86.0  rhythm    pain  0  ; temp    heartrate  114.0  resprate  24.0  o2sat  98.0  sbp  171.0  dbp  96.0  rhythm    pain  5  ; temp  100.0  heartrate  103.0  resprate  24.0  o2sat  97.0  sbp  154.0  dbp  86.0  rhythm    pain  4  $hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  92  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  227  mg dl; chemistry blood glucose  201  mg dl; blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  flush  3  ml ; valganciclovir  900  mg ; trazodone  75  mg ; tramadol  50  mg ; tamsulosin  0.8  mg ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; baclofen  10  mg ; acetaminophen  650  mg ; insulin  0  unit ; 0.9% sodium chloride  50  ml ; ampicillin sodium  500  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; soln  100  ml ; acetaminophen iv  1000  mg ; sodium chloride 0.9%  1000  ml ; sulfameth trimethoprim ss  1  tab ; sertraline  25  mg ; metoprolol tartrate  75  mg ; aspirin  81  mg ; sodium bicarbonate  650  mg ; bag  2  bag ; magnesium sulfate  4  gm ; mycophenolate sodium dr  360  mg ; daptomycin  600  mg ; warfarin  1  mg ; warfarin  2  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
dependence on wheelchair other complication of kidney transplant hyperparathyroidism, unspecified infection and inflammatory reaction due to indwelling urethral catheter, initial encounter other retention of urine urinary tract infection, site not specified unspecified hydronephrosis sepsis due to enterococcus enterococcus as the cause of diseases classified elsewhere type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye long term (current) use of anticoagulants unspecified place or not applicable aphasia following cerebral infarction other forms of acute ischemic heart disease type 1 diabetes mellitus with diabetic chronic kidney disease bladder-neck obstruction urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of insulin resistance to vancomycin chronic diastolic (congestive) heart failure type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic kidney disease, stage 3 (moderate) type 1 diabetes mellitus with hyperglycemia paroxysmal atrial fibrillation hypoxemia hypotension, unspecified anemia, unspecified infection and inflammatory reaction due to other urinary stents, initial encounter hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side hypokalemia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other secondary pulmonary hypertension unspecified atrial fibrillation retention of urine, unspecified long term (current) use of insulin dependence on wheelchair acute on chronic diastolic (congestive) heart failure hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease aphasia following unspecified cerebrovascular disease kidney transplant status panic disorder [episodic paroxysmal anxiety] long term (current) use of anticoagulants kidney transplant failure unspecified atrial fibrillation
asian m 55 $nan$hematology blood hematocrit  24.2  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  107  k ul; hematology blood platelet count  133  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  219  mg dl; chemistry blood lactate dehydrogenase (ld)  142  iu l$sodium chloride 0.9%  flush  3  ml ; valganciclovir  900  mg ; trazodone  75  mg ; tramadol  50  mg ; tamsulosin  0.8  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; baclofen  10  mg ; insulin  0  unit ; acetaminophen  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; sodium chloride 0.9%  1000  ml ; sulfameth trimethoprim ss  1  tab ; aspirin  81  mg ; sodium bicarbonate  650  mg ; bag  2  bag ; magnesium sulfate  4  gm ; mycophenolate sodium dr  360  mg ; daptomycin  600  mg ; warfarin  1  mg ; warfarin  2  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; tacrolimus  3  mg ; atorvastatin  40  mg ; insulin  30  unit ; neutra-phos  1  pkt ; 
dependence on wheelchair other complication of kidney transplant hyperparathyroidism, unspecified infection and inflammatory reaction due to indwelling urethral catheter, initial encounter other retention of urine urinary tract infection, site not specified unspecified hydronephrosis sepsis due to enterococcus enterococcus as the cause of diseases classified elsewhere type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye long term (current) use of anticoagulants unspecified place or not applicable aphasia following cerebral infarction other forms of acute ischemic heart disease type 1 diabetes mellitus with diabetic chronic kidney disease bladder-neck obstruction urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of insulin resistance to vancomycin chronic diastolic (congestive) heart failure type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic kidney disease, stage 3 (moderate) type 1 diabetes mellitus with hyperglycemia paroxysmal atrial fibrillation hypoxemia hypotension, unspecified anemia, unspecified infection and inflammatory reaction due to other urinary stents, initial encounter hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side hypokalemia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other secondary pulmonary hypertension unspecified atrial fibrillation retention of urine, unspecified long term (current) use of insulin dependence on wheelchair acute on chronic diastolic (congestive) heart failure hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease aphasia following unspecified cerebrovascular disease kidney transplant status panic disorder [episodic paroxysmal anxiety] long term (current) use of anticoagulants kidney transplant failure unspecified atrial fibrillation
asian m 55 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  200  mg dl; chemistry blood glucose  195  mg dl$sodium chloride 0.9%  flush  3  ml ; valganciclovir  900  mg ; trazodone  75  mg ; tramadol  50  mg ; tamsulosin  0.8  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; baclofen  10  mg ; insulin  0  unit ; acetaminophen  1000  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  81  mg ; sodium bicarbonate  650  mg ; mycophenolate sodium dr  360  mg ; daptomycin  600  mg ; warfarin  1  mg ; warfarin  2  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; tacrolimus  3  mg ; atorvastatin  40  mg ; insulin  30  unit ; neutra-phos  1  pkt ; polyethylene glycol  17  g ; metoprolol tartrate  5  mg ; nitroglycerin sl  0.4  mg ; potassium chloride  40  meq ; warfarin  1.5  mg ; neutra-phos  2  pkt ; 
dependence on wheelchair other complication of kidney transplant hyperparathyroidism, unspecified infection and inflammatory reaction due to indwelling urethral catheter, initial encounter other retention of urine urinary tract infection, site not specified unspecified hydronephrosis sepsis due to enterococcus enterococcus as the cause of diseases classified elsewhere type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye long term (current) use of anticoagulants unspecified place or not applicable aphasia following cerebral infarction other forms of acute ischemic heart disease type 1 diabetes mellitus with diabetic chronic kidney disease bladder-neck obstruction urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of insulin resistance to vancomycin chronic diastolic (congestive) heart failure type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic kidney disease, stage 3 (moderate) type 1 diabetes mellitus with hyperglycemia paroxysmal atrial fibrillation hypoxemia hypotension, unspecified anemia, unspecified infection and inflammatory reaction due to other urinary stents, initial encounter hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side hypokalemia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other secondary pulmonary hypertension unspecified atrial fibrillation retention of urine, unspecified long term (current) use of insulin dependence on wheelchair acute on chronic diastolic (congestive) heart failure hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease aphasia following unspecified cerebrovascular disease kidney transplant status panic disorder [episodic paroxysmal anxiety] long term (current) use of anticoagulants kidney transplant failure unspecified atrial fibrillation
asian m 55 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  197  mg dl$sodium chloride 0.9%  flush  3  ml ; valganciclovir  900  mg ; trazodone  75  mg ; tramadol  50  mg ; tamsulosin  0.8  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; baclofen  10  mg ; insulin  0  unit ; acetaminophen  1000  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  81  mg ; sodium bicarbonate  650  mg ; mycophenolate sodium dr  360  mg ; daptomycin  600  mg ; atorvastatin  40  mg ; insulin  30  unit ; polyethylene glycol  17  g ; metoprolol tartrate  5  mg ; nitroglycerin sl  0.4  mg ; potassium chloride  40  meq ; warfarin  1.5  mg ; neutra-phos  2  pkt ; 
dependence on wheelchair other complication of kidney transplant hyperparathyroidism, unspecified infection and inflammatory reaction due to indwelling urethral catheter, initial encounter other retention of urine urinary tract infection, site not specified unspecified hydronephrosis sepsis due to enterococcus enterococcus as the cause of diseases classified elsewhere type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye long term (current) use of anticoagulants unspecified place or not applicable aphasia following cerebral infarction other forms of acute ischemic heart disease type 1 diabetes mellitus with diabetic chronic kidney disease bladder-neck obstruction urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of insulin resistance to vancomycin chronic diastolic (congestive) heart failure type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic kidney disease, stage 3 (moderate) type 1 diabetes mellitus with hyperglycemia paroxysmal atrial fibrillation hypoxemia hypotension, unspecified anemia, unspecified infection and inflammatory reaction due to other urinary stents, initial encounter hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side hypokalemia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other secondary pulmonary hypertension unspecified atrial fibrillation retention of urine, unspecified long term (current) use of insulin dependence on wheelchair acute on chronic diastolic (congestive) heart failure hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease aphasia following unspecified cerebrovascular disease kidney transplant status panic disorder [episodic paroxysmal anxiety] long term (current) use of anticoagulants kidney transplant failure unspecified atrial fibrillation
asian m 55 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  211  mg dl; chemistry blood glucose  273  mg dl$sodium chloride 0.9%  flush  3  ml ; valganciclovir  900  mg ; trazodone  75  mg ; tramadol  50  mg ; tamsulosin  0.8  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; baclofen  10  mg ; insulin  0  unit ; acetaminophen  1000  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  81  mg ; sodium bicarbonate  650  mg ; mycophenolate sodium dr  360  mg ; daptomycin  600  mg ; atorvastatin  40  mg ; insulin  30  unit ; polyethylene glycol  17  g ; warfarin  1.5  mg ; metoprolol tartrate  37.5  mg ; potassium chloride (powder)  40  meq ; 
dependence on wheelchair other complication of kidney transplant hyperparathyroidism, unspecified infection and inflammatory reaction due to indwelling urethral catheter, initial encounter other retention of urine urinary tract infection, site not specified unspecified hydronephrosis sepsis due to enterococcus enterococcus as the cause of diseases classified elsewhere type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye long term (current) use of anticoagulants unspecified place or not applicable aphasia following cerebral infarction other forms of acute ischemic heart disease type 1 diabetes mellitus with diabetic chronic kidney disease bladder-neck obstruction urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of insulin resistance to vancomycin chronic diastolic (congestive) heart failure type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic kidney disease, stage 3 (moderate) type 1 diabetes mellitus with hyperglycemia paroxysmal atrial fibrillation hypoxemia hypotension, unspecified anemia, unspecified infection and inflammatory reaction due to other urinary stents, initial encounter hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side hypokalemia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other secondary pulmonary hypertension unspecified atrial fibrillation retention of urine, unspecified long term (current) use of insulin dependence on wheelchair acute on chronic diastolic (congestive) heart failure hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease aphasia following unspecified cerebrovascular disease kidney transplant status panic disorder [episodic paroxysmal anxiety] long term (current) use of anticoagulants kidney transplant failure unspecified atrial fibrillation
asian m 55 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  163  mg dl; chemistry blood lactate dehydrogenase (ld)  115  iu l$sodium chloride 0.9%  flush  3  ml ; valganciclovir  900  mg ; trazodone  75  mg ; tramadol  50  mg ; tamsulosin  0.8  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; baclofen  10  mg ; insulin  0  unit ; acetaminophen  1000  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  81  mg ; sodium bicarbonate  650  mg ; mycophenolate sodium dr  360  mg ; daptomycin  600  mg ; atorvastatin  40  mg ; insulin  30  unit ; polyethylene glycol  17  g ; warfarin  1.5  mg ; potassium chloride (powder)  40  meq ; metoprolol succinate xl  75  mg ; nystatin cream  1  appl ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; amoxicillin  500  mg ; warfarin  3  mg ; 
dependence on wheelchair other complication of kidney transplant hyperparathyroidism, unspecified infection and inflammatory reaction due to indwelling urethral catheter, initial encounter other retention of urine urinary tract infection, site not specified unspecified hydronephrosis sepsis due to enterococcus enterococcus as the cause of diseases classified elsewhere type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye long term (current) use of anticoagulants unspecified place or not applicable aphasia following cerebral infarction other forms of acute ischemic heart disease type 1 diabetes mellitus with diabetic chronic kidney disease bladder-neck obstruction urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of insulin resistance to vancomycin chronic diastolic (congestive) heart failure type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic kidney disease, stage 3 (moderate) type 1 diabetes mellitus with hyperglycemia paroxysmal atrial fibrillation hypoxemia hypotension, unspecified anemia, unspecified infection and inflammatory reaction due to other urinary stents, initial encounter hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side hypokalemia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other secondary pulmonary hypertension unspecified atrial fibrillation retention of urine, unspecified long term (current) use of insulin dependence on wheelchair acute on chronic diastolic (congestive) heart failure hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease aphasia following unspecified cerebrovascular disease kidney transplant status panic disorder [episodic paroxysmal anxiety] long term (current) use of anticoagulants kidney transplant failure unspecified atrial fibrillation
asian m 55 $nan$nan$sodium chloride 0.9%  flush  3  ml ; valganciclovir  900  mg ; trazodone  75  mg ; tramadol  50  mg ; tamsulosin  0.8  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; baclofen  10  mg ; insulin  0  unit ; acetaminophen  1000  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  81  mg ; sodium bicarbonate  650  mg ; mycophenolate sodium dr  360  mg ; atorvastatin  40  mg ; insulin  30  unit ; polyethylene glycol  17  g ; metoprolol succinate xl  75  mg ; nystatin cream  1  appl ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; amoxicillin  500  mg ; warfarin  3  mg ; 
dependence on wheelchair other complication of kidney transplant hyperparathyroidism, unspecified infection and inflammatory reaction due to indwelling urethral catheter, initial encounter other retention of urine urinary tract infection, site not specified unspecified hydronephrosis sepsis due to enterococcus enterococcus as the cause of diseases classified elsewhere type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye long term (current) use of anticoagulants unspecified place or not applicable aphasia following cerebral infarction other forms of acute ischemic heart disease type 1 diabetes mellitus with diabetic chronic kidney disease bladder-neck obstruction urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure long term (current) use of insulin resistance to vancomycin chronic diastolic (congestive) heart failure type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure chronic kidney disease, stage 3 (moderate) type 1 diabetes mellitus with hyperglycemia paroxysmal atrial fibrillation hypoxemia hypotension, unspecified anemia, unspecified infection and inflammatory reaction due to other urinary stents, initial encounter hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side hypokalemia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other secondary pulmonary hypertension unspecified atrial fibrillation retention of urine, unspecified long term (current) use of insulin dependence on wheelchair acute on chronic diastolic (congestive) heart failure hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease aphasia following unspecified cerebrovascular disease kidney transplant status panic disorder [episodic paroxysmal anxiety] long term (current) use of anticoagulants kidney transplant failure unspecified atrial fibrillation
black african american m 67 $temp  97.6  heartrate  93.0  resprate  28.0  o2sat  99.0  sbp  150.0  dbp  111.0  rhythm    pain  6  ; temp  97.6  heartrate  89.0  resprate  27.0  o2sat  100.0  sbp  125.0  dbp  74.0  rhythm    pain  0  $nan$aspirin  325  mg ; folic acid  1  mg ; 
esophageal reflux other malignant neoplasm without specification of site chronic airway obstruction, not elsewhere classified eosinophilia chronic kidney disease, stage ii (mild) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other pulmonary embolism and infarction secondary malignant neoplasm of pleura acute venous embolism and thrombosis of unspecified deep vessels of lower extremity secondary malignant neoplasm of pleura gout, unspecified malignant neoplasm of bronchus and lung, unspecified acute venous embolism and thrombosis of deep vessels of distal lower extremity hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage ii (mild) other pulmonary embolism and infarction other postprocedural status peripheral vascular disease, unspecified personal history of tobacco use chronic airway obstruction, not elsewhere classified chronic kidney disease, stage ii (mild) neoplasm related pain (acute) (chronic) loss of weight secondary malignant neoplasm of pleura unspecified disorder of lipoid metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified pleural effusion personal history of tobacco use chest pain, unspecified other acute postoperative pain esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified forms of effusion, except tuberculous chronic airway obstruction, not elsewhere classified acute kidney failure, unspecified gout, unspecified esophageal reflux chronic kidney disease, stage ii (mild) other postprocedural status personal history of tobacco use chronic kidney disease, stage ii (mild) chronic airway obstruction, not elsewhere classified arthropathy, unspecified, site unspecified esophageal reflux gout, unspecified tobacco use disorder hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aneurysm of iliac artery
black african american m 67 $nan$hematology blood hematocrit  35.4  %; hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  102  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  75  mg dl; chemistry blood % hemoglobin a1c  5.6  %$aspirin  325  mg ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; enoxaparin sodium  80  mg ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; senna  1  tab ; labetalol  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ondansetron  8  mg ; oxycodone (immediate release)   5-10  mg ; prochlorperazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  10  mg ; insulin  0  unit ; megestrol acetate  400  mg ; aspirin  300  mg ; aspirin  75  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; d5 1 2ns  1000  ml ; 
esophageal reflux other malignant neoplasm without specification of site chronic airway obstruction, not elsewhere classified eosinophilia chronic kidney disease, stage ii (mild) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other pulmonary embolism and infarction secondary malignant neoplasm of pleura acute venous embolism and thrombosis of unspecified deep vessels of lower extremity secondary malignant neoplasm of pleura gout, unspecified malignant neoplasm of bronchus and lung, unspecified acute venous embolism and thrombosis of deep vessels of distal lower extremity hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage ii (mild) other pulmonary embolism and infarction other postprocedural status peripheral vascular disease, unspecified personal history of tobacco use chronic airway obstruction, not elsewhere classified chronic kidney disease, stage ii (mild) neoplasm related pain (acute) (chronic) loss of weight secondary malignant neoplasm of pleura unspecified disorder of lipoid metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified pleural effusion personal history of tobacco use chest pain, unspecified other acute postoperative pain esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified forms of effusion, except tuberculous chronic airway obstruction, not elsewhere classified acute kidney failure, unspecified gout, unspecified esophageal reflux chronic kidney disease, stage ii (mild) other postprocedural status personal history of tobacco use chronic kidney disease, stage ii (mild) chronic airway obstruction, not elsewhere classified arthropathy, unspecified, site unspecified esophageal reflux gout, unspecified tobacco use disorder hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aneurysm of iliac artery
black african american m 67 $nan$nan$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  80  mg ; acetaminophen iv  1000  mg ; labetalol  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; oxycodone (immediate release)   5-10  mg ; prochlorperazine  10  mg ; dextrose 50%  12.5  gm ; megestrol acetate  400  mg ; aspirin  300  mg ; aspirin  75  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; d5 1 2ns  1000  ml ; lorazepam  0.25  mg ; labetalol  10  mg ; d5ns  1000  ml ; 
esophageal reflux other malignant neoplasm without specification of site chronic airway obstruction, not elsewhere classified eosinophilia chronic kidney disease, stage ii (mild) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other pulmonary embolism and infarction secondary malignant neoplasm of pleura acute venous embolism and thrombosis of unspecified deep vessels of lower extremity secondary malignant neoplasm of pleura gout, unspecified malignant neoplasm of bronchus and lung, unspecified acute venous embolism and thrombosis of deep vessels of distal lower extremity hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage ii (mild) other pulmonary embolism and infarction other postprocedural status peripheral vascular disease, unspecified personal history of tobacco use chronic airway obstruction, not elsewhere classified chronic kidney disease, stage ii (mild) neoplasm related pain (acute) (chronic) loss of weight secondary malignant neoplasm of pleura unspecified disorder of lipoid metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified pleural effusion personal history of tobacco use chest pain, unspecified other acute postoperative pain esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified forms of effusion, except tuberculous chronic airway obstruction, not elsewhere classified acute kidney failure, unspecified gout, unspecified esophageal reflux chronic kidney disease, stage ii (mild) other postprocedural status personal history of tobacco use chronic kidney disease, stage ii (mild) chronic airway obstruction, not elsewhere classified arthropathy, unspecified, site unspecified esophageal reflux gout, unspecified tobacco use disorder hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aneurysm of iliac artery
black african american m 67 $nan$nan$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  80  mg ; acetaminophen iv  1000  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; valsartan  80  mg ; simvastatin  10  mg ; artificial tears  1-2  drop ; 
esophageal reflux other malignant neoplasm without specification of site chronic airway obstruction, not elsewhere classified eosinophilia chronic kidney disease, stage ii (mild) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other pulmonary embolism and infarction secondary malignant neoplasm of pleura acute venous embolism and thrombosis of unspecified deep vessels of lower extremity secondary malignant neoplasm of pleura gout, unspecified malignant neoplasm of bronchus and lung, unspecified acute venous embolism and thrombosis of deep vessels of distal lower extremity hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage ii (mild) other pulmonary embolism and infarction other postprocedural status peripheral vascular disease, unspecified personal history of tobacco use chronic airway obstruction, not elsewhere classified chronic kidney disease, stage ii (mild) neoplasm related pain (acute) (chronic) loss of weight secondary malignant neoplasm of pleura unspecified disorder of lipoid metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified pleural effusion personal history of tobacco use chest pain, unspecified other acute postoperative pain esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified forms of effusion, except tuberculous chronic airway obstruction, not elsewhere classified acute kidney failure, unspecified gout, unspecified esophageal reflux chronic kidney disease, stage ii (mild) other postprocedural status personal history of tobacco use chronic kidney disease, stage ii (mild) chronic airway obstruction, not elsewhere classified arthropathy, unspecified, site unspecified esophageal reflux gout, unspecified tobacco use disorder hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aneurysm of iliac artery
black african american m 67 $nan$nan$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  80  mg ; acetaminophen iv  1000  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; valsartan  80  mg ; simvastatin  10  mg ; artificial tears  1-2  drop ; oxycodone (immediate release)   5  mg ; acetaminophen  325-650  mg ; labetalol  200  mg ; mirtazapine  7.5  mg ; oxycodone (immediate release)   10  mg ; morphine sulfate (oral soln.)  5-10  mg ; oxycodone liquid  10-15  mg ; 
esophageal reflux other malignant neoplasm without specification of site chronic airway obstruction, not elsewhere classified eosinophilia chronic kidney disease, stage ii (mild) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other pulmonary embolism and infarction secondary malignant neoplasm of pleura acute venous embolism and thrombosis of unspecified deep vessels of lower extremity secondary malignant neoplasm of pleura gout, unspecified malignant neoplasm of bronchus and lung, unspecified acute venous embolism and thrombosis of deep vessels of distal lower extremity hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage ii (mild) other pulmonary embolism and infarction other postprocedural status peripheral vascular disease, unspecified personal history of tobacco use chronic airway obstruction, not elsewhere classified chronic kidney disease, stage ii (mild) neoplasm related pain (acute) (chronic) loss of weight secondary malignant neoplasm of pleura unspecified disorder of lipoid metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified pleural effusion personal history of tobacco use chest pain, unspecified other acute postoperative pain esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified forms of effusion, except tuberculous chronic airway obstruction, not elsewhere classified acute kidney failure, unspecified gout, unspecified esophageal reflux chronic kidney disease, stage ii (mild) other postprocedural status personal history of tobacco use chronic kidney disease, stage ii (mild) chronic airway obstruction, not elsewhere classified arthropathy, unspecified, site unspecified esophageal reflux gout, unspecified tobacco use disorder hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aneurysm of iliac artery
black african american m 67 $nan$nan$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  80  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; ondansetron  4  mg ; bisacodyl  10  mg ; valsartan  80  mg ; simvastatin  10  mg ; artificial tears  1-2  drop ; acetaminophen  325-650  mg ; oxycodone liquid  10-15  mg ; carvedilol  12.5  mg ; mirtazapine  15  mg ; 
esophageal reflux other malignant neoplasm without specification of site chronic airway obstruction, not elsewhere classified eosinophilia chronic kidney disease, stage ii (mild) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other pulmonary embolism and infarction secondary malignant neoplasm of pleura acute venous embolism and thrombosis of unspecified deep vessels of lower extremity secondary malignant neoplasm of pleura gout, unspecified malignant neoplasm of bronchus and lung, unspecified acute venous embolism and thrombosis of deep vessels of distal lower extremity hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage ii (mild) other pulmonary embolism and infarction other postprocedural status peripheral vascular disease, unspecified personal history of tobacco use chronic airway obstruction, not elsewhere classified chronic kidney disease, stage ii (mild) neoplasm related pain (acute) (chronic) loss of weight secondary malignant neoplasm of pleura unspecified disorder of lipoid metabolism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified pleural effusion personal history of tobacco use chest pain, unspecified other acute postoperative pain esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified forms of effusion, except tuberculous chronic airway obstruction, not elsewhere classified acute kidney failure, unspecified gout, unspecified esophageal reflux chronic kidney disease, stage ii (mild) other postprocedural status personal history of tobacco use chronic kidney disease, stage ii (mild) chronic airway obstruction, not elsewhere classified arthropathy, unspecified, site unspecified esophageal reflux gout, unspecified tobacco use disorder hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aneurysm of iliac artery
white m 91 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry urine chloride, urine  99  meq l; chemistry urine creatinine, urine  76  mg dl; chemistry urine potassium, urine  32  meq l; chemistry urine sodium, urine  109  meq l; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  92  mg dl; chemistry urine protein creatinine ratio  0.5  ratio$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; levothyroxine sodium  75  mcg ; amlodipine  2.5  mg ; heparin  5000  unit ; exelon  1.5  mg ; 
 
white m 91 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; levothyroxine sodium  75  mcg ; amlodipine  2.5  mg ; heparin  5000  unit ; exelon  1.5  mg ; trazodone  50  mg ; amlodipine  5  mg ; isosorbide dinitrate  30  mg ; 
 
white m 91 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; levothyroxine sodium  75  mcg ; heparin  5000  unit ; exelon  1.5  mg ; trazodone  50  mg ; amlodipine  5  mg ; isosorbide dinitrate  30  mg ; amlodipine  10  mg ; 
 
white f 86 $temp    heartrate  102.0  resprate  30.0  o2sat  98.0  sbp  131.0  dbp  69.0  rhythm    pain    ; temp  98.9  heartrate  96.0  resprate  23.0  o2sat  98.0  sbp  118.0  dbp  58.0  rhythm    pain  0  $hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  330  mg dl; chemistry blood glucose  292  mg dl; chemistry blood glucose  218  mg dl; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  2.2  mmol l; chemistry blood % hemoglobin a1c  9.0  %$bag  1  bag ; senna  8.6  mg ; bisacodyl  10  mg ; potassium chloride  40  meq ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; metoprolol tartrate  6.25  mg ; heparin  1200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; trazodone  50  mg ; oxycodone (immediate release)  5  mg ; acetaminophen  500-1000  mg ; pantoprazole  40  mg ; gabapentin  1200  mg ; furosemide  80  mg ; metronidazole  500  mg ; metoprolol tartrate  12.5  mg ; furosemide  120  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; chlorothiazide sodium  500  mg ; aspirin  81  mg ; vitamin d  400  unit ; clopidogrel  75  mg ; escitalopram oxalate  10  mg ; 
hypertensive heart disease with heart failure type 2 diabetes mellitus without complications old myocardial infarction other chronic pain presence of coronary angioplasty implant and graft presence of left artificial hip joint chronic combined systolic (congestive) and diastolic (congestive) heart failure unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere hyperlipidemia, unspecified collapsed vertebra, not elsewhere classified, thoracic region, initial encounter for fracture atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of oral hypoglycemic drugs personal history of malignant neoplasm of other parts of uterus headache collapsed vertebra, not elsewhere classified, thoracolumbar region, initial encounter for fracture gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation presence of artificial knee joint, bilateral ulcer of esophagus without bleeding pain in left shoulder atherosclerosis of other arteries urinary tract infection, site not specified long term (current) use of aspirin old myocardial infarction unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause low back pain other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of artificial knee joint, bilateral type 2 diabetes mellitus without complications chronic combined systolic (congestive) and diastolic (congestive) heart failure stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter atherosclerotic heart disease of native coronary artery with unstable angina pectoris gastro-esophageal reflux disease without esophagitis hyperlipidemia, unspecified presence of left artificial hip joint gastro-esophageal reflux disease without esophagitis acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure presence of left artificial hip joint presence of coronary angioplasty implant and graft presence of artificial knee joint, bilateral old myocardial infarction adverse effect of other drugs, medicaments and biological substances, initial encounter atrioventricular block, second degree patient room in hospital as the place of occurrence of the external cause atherosclerotic heart disease of native coronary artery without angina pectoris st elevation (stemi) myocardial infarction involving right coronary artery toxic gastroenteritis and colitis orthostatic hypotension type 2 diabetes mellitus without complications
white f 86 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  251  mg dl; chemistry blood glucose  232  mg dl; blood gas blood lactate  1.3  mmol l$bag  1  bag ; senna  8.6  mg ; bisacodyl  10  mg ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; trazodone  50  mg ; oxycodone (immediate release)  5  mg ; acetaminophen  500-1000  mg ; pantoprazole  40  mg ; gabapentin  1200  mg ; metoprolol tartrate  12.5  mg ; furosemide  120  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; chlorothiazide sodium  500  mg ; aspirin  81  mg ; vitamin d  400  unit ; clopidogrel  75  mg ; vial  1  vial ; ceftriaxone  1  gm ; atorvastatin  80  mg ; miconazole powder 2%  1  appl ; artificial tears  1-2  drop ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; psyllium wafer  1-2  waf ; pramipexole  0.25  mg ; furosemide  20  mg ; furosemide  100  mg ; sodium chloride 0.9%  flush  3-10  ml ; 
hypertensive heart disease with heart failure type 2 diabetes mellitus without complications old myocardial infarction other chronic pain presence of coronary angioplasty implant and graft presence of left artificial hip joint chronic combined systolic (congestive) and diastolic (congestive) heart failure unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere hyperlipidemia, unspecified collapsed vertebra, not elsewhere classified, thoracic region, initial encounter for fracture atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of oral hypoglycemic drugs personal history of malignant neoplasm of other parts of uterus headache collapsed vertebra, not elsewhere classified, thoracolumbar region, initial encounter for fracture gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation presence of artificial knee joint, bilateral ulcer of esophagus without bleeding pain in left shoulder atherosclerosis of other arteries urinary tract infection, site not specified long term (current) use of aspirin old myocardial infarction unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause low back pain other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of artificial knee joint, bilateral type 2 diabetes mellitus without complications chronic combined systolic (congestive) and diastolic (congestive) heart failure stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter atherosclerotic heart disease of native coronary artery with unstable angina pectoris gastro-esophageal reflux disease without esophagitis hyperlipidemia, unspecified presence of left artificial hip joint gastro-esophageal reflux disease without esophagitis acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure presence of left artificial hip joint presence of coronary angioplasty implant and graft presence of artificial knee joint, bilateral old myocardial infarction adverse effect of other drugs, medicaments and biological substances, initial encounter atrioventricular block, second degree patient room in hospital as the place of occurrence of the external cause atherosclerotic heart disease of native coronary artery without angina pectoris st elevation (stemi) myocardial infarction involving right coronary artery toxic gastroenteritis and colitis orthostatic hypotension type 2 diabetes mellitus without complications
white f 86 $nan$hematology blood hematocrit  34.1  %; hematology blood hematocrit  36.9  %; hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  205  k ul; hematology blood platelet count  226  k ul; hematology blood platelet count  164  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  25  meq l; chemistry blood anion gap  26  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; hematology urine wbc  44  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  437  mg dl; chemistry blood glucose  426  mg dl; chemistry blood glucose  348  mg dl; chemistry blood lactate dehydrogenase (ld)  1470  iu l; chemistry blood lactate dehydrogenase (ld)  1155  iu l; chemistry blood albumin  2.7  g dl; blood gas blood free calcium  1.01  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  3.7  mmol l; blood gas blood lactate  4.0  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  12.1  mmol l; blood gas blood lactate  6.9  mmol l; blood gas blood lactate  9.7  mmol l; blood gas blood lactate  6.0  mmol l; blood gas blood chloride, whole blood  99  meq l; blood gas blood glucose  133  mg dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  133  meq l; hematology urine glucose  70  mg dl$senna  8.6  mg ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; trazodone  50  mg ; oxycodone (immediate release)  5  mg ; acetaminophen  500-1000  mg ; pantoprazole  40  mg ; metoprolol tartrate  12.5  mg ; aspirin  81  mg ; vitamin d  400  unit ; clopidogrel  75  mg ; vial  1  vial ; ceftriaxone  1  gm ; atorvastatin  80  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  3-10  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  100  ml ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; rosuvastatin calcium  20  mg ; d5w  250  ml ; dopamine  400  mg ; 0.9% sodium chloride  100  ml ; vasopressin  40  unit ; gabapentin  600  mg ; furosemide  160  mg ; sodium bicarbonate  50  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; cefepime  2  g ; acetaminophen (liquid)  1000  mg ; chlorothiazide  500  mg ; lansoprazole oral disintegrating tab  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; dobutamine  250  mg ; ns  100  ml ; acetaminophen iv  1000  mg ; 
hypertensive heart disease with heart failure type 2 diabetes mellitus without complications old myocardial infarction other chronic pain presence of coronary angioplasty implant and graft presence of left artificial hip joint chronic combined systolic (congestive) and diastolic (congestive) heart failure unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere hyperlipidemia, unspecified collapsed vertebra, not elsewhere classified, thoracic region, initial encounter for fracture atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of oral hypoglycemic drugs personal history of malignant neoplasm of other parts of uterus headache collapsed vertebra, not elsewhere classified, thoracolumbar region, initial encounter for fracture gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation presence of artificial knee joint, bilateral ulcer of esophagus without bleeding pain in left shoulder atherosclerosis of other arteries urinary tract infection, site not specified long term (current) use of aspirin old myocardial infarction unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause low back pain other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of artificial knee joint, bilateral type 2 diabetes mellitus without complications chronic combined systolic (congestive) and diastolic (congestive) heart failure stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter atherosclerotic heart disease of native coronary artery with unstable angina pectoris gastro-esophageal reflux disease without esophagitis hyperlipidemia, unspecified presence of left artificial hip joint gastro-esophageal reflux disease without esophagitis acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure presence of left artificial hip joint presence of coronary angioplasty implant and graft presence of artificial knee joint, bilateral old myocardial infarction adverse effect of other drugs, medicaments and biological substances, initial encounter atrioventricular block, second degree patient room in hospital as the place of occurrence of the external cause atherosclerotic heart disease of native coronary artery without angina pectoris st elevation (stemi) myocardial infarction involving right coronary artery toxic gastroenteritis and colitis orthostatic hypotension type 2 diabetes mellitus without complications
white f 86 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  64  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  6.7  mg dl; chemistry blood glucose  287  mg dl; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  9.0  g dl$sodium chloride 0.9%  flush  10  ml ; sterile water  100  ml ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; rosuvastatin calcium  20  mg ; d5w  250  ml ; dopamine  400  mg ; cefepime  2  g ; lansoprazole oral disintegrating tab  30  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; dobutamine  250  mg ; ns  100  ml ; acetaminophen iv  1000  mg ; ceftazidime  2  g ; 
hypertensive heart disease with heart failure type 2 diabetes mellitus without complications old myocardial infarction other chronic pain presence of coronary angioplasty implant and graft presence of left artificial hip joint chronic combined systolic (congestive) and diastolic (congestive) heart failure unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere hyperlipidemia, unspecified collapsed vertebra, not elsewhere classified, thoracic region, initial encounter for fracture atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of oral hypoglycemic drugs personal history of malignant neoplasm of other parts of uterus headache collapsed vertebra, not elsewhere classified, thoracolumbar region, initial encounter for fracture gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation presence of artificial knee joint, bilateral ulcer of esophagus without bleeding pain in left shoulder atherosclerosis of other arteries urinary tract infection, site not specified long term (current) use of aspirin old myocardial infarction unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause low back pain other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of artificial knee joint, bilateral type 2 diabetes mellitus without complications chronic combined systolic (congestive) and diastolic (congestive) heart failure stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter atherosclerotic heart disease of native coronary artery with unstable angina pectoris gastro-esophageal reflux disease without esophagitis hyperlipidemia, unspecified presence of left artificial hip joint gastro-esophageal reflux disease without esophagitis acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure presence of left artificial hip joint presence of coronary angioplasty implant and graft presence of artificial knee joint, bilateral old myocardial infarction adverse effect of other drugs, medicaments and biological substances, initial encounter atrioventricular block, second degree patient room in hospital as the place of occurrence of the external cause atherosclerotic heart disease of native coronary artery without angina pectoris st elevation (stemi) myocardial infarction involving right coronary artery toxic gastroenteritis and colitis orthostatic hypotension type 2 diabetes mellitus without complications
white f 66 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  370  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  44  mg dl; chemistry urine sodium, urine  84  meq l; chemistry urine urea nitrogen, urine  515  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  140  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; insulin  0  unit ; acetaminophen  650  mg ; verapamil sr  240  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; venlafaxine xr  150  mg ; pregabalin  25  mg ; pregabalin  375  mg ; lisinopril  20  mg ; lidocaine 5% patch  1  ptch ; 0.9% sodium chloride  500  ml ; docusate sodium  200  mg ; senna  2  tab ; venlafaxine xr  225  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled tobacco use disorder other acquired deformities of ankle and foot other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person boarding or alighting a car injured in collision with railway train or railway vehicle lumbosacral spondylosis without myelopathy bariatric surgery status personal history of malignant neoplasm of bronchus and lung depressive disorder, not elsewhere classified unspecified essential hypertension unspecified hereditary and idiopathic peripheral neuropathy other mechanical complication of other internal orthopedic device, implant, and graft arthrodesis status lumbago unspecified essential hypertension obesity, unspecified other and unspecified hyperlipidemia osteoarthrosis, unspecified whether generalized or localized, lower leg diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other accidents superficial injury of cornea tobacco use disorder other acquired deformities of ankle and foot backache, unspecified bariatric surgery status personal history of malignant neoplasm of bronchus and lung other specified intestinal obstruction unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bariatric surgery status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension delirium due to conditions classified elsewhere depressive disorder, not elsewhere classified intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) opioid type dependence, continuous polyneuropathy in diabetes
white f 66 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  333  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; acetaminophen  650  mg ; heparin  5000  unit ; venlafaxine xr  150  mg ; pregabalin  25  mg ; pregabalin  375  mg ; lidocaine 5% patch  1  ptch ; 0.9% sodium chloride  500  ml ; docusate sodium  200  mg ; senna  2  tab ; venlafaxine xr  225  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled tobacco use disorder other acquired deformities of ankle and foot other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person boarding or alighting a car injured in collision with railway train or railway vehicle lumbosacral spondylosis without myelopathy bariatric surgery status personal history of malignant neoplasm of bronchus and lung depressive disorder, not elsewhere classified unspecified essential hypertension unspecified hereditary and idiopathic peripheral neuropathy other mechanical complication of other internal orthopedic device, implant, and graft arthrodesis status lumbago unspecified essential hypertension obesity, unspecified other and unspecified hyperlipidemia osteoarthrosis, unspecified whether generalized or localized, lower leg diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other accidents superficial injury of cornea tobacco use disorder other acquired deformities of ankle and foot backache, unspecified bariatric surgery status personal history of malignant neoplasm of bronchus and lung other specified intestinal obstruction unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bariatric surgery status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension delirium due to conditions classified elsewhere depressive disorder, not elsewhere classified intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) opioid type dependence, continuous polyneuropathy in diabetes
white f 66 $nan$nan$sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; acetaminophen  650  mg ; heparin  5000  unit ; venlafaxine xr  150  mg ; pregabalin  25  mg ; pregabalin  375  mg ; lidocaine 5% patch  1  ptch ; docusate sodium  200  mg ; senna  2  tab ; venlafaxine xr  225  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled tobacco use disorder other acquired deformities of ankle and foot other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person boarding or alighting a car injured in collision with railway train or railway vehicle lumbosacral spondylosis without myelopathy bariatric surgery status personal history of malignant neoplasm of bronchus and lung depressive disorder, not elsewhere classified unspecified essential hypertension unspecified hereditary and idiopathic peripheral neuropathy other mechanical complication of other internal orthopedic device, implant, and graft arthrodesis status lumbago unspecified essential hypertension obesity, unspecified other and unspecified hyperlipidemia osteoarthrosis, unspecified whether generalized or localized, lower leg diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other accidents superficial injury of cornea tobacco use disorder other acquired deformities of ankle and foot backache, unspecified bariatric surgery status personal history of malignant neoplasm of bronchus and lung other specified intestinal obstruction unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bariatric surgery status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension delirium due to conditions classified elsewhere depressive disorder, not elsewhere classified intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) opioid type dependence, continuous polyneuropathy in diabetes
black african american f 29 $temp  97.7  heartrate  85.0  resprate  19.0  o2sat  98.0  sbp  136.0  dbp  103.0  rhythm    pain  0  $chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  81  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lorazepam  2  mg ; heparin  5000  unit ; ondansetron  4  mg ; trokendi xr  400  mg ; trokendi xr  200  mg ; levetiracetam  2000  mg ; 
 
black african american f 29 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lorazepam  2  mg ; heparin  5000  unit ; ondansetron  4  mg ; trokendi xr  400  mg ; trokendi xr  200  mg ; levetiracetam  2000  mg ; 
 
white f 35 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  23.6  %; hematology blood hematocrit  25.2  %; hematology blood hematocrit  21.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  197  k ul; hematology blood platelet count  178  k ul; hematology blood platelet count  176  k ul; hematology blood platelet count  154  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.9  ; hematology urine wbc  3  # hpf; hematology urine wbc  1  # hpf; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood bilirubin, indirect  1.7  mg dl; chemistry blood bilirubin, indirect  1.8  mg dl; chemistry blood bilirubin, total  7.7  mg dl; chemistry blood bilirubin, total  7.6  mg dl; chemistry blood bilirubin, total  8.4  mg dl; chemistry blood bilirubin, total  8.0  mg dl; chemistry blood bilirubin, total  7.6  mg dl; chemistry blood glucose  64  mg dl; chemistry blood glucose  37  mg dl; chemistry blood glucose  38  mg dl; chemistry blood lactate dehydrogenase (ld)  2046  iu l; chemistry blood lactate dehydrogenase (ld)  1911  iu l; chemistry blood lactate dehydrogenase (ld)  2039  iu l; chemistry blood lactate dehydrogenase (ld)  2083  iu l; chemistry blood lactate dehydrogenase (ld)  1895  iu l; chemistry blood albumin  1.9  g dl; chemistry blood albumin  1.7  g dl; chemistry blood albumin  2.0  g dl; chemistry blood albumin  1.8  g dl; chemistry blood albumin  1.6  g dl; hematology blood bands  23  %; blood gas blood free calcium  1.01  mmol l; blood gas blood lactate  5.5  mmol l; blood gas blood lactate  6.0  mmol l; blood gas blood lactate  5.1  mmol l; blood gas blood lactate  6.7  mmol l; blood gas blood lactate  6.6  mmol l; chemistry blood bilirubin, direct  6.0  mg dl; chemistry blood bilirubin, direct  5.8  mg dl; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  42  mg dl; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  8.6  g dl; blood gas blood hemoglobin  9.1  g dl; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood sodium, whole blood  131  meq l$bisacodyl  10  mg ; senna  1  tab ; docusate sodium (liquid)  100  mg ; lactulose  30  ml ; dextrose 50%  25  gm ; oseltamivir phosphate  75  mg ; lidocaine 1%  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  gm ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  100  ml ; acyclovir  400  mg ; soln.  250  ml ; mannitol 20%  50  g ; azithromycin  250  mg ; rimantadine  100  mg ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  500  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  21.5  %; hematology blood hematocrit  21.3  %; hematology blood hematocrit  21.9  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  154  k ul; hematology blood platelet count  127  k ul; hematology blood platelet count  177  k ul; hematology blood platelet count  147  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.7  ; chemistry urine creatinine, urine  101  mg dl; chemistry urine potassium, urine  26  meq l; chemistry urine sodium, urine  13  meq l; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  6.7  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  8.0  mg dl; chemistry blood bilirubin, total  7.9  mg dl; chemistry blood bilirubin, total  8.0  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  67  mg dl; chemistry blood glucose  61  mg dl; chemistry blood lactate dehydrogenase (ld)  1937  iu l; chemistry blood lactate dehydrogenase (ld)  1880  iu l; chemistry blood albumin  1.6  g dl; chemistry blood albumin  1.7  g dl; chemistry blood albumin  1.6  g dl; blood gas blood lactate  5.0  mmol l; blood gas blood lactate  6.4  mmol l; blood gas blood glucose  54  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  mod  mg dl$bisacodyl  10  mg ; senna  1  tab ; docusate sodium (liquid)  100  mg ; lactulose  30  ml ; dextrose 50%  25  gm ; oseltamivir phosphate  75  mg ; lidocaine 1%  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  gm ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  100  ml ; acyclovir  400  mg ; soln.  250  ml ; mannitol 20%  50  g ; azithromycin  250  mg ; rimantadine  100  mg ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  500  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; d5ns  1000  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; albumin 25% (12.5g   50ml)  62.5  g ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; ganciclovir  150  mg ; acyclovir  600  mg ; sodium chloride 0.9%  flush  10  ml ; d5 1 2ns  1000  ml ; cytomegalovirus immune glob  7500  mg ; bag  150  ml ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  30.0  %; hematology blood hematocrit  25.2  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  137  k ul; hematology blood platelet count  123  k ul; hematology blood platelet count  135  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  8.6  mg dl; chemistry blood bilirubin, total  8.6  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  91  mg dl; blood gas blood free calcium  1.03  mmol l$bisacodyl  10  mg ; senna  1  tab ; docusate sodium (liquid)  100  mg ; lactulose  30  ml ; dextrose 50%  25  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; azithromycin  250  mg ; rimantadine  100  mg ; propofol  1000  mg ; propofol  200  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; d5 1 2ns  1000  ml ; bag  150  ml ; ganciclovir  380  mg ; albumin 5% (12.5g   250ml)  12.5  g ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  24.2  %; hematology blood hematocrit  23.7  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  137  k ul; hematology blood platelet count  144  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, indirect  1.6  mg dl; chemistry blood bilirubin, total  7.7  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  886  iu l; chemistry blood bilirubin, direct  6.1  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  lg  mg dl$dextrose 50%  25  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; azithromycin  250  mg ; rimantadine  100  mg ; propofol  200  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; d5 1 2ns  1000  ml ; ganciclovir  380  mg ; albumin 5% (12.5g   250ml)  12.5  g ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; bag  300  ml ; cytomegalovirus immune glob  15,000  mg ; mesalamine  1000  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  25.7  %; hematology blood hematocrit  23.7  %; hematology blood hematocrit  30.6  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  145  k ul; hematology blood platelet count  172  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  6.5  mg dl; chemistry blood bilirubin, total  5.8  mg dl; chemistry blood glucose  121  mg dl; chemistry blood lactate dehydrogenase (ld)  716  iu l; chemistry blood albumin  1.5  g dl; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood chloride, whole blood  110  meq l; blood gas blood glucose  101  mg dl; blood gas blood hematocrit, calculated  28  %; blood gas blood hemoglobin  9.2  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood sodium, whole blood  136  meq l$dextrose 50%  25  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; azithromycin  250  mg ; rimantadine  100  mg ; propofol  200  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; bag  300  ml ; cytomegalovirus immune glob  15,000  mg ; mesalamine  1000  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; neutra-phos  2  pkt ; albumin 25% (12.5g   50ml)  25  g ; diphenhydramine  25  mg ; rifaximin  200  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  22.7  %; hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  155  k ul; hematology blood platelet count  162  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, indirect  1.5  mg dl; chemistry blood bilirubin, total  5.2  mg dl; chemistry blood glucose  124  mg dl; chemistry blood albumin  2.0  g dl; blood gas blood free calcium  1.02  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  3.4  mmol l; chemistry blood bilirubin, direct  3.7  mg dl; blood gas blood chloride, whole blood  109  meq l; blood gas blood chloride, whole blood  110  meq l; blood gas blood glucose  126  mg dl; blood gas blood glucose  122  mg dl; blood gas blood glucose  116  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  8.7  g dl; blood gas blood hemoglobin  10.7  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  137  meq l$dextrose 50%  25  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; azithromycin  250  mg ; propofol  200  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; bag  300  ml ; cytomegalovirus immune glob  15,000  mg ; mesalamine  1000  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; neutra-phos  2  pkt ; albumin 25% (12.5g   50ml)  25  g ; diphenhydramine  25  mg ; rifaximin  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; furosemide  20  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  29.5  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  185  k ul; hematology blood platelet count  189  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, indirect  2.0  mg dl; chemistry blood bilirubin, total  6.5  mg dl; chemistry blood glucose  96  mg dl; blood gas blood free calcium  1.10  mmol l; chemistry blood bilirubin, direct  4.5  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$dextrose 50%  25  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; azithromycin  250  mg ; propofol  200  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; mesalamine  1000  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; albumin 25% (12.5g   50ml)  25  g ; rifaximin  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; furosemide  20  mg ; acetaminophen  325  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; furosemide  100  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, indirect  1.4  mg dl; chemistry blood bilirubin, total  5.4  mg dl; chemistry blood glucose  111  mg dl; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.2  mmol l; chemistry blood bilirubin, direct  4.0  mg dl; blood gas blood glucose  102  mg dl; blood gas blood glucose  115  mg dl$dextrose 50%  25  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; propofol  200  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; mesalamine  1000  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; rifaximin  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetaminophen  325  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; furosemide  100  mg ; potassium chloride  20  meq ; ondansetron  4  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, indirect  1.7  mg dl; chemistry blood bilirubin, total  6.6  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  109  mg dl; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  1.09  mmol l; chemistry blood bilirubin, direct  4.9  mg dl$dextrose 50%  25  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; propofol  200  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; mesalamine  1000  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; rifaximin  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetaminophen  325  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; ondansetron  4  mg ; 5% dextrose  250  ml ; sodium phosphate  15  mmol ; 5% dextrose  500  ml ; sodium phosphate  15-30  mmol ; hydromorphone (dilaudid)  1-2  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  4.7  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  119  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  0.96  mmol l; blood gas blood chloride, whole blood  99  meq l; blood gas blood glucose  93  mg dl; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood sodium, whole blood  130  meq l$dextrose 50%  25  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; propofol  200  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; mesalamine  1000  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; rifaximin  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; 5% dextrose  250  ml ; sodium phosphate  15  mmol ; 5% dextrose  500  ml ; sodium phosphate  15-30  mmol ; hydromorphone (dilaudid)  1-2  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  461  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  3.8  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  113  mg dl; chemistry blood albumin  2.5  g dl$dextrose 50%  25  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; propofol  200  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; mesalamine  1000  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; rifaximin  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; 5% dextrose  250  ml ; sodium phosphate  15  mmol ; 5% dextrose  500  ml ; sodium phosphate  15-30  mmol ; hydromorphone (dilaudid)  1-2  mg ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; heparin flush (10 units ml)  1  ml ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  537  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.5  ; chemistry urine sodium, urine  149  meq l; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  504  iu l$dextrose 50%  25  gm ; lansoprazole oral disintegrating tab  30  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; mesalamine  1000  mg ; rifaximin  200  mg ; insulin  0  unit ; 5% dextrose  250  ml ; sodium phosphate  15  mmol ; 5% dextrose  500  ml ; sodium phosphate  15-30  mmol ; hydromorphone (dilaudid)  1-2  mg ; heparin flush (10 units ml)  1  ml ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  2-4  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  621  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.5  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  106  mg dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; mesalamine  1000  mg ; heparin flush (10 units ml)  1  ml ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  2-4  mg ; rifaximin  400  mg ; zolpidem tartrate  5  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  663  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood bilirubin, total  3.6  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  473  iu l$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; mesalamine  1000  mg ; heparin flush (10 units ml)  1  ml ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; hydromorphone (dilaudid)  2-4  mg ; rifaximin  400  mg ; zolpidem tartrate  5  mg ; phytonadione  5  mg ; zolpidem tartrate  5-10  mg ; diphenhydramine  50  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  689  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  406  iu l$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; mesalamine  1000  mg ; omeprazole  20  mg ; phytonadione  5  mg ; diphenhydramine  50  mg ; ursodiol  300  mg ; trazodone  25  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  734  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  365  iu l$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; ganciclovir  380  mg ; mesalamine  1000  mg ; omeprazole  20  mg ; phytonadione  5  mg ; diphenhydramine  50  mg ; ursodiol  300  mg ; trazodone  25  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white f 35 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  724  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  315  iu l$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; mesalamine  1000  mg ; omeprazole  20  mg ; phytonadione  5  mg ; diphenhydramine  50  mg ; ursodiol  300  mg ; valganciclovir  900  mg ; 
mental disorders of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition long-term (current) use of insulin motorcycle driver injured in collision with fixed or stationary object in nontraffic accident nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified depressive disorder, not elsewhere classified abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition other specified disorders of biliary tract regional enteritis of unspecified site second-degree perineal laceration, delivered, with or without mention of antepartum condition regional enteritis of small intestine other current conditions classifiable elsewhere of mother, antepartum condition or complication
white m 55 $nan$nan$lactated ringers  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; metoclopramide  10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; heparin  5000  unit ; soln  100  ml ; acetaminophen iv  1000  mg ; ketorolac  30  mg ; lamotrigine  200  mg ; phenobarbital  64.8  mg ; adderall  60  mg ; 
paralytic ileus abscess of intestine other digestive system complications obstructive sleep apnea (adult)(pediatric) other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation epilepsy, unspecified, without mention of intractable epilepsy multiple sclerosis diverticulitis of colon (without mention of hemorrhage) cardiac complications, not elsewhere classified laparoscopic surgical procedure converted to open procedure unspecified essential hypertension multiple sclerosis unspecified essential hypertension epilepsy, unspecified, without mention of intractable epilepsy peritoneal abscess arthropathy, unspecified, site unspecified fever, unspecified multiple sclerosis unspecified essential hypertension abscess of intestine scoliosis [and kyphoscoliosis], idiopathic diverticulitis of colon (without mention of hemorrhage) epilepsy, unspecified, without mention of intractable epilepsy 
white m 55 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  82  mg dl$lactated ringers  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoclopramide  10  mg ; heparin  5000  unit ; soln  100  ml ; acetaminophen iv  1000  mg ; ketorolac  30  mg ; lamotrigine  200  mg ; phenobarbital  64.8  mg ; adderall  60  mg ; oxycodone (immediate release)   5-10  mg ; magnesium sulfate  4  gm ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; amlodipine  5  mg ; 
paralytic ileus abscess of intestine other digestive system complications obstructive sleep apnea (adult)(pediatric) other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation epilepsy, unspecified, without mention of intractable epilepsy multiple sclerosis diverticulitis of colon (without mention of hemorrhage) cardiac complications, not elsewhere classified laparoscopic surgical procedure converted to open procedure unspecified essential hypertension multiple sclerosis unspecified essential hypertension epilepsy, unspecified, without mention of intractable epilepsy peritoneal abscess arthropathy, unspecified, site unspecified fever, unspecified multiple sclerosis unspecified essential hypertension abscess of intestine scoliosis [and kyphoscoliosis], idiopathic diverticulitis of colon (without mention of hemorrhage) epilepsy, unspecified, without mention of intractable epilepsy 
white m 55 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ketorolac  30  mg ; lamotrigine  200  mg ; phenobarbital  64.8  mg ; adderall  60  mg ; oxycodone (immediate release)   5-10  mg ; magnesium sulfate  4  gm ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; amlodipine  5  mg ; 
paralytic ileus abscess of intestine other digestive system complications obstructive sleep apnea (adult)(pediatric) other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation epilepsy, unspecified, without mention of intractable epilepsy multiple sclerosis diverticulitis of colon (without mention of hemorrhage) cardiac complications, not elsewhere classified laparoscopic surgical procedure converted to open procedure unspecified essential hypertension multiple sclerosis unspecified essential hypertension epilepsy, unspecified, without mention of intractable epilepsy peritoneal abscess arthropathy, unspecified, site unspecified fever, unspecified multiple sclerosis unspecified essential hypertension abscess of intestine scoliosis [and kyphoscoliosis], idiopathic diverticulitis of colon (without mention of hemorrhage) epilepsy, unspecified, without mention of intractable epilepsy 
black african american m 77 $temp  98.6  heartrate  69.0  resprate  18.0  o2sat  93.0  sbp  136.0  dbp  92.0  rhythm    pain  0  $hematology blood hematocrit  42.1  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  150  mg dl; chemistry blood lactate dehydrogenase (ld)  255  iu l; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; pravastatin  20  mg ; doxazosin  4  mg ; acetaminophen  1000  mg ; hydrochlorothiazide  25  mg ; finasteride  5  mg ; aspirin  81  mg ; potassium chloride  40  meq ; 
sleep apnea, unspecified hypertensive urgency essential (primary) hypertension personal history of nicotine dependence acute kidney failure, unspecified hypotension, unspecified other chest pain patient's other noncompliance with medication regimen hyperlipidemia, unspecified personal history of malignant neoplasm of prostate benign prostatic hyperplasia without lower urinary tract symptoms type 2 diabetes mellitus without complications personal history of malignant neoplasm of prostate anemia, unspecified other and unspecified hyperlipidemia loss of weight leukocytosis, unspecified pain in limb enlargement of lymph nodes other respiratory abnormalities unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) swelling of limb fever, unspecified sciatica sepsis unspecified essential hypertension unspecified septicemia personal history of tobacco use orchitis and epididymitis, unspecified malignant neoplasm of prostate other and unspecified hyperlipidemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension cellulitis and abscess of leg, except foot 
black african american m 77 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  134  mg dl$sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; pravastatin  20  mg ; doxazosin  4  mg ; acetaminophen  1000  mg ; hydrochlorothiazide  25  mg ; finasteride  5  mg ; aspirin  81  mg ; potassium chloride  40  meq ; amlodipine  10  mg ; 
sleep apnea, unspecified hypertensive urgency essential (primary) hypertension personal history of nicotine dependence acute kidney failure, unspecified hypotension, unspecified other chest pain patient's other noncompliance with medication regimen hyperlipidemia, unspecified personal history of malignant neoplasm of prostate benign prostatic hyperplasia without lower urinary tract symptoms type 2 diabetes mellitus without complications personal history of malignant neoplasm of prostate anemia, unspecified other and unspecified hyperlipidemia loss of weight leukocytosis, unspecified pain in limb enlargement of lymph nodes other respiratory abnormalities unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) swelling of limb fever, unspecified sciatica sepsis unspecified essential hypertension unspecified septicemia personal history of tobacco use orchitis and epididymitis, unspecified malignant neoplasm of prostate other and unspecified hyperlipidemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension cellulitis and abscess of leg, except foot 
black african american m 77 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  163  mg dl$sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; doxazosin  4  mg ; acetaminophen  1000  mg ; hydrochlorothiazide  25  mg ; finasteride  5  mg ; aspirin  81  mg ; amlodipine  10  mg ; atorvastatin  40  mg ; 
sleep apnea, unspecified hypertensive urgency essential (primary) hypertension personal history of nicotine dependence acute kidney failure, unspecified hypotension, unspecified other chest pain patient's other noncompliance with medication regimen hyperlipidemia, unspecified personal history of malignant neoplasm of prostate benign prostatic hyperplasia without lower urinary tract symptoms type 2 diabetes mellitus without complications personal history of malignant neoplasm of prostate anemia, unspecified other and unspecified hyperlipidemia loss of weight leukocytosis, unspecified pain in limb enlargement of lymph nodes other respiratory abnormalities unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) swelling of limb fever, unspecified sciatica sepsis unspecified essential hypertension unspecified septicemia personal history of tobacco use orchitis and epididymitis, unspecified malignant neoplasm of prostate other and unspecified hyperlipidemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension cellulitis and abscess of leg, except foot 
black african american m 77 $nan$nan$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; doxazosin  4  mg ; acetaminophen  1000  mg ; hydrochlorothiazide  25  mg ; finasteride  5  mg ; aspirin  81  mg ; amlodipine  10  mg ; atorvastatin  40  mg ; 
sleep apnea, unspecified hypertensive urgency essential (primary) hypertension personal history of nicotine dependence acute kidney failure, unspecified hypotension, unspecified other chest pain patient's other noncompliance with medication regimen hyperlipidemia, unspecified personal history of malignant neoplasm of prostate benign prostatic hyperplasia without lower urinary tract symptoms type 2 diabetes mellitus without complications personal history of malignant neoplasm of prostate anemia, unspecified other and unspecified hyperlipidemia loss of weight leukocytosis, unspecified pain in limb enlargement of lymph nodes other respiratory abnormalities unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) swelling of limb fever, unspecified sciatica sepsis unspecified essential hypertension unspecified septicemia personal history of tobacco use orchitis and epididymitis, unspecified malignant neoplasm of prostate other and unspecified hyperlipidemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension cellulitis and abscess of leg, except foot 
white m 81 $nan$nan$cyanocobalamin  2000  mcg ; 
 
white m 81 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  131  mg dl$ns  1000  ml ; cyanocobalamin  2000  mcg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; albuterol  1-2  puff ; acetaminophen  325-650  mg ; neutra-phos  1  pkt ; tamsulosin  0.4  mg ; 
 
white m 81 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  100  mg dl$cyanocobalamin  2000  mcg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; albuterol  1-2  puff ; acetaminophen  325-650  mg ; neutra-phos  1  pkt ; potassium chloride  40  meq ; 
 
white m 81 $nan$nan$cyanocobalamin  2000  mcg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; albuterol  1-2  puff ; acetaminophen  325-650  mg ; potassium chloride  40  meq ; 
 
white m 68 $temp  98.2  heartrate  63.0  resprate  18.0  o2sat  100.0  sbp  140.0  dbp  82.0  rhythm    pain  0  $hematology urine wbc  1  # hpf; hematology urine glucose  150  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  500  mg ; neutra-phos  1  pkt ; diazepam  5  mg ; amoxicillin-clavulanic acid  875  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; insulin  0  unit ; polyethylene glycol  17  g ; 
 
white m 68 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  379  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  291  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; neutra-phos  1  pkt ; diazepam  5  mg ; amoxicillin-clavulanic acid  875  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; insulin  0  unit ; polyethylene glycol  17  g ; alprazolam  1  mg ; bupropion (sustained release)  100  mg ; soma  175  mg ; 5% dextrose  250  ml ; thiamine  500  mg ; insulin  5  unit ; methadone  40  mg ; methadone  50  mg ; senna  8.6  mg ; insulin  4  unit ; bisacodyl  10  mg ; insulin  1  unit ; insulin  10  unit ; insulin  2  unit ; 
 
white m 68 $nan$hematology blood hematocrit  39.6  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  334  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.7  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  199  mg dl; chemistry blood albumin  3.5  g dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; alprazolam  1  mg ; bupropion (sustained release)  100  mg ; soma  175  mg ; methadone  40  mg ; methadone  50  mg ; senna  8.6  mg ; insulin  4  unit ; bisacodyl  10  mg ; insulin  1  unit ; insulin  10  unit ; insulin  2  unit ; neutra-phos  2  pkt ; insulin  11  unit ; thiamine  100  mg ; folic acid  1  mg ; insulin  6  unit ; alprazolam  0.5  mg ; 
 
white m 68 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  85  mg dl; chemistry blood albumin  3.4  g dl; hematology urine glucose  1000  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; bupropion (sustained release)  100  mg ; soma  175  mg ; methadone  40  mg ; methadone  50  mg ; senna  8.6  mg ; bisacodyl  10  mg ; thiamine  100  mg ; folic acid  1  mg ; insulin  6  unit ; alprazolam  0.5  mg ; 
 
white m 68 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; bupropion (sustained release)  100  mg ; methadone  40  mg ; methadone  50  mg ; senna  8.6  mg ; bisacodyl  10  mg ; thiamine  100  mg ; folic acid  1  mg ; insulin  6  unit ; 
 
white m 69 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  159  k ul$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; hydromorphone (dilaudid)  2-4  mg ; calcium carbonate  1500  mg ; docusate sodium  100  mg ; liothyronine sodium  12.5  mcg ; heparin  5000  unit ; 
personal history of malignant neoplasm of thyroid cellulitis and abscess of neck nontoxic uninodular goiter other postoperative infection unspecified essential hypertension other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cellulitis and abscess of neck other postoperative infection malignant neoplasm of thyroid gland 
white m 69 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; hydromorphone (dilaudid)  2-4  mg ; calcium carbonate  1500  mg ; docusate sodium  100  mg ; liothyronine sodium  12.5  mcg ; heparin  5000  unit ; 
personal history of malignant neoplasm of thyroid cellulitis and abscess of neck nontoxic uninodular goiter other postoperative infection unspecified essential hypertension other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation cellulitis and abscess of neck other postoperative infection malignant neoplasm of thyroid gland 
white m 84 $nan$nan$aspirin  81  mg ; amlodipine  5  mg ; furosemide  40  mg ; lisinopril  5  mg ; simvastatin  40  mg ; atenolol  25  mg ; prednisone  40  mg ; 
peripheral vascular disease, unspecified unspecified essential hypertension coronary atherosclerosis of autologous vein bypass graft intermediate coronary syndrome coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified aortocoronary bypass status other amyloidosis atrial fibrillation congestive heart failure, unspecified atrial fibrillation pure hypercholesterolemia acute on chronic diastolic heart failure benign essential hypertension localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy aortocoronary bypass status other and unspecified hyperlipidemia abnormal coagulation profile atrial fibrillation old myocardial infarction unspecified essential hypertension hemiplegia, unspecified, affecting unspecified side long-term (current) use of anticoagulants other convulsions anticoagulants causing adverse effects in therapeutic use atherosclerosis of native arteries of the extremities, unspecified aortocoronary bypass status intracerebral hemorrhage coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft aortocoronary bypass status atrial fibrillation pure hypercholesterolemia unspecified essential hypertension cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure percutaneous transluminal coronary angioplasty status acute diastolic heart failure chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia injury to bladder and urethra, without mention of open wound into cavity anemia, unspecified congestive heart failure, unspecified atrial fibrillation unspecified essential hypertension other specified cardiac dysrhythmias old myocardial infarction atherosclerosis of native arteries of the extremities, unspecified coronary atherosclerosis of native coronary artery
white m 84 $nan$hematology blood hematocrit  43.9  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  197  mg dl; blood gas blood lactate  1.0  mmol l$aspirin  81  mg ; amlodipine  5  mg ; furosemide  40  mg ; lisinopril  5  mg ; simvastatin  40  mg ; atenolol  25  mg ; prednisone  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  750  mg ; albuterol-ipratropium  1-2  puff ; benzonatate  100  mg ; pantoprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 5% dextrose  250  ml ; azithromycin   500  mg ; methylprednisolone sodium succ  80  mg ; 
peripheral vascular disease, unspecified unspecified essential hypertension coronary atherosclerosis of autologous vein bypass graft intermediate coronary syndrome coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified aortocoronary bypass status other amyloidosis atrial fibrillation congestive heart failure, unspecified atrial fibrillation pure hypercholesterolemia acute on chronic diastolic heart failure benign essential hypertension localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy aortocoronary bypass status other and unspecified hyperlipidemia abnormal coagulation profile atrial fibrillation old myocardial infarction unspecified essential hypertension hemiplegia, unspecified, affecting unspecified side long-term (current) use of anticoagulants other convulsions anticoagulants causing adverse effects in therapeutic use atherosclerosis of native arteries of the extremities, unspecified aortocoronary bypass status intracerebral hemorrhage coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft aortocoronary bypass status atrial fibrillation pure hypercholesterolemia unspecified essential hypertension cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure percutaneous transluminal coronary angioplasty status acute diastolic heart failure chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia injury to bladder and urethra, without mention of open wound into cavity anemia, unspecified congestive heart failure, unspecified atrial fibrillation unspecified essential hypertension other specified cardiac dysrhythmias old myocardial infarction atherosclerosis of native arteries of the extremities, unspecified coronary atherosclerosis of native coronary artery
white m 84 $nan$hematology blood hematocrit  42.1  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry urine chloride, urine  32  meq l; chemistry urine creatinine, urine  87  mg dl; chemistry urine potassium, urine  24  meq l; chemistry urine sodium, urine  31  meq l; chemistry urine urea nitrogen, urine  459  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  111  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$aspirin  81  mg ; amlodipine  5  mg ; furosemide  40  mg ; lisinopril  5  mg ; simvastatin  40  mg ; atenolol  25  mg ; prednisone  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  750  mg ; benzonatate  100  mg ; pantoprazole  40  mg ; 5% dextrose  250  ml ; azithromycin   500  mg ; methylprednisolone sodium succ  80  mg ; fluticasone propionate nasal  1  spry ; 0.9% sodium chloride  500  ml ; 
peripheral vascular disease, unspecified unspecified essential hypertension coronary atherosclerosis of autologous vein bypass graft intermediate coronary syndrome coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified aortocoronary bypass status other amyloidosis atrial fibrillation congestive heart failure, unspecified atrial fibrillation pure hypercholesterolemia acute on chronic diastolic heart failure benign essential hypertension localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy aortocoronary bypass status other and unspecified hyperlipidemia abnormal coagulation profile atrial fibrillation old myocardial infarction unspecified essential hypertension hemiplegia, unspecified, affecting unspecified side long-term (current) use of anticoagulants other convulsions anticoagulants causing adverse effects in therapeutic use atherosclerosis of native arteries of the extremities, unspecified aortocoronary bypass status intracerebral hemorrhage coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft aortocoronary bypass status atrial fibrillation pure hypercholesterolemia unspecified essential hypertension cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure percutaneous transluminal coronary angioplasty status acute diastolic heart failure chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia injury to bladder and urethra, without mention of open wound into cavity anemia, unspecified congestive heart failure, unspecified atrial fibrillation unspecified essential hypertension other specified cardiac dysrhythmias old myocardial infarction atherosclerosis of native arteries of the extremities, unspecified coronary atherosclerosis of native coronary artery
white m 84 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  144  mg dl$aspirin  81  mg ; amlodipine  5  mg ; lisinopril  5  mg ; simvastatin  40  mg ; atenolol  25  mg ; prednisone  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  750  mg ; benzonatate  100  mg ; pantoprazole  40  mg ; fluticasone propionate nasal  1  spry ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; potassium chloride  20  meq ; 
peripheral vascular disease, unspecified unspecified essential hypertension coronary atherosclerosis of autologous vein bypass graft intermediate coronary syndrome coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified aortocoronary bypass status other amyloidosis atrial fibrillation congestive heart failure, unspecified atrial fibrillation pure hypercholesterolemia acute on chronic diastolic heart failure benign essential hypertension localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy aortocoronary bypass status other and unspecified hyperlipidemia abnormal coagulation profile atrial fibrillation old myocardial infarction unspecified essential hypertension hemiplegia, unspecified, affecting unspecified side long-term (current) use of anticoagulants other convulsions anticoagulants causing adverse effects in therapeutic use atherosclerosis of native arteries of the extremities, unspecified aortocoronary bypass status intracerebral hemorrhage coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft aortocoronary bypass status atrial fibrillation pure hypercholesterolemia unspecified essential hypertension cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure percutaneous transluminal coronary angioplasty status acute diastolic heart failure chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia injury to bladder and urethra, without mention of open wound into cavity anemia, unspecified congestive heart failure, unspecified atrial fibrillation unspecified essential hypertension other specified cardiac dysrhythmias old myocardial infarction atherosclerosis of native arteries of the extremities, unspecified coronary atherosclerosis of native coronary artery
white m 84 $nan$nan$aspirin  81  mg ; amlodipine  5  mg ; simvastatin  40  mg ; atenolol  25  mg ; prednisone  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levetiracetam  750  mg ; benzonatate  100  mg ; pantoprazole  40  mg ; fluticasone propionate nasal  1  spry ; senna  1  tab ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; potassium chloride  20  meq ; 
peripheral vascular disease, unspecified unspecified essential hypertension coronary atherosclerosis of autologous vein bypass graft intermediate coronary syndrome coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified aortocoronary bypass status other amyloidosis atrial fibrillation congestive heart failure, unspecified atrial fibrillation pure hypercholesterolemia acute on chronic diastolic heart failure benign essential hypertension localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy aortocoronary bypass status other and unspecified hyperlipidemia abnormal coagulation profile atrial fibrillation old myocardial infarction unspecified essential hypertension hemiplegia, unspecified, affecting unspecified side long-term (current) use of anticoagulants other convulsions anticoagulants causing adverse effects in therapeutic use atherosclerosis of native arteries of the extremities, unspecified aortocoronary bypass status intracerebral hemorrhage coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft aortocoronary bypass status atrial fibrillation pure hypercholesterolemia unspecified essential hypertension cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure percutaneous transluminal coronary angioplasty status acute diastolic heart failure chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia injury to bladder and urethra, without mention of open wound into cavity anemia, unspecified congestive heart failure, unspecified atrial fibrillation unspecified essential hypertension other specified cardiac dysrhythmias old myocardial infarction atherosclerosis of native arteries of the extremities, unspecified coronary atherosclerosis of native coronary artery
white m 65 $nan$hematology blood hematocrit  18.9  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  24  k ul; hematology blood platelet count  24  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  159  mg dl; chemistry blood lactate dehydrogenase (ld)  126  iu l; chemistry blood albumin  3.5  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; acyclovir  400  mg ; atenolol  12.5  mg ; atovaquone suspension  1500  mg ; etravirine  200  mg ; finasteride  5  mg ; fluconazole  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lamivudine  150  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; raltegravir  400  mg ; rosuvastatin calcium  40  mg ; vitamin d  1000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; insulin  0  unit ; insulin  34  unit ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; caphosol  30  ml ; lidocaine viscous 2%  15  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  50  ml ; daptomycin  376  mg ; 
percutaneous transluminal coronary angioplasty status personal history of tobacco use polyneuropathy in diabetes streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] urinary tract infection, site not specified acute myeloid leukemia, in relapse asymptomatic human immunodeficiency virus [hiv] infection status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia fever presenting with conditions classified elsewhere neutropenia, unspecified other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of antineoplastic chemotherapy personal history of tobacco use polyneuropathy in diabetes asymptomatic human immunodeficiency virus [hiv] infection status neutropenia, unspecified long-term (current) use of insulin other and unspecified hyperlipidemia acute myeloid leukemia, without mention of having achieved remission fever presenting with conditions classified elsewhere bloodstream infection due to central venous catheter other toe(s) amputation status hematoma complicating a procedure coronary atherosclerosis of native coronary artery loss of weight background diabetic retinopathy acute myeloid leukemia, without mention of having achieved remission pedal cycle driver injured in noncollision transport accident in nontraffic accident body mass index less than 19, adult driver of special construction vehicle injured in traffic accident diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled foot amputation status polyneuropathy in diabetes acidosis other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status personal history of tobacco use flatulence, eructation, and gas pain coronary atherosclerosis of native coronary artery family history of diabetes mellitus long-term (current) use of steroids other and unspecified diseases of the oral soft tissues acute apical periodontitis of pulpal origin
white m 65 $nan$hematology blood hematocrit  20.3  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  19  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  199  mg dl; chemistry blood lactate dehydrogenase (ld)  144  iu l; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; atenolol  12.5  mg ; atovaquone suspension  1500  mg ; etravirine  200  mg ; finasteride  5  mg ; fluconazole  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lamivudine  150  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; raltegravir  400  mg ; rosuvastatin calcium  40  mg ; vitamin d  1000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; insulin  0  unit ; insulin  34  unit ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; caphosol  30  ml ; lidocaine viscous 2%  15  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
percutaneous transluminal coronary angioplasty status personal history of tobacco use polyneuropathy in diabetes streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] urinary tract infection, site not specified acute myeloid leukemia, in relapse asymptomatic human immunodeficiency virus [hiv] infection status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia fever presenting with conditions classified elsewhere neutropenia, unspecified other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of antineoplastic chemotherapy personal history of tobacco use polyneuropathy in diabetes asymptomatic human immunodeficiency virus [hiv] infection status neutropenia, unspecified long-term (current) use of insulin other and unspecified hyperlipidemia acute myeloid leukemia, without mention of having achieved remission fever presenting with conditions classified elsewhere bloodstream infection due to central venous catheter other toe(s) amputation status hematoma complicating a procedure coronary atherosclerosis of native coronary artery loss of weight background diabetic retinopathy acute myeloid leukemia, without mention of having achieved remission pedal cycle driver injured in noncollision transport accident in nontraffic accident body mass index less than 19, adult driver of special construction vehicle injured in traffic accident diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled foot amputation status polyneuropathy in diabetes acidosis other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status personal history of tobacco use flatulence, eructation, and gas pain coronary atherosclerosis of native coronary artery family history of diabetes mellitus long-term (current) use of steroids other and unspecified diseases of the oral soft tissues acute apical periodontitis of pulpal origin
white m 65 $nan$hematology blood hematocrit  20.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  12  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; chemistry urine chloride, urine  115  meq l; chemistry urine creatinine, urine  68  mg dl; chemistry urine potassium, urine  38  meq l; chemistry urine sodium, urine  104  meq l; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  248  mg dl; chemistry blood lactate dehydrogenase (ld)  139  iu l; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; atenolol  12.5  mg ; atovaquone suspension  1500  mg ; etravirine  200  mg ; finasteride  5  mg ; fluconazole  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lamivudine  150  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; raltegravir  400  mg ; rosuvastatin calcium  40  mg ; vitamin d  1000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; insulin  0  unit ; insulin  34  unit ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; caphosol  30  ml ; lidocaine viscous 2%  15  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
percutaneous transluminal coronary angioplasty status personal history of tobacco use polyneuropathy in diabetes streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] urinary tract infection, site not specified acute myeloid leukemia, in relapse asymptomatic human immunodeficiency virus [hiv] infection status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia fever presenting with conditions classified elsewhere neutropenia, unspecified other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of antineoplastic chemotherapy personal history of tobacco use polyneuropathy in diabetes asymptomatic human immunodeficiency virus [hiv] infection status neutropenia, unspecified long-term (current) use of insulin other and unspecified hyperlipidemia acute myeloid leukemia, without mention of having achieved remission fever presenting with conditions classified elsewhere bloodstream infection due to central venous catheter other toe(s) amputation status hematoma complicating a procedure coronary atherosclerosis of native coronary artery loss of weight background diabetic retinopathy acute myeloid leukemia, without mention of having achieved remission pedal cycle driver injured in noncollision transport accident in nontraffic accident body mass index less than 19, adult driver of special construction vehicle injured in traffic accident diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled foot amputation status polyneuropathy in diabetes acidosis other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status personal history of tobacco use flatulence, eructation, and gas pain coronary atherosclerosis of native coronary artery family history of diabetes mellitus long-term (current) use of steroids other and unspecified diseases of the oral soft tissues acute apical periodontitis of pulpal origin
white m 65 $nan$hematology blood hematocrit  20.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  13  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  247  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; atenolol  12.5  mg ; atovaquone suspension  1500  mg ; etravirine  200  mg ; finasteride  5  mg ; fluconazole  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lamivudine  150  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; raltegravir  400  mg ; rosuvastatin calcium  40  mg ; vitamin d  1000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; insulin  0  unit ; insulin  34  unit ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; caphosol  30  ml ; lidocaine viscous 2%  15  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
percutaneous transluminal coronary angioplasty status personal history of tobacco use polyneuropathy in diabetes streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] urinary tract infection, site not specified acute myeloid leukemia, in relapse asymptomatic human immunodeficiency virus [hiv] infection status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia fever presenting with conditions classified elsewhere neutropenia, unspecified other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of antineoplastic chemotherapy personal history of tobacco use polyneuropathy in diabetes asymptomatic human immunodeficiency virus [hiv] infection status neutropenia, unspecified long-term (current) use of insulin other and unspecified hyperlipidemia acute myeloid leukemia, without mention of having achieved remission fever presenting with conditions classified elsewhere bloodstream infection due to central venous catheter other toe(s) amputation status hematoma complicating a procedure coronary atherosclerosis of native coronary artery loss of weight background diabetic retinopathy acute myeloid leukemia, without mention of having achieved remission pedal cycle driver injured in noncollision transport accident in nontraffic accident body mass index less than 19, adult driver of special construction vehicle injured in traffic accident diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled foot amputation status polyneuropathy in diabetes acidosis other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status personal history of tobacco use flatulence, eructation, and gas pain coronary atherosclerosis of native coronary artery family history of diabetes mellitus long-term (current) use of steroids other and unspecified diseases of the oral soft tissues acute apical periodontitis of pulpal origin
white m 65 $nan$hematology blood hematocrit  19.7  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  29  k ul; hematology blood platelet count  9  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  172  mg dl; chemistry blood lactate dehydrogenase (ld)  138  iu l; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; atenolol  12.5  mg ; atovaquone suspension  1500  mg ; etravirine  200  mg ; finasteride  5  mg ; fluconazole  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lamivudine  150  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; raltegravir  400  mg ; rosuvastatin calcium  40  mg ; vitamin d  1000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; insulin  0  unit ; insulin  34  unit ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; caphosol  30  ml ; lidocaine viscous 2%  15  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; daptomycin  360  mg ; 0.9% sodium chloride  100  ml ; decitabine  36  mg ; ondansetron  8  mg ; *nf* ertapenem sodium  1  g ; 
percutaneous transluminal coronary angioplasty status personal history of tobacco use polyneuropathy in diabetes streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] urinary tract infection, site not specified acute myeloid leukemia, in relapse asymptomatic human immunodeficiency virus [hiv] infection status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia fever presenting with conditions classified elsewhere neutropenia, unspecified other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of antineoplastic chemotherapy personal history of tobacco use polyneuropathy in diabetes asymptomatic human immunodeficiency virus [hiv] infection status neutropenia, unspecified long-term (current) use of insulin other and unspecified hyperlipidemia acute myeloid leukemia, without mention of having achieved remission fever presenting with conditions classified elsewhere bloodstream infection due to central venous catheter other toe(s) amputation status hematoma complicating a procedure coronary atherosclerosis of native coronary artery loss of weight background diabetic retinopathy acute myeloid leukemia, without mention of having achieved remission pedal cycle driver injured in noncollision transport accident in nontraffic accident body mass index less than 19, adult driver of special construction vehicle injured in traffic accident diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled foot amputation status polyneuropathy in diabetes acidosis other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status personal history of tobacco use flatulence, eructation, and gas pain coronary atherosclerosis of native coronary artery family history of diabetes mellitus long-term (current) use of steroids other and unspecified diseases of the oral soft tissues acute apical periodontitis of pulpal origin
white m 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; atenolol  12.5  mg ; atovaquone suspension  1500  mg ; etravirine  200  mg ; finasteride  5  mg ; fluconazole  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lamivudine  150  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; raltegravir  400  mg ; rosuvastatin calcium  40  mg ; vitamin d  1000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; insulin  0  unit ; insulin  34  unit ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; caphosol  30  ml ; lidocaine viscous 2%  15  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; daptomycin  360  mg ; 0.9% sodium chloride  100  ml ; decitabine  36  mg ; ondansetron  8  mg ; *nf* ertapenem sodium  1  g ; 
percutaneous transluminal coronary angioplasty status personal history of tobacco use polyneuropathy in diabetes streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] urinary tract infection, site not specified acute myeloid leukemia, in relapse asymptomatic human immunodeficiency virus [hiv] infection status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia fever presenting with conditions classified elsewhere neutropenia, unspecified other pancytopenia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of antineoplastic chemotherapy personal history of tobacco use polyneuropathy in diabetes asymptomatic human immunodeficiency virus [hiv] infection status neutropenia, unspecified long-term (current) use of insulin other and unspecified hyperlipidemia acute myeloid leukemia, without mention of having achieved remission fever presenting with conditions classified elsewhere bloodstream infection due to central venous catheter other toe(s) amputation status hematoma complicating a procedure coronary atherosclerosis of native coronary artery loss of weight background diabetic retinopathy acute myeloid leukemia, without mention of having achieved remission pedal cycle driver injured in noncollision transport accident in nontraffic accident body mass index less than 19, adult driver of special construction vehicle injured in traffic accident diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled foot amputation status polyneuropathy in diabetes acidosis other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status personal history of tobacco use flatulence, eructation, and gas pain coronary atherosclerosis of native coronary artery family history of diabetes mellitus long-term (current) use of steroids other and unspecified diseases of the oral soft tissues acute apical periodontitis of pulpal origin
white f 66 $temp  98.54  heartrate  99.0  resprate  20.0  o2sat  100.0  sbp  135.0  dbp  68.0  rhythm    pain  7  ; temp  98.1  heartrate  94.0  resprate  19.0  o2sat  100.0  sbp  137.0  dbp  65.0  rhythm    pain  0  $hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  124  mg dl; chemistry blood albumin  3.5  g dl; blood gas blood lactate  1.7  mmol l$nan
 
white f 66 $temp  98.1  heartrate  101.0  resprate  18.0  o2sat  99.0  sbp  154.0  dbp  101.0  rhythm    pain  3  $hematology blood hematocrit  34.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  180  mg dl; chemistry blood lactate dehydrogenase (ld)  202  iu l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levothyroxine sodium  25  mcg ; lithium carbonate  300  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sofosbuvir  400  mg ; oxycodone (immediate release)   2.5  mg ; prednisone  40  mg ; ribasphere  600  mg ; senna  8.6  mg ; docusate sodium  100  mg ; levofloxacin  750  mg ; potassium chloride  20  meq ; ribasphere  400  mg ; acetaminophen  650  mg ; guaifenesin er  600  mg ; furosemide  10  mg ; metoprolol tartrate  25  mg ; albuterol inhaler  1  puff ; 
 
white f 66 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  93  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; lithium carbonate  300  mg ; albuterol 0.083% neb soln  1  neb ; oxycodone (immediate release)   2.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; levofloxacin  750  mg ; ribasphere  400  mg ; acetaminophen  650  mg ; guaifenesin er  600  mg ; furosemide  10  mg ; metoprolol tartrate  25  mg ; albuterol inhaler  1  puff ; levothyroxine sodium  37.5  mcg ; fluticasone-salmeterol diskus (100 50)  1  inh ; metoprolol tartrate  50  mg ; 
 
white f 66 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  85  mg dl; chemistry blood glucose  89  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; lithium carbonate  300  mg ; albuterol 0.083% neb soln  1  neb ; oxycodone (immediate release)   2.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; ribasphere  400  mg ; acetaminophen  650  mg ; guaifenesin er  600  mg ; albuterol inhaler  1  puff ; levothyroxine sodium  37.5  mcg ; fluticasone-salmeterol diskus (100 50)  1  inh ; metoprolol tartrate  50  mg ; cepastat (phenol) lozenge  1  loz ; 
 
white m 81 $nan$nan$aspirin  81  mg ; nephrocaps  1  cap ; omeprazole  20  mg ; 
gross hematuria ulcerative colitis, unspecified personal history of malignant neoplasm of prostate other second degree atrioventricular block retention of urine, unspecified long-term (current) use of insulin backache, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension polyneuropathy in diabetes iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified hemorrhage complicating a procedure other disorders of neurohypophysis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux pure hypercholesterolemia cystitis cystica personal history of tobacco use regional enteritis of unspecified site other second degree atrioventricular block polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified ulcer of other part of foot pure hypercholesterolemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) malignant neoplasm of prostate esophageal reflux dysthymic disorder unspecified essential hypertension 
white m 81 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  80  meq l; chemistry blood chloride  81  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  111  meq l; chemistry blood sodium  112  meq l; chemistry blood sodium  113  meq l; chemistry blood sodium  108  meq l; chemistry blood sodium  110  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  25  meq l; chemistry urine creatinine, urine  109  mg dl; chemistry urine creatinine, urine  195  mg dl; chemistry urine sodium, urine  20  meq l; chemistry urine sodium, urine  17  meq l; chemistry urine urea nitrogen, urine  567  mg dl; hematology urine wbc  694  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  175  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  327  iu l; blood gas blood lactate  0.8  mmol l$aspirin  81  mg ; nephrocaps  1  cap ; omeprazole  20  mg ; heparin  5000  unit ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; gabapentin  300  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; tamsulosin  0.8  mg ; latanoprost 0.005% ophth. soln.  1  drop ; oxycodone-acetaminophen  1-2  tab ; lidocaine 5% patch  1  ptch ; sodium chloride 3% (hypertonic)  500  ml ; sodium chloride  1  gm ; ciprofloxacin hcl  750  mg ; metronidazole (flagyl)  500  mg ; potassium chloride  20  meq ; insulin  0  unit ; 0.9% sodium chloride  500  ml ; aspirin  325  mg ; lidocaine 5% patch  2  ptch ; albuterol inhaler  2  puff ; 0.9% sodium chloride  250  ml ; 0.9% sodium chloride  1000  ml ; sw  50  ml ; acetaminophen  325  mg ; sodium chloride 0.9%  flush  10  ml ; 
gross hematuria ulcerative colitis, unspecified personal history of malignant neoplasm of prostate other second degree atrioventricular block retention of urine, unspecified long-term (current) use of insulin backache, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension polyneuropathy in diabetes iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified hemorrhage complicating a procedure other disorders of neurohypophysis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux pure hypercholesterolemia cystitis cystica personal history of tobacco use regional enteritis of unspecified site other second degree atrioventricular block polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified ulcer of other part of foot pure hypercholesterolemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) malignant neoplasm of prostate esophageal reflux dysthymic disorder unspecified essential hypertension 
white m 81 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  6  meq l; chemistry blood anion gap  8  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  120  meq l; chemistry blood sodium  118  meq l; chemistry blood sodium  119  meq l; chemistry blood sodium  114  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry urine chloride, urine  24  meq l; chemistry urine chloride, urine  50  meq l; chemistry urine chloride, urine  145  meq l; chemistry urine chloride, urine  135  meq l; chemistry urine creatinine, urine  174  mg dl; chemistry urine creatinine, urine  23  mg dl; chemistry urine creatinine, urine  94  mg dl; chemistry urine creatinine, urine  47  mg dl; chemistry urine potassium, urine  23  meq l; chemistry urine sodium, urine  35  meq l; chemistry urine sodium, urine  67  meq l; chemistry urine sodium, urine  84  meq l; chemistry urine urea nitrogen, urine  651  mg dl; chemistry urine urea nitrogen, urine  228  mg dl; chemistry urine urea nitrogen, urine  560  mg dl; chemistry urine urea nitrogen, urine  390  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  112  mg dl$nephrocaps  1  cap ; omeprazole  20  mg ; heparin  5000  unit ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; tamsulosin  0.8  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride  1  gm ; ciprofloxacin hcl  750  mg ; metronidazole (flagyl)  500  mg ; potassium chloride  20  meq ; insulin  0  unit ; aspirin  325  mg ; lidocaine 5% patch  2  ptch ; albuterol inhaler  2  puff ; 0.9% sodium chloride  1000  ml ; sw  50  ml ; acetaminophen  325  mg ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; sw  100  ml ; potassium chloride  40  meq ; magnesium sulfate  2  gm ; neutra-phos  1  pkt ; 
gross hematuria ulcerative colitis, unspecified personal history of malignant neoplasm of prostate other second degree atrioventricular block retention of urine, unspecified long-term (current) use of insulin backache, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension polyneuropathy in diabetes iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified hemorrhage complicating a procedure other disorders of neurohypophysis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux pure hypercholesterolemia cystitis cystica personal history of tobacco use regional enteritis of unspecified site other second degree atrioventricular block polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified ulcer of other part of foot pure hypercholesterolemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) malignant neoplasm of prostate esophageal reflux dysthymic disorder unspecified essential hypertension 
white m 81 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  123  meq l; chemistry blood sodium  119  meq l; chemistry blood sodium  120  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry urine chloride, urine  142  meq l; chemistry urine chloride, urine  151  meq l; chemistry urine chloride, urine  161  meq l; chemistry urine creatinine, urine  52  mg dl; chemistry urine creatinine, urine  78  mg dl; chemistry urine creatinine, urine  72  mg dl; chemistry urine potassium, urine  21  meq l; chemistry urine potassium, urine  38  meq l; chemistry urine potassium, urine  42  meq l; chemistry urine sodium, urine  96  meq l; chemistry urine sodium, urine  101  meq l; chemistry urine sodium, urine  110  meq l; chemistry urine urea nitrogen, urine  316  mg dl; chemistry urine urea nitrogen, urine  421  mg dl; chemistry urine urea nitrogen, urine  518  mg dl; hematology urine wbc  42  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  122  mg dl$nephrocaps  1  cap ; omeprazole  20  mg ; heparin  5000  unit ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; tamsulosin  0.8  mg ; latanoprost 0.005% ophth. soln.  1  drop ; ciprofloxacin hcl  750  mg ; insulin  0  unit ; aspirin  325  mg ; lidocaine 5% patch  2  ptch ; albuterol inhaler  2  puff ; acetaminophen  325  mg ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; neutra-phos  1  pkt ; haloperidol  0.5  mg ; iso-osmotic dextrose  50  ml ; 
gross hematuria ulcerative colitis, unspecified personal history of malignant neoplasm of prostate other second degree atrioventricular block retention of urine, unspecified long-term (current) use of insulin backache, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension polyneuropathy in diabetes iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified hemorrhage complicating a procedure other disorders of neurohypophysis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux pure hypercholesterolemia cystitis cystica personal history of tobacco use regional enteritis of unspecified site other second degree atrioventricular block polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified ulcer of other part of foot pure hypercholesterolemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) malignant neoplasm of prostate esophageal reflux dysthymic disorder unspecified essential hypertension 
white m 81 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry urine chloride, urine  180  meq l; chemistry urine creatinine, urine  91  mg dl; chemistry urine sodium, urine  144  meq l; chemistry urine urea nitrogen, urine  487  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  193  mg dl$ceftriaxone  1  g ; omeprazole  20  mg ; heparin  5000  unit ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; tamsulosin  0.8  mg ; latanoprost 0.005% ophth. soln.  1  drop ; insulin  0  unit ; aspirin  325  mg ; lidocaine 5% patch  2  ptch ; albuterol inhaler  2  puff ; acetaminophen  325  mg ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; haloperidol  0.5  mg ; iso-osmotic dextrose  50  ml ; olanzapine (disintegrating tablet)  5  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  12.5  mg ; trazodone  25  mg ; 
gross hematuria ulcerative colitis, unspecified personal history of malignant neoplasm of prostate other second degree atrioventricular block retention of urine, unspecified long-term (current) use of insulin backache, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension polyneuropathy in diabetes iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified hemorrhage complicating a procedure other disorders of neurohypophysis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux pure hypercholesterolemia cystitis cystica personal history of tobacco use regional enteritis of unspecified site other second degree atrioventricular block polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified ulcer of other part of foot pure hypercholesterolemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) malignant neoplasm of prostate esophageal reflux dysthymic disorder unspecified essential hypertension 
white m 81 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry urine creatinine, urine  55  mg dl; chemistry urine sodium, urine  56  meq l; chemistry urine urea nitrogen, urine  485  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  121  mg dl$ceftriaxone  1  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; omeprazole  20  mg ; heparin  5000  unit ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; tamsulosin  0.8  mg ; latanoprost 0.005% ophth. soln.  1  drop ; insulin  0  unit ; aspirin  325  mg ; lidocaine 5% patch  2  ptch ; albuterol inhaler  2  puff ; acetaminophen  325  mg ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; olanzapine (disintegrating tablet)  5  mg ; trazodone  25  mg ; haloperidol  1  mg ; 
gross hematuria ulcerative colitis, unspecified personal history of malignant neoplasm of prostate other second degree atrioventricular block retention of urine, unspecified long-term (current) use of insulin backache, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension polyneuropathy in diabetes iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified hemorrhage complicating a procedure other disorders of neurohypophysis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux pure hypercholesterolemia cystitis cystica personal history of tobacco use regional enteritis of unspecified site other second degree atrioventricular block polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified ulcer of other part of foot pure hypercholesterolemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) malignant neoplasm of prostate esophageal reflux dysthymic disorder unspecified essential hypertension 
white m 81 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  124  mg dl$ceftriaxone  1  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; omeprazole  20  mg ; heparin  5000  unit ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; tamsulosin  0.8  mg ; latanoprost 0.005% ophth. soln.  1  drop ; insulin  0  unit ; aspirin  325  mg ; lidocaine 5% patch  2  ptch ; albuterol inhaler  2  puff ; acetaminophen  325  mg ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; trazodone  25  mg ; haloperidol  1  mg ; 
gross hematuria ulcerative colitis, unspecified personal history of malignant neoplasm of prostate other second degree atrioventricular block retention of urine, unspecified long-term (current) use of insulin backache, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension polyneuropathy in diabetes iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified hemorrhage complicating a procedure other disorders of neurohypophysis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux pure hypercholesterolemia cystitis cystica personal history of tobacco use regional enteritis of unspecified site other second degree atrioventricular block polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified ulcer of other part of foot pure hypercholesterolemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) malignant neoplasm of prostate esophageal reflux dysthymic disorder unspecified essential hypertension 
white m 81 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  129  mg dl$ceftriaxone  1  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; omeprazole  20  mg ; heparin  5000  unit ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; tamsulosin  0.8  mg ; latanoprost 0.005% ophth. soln.  1  drop ; insulin  0  unit ; aspirin  325  mg ; lidocaine 5% patch  2  ptch ; albuterol inhaler  2  puff ; acetaminophen  325  mg ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; trazodone  25  mg ; potassium chloride  60  meq ; indomethacin  25  mg ; 
gross hematuria ulcerative colitis, unspecified personal history of malignant neoplasm of prostate other second degree atrioventricular block retention of urine, unspecified long-term (current) use of insulin backache, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension polyneuropathy in diabetes iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified hemorrhage complicating a procedure other disorders of neurohypophysis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux pure hypercholesterolemia cystitis cystica personal history of tobacco use regional enteritis of unspecified site other second degree atrioventricular block polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified ulcer of other part of foot pure hypercholesterolemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) malignant neoplasm of prostate esophageal reflux dysthymic disorder unspecified essential hypertension 
white m 81 $nan$nan$ceftriaxone  1  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; omeprazole  20  mg ; heparin  5000  unit ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; tamsulosin  0.8  mg ; latanoprost 0.005% ophth. soln.  1  drop ; insulin  0  unit ; aspirin  325  mg ; lidocaine 5% patch  2  ptch ; albuterol inhaler  2  puff ; acetaminophen  325  mg ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; trazodone  25  mg ; potassium chloride  60  meq ; indomethacin  25  mg ; 
gross hematuria ulcerative colitis, unspecified personal history of malignant neoplasm of prostate other second degree atrioventricular block retention of urine, unspecified long-term (current) use of insulin backache, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension polyneuropathy in diabetes iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified hemorrhage complicating a procedure other disorders of neurohypophysis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux pure hypercholesterolemia cystitis cystica personal history of tobacco use regional enteritis of unspecified site other second degree atrioventricular block polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified ulcer of other part of foot pure hypercholesterolemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) malignant neoplasm of prostate esophageal reflux dysthymic disorder unspecified essential hypertension 
white m 94 $nan$nan$furosemide  20  mg ; 
other and unspecified hyperlipidemia unspecified essential hypertension chronic total occlusion of coronary artery syncope and collapse abdominal aneurysm without mention of rupture coronary atherosclerosis of native coronary artery
white m 94 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  150  mg dl; chemistry blood albumin  3.4  g dl; chemistry blood % hemoglobin a1c  5.2  %$furosemide  20  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; clopidogrel  300  mg ; tamsulosin  0.4  mg ; tramadol  50  mg ; aspirin  325  mg ; clopidogrel  75  mg ; metoprolol succinate xl  25  mg ; isosorbide mononitrate (extended release)  120  mg ; eplerenone  25  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
other and unspecified hyperlipidemia unspecified essential hypertension chronic total occlusion of coronary artery syncope and collapse abdominal aneurysm without mention of rupture coronary atherosclerosis of native coronary artery
white m 94 $nan$nan$furosemide  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; tamsulosin  0.4  mg ; tramadol  50  mg ; clopidogrel  75  mg ; metoprolol succinate xl  25  mg ; isosorbide mononitrate (extended release)  120  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; pantoprazole  40  mg ; aspirin  81  mg ; 
other and unspecified hyperlipidemia unspecified essential hypertension chronic total occlusion of coronary artery syncope and collapse abdominal aneurysm without mention of rupture coronary atherosclerosis of native coronary artery
white f 76 $nan$nan$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; multivitamins  1  tab ; citalopram hydrobromide  20  mg ; folic acid  1  mg ; 
 
white f 76 $nan$hematology blood hematocrit  33.8  %; hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  103  k ul; hematology blood platelet count  103  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  117  meq l; chemistry blood chloride  121  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  6.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  151  mg dl; chemistry blood lactate dehydrogenase (ld)  136  iu l; chemistry blood albumin  2.5  g dl; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.15  mmol l$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; multivitamins  1  tab ; citalopram hydrobromide  20  mg ; folic acid  1  mg ; influenza virus vaccine  0.5  ml ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; divalproex sod. sprinkles  250  mg ; mirapex  0.125  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  1  tab ; 5% dextrose  1000  ml ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; pantoprazole  40  mg ; levofloxacin  250  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; carbidopa-levodopa (25-100)  1  tab ; entacapone  200  mg ; quetiapine fumarate  12.5  mg ; sw  100  ml ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; ns (mini bag plus)  100  ml ; cefepime  2  g ; neutra-phos  2  pkt ; morphine sulfate  1-8  mg ; lorazepam  0.5-2  mg ; scopolamine patch  1  ptch ; d5w  100  ml ; morphine sulfate  100  mg ; 
 
white f 76 $nan$nan$citalopram hydrobromide  20  mg ; influenza virus vaccine  0.5  ml ; docusate sodium (liquid)  100  mg ; divalproex sod. sprinkles  250  mg ; mirapex  0.125  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  1  tab ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; carbidopa-levodopa (25-100)  1  tab ; entacapone  200  mg ; quetiapine fumarate  12.5  mg ; sw  100  ml ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; neutra-phos  2  pkt ; lorazepam  0.5-2  mg ; scopolamine patch  1  ptch ; d5w  100  ml ; morphine sulfate  100  mg ; 
 
white m 44 $nan$hematology blood hematocrit  42.1  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; lr  1000  ml ; 
 
white f 67 $nan$hematology blood hematocrit  31.7  %; hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  284  k ul; hematology blood platelet count  254  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  4.3  ; chemistry blood glucose  110  mg dl; chemistry blood glucose  111  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; 
 
white f 52 $temp  96.6  heartrate  80.0  resprate  16.0  o2sat  99.0  sbp  179.0  dbp  106.0  rhythm    pain  5  ; temp  98.1  heartrate  75.0  resprate  18.0  o2sat  98.0  sbp  136.0  dbp  95.0  rhythm    pain  0  $hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  106  mg dl; blood gas blood lactate  0.9  mmol l$nan
cerebral aneurysm, nonruptured gastro-esophageal reflux disease without esophagitis obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence cerebral aneurysm, nonruptured mitral valve disorders pure hypercholesterolemia 
white f 52 $temp  98.2  heartrate  62.0  resprate  18.0  o2sat  96.0  sbp  130.0  dbp  72.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3-10  ml ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  1000  mg ; aspirin  81  mg ; ticagrelor  90  mg ; 
cerebral aneurysm, nonruptured gastro-esophageal reflux disease without esophagitis obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence cerebral aneurysm, nonruptured mitral valve disorders pure hypercholesterolemia 
white f 48 $temp  98.0  heartrate  79.0  resprate  15.0  o2sat    sbp  103.0  dbp  63.0  rhythm    pain  4  $hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  4.4  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; oxcarbazepine  450  mg ; heparin  5000  unit ; phenytoin sodium extended  400  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; oxcarbazepine  450  mg ; heparin  5000  unit ; lacosamide  50  mg ; senna  1  tab ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$hematology urine wbc  11  # hpf$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; oxcarbazepine  450  mg ; heparin  5000  unit ; lacosamide  50  mg ; senna  1  tab ; docusate sodium  100  mg ; phenytoin sodium extended  100  mg ; bisacodyl  10  mg ; lacosamide  75  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; oxcarbazepine  450  mg ; heparin  5000  unit ; docusate sodium  100  mg ; phenytoin sodium extended  100  mg ; bisacodyl  10  mg ; lacosamide  75  mg ; lacosamide  25  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bisacodyl  10  mg ; lacosamide  25  mg ; lacosamide  100  mg ; oxcarbazepine  300  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bisacodyl  10  mg ; lacosamide  125  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$hematology blood hematocrit  43.8  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bisacodyl  10  mg ; lacosamide  150  mg ; lorazepam  1  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bisacodyl  10  mg ; lacosamide  150  mg ; clobazam  5  mg ; nystatin oral suspension  5  ml ; phenytoin infatab  300  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  4.2  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bisacodyl  10  mg ; lacosamide  150  mg ; clobazam  5  mg ; nystatin oral suspension  5  ml ; phenytoin infatab  300  mg ; phenytoin sodium extended  300  mg ; phenytoin infatab  100  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bisacodyl  10  mg ; lacosamide  150  mg ; nystatin oral suspension  5  ml ; phenytoin sodium extended  300  mg ; clobazam  10  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bisacodyl  10  mg ; lacosamide  150  mg ; nystatin oral suspension  5  ml ; clobazam  10  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bisacodyl  10  mg ; lacosamide  150  mg ; nystatin oral suspension  5  ml ; clobazam  10  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bisacodyl  10  mg ; lacosamide  150  mg ; nystatin oral suspension  5  ml ; clobazam  10  mg ; 
epilepsy, unspecified, with intractable epilepsy epilepsy, unspecified, with intractable epilepsy generalized convulsive epilepsy, with intractable epilepsy 
white f 20 $nan$nan$influenza virus vaccine  0.5  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; hydroxyzine  25  mg ; sertraline  50  mg ; sertraline  75  mg ; 
depressive disorder, not elsewhere classified suicidal ideation
white f 20 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; hydroxyzine  25  mg ; sertraline  75  mg ; sertraline  100  mg ; 
depressive disorder, not elsewhere classified suicidal ideation
white f 20 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; hydroxyzine  25  mg ; sertraline  100  mg ; quetiapine fumarate  25  mg ; 
depressive disorder, not elsewhere classified suicidal ideation
white f 20 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; hydroxyzine  25  mg ; sertraline  100  mg ; quetiapine fumarate  25  mg ; 
depressive disorder, not elsewhere classified suicidal ideation
white f 76 $temp  98.5  heartrate  85.0  resprate  18.0  o2sat  97.0  sbp  131.0  dbp  79.0  rhythm    pain  0  ; temp  98.4  heartrate  90.0  resprate  16.0  o2sat  100.0  sbp  118.0  dbp  56.0  rhythm    pain    $nan$volumen (barium sulfate 0.1% suspension)  900  ml ; 
migraine, unspecified, not intractable, without status migrainosus unspecified intestinal obstruction, unspecified as to partial versus complete obstruction dehydration hypothyroidism, unspecified personal history of other malignant neoplasm of skin ulcerative colitis, unspecified, without complications herpesviral infection of urogenital system, unspecified ileostomy status hyperlipidemia, unspecified ileostomy status frequency of micturition hypothyroidism, unspecified hyperlipidemia, unspecified personal history of malignant melanoma of skin syncope and collapse partial intestinal obstruction, unspecified as to cause personal history of other malignant neoplasm of skin herpesviral infection of urogenital system, unspecified parastomal hernia without obstruction or gangrene ileostomy status hyperlipidemia, unspecified acquired absence of other specified parts of digestive tract hypothyroidism, unspecified personal history of other malignant neoplasm of skin nausea intestinal adhesions [bands], with partial obstruction herpesviral infection of urogenital system, unspecified acquired absence of other specified parts of digestive tract personal history of malignant melanoma of skin hyperlipidemia, unspecified ileostomy status personal history of other malignant neoplasm of skin hypothyroidism, unspecified herpesviral infection of urogenital system, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hyperkalemia unspecified place or not applicable body mass index (bmi) 19.9 or less, adult adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperlipidemia, unspecified personal history of other malignant neoplasm of skin pressure ulcer of sacral region, unspecified stage operating room of hospital as the place of occurrence of the external cause acute posthemorrhagic anemia ileus, unspecified personal history of malignant melanoma of skin patient room in hospital as the place of occurrence of the external cause surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 76 $temp  98.5  heartrate  88.0  resprate  16.0  o2sat  100.0  sbp  111.0  dbp  60.0  rhythm    pain  2  $hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  482  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  124  mg dl$volumen (barium sulfate 0.1% suspension)  900  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; levothyroxine sodium  50  mcg ; fat emulsion 20%  250  ml ; chloraseptic throat spray  1  spry ; ondansetron  4  mg ; 
migraine, unspecified, not intractable, without status migrainosus unspecified intestinal obstruction, unspecified as to partial versus complete obstruction dehydration hypothyroidism, unspecified personal history of other malignant neoplasm of skin ulcerative colitis, unspecified, without complications herpesviral infection of urogenital system, unspecified ileostomy status hyperlipidemia, unspecified ileostomy status frequency of micturition hypothyroidism, unspecified hyperlipidemia, unspecified personal history of malignant melanoma of skin syncope and collapse partial intestinal obstruction, unspecified as to cause personal history of other malignant neoplasm of skin herpesviral infection of urogenital system, unspecified parastomal hernia without obstruction or gangrene ileostomy status hyperlipidemia, unspecified acquired absence of other specified parts of digestive tract hypothyroidism, unspecified personal history of other malignant neoplasm of skin nausea intestinal adhesions [bands], with partial obstruction herpesviral infection of urogenital system, unspecified acquired absence of other specified parts of digestive tract personal history of malignant melanoma of skin hyperlipidemia, unspecified ileostomy status personal history of other malignant neoplasm of skin hypothyroidism, unspecified herpesviral infection of urogenital system, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hyperkalemia unspecified place or not applicable body mass index (bmi) 19.9 or less, adult adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperlipidemia, unspecified personal history of other malignant neoplasm of skin pressure ulcer of sacral region, unspecified stage operating room of hospital as the place of occurrence of the external cause acute posthemorrhagic anemia ileus, unspecified personal history of malignant melanoma of skin patient room in hospital as the place of occurrence of the external cause surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 76 $nan$hematology blood hematocrit  20.9  %; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  406  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; fat emulsion 20%  250  ml ; chloraseptic throat spray  1  spry ; ondansetron  4  mg ; levothyroxine sodium  25  mcg ; acetaminophen iv  1000  mg ; cepacol (sore throat lozenge)  1  loz ; d5 1 2ns  1000  ml ; vial  1  vial ; pantoprazole  40  mg ; lorazepam  0.125  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; 
migraine, unspecified, not intractable, without status migrainosus unspecified intestinal obstruction, unspecified as to partial versus complete obstruction dehydration hypothyroidism, unspecified personal history of other malignant neoplasm of skin ulcerative colitis, unspecified, without complications herpesviral infection of urogenital system, unspecified ileostomy status hyperlipidemia, unspecified ileostomy status frequency of micturition hypothyroidism, unspecified hyperlipidemia, unspecified personal history of malignant melanoma of skin syncope and collapse partial intestinal obstruction, unspecified as to cause personal history of other malignant neoplasm of skin herpesviral infection of urogenital system, unspecified parastomal hernia without obstruction or gangrene ileostomy status hyperlipidemia, unspecified acquired absence of other specified parts of digestive tract hypothyroidism, unspecified personal history of other malignant neoplasm of skin nausea intestinal adhesions [bands], with partial obstruction herpesviral infection of urogenital system, unspecified acquired absence of other specified parts of digestive tract personal history of malignant melanoma of skin hyperlipidemia, unspecified ileostomy status personal history of other malignant neoplasm of skin hypothyroidism, unspecified herpesviral infection of urogenital system, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hyperkalemia unspecified place or not applicable body mass index (bmi) 19.9 or less, adult adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperlipidemia, unspecified personal history of other malignant neoplasm of skin pressure ulcer of sacral region, unspecified stage operating room of hospital as the place of occurrence of the external cause acute posthemorrhagic anemia ileus, unspecified personal history of malignant melanoma of skin patient room in hospital as the place of occurrence of the external cause surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 76 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  113  mg dl$bupivacaine 0.1%  250  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; chloraseptic throat spray  1  spry ; levothyroxine sodium  25  mcg ; acetaminophen iv  1000  mg ; cepacol (sore throat lozenge)  1  loz ; vial  1  vial ; pantoprazole  40  mg ; lorazepam  0.125  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 5% dextrose  100  ml ; naloxone  2  mg ; 0.9% sodium chl (yellow cadd)  1  cadd ; d5lr  1000  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; fentanyl citrate  12.5-25  mcg ; acetaminophen iv  500  mg ; bag  50  ml ; 
migraine, unspecified, not intractable, without status migrainosus unspecified intestinal obstruction, unspecified as to partial versus complete obstruction dehydration hypothyroidism, unspecified personal history of other malignant neoplasm of skin ulcerative colitis, unspecified, without complications herpesviral infection of urogenital system, unspecified ileostomy status hyperlipidemia, unspecified ileostomy status frequency of micturition hypothyroidism, unspecified hyperlipidemia, unspecified personal history of malignant melanoma of skin syncope and collapse partial intestinal obstruction, unspecified as to cause personal history of other malignant neoplasm of skin herpesviral infection of urogenital system, unspecified parastomal hernia without obstruction or gangrene ileostomy status hyperlipidemia, unspecified acquired absence of other specified parts of digestive tract hypothyroidism, unspecified personal history of other malignant neoplasm of skin nausea intestinal adhesions [bands], with partial obstruction herpesviral infection of urogenital system, unspecified acquired absence of other specified parts of digestive tract personal history of malignant melanoma of skin hyperlipidemia, unspecified ileostomy status personal history of other malignant neoplasm of skin hypothyroidism, unspecified herpesviral infection of urogenital system, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hyperkalemia unspecified place or not applicable body mass index (bmi) 19.9 or less, adult adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperlipidemia, unspecified personal history of other malignant neoplasm of skin pressure ulcer of sacral region, unspecified stage operating room of hospital as the place of occurrence of the external cause acute posthemorrhagic anemia ileus, unspecified personal history of malignant melanoma of skin patient room in hospital as the place of occurrence of the external cause surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 76 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  356  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; chloraseptic throat spray  1  spry ; levothyroxine sodium  25  mcg ; cepacol (sore throat lozenge)  1  loz ; vial  1  vial ; pantoprazole  40  mg ; lorazepam  0.125  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; bag  50  ml ; neutra-phos  1  pkt ; 
migraine, unspecified, not intractable, without status migrainosus unspecified intestinal obstruction, unspecified as to partial versus complete obstruction dehydration hypothyroidism, unspecified personal history of other malignant neoplasm of skin ulcerative colitis, unspecified, without complications herpesviral infection of urogenital system, unspecified ileostomy status hyperlipidemia, unspecified ileostomy status frequency of micturition hypothyroidism, unspecified hyperlipidemia, unspecified personal history of malignant melanoma of skin syncope and collapse partial intestinal obstruction, unspecified as to cause personal history of other malignant neoplasm of skin herpesviral infection of urogenital system, unspecified parastomal hernia without obstruction or gangrene ileostomy status hyperlipidemia, unspecified acquired absence of other specified parts of digestive tract hypothyroidism, unspecified personal history of other malignant neoplasm of skin nausea intestinal adhesions [bands], with partial obstruction herpesviral infection of urogenital system, unspecified acquired absence of other specified parts of digestive tract personal history of malignant melanoma of skin hyperlipidemia, unspecified ileostomy status personal history of other malignant neoplasm of skin hypothyroidism, unspecified herpesviral infection of urogenital system, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hyperkalemia unspecified place or not applicable body mass index (bmi) 19.9 or less, adult adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperlipidemia, unspecified personal history of other malignant neoplasm of skin pressure ulcer of sacral region, unspecified stage operating room of hospital as the place of occurrence of the external cause acute posthemorrhagic anemia ileus, unspecified personal history of malignant melanoma of skin patient room in hospital as the place of occurrence of the external cause surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 76 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; chloraseptic throat spray  1  spry ; levothyroxine sodium  25  mcg ; cepacol (sore throat lozenge)  1  loz ; vial  1  vial ; pantoprazole  40  mg ; lorazepam  0.125  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; neutra-phos  1  pkt ; acyclovir  400  mg ; vitamin d  400  unit ; simvastatin  10  mg ; amitriptyline  10  mg ; 
migraine, unspecified, not intractable, without status migrainosus unspecified intestinal obstruction, unspecified as to partial versus complete obstruction dehydration hypothyroidism, unspecified personal history of other malignant neoplasm of skin ulcerative colitis, unspecified, without complications herpesviral infection of urogenital system, unspecified ileostomy status hyperlipidemia, unspecified ileostomy status frequency of micturition hypothyroidism, unspecified hyperlipidemia, unspecified personal history of malignant melanoma of skin syncope and collapse partial intestinal obstruction, unspecified as to cause personal history of other malignant neoplasm of skin herpesviral infection of urogenital system, unspecified parastomal hernia without obstruction or gangrene ileostomy status hyperlipidemia, unspecified acquired absence of other specified parts of digestive tract hypothyroidism, unspecified personal history of other malignant neoplasm of skin nausea intestinal adhesions [bands], with partial obstruction herpesviral infection of urogenital system, unspecified acquired absence of other specified parts of digestive tract personal history of malignant melanoma of skin hyperlipidemia, unspecified ileostomy status personal history of other malignant neoplasm of skin hypothyroidism, unspecified herpesviral infection of urogenital system, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hyperkalemia unspecified place or not applicable body mass index (bmi) 19.9 or less, adult adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperlipidemia, unspecified personal history of other malignant neoplasm of skin pressure ulcer of sacral region, unspecified stage operating room of hospital as the place of occurrence of the external cause acute posthemorrhagic anemia ileus, unspecified personal history of malignant melanoma of skin patient room in hospital as the place of occurrence of the external cause surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 76 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  1  loz ; vial  1  vial ; pantoprazole  40  mg ; lorazepam  0.125  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; acyclovir  400  mg ; vitamin d  400  unit ; simvastatin  10  mg ; acetaminophen  1000  mg ; 
migraine, unspecified, not intractable, without status migrainosus unspecified intestinal obstruction, unspecified as to partial versus complete obstruction dehydration hypothyroidism, unspecified personal history of other malignant neoplasm of skin ulcerative colitis, unspecified, without complications herpesviral infection of urogenital system, unspecified ileostomy status hyperlipidemia, unspecified ileostomy status frequency of micturition hypothyroidism, unspecified hyperlipidemia, unspecified personal history of malignant melanoma of skin syncope and collapse partial intestinal obstruction, unspecified as to cause personal history of other malignant neoplasm of skin herpesviral infection of urogenital system, unspecified parastomal hernia without obstruction or gangrene ileostomy status hyperlipidemia, unspecified acquired absence of other specified parts of digestive tract hypothyroidism, unspecified personal history of other malignant neoplasm of skin nausea intestinal adhesions [bands], with partial obstruction herpesviral infection of urogenital system, unspecified acquired absence of other specified parts of digestive tract personal history of malignant melanoma of skin hyperlipidemia, unspecified ileostomy status personal history of other malignant neoplasm of skin hypothyroidism, unspecified herpesviral infection of urogenital system, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hyperkalemia unspecified place or not applicable body mass index (bmi) 19.9 or less, adult adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperlipidemia, unspecified personal history of other malignant neoplasm of skin pressure ulcer of sacral region, unspecified stage operating room of hospital as the place of occurrence of the external cause acute posthemorrhagic anemia ileus, unspecified personal history of malignant melanoma of skin patient room in hospital as the place of occurrence of the external cause surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 76 $nan$nan$heparin  5000  unit ; acyclovir  400  mg ; vitamin d  400  unit ; simvastatin  10  mg ; acetaminophen  1000  mg ; 
migraine, unspecified, not intractable, without status migrainosus unspecified intestinal obstruction, unspecified as to partial versus complete obstruction dehydration hypothyroidism, unspecified personal history of other malignant neoplasm of skin ulcerative colitis, unspecified, without complications herpesviral infection of urogenital system, unspecified ileostomy status hyperlipidemia, unspecified ileostomy status frequency of micturition hypothyroidism, unspecified hyperlipidemia, unspecified personal history of malignant melanoma of skin syncope and collapse partial intestinal obstruction, unspecified as to cause personal history of other malignant neoplasm of skin herpesviral infection of urogenital system, unspecified parastomal hernia without obstruction or gangrene ileostomy status hyperlipidemia, unspecified acquired absence of other specified parts of digestive tract hypothyroidism, unspecified personal history of other malignant neoplasm of skin nausea intestinal adhesions [bands], with partial obstruction herpesviral infection of urogenital system, unspecified acquired absence of other specified parts of digestive tract personal history of malignant melanoma of skin hyperlipidemia, unspecified ileostomy status personal history of other malignant neoplasm of skin hypothyroidism, unspecified herpesviral infection of urogenital system, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hyperkalemia unspecified place or not applicable body mass index (bmi) 19.9 or less, adult adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperlipidemia, unspecified personal history of other malignant neoplasm of skin pressure ulcer of sacral region, unspecified stage operating room of hospital as the place of occurrence of the external cause acute posthemorrhagic anemia ileus, unspecified personal history of malignant melanoma of skin patient room in hospital as the place of occurrence of the external cause surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 69 $temp  98.0  heartrate  76.0  resprate  18.0  o2sat  99.0  sbp  126.0  dbp  78.0  rhythm    pain  0  $hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; allopurinol  300  mg ; dicyclomine  20  mg ; escitalopram oxalate  20  mg ; fluticasone propionate 110mcg  2  puff ; losartan potassium  100  mg ; montelukast  10  mg ; omeprazole  20  mg ; verapamil  80  mg ; acetaminophen  1000  mg ; heparin  1500-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sulfameth trimethoprim ds  1  tab ; rivaroxaban  15  mg ; 
 
white f 69 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  134  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; allopurinol  300  mg ; dicyclomine  20  mg ; escitalopram oxalate  20  mg ; fluticasone propionate 110mcg  2  puff ; losartan potassium  100  mg ; montelukast  10  mg ; verapamil  80  mg ; acetaminophen  1000  mg ; sulfameth trimethoprim ds  1  tab ; rivaroxaban  15  mg ; apixaban  10  mg ; 
 
white m 66 $nan$hematology blood hematocrit  43.0  %; hematology blood hemoglobin  15.3  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  116  mg dl; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  2.0  mmol l$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; nystatin  500,000  unit ; trazodone  50-100  mg ; trazodone  50  mg ; acetaminophen  325-650  mg ; lorazepam  1-2  mg ; metoprolol tartrate  5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen (rectal)     ; haloperidol  1  mg ; haloperidol     ; haloperidol  2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; carbamazepine  300  mg ; heparin  5000  unit ; zonisamide  400  mg ; aspirin  81  mg ; simvastatin  40  mg ; amlodipine  5  mg ; lisinopril  40  mg ; methimazole  7.5  mg ; senna  1  tab ; diazepam     ; lorazepam  2  mg ; lorazepam  0.5  mg ; hydralazine  10  mg ; olanzapine (disintegrating tablet)  5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 5% dextrose  500  ml ; potassium chloride  40  meq ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; diazepam  5  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1500  mg ; metoprolol tartrate  75  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; 
grand mal status other and unspecified hyperlipidemia other specified metabolic disorders unspecified essential hypertension other late effects of cerebrovascular disease unspecified fall subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft cerebral edema goiter, unspecified other convulsions other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of unspecified type of vessel, native or graft urinary tract infection, site not specified unspecified essential hypertension personal history of other diseases of circulatory system personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status cerebral atherosclerosis epilepsy, unspecified, without mention of intractable epilepsy subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness vascular dementia, uncomplicated late effects of cerebrovascular disease, hemiplegia affecting unspecified side other and unspecified hyperlipidemia hyposmolality and/or hyponatremia other specified metabolic disorders late effects of cerebrovascular disease, aphasia unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft unspecified fall electrolyte and fluid disorders not elsewhere classified generalized convulsive epilepsy, without mention of intractable epilepsy hypopotassemia other and unspecified hyperlipidemia chronic maxillary sinusitis vascular dementia, uncomplicated urinary tract infection, site not specified hyposmolality and/or hyponatremia late effects of cerebrovascular disease, hemiplegia affecting dominant side atrial fibrillation encephalopathy, unspecified unspecified essential hypertension cerebral atherosclerosis late effects of cerebrovascular disease, aphasia 
white m 66 $nan$hematology blood hematocrit  43.4  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  85  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nystatin  500,000  unit ; acetaminophen  325-650  mg ; metoprolol tartrate  5  mg ; haloperidol  1  mg ; haloperidol  2  mg ; heparin  5000  unit ; methimazole  7.5  mg ; senna  1  tab ; lorazepam  2  mg ; lorazepam  0.5  mg ; hydralazine  10  mg ; olanzapine (disintegrating tablet)  5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 5% dextrose  500  ml ; potassium chloride  40  meq ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; diazepam  5  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1500  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; levetiracetam  1000  mg ; metoprolol tartrate  25  mg ; 
grand mal status other and unspecified hyperlipidemia other specified metabolic disorders unspecified essential hypertension other late effects of cerebrovascular disease unspecified fall subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft cerebral edema goiter, unspecified other convulsions other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of unspecified type of vessel, native or graft urinary tract infection, site not specified unspecified essential hypertension personal history of other diseases of circulatory system personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status cerebral atherosclerosis epilepsy, unspecified, without mention of intractable epilepsy subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness vascular dementia, uncomplicated late effects of cerebrovascular disease, hemiplegia affecting unspecified side other and unspecified hyperlipidemia hyposmolality and/or hyponatremia other specified metabolic disorders late effects of cerebrovascular disease, aphasia unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft unspecified fall electrolyte and fluid disorders not elsewhere classified generalized convulsive epilepsy, without mention of intractable epilepsy hypopotassemia other and unspecified hyperlipidemia chronic maxillary sinusitis vascular dementia, uncomplicated urinary tract infection, site not specified hyposmolality and/or hyponatremia late effects of cerebrovascular disease, hemiplegia affecting dominant side atrial fibrillation encephalopathy, unspecified unspecified essential hypertension cerebral atherosclerosis late effects of cerebrovascular disease, aphasia 
white m 66 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  95  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nystatin  500,000  unit ; acetaminophen  325-650  mg ; metoprolol tartrate  5  mg ; heparin  5000  unit ; methimazole  7.5  mg ; senna  1  tab ; ranitidine  150  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; 
grand mal status other and unspecified hyperlipidemia other specified metabolic disorders unspecified essential hypertension other late effects of cerebrovascular disease unspecified fall subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft cerebral edema goiter, unspecified other convulsions other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of unspecified type of vessel, native or graft urinary tract infection, site not specified unspecified essential hypertension personal history of other diseases of circulatory system personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status cerebral atherosclerosis epilepsy, unspecified, without mention of intractable epilepsy subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness vascular dementia, uncomplicated late effects of cerebrovascular disease, hemiplegia affecting unspecified side other and unspecified hyperlipidemia hyposmolality and/or hyponatremia other specified metabolic disorders late effects of cerebrovascular disease, aphasia unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft unspecified fall electrolyte and fluid disorders not elsewhere classified generalized convulsive epilepsy, without mention of intractable epilepsy hypopotassemia other and unspecified hyperlipidemia chronic maxillary sinusitis vascular dementia, uncomplicated urinary tract infection, site not specified hyposmolality and/or hyponatremia late effects of cerebrovascular disease, hemiplegia affecting dominant side atrial fibrillation encephalopathy, unspecified unspecified essential hypertension cerebral atherosclerosis late effects of cerebrovascular disease, aphasia 
black african american f 21 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; ibuprofen  600  mg ; 
 
black african american f 21 $nan$hematology blood hematocrit  37.8  %$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; ibuprofen  600  mg ; medroxyprogesterone acetate  150  mg ; 
 
black african american f 21 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; medroxyprogesterone acetate  150  mg ; 
 
white m 71 $nan$nan$clopidogrel  75  mg ; aspirin  81  mg ; allopurinol  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; 
atherosclerosis of native arteries of the extremities with ulceration chronic osteomyelitis, ankle and foot ulcer of other part of foot streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b bacteroides fragilis chronic total occlusion of artery of the extremities cellulitis and abscess of foot, except toes gout, unspecified
white m 71 $nan$hematology blood hematocrit  35.9  %; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl$clopidogrel  75  mg ; aspirin  81  mg ; allopurinol  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; pneumococcal vac polyvalent  0.5  ml ; 
atherosclerosis of native arteries of the extremities with ulceration chronic osteomyelitis, ankle and foot ulcer of other part of foot streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b bacteroides fragilis chronic total occlusion of artery of the extremities cellulitis and abscess of foot, except toes gout, unspecified
hispanic latino m 32 $nan$hematology blood hematocrit  28.6  %; hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  245  k ul; hematology blood platelet count  199  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  465  iu l; chemistry blood lactate dehydrogenase (ld)  317  iu l; chemistry blood albumin  3.3  g dl; chemistry blood albumin  3.2  g dl; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.4  mmol l$amiodarone  600  mg ; sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; furosemide  120  mg ; d5w  100  ml ; milrinone  20  mg ; 5% dextrose (excel bag)  500  ml ; allopurinol  150  mg ; diazepam  10  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; allopurinol  150  mg ; diazepam  10  mg ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; furosemide  80  mg ; carvedilol  3.125  mg ; lidocaine 5% patch  1  ptch ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  79  mg dl; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; allopurinol  150  mg ; diazepam  10  mg ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; torsemide  20  mg ; lisinopril  2.5  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; allopurinol  150  mg ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; torsemide  20  mg ; lisinopril  2.5  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; acetaminophen  1000  mg ; lactulose enema  1000  ml ; sodium chloride 0.9%  1000  ml ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  124  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, indirect  1.0  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  111  mg dl; chemistry blood lactate dehydrogenase (ld)  291  iu l; chemistry blood albumin  3.5  g dl; chemistry blood bilirubin, direct  1.1  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; allopurinol  150  mg ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; lactulose enema  1000  ml ; sodium chloride 0.9%  1000  ml ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  23  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  124  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; allopurinol  150  mg ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; magnesium oxide  400  mg ; lactulose  15  ml ; ranitidine  150  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  76  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; senna  8.6  mg ; allopurinol  150  mg ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; lactulose  15  ml ; ranitidine  150  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; allopurinol  150  mg ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; simethicone  40-80  mg ; lactulose  30  ml ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  82  meq l; chemistry blood chloride  81  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  119  meq l; chemistry blood sodium  117  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.6  ; chemistry urine creatinine, urine  140  mg dl; chemistry urine urea nitrogen, urine  309  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  256  iu l$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; allopurinol  150  mg ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen  325-650  mg ; simethicone  40-80  mg ; lactulose  30  ml ; 5% dextrose  50  ml ; furosemide  160  mg ; potassium chloride (powder)  40  meq ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  27  meq l; chemistry blood anion gap  24  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  84  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  121  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  322  iu l; chemistry blood albumin  4.1  g dl; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  4.0  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  3.6  mmol l; blood gas blood lactate  4.2  mmol l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood sodium, whole blood  125  meq l; blood gas blood sodium, whole blood  125  meq l; blood gas blood sodium, whole blood  122  meq l$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; allopurinol  150  mg ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; simethicone  80  mg ; torsemide  60  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  25  meq l; chemistry blood anion gap  25  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  83  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  123  meq l; chemistry blood sodium  124  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  88  mg dl; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  2.8  mmol l$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; allopurinol  150  mg ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; simethicone  80  mg ; torsemide  60  mg ; torsemide  40  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  82  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  97  mg dl; blood gas blood lactate  2.3  mmol l$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; allopurinol  150  mg ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; simethicone  80  mg ; mineral oil  15  ml ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  83  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; allopurinol  150  mg ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; simethicone  80  mg ; mineral oil  15  ml ; senna  17.2  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  22  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  82  meq l; chemistry blood chloride  84  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  121  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza vaccine quadrivalent  0.5  ml ; allopurinol  150  mg ; heparin  5000  unit ; amiodarone  400  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; simethicone  80  mg ; senna  17.2  mg ; 0.9% sodium chloride  50  ml ; furosemide  200  mg ; chlorothiazide sodium  500  mg ; furosemide  250  mg ; furosemide  100  mg ; benzonatate  200  mg ; hydralazine  10  mg ; isosorbide dinitrate  10  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  82  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  2.5  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  68  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; hydralazine  10  mg ; isosorbide dinitrate  10  mg ; potassium chloride  80  meq ; 0.9% sodium chloride  500  ml ; hydralazine  20  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  27  meq l; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  84  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  76  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; isosorbide dinitrate  10  mg ; potassium chloride  80  meq ; 0.9% sodium chloride  500  ml ; hydralazine  20  mg ; amiodarone  200  mg ; spironolactone  12.5  mg ; 5% dextrose  25  ml ; chlorothiazide sodium  250  mg ; isosorbide dinitrate  20  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  83  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  83  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  98  mg dl; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; spironolactone  12.5  mg ; 5% dextrose  25  ml ; chlorothiazide sodium  250  mg ; isosorbide dinitrate  20  mg ; captopril  3.125  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; isosorbide dinitrate  20  mg ; captopril  3.125  mg ; trazodone  50  mg ; captopril  6.25  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; isosorbide dinitrate  20  mg ; trazodone  50  mg ; metolazone  5  mg ; captopril  12.5  mg ; oxycodone (immediate release)  5  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  83  meq l; chemistry blood chloride  82  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  71  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; metolazone  5  mg ; captopril  12.5  mg ; oxycodone (immediate release)  5  mg ; captopril  18.75  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  81  meq l; chemistry blood chloride  78  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  68  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  83  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  66  mg dl; chemistry blood glucose  84  mg dl; blood gas blood lactate  1.7  mmol l$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; maalox diphenhydramine lidocaine  15-30  ml ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  83  meq l; chemistry blood chloride  84  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  55  mg dl; chemistry blood glucose  74  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; maalox diphenhydramine lidocaine  15-30  ml ; lisinopril  10  mg ; magnesium oxide  800  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  81  meq l; chemistry blood chloride  81  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  57  mg dl; chemistry blood glucose  74  mg dl$bag  2  bag ; sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; magnesium oxide  800  mg ; colchicine  0.6  mg ; colchicine  0.3  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  81  meq l; chemistry blood chloride  83  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  120  meq l; chemistry blood sodium  120  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine chloride, urine  26  meq l; chemistry urine creatinine, urine  48  mg dl; chemistry urine potassium, urine  35  meq l; chemistry urine sodium, urine  25  meq l; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  84  mg dl; chemistry blood glucose  76  mg dl$bag  2  bag ; sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  81  meq l; chemistry blood chloride  83  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  118  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  48  mg dl; chemistry urine creatinine, urine  29  mg dl; chemistry urine potassium, urine  24  meq l; chemistry urine sodium, urine  35  meq l; chemistry urine urea nitrogen, urine  323  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  80  mg dl; blood gas blood sodium, whole blood  121  meq l$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; tolvaptan  15  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  81  meq l; chemistry blood chloride  81  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  120  meq l; chemistry blood sodium  121  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  45  mg dl; chemistry urine creatinine, urine  37  mg dl; chemistry urine urea nitrogen, urine  408  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  75  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; torsemide  100  mg ; tramadol  25  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  120  meq l; chemistry blood sodium  117  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; tramadol  25  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  121  meq l; chemistry blood sodium  123  meq l; chemistry blood sodium  120  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry urine chloride, urine  20  meq l; chemistry urine creatinine, urine  63  mg dl; chemistry urine potassium, urine  36  meq l; chemistry urine urea nitrogen, urine  366  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  85  mg dl; chemistry blood glucose  82  mg dl; blood gas blood lactate  2.1  mmol l$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  87  mg dl; blood gas blood lactate  1.8  mmol l$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; furosemide  60  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  83  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry urine creatinine, urine  37  mg dl; chemistry urine sodium, urine  42  meq l; chemistry urine urea nitrogen, urine  347  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  80  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; furosemide  20  mg ; lorazepam  0.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  25  meq l; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; furosemide  20  mg ; lorazepam  0.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; bumetanide  2  mg ; bag  40  ml ; bumetanide  10  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; bumetanide  2  mg ; bag  40  ml ; bumetanide  10  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; bag  40  ml ; bumetanide  10  mg ; bumetanide  5  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  83  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  124  meq l; chemistry blood sodium  124  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  80  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; bumetanide  3  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  27  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  83  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  121  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  81  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; digoxin  0.125  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  82  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  84  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  105  mg dl; chemistry blood albumin  4.2  g dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; digoxin  0.125  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  70  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; digoxin  0.125  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; digoxin  0.125  mg ; lisinopril  5  mg ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  77  mg dl; chemistry blood glucose  73  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; digoxin  0.125  mg ; lisinopril  5  mg ; 
 
hispanic latino m 32 $nan$chemistry blood anion gap  22  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  73  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; digoxin  0.125  mg ; lisinopril  5  mg ; 
 
hispanic latino m 32 $nan$chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  62  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; 
 
hispanic latino m 32 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; bumetanide  4  mg ; 
 
hispanic latino m 32 $nan$nan$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; bumetanide  4  mg ; 
 
hispanic latino m 32 $nan$chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  75  mg dl$sodium chloride 0.9%  flush  3  ml ; allopurinol  150  mg ; lidocaine 5% patch  1  ptch ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; benzonatate  200  mg ; amiodarone  200  mg ; trazodone  50  mg ; lisinopril  10  mg ; apixaban  5  mg ; oxycodone (immediate release)  2.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; bumetanide  1  mg ; 
 
white f 50 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  132  iu l; chemistry blood albumin  3.7  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; lorazepam  0.25  mg ; acetaminophen  325-650  mg ; ondansetron odt  4-8  mg ; heparin  5000  unit ; ondansetron  4  mg ; 
 
white f 50 $nan$chemistry blood bilirubin, total  0.3  mg dl; chemistry blood lactate dehydrogenase (ld)  114  iu l; chemistry blood albumin  3.8  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; lorazepam  0.25  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; ondansetron  4  mg ; 
 
white m 58 $temp  97.9  heartrate  92.0  resprate  18.0  o2sat  96.0  sbp  154.0  dbp  89.0  rhythm    pain  10  $chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  255  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; diazepam  10  mg ; atorvastatin  20  mg ; betamethasone dipro 0.05% cream  1  appl ; oxycodone (immediate release)  30  mg ; diazepam  15  mg ; ondansetron  4  mg ; 0.9% sodium chloride  50  ml ; thiamine  100  mg ; diazepam  20  mg ; clonidine  0.1  mg ; amlodipine  5  mg ; lisinopril  5  mg ; multivitamins  1  tab ; folic acid  1  mg ; albuterol inhaler  2  puff ; docusate sodium  100  mg ; 
therapeutic (nonsurgical) and rehabilitative gastroenterology and urology devices associated with adverse incidents cardiomyopathy, unspecified nicotine dependence, cigarettes, uncomplicated disorder of adrenal gland, unspecified unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified enterostomy malfunction gastro-esophageal reflux disease without esophagitis unspecified viral hepatitis c without hepatic coma opioid dependence, uncomplicated essential (primary) hypertension alcohol dependence, uncomplicated other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of cardiac pacemaker epilepsy, unspecified, not intractable, without status epilepticus enterostomy malfunction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause unspecified asthma, uncomplicated presence of cardiac pacemaker dysphagia, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of esophagus essential (primary) hypertension cardiomyopathy, unspecified unspecified viral hepatitis c without hepatic coma other chronic pain other cardiomyopathies other psychoactive substance dependence, uncomplicated surgical instruments, materials and gastroenterology and urology devices (including sutures) associated with adverse incidents chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits postgastric surgery syndromes diarrhea, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of unspecified artificial hip joint major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified opioid dependence, uncomplicated hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease dysphagia, unspecified epilepsy, unspecified, not intractable, without status epilepticus enterostomy infection opioid dependence, uncomplicated delirium due to known physiological condition other specified sepsis operating room of hospital as the place of occurrence of the external cause unspecified place in nursing home as the place of occurrence of the external cause
white m 58 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  128  mg dl; chemistry blood albumin  3.8  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  20  mg ; betamethasone dipro 0.05% cream  1  appl ; oxycodone (immediate release)  30  mg ; ondansetron  4  mg ; 0.9% sodium chloride  50  ml ; thiamine  100  mg ; diazepam  20  mg ; clonidine  0.1  mg ; amlodipine  5  mg ; lisinopril  5  mg ; multivitamins  1  tab ; folic acid  1  mg ; albuterol inhaler  2  puff ; docusate sodium  100  mg ; nicotine lozenge  2  mg ; nicotine patch  14  mg day ; potassium chloride  20  meq ; nicotine polacrilex  2  mg ; 
therapeutic (nonsurgical) and rehabilitative gastroenterology and urology devices associated with adverse incidents cardiomyopathy, unspecified nicotine dependence, cigarettes, uncomplicated disorder of adrenal gland, unspecified unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified enterostomy malfunction gastro-esophageal reflux disease without esophagitis unspecified viral hepatitis c without hepatic coma opioid dependence, uncomplicated essential (primary) hypertension alcohol dependence, uncomplicated other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of cardiac pacemaker epilepsy, unspecified, not intractable, without status epilepticus enterostomy malfunction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause unspecified asthma, uncomplicated presence of cardiac pacemaker dysphagia, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of esophagus essential (primary) hypertension cardiomyopathy, unspecified unspecified viral hepatitis c without hepatic coma other chronic pain other cardiomyopathies other psychoactive substance dependence, uncomplicated surgical instruments, materials and gastroenterology and urology devices (including sutures) associated with adverse incidents chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits postgastric surgery syndromes diarrhea, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of unspecified artificial hip joint major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified opioid dependence, uncomplicated hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease dysphagia, unspecified epilepsy, unspecified, not intractable, without status epilepticus enterostomy infection opioid dependence, uncomplicated delirium due to known physiological condition other specified sepsis operating room of hospital as the place of occurrence of the external cause unspecified place in nursing home as the place of occurrence of the external cause
white m 58 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  150  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  20  mg ; betamethasone dipro 0.05% cream  1  appl ; oxycodone (immediate release)  30  mg ; ondansetron  4  mg ; 0.9% sodium chloride  50  ml ; thiamine  100  mg ; diazepam  20  mg ; clonidine  0.1  mg ; amlodipine  5  mg ; lisinopril  5  mg ; multivitamins  1  tab ; folic acid  1  mg ; albuterol inhaler  2  puff ; docusate sodium  100  mg ; nicotine lozenge  2  mg ; potassium chloride  20  meq ; nicotine polacrilex  2  mg ; nicotine patch  21  mg day ; diazepam  4  mg ; acetaminophen  500  mg ; simethicone  40-80  mg ; 
therapeutic (nonsurgical) and rehabilitative gastroenterology and urology devices associated with adverse incidents cardiomyopathy, unspecified nicotine dependence, cigarettes, uncomplicated disorder of adrenal gland, unspecified unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified enterostomy malfunction gastro-esophageal reflux disease without esophagitis unspecified viral hepatitis c without hepatic coma opioid dependence, uncomplicated essential (primary) hypertension alcohol dependence, uncomplicated other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of cardiac pacemaker epilepsy, unspecified, not intractable, without status epilepticus enterostomy malfunction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause unspecified asthma, uncomplicated presence of cardiac pacemaker dysphagia, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of esophagus essential (primary) hypertension cardiomyopathy, unspecified unspecified viral hepatitis c without hepatic coma other chronic pain other cardiomyopathies other psychoactive substance dependence, uncomplicated surgical instruments, materials and gastroenterology and urology devices (including sutures) associated with adverse incidents chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits postgastric surgery syndromes diarrhea, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of unspecified artificial hip joint major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified opioid dependence, uncomplicated hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease dysphagia, unspecified epilepsy, unspecified, not intractable, without status epilepticus enterostomy infection opioid dependence, uncomplicated delirium due to known physiological condition other specified sepsis operating room of hospital as the place of occurrence of the external cause unspecified place in nursing home as the place of occurrence of the external cause
white m 58 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  20  mg ; betamethasone dipro 0.05% cream  1  appl ; oxycodone (immediate release)  30  mg ; ondansetron  4  mg ; 0.9% sodium chloride  50  ml ; thiamine  100  mg ; amlodipine  5  mg ; lisinopril  5  mg ; multivitamins  1  tab ; folic acid  1  mg ; albuterol inhaler  2  puff ; docusate sodium  100  mg ; nicotine lozenge  2  mg ; nicotine polacrilex  2  mg ; nicotine patch  21  mg day ; diazepam  4  mg ; acetaminophen  500  mg ; simethicone  40-80  mg ; senna  8.6  mg ; bisacodyl  10  mg ; diazepam  6  mg ; 
therapeutic (nonsurgical) and rehabilitative gastroenterology and urology devices associated with adverse incidents cardiomyopathy, unspecified nicotine dependence, cigarettes, uncomplicated disorder of adrenal gland, unspecified unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified enterostomy malfunction gastro-esophageal reflux disease without esophagitis unspecified viral hepatitis c without hepatic coma opioid dependence, uncomplicated essential (primary) hypertension alcohol dependence, uncomplicated other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of cardiac pacemaker epilepsy, unspecified, not intractable, without status epilepticus enterostomy malfunction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause unspecified asthma, uncomplicated presence of cardiac pacemaker dysphagia, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of esophagus essential (primary) hypertension cardiomyopathy, unspecified unspecified viral hepatitis c without hepatic coma other chronic pain other cardiomyopathies other psychoactive substance dependence, uncomplicated surgical instruments, materials and gastroenterology and urology devices (including sutures) associated with adverse incidents chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits postgastric surgery syndromes diarrhea, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of unspecified artificial hip joint major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified opioid dependence, uncomplicated hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease dysphagia, unspecified epilepsy, unspecified, not intractable, without status epilepticus enterostomy infection opioid dependence, uncomplicated delirium due to known physiological condition other specified sepsis operating room of hospital as the place of occurrence of the external cause unspecified place in nursing home as the place of occurrence of the external cause
white m 58 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  133  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  20  mg ; betamethasone dipro 0.05% cream  1  appl ; oxycodone (immediate release)  30  mg ; ondansetron  4  mg ; amlodipine  5  mg ; lisinopril  5  mg ; multivitamins  1  tab ; folic acid  1  mg ; albuterol inhaler  2  puff ; docusate sodium  100  mg ; nicotine lozenge  2  mg ; nicotine polacrilex  2  mg ; nicotine patch  21  mg day ; acetaminophen  500  mg ; simethicone  40-80  mg ; senna  8.6  mg ; bisacodyl  10  mg ; diazepam  6  mg ; 
therapeutic (nonsurgical) and rehabilitative gastroenterology and urology devices associated with adverse incidents cardiomyopathy, unspecified nicotine dependence, cigarettes, uncomplicated disorder of adrenal gland, unspecified unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified enterostomy malfunction gastro-esophageal reflux disease without esophagitis unspecified viral hepatitis c without hepatic coma opioid dependence, uncomplicated essential (primary) hypertension alcohol dependence, uncomplicated other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of cardiac pacemaker epilepsy, unspecified, not intractable, without status epilepticus enterostomy malfunction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause unspecified asthma, uncomplicated presence of cardiac pacemaker dysphagia, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of esophagus essential (primary) hypertension cardiomyopathy, unspecified unspecified viral hepatitis c without hepatic coma other chronic pain other cardiomyopathies other psychoactive substance dependence, uncomplicated surgical instruments, materials and gastroenterology and urology devices (including sutures) associated with adverse incidents chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits postgastric surgery syndromes diarrhea, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of unspecified artificial hip joint major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified opioid dependence, uncomplicated hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease dysphagia, unspecified epilepsy, unspecified, not intractable, without status epilepticus enterostomy infection opioid dependence, uncomplicated delirium due to known physiological condition other specified sepsis operating room of hospital as the place of occurrence of the external cause unspecified place in nursing home as the place of occurrence of the external cause
white m 58 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  93  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; atorvastatin  20  mg ; betamethasone dipro 0.05% cream  1  appl ; oxycodone (immediate release)  30  mg ; ondansetron  4  mg ; amlodipine  5  mg ; lisinopril  5  mg ; multivitamins  1  tab ; folic acid  1  mg ; albuterol inhaler  2  puff ; docusate sodium  100  mg ; nicotine lozenge  2  mg ; nicotine polacrilex  2  mg ; nicotine patch  21  mg day ; acetaminophen  500  mg ; simethicone  40-80  mg ; senna  8.6  mg ; bisacodyl  10  mg ; 
therapeutic (nonsurgical) and rehabilitative gastroenterology and urology devices associated with adverse incidents cardiomyopathy, unspecified nicotine dependence, cigarettes, uncomplicated disorder of adrenal gland, unspecified unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified enterostomy malfunction gastro-esophageal reflux disease without esophagitis unspecified viral hepatitis c without hepatic coma opioid dependence, uncomplicated essential (primary) hypertension alcohol dependence, uncomplicated other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of cardiac pacemaker epilepsy, unspecified, not intractable, without status epilepticus enterostomy malfunction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause unspecified asthma, uncomplicated presence of cardiac pacemaker dysphagia, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of esophagus essential (primary) hypertension cardiomyopathy, unspecified unspecified viral hepatitis c without hepatic coma other chronic pain other cardiomyopathies other psychoactive substance dependence, uncomplicated surgical instruments, materials and gastroenterology and urology devices (including sutures) associated with adverse incidents chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits postgastric surgery syndromes diarrhea, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of unspecified artificial hip joint major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified opioid dependence, uncomplicated hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease dysphagia, unspecified epilepsy, unspecified, not intractable, without status epilepticus enterostomy infection opioid dependence, uncomplicated delirium due to known physiological condition other specified sepsis operating room of hospital as the place of occurrence of the external cause unspecified place in nursing home as the place of occurrence of the external cause
white m 58 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; atorvastatin  20  mg ; betamethasone dipro 0.05% cream  1  appl ; oxycodone (immediate release)  30  mg ; ondansetron  4  mg ; amlodipine  5  mg ; lisinopril  5  mg ; multivitamins  1  tab ; folic acid  1  mg ; albuterol inhaler  2  puff ; docusate sodium  100  mg ; nicotine lozenge  2  mg ; nicotine polacrilex  2  mg ; nicotine patch  21  mg day ; acetaminophen  500  mg ; simethicone  40-80  mg ; senna  8.6  mg ; bisacodyl  10  mg ; 
therapeutic (nonsurgical) and rehabilitative gastroenterology and urology devices associated with adverse incidents cardiomyopathy, unspecified nicotine dependence, cigarettes, uncomplicated disorder of adrenal gland, unspecified unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified enterostomy malfunction gastro-esophageal reflux disease without esophagitis unspecified viral hepatitis c without hepatic coma opioid dependence, uncomplicated essential (primary) hypertension alcohol dependence, uncomplicated other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of cardiac pacemaker epilepsy, unspecified, not intractable, without status epilepticus enterostomy malfunction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause unspecified asthma, uncomplicated presence of cardiac pacemaker dysphagia, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of esophagus essential (primary) hypertension cardiomyopathy, unspecified unspecified viral hepatitis c without hepatic coma other chronic pain other cardiomyopathies other psychoactive substance dependence, uncomplicated surgical instruments, materials and gastroenterology and urology devices (including sutures) associated with adverse incidents chronic kidney disease, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits postgastric surgery syndromes diarrhea, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of unspecified artificial hip joint major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified opioid dependence, uncomplicated hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease dysphagia, unspecified epilepsy, unspecified, not intractable, without status epilepticus enterostomy infection opioid dependence, uncomplicated delirium due to known physiological condition other specified sepsis operating room of hospital as the place of occurrence of the external cause unspecified place in nursing home as the place of occurrence of the external cause
white m 46 $nan$nan$omeprazole  20  mg ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; heparin  5000  unit ; docusate sodium  100  mg ; cepacol (menthol)  1  loz ; 
unspecified disorder of penis pneumonia, organism unspecified attention to colostomy iron deficiency anemia, unspecified other specified disorders of bladder chronic pain due to trauma surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation urinary tract infection, site not specified other urogenital trichomoniasis unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident late effect of fracture of spine and trunk without mention of spinal cord lesion infection and inflammatory reaction due to other genitourinary device, implant, and graft sepsis esophageal reflux septicemia due to pseudomonas depressive disorder, not elsewhere classified backache, unspecified late effects of motor vehicle accident abdominal pain, generalized constipation, unspecified esophageal reflux aftercare for healing traumatic fracture of vertebrae aftercare for healing traumatic fracture of other bone colostomy status unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident depressive disorder, not elsewhere classified vascular disorders of male genital organs surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other internal prosthetic device, implant, and graft other specified disorders of bladder late effects of motor vehicle accident pressure ulcer, lower back nausea alone late effect of internal injury to intra-abdominal organs pressure ulcer, stage ii 
white m 46 $nan$nan$omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; heparin  5000  unit ; docusate sodium  100  mg ; cepacol (menthol)  1  loz ; 
unspecified disorder of penis pneumonia, organism unspecified attention to colostomy iron deficiency anemia, unspecified other specified disorders of bladder chronic pain due to trauma surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation urinary tract infection, site not specified other urogenital trichomoniasis unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident late effect of fracture of spine and trunk without mention of spinal cord lesion infection and inflammatory reaction due to other genitourinary device, implant, and graft sepsis esophageal reflux septicemia due to pseudomonas depressive disorder, not elsewhere classified backache, unspecified late effects of motor vehicle accident abdominal pain, generalized constipation, unspecified esophageal reflux aftercare for healing traumatic fracture of vertebrae aftercare for healing traumatic fracture of other bone colostomy status unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident depressive disorder, not elsewhere classified vascular disorders of male genital organs surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other internal prosthetic device, implant, and graft other specified disorders of bladder late effects of motor vehicle accident pressure ulcer, lower back nausea alone late effect of internal injury to intra-abdominal organs pressure ulcer, stage ii 
white m 46 $nan$nan$omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; cepacol (menthol)  1  loz ; ketorolac  15  mg ; 
unspecified disorder of penis pneumonia, organism unspecified attention to colostomy iron deficiency anemia, unspecified other specified disorders of bladder chronic pain due to trauma surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation urinary tract infection, site not specified other urogenital trichomoniasis unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident late effect of fracture of spine and trunk without mention of spinal cord lesion infection and inflammatory reaction due to other genitourinary device, implant, and graft sepsis esophageal reflux septicemia due to pseudomonas depressive disorder, not elsewhere classified backache, unspecified late effects of motor vehicle accident abdominal pain, generalized constipation, unspecified esophageal reflux aftercare for healing traumatic fracture of vertebrae aftercare for healing traumatic fracture of other bone colostomy status unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident depressive disorder, not elsewhere classified vascular disorders of male genital organs surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other internal prosthetic device, implant, and graft other specified disorders of bladder late effects of motor vehicle accident pressure ulcer, lower back nausea alone late effect of internal injury to intra-abdominal organs pressure ulcer, stage ii 
white m 46 $nan$nan$omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; cepacol (menthol)  1  loz ; ketorolac  15  mg ; acetaminophen  1000  mg ; bisacodyl  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic sodium chloride  100  ml ; famotidine  40  mg ; d5 1 2ns  1000  ml ; 
unspecified disorder of penis pneumonia, organism unspecified attention to colostomy iron deficiency anemia, unspecified other specified disorders of bladder chronic pain due to trauma surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation urinary tract infection, site not specified other urogenital trichomoniasis unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident late effect of fracture of spine and trunk without mention of spinal cord lesion infection and inflammatory reaction due to other genitourinary device, implant, and graft sepsis esophageal reflux septicemia due to pseudomonas depressive disorder, not elsewhere classified backache, unspecified late effects of motor vehicle accident abdominal pain, generalized constipation, unspecified esophageal reflux aftercare for healing traumatic fracture of vertebrae aftercare for healing traumatic fracture of other bone colostomy status unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident depressive disorder, not elsewhere classified vascular disorders of male genital organs surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other internal prosthetic device, implant, and graft other specified disorders of bladder late effects of motor vehicle accident pressure ulcer, lower back nausea alone late effect of internal injury to intra-abdominal organs pressure ulcer, stage ii 
white m 46 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  117  mg dl$omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; cepacol (menthol)  1  loz ; acetaminophen  1000  mg ; bisacodyl  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic sodium chloride  100  ml ; famotidine  40  mg ; d5 1 2ns  1000  ml ; neu  1  pkt ; 
unspecified disorder of penis pneumonia, organism unspecified attention to colostomy iron deficiency anemia, unspecified other specified disorders of bladder chronic pain due to trauma surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation urinary tract infection, site not specified other urogenital trichomoniasis unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident late effect of fracture of spine and trunk without mention of spinal cord lesion infection and inflammatory reaction due to other genitourinary device, implant, and graft sepsis esophageal reflux septicemia due to pseudomonas depressive disorder, not elsewhere classified backache, unspecified late effects of motor vehicle accident abdominal pain, generalized constipation, unspecified esophageal reflux aftercare for healing traumatic fracture of vertebrae aftercare for healing traumatic fracture of other bone colostomy status unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident depressive disorder, not elsewhere classified vascular disorders of male genital organs surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other internal prosthetic device, implant, and graft other specified disorders of bladder late effects of motor vehicle accident pressure ulcer, lower back nausea alone late effect of internal injury to intra-abdominal organs pressure ulcer, stage ii 
white m 46 $nan$nan$omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; cepacol (menthol)  1  loz ; neu  1  pkt ; 
unspecified disorder of penis pneumonia, organism unspecified attention to colostomy iron deficiency anemia, unspecified other specified disorders of bladder chronic pain due to trauma surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation urinary tract infection, site not specified other urogenital trichomoniasis unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident late effect of fracture of spine and trunk without mention of spinal cord lesion infection and inflammatory reaction due to other genitourinary device, implant, and graft sepsis esophageal reflux septicemia due to pseudomonas depressive disorder, not elsewhere classified backache, unspecified late effects of motor vehicle accident abdominal pain, generalized constipation, unspecified esophageal reflux aftercare for healing traumatic fracture of vertebrae aftercare for healing traumatic fracture of other bone colostomy status unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident depressive disorder, not elsewhere classified vascular disorders of male genital organs surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other internal prosthetic device, implant, and graft other specified disorders of bladder late effects of motor vehicle accident pressure ulcer, lower back nausea alone late effect of internal injury to intra-abdominal organs pressure ulcer, stage ii 
white m 71 $temp  98.1  heartrate  76.0  resprate  18.0  o2sat  95.0  sbp  120.0  dbp  76.0  rhythm    pain  7  $nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; acetaminophen  325-650  mg ; morphine sulfate  1-4  mg ; hydroxyzine  25  mg ; multivitamins  1  tab ; nicotine lozenge  2  mg ; nicotine patch  14  mg ; omeprazole  20  mg ; trazodone  75  mg ; 
alcohol dependence, in remission bipolar disorder, unspecified obstruction of bile duct anemia, unspecified dehydration alcohol-induced chronic pancreatitis solitary pulmonary nodule hypovolemia other specified diseases of pancreas nicotine dependence, cigarettes, uncomplicated alcohol abuse, uncomplicated essential (primary) hypertension hyperlipidemia, unspecified 
white m 71 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  148  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; acetaminophen  325-650  mg ; morphine sulfate  1-4  mg ; hydroxyzine  25  mg ; multivitamins  1  tab ; nicotine lozenge  2  mg ; nicotine patch  14  mg ; omeprazole  20  mg ; trazodone  75  mg ; olanzapine  15  mg ; 
alcohol dependence, in remission bipolar disorder, unspecified obstruction of bile duct anemia, unspecified dehydration alcohol-induced chronic pancreatitis solitary pulmonary nodule hypovolemia other specified diseases of pancreas nicotine dependence, cigarettes, uncomplicated alcohol abuse, uncomplicated essential (primary) hypertension hyperlipidemia, unspecified 
black african american f 50 $nan$nan$cefazolin  2  g ; iso-osmotic dextrose  50  ml ; heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5  mg ; acetaminophen  1000  mg ; cepacol (sore throat lozenge)  1-4  loz ; oxycodone (immediate release)  5-10  mg ; 
 
black african american f 50 $nan$nan$cefazolin  2  g ; iso-osmotic dextrose  50  ml ; heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; cepacol (sore throat lozenge)  1-4  loz ; oxycodone (immediate release)  5-10  mg ; aspirin  81  mg ; docusate sodium  100  mg ; 
 
black african american f 55 $temp  97.1  heartrate  60.0  resprate  18.0  o2sat  98.0  sbp  113.0  dbp  79.0  rhythm    pain  5  ; temp    heartrate  52.0  resprate  17.0  o2sat  100.0  sbp  120.0  dbp  71.0  rhythm    pain  0  ; temp    heartrate  65.0  resprate  18.0  o2sat  100.0  sbp  114.0  dbp  94.0  rhythm    pain    ; temp    heartrate  52.0  resprate  20.0  o2sat  100.0  sbp  114.0  dbp  94.0  rhythm    pain  4  ; temp  98.3  heartrate  57.0  resprate  20.0  o2sat  100.0  sbp  123.0  dbp  73.0  rhythm    pain    ; temp    heartrate  51.0  resprate  16.0  o2sat  99.0  sbp  116.0  dbp  71.0  rhythm    pain    ; temp    heartrate  48.0  resprate  19.0  o2sat  100.0  sbp  124.0  dbp  70.0  rhythm    pain    ; temp    heartrate  46.0  resprate  17.0  o2sat  100.0  sbp  118.0  dbp  72.0  rhythm    pain    ; temp    heartrate  49.0  resprate  19.0  o2sat  100.0  sbp  116.0  dbp  73.0  rhythm    pain    ; temp    heartrate  50.0  resprate  21.0  o2sat  100.0  sbp  106.0  dbp  67.0  rhythm    pain    ; temp    heartrate  51.0  resprate  18.0  o2sat  100.0  sbp  110.0  dbp  69.0  rhythm    pain    ; temp    heartrate  49.0  resprate  17.0  o2sat  100.0  sbp  110.0  dbp  68.0  rhythm    pain    ; temp    heartrate  48.0  resprate  20.0  o2sat  100.0  sbp  116.0  dbp  73.0  rhythm    pain    ; temp    heartrate  50.0  resprate  17.0  o2sat  100.0  sbp  109.0  dbp  71.0  rhythm    pain    ; temp    heartrate  57.0  resprate  17.0  o2sat  100.0  sbp  107.0  dbp  65.0  rhythm    pain    ; temp    heartrate  52.0  resprate  15.0  o2sat  100.0  sbp  99.0  dbp  65.0  rhythm    pain    ; temp    heartrate  58.0  resprate  20.0  o2sat  100.0  sbp  100.0  dbp  65.0  rhythm    pain    ; temp    heartrate  48.0  resprate  15.0  o2sat  100.0  sbp  122.0  dbp  73.0  rhythm    pain    ; temp  98.1  heartrate  48.0  resprate  14.0  o2sat  100.0  sbp  119.0  dbp  73.0  rhythm    pain  0  ; temp  98.1  heartrate  59.0  resprate  17.0  o2sat  100.0  sbp  118.0  dbp  72.0  rhythm    pain  0  $nan$heparin  5000  unit ; 
 
black african american f 55 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  86  mg dl$heparin  5000  unit ; clopidogrel  600  mg ; sodium chloride 0.9%  flush  3-10  ml ; vitamin d  3000  unit ; sodium chloride 0.9%  1000  ml ; clopidogrel  75  mg ; aspirin  81  mg ; prednisone  5  mg ; 
 
black african american f 55 $nan$nan$heparin  5000  unit ; clopidogrel  600  mg ; sodium chloride 0.9%  flush  3-10  ml ; vitamin d  3000  unit ; clopidogrel  75  mg ; aspirin  81  mg ; prednisone  5  mg ; atorvastatin  80  mg ; 
 
asian f 26 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
asian f 26 $nan$hematology blood hematocrit  26.4  %$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
asian f 26 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
asian f 26 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
asian f 26 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; cephalexin  500  mg ; 
 
white f 53 $nan$hematology blood hematocrit  24.6  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  250  k ul; hematology blood platelet count  285  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  149  mg dl; chemistry blood glucose  148  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  136  mg dl; blood gas blood hematocrit, calculated  31  %; blood gas blood hemoglobin  10.4  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  137  meq l$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  50  mg ; ondansetron  4  mg ; albuterol inhaler  1-2  puff ; clonazepam  0.25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sw  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; ketorolac  15  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; fluticasone propionate nasal  1  spry ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; 
incisional hernia without mention of obstruction or gangrene multiple sclerosis pelvic peritoneal adhesions, female (postoperative) (postinfection) personal history of venous thrombosis and embolism pulmonary collapse laparoscopic surgical procedure converted to open procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled asthma, unspecified type, unspecified endometriosis of ovary obesity, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation polycystic ovaries urinary complications, not elsewhere classified oliguria and anuria
white f 53 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  174  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  50  mg ; ondansetron  4  mg ; albuterol inhaler  1-2  puff ; clonazepam  0.25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; sw  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; ketorolac  15  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; fluticasone propionate nasal  1  spry ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; xopenex neb  0.63  mg ; prochlorperazine  10  mg ; 
incisional hernia without mention of obstruction or gangrene multiple sclerosis pelvic peritoneal adhesions, female (postoperative) (postinfection) personal history of venous thrombosis and embolism pulmonary collapse laparoscopic surgical procedure converted to open procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled asthma, unspecified type, unspecified endometriosis of ovary obesity, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation polycystic ovaries urinary complications, not elsewhere classified oliguria and anuria
white f 53 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  321  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  50  mg ; ondansetron  4  mg ; clonazepam  0.25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ketorolac  15  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; fluticasone propionate nasal  1  spry ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; xopenex neb  0.63  mg ; prochlorperazine  10  mg ; metoclopramide  10  mg ; acetaminophen  500-1000  mg ; 
incisional hernia without mention of obstruction or gangrene multiple sclerosis pelvic peritoneal adhesions, female (postoperative) (postinfection) personal history of venous thrombosis and embolism pulmonary collapse laparoscopic surgical procedure converted to open procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled asthma, unspecified type, unspecified endometriosis of ovary obesity, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation polycystic ovaries urinary complications, not elsewhere classified oliguria and anuria
white f 53 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  443  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  50  mg ; ondansetron  4  mg ; clonazepam  0.25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ketorolac  15  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; fluticasone propionate nasal  1  spry ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; xopenex neb  0.63  mg ; prochlorperazine  10  mg ; metoclopramide  10  mg ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; potassium chloride  40  meq ; morphine sulfate  0.5  mg ; 0.9% sodium chloride  500  ml ; ferrous sulfate  325  mg ; morphine sr (ms contin)  15  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; morphine sulfate  2-4  mg ; lidocaine 1%  10  ml ; simvastatin  20  mg ; 
incisional hernia without mention of obstruction or gangrene multiple sclerosis pelvic peritoneal adhesions, female (postoperative) (postinfection) personal history of venous thrombosis and embolism pulmonary collapse laparoscopic surgical procedure converted to open procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled asthma, unspecified type, unspecified endometriosis of ovary obesity, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation polycystic ovaries urinary complications, not elsewhere classified oliguria and anuria
white f 53 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  458  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ondansetron  4  mg ; clonazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; fluticasone propionate nasal  1  spry ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; prochlorperazine  10  mg ; metoclopramide  10  mg ; acetaminophen  500-1000  mg ; 0.9% sodium chloride  500  ml ; ferrous sulfate  325  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; morphine sulfate  2-4  mg ; lidocaine 1%  10  ml ; simvastatin  20  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 
incisional hernia without mention of obstruction or gangrene multiple sclerosis pelvic peritoneal adhesions, female (postoperative) (postinfection) personal history of venous thrombosis and embolism pulmonary collapse laparoscopic surgical procedure converted to open procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled asthma, unspecified type, unspecified endometriosis of ovary obesity, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation polycystic ovaries urinary complications, not elsewhere classified oliguria and anuria
white f 53 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ondansetron  4  mg ; clonazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; fluticasone propionate nasal  1  spry ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; prochlorperazine  10  mg ; metoclopramide  10  mg ; acetaminophen  500-1000  mg ; ferrous sulfate  325  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; morphine sulfate  2-4  mg ; simvastatin  20  mg ; sw  50  ml ; magnesium sulfate  2  gm ; simethicone  40-80  mg ; ibuprofen  800  mg ; 
incisional hernia without mention of obstruction or gangrene multiple sclerosis pelvic peritoneal adhesions, female (postoperative) (postinfection) personal history of venous thrombosis and embolism pulmonary collapse laparoscopic surgical procedure converted to open procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled asthma, unspecified type, unspecified endometriosis of ovary obesity, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation polycystic ovaries urinary complications, not elsewhere classified oliguria and anuria
white f 53 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; clonazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; fluticasone propionate nasal  1  spry ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; prochlorperazine  10  mg ; metoclopramide  10  mg ; acetaminophen  500-1000  mg ; ferrous sulfate  325  mg ; simvastatin  20  mg ; simethicone  40-80  mg ; ibuprofen  800  mg ; metformin (glucophage)  500  mg ; 
incisional hernia without mention of obstruction or gangrene multiple sclerosis pelvic peritoneal adhesions, female (postoperative) (postinfection) personal history of venous thrombosis and embolism pulmonary collapse laparoscopic surgical procedure converted to open procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled asthma, unspecified type, unspecified endometriosis of ovary obesity, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation polycystic ovaries urinary complications, not elsewhere classified oliguria and anuria
white m 51 $temp    heartrate  90.0  resprate  15.0  o2sat  100.0  sbp  123.0  dbp  81.0  rhythm    pain    ; temp    heartrate  90.0  resprate  16.0  o2sat  100.0  sbp  122.0  dbp  79.0  rhythm    pain    ; temp    heartrate  90.0  resprate  16.0  o2sat  100.0  sbp  123.0  dbp  78.0  rhythm    pain    ; temp    heartrate  89.0  resprate  17.0  o2sat  100.0  sbp  121.0  dbp  78.0  rhythm    pain    ; temp    heartrate  110.0  resprate  18.0  o2sat  100.0  sbp  136.0  dbp  96.0  rhythm    pain    ; temp  100.7  heartrate  107.0  resprate  20.0  o2sat  100.0  sbp  146.0  dbp  90.0  rhythm    pain    $hematology blood hematocrit  38.7  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  33  meq l; chemistry urine creatinine, urine  21  mg dl; chemistry urine potassium, urine  15  meq l; chemistry urine sodium, urine  35  meq l; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  97  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  1000  ml ; nimodipine  60  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  17.2  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; fentanyl citrate  25-100  mcg ; labetalol  5-10  mg ; propofol  1000  mg ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
 
white m 51 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  118  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; nimodipine  60  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  17.2  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; fentanyl citrate  25-100  mcg ; labetalol  5-10  mg ; propofol  1000  mg ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; sodium chloride 0.9%  flush  3  ml ; dexmedetomidine  0.4  mg ; 
 
white m 51 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  113  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; ondansetron  4  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; fentanyl citrate  25-100  mcg ; labetalol  5-10  mg ; propofol  1000  mg ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; dexmedetomidine  0.4  mg ; ipratropium-albuterol neb  1  neb ; methadone  10  mg ; methadone  5  mg ; clonidine  0.1  mg ; lorazepam  0.5-2  mg ; labetalol  200  mg ; heparin  5000  unit ; 
 
white m 51 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  106  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; ondansetron  4  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; fentanyl citrate  25-100  mcg ; labetalol  5-10  mg ; propofol  1000  mg ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; dexmedetomidine  0.4  mg ; ipratropium-albuterol neb  1  neb ; methadone  10  mg ; methadone  5  mg ; clonidine  0.1  mg ; lorazepam  0.5-2  mg ; labetalol  200  mg ; heparin  5000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; methadone  20  mg ; clonidine  0.2  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; ziprasidone hydrochloride  20  mg ; 
 
white m 51 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  108  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; ondansetron  4  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; fentanyl citrate  25-100  mcg ; labetalol  5-10  mg ; sodium chloride 0.9%  flush  3  ml ; dexmedetomidine  0.4  mg ; ipratropium-albuterol neb  1  neb ; methadone  5  mg ; labetalol  200  mg ; heparin  5000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; methadone  20  mg ; clonidine  0.2  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; ziprasidone hydrochloride  20  mg ; quetiapine fumarate  25  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; diphenhydramine  25  mg ; methadone  60  mg ; 
 
white m 51 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  105  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; fentanyl citrate  25-100  mcg ; sodium chloride 0.9%  flush  3  ml ; dexmedetomidine  0.4  mg ; ipratropium-albuterol neb  1  neb ; methadone  5  mg ; labetalol  200  mg ; heparin  5000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; clonidine  0.2  mg ; quetiapine fumarate  25  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; diphenhydramine  25  mg ; methadone  60  mg ; miconazole powder 2%  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; methadone  80  mg ; 
 
white m 51 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  99  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; fentanyl citrate  25-100  mcg ; sodium chloride 0.9%  flush  3  ml ; dexmedetomidine  0.4  mg ; ipratropium-albuterol neb  1  neb ; labetalol  200  mg ; heparin  5000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; clonidine  0.2  mg ; quetiapine fumarate  25  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; miconazole powder 2%  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; methadone  85  mg ; quetiapine fumarate  37.5  mg ; hydrocortisone cream 1%  1  appl ; lorazepam  2  mg ; haloperidol  1-2  mg ; levetiracetam  1000  mg ; 
 
white m 51 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  107  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  200  mg ; heparin  5000  unit ; clonidine  0.2  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; miconazole powder 2%  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; methadone  85  mg ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; levetiracetam  1000  mg ; haloperidol  2  mg ; 
 
white m 51 $nan$nan$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  200  mg ; heparin  5000  unit ; clonidine  0.2  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; miconazole powder 2%  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; methadone  85  mg ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; levetiracetam  1000  mg ; haloperidol  2  mg ; haloperidol  1  mg ; 
 
white m 51 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.6  g dl; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  74  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  102  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  6.5  mg dl; chemistry blood glucose  923  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  200  mg ; heparin  5000  unit ; clonidine  0.2  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; miconazole powder 2%  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; methadone  85  mg ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; levetiracetam  1000  mg ; haloperidol  2  mg ; haloperidol  1  mg ; morphine sulfate  1-2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 
 
white m 51 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  411  k ul; hematology blood platelet count  458  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry urine chloride, urine  139  meq l; chemistry urine creatinine, urine  160  mg dl; chemistry urine potassium, urine  82  meq l; chemistry urine sodium, urine  65  meq l; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  125  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  200  mg ; clonidine  0.2  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; miconazole powder 2%  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; methadone  85  mg ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; levetiracetam  1000  mg ; morphine sulfate  1-2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; morphine sulfate  6  mg ; haloperidol  2-4  mg ; 
 
white m 51 $nan$nan$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  200  mg ; clonidine  0.2  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; miconazole powder 2%  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; methadone  85  mg ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; levetiracetam  1000  mg ; morphine sulfate  1-2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; haloperidol  4  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lorazepam  1  mg ; 
 
white m 51 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  421  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  104  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  200  mg ; clonidine  0.2  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; miconazole powder 2%  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; levetiracetam  1000  mg ; morphine sulfate  1-2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lorazepam  1  mg ; methadone  40  mg ; 
 
white m 51 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  517  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  92  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  200  mg ; clonidine  0.2  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; levetiracetam  1000  mg ; morphine sulfate  1-2  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lorazepam  1  mg ; methadone  40  mg ; sodium chloride  1  gm ; 
 
white m 51 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  543  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  153  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  200  mg ; clonidine  0.2  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; levetiracetam  1000  mg ; morphine sulfate  1-2  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lorazepam  1  mg ; methadone  40  mg ; sodium chloride  1  gm ; levetiracetam  1500  mg ; sodium chloride  2  gm ; acetaminophen iv  1000  mg ; 0.9% sodium chloride  250  ml ; phenytoin sodium  1500  mg ; 
 
white m 51 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  470  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  153  mg dl; chemistry blood albumin  3.6  g dl$bisacodyl  10  mg ; sw  200  ml ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  200  mg ; clonidine  0.2  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lorazepam  1  mg ; methadone  40  mg ; levetiracetam  1500  mg ; sodium chloride  2  gm ; acetaminophen iv  1000  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; labetalol  10  mg ; phenytoin sodium  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; phenytoin sodium (iv)  100  mg ; 
 
white m 51 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  451  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  151  mg dl$bisacodyl  10  mg ; sw  200  ml ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lorazepam  1  mg ; sodium chloride  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; phenytoin infatab  100  mg ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; potassium phosphate  15  mmol ; labetalol  100  mg ; vial  1  vial ; 
 
white m 51 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  406  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  115  mg dl; chemistry blood albumin  3.2  g dl$bisacodyl  10  mg ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lorazepam  1  mg ; sodium chloride  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; potassium phosphate  15  mmol ; vial  1  vial ; neutra-phos  2  pkt ; potassium chloride (powder)  60  meq ; metoprolol tartrate  5  mg ; 
 
white m 51 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  406  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  123  mg dl; chemistry blood albumin  3.4  g dl$bisacodyl  10  mg ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lorazepam  1  mg ; sodium chloride  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; vial  1  vial ; neutra-phos  2  pkt ; potassium chloride (powder)  60  meq ; metoprolol tartrate  5  mg ; phenytoin sodium  500  mg ; valproate sodium  1500  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  400  mg ; 
 
white m 51 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  351  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  113  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; lorazepam  1  mg ; sodium chloride  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; phenytoin sodium  500  mg ; valproate sodium  1500  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  400  mg ; phenytoin sodium  760  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; valproate sodium  250  mg ; 
 
white m 51 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  193  iu l; chemistry blood albumin  3.3  g dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-1  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; lorazepam  1  mg ; sodium chloride  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; phenytoin sodium  760  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; valproate sodium  250  mg ; phenytoin sodium  1250  mg ; 0.9% sodium chloride  400  ml ; 
 
white m 51 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  129  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; lorazepam  1  mg ; sodium chloride  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  400  ml ; fluoxetine  10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white m 51 $nan$hematology blood hematocrit  35.7  %; hematology blood hematocrit  40.4  %; hematology blood hematocrit  31.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  13.3  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  287  k ul; hematology blood platelet count  351  k ul; hematology blood platelet count  288  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  7  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  129  meq l; chemistry blood creatinine  0  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  1.3  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology urine wbc  8  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  2.6  mg dl; chemistry blood glucose  47  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  138  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; lorazepam  1  mg ; sodium chloride  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydromorphone (dilaudid)  0.5-1  mg ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; 
 
white m 51 $nan$hematology blood hematocrit  31.9  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  261  k ul; hematology blood platelet count  237  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  131  mg dl; chemistry blood albumin  3.4  g dl; chemistry blood albumin  3.2  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood glucose  130  mg dl; blood gas blood glucose  130  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; amlodipine  5  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; lorazepam  1  mg ; sodium chloride  2  gm ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydromorphone (dilaudid)  0.5-1  mg ; metoprolol tartrate  12.5  mg ; oxycodone (immediate release)   10  mg ; fosphenytoin  100  mg pe ; ceftriaxone  2  gm ; propofol  20  mg ; rocuronium  100  mg ; fosphenytoin  1000  mg pe ; 
 
white m 51 $nan$hematology blood hematocrit  27.4  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  227  k ul; hematology blood platelet count  212  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  131  mg dl; chemistry blood albumin  2.7  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood glucose  106  mg dl; blood gas blood potassium, whole blood  3.5  meq l$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocortisone cream 1%  1  appl ; haloperidol  1-2  mg ; lorazepam  1  mg ; sodium chloride  2  gm ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; fosphenytoin  100  mg pe ; propofol  20  mg ; rocuronium  100  mg ; fosphenytoin  1000  mg pe ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  80  meq ; vancomycin  250  mg ; carvedilol  12.5  mg ; vancomycin  1750  mg ; lisinopril  10  mg ; 
 
white m 51 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  123  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; haloperidol  1-2  mg ; lorazepam  1  mg ; sodium chloride  2  gm ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; fosphenytoin  100  mg pe ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  80  meq ; carvedilol  12.5  mg ; vancomycin  1750  mg ; lisinopril  10  mg ; labetalol  10-20  mg ; lisinopril  20  mg ; neutra-phos  1  pkt ; quetiapine fumarate  25-50  mg ; fosphenytoin  125  mg pe ; 
 
white m 51 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  111  mg dl; chemistry blood albumin  3.0  g dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; haloperidol  1-2  mg ; lorazepam  1  mg ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  80  meq ; carvedilol  12.5  mg ; vancomycin  1750  mg ; lisinopril  20  mg ; quetiapine fumarate  25-50  mg ; fosphenytoin  125  mg pe ; fosphenytoin  1400  mg pe ; 
 
white m 51 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  306  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  125  mg dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; haloperidol  1-2  mg ; lorazepam  1  mg ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  80  meq ; carvedilol  12.5  mg ; vancomycin  1750  mg ; lisinopril  20  mg ; quetiapine fumarate  25-50  mg ; fosphenytoin  125  mg pe ; fosphenytoin  1400  mg pe ; 
 
white m 51 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  108  mg dl; chemistry blood albumin  3.1  g dl$bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; ondansetron  4  mg ; sarna lotion  1  appl ; tamsulosin  0.4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; haloperidol  1-2  mg ; lorazepam  1  mg ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  80  meq ; carvedilol  12.5  mg ; lisinopril  20  mg ; quetiapine fumarate  25-50  mg ; fosphenytoin  125  mg pe ; fosphenytoin  1400  mg pe ; prochlorperazine  10  mg ; ibuprofen  400  mg ; tramadol (ultram)  50  mg ; fosphenytoin  300  mg pe ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; phenytoin (suspension)  150  mg ; 
 
white m 51 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  109  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; sarna lotion  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  80  meq ; prochlorperazine  10  mg ; ibuprofen  400  mg ; tramadol (ultram)  50  mg ; fosphenytoin  300  mg pe ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; phenytoin (suspension)  150  mg ; 
 
white m 51 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  327  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  121  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; sarna lotion  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  80  meq ; phenytoin (suspension)  150  mg ; phenytoin sodium  1000  mg ; 
 
white m 51 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  111  mg dl; chemistry blood lactate dehydrogenase (ld)  168  iu l; chemistry blood albumin  3.1  g dl$bisacodyl  10  mg ; ondansetron  4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; phenytoin sodium  1000  mg ; phenytoin (suspension)  200  mg ; 
 
white m 51 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  101  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; levetiracetam oral solution  1500  mg ; acetaminophen (liquid)  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; phenytoin (suspension)  200  mg ; phenytoin sodium extended  200  mg ; 
 
white m 51 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  361  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood albumin  3.3  g dl$bisacodyl  10  mg ; ondansetron  4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; phenytoin sodium extended  200  mg ; acetaminophen  325-650  mg ; 
 
white m 51 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  361  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  99  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; phenytoin sodium extended  200  mg ; acetaminophen  325-650  mg ; 
 
white m 51 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  92  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; phenytoin sodium extended  200  mg ; acetaminophen  325-650  mg ; 
 
white m 51 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  363  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  3.6  g dl$bisacodyl  10  mg ; ondansetron  4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; phenytoin sodium extended  200  mg ; acetaminophen  325-650  mg ; 
 
white m 51 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  3.3  g dl$bisacodyl  10  mg ; ondansetron  4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; phenytoin sodium extended  200  mg ; acetaminophen  325-650  mg ; 
 
white m 51 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  117  mg dl$bisacodyl  10  mg ; ondansetron  4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; phenytoin sodium extended  200  mg ; acetaminophen  325-650  mg ; 
 
white m 51 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  309  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood albumin  3.8  g dl$bisacodyl  10  mg ; ondansetron  4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  10-20  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; phenytoin sodium extended  200  mg ; acetaminophen  325-650  mg ; 
 
black african american f 80 $nan$nan$insulin  22  unit ; vitamin d  800  unit ; calcium carbonate  500  mg ; amlodipine  5  mg ; aspirin  81  mg ; enalapril maleate  20  mg ; omeprazole  20  mg ; prednisone  5  mg ; simvastatin  10  mg ; lidocaine 5% patch  1  ptch ; 
systemic lupus erythematosus unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoarthrosis, unspecified whether generalized or localized, site unspecified long-term (current) use of insulin old myocardial infarction postinflammatory pulmonary fibrosis osteoporosis, unspecified pleurisy without mention of effusion or current tuberculosis rheumatoid arthritis malignant essential hypertension 
black african american f 80 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  138  mg dl$insulin  22  unit ; vitamin d  800  unit ; calcium carbonate  500  mg ; amlodipine  5  mg ; aspirin  81  mg ; enalapril maleate  20  mg ; omeprazole  20  mg ; prednisone  5  mg ; simvastatin  10  mg ; lidocaine 5% patch  1  ptch ; docusate sodium  100  mg ; heparin  5000  unit ; hydroxychloroquine sulfate  200  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  2  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; potassium chloride  20  meq ; amlodipine  10  mg ; 
systemic lupus erythematosus unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoarthrosis, unspecified whether generalized or localized, site unspecified long-term (current) use of insulin old myocardial infarction postinflammatory pulmonary fibrosis osteoporosis, unspecified pleurisy without mention of effusion or current tuberculosis rheumatoid arthritis malignant essential hypertension 
black african american f 80 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  116  mg dl$insulin  22  unit ; vitamin d  800  unit ; calcium carbonate  500  mg ; aspirin  81  mg ; enalapril maleate  20  mg ; omeprazole  20  mg ; prednisone  5  mg ; simvastatin  10  mg ; lidocaine 5% patch  1  ptch ; docusate sodium  100  mg ; heparin  5000  unit ; hydroxychloroquine sulfate  200  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  2  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; potassium chloride  20  meq ; insulin  19  unit ; 
systemic lupus erythematosus unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoarthrosis, unspecified whether generalized or localized, site unspecified long-term (current) use of insulin old myocardial infarction postinflammatory pulmonary fibrosis osteoporosis, unspecified pleurisy without mention of effusion or current tuberculosis rheumatoid arthritis malignant essential hypertension 
black african american f 80 $nan$nan$vitamin d  800  unit ; calcium carbonate  500  mg ; aspirin  81  mg ; enalapril maleate  20  mg ; omeprazole  20  mg ; prednisone  5  mg ; simvastatin  10  mg ; lidocaine 5% patch  1  ptch ; docusate sodium  100  mg ; heparin  5000  unit ; hydroxychloroquine sulfate  200  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  2  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  19  unit ; terazosin  2  mg ; 
systemic lupus erythematosus unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoarthrosis, unspecified whether generalized or localized, site unspecified long-term (current) use of insulin old myocardial infarction postinflammatory pulmonary fibrosis osteoporosis, unspecified pleurisy without mention of effusion or current tuberculosis rheumatoid arthritis malignant essential hypertension 
white f 84 $temp  98.3  heartrate  96.0  resprate  18.0  o2sat  94.0  sbp  102.0  dbp  86.0  rhythm    pain  0  ; temp  97.7  heartrate  90.0  resprate  16.0  o2sat  96.0  sbp  102.0  dbp  73.0  rhythm    pain    ; temp  98.3  heartrate  89.0  resprate  22.0  o2sat  94.0  sbp  98.0  dbp  50.0  rhythm    pain  0  ; temp    heartrate  107.0  resprate  18.0  o2sat  97.0  sbp  118.0  dbp  74.0  rhythm    pain  0  ; temp    heartrate  94.0  resprate  17.0  o2sat  93.0  sbp    dbp    rhythm    pain    ; temp    heartrate  30.0  resprate  26.0  o2sat  93.0  sbp    dbp    rhythm    pain    $hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  7.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  35  # hpf; chemistry blood glucose  101  mg dl; blood gas blood lactate  1.8  mmol l; blood gas blood potassium, whole blood  5.6  meq l; blood gas blood potassium, whole blood  3.6  meq l$nan
left lower quadrant pain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits thyrotoxicosis, unspecified without thyrotoxic crisis or storm hypertensive heart disease with heart failure old myocardial infarction unspecified atrial fibrillation thoracoabdominal aortic aneurysm, without rupture atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified chronic obstructive pulmonary disease, unspecified insomnia, unspecified collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis
white f 84 $temp    heartrate  50.0  resprate  21.0  o2sat  93.0  sbp    dbp    rhythm    pain    ; temp    heartrate  113.0  resprate  21.0  o2sat  93.0  sbp  114.0  dbp  61.0  rhythm    pain  0  $hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  96  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; bisacodyl  10  mg ; metoprolol succinate xl  25  mg ; mirtazapine  45  mg ; gabapentin  600  mg ; gabapentin  1200  mg ; digoxin  0.125  mg ; pantoprazole  40  mg ; methimazole  10  mg ; pravastatin  80  mg ; furosemide  20  mg ; levetiracetam  1500  mg ; trazodone  25  mg ; levofloxacin  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; heparin  5000  unit ; 
left lower quadrant pain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits thyrotoxicosis, unspecified without thyrotoxic crisis or storm hypertensive heart disease with heart failure old myocardial infarction unspecified atrial fibrillation thoracoabdominal aortic aneurysm, without rupture atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified chronic obstructive pulmonary disease, unspecified insomnia, unspecified collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis
white f 84 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; bisacodyl  10  mg ; metoprolol succinate xl  25  mg ; mirtazapine  45  mg ; gabapentin  600  mg ; gabapentin  1200  mg ; digoxin  0.125  mg ; pantoprazole  40  mg ; methimazole  10  mg ; pravastatin  80  mg ; furosemide  20  mg ; levetiracetam  1500  mg ; trazodone  25  mg ; levofloxacin  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; bag  1  bag ; magnesium sulfate  2  gm ; 
left lower quadrant pain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits thyrotoxicosis, unspecified without thyrotoxic crisis or storm hypertensive heart disease with heart failure old myocardial infarction unspecified atrial fibrillation thoracoabdominal aortic aneurysm, without rupture atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified chronic obstructive pulmonary disease, unspecified insomnia, unspecified collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis
white f 84 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; bisacodyl  10  mg ; metoprolol succinate xl  25  mg ; mirtazapine  45  mg ; gabapentin  600  mg ; gabapentin  1200  mg ; digoxin  0.125  mg ; pantoprazole  40  mg ; methimazole  10  mg ; pravastatin  80  mg ; furosemide  20  mg ; levetiracetam  1500  mg ; trazodone  25  mg ; levofloxacin  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium oxide  400  mg ; 
left lower quadrant pain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits thyrotoxicosis, unspecified without thyrotoxic crisis or storm hypertensive heart disease with heart failure old myocardial infarction unspecified atrial fibrillation thoracoabdominal aortic aneurysm, without rupture atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified chronic obstructive pulmonary disease, unspecified insomnia, unspecified collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis
white f 84 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  120  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; bisacodyl  10  mg ; mirtazapine  45  mg ; methimazole  10  mg ; pravastatin  80  mg ; levetiracetam  1500  mg ; levofloxacin  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; magnesium oxide  400  mg ; metoprolol succinate xl  37.5  mg ; digoxin  0.0625  mg ; 
left lower quadrant pain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits thyrotoxicosis, unspecified without thyrotoxic crisis or storm hypertensive heart disease with heart failure old myocardial infarction unspecified atrial fibrillation thoracoabdominal aortic aneurysm, without rupture atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified chronic obstructive pulmonary disease, unspecified insomnia, unspecified collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis
white f 84 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; bisacodyl  10  mg ; mirtazapine  45  mg ; methimazole  10  mg ; pravastatin  80  mg ; levetiracetam  1500  mg ; levofloxacin  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol succinate xl  37.5  mg ; digoxin  0.0625  mg ; potassium chloride  20  meq ; 
left lower quadrant pain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits thyrotoxicosis, unspecified without thyrotoxic crisis or storm hypertensive heart disease with heart failure old myocardial infarction unspecified atrial fibrillation thoracoabdominal aortic aneurysm, without rupture atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified chronic obstructive pulmonary disease, unspecified insomnia, unspecified collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis
white f 84 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; bisacodyl  10  mg ; mirtazapine  45  mg ; methimazole  10  mg ; pravastatin  80  mg ; levetiracetam  1500  mg ; levofloxacin  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol succinate xl  37.5  mg ; digoxin  0.0625  mg ; potassium chloride  20  meq ; 
left lower quadrant pain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits thyrotoxicosis, unspecified without thyrotoxic crisis or storm hypertensive heart disease with heart failure old myocardial infarction unspecified atrial fibrillation thoracoabdominal aortic aneurysm, without rupture atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified chronic obstructive pulmonary disease, unspecified insomnia, unspecified collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis
white f 36 $nan$nan$syringe  2  ml ; betamethasone na. phos acet  12  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$syringe  2  ml ; betamethasone na. phos acet  12  mg ; indomethacin  25  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$syringe  2  ml ; betamethasone na. phos acet  12  mg ; indomethacin  25  mg ; sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$indomethacin  25  mg ; sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; docusate sodium  200  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  170  k ul$sodium chloride 0.9%  flush  3  ml ; prenatal vitamins  1  tab ; aspirin  81  mg ; calcium carbonate  500  mg ; ranitidine  150  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  159  k ul$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; 0.9% sodium chloride  100  ml ; erythromycin  250  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; 0.9% sodium chloride  100  ml ; erythromycin  250  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$amoxicillin  500  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$amoxicillin  500  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$amoxicillin  500  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$amoxicillin  500  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$amoxicillin  500  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$amoxicillin  500  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  178  k ul; hematology blood fetal hemoglobin  .5  %$ibuprofen  600  mg ; acetaminophen  500-1000  mg ; simethicone  80  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$ibuprofen  600  mg ; acetaminophen  500-1000  mg ; simethicone  80  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 36 $nan$nan$ibuprofen  600  mg ; acetaminophen  500-1000  mg ; simethicone  80  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
twin gestation, dichorionic/diamniotic (two placentae, two amniotic sacs) twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication elderly primigravida, antepartum condition or complication burn due to other powered watercraft on fire cervical shortening, antepartum condition or complication long-term (current) use of aspirin need for prophylactic vaccination and inoculation against varicella motorcycle driver injured in collision with fixed or stationary object in nontraffic accident need for prophylactic vaccination and inoculation against rubella alone premature rupture of membranes, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn rhesus isoimmunization, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 24 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  398  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  236  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  gm ; 5% dextrose  250  ml ; azithromycin   500  mg ; gabapentin  800  mg ; tramadol (ultram)  50  mg ; ibuprofen  400  mg ; syringe  1  ml ; heparin sodium  5000  unit ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; oseltamivir  75  mg ; montelukast sodium  10  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; methadone  15  mg ; prednisone  60  mg ; levofloxacin  500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; quetiapine fumarate  25  mg ; lorazepam  1  mg ; phenazopyridine  100  mg ; famotidine  20  mg ; acetaminophen  325-650  mg ; ibuprofen  600  mg ; methadone  10  mg ; clonazepam  0.5  mg ; quetiapine fumarate  50  mg ; 
knee joint replacement poisoning by tranquilizers and other psychotropic agents, undetermined whether accidentally or purposely inflicted pneumonia, organism unspecified asthma, unspecified type, unspecified other specified cardiac dysrhythmias poisoning by other tranquilizers other alteration of consciousness opioid type dependence, continuous bipolar disorder, unspecified chronic hepatitis c without mention of hepatic coma anemia, unspecified pyogenic arthritis, lower leg unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified effusion of joint, lower leg hyposmolality and/or hyponatremia other specified cardiac dysrhythmias cellulitis and abscess of hand, except fingers and thumb other, mixed, or unspecified drug abuse, unspecified opioid type dependence, unspecified severe sepsis streptococcal septicemia unspecified viral hepatitis c without hepatic coma infection and inflammatory reaction due to internal joint prosthesis septic shock acidosis hyperpotassemia methemoglobinemia asthma, unspecified type, with (acute) exacerbation endocarditis, valve unspecified, unspecified cause acute respiratory failure drug withdrawal aseptic necrosis of medial femoral condyle chronic hepatitis c without mention of hepatic coma long-term (current) use of steroids long-term (current) use of other medications opioid type dependence, in remission common variable immunodeficiency unspecified sinusitis (chronic) asthma, unspecified type, with (acute) exacerbation dysthymic disorder osteoarthrosis, unspecified whether generalized or localized, lower leg asthma, unspecified type, unspecified unspecified viral hepatitis c without hepatic coma depressive disorder, not elsewhere classified aseptic necrosis of bone, other
white f 24 $nan$hematology urine wbc  1  # hpf$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  gm ; gabapentin  800  mg ; syringe  1  ml ; heparin sodium  5000  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; oseltamivir  75  mg ; montelukast sodium  10  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; prednisone  60  mg ; levofloxacin  500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; lorazepam  1  mg ; phenazopyridine  100  mg ; famotidine  20  mg ; acetaminophen  325-650  mg ; ibuprofen  600  mg ; methadone  10  mg ; quetiapine fumarate  50  mg ; quetiapine fumarate  100  mg ; hydroxyzine  25  mg ; nicotine patch  14  mg ; prednisone  30  mg ; lorazepam  1-2  mg ; haloperidol  2.5  mg ; lidocaine 1%  10  ml ; morphine sulfate  2  mg ; gabapentin  600  mg ; 
knee joint replacement poisoning by tranquilizers and other psychotropic agents, undetermined whether accidentally or purposely inflicted pneumonia, organism unspecified asthma, unspecified type, unspecified other specified cardiac dysrhythmias poisoning by other tranquilizers other alteration of consciousness opioid type dependence, continuous bipolar disorder, unspecified chronic hepatitis c without mention of hepatic coma anemia, unspecified pyogenic arthritis, lower leg unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified effusion of joint, lower leg hyposmolality and/or hyponatremia other specified cardiac dysrhythmias cellulitis and abscess of hand, except fingers and thumb other, mixed, or unspecified drug abuse, unspecified opioid type dependence, unspecified severe sepsis streptococcal septicemia unspecified viral hepatitis c without hepatic coma infection and inflammatory reaction due to internal joint prosthesis septic shock acidosis hyperpotassemia methemoglobinemia asthma, unspecified type, with (acute) exacerbation endocarditis, valve unspecified, unspecified cause acute respiratory failure drug withdrawal aseptic necrosis of medial femoral condyle chronic hepatitis c without mention of hepatic coma long-term (current) use of steroids long-term (current) use of other medications opioid type dependence, in remission common variable immunodeficiency unspecified sinusitis (chronic) asthma, unspecified type, with (acute) exacerbation dysthymic disorder osteoarthrosis, unspecified whether generalized or localized, lower leg asthma, unspecified type, unspecified unspecified viral hepatitis c without hepatic coma depressive disorder, not elsewhere classified aseptic necrosis of bone, other
white f 24 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  424  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; montelukast sodium  10  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; levofloxacin  500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; phenazopyridine  100  mg ; famotidine  20  mg ; acetaminophen  325-650  mg ; ibuprofen  600  mg ; quetiapine fumarate  50  mg ; quetiapine fumarate  100  mg ; nicotine patch  14  mg ; prednisone  30  mg ; lorazepam  1-2  mg ; haloperidol  2.5  mg ; lidocaine 1%  10  ml ; morphine sulfate  2  mg ; gabapentin  600  mg ; calcium carbonate  500  mg ; methadone  5  mg ; lidocaine 5% patch  1  ptch ; cefpodoxime proxetil  200  mg ; levofloxacin  750  mg ; diphenoxylate-atropine  1  tab ; 
knee joint replacement poisoning by tranquilizers and other psychotropic agents, undetermined whether accidentally or purposely inflicted pneumonia, organism unspecified asthma, unspecified type, unspecified other specified cardiac dysrhythmias poisoning by other tranquilizers other alteration of consciousness opioid type dependence, continuous bipolar disorder, unspecified chronic hepatitis c without mention of hepatic coma anemia, unspecified pyogenic arthritis, lower leg unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified effusion of joint, lower leg hyposmolality and/or hyponatremia other specified cardiac dysrhythmias cellulitis and abscess of hand, except fingers and thumb other, mixed, or unspecified drug abuse, unspecified opioid type dependence, unspecified severe sepsis streptococcal septicemia unspecified viral hepatitis c without hepatic coma infection and inflammatory reaction due to internal joint prosthesis septic shock acidosis hyperpotassemia methemoglobinemia asthma, unspecified type, with (acute) exacerbation endocarditis, valve unspecified, unspecified cause acute respiratory failure drug withdrawal aseptic necrosis of medial femoral condyle chronic hepatitis c without mention of hepatic coma long-term (current) use of steroids long-term (current) use of other medications opioid type dependence, in remission common variable immunodeficiency unspecified sinusitis (chronic) asthma, unspecified type, with (acute) exacerbation dysthymic disorder osteoarthrosis, unspecified whether generalized or localized, lower leg asthma, unspecified type, unspecified unspecified viral hepatitis c without hepatic coma depressive disorder, not elsewhere classified aseptic necrosis of bone, other
white f 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ipratropium bromide neb  1  neb ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; montelukast sodium  10  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; famotidine  20  mg ; acetaminophen  325-650  mg ; ibuprofen  600  mg ; quetiapine fumarate  50  mg ; quetiapine fumarate  100  mg ; nicotine patch  14  mg ; haloperidol  2.5  mg ; gabapentin  600  mg ; calcium carbonate  500  mg ; methadone  5  mg ; lidocaine 5% patch  1  ptch ; cefpodoxime proxetil  200  mg ; levofloxacin  750  mg ; diphenoxylate-atropine  1  tab ; 
knee joint replacement poisoning by tranquilizers and other psychotropic agents, undetermined whether accidentally or purposely inflicted pneumonia, organism unspecified asthma, unspecified type, unspecified other specified cardiac dysrhythmias poisoning by other tranquilizers other alteration of consciousness opioid type dependence, continuous bipolar disorder, unspecified chronic hepatitis c without mention of hepatic coma anemia, unspecified pyogenic arthritis, lower leg unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified effusion of joint, lower leg hyposmolality and/or hyponatremia other specified cardiac dysrhythmias cellulitis and abscess of hand, except fingers and thumb other, mixed, or unspecified drug abuse, unspecified opioid type dependence, unspecified severe sepsis streptococcal septicemia unspecified viral hepatitis c without hepatic coma infection and inflammatory reaction due to internal joint prosthesis septic shock acidosis hyperpotassemia methemoglobinemia asthma, unspecified type, with (acute) exacerbation endocarditis, valve unspecified, unspecified cause acute respiratory failure drug withdrawal aseptic necrosis of medial femoral condyle chronic hepatitis c without mention of hepatic coma long-term (current) use of steroids long-term (current) use of other medications opioid type dependence, in remission common variable immunodeficiency unspecified sinusitis (chronic) asthma, unspecified type, with (acute) exacerbation dysthymic disorder osteoarthrosis, unspecified whether generalized or localized, lower leg asthma, unspecified type, unspecified unspecified viral hepatitis c without hepatic coma depressive disorder, not elsewhere classified aseptic necrosis of bone, other
hispanic latino m 83 $nan$nan$amlodipine  5  mg ; omeprazole  20  mg ; bisacodyl  10  mg ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$hematology blood hematocrit  37.3  %; hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  248  k ul; hematology blood platelet count  255  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  132  mg dl; blood gas blood lactate  1.2  mmol l$amlodipine  5  mg ; omeprazole  20  mg ; bisacodyl  10  mg ; lactated ringers  1000  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; morphine sulfate  1-2  mg ; alprazolam  0.25  mg ; 0.9% sodium chloride  500  ml ; acetaminophen  325-650  mg ; bag  100  ml ; magnesium sulfate  4  gm ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 0.9% sodium chloride  1000  ml ; polyethylene glycol  17  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; sodium chloride 0.9%  flush  3  ml ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  135  mg dl; chemistry blood albumin  3.1  g dl$omeprazole  20  mg ; bisacodyl  10  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  1-2  mg ; alprazolam  0.25  mg ; acetaminophen  325-650  mg ; bag  100  ml ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; vial  1  vial ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; bag  50  ml ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  101  mg dl$vial  1  vial ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; bag  50  ml ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$hematology blood hematocrit  27.6  %; hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  96  mg dl$vial  1  vial ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; bag  50  ml ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  82  mg dl$vial  1  vial ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; d5 1 2ns  1000  ml ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$nan$vial  1  vial ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; d5 1 2ns  1000  ml ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  2.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  122  mg dl$morphine sulfate  2-4  mg ; morphine sulfate  4  mg ; potassium chloride (powder)  40  meq ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry urine chloride, urine  91  meq l; chemistry urine creatinine, urine  13  mg dl; chemistry urine potassium, urine  6  meq l; chemistry urine sodium, urine  99  meq l; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  105  mg dl$morphine sulfate  2-4  mg ; morphine sulfate  4  mg ; potassium chloride (powder)  40  meq ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; potassium chloride (powder)  60  meq ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  103  mg dl$acetaminophen  650  mg ; potassium chloride (powder)  60  meq ; potassium phosphate  30  mmol ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  115  mg dl$acetaminophen  650  mg ; potassium phosphate  30  mmol ; loperamide  2  mg ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
hispanic latino m 83 $nan$nan$acetaminophen  650  mg ; loperamide  2  mg ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction retained cholelithiasis following cholecystectomy removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux unspecified essential hypertension acute appendicitis with generalized peritonitis
white f 49 $nan$hematology blood hematocrit  29.9  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  293  k ul; hematology blood platelet count  441  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  358  iu l; chemistry blood lactate dehydrogenase (ld)  320  iu l; chemistry blood albumin  3.8  g dl; hematology blood bands  0  %$ns  1000  ml ; ns  250  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; d5w  50  ml ; aldesleukin  43.5  mu ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; 
malignant neoplasm of liver, secondary dermatitis due to drugs and medicines taken internally encounter for antineoplastic immunotherapy secondary malignant neoplasm of other specified sites unspecified essential hypertension toxic encephalopathy secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes personal history of malignant neoplasm of kidney secondary thrombocytopenia acute kidney failure, unspecified acidosis antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use shock, unspecified anemia, unspecified malignant neoplasm of kidney, except pelvis family history of malignant neoplasm of gastrointestinal tract secondary malignant neoplasm of other specified sites chronic passive congestion of liver secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes calculus of gallbladder with other cholecystitis, without mention of obstruction other venous embolism and thrombosis of inferior vena cava unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung 
white f 49 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  402  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  70  mg dl; chemistry blood lactate dehydrogenase (ld)  489  iu l; chemistry blood albumin  2.5  g dl; hematology blood bands  2  %$ns  1000  ml ; ns  250  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; d5w  50  ml ; aldesleukin  43.5  mu ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; 
malignant neoplasm of liver, secondary dermatitis due to drugs and medicines taken internally encounter for antineoplastic immunotherapy secondary malignant neoplasm of other specified sites unspecified essential hypertension toxic encephalopathy secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes personal history of malignant neoplasm of kidney secondary thrombocytopenia acute kidney failure, unspecified acidosis antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use shock, unspecified anemia, unspecified malignant neoplasm of kidney, except pelvis family history of malignant neoplasm of gastrointestinal tract secondary malignant neoplasm of other specified sites chronic passive congestion of liver secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes calculus of gallbladder with other cholecystitis, without mention of obstruction other venous embolism and thrombosis of inferior vena cava unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung 
white f 49 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  480  iu l; hematology blood bands  0  %$ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; d5w  50  ml ; aldesleukin  43.5  mu ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; 
malignant neoplasm of liver, secondary dermatitis due to drugs and medicines taken internally encounter for antineoplastic immunotherapy secondary malignant neoplasm of other specified sites unspecified essential hypertension toxic encephalopathy secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes personal history of malignant neoplasm of kidney secondary thrombocytopenia acute kidney failure, unspecified acidosis antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use shock, unspecified anemia, unspecified malignant neoplasm of kidney, except pelvis family history of malignant neoplasm of gastrointestinal tract secondary malignant neoplasm of other specified sites chronic passive congestion of liver secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes calculus of gallbladder with other cholecystitis, without mention of obstruction other venous embolism and thrombosis of inferior vena cava unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung 
white f 49 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  398  iu l; chemistry blood albumin  2.4  g dl; hematology blood bands  0  %$ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; d5w  50  ml ; aldesleukin  43.5  mu ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; 
malignant neoplasm of liver, secondary dermatitis due to drugs and medicines taken internally encounter for antineoplastic immunotherapy secondary malignant neoplasm of other specified sites unspecified essential hypertension toxic encephalopathy secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes personal history of malignant neoplasm of kidney secondary thrombocytopenia acute kidney failure, unspecified acidosis antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use shock, unspecified anemia, unspecified malignant neoplasm of kidney, except pelvis family history of malignant neoplasm of gastrointestinal tract secondary malignant neoplasm of other specified sites chronic passive congestion of liver secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes calculus of gallbladder with other cholecystitis, without mention of obstruction other venous embolism and thrombosis of inferior vena cava unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung 
white f 49 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  492  iu l; hematology blood bands  11  %$ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; d5w  50  ml ; aldesleukin  43.5  mu ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; hydroxyzine  50  mg ; sodium bicarbonate  100  meq ; sodium bicarb  50  meq ; 
malignant neoplasm of liver, secondary dermatitis due to drugs and medicines taken internally encounter for antineoplastic immunotherapy secondary malignant neoplasm of other specified sites unspecified essential hypertension toxic encephalopathy secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes personal history of malignant neoplasm of kidney secondary thrombocytopenia acute kidney failure, unspecified acidosis antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use shock, unspecified anemia, unspecified malignant neoplasm of kidney, except pelvis family history of malignant neoplasm of gastrointestinal tract secondary malignant neoplasm of other specified sites chronic passive congestion of liver secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes calculus of gallbladder with other cholecystitis, without mention of obstruction other venous embolism and thrombosis of inferior vena cava unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung 
white f 49 $nan$chemistry blood bicarbonate  23  meq l$acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; hydroxyzine  50  mg ; sodium bicarbonate  100  meq ; sodium bicarb  50  meq ; nystatin  500,000  unit ; nystatin oral suspension  5  ml ; 
malignant neoplasm of liver, secondary dermatitis due to drugs and medicines taken internally encounter for antineoplastic immunotherapy secondary malignant neoplasm of other specified sites unspecified essential hypertension toxic encephalopathy secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes personal history of malignant neoplasm of kidney secondary thrombocytopenia acute kidney failure, unspecified acidosis antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use shock, unspecified anemia, unspecified malignant neoplasm of kidney, except pelvis family history of malignant neoplasm of gastrointestinal tract secondary malignant neoplasm of other specified sites chronic passive congestion of liver secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes calculus of gallbladder with other cholecystitis, without mention of obstruction other venous embolism and thrombosis of inferior vena cava unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung 
white f 49 $nan$nan$acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; hydroxyzine  50  mg ; sodium bicarb  50  meq ; nystatin oral suspension  5  ml ; 
malignant neoplasm of liver, secondary dermatitis due to drugs and medicines taken internally encounter for antineoplastic immunotherapy secondary malignant neoplasm of other specified sites unspecified essential hypertension toxic encephalopathy secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes personal history of malignant neoplasm of kidney secondary thrombocytopenia acute kidney failure, unspecified acidosis antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use shock, unspecified anemia, unspecified malignant neoplasm of kidney, except pelvis family history of malignant neoplasm of gastrointestinal tract secondary malignant neoplasm of other specified sites chronic passive congestion of liver secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes calculus of gallbladder with other cholecystitis, without mention of obstruction other venous embolism and thrombosis of inferior vena cava unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung 
other f 43 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15-30  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; diphenhydramine  25  mg ; 
 
other f 43 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15-30  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
other f 43 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
other f 43 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; ferrous gluconate  325  mg ; 
 
other f 43 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; ferrous gluconate  325  mg ; varicella virus  0.5  ml ; 
 
white m 52 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  124  mg dl$atenolol  100  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; albuterol inhaler  1  puff ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; heparin  5000  unit ; hydromorphone (dilaudid)  1  mg ; 
 
white m 52 $nan$nan$atenolol  100  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; albuterol inhaler  1  puff ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; hydromorphone (dilaudid)  1  mg ; hydromorphone (dilaudid)  1-2  mg ; oxycodone (immediate release)   5-15  mg ; diazepam  5  mg ; cyclobenzaprine  10  mg ; oxycodone (immediate release)   10-20  mg ; 
 
white m 52 $nan$nan$atenolol  100  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; albuterol inhaler  1  puff ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; cyclobenzaprine  10  mg ; oxycodone (immediate release)   10-20  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5  mg ; methocarbamol  1000  mg ; hydromorphone (dilaudid)  4-6  mg ; 0.9% sodium chloride  500  ml ; lidocaine jelly 2% (urojet)  1  appl ; 
 
white m 52 $nan$nan$atenolol  100  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; ondansetron  4  mg ; albuterol inhaler  1  puff ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5  mg ; methocarbamol  1000  mg ; hydromorphone (dilaudid)  4-6  mg ; 0.9% sodium chloride  500  ml ; lidocaine jelly 2% (urojet)  1  appl ; tizanidine  2  mg ; oxycodone (immediate release)   10  mg ; tamsulosin  0.4  mg ; ketorolac  15  mg ; oxycodone sr (oxycontin)  20  mg ; ketorolac  30  mg ; tizanidine  4  mg ; hydromorphone (dilaudid)  4  mg ; 
 
white m 52 $nan$nan$atenolol  100  mg ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; ondansetron  4  mg ; albuterol inhaler  1  puff ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  650  mg ; tizanidine  2  mg ; tamsulosin  0.4  mg ; ketorolac  30  mg ; tizanidine  4  mg ; hydromorphone (dilaudid)  4  mg ; acetaminophen  1000  mg ; 
 
white f 71 $temp    heartrate  87.0  resprate  16.0  o2sat  99.0  sbp  138.0  dbp  86.0  rhythm    pain  3  ; temp  97.9  heartrate  98.0  resprate  21.0  o2sat  99.0  sbp  159.0  dbp  75.0  rhythm    pain    $hematology blood hematocrit  41.4  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  108  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen  500-1000  mg ; oxycodone (immediate release)  2.5  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; levetiracetam  1000  mg ; docusate sodium  100  mg ; 
 
white f 71 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; levetiracetam  1000  mg ; docusate sodium  100  mg ; 
 
unknown f 70 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  184  mg dl$heparin  5000  unit ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  20  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; 
 
unknown f 70 $nan$hematology blood inr(pt)  1.1  $heparin  5000  unit ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; prednisone  2.5  mg ; simvastatin  40  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; enoxaparin sodium  100  mg ; warfarin  1  mg ; hydromorphone (dilaudid)  1-2  mg ; promethazine  6.25  mg ; furosemide  20  mg ; 
 
unknown f 70 $nan$hematology blood inr(pt)  1.3  $pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; prednisone  2.5  mg ; simvastatin  40  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; enoxaparin sodium  100  mg ; warfarin  1  mg ; hydromorphone (dilaudid)  1-2  mg ; promethazine  6.25  mg ; furosemide  20  mg ; warfarin  2  mg ; 
 
unknown f 70 $nan$hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  $pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; prednisone  2.5  mg ; simvastatin  40  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; enoxaparin sodium  100  mg ; warfarin  1  mg ; hydromorphone (dilaudid)  1-2  mg ; promethazine  6.25  mg ; warfarin  2  mg ; docusate sodium  100  mg ; 
 
unknown f 70 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; prednisone  2.5  mg ; simvastatin  40  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; enoxaparin sodium  100  mg ; warfarin  1  mg ; hydromorphone (dilaudid)  1-2  mg ; promethazine  6.25  mg ; warfarin  2  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; 
 
white m 73 $nan$hematology blood hematocrit  37.7  %; hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  124  k ul; hematology blood platelet count  137  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  175  mg dl; chemistry blood albumin  3.5  g dl; chemistry blood % hemoglobin a1c  9.7  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; heparin  5000  unit ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  16  unit ; omeprazole  20  mg ; oxybutynin  5  mg ; amlodipine  5  mg ; tamsulosin  0.4  mg ; lisinopril  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  20  mg ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  12.5  mg ; sodium chloride 0.9%  1000  ml ; vitamin d  1000  unit ; rosuvastatin calcium  10  mg ; rosuvastatin calcium  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  137  k ul; hematology blood platelet count  130  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  294  mg dl; chemistry blood glucose  235  mg dl; chemistry blood lactate dehydrogenase (ld)  206  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; heparin  5000  unit ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; omeprazole  20  mg ; oxybutynin  5  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  10  ml ; vitamin d  1000  unit ; rosuvastatin calcium  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; mupirocin ointment 2%  1  appl ; metoprolol tartrate  25  mg ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  165  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; heparin  5000  unit ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; omeprazole  20  mg ; oxybutynin  5  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  10  ml ; vitamin d  1000  unit ; rosuvastatin calcium  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; mupirocin ointment 2%  1  appl ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  205  mg dl$acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; heparin  5000  unit ; simethicone  40-80  mg ; omeprazole  20  mg ; oxybutynin  5  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; rosuvastatin calcium  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; mupirocin ointment 2%  1  appl ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  295  mg dl; chemistry blood lactate dehydrogenase (ld)  178  iu l$acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; heparin  5000  unit ; simethicone  40-80  mg ; omeprazole  20  mg ; oxybutynin  5  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; rosuvastatin calcium  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; mupirocin ointment 2%  1  appl ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  244  mg dl; chemistry blood lactate dehydrogenase (ld)  165  iu l$acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; heparin  5000  unit ; simethicone  40-80  mg ; omeprazole  20  mg ; oxybutynin  5  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; rosuvastatin calcium  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; mupirocin ointment 2%  1  appl ; insulin  23  unit ; metoprolol succinate xl  50  mg ; magnesium oxide  400  mg ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  224  mg dl; hematology urine glucose  150  mg dl$acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; heparin  5000  unit ; simethicone  40-80  mg ; omeprazole  20  mg ; oxybutynin  5  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; rosuvastatin calcium  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; mupirocin ointment 2%  1  appl ; insulin  23  unit ; metoprolol succinate xl  50  mg ; magnesium oxide  400  mg ; cephalexin  500  mg ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$hematology blood hematocrit  37.3  %; hematology blood hematocrit  26.7  %; hematology blood hematocrit  30.5  %; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  141  k ul; hematology blood platelet count  98  k ul; hematology blood platelet count  95  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  323  mg dl; chemistry blood lactate dehydrogenase (ld)  176  iu l; chemistry blood albumin  3.7  g dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood chloride, whole blood  106  meq l; blood gas blood glucose  176  mg dl; blood gas blood glucose  198  mg dl; blood gas blood glucose  234  mg dl; blood gas blood glucose  205  mg dl; blood gas blood glucose  212  mg dl; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hemoglobin  11.3  g dl; blood gas blood hemoglobin  9.4  g dl; blood gas blood hemoglobin  9.7  g dl; blood gas blood hemoglobin  9.3  g dl; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  5.5  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  135  meq l$bag  1  ml ; 0.9% sodium chloride  100  ml ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; heparin  5000  unit ; simethicone  40-80  mg ; omeprazole  20  mg ; oxybutynin  5  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; rosuvastatin calcium  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; insulin  23  unit ; metoprolol succinate xl  50  mg ; cephalexin  500  mg ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; sterile water  50  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; insulin human regular  100  unit ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; tramadol  25  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; inv-dexmedetomidine  400  mcg ; bag  100  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; inv-acetaminophen   1000  mg ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  111  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood potassium, whole blood  4.4  meq l$bag  1  ml ; dextrose 5%  1000  ml ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; insulin human regular  100  unit ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; tramadol  25  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; bag  100  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; milk of magnesia  30  ml ; aspirin  81  mg ; insulin  25  unit ; tramadol  50  mg ; hydromorphone (dilaudid)  2-4  mg ; albumin 5% (12.5g   250ml)  25  g ; heparin flush (10 units ml)  1  ml ; bisacodyl  10  mg ; metformin (glucophage)  500  mg ; inv-acetaminophen   1000  mg ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  240  mg dl$ondansetron  4  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; milk of magnesia  30  ml ; tramadol  50  mg ; hydromorphone (dilaudid)  2-4  mg ; heparin flush (10 units ml)  1  ml ; bisacodyl  10  mg ; metformin (glucophage)  500  mg ; insulin  6  unit ; insulin  10  unit ; insulin  12  unit ; metformin (glucophage)  1000  mg ; insulin  27  unit ; insulin  30  unit ; furosemide  40  mg ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  112  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  216  mg dl$ondansetron  4  mg ; milk of magnesia  30  ml ; tramadol  50  mg ; hydromorphone (dilaudid)  2-4  mg ; heparin flush (10 units ml)  1  ml ; bisacodyl  10  mg ; insulin  6  unit ; insulin  10  unit ; insulin  12  unit ; metformin (glucophage)  1000  mg ; insulin  27  unit ; insulin  30  unit ; furosemide  40  mg ; insulin  18  unit ; insulin  38  unit ; insulin  40  unit ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white m 73 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  177  mg dl$ondansetron  4  mg ; milk of magnesia  30  ml ; tramadol  50  mg ; hydromorphone (dilaudid)  2-4  mg ; heparin flush (10 units ml)  1  ml ; bisacodyl  10  mg ; insulin  10  unit ; metformin (glucophage)  1000  mg ; insulin  27  unit ; insulin  30  unit ; furosemide  40  mg ; insulin  18  unit ; insulin  40  unit ; polyethylene glycol  17  g ; insulin  19  unit ; 
hyperlipidemia, unspecified unilateral primary osteoarthritis, right knee hypo-osmolality and hyponatremia unspecified cirrhosis of liver chronic kidney disease, unspecified personal history of malignant neoplasm of prostate hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute kidney failure, unspecified phimosis personal history of irradiation family history of diabetes mellitus unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence long term (current) use of insulin type 2 diabetes mellitus without complications retention of urine, unspecified other and unspecified hyperlipidemia hypotension, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypovolemia long-term (current) use of other medications acute kidney failure, unspecified unspecified essential hypertension long-term (current) use of insulin loss of weight esophageal reflux viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta personal history of malignant neoplasm of prostate iron deficiency anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia long-term (current) use of insulin regional enteritis of small intestine chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta cirrhosis of liver without mention of alcohol
white f 45 $nan$nan$5% dextrose  150  ml ; gentamicin sulfate  350  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; 
elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident third-stage postpartum hemorrhage, delivered, with mention of postpartum complication 
white f 45 $nan$hematology blood hematocrit  27.1  %; hematology blood hematocrit  25.2  %; hematology blood hematocrit  25.9  %; hematology blood hematocrit  23.9  %; hematology blood hematocrit  23.0  %; hematology blood hematocrit  25.0  %; hematology blood hematocrit  25.7  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  117  k ul; hematology blood platelet count  106  k ul; hematology blood platelet count  92  k ul; hematology blood platelet count  82  k ul; hematology blood platelet count  84  k ul; hematology blood platelet count  86  k ul; hematology blood platelet count  84  k ul; hematology blood platelet count  96  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  6  meq l; chemistry blood anion gap  4  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  101  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.30  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  107  meq l; blood gas blood chloride, whole blood  106  meq l; blood gas blood glucose  102  mg dl; blood gas blood glucose  120  mg dl; blood gas blood glucose  120  mg dl; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  9.0  g dl; blood gas blood hemoglobin  9.2  g dl; blood gas blood hemoglobin  8.8  g dl; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood calculated bicarbonate, whole blood  24  meq l$sw  600  ml ; 5% dextrose  150  ml ; gentamicin sulfate  350  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; propofol  1000  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; sw  400  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; 5% dextrose  500  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; fentanyl citrate  25-100  mcg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; maalox diphenhydramine lidocaine  15-30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; acetaminophen iv  1000  mg ; sodium chloride 0.9%  flush  10  ml ; hydromorphone (dilaudid)  0.5  mg ; escitalopram oxalate  15  mg ; hydromorphone (dilaudid)  0.12  mg ; soln  100  ml ; 
elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident third-stage postpartum hemorrhage, delivered, with mention of postpartum complication 
white f 45 $nan$hematology blood hematocrit  23.5  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  77  k ul; hematology blood platelet count  86  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  11  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  130  mg dl; blood gas blood free calcium  1.12  mmol l$sw  600  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; potassium chloride  60  meq ; 5% dextrose  500  ml ; bag  100  ml ; magnesium sulfate  4  gm ; hydromorphone (dilaudid)  20  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  0.24  mg ; famotidine  20  mg ; lorazepam  0.25  mg ; heparin  5000  unit ; iso-osmotic sodium chloride  50  ml ; 
elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident third-stage postpartum hemorrhage, delivered, with mention of postpartum complication 
white f 45 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  93  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  114  mg dl$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; iso-osmotic sodium chloride  50  ml ; ondansetron  4  mg ; ketorolac  15-30  mg ; neutra-phos  1  pkt ; acetaminophen  1000  mg ; simethicone  40-80  mg ; zolpidem tartrate  5  mg ; oxycodone (immediate release)   5-10  mg ; lorazepam  0.5  mg ; 
elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident third-stage postpartum hemorrhage, delivered, with mention of postpartum complication 
white f 45 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  106  mg dl$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; ketorolac  15-30  mg ; neutra-phos  1  pkt ; acetaminophen  1000  mg ; simethicone  40-80  mg ; oxycodone (immediate release)   5-10  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; nitrofurantoin (macrodantin)  100  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; 
elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident third-stage postpartum hemorrhage, delivered, with mention of postpartum complication 
white f 45 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  106  mg dl$heparin  5000  unit ; ketorolac  15-30  mg ; acetaminophen  1000  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-4  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; nitrofurantoin (macrodantin)  100  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; 
elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident third-stage postpartum hemorrhage, delivered, with mention of postpartum complication 
black african american m 66 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  121  mg dl; chemistry blood lactate dehydrogenase (ld)  221  iu l; chemistry blood albumin  3.4  g dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 0.9% sodium chloride  50  ml ; daptomycin  650  mg ; heparin  5000  unit ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  6.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  98  mg dl; blood gas blood potassium, whole blood  4.0  meq l$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; heparin  5000  unit ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  8  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; lactated ringers  1000  ml ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  131  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; heparin  5000  unit ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactated ringers  1000  ml ; insulin  15  unit ; sodium chloride 0.9%  flush  10-20  ml ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  159  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; d5 1 2ns  1000  ml ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  103  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; d5 1 2ns  1000  ml ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  101  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  153  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  167  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  177  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; bag  1  bag ; magnesium sulfate  4  gm ; clopidogrel  75  mg ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  104  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; clopidogrel  75  mg ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  27.2  %; hematology blood hematocrit  25.6  %; hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  264  k ul; hematology blood platelet count  264  k ul; hematology blood platelet count  281  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  188  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; clopidogrel  75  mg ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  20.1  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  6.0  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  209  k ul; hematology blood platelet count  247  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  140  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; clopidogrel  75  mg ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  24.0  %; hematology blood hematocrit  21.2  %; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  215  k ul; hematology blood platelet count  185  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  114  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; tacrolimus  3  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  24.5  %; hematology blood hematocrit  22.6  %; hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  204  k ul; hematology blood platelet count  204  k ul; hematology blood platelet count  214  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  123  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; tacrolimus  4  mg ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  22.0  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  145  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; tacrolimus  4  mg ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  236  k ul; hematology blood platelet count  247  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  140  iu l; chemistry blood lactate dehydrogenase (ld)  149  iu l$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; pantoprazole  40  mg ; ursodiol  300  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; tacrolimus  4  mg ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  306  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  117  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; ursodiol  300  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tacrolimus  4  mg ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  25.5  %; hematology blood hematocrit  27.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  329  k ul; hematology blood platelet count  361  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  126  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; ursodiol  300  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tacrolimus  4  mg ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  369  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  122  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; ursodiol  300  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  356  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  138  mg dl; chemistry blood bilirubin, direct  0.3  mg dl; blood gas blood potassium, whole blood  4.6  meq l$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; ursodiol  300  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  3  unit ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  373  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  14  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  135  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; ursodiol  300  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  3  unit ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  387  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  144  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; ursodiol  300  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  3  unit ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
black african american m 66 $nan$nan$aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; multivitamins w minerals  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; sarna lotion  1  appl ; docusate sodium  100  mg ; ursodiol  300  mg ; mirtazapine  7.5  mg ; mycophenolate mofetil  250  mg ; amlodipine  10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  3  unit ; 
dysphagia, unspecified iron deficiency anemia secondary to blood loss (chronic) personal history of malignant neoplasm of liver physical restraint status essential (primary) hypertension nonrheumatic aortic (valve) stenosis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to vancomycin pyothorax without fistula coagulation defect, unspecified other place in hospital as the place of occurrence of the external cause hemothorax alcohol dependence, in remission insomnia, unspecified stricture of artery liver transplant status enterococcus as the cause of diseases classified elsewhere obstruction of bile duct long term (current) use of insulin nonspecific reaction to tuberculin skin test without active tuberculosis other postprocedural shock, initial encounter hyperkalemia disorientation, unspecified other postprocedural complications and disorders of digestive system type 2 diabetes mellitus with hyperglycemia nonrheumatic aortic (valve) stenosis long term (current) use of antithrombotics/antiplatelets essential (primary) hypertension hyperkalemia other complications of liver transplant surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of malignant neoplasm of liver long term (current) use of insulin type 2 diabetes mellitus without complications unspecified place or not applicable anemia, unspecified other complications of liver transplant candidal stomatitis long term (current) use of insulin body mass index (bmi) 21.0-21.9, adult hemoperitoneum type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere contusion of abdominal wall, initial encounter other cholangitis nonrheumatic aortic (valve) stenosis essential (primary) hypertension unspecified protein-calorie malnutrition
white m 47 $nan$nan$quetiapine fumarate  25  mg ; thiamine  100  mg ; folic acid  1  mg ; diazepam  5-10  mg ; carbamazepine  200  mg ; fluticasone propionate 110mcg  2  puff ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  50  mg ; albuterol mdi  2  puff ; magnesium sulfate  2  gm ; 
asthma, unspecified type, with (acute) exacerbation alcohol withdrawal epilepsy, unspecified, without mention of intractable epilepsy thrombocytopenia, unspecified alcoholic fatty liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident anxiety state, unspecified acidosis tobacco use disorder disorders of phosphorus metabolism diarrhea acute pancreatitis disorders of magnesium metabolism other and unspecified alcohol dependence, continuous tobacco use disorder lack of housing epilepsy, unspecified, without mention of intractable epilepsy aftercare for healing traumatic fracture of other bone asthma, unspecified type, unspecified benign essential hypertension driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident alcohol withdrawal delirium acute alcoholic intoxication in alcoholism, unspecified hypoxemia profound impairment, one eye, impairment level not further specified asthma, unspecified type, unspecified acute alcoholic intoxication in alcoholism, continuous alcohol withdrawal acute alcoholic hepatitis pneumonitis due to inhalation of food or vomitus driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing disorders of magnesium metabolism diarrhea tobacco use disorder asthma, unspecified type, unspecified alcohol withdrawal driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident iron deficiency anemia, unspecified acute alcoholic intoxication in alcoholism, continuous other convulsions unemployment lack of housing personal history of noncompliance with medical treatment, presenting hazards to health diplopia closed fracture of other facial bones
white m 47 $nan$hematology blood hematocrit  43.2  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  78  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  62  mg dl$quetiapine fumarate  25  mg ; thiamine  100  mg ; folic acid  1  mg ; diazepam  5-10  mg ; carbamazepine  200  mg ; fluticasone propionate 110mcg  2  puff ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  50  mg ; albuterol mdi  2  puff ; magnesium sulfate  2  gm ; multivitamins  1  tab ; acetaminophen  650  mg ; d5 1 2ns  1000  ml ; loperamide  2  mg ; promethazine  12.5  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium oxide  400  mg ; 
asthma, unspecified type, with (acute) exacerbation alcohol withdrawal epilepsy, unspecified, without mention of intractable epilepsy thrombocytopenia, unspecified alcoholic fatty liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident anxiety state, unspecified acidosis tobacco use disorder disorders of phosphorus metabolism diarrhea acute pancreatitis disorders of magnesium metabolism other and unspecified alcohol dependence, continuous tobacco use disorder lack of housing epilepsy, unspecified, without mention of intractable epilepsy aftercare for healing traumatic fracture of other bone asthma, unspecified type, unspecified benign essential hypertension driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident alcohol withdrawal delirium acute alcoholic intoxication in alcoholism, unspecified hypoxemia profound impairment, one eye, impairment level not further specified asthma, unspecified type, unspecified acute alcoholic intoxication in alcoholism, continuous alcohol withdrawal acute alcoholic hepatitis pneumonitis due to inhalation of food or vomitus driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing disorders of magnesium metabolism diarrhea tobacco use disorder asthma, unspecified type, unspecified alcohol withdrawal driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident iron deficiency anemia, unspecified acute alcoholic intoxication in alcoholism, continuous other convulsions unemployment lack of housing personal history of noncompliance with medical treatment, presenting hazards to health diplopia closed fracture of other facial bones
white m 47 $nan$hematology blood hematocrit  42.2  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  59  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  112  mg dl; chemistry blood albumin  3.6  g dl$quetiapine fumarate  25  mg ; thiamine  100  mg ; folic acid  1  mg ; diazepam  5-10  mg ; carbamazepine  200  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  50  mg ; albuterol mdi  2  puff ; multivitamins  1  tab ; d5 1 2ns  1000  ml ; loperamide  2  mg ; promethazine  12.5  mg ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; 
asthma, unspecified type, with (acute) exacerbation alcohol withdrawal epilepsy, unspecified, without mention of intractable epilepsy thrombocytopenia, unspecified alcoholic fatty liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident anxiety state, unspecified acidosis tobacco use disorder disorders of phosphorus metabolism diarrhea acute pancreatitis disorders of magnesium metabolism other and unspecified alcohol dependence, continuous tobacco use disorder lack of housing epilepsy, unspecified, without mention of intractable epilepsy aftercare for healing traumatic fracture of other bone asthma, unspecified type, unspecified benign essential hypertension driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident alcohol withdrawal delirium acute alcoholic intoxication in alcoholism, unspecified hypoxemia profound impairment, one eye, impairment level not further specified asthma, unspecified type, unspecified acute alcoholic intoxication in alcoholism, continuous alcohol withdrawal acute alcoholic hepatitis pneumonitis due to inhalation of food or vomitus driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing disorders of magnesium metabolism diarrhea tobacco use disorder asthma, unspecified type, unspecified alcohol withdrawal driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident iron deficiency anemia, unspecified acute alcoholic intoxication in alcoholism, continuous other convulsions unemployment lack of housing personal history of noncompliance with medical treatment, presenting hazards to health diplopia closed fracture of other facial bones
white m 47 $nan$hematology blood hematocrit  45.0  %; hematology blood hematocrit  42.9  %; hematology blood hemoglobin  14.5  g dl; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  84  k ul; hematology blood platelet count  77  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  100  mg dl$quetiapine fumarate  25  mg ; thiamine  100  mg ; folic acid  1  mg ; diazepam  5-10  mg ; carbamazepine  200  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  50  mg ; albuterol mdi  2  puff ; multivitamins  1  tab ; loperamide  2  mg ; promethazine  12.5  mg ; potassium chloride  40  meq ; 
asthma, unspecified type, with (acute) exacerbation alcohol withdrawal epilepsy, unspecified, without mention of intractable epilepsy thrombocytopenia, unspecified alcoholic fatty liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident anxiety state, unspecified acidosis tobacco use disorder disorders of phosphorus metabolism diarrhea acute pancreatitis disorders of magnesium metabolism other and unspecified alcohol dependence, continuous tobacco use disorder lack of housing epilepsy, unspecified, without mention of intractable epilepsy aftercare for healing traumatic fracture of other bone asthma, unspecified type, unspecified benign essential hypertension driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident alcohol withdrawal delirium acute alcoholic intoxication in alcoholism, unspecified hypoxemia profound impairment, one eye, impairment level not further specified asthma, unspecified type, unspecified acute alcoholic intoxication in alcoholism, continuous alcohol withdrawal acute alcoholic hepatitis pneumonitis due to inhalation of food or vomitus driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing disorders of magnesium metabolism diarrhea tobacco use disorder asthma, unspecified type, unspecified alcohol withdrawal driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident iron deficiency anemia, unspecified acute alcoholic intoxication in alcoholism, continuous other convulsions unemployment lack of housing personal history of noncompliance with medical treatment, presenting hazards to health diplopia closed fracture of other facial bones
white m 47 $nan$nan$quetiapine fumarate  25  mg ; thiamine  100  mg ; folic acid  1  mg ; diazepam  5-10  mg ; carbamazepine  200  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  50  mg ; albuterol mdi  2  puff ; multivitamins  1  tab ; loperamide  2  mg ; promethazine  12.5  mg ; 
asthma, unspecified type, with (acute) exacerbation alcohol withdrawal epilepsy, unspecified, without mention of intractable epilepsy thrombocytopenia, unspecified alcoholic fatty liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident anxiety state, unspecified acidosis tobacco use disorder disorders of phosphorus metabolism diarrhea acute pancreatitis disorders of magnesium metabolism other and unspecified alcohol dependence, continuous tobacco use disorder lack of housing epilepsy, unspecified, without mention of intractable epilepsy aftercare for healing traumatic fracture of other bone asthma, unspecified type, unspecified benign essential hypertension driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident alcohol withdrawal delirium acute alcoholic intoxication in alcoholism, unspecified hypoxemia profound impairment, one eye, impairment level not further specified asthma, unspecified type, unspecified acute alcoholic intoxication in alcoholism, continuous alcohol withdrawal acute alcoholic hepatitis pneumonitis due to inhalation of food or vomitus driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing disorders of magnesium metabolism diarrhea tobacco use disorder asthma, unspecified type, unspecified alcohol withdrawal driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident iron deficiency anemia, unspecified acute alcoholic intoxication in alcoholism, continuous other convulsions unemployment lack of housing personal history of noncompliance with medical treatment, presenting hazards to health diplopia closed fracture of other facial bones
white m 47 $nan$hematology blood hematocrit  44.6  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  107  mg dl$thiamine  100  mg ; folic acid  1  mg ; carbamazepine  200  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; albuterol mdi  2  puff ; multivitamins  1  tab ; loperamide  2  mg ; 
asthma, unspecified type, with (acute) exacerbation alcohol withdrawal epilepsy, unspecified, without mention of intractable epilepsy thrombocytopenia, unspecified alcoholic fatty liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident anxiety state, unspecified acidosis tobacco use disorder disorders of phosphorus metabolism diarrhea acute pancreatitis disorders of magnesium metabolism other and unspecified alcohol dependence, continuous tobacco use disorder lack of housing epilepsy, unspecified, without mention of intractable epilepsy aftercare for healing traumatic fracture of other bone asthma, unspecified type, unspecified benign essential hypertension driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident alcohol withdrawal delirium acute alcoholic intoxication in alcoholism, unspecified hypoxemia profound impairment, one eye, impairment level not further specified asthma, unspecified type, unspecified acute alcoholic intoxication in alcoholism, continuous alcohol withdrawal acute alcoholic hepatitis pneumonitis due to inhalation of food or vomitus driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing disorders of magnesium metabolism diarrhea tobacco use disorder asthma, unspecified type, unspecified alcohol withdrawal driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident iron deficiency anemia, unspecified acute alcoholic intoxication in alcoholism, continuous other convulsions unemployment lack of housing personal history of noncompliance with medical treatment, presenting hazards to health diplopia closed fracture of other facial bones
white m 47 $nan$hematology blood hematocrit  46.1  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.4  mg dl; chemistry blood glucose  109  mg dl$thiamine  100  mg ; folic acid  1  mg ; carbamazepine  200  mg ; fluticasone propionate 110mcg  2  puff ; sodium chloride 0.9%  flush  3  ml ; albuterol mdi  2  puff ; multivitamins  1  tab ; loperamide  2  mg ; diazepam  5  mg ; olanzapine  5  mg ; 
asthma, unspecified type, with (acute) exacerbation alcohol withdrawal epilepsy, unspecified, without mention of intractable epilepsy thrombocytopenia, unspecified alcoholic fatty liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident anxiety state, unspecified acidosis tobacco use disorder disorders of phosphorus metabolism diarrhea acute pancreatitis disorders of magnesium metabolism other and unspecified alcohol dependence, continuous tobacco use disorder lack of housing epilepsy, unspecified, without mention of intractable epilepsy aftercare for healing traumatic fracture of other bone asthma, unspecified type, unspecified benign essential hypertension driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident alcohol withdrawal delirium acute alcoholic intoxication in alcoholism, unspecified hypoxemia profound impairment, one eye, impairment level not further specified asthma, unspecified type, unspecified acute alcoholic intoxication in alcoholism, continuous alcohol withdrawal acute alcoholic hepatitis pneumonitis due to inhalation of food or vomitus driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing disorders of magnesium metabolism diarrhea tobacco use disorder asthma, unspecified type, unspecified alcohol withdrawal driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident iron deficiency anemia, unspecified acute alcoholic intoxication in alcoholism, continuous other convulsions unemployment lack of housing personal history of noncompliance with medical treatment, presenting hazards to health diplopia closed fracture of other facial bones
white f 52 $nan$nan$atorvastatin  20  mg ; warfarin  4  mg ; 
localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy atrial fibrillation long-term (current) use of anticoagulants atrial flutter cerebral artery occlusion, unspecified with cerebral infarction atrial fibrillation other convulsions atrial flutter
white f 52 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  94  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$atorvastatin  20  mg ; warfarin  4  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; propafenone hcl  150  mg ; levetiracetam  1250  mg ; 
localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy atrial fibrillation long-term (current) use of anticoagulants atrial flutter cerebral artery occlusion, unspecified with cerebral infarction atrial fibrillation other convulsions atrial flutter
white f 52 $nan$nan$atorvastatin  20  mg ; warfarin  4  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; propafenone hcl  150  mg ; levetiracetam  1250  mg ; warfarin  5  mg ; 
localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy atrial fibrillation long-term (current) use of anticoagulants atrial flutter cerebral artery occlusion, unspecified with cerebral infarction atrial fibrillation other convulsions atrial flutter
white f 84 $nan$nan$citalopram hydrobromide  20  mg ; aspirin  81  mg ; omeprazole  20  mg ; levothyroxine sodium  25  mcg ; amiodarone  100  mg ; 
 
white f 84 $nan$hematology blood hematocrit  32.2  %; hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  209  iu l$citalopram hydrobromide  20  mg ; aspirin  81  mg ; omeprazole  20  mg ; levothyroxine sodium  25  mcg ; amiodarone  100  mg ; warfarin  2  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; gabapentin  300  mg ; 0.9% sodium chloride  1000  ml ; calcium carbonate  500  mg ; vitamin d  400  unit ; namenda  10  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; donepezil  10  mg ; methocarbamol  500  mg ; amoxicillin  250  mg ; tramadol (ultram)  50  mg ; 
 
white f 84 $nan$nan$citalopram hydrobromide  20  mg ; aspirin  81  mg ; omeprazole  20  mg ; levothyroxine sodium  25  mcg ; amiodarone  100  mg ; warfarin  2  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; gabapentin  300  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; namenda  10  mg ; acetaminophen  1000  mg ; donepezil  10  mg ; methocarbamol  500  mg ; tramadol (ultram)  50  mg ; senna  1  tab ; 
 
black african american f 68 $nan$nan$insulin  25  unit ; aspirin  325  mg ; clopidogrel  75  mg ; nicotine patch  14  mg ; citalopram hydrobromide  40  mg ; 
atrial fibrillation unspecified essential hypertension esophageal reflux polyneuropathy in diabetes personal history of tobacco use chronic airway obstruction, not elsewhere classified obesity, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified atherosclerosis of native arteries of the extremities with rest pain spondylosis of unspecified site, without mention of myelopathy polyneuropathy in diabetes anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension chronic total occlusion of artery of the extremities chronic obstructive asthma, unspecified obesity, unspecified pure hypercholesterolemia atherosclerosis of native arteries of the extremities with intermittent claudication esophageal reflux depressive disorder, not elsewhere classified tobacco use disorder
black african american f 68 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  397  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  140  mg dl; chemistry blood % hemoglobin a1c  6.0  %$insulin  25  unit ; aspirin  325  mg ; clopidogrel  75  mg ; nicotine patch  14  mg ; citalopram hydrobromide  40  mg ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; nitroglycerin sl  0.3  mg ; morphine sulfate  1  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; ranitidine  150  mg ; metoprolol tartrate  25  mg ; valsartan  80  mg ; bupropion (sustained release)  150  mg ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; insulin  0  unit ; pravastatin  80  mg ; morphine sulfate  2  mg ; dicloxacillin  500  mg ; ondansetron  4  mg ; miconazole powder 2%  1  appl ; 
atrial fibrillation unspecified essential hypertension esophageal reflux polyneuropathy in diabetes personal history of tobacco use chronic airway obstruction, not elsewhere classified obesity, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified atherosclerosis of native arteries of the extremities with rest pain spondylosis of unspecified site, without mention of myelopathy polyneuropathy in diabetes anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension chronic total occlusion of artery of the extremities chronic obstructive asthma, unspecified obesity, unspecified pure hypercholesterolemia atherosclerosis of native arteries of the extremities with intermittent claudication esophageal reflux depressive disorder, not elsewhere classified tobacco use disorder
black african american f 68 $nan$nan$insulin  25  unit ; aspirin  325  mg ; clopidogrel  75  mg ; nicotine patch  14  mg ; citalopram hydrobromide  40  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; ranitidine  150  mg ; metoprolol tartrate  25  mg ; valsartan  80  mg ; bupropion (sustained release)  150  mg ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; insulin  0  unit ; pravastatin  80  mg ; morphine sulfate  2  mg ; dicloxacillin  500  mg ; ondansetron  4  mg ; miconazole powder 2%  1  appl ; cyclobenzaprine  10  mg ; 
atrial fibrillation unspecified essential hypertension esophageal reflux polyneuropathy in diabetes personal history of tobacco use chronic airway obstruction, not elsewhere classified obesity, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified atherosclerosis of native arteries of the extremities with rest pain spondylosis of unspecified site, without mention of myelopathy polyneuropathy in diabetes anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension chronic total occlusion of artery of the extremities chronic obstructive asthma, unspecified obesity, unspecified pure hypercholesterolemia atherosclerosis of native arteries of the extremities with intermittent claudication esophageal reflux depressive disorder, not elsewhere classified tobacco use disorder
black african american f 68 $nan$nan$insulin  25  unit ; aspirin  325  mg ; clopidogrel  75  mg ; nicotine patch  14  mg ; citalopram hydrobromide  40  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; ranitidine  150  mg ; metoprolol tartrate  25  mg ; valsartan  80  mg ; bupropion (sustained release)  150  mg ; docusate sodium  100  mg ; senna  1  tab ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; insulin  0  unit ; pravastatin  80  mg ; dicloxacillin  500  mg ; ondansetron  4  mg ; miconazole powder 2%  1  appl ; cyclobenzaprine  10  mg ; 
atrial fibrillation unspecified essential hypertension esophageal reflux polyneuropathy in diabetes personal history of tobacco use chronic airway obstruction, not elsewhere classified obesity, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified atherosclerosis of native arteries of the extremities with rest pain spondylosis of unspecified site, without mention of myelopathy polyneuropathy in diabetes anemia, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension chronic total occlusion of artery of the extremities chronic obstructive asthma, unspecified obesity, unspecified pure hypercholesterolemia atherosclerosis of native arteries of the extremities with intermittent claudication esophageal reflux depressive disorder, not elsewhere classified tobacco use disorder
white f 71 $nan$hematology blood hematocrit  28.7  %; hematology blood hematocrit  35.5  %; hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  333  k ul; hematology blood platelet count  378  k ul; hematology blood platelet count  189  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; chemistry urine chloride, urine  19  meq l; chemistry urine creatinine, urine  58  mg dl; chemistry urine sodium, urine  51  meq l; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood bilirubin, total  2.9  mg dl; chemistry blood bilirubin, total  3.1  mg dl; chemistry blood glucose  152  mg dl; chemistry blood glucose  315  mg dl; chemistry blood glucose  250  mg dl; chemistry blood lactate dehydrogenase (ld)  521  iu l; chemistry blood albumin  2.0  g dl; chemistry blood albumin  3.9  g dl; chemistry blood albumin  3.7  g dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  0.87  mmol l; blood gas blood free calcium  0.99  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  4.8  mmol l; blood gas blood lactate  4.8  mmol l; blood gas blood lactate  4.6  mmol l; blood gas blood lactate  5.7  mmol l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  110  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood glucose  171  mg dl; blood gas blood glucose  141  mg dl; blood gas blood glucose  153  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  9.8  g dl; blood gas blood hemoglobin  11.2  g dl; blood gas blood hemoglobin  8.6  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  135  meq l$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  10  ml ; promethazine  12.5  mg ; promethazine  12.5-25  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; ondansetron  4  mg ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; propofol  1000  mg ; propofol  200  mg ; d5 1 2ns  1000  ml ; albumin 25% (12.5g   50ml)  50  g ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levothyroxine sodium  25  mcg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  50-100  ml ; potassium chloride  20-40  meq ; sw  100  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 5% dextrose  250  ml ; phenylephrine  60  mg ; 1 2 ns  1000  ml ; sodium bicarbonate  100  meq ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, indirect  1.0  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  162  mg dl; chemistry blood glucose  140  mg dl; chemistry blood albumin  3.6  g dl; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.3  mmol l; chemistry blood bilirubin, direct  0.8  mg dl$sodium chloride 0.9%  flush  10  ml ; promethazine  12.5  mg ; promethazine  12.5-25  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; ondansetron  4  mg ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; propofol  1000  mg ; propofol  200  mg ; d5 1 2ns  1000  ml ; albumin 25% (12.5g   50ml)  50  g ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levothyroxine sodium  25  mcg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  50-100  ml ; potassium chloride  20-40  meq ; sw  100  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 1 2 ns  1000  ml ; sodium bicarbonate  100  meq ; morphine sulfate  2-4  mg ; sertraline  100  mg ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; morphine sulfate  2  mg ; furosemide  20  mg ; metoprolol tartrate  5  mg ; alprazolam  0.5  mg ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  126  mg dl; chemistry blood albumin  3.7  g dl; blood gas blood lactate  2.0  mmol l$sodium chloride 0.9%  flush  10  ml ; promethazine  12.5-25  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; ondansetron  4  mg ; insulin  0  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  50-100  ml ; potassium chloride  20-40  meq ; sw  100  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; sertraline  100  mg ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; morphine sulfate  2  mg ; furosemide  20  mg ; metoprolol tartrate  5  mg ; alprazolam  0.5  mg ; morphine sulfate  1  mg ; fentanyl citrate  12.5-25  mcg ; hydralazine  5  mg ; valsartan  160  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  325  mg ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  2.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  137  mg dl; blood gas blood lactate  2.3  mmol l$sodium chloride 0.9%  flush  10  ml ; promethazine  12.5-25  mg ; heparin  5000  unit ; ondansetron  4  mg ; insulin  0  unit ; sertraline  100  mg ; alprazolam  0.5  mg ; valsartan  160  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  325  mg ; valsartan  80  mg ; hydralazine  10  mg ; heparin flush (10 units ml)  1  ml ; rifaximin  200  mg ; neutra-phos  2  pkt ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; ondansetron  4  mg ; insulin  0  unit ; sertraline  100  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin flush (10 units ml)  1  ml ; rifaximin  200  mg ; neutra-phos  2  pkt ; valsartan  320  mg ; hydrocodone-acetaminophen  1  tab ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  86  mg dl; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; ondansetron  4  mg ; insulin  0  unit ; sertraline  100  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin flush (10 units ml)  1  ml ; rifaximin  200  mg ; valsartan  320  mg ; hydrocodone-acetaminophen  1  tab ; milk of magnesia  60  ml ; bisacodyl  10  mg ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  2.8  meq l; chemistry blood potassium  2.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology urine wbc  3-5  # hpf; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  3.1  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; insulin  0  unit ; sertraline  100  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin flush (10 units ml)  1  ml ; rifaximin  200  mg ; valsartan  320  mg ; hydrocodone-acetaminophen  1  tab ; milk of magnesia  60  ml ; bisacodyl  10  mg ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  2.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  6-10  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.0  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; insulin  0  unit ; sertraline  100  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin flush (10 units ml)  1  ml ; rifaximin  200  mg ; valsartan  320  mg ; hydrocodone-acetaminophen  1  tab ; diphenhydramine  25  mg ; magnesium oxide  280  mg ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  2.7  g dl$sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; insulin  0  unit ; sertraline  100  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; rifaximin  200  mg ; valsartan  320  mg ; hydrocodone-acetaminophen  1  tab ; diphenhydramine  25  mg ; calcium carbonate suspension  1250  mg ; enoxaparin sodium  70  mg ; heparin sodium  25,000  unit ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  104  mg dl; chemistry blood albumin  2.6  g dl$d5w  250  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; insulin  0  unit ; sertraline  100  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; rifaximin  200  mg ; valsartan  320  mg ; hydrocodone-acetaminophen  1  tab ; heparin sodium  25,000  unit ; neutra-phos  1  pkt ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  2.7  g dl$sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; insulin  0  unit ; sertraline  100  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; valsartan  320  mg ; hydrocodone-acetaminophen  1  tab ; neutra-phos  1  pkt ; levofloxacin  500  mg ; metronidazole (flagyl)  500  mg ; warfarin  10  mg ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  3.3  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  2.6  g dl$sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; insulin  0  unit ; sertraline  100  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; valsartan  320  mg ; hydrocodone-acetaminophen  1  tab ; levofloxacin  500  mg ; metronidazole (flagyl)  500  mg ; warfarin  10  mg ; warfarin  2  mg ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
white f 71 $nan$nan$sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; sertraline  100  mg ; levothyroxine sodium  50  mcg ; hydrochlorothiazide  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; valsartan  320  mg ; hydrocodone-acetaminophen  1  tab ; levofloxacin  500  mg ; metronidazole (flagyl)  500  mg ; warfarin  2  mg ; 
other and unspecified hyperlipidemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of kidney, except pelvis obstruction of bile duct chronic airway obstruction, not elsewhere classified unspecified acquired hypothyroidism unspecified essential hypertension agoraphobia with panic disorder malignant neoplasm of liver, secondary 
unknown m 75 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry urine chloride, urine  85  meq l; chemistry urine creatinine, urine  63  mg dl; chemistry urine potassium, urine  24  meq l; chemistry urine sodium, urine  88  meq l; chemistry urine urea nitrogen, urine  369  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  197  mg dl; chemistry blood glucose  334  mg dl; chemistry blood albumin  2.7  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  4.5  mmol l$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; 0.9% sodium chloride  1000  ml ; insulin  58  unit ; insulin  0  unit ; aspirin  325  mg ; omeprazole  40  mg ; 5% dextrose  100  ml ; diltiazem  10  mg ; metoprolol tartrate  25  mg ; metoprolol tartrate  5  mg ; vial  1  vial ; pantoprazole  40  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
unknown m 75 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  222  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; 0.9% sodium chloride  1000  ml ; insulin  58  unit ; insulin  0  unit ; aspirin  325  mg ; metoprolol tartrate  25  mg ; metoprolol tartrate  5  mg ; vial  1  vial ; pantoprazole  40  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; rifaximin  550  mg ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; lactulose  0  ml ; 
 
unknown m 75 $nan$hematology blood hematocrit  22.3  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  89  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  193  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  58  unit ; insulin  0  unit ; lidocaine 1%  5  ml ; rifaximin  550  mg ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; lactulose  0  ml ; 
 
unknown m 75 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lidocaine 1%  5  ml ; rifaximin  550  mg ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; lactulose  0  ml ; 
 
unknown m 75 $nan$hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  107  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lidocaine 1%  5  ml ; rifaximin  550  mg ; sodium chloride 0.9%  flush  10  ml ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; lactulose  0  ml ; 
 
white m 53 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  438  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  67  mg dl$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin   500  mg ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; sodium chloride 0.9%  1000  ml ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white m 53 $nan$hematology blood hematocrit  30.9  %; hematology blood hematocrit  34.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  410  k ul; hematology blood platelet count  435  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  81  mg dl$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin   500  mg ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; sodium chloride 0.9%  1000  ml ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white m 53 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  381  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  102  mg dl$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin   500  mg ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white m 53 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  452  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  122  mg dl; hematology blood wbc count  13.5  k ul$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin   500  mg ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white m 53 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  473  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  107  mg dl$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin   500  mg ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white m 53 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  453  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white m 53 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ceftriaxone  2  gm ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white m 53 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  470  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ceftriaxone  2  gm ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white m 53 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  499  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ceftriaxone  2  gm ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white m 53 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  497  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ceftriaxone  2  gm ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white m 53 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; gabapentin  800  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; mirtazapine  30  mg ; topiramate (topamax)  100  mg ; oxycodone (immediate release)   5  mg ; sumatriptan succinate  100  mg ; escitalopram oxalate  10  mg ; fentanyl patch  25  mcg h ; methylphenidate sr  20  mg ; bupropion (sustained release)  150  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ceftriaxone  2  gm ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
personal history of tobacco use other and unspecified hyperlipidemia depressive disorder, not elsewhere classified other chest pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain bacterial pneumonia, unspecified raynaud's syndrome anxiety state, unspecified unilateral paralysis of vocal cords or larynx, partial dysphonia other and unspecified hyperlipidemia depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) unspecified adjustment reaction other and unspecified hyperlipidemia unilateral paralysis of vocal cords or larynx, partial obstructive sleep apnea (adult)(pediatric) raynaud's syndrome unspecified disease of pericardium other chronic pain dysthymic disorder raynaud's syndrome other and unspecified hyperlipidemia personal history of tobacco use shortness of breath street and highway accidents acquired absence of organ, lung pain in joint, lower leg other chest pain other external cause status dysthymic disorder motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle aspergillosis personal history of tobacco use dysthymic disorder aspergillosis personal history of tobacco use pure hypercholesterolemia fitting and adjustment, other device hemoptysis empyema with fistula empyema with fistula depressive disorder, not elsewhere classified aspergillosis other and unspecified hyperlipidemia depressive disorder, not elsewhere classified empyema with fistula
white f 77 $nan$hematology blood hematocrit  25.7  %$vitamin d  400  unit ; multivitamins  1  cap ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  100  mcg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; ns  100  ml ; cefazolin  2  gm ; enoxaparin sodium  30  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; trazodone  50  mg ; senna  1  tab ; milk of magnesia  30  ml ; bisacodyl  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; albuterol 0.083% neb soln  1  neb ; calcium carbonate  500  mg ; naproxen  500  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; metoprolol  25  mg ; 
 
white f 77 $nan$hematology blood hematocrit  24.7  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  248  k ul; hematology blood platelet count  255  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  92  mg dl$vitamin d  400  unit ; multivitamins  1  cap ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  100  mcg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen  650  mg ; enoxaparin sodium  30  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; trazodone  50  mg ; senna  1  tab ; milk of magnesia  30  ml ; bisacodyl  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; albuterol 0.083% neb soln  1  neb ; calcium carbonate  500  mg ; naproxen  500  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; metoprolol  25  mg ; oxycodone sr (oxycontin)  10  mg ; cefazolin  2  g ; oxycodone (immediate release)   5-10  mg ; 
 
white f 77 $nan$nan$vitamin d  400  unit ; multivitamins  1  cap ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  100  mcg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen  650  mg ; enoxaparin sodium  30  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; trazodone  50  mg ; senna  1  tab ; milk of magnesia  30  ml ; bisacodyl  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; albuterol 0.083% neb soln  1  neb ; calcium carbonate  500  mg ; naproxen  500  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; metoprolol  25  mg ; cefazolin  2  g ; oxycodone (immediate release)   5-10  mg ; pneumococcal vac polyvalent  0.5  ml ; 
 
white f 77 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  219  k ul$vitamin d  400  unit ; multivitamins  1  cap ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  100  mcg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen  650  mg ; enoxaparin sodium  30  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; trazodone  50  mg ; senna  1  tab ; milk of magnesia  30  ml ; bisacodyl  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; albuterol 0.083% neb soln  1  neb ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; metoprolol  25  mg ; oxycodone (immediate release)   5-10  mg ; pneumococcal vac polyvalent  0.5  ml ; 
 
white m 91 $temp  98.0  heartrate  65.0  resprate  15.0  o2sat  100.0  sbp  123.0  dbp  70.0  rhythm  normal sinus rhythm  pain  0  $hematology urine wbc  13  # hpf; hematology urine glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; morphine sulfate  1-2  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; phenytoin sodium  100  mg ; acetaminophen iv  1000  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; hydralazine  10-20  mg ; ondansetron  4  mg ; senna  8.6  mg ; oxycodone (immediate release)   5-10  mg ; doxazosin  8  mg ; 
 
white m 91 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  5.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; phenytoin sodium  100  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; hydralazine  10-20  mg ; ondansetron  4  mg ; senna  8.6  mg ; oxycodone (immediate release)   5-10  mg ; doxazosin  8  mg ; simvastatin  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; 
 
white m 91 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  136  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; oxycodone (immediate release)   5-10  mg ; doxazosin  8  mg ; simvastatin  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; 
 
white m 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; senna  8.6  mg ; oxycodone (immediate release)   5-10  mg ; doxazosin  8  mg ; simvastatin  40  mg ; heparin  5000  unit ; levetiracetam  500  mg ; 
 
white f 43 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  90  mg dl$hydralazine  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lisinopril  20  mg ; venlafaxine xr  225  mg ; lorazepam  0.5  mg ; 
 
white m 70 $nan$nan$fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; 
chronic systolic heart failure fistula of intestine, excluding rectum and anus anemia, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation late effects of cerebrovascular disease, other speech and language deficits coronary atherosclerosis of native coronary artery esophageal reflux gastroparesis intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) chronic obstructive asthma, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia old myocardial infarction percutaneous transluminal coronary angioplasty status unspecified essential hypertension atrial fibrillation acute venous embolism and thrombosis of deep vessels of proximal lower extremity acidosis persistent postoperative fistula unspecified peritonitis cervicalgia retention of urine, unspecified chronic obstructive asthma, unspecified old myocardial infarction barrett's esophagus unspecified essential hypertension other postoperative infection chronic systolic heart failure congestive heart failure, unspecified other chronic pain polymyalgia rheumatica esophageal reflux removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) acute kidney failure, unspecified coronary atherosclerosis of native coronary artery hyperpotassemia other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified intestinal obstruction peritoneal adhesions (postoperative) (postinfection) polymyalgia rheumatica calculus of gallbladder with acute cholecystitis, without mention of obstruction unspecified septicemia severe sepsis chronic systolic heart failure percutaneous transluminal coronary angioplasty status removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white m 70 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  425  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  100  mg dl$pantoprazole  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; heparin flush (10 units ml)  2  ml ; lr  1000  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; metoprolol tartrate  5  mg ; morphine sulfate  1-2  mg ; acetaminophen  650  mg ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; ondansetron  4  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; prochlorperazine  10  mg ; nystatin oral suspension  5  ml ; 
chronic systolic heart failure fistula of intestine, excluding rectum and anus anemia, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation late effects of cerebrovascular disease, other speech and language deficits coronary atherosclerosis of native coronary artery esophageal reflux gastroparesis intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) chronic obstructive asthma, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia old myocardial infarction percutaneous transluminal coronary angioplasty status unspecified essential hypertension atrial fibrillation acute venous embolism and thrombosis of deep vessels of proximal lower extremity acidosis persistent postoperative fistula unspecified peritonitis cervicalgia retention of urine, unspecified chronic obstructive asthma, unspecified old myocardial infarction barrett's esophagus unspecified essential hypertension other postoperative infection chronic systolic heart failure congestive heart failure, unspecified other chronic pain polymyalgia rheumatica esophageal reflux removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) acute kidney failure, unspecified coronary atherosclerosis of native coronary artery hyperpotassemia other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified intestinal obstruction peritoneal adhesions (postoperative) (postinfection) polymyalgia rheumatica calculus of gallbladder with acute cholecystitis, without mention of obstruction unspecified septicemia severe sepsis chronic systolic heart failure percutaneous transluminal coronary angioplasty status removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white m 70 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  384  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  84  mg dl; chemistry blood glucose  101  mg dl$pantoprazole  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; heparin flush (10 units ml)  2  ml ; lr  1000  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; metoprolol tartrate  5  mg ; morphine sulfate  1-2  mg ; acetaminophen  650  mg ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; ondansetron  4  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; prochlorperazine  10  mg ; nystatin oral suspension  5  ml ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; cefepime  2  g ; sodium chloride 0.9%  flush  3  ml ; 
chronic systolic heart failure fistula of intestine, excluding rectum and anus anemia, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation late effects of cerebrovascular disease, other speech and language deficits coronary atherosclerosis of native coronary artery esophageal reflux gastroparesis intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) chronic obstructive asthma, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia old myocardial infarction percutaneous transluminal coronary angioplasty status unspecified essential hypertension atrial fibrillation acute venous embolism and thrombosis of deep vessels of proximal lower extremity acidosis persistent postoperative fistula unspecified peritonitis cervicalgia retention of urine, unspecified chronic obstructive asthma, unspecified old myocardial infarction barrett's esophagus unspecified essential hypertension other postoperative infection chronic systolic heart failure congestive heart failure, unspecified other chronic pain polymyalgia rheumatica esophageal reflux removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) acute kidney failure, unspecified coronary atherosclerosis of native coronary artery hyperpotassemia other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified intestinal obstruction peritoneal adhesions (postoperative) (postinfection) polymyalgia rheumatica calculus of gallbladder with acute cholecystitis, without mention of obstruction unspecified septicemia severe sepsis chronic systolic heart failure percutaneous transluminal coronary angioplasty status removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white m 70 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  381  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  79  mg dl$pantoprazole  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; lr  1000  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; metoprolol tartrate  5  mg ; morphine sulfate  1-2  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ondansetron  4  mg ; nystatin oral suspension  5  ml ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3  ml ; bag  100  ml ; magnesium sulfate  4  gm ; metoprolol tartrate  12.5  mg ; docusate sodium  100  mg ; 
chronic systolic heart failure fistula of intestine, excluding rectum and anus anemia, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation late effects of cerebrovascular disease, other speech and language deficits coronary atherosclerosis of native coronary artery esophageal reflux gastroparesis intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) chronic obstructive asthma, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia old myocardial infarction percutaneous transluminal coronary angioplasty status unspecified essential hypertension atrial fibrillation acute venous embolism and thrombosis of deep vessels of proximal lower extremity acidosis persistent postoperative fistula unspecified peritonitis cervicalgia retention of urine, unspecified chronic obstructive asthma, unspecified old myocardial infarction barrett's esophagus unspecified essential hypertension other postoperative infection chronic systolic heart failure congestive heart failure, unspecified other chronic pain polymyalgia rheumatica esophageal reflux removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) acute kidney failure, unspecified coronary atherosclerosis of native coronary artery hyperpotassemia other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified intestinal obstruction peritoneal adhesions (postoperative) (postinfection) polymyalgia rheumatica calculus of gallbladder with acute cholecystitis, without mention of obstruction unspecified septicemia severe sepsis chronic systolic heart failure percutaneous transluminal coronary angioplasty status removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white m 70 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  400  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  97  mg dl$pantoprazole  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; bisacodyl  10  mg ; lr  1000  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; morphine sulfate  1-2  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  3  ml ; bag  100  ml ; magnesium sulfate  4  gm ; metoprolol tartrate  12.5  mg ; docusate sodium  100  mg ; potassium chloride  20  meq ; neutra-phos  1  pkt ; 
chronic systolic heart failure fistula of intestine, excluding rectum and anus anemia, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation late effects of cerebrovascular disease, other speech and language deficits coronary atherosclerosis of native coronary artery esophageal reflux gastroparesis intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) chronic obstructive asthma, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia old myocardial infarction percutaneous transluminal coronary angioplasty status unspecified essential hypertension atrial fibrillation acute venous embolism and thrombosis of deep vessels of proximal lower extremity acidosis persistent postoperative fistula unspecified peritonitis cervicalgia retention of urine, unspecified chronic obstructive asthma, unspecified old myocardial infarction barrett's esophagus unspecified essential hypertension other postoperative infection chronic systolic heart failure congestive heart failure, unspecified other chronic pain polymyalgia rheumatica esophageal reflux removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) acute kidney failure, unspecified coronary atherosclerosis of native coronary artery hyperpotassemia other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified intestinal obstruction peritoneal adhesions (postoperative) (postinfection) polymyalgia rheumatica calculus of gallbladder with acute cholecystitis, without mention of obstruction unspecified septicemia severe sepsis chronic systolic heart failure percutaneous transluminal coronary angioplasty status removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white m 70 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  448  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry urine chloride, urine  36  meq l; chemistry urine creatinine, urine  17  mg dl; chemistry urine potassium, urine  6  meq l; chemistry urine sodium, urine  47  meq l; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  104  mg dl$pantoprazole  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; bisacodyl  10  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; morphine sulfate  1-2  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  12.5  mg ; docusate sodium  100  mg ; neutra-phos  1  pkt ; calcitriol  0.25  mcg ; warfarin  6  mg ; sucralfate  1  gm ; aspirin  81  mg ; pravastatin  40  mg ; 
chronic systolic heart failure fistula of intestine, excluding rectum and anus anemia, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation late effects of cerebrovascular disease, other speech and language deficits coronary atherosclerosis of native coronary artery esophageal reflux gastroparesis intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) chronic obstructive asthma, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia old myocardial infarction percutaneous transluminal coronary angioplasty status unspecified essential hypertension atrial fibrillation acute venous embolism and thrombosis of deep vessels of proximal lower extremity acidosis persistent postoperative fistula unspecified peritonitis cervicalgia retention of urine, unspecified chronic obstructive asthma, unspecified old myocardial infarction barrett's esophagus unspecified essential hypertension other postoperative infection chronic systolic heart failure congestive heart failure, unspecified other chronic pain polymyalgia rheumatica esophageal reflux removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) acute kidney failure, unspecified coronary atherosclerosis of native coronary artery hyperpotassemia other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified intestinal obstruction peritoneal adhesions (postoperative) (postinfection) polymyalgia rheumatica calculus of gallbladder with acute cholecystitis, without mention of obstruction unspecified septicemia severe sepsis chronic systolic heart failure percutaneous transluminal coronary angioplasty status removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white m 70 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood glucose  102  mg dl$pantoprazole  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; bisacodyl  10  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; morphine sulfate  1-2  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  12.5  mg ; docusate sodium  100  mg ; calcitriol  0.25  mcg ; warfarin  6  mg ; sucralfate  1  gm ; aspirin  81  mg ; pravastatin  40  mg ; morphine sulfate  1  mg ; 
chronic systolic heart failure fistula of intestine, excluding rectum and anus anemia, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation late effects of cerebrovascular disease, other speech and language deficits coronary atherosclerosis of native coronary artery esophageal reflux gastroparesis intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) chronic obstructive asthma, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia old myocardial infarction percutaneous transluminal coronary angioplasty status unspecified essential hypertension atrial fibrillation acute venous embolism and thrombosis of deep vessels of proximal lower extremity acidosis persistent postoperative fistula unspecified peritonitis cervicalgia retention of urine, unspecified chronic obstructive asthma, unspecified old myocardial infarction barrett's esophagus unspecified essential hypertension other postoperative infection chronic systolic heart failure congestive heart failure, unspecified other chronic pain polymyalgia rheumatica esophageal reflux removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) acute kidney failure, unspecified coronary atherosclerosis of native coronary artery hyperpotassemia other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified intestinal obstruction peritoneal adhesions (postoperative) (postinfection) polymyalgia rheumatica calculus of gallbladder with acute cholecystitis, without mention of obstruction unspecified septicemia severe sepsis chronic systolic heart failure percutaneous transluminal coronary angioplasty status removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white m 70 $nan$nan$pantoprazole  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; bisacodyl  10  mg ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; morphine sulfate  1-2  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  12.5  mg ; docusate sodium  100  mg ; calcitriol  0.25  mcg ; warfarin  6  mg ; sucralfate  1  gm ; aspirin  81  mg ; pravastatin  40  mg ; morphine sulfate  1  mg ; 
chronic systolic heart failure fistula of intestine, excluding rectum and anus anemia, unspecified surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation late effects of cerebrovascular disease, other speech and language deficits coronary atherosclerosis of native coronary artery esophageal reflux gastroparesis intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) chronic obstructive asthma, unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia old myocardial infarction percutaneous transluminal coronary angioplasty status unspecified essential hypertension atrial fibrillation acute venous embolism and thrombosis of deep vessels of proximal lower extremity acidosis persistent postoperative fistula unspecified peritonitis cervicalgia retention of urine, unspecified chronic obstructive asthma, unspecified old myocardial infarction barrett's esophagus unspecified essential hypertension other postoperative infection chronic systolic heart failure congestive heart failure, unspecified other chronic pain polymyalgia rheumatica esophageal reflux removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) acute kidney failure, unspecified coronary atherosclerosis of native coronary artery hyperpotassemia other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified intestinal obstruction peritoneal adhesions (postoperative) (postinfection) polymyalgia rheumatica calculus of gallbladder with acute cholecystitis, without mention of obstruction unspecified septicemia severe sepsis chronic systolic heart failure percutaneous transluminal coronary angioplasty status removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white m 57 $temp  98.0  heartrate  69.0  resprate  16.0  o2sat  99.0  sbp  130.0  dbp  50.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  35.5  %; hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  156  k ul; hematology blood platelet count  157  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  5.8  mg dl; chemistry blood creatinine  6.0  mg dl; chemistry blood creatinine  6.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  383  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  123  mg dl$0.9% sodium chloride  2  bag ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; famotidine  20  mg ; carvedilol  37.5  mg ; lorazepam  0.5  mg ; pilocarpine 1%  1  drop ; acetaminophen  325-650  mg ; sodium chloride 0.9%  1000  ml ; insulin  10  unit ; insulin  0  unit ; labetalol  10-20  mg ; hydralazine  10  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; trazodone  25  mg ; docusate sodium  100  mg ; hydralazine  25  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; timolol maleate 0.5%  1  drop ; levetiracetam  500  mg ; losartan potassium  25  mg ; bupropion (sustained release)  150  mg ; ondansetron  4  mg ; d5ns  1000  ml ; latanoprost 0.005% ophth. soln.  1  drop ; senna  8.6  mg ; citalopram  40  mg ; simvastatin  40  mg ; insulin  15  unit ; lidocaine 1%  1  ml ; 
background diabetic retinopathy long-term (current) use of insulin long-term (current) use of aspirin legal blindness, as defined in u.s.a. kidney replaced by transplant nephrotic syndrome in diseases classified elsewhere foot amputation status diabetes with neurological manifestations, type i [juvenile type], uncontrolled removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft depressive disorder, not elsewhere classified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease anemia, unspecified below knee amputation status other and unspecified hyperlipidemia diastolic heart failure, unspecified polyneuropathy in diabetes unspecified glaucoma aortocoronary bypass status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status end stage renal disease peripheral vascular disease, unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled disruption of external operation (surgical) wound diabetes with renal manifestations, type i [juvenile type], uncontrolled congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease coronary atherosclerosis of unspecified type of vessel, native or graft other amputation stump complication anemia, unspecified peripheral autonomic neuropathy in disorders classified elsewhere legal blindness, as defined in u.s.a. amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation renal dialysis status family history of other cardiovascular diseases depressive disorder, not elsewhere classified long-term (current) use of insulin diabetes with other specified manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of tobacco use end stage renal disease below knee amputation status family history of other digestive disorders diabetes with renal manifestations, type i [juvenile type], uncontrolled depressive disorder, not elsewhere classified
white m 57 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  4.3  mg dl; chemistry blood creatinine  4.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  487  mg dl; chemistry blood glucose  274  mg dl$0.9% sodium chloride  2  bag ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; famotidine  20  mg ; carvedilol  37.5  mg ; lorazepam  0.5  mg ; pilocarpine 1%  1  drop ; acetaminophen  325-650  mg ; insulin  10  unit ; labetalol  10-20  mg ; hydralazine  10  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; trazodone  25  mg ; docusate sodium  100  mg ; hydralazine  25  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; timolol maleate 0.5%  1  drop ; levetiracetam  500  mg ; losartan potassium  25  mg ; bupropion (sustained release)  150  mg ; ondansetron  4  mg ; latanoprost 0.005% ophth. soln.  1  drop ; senna  8.6  mg ; citalopram  40  mg ; simvastatin  40  mg ; insulin  15  unit ; lidocaine 1%  1  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; losartan potassium  50  mg ; insulin  16  unit ; 
background diabetic retinopathy long-term (current) use of insulin long-term (current) use of aspirin legal blindness, as defined in u.s.a. kidney replaced by transplant nephrotic syndrome in diseases classified elsewhere foot amputation status diabetes with neurological manifestations, type i [juvenile type], uncontrolled removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft depressive disorder, not elsewhere classified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease anemia, unspecified below knee amputation status other and unspecified hyperlipidemia diastolic heart failure, unspecified polyneuropathy in diabetes unspecified glaucoma aortocoronary bypass status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status end stage renal disease peripheral vascular disease, unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled disruption of external operation (surgical) wound diabetes with renal manifestations, type i [juvenile type], uncontrolled congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease coronary atherosclerosis of unspecified type of vessel, native or graft other amputation stump complication anemia, unspecified peripheral autonomic neuropathy in disorders classified elsewhere legal blindness, as defined in u.s.a. amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation renal dialysis status family history of other cardiovascular diseases depressive disorder, not elsewhere classified long-term (current) use of insulin diabetes with other specified manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of tobacco use end stage renal disease below knee amputation status family history of other digestive disorders diabetes with renal manifestations, type i [juvenile type], uncontrolled depressive disorder, not elsewhere classified
white m 57 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  127  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; carvedilol  37.5  mg ; pilocarpine 1%  1  drop ; acetaminophen  325-650  mg ; trazodone  25  mg ; docusate sodium  100  mg ; hydralazine  25  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; timolol maleate 0.5%  1  drop ; levetiracetam  500  mg ; bupropion (sustained release)  150  mg ; latanoprost 0.005% ophth. soln.  1  drop ; senna  8.6  mg ; citalopram  40  mg ; simvastatin  40  mg ; lidocaine 1%  1  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; losartan potassium  50  mg ; insulin  16  unit ; zolpidem tartrate  5  mg ; 
background diabetic retinopathy long-term (current) use of insulin long-term (current) use of aspirin legal blindness, as defined in u.s.a. kidney replaced by transplant nephrotic syndrome in diseases classified elsewhere foot amputation status diabetes with neurological manifestations, type i [juvenile type], uncontrolled removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft depressive disorder, not elsewhere classified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease anemia, unspecified below knee amputation status other and unspecified hyperlipidemia diastolic heart failure, unspecified polyneuropathy in diabetes unspecified glaucoma aortocoronary bypass status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status end stage renal disease peripheral vascular disease, unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled disruption of external operation (surgical) wound diabetes with renal manifestations, type i [juvenile type], uncontrolled congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease coronary atherosclerosis of unspecified type of vessel, native or graft other amputation stump complication anemia, unspecified peripheral autonomic neuropathy in disorders classified elsewhere legal blindness, as defined in u.s.a. amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation renal dialysis status family history of other cardiovascular diseases depressive disorder, not elsewhere classified long-term (current) use of insulin diabetes with other specified manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of tobacco use end stage renal disease below knee amputation status family history of other digestive disorders diabetes with renal manifestations, type i [juvenile type], uncontrolled depressive disorder, not elsewhere classified
white m 57 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; carvedilol  37.5  mg ; pilocarpine 1%  1  drop ; acetaminophen  325-650  mg ; trazodone  25  mg ; docusate sodium  100  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; timolol maleate 0.5%  1  drop ; levetiracetam  500  mg ; bupropion (sustained release)  150  mg ; latanoprost 0.005% ophth. soln.  1  drop ; senna  8.6  mg ; citalopram  40  mg ; simvastatin  40  mg ; lidocaine 1%  1  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; losartan potassium  50  mg ; insulin  16  unit ; zolpidem tartrate  5  mg ; terazosin  5  mg ; 
background diabetic retinopathy long-term (current) use of insulin long-term (current) use of aspirin legal blindness, as defined in u.s.a. kidney replaced by transplant nephrotic syndrome in diseases classified elsewhere foot amputation status diabetes with neurological manifestations, type i [juvenile type], uncontrolled removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft depressive disorder, not elsewhere classified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease anemia, unspecified below knee amputation status other and unspecified hyperlipidemia diastolic heart failure, unspecified polyneuropathy in diabetes unspecified glaucoma aortocoronary bypass status car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident renal dialysis status end stage renal disease peripheral vascular disease, unspecified diabetes with other specified manifestations, type i [juvenile type], uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled disruption of external operation (surgical) wound diabetes with renal manifestations, type i [juvenile type], uncontrolled congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease coronary atherosclerosis of unspecified type of vessel, native or graft other amputation stump complication anemia, unspecified peripheral autonomic neuropathy in disorders classified elsewhere legal blindness, as defined in u.s.a. amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation renal dialysis status family history of other cardiovascular diseases depressive disorder, not elsewhere classified long-term (current) use of insulin diabetes with other specified manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled personal history of tobacco use end stage renal disease below knee amputation status family history of other digestive disorders diabetes with renal manifestations, type i [juvenile type], uncontrolled depressive disorder, not elsewhere classified
white f 89 $temp  100.3  heartrate  108.0  resprate  20.0  o2sat  96.0  sbp  140.0  dbp  82.0  rhythm    pain  0  ; temp  100.4  heartrate  117.0  resprate  24.0  o2sat  95.0  sbp    dbp    rhythm    pain    $nan$memantine  15  mg ; 
atrial fibrillation chest pain, unspecified unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling subdural hemorrhage following injury without mention of open intracranial wound, unspecified state of consciousness abrasion or friction burn of face, neck, and scalp except eye, without mention of infection
white f 89 $temp  98.4  heartrate  118.0  resprate  24.0  o2sat  95.0  sbp  160.0  dbp  111.0  rhythm    pain  0  ; temp  102.2  heartrate  118.0  resprate  20.0  o2sat  94.0  sbp  149.0  dbp  89.0  rhythm    pain  0  ; temp    heartrate  103.0  resprate  18.0  o2sat  94.0  sbp  135.0  dbp  73.0  rhythm    pain    ; temp  98.1  heartrate  96.0  resprate  18.0  o2sat  96.0  sbp  106.0  dbp  63.0  rhythm    pain  0  $hematology blood hematocrit  40.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  84  mg dl$memantine  15  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; bisacodyl  10  mg ; levofloxacin  750  mg ; omeprazole  20  mg ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; acetaminophen  650  mg ; furosemide  40  mg ; atorvastatin  10  mg ; donepezil  2.5  mg ; levothyroxine sodium  25  mcg ; metoprolol tartrate  50  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; rivaroxaban  15  mg ; furosemide  20  mg ; olanzapine  2.5  mg ; potassium chloride  40  meq ; 
atrial fibrillation chest pain, unspecified unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling subdural hemorrhage following injury without mention of open intracranial wound, unspecified state of consciousness abrasion or friction burn of face, neck, and scalp except eye, without mention of infection
white f 89 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  149  mg dl$memantine  15  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; bisacodyl  10  mg ; levofloxacin  750  mg ; omeprazole  20  mg ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; acetaminophen  650  mg ; furosemide  40  mg ; atorvastatin  10  mg ; donepezil  2.5  mg ; levothyroxine sodium  25  mcg ; rivaroxaban  15  mg ; furosemide  20  mg ; olanzapine  2.5  mg ; olanzapine  5  mg ; 
atrial fibrillation chest pain, unspecified unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling subdural hemorrhage following injury without mention of open intracranial wound, unspecified state of consciousness abrasion or friction burn of face, neck, and scalp except eye, without mention of infection
white f 89 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  117  mg dl$memantine  15  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; bisacodyl  10  mg ; levofloxacin  750  mg ; omeprazole  20  mg ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; acetaminophen  650  mg ; atorvastatin  10  mg ; donepezil  2.5  mg ; levothyroxine sodium  25  mcg ; rivaroxaban  15  mg ; 
atrial fibrillation chest pain, unspecified unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling subdural hemorrhage following injury without mention of open intracranial wound, unspecified state of consciousness abrasion or friction burn of face, neck, and scalp except eye, without mention of infection
white f 89 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  143  mg dl; blood gas blood lactate  1.4  mmol l$memantine  15  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; bisacodyl  10  mg ; levofloxacin  750  mg ; omeprazole  20  mg ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; acetaminophen  650  mg ; atorvastatin  10  mg ; donepezil  2.5  mg ; levothyroxine sodium  25  mcg ; rivaroxaban  15  mg ; memantine  10  mg ; losartan potassium  50  mg ; 
atrial fibrillation chest pain, unspecified unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling subdural hemorrhage following injury without mention of open intracranial wound, unspecified state of consciousness abrasion or friction burn of face, neck, and scalp except eye, without mention of infection
white f 89 $nan$nan$memantine  15  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; bisacodyl  10  mg ; levofloxacin  750  mg ; omeprazole  20  mg ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; acetaminophen  650  mg ; atorvastatin  10  mg ; donepezil  2.5  mg ; levothyroxine sodium  25  mcg ; rivaroxaban  15  mg ; memantine  10  mg ; losartan potassium  50  mg ; 
atrial fibrillation chest pain, unspecified unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling subdural hemorrhage following injury without mention of open intracranial wound, unspecified state of consciousness abrasion or friction burn of face, neck, and scalp except eye, without mention of infection
white f 89 $nan$nan$memantine  15  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; senna  8.6  mg ; bisacodyl  10  mg ; levofloxacin  750  mg ; omeprazole  20  mg ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; acetaminophen  650  mg ; atorvastatin  10  mg ; donepezil  2.5  mg ; levothyroxine sodium  25  mcg ; rivaroxaban  15  mg ; memantine  10  mg ; 
atrial fibrillation chest pain, unspecified unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling subdural hemorrhage following injury without mention of open intracranial wound, unspecified state of consciousness abrasion or friction burn of face, neck, and scalp except eye, without mention of infection
white f 62 $nan$nan$insulin  34  unit ; atorvastatin  5  mg ; fluocinonide 0.05% cream  1  appl ; levothyroxine sodium  88  mcg ; valsartan  160  mg ; clobetasol propionate 0.05% gel  1  appl ; 
 
white f 62 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  183  mg dl$insulin  34  unit ; atorvastatin  5  mg ; fluocinonide 0.05% cream  1  appl ; levothyroxine sodium  88  mcg ; valsartan  160  mg ; clobetasol propionate 0.05% gel  1  appl ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; insulin  46  unit ; heparin  5000  unit ; docusate sodium  100  mg ; omeprazole  20  mg ; 
 
white f 62 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  116  mg dl$atorvastatin  5  mg ; fluocinonide 0.05% cream  1  appl ; levothyroxine sodium  88  mcg ; valsartan  160  mg ; clobetasol propionate 0.05% gel  1  appl ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; docusate sodium  100  mg ; omeprazole  20  mg ; sw  50  ml ; magnesium sulfate  2  gm ; ibuprofen  400-600  mg ; 
 
white f 62 $nan$nan$atorvastatin  5  mg ; fluocinonide 0.05% cream  1  appl ; levothyroxine sodium  88  mcg ; valsartan  160  mg ; clobetasol propionate 0.05% gel  1  appl ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; docusate sodium  100  mg ; omeprazole  20  mg ; sw  50  ml ; magnesium sulfate  2  gm ; ibuprofen  400-600  mg ; cephalexin  500  mg ; 
 
white f 51 $nan$hematology blood hematocrit  36.4  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  213  mg dl; chemistry blood % hemoglobin a1c  10.9  %$sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen  1-2  tab ; morphine sulfate  2  mg ; insulin  0  unit ; heparin  5000  unit ; morphine sulfate ir  60  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; folic acid  1  mg ; hydroxychloroquine sulfate  200  mg ; morphine sulfate ir  15  mg ; morphine sulfate ir  30  mg ; acetaminophen  1000  mg ; glyburide  5  mg ; 
 
white f 51 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology urine wbc  4  # hpf; chemistry blood glucose  109  mg dl; hematology urine glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; heparin  5000  unit ; morphine sulfate ir  60  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; folic acid  1  mg ; hydroxychloroquine sulfate  200  mg ; morphine sulfate ir  15  mg ; morphine sulfate ir  30  mg ; acetaminophen  1000  mg ; glyburide  5  mg ; amitriptyline  100  mg ; pregabalin  150  mg ; lisinopril  5  mg ; potassium chloride  40  meq ; metformin (glucophage)  500  mg ; 
 
white m 49 $temp  99.2  heartrate  76.0  resprate  18.0  o2sat  95.0  sbp  117.0  dbp  75.0  rhythm    pain    $hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  175  mg dl$insulin  9  unit ; ciprofloxacin hcl  500  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  40  mg ; citalopram  40  mg ; heparin  5000  unit ; emtricitabine-tenofovir (truvada)  1  tab ; insulin  0  unit ; lactated ringers  1000  ml ; metronidazole  500  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; 
type 1 diabetes mellitus with diabetic polyneuropathy hyperlipidemia, unspecified major depressive disorder, single episode, unspecified long term (current) use of insulin personal history of nicotine dependence streptococcus, group b, as the cause of diseases classified elsewhere non-pressure chronic ulcer of other part of right foot with unspecified severity type 1 diabetes mellitus with foot ulcer local infection of the skin and subcutaneous tissue, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause personal history of nicotine dependence presence of insulin pump (external) (internal) hyperlipidemia, unspecified patient's unintentional underdosing of medication regimen for other reason long term (current) use of insulin underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter fall on stairs or ladders in water transport injuring unspecified person major depressive disorder, single episode, unspecified other disorders of phosphorus metabolism type 1 diabetes mellitus with diabetic neuropathy, unspecified type 1 diabetes mellitus with ketoacidosis without coma acute kidney failure, unspecified elevated white blood cell count, unspecified iron deficiency anemia secondary to blood loss (chronic) other acute postprocedural pain type 1 diabetes mellitus with diabetic neuropathy, unspecified hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence acute appendicitis with generalized peritonitis long term (current) use of insulin type 1 diabetes mellitus with hypoglycemia without coma major depressive disorder, single episode, unspecified personal history of nicotine dependence acute appendicitis with localized peritonitis type 1 diabetes mellitus without complications long term (current) use of insulin hyperlipidemia, unspecified methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified long term (current) use of insulin personal history of nicotine dependence other specified bacterial agents as the cause of diseases classified elsewhere non-pressure chronic ulcer of other part of left foot with unspecified severity other acute osteomyelitis, right ankle and foot non-pressure chronic ulcer of other part of right foot with unspecified severity streptococcus, group b, as the cause of diseases classified elsewhere 
white m 49 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  97  mg dl$insulin  9  unit ; ciprofloxacin hcl  500  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  40  mg ; citalopram  40  mg ; heparin  5000  unit ; emtricitabine-tenofovir (truvada)  1  tab ; insulin  0  unit ; lactated ringers  1000  ml ; metronidazole  500  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; 
type 1 diabetes mellitus with diabetic polyneuropathy hyperlipidemia, unspecified major depressive disorder, single episode, unspecified long term (current) use of insulin personal history of nicotine dependence streptococcus, group b, as the cause of diseases classified elsewhere non-pressure chronic ulcer of other part of right foot with unspecified severity type 1 diabetes mellitus with foot ulcer local infection of the skin and subcutaneous tissue, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause personal history of nicotine dependence presence of insulin pump (external) (internal) hyperlipidemia, unspecified patient's unintentional underdosing of medication regimen for other reason long term (current) use of insulin underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter fall on stairs or ladders in water transport injuring unspecified person major depressive disorder, single episode, unspecified other disorders of phosphorus metabolism type 1 diabetes mellitus with diabetic neuropathy, unspecified type 1 diabetes mellitus with ketoacidosis without coma acute kidney failure, unspecified elevated white blood cell count, unspecified iron deficiency anemia secondary to blood loss (chronic) other acute postprocedural pain type 1 diabetes mellitus with diabetic neuropathy, unspecified hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence acute appendicitis with generalized peritonitis long term (current) use of insulin type 1 diabetes mellitus with hypoglycemia without coma major depressive disorder, single episode, unspecified personal history of nicotine dependence acute appendicitis with localized peritonitis type 1 diabetes mellitus without complications long term (current) use of insulin hyperlipidemia, unspecified methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified long term (current) use of insulin personal history of nicotine dependence other specified bacterial agents as the cause of diseases classified elsewhere non-pressure chronic ulcer of other part of left foot with unspecified severity other acute osteomyelitis, right ankle and foot non-pressure chronic ulcer of other part of right foot with unspecified severity streptococcus, group b, as the cause of diseases classified elsewhere 
black african american f 46 $temp  97.9  heartrate  90.0  resprate  18.0  o2sat  100.0  sbp  117.0  dbp  84.0  rhythm    pain    $hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  149  iu l; chemistry blood albumin  2.5  g dl; blood gas blood lactate  1.3  mmol l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325  mg ; tacrolimus  2  mg ; ondansetron  4  mg ; heparin  5000  unit ; mycophenolate mofetil  500  mg ; prednisone  10  mg ; citalopram  10  mg ; oxycodone (immediate release)   5  mg ; 
 
black african american f 46 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry urine chloride, urine  99  meq l; chemistry urine creatinine, urine  64  mg dl; chemistry urine potassium, urine  27  meq l; chemistry urine sodium, urine  107  meq l; chemistry urine urea nitrogen, urine  310  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  108  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; ondansetron  4  mg ; heparin  5000  unit ; mycophenolate mofetil  500  mg ; prednisone  10  mg ; citalopram  10  mg ; oxycodone (immediate release)   5  mg ; bag  50  ml ; magnesium sulfate  4  gm ; diazepam  5  mg ; 
 
black african american f 46 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  91  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; ondansetron  4  mg ; heparin  5000  unit ; mycophenolate mofetil  500  mg ; prednisone  10  mg ; citalopram  10  mg ; bag  50  ml ; magnesium sulfate  4  gm ; diazepam  5  mg ; 
 
black african american f 46 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; ondansetron  4  mg ; heparin  5000  unit ; mycophenolate mofetil  500  mg ; prednisone  10  mg ; citalopram  10  mg ; 
 
black african american f 92 $temp    heartrate  64.0  resprate  18.0  o2sat  99.0  sbp  135.0  dbp  68.0  rhythm    pain  2  $hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  232  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  1000  mg ; polyethylene glycol  17  g ; tramadol (ultram)  50  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.25  mg ; oxycodone (immediate release)   2.5  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; timolol maleate 0.5%  1  drop ; metoprolol tartrate  75  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; vitamin d  800  unit ; aspirin  81  mg ; irbesartan  300  mg ; cyanocobalamin  1000  mcg ; amlodipine  5  mg ; omeprazole  20  mg ; metoprolol succinate xl  50  mg ; multivitamins  1  tab ; fentanyl patch  25  mcg h ; phenazopyridine  100  mg ; ondansetron  4  mg ; morphine sulfate  1  mg ; senna  2  tab ; latanoprost 0.005% ophth. soln.  1  drop ; artificial tears  1-2  drop ; 
urinary tract infection, site not specified personal history of malignant neoplasm of bronchus and lung dementia, unspecified, without behavioral disturbance altered mental status shortness of breath unspecified glaucoma depressive disorder, not elsewhere classified solitary pulmonary nodule coronary atherosclerosis of native coronary artery glaucoma stage, unspecified do not resuscitate status esophageal reflux chronic airway obstruction, not elsewhere classified polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, uncontrolled streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] pulmonary collapse other chronic pulmonary heart diseases diarrhea atrial flutter chronic airway obstruction, not elsewhere classified toxic encephalopathy personal history of malignant neoplasm of bronchus and lung bacterial pneumonia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled dementia, unspecified, without behavioral disturbance hypovolemia acute cystitis pneumonitis due to inhalation of food or vomitus personal history of tobacco use other and unspecified hyperlipidemia benign essential hypertension do not resuscitate status foreign body in larynx irritable bowel syndrome spinal stenosis, unspecified region abdominal pain, other specified site malignant neoplasm of upper lobe, bronchus or lung acute respiratory failure acidosis constipation, unspecified esophageal reflux inhalation and ingestion of other object causing obstruction of respiratory tract or suffocation 
black african american f 92 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  1000  mg ; polyethylene glycol  17  g ; tramadol (ultram)  50  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.25  mg ; oxycodone (immediate release)   2.5  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; timolol maleate 0.5%  1  drop ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; vitamin d  800  unit ; aspirin  81  mg ; irbesartan  300  mg ; cyanocobalamin  1000  mcg ; amlodipine  5  mg ; omeprazole  20  mg ; metoprolol succinate xl  50  mg ; multivitamins  1  tab ; fentanyl patch  25  mcg h ; phenazopyridine  100  mg ; ondansetron  4  mg ; morphine sulfate  1  mg ; senna  2  tab ; latanoprost 0.005% ophth. soln.  1  drop ; artificial tears  1-2  drop ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  500  ml ; bisacodyl  10  mg ; 
urinary tract infection, site not specified personal history of malignant neoplasm of bronchus and lung dementia, unspecified, without behavioral disturbance altered mental status shortness of breath unspecified glaucoma depressive disorder, not elsewhere classified solitary pulmonary nodule coronary atherosclerosis of native coronary artery glaucoma stage, unspecified do not resuscitate status esophageal reflux chronic airway obstruction, not elsewhere classified polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, uncontrolled streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] pulmonary collapse other chronic pulmonary heart diseases diarrhea atrial flutter chronic airway obstruction, not elsewhere classified toxic encephalopathy personal history of malignant neoplasm of bronchus and lung bacterial pneumonia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled dementia, unspecified, without behavioral disturbance hypovolemia acute cystitis pneumonitis due to inhalation of food or vomitus personal history of tobacco use other and unspecified hyperlipidemia benign essential hypertension do not resuscitate status foreign body in larynx irritable bowel syndrome spinal stenosis, unspecified region abdominal pain, other specified site malignant neoplasm of upper lobe, bronchus or lung acute respiratory failure acidosis constipation, unspecified esophageal reflux inhalation and ingestion of other object causing obstruction of respiratory tract or suffocation 
black african american f 92 $nan$hematology blood hematocrit  32.7  %; hematology blood hematocrit  34.8  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  1000  mg ; polyethylene glycol  17  g ; tramadol (ultram)  50  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.25  mg ; oxycodone (immediate release)   2.5  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; timolol maleate 0.5%  1  drop ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; vitamin d  800  unit ; aspirin  81  mg ; irbesartan  300  mg ; cyanocobalamin  1000  mcg ; amlodipine  5  mg ; omeprazole  20  mg ; metoprolol succinate xl  50  mg ; multivitamins  1  tab ; fentanyl patch  25  mcg h ; phenazopyridine  100  mg ; senna  2  tab ; latanoprost 0.005% ophth. soln.  1  drop ; artificial tears  1-2  drop ; 0.9% sodium chloride  500  ml ; bisacodyl  10  mg ; bag  50  ml ; magnesium sulfate  2  gm ; lactulose  30  ml ; 
urinary tract infection, site not specified personal history of malignant neoplasm of bronchus and lung dementia, unspecified, without behavioral disturbance altered mental status shortness of breath unspecified glaucoma depressive disorder, not elsewhere classified solitary pulmonary nodule coronary atherosclerosis of native coronary artery glaucoma stage, unspecified do not resuscitate status esophageal reflux chronic airway obstruction, not elsewhere classified polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, uncontrolled streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] pulmonary collapse other chronic pulmonary heart diseases diarrhea atrial flutter chronic airway obstruction, not elsewhere classified toxic encephalopathy personal history of malignant neoplasm of bronchus and lung bacterial pneumonia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled dementia, unspecified, without behavioral disturbance hypovolemia acute cystitis pneumonitis due to inhalation of food or vomitus personal history of tobacco use other and unspecified hyperlipidemia benign essential hypertension do not resuscitate status foreign body in larynx irritable bowel syndrome spinal stenosis, unspecified region abdominal pain, other specified site malignant neoplasm of upper lobe, bronchus or lung acute respiratory failure acidosis constipation, unspecified esophageal reflux inhalation and ingestion of other object causing obstruction of respiratory tract or suffocation 
black african american f 92 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.25  mg ; oxycodone (immediate release)   2.5  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; timolol maleate 0.5%  1  drop ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; vitamin d  800  unit ; aspirin  81  mg ; irbesartan  300  mg ; cyanocobalamin  1000  mcg ; amlodipine  5  mg ; omeprazole  20  mg ; metoprolol succinate xl  50  mg ; multivitamins  1  tab ; fentanyl patch  25  mcg h ; phenazopyridine  100  mg ; senna  2  tab ; latanoprost 0.005% ophth. soln.  1  drop ; artificial tears  1-2  drop ; bisacodyl  10  mg ; bag  50  ml ; magnesium sulfate  2  gm ; lactulose  30  ml ; lactulose enema  1000  ml ; 
urinary tract infection, site not specified personal history of malignant neoplasm of bronchus and lung dementia, unspecified, without behavioral disturbance altered mental status shortness of breath unspecified glaucoma depressive disorder, not elsewhere classified solitary pulmonary nodule coronary atherosclerosis of native coronary artery glaucoma stage, unspecified do not resuscitate status esophageal reflux chronic airway obstruction, not elsewhere classified polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, uncontrolled streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] pulmonary collapse other chronic pulmonary heart diseases diarrhea atrial flutter chronic airway obstruction, not elsewhere classified toxic encephalopathy personal history of malignant neoplasm of bronchus and lung bacterial pneumonia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled dementia, unspecified, without behavioral disturbance hypovolemia acute cystitis pneumonitis due to inhalation of food or vomitus personal history of tobacco use other and unspecified hyperlipidemia benign essential hypertension do not resuscitate status foreign body in larynx irritable bowel syndrome spinal stenosis, unspecified region abdominal pain, other specified site malignant neoplasm of upper lobe, bronchus or lung acute respiratory failure acidosis constipation, unspecified esophageal reflux inhalation and ingestion of other object causing obstruction of respiratory tract or suffocation 
black african american f 74 $temp  98.0  heartrate  73.0  resprate  17.0  o2sat  100.0  sbp  193.0  dbp  70.0  rhythm    pain  0  $hematology blood hematocrit  34.3  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  86  mg dl; chemistry blood albumin  4.2  g dl; chemistry blood % hemoglobin a1c  5.5  %$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; brimonidine tartrate 0.15% ophth.  1  drop ; isosorbide mononitrate (extended release)  60  mg ; latanoprost 0.005% ophth. soln.  1  drop ; ranitidine  300  mg ; timolol maleate 0.5%  1  drop ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bag  1  bag ; magnesium sulfate  2  gm ; sodium chloride 0.9%  1000  ml ; metoprolol tartrate  50  mg ; metoprolol tartrate  12.5  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
black african american f 74 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  92  mg dl; hematology urine glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; brimonidine tartrate 0.15% ophth.  1  drop ; latanoprost 0.005% ophth. soln.  1  drop ; ranitidine  300  mg ; timolol maleate 0.5%  1  drop ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; metoprolol tartrate  12.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atorvastatin  40  mg ; mirtazapine  15  mg ; insulin  6  unit ; insulin  4  unit ; novolog  6  units ; novolog  10  units ; metoprolol tartrate  25  mg ; metformin (glucophage)  1000  mg ; 
 
black african american f 74 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  147  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; brimonidine tartrate 0.15% ophth.  1  drop ; latanoprost 0.005% ophth. soln.  1  drop ; ranitidine  300  mg ; timolol maleate 0.5%  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  40  mg ; metformin (glucophage)  1000  mg ; metoprolol succinate xl  100  mg ; 
 
black african american f 74 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  142  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; brimonidine tartrate 0.15% ophth.  1  drop ; latanoprost 0.005% ophth. soln.  1  drop ; ranitidine  300  mg ; timolol maleate 0.5%  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  40  mg ; metformin (glucophage)  1000  mg ; metoprolol succinate xl  100  mg ; 
 
black african american f 74 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; brimonidine tartrate 0.15% ophth.  1  drop ; latanoprost 0.005% ophth. soln.  1  drop ; ranitidine  300  mg ; timolol maleate 0.5%  1  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  40  mg ; metformin (glucophage)  1000  mg ; metoprolol succinate xl  100  mg ; 
 
white m 23 $temp  100.5  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $hematology blood hematocrit  46.1  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  4.9  g dl; blood gas blood lactate  1.4  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
white m 23 $temp  98.5  heartrate  76.0  resprate  18.0  o2sat  98.0  sbp  115.0  dbp  64.0  rhythm    pain  5  $nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; 
 
white f 42 $temp  98.9  heartrate  95.0  resprate  18.0  o2sat  98.0  sbp  141.0  dbp  91.0  rhythm    pain  10  ; temp  98.1  heartrate  80.0  resprate  16.0  o2sat  98.0  sbp  135.0  dbp  74.0  rhythm    pain  10  $hematology blood inr(pt)  1.2  $nan
other viral diseases in the mother, delivered, with or without mention of antepartum condition long-term (current) use of steroids long-term (current) use of other medications cervicalgia motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other disorders of iron metabolism first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other complications of puerperium, delivered, with mention of postpartum complication rheumatoid arthritis idiopathic pulmonary hemosiderosis genital herpes, unspecified elderly multigravida, delivered with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition rheumatoid arthritis first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other and unspecified cord entanglement, without mention of compression, complicating labor and delivery, delivered, with or without mention of antepartum condition bone and joint disorders of back, pelvis, and lower limbs of mother, antepartum condition or complication calculus of kidney long-term (current) use of steroids rheumatoid arthritis other current conditions classifiable elsewhere of mother, antepartum condition or complication 
white f 42 $temp  98.5  heartrate  86.0  resprate  17.0  o2sat  100.0  sbp  140.0  dbp  83.0  rhythm    pain  6  $hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  363  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  84  mg dl$acetaminophen-caff-butalbital  1-2  tab ; cyclobenzaprine  10  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; prednisone  5  mg ; sulfasalazine_  500  mg ; diazepam  5  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; oxycodone (immediate release)  5  mg ; ketorolac  15  mg ; sodium chloride 0.9%  1000  ml ; prochlorperazine  10  mg ; fluticasone propionate nasal  2  spry ; 
other viral diseases in the mother, delivered, with or without mention of antepartum condition long-term (current) use of steroids long-term (current) use of other medications cervicalgia motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other disorders of iron metabolism first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other complications of puerperium, delivered, with mention of postpartum complication rheumatoid arthritis idiopathic pulmonary hemosiderosis genital herpes, unspecified elderly multigravida, delivered with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition rheumatoid arthritis first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other and unspecified cord entanglement, without mention of compression, complicating labor and delivery, delivered, with or without mention of antepartum condition bone and joint disorders of back, pelvis, and lower limbs of mother, antepartum condition or complication calculus of kidney long-term (current) use of steroids rheumatoid arthritis other current conditions classifiable elsewhere of mother, antepartum condition or complication 
white f 42 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  353  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; prednisone  5  mg ; sulfasalazine_  500  mg ; acetaminophen  1000  mg ; ketorolac  15  mg ; sodium chloride 0.9%  1000  ml ; prochlorperazine  10  mg ; fluticasone propionate nasal  2  spry ; acetaminophen  650  mg ; 
other viral diseases in the mother, delivered, with or without mention of antepartum condition long-term (current) use of steroids long-term (current) use of other medications cervicalgia motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other disorders of iron metabolism first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other complications of puerperium, delivered, with mention of postpartum complication rheumatoid arthritis idiopathic pulmonary hemosiderosis genital herpes, unspecified elderly multigravida, delivered with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition rheumatoid arthritis first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other and unspecified cord entanglement, without mention of compression, complicating labor and delivery, delivered, with or without mention of antepartum condition bone and joint disorders of back, pelvis, and lower limbs of mother, antepartum condition or complication calculus of kidney long-term (current) use of steroids rheumatoid arthritis other current conditions classifiable elsewhere of mother, antepartum condition or complication 
white f 42 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  345  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  70  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; prednisone  5  mg ; sulfasalazine_  500  mg ; prochlorperazine  10  mg ; fluticasone propionate nasal  2  spry ; ramelteon  8  mg ; 
other viral diseases in the mother, delivered, with or without mention of antepartum condition long-term (current) use of steroids long-term (current) use of other medications cervicalgia motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other disorders of iron metabolism first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other complications of puerperium, delivered, with mention of postpartum complication rheumatoid arthritis idiopathic pulmonary hemosiderosis genital herpes, unspecified elderly multigravida, delivered with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition rheumatoid arthritis first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other and unspecified cord entanglement, without mention of compression, complicating labor and delivery, delivered, with or without mention of antepartum condition bone and joint disorders of back, pelvis, and lower limbs of mother, antepartum condition or complication calculus of kidney long-term (current) use of steroids rheumatoid arthritis other current conditions classifiable elsewhere of mother, antepartum condition or complication 
white f 42 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; prednisone  5  mg ; sulfasalazine_  500  mg ; prochlorperazine  10  mg ; fluticasone propionate nasal  2  spry ; ramelteon  8  mg ; 
other viral diseases in the mother, delivered, with or without mention of antepartum condition long-term (current) use of steroids long-term (current) use of other medications cervicalgia motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other disorders of iron metabolism first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other complications of puerperium, delivered, with mention of postpartum complication rheumatoid arthritis idiopathic pulmonary hemosiderosis genital herpes, unspecified elderly multigravida, delivered with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition rheumatoid arthritis first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other and unspecified cord entanglement, without mention of compression, complicating labor and delivery, delivered, with or without mention of antepartum condition bone and joint disorders of back, pelvis, and lower limbs of mother, antepartum condition or complication calculus of kidney long-term (current) use of steroids rheumatoid arthritis other current conditions classifiable elsewhere of mother, antepartum condition or complication 
black african american f 74 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  105  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; fentanyl patch  12  mcg h ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lacosamide  100  mg ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; levetiracetam oral solution  1000  mg ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  145  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; fentanyl patch  12  mcg h ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; levetiracetam oral solution  1000  mg ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; lacosamide  150  mg ; d5 1 2ns  1000  ml ; valproic acid  1250  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  1125  mg ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  140  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; fentanyl patch  12  mcg h ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  50  ml ; valproate sodium  1125  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; valproate sodium  125  mg ; lorazepam  1  mg ; 0.9% sodium chloride  150  ml ; valproate sodium  1500  mg ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  134  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; fentanyl patch  12  mcg h ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; 0.9% sodium chloride  150  ml ; valproate sodium  1500  mg ; valproate sodium  250  mg ; valproate sodium  500  mg ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  129  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; d5 1 2ns  1000  ml ; valproate sodium  500  mg ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  193  mg dl; chemistry blood albumin  3.2  g dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; d5 1 2ns  1000  ml ; valproate sodium  500  mg ; 5% dextrose  50  ml ; ceftazidime  500  mg ; vial  1  vial ; ceftazidime  1  g ; valproic acid  750  mg ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  119  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; d5 1 2ns  1000  ml ; vial  1  vial ; ceftazidime  1  g ; divalproex sod. sprinkles  750  mg ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  96  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; d5 1 2ns  1000  ml ; vial  1  vial ; ceftazidime  1  g ; divalproex sod. sprinkles  750  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; oxycodone liquid  5  mg ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  116  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; d5 1 2ns  1000  ml ; vial  1  vial ; ceftazidime  1  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; ondansetron  4  mg ; oxycodone liquid  5  mg ; valproate sodium  750  mg ; divalproex (delayed release)  750  mg ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  115  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; d5 1 2ns  1000  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; ondansetron  4  mg ; oxycodone liquid  5  mg ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  2  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  107  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; d5 1 2ns  1000  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; ondansetron  4  mg ; oxycodone liquid  5  mg ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  2  mg dl; chemistry blood glucose  117  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; d5 1 2ns  1000  ml ; ondansetron  4  mg ; oxycodone liquid  5  mg ; lidocaine 5% patch  1  ptch ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american f 74 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  30  ml ; latanoprost 0.005% ophth. soln.  1  drop ; mirtazapine  7.5  mg ; multivitamins w minerals  1  tab ; omeprazole  20  mg ; sertraline  50  mg ; insulin  0  unit ; bisacodyl  10  mg ; acetaminophen (liquid)  650  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; ondansetron  4  mg ; oxycodone liquid  5  mg ; lidocaine 5% patch  1  ptch ; 
headache malignant neoplasm of brain, unspecified weakness adverse effect of glucocorticoids and synthetic analogues, initial encounter drug-induced myopathy unspecified glaucoma radiculopathy, lumbar region unspecified place or not applicable type 2 diabetes mellitus with diabetic neuropathy, unspecified syncope and collapse unsteadiness on feet personal history of irradiation unspecified protein-calorie malnutrition personal history of antineoplastic chemotherapy malignant neoplasm of overlapping sites of brain major depressive disorder, single episode, unspecified type 2 diabetes mellitus without complications unspecified glaucoma type 2 diabetes mellitus with diabetic neuropathy, unspecified unspecified convulsions malignant neoplasm of overlapping sites of brain hemiplegia, unspecified affecting left nondominant side long term (current) use of oral hypoglycemic drugs gastro-esophageal reflux disease without esophagitis antineoplastic chemotherapy induced pancytopenia major depressive disorder, single episode, unspecified anorexia malignant neoplasm of parietal lobe malignant neoplasm of frontal lobe low back pain gastro-esophageal reflux disease without esophagitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter sickle-cell trait unspecified place or not applicable klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified long term (current) use of oral hypoglycemic drugs hydroureter epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 19.9 or less, adult dysarthria and anarthria urinary tract infection, site not specified unspecified convulsions hyperosmolality and hypernatremia radiculopathy, lumbar region unspecified glaucoma
black african american m 57 $nan$hematology blood hematocrit  28.7  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  144  k ul; hematology blood platelet count  171  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  8.9  meq l; chemistry blood potassium  5.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry urine creatinine, urine  122  mg dl; chemistry urine sodium, urine  22  meq l; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  356  mg dl; chemistry blood glucose  324  mg dl; chemistry blood glucose  164  mg dl; chemistry blood glucose  161  mg dl; chemistry blood glucose  171  mg dl; chemistry urine protein creatinine ratio  0.1  ratio; hematology urine glucose  tr  mg dl; hematology urine bilirubin  neg  mg dl$0.9% sodium chloride  1000  ml ; sodium polystyrene sulfonate  30  gm ; sw  50  ml ; magnesium sulfate  2  gm ; insulin  10  unit ; sodium bicarb  100  meq ; calcium gluconate  1  gm ; insulin  0  unit ; heparin  5000  unit ; methadone  40  mg ; methadone  30  mg ; omeprazole  40  mg ; aspirin  81  mg ; diltiazem extended-release  120  mg ; diltiazem extended-release  180  mg ; ranitidine  75  mg ; 
other chronic pain cirrhosis of liver without mention of alcohol ulcer of ankle other disorders of plasma protein metabolism malignant neoplasm of liver, primary unspecified essential hypertension ulcer of other part of foot polyneuropathy in diabetes anxiety state, unspecified passenger in heavy transport vehicle injured in collision with other and unspecified motor vehicles in nontraffic accident hypopotassemia inappropriate diet and eating habits fluid overload disorder postlaminectomy syndrome, lumbar region esophagitis, unspecified other psoriasis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled edema of male genital organs other ascites venous (peripheral) insufficiency, unspecified alcohol abuse, unspecified long-term (current) use of insulin calculus of gallbladder without mention of cholecystitis, without mention of obstruction unspecified viral hepatitis c without hepatic coma anemia of other chronic disease esophageal reflux malignant neoplasm of liver, primary unspecified erythematous condition other ascites other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other specified complications of procedures not elsewhere classified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled abdominal pain, epigastric acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma other acute postoperative pain rash and other nonspecific skin eruption other psoriasis cirrhosis of liver without mention of alcohol chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified disorders of stomach and duodenum esophageal reflux unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, without mention of bleeding ulcer of ankle malignant neoplasm of liver, primary
black african american m 57 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  73  mg dl$sodium polystyrene sulfonate  30  gm ; sw  50  ml ; magnesium sulfate  2  gm ; insulin  10  unit ; sodium bicarb  100  meq ; calcium gluconate  1  gm ; heparin  5000  unit ; methadone  30  mg ; aspirin  81  mg ; ranitidine  75  mg ; clonazepam  0.5  mg ; insulin  110  unit ; sodium chloride 0.9%  flush  3  ml ; 
other chronic pain cirrhosis of liver without mention of alcohol ulcer of ankle other disorders of plasma protein metabolism malignant neoplasm of liver, primary unspecified essential hypertension ulcer of other part of foot polyneuropathy in diabetes anxiety state, unspecified passenger in heavy transport vehicle injured in collision with other and unspecified motor vehicles in nontraffic accident hypopotassemia inappropriate diet and eating habits fluid overload disorder postlaminectomy syndrome, lumbar region esophagitis, unspecified other psoriasis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled edema of male genital organs other ascites venous (peripheral) insufficiency, unspecified alcohol abuse, unspecified long-term (current) use of insulin calculus of gallbladder without mention of cholecystitis, without mention of obstruction unspecified viral hepatitis c without hepatic coma anemia of other chronic disease esophageal reflux malignant neoplasm of liver, primary unspecified erythematous condition other ascites other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other specified complications of procedures not elsewhere classified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled abdominal pain, epigastric acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma other acute postoperative pain rash and other nonspecific skin eruption other psoriasis cirrhosis of liver without mention of alcohol chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified disorders of stomach and duodenum esophageal reflux unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, without mention of bleeding ulcer of ankle malignant neoplasm of liver, primary
black african american m 57 $nan$nan$heparin  5000  unit ; methadone  30  mg ; aspirin  81  mg ; ranitidine  75  mg ; clonazepam  0.5  mg ; insulin  110  unit ; sodium chloride 0.9%  flush  3  ml ; 
other chronic pain cirrhosis of liver without mention of alcohol ulcer of ankle other disorders of plasma protein metabolism malignant neoplasm of liver, primary unspecified essential hypertension ulcer of other part of foot polyneuropathy in diabetes anxiety state, unspecified passenger in heavy transport vehicle injured in collision with other and unspecified motor vehicles in nontraffic accident hypopotassemia inappropriate diet and eating habits fluid overload disorder postlaminectomy syndrome, lumbar region esophagitis, unspecified other psoriasis diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled edema of male genital organs other ascites venous (peripheral) insufficiency, unspecified alcohol abuse, unspecified long-term (current) use of insulin calculus of gallbladder without mention of cholecystitis, without mention of obstruction unspecified viral hepatitis c without hepatic coma anemia of other chronic disease esophageal reflux malignant neoplasm of liver, primary unspecified erythematous condition other ascites other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other specified complications of procedures not elsewhere classified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled abdominal pain, epigastric acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma other acute postoperative pain rash and other nonspecific skin eruption other psoriasis cirrhosis of liver without mention of alcohol chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified disorders of stomach and duodenum esophageal reflux unspecified essential hypertension diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, without mention of bleeding ulcer of ankle malignant neoplasm of liver, primary
white f 66 $nan$nan$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
fall from other slipping, tripping, or stumbling trimalleolar fracture, closed
white f 66 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  111  mg dl$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; acetaminophen  325  mg ; docusate sodium  100  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; niacin sr  500  mg ; sulfameth trimethoprim ds  1  tab ; 
fall from other slipping, tripping, or stumbling trimalleolar fracture, closed
white f 66 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; acetaminophen  325  mg ; docusate sodium  100  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; niacin sr  500  mg ; sulfameth trimethoprim ds  1  tab ; miconazole nitrate vag cream 2%  1  appl ; 
fall from other slipping, tripping, or stumbling trimalleolar fracture, closed
white f 26 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  143  mg dl$famotidine  20  mg ; citalopram  40  mg ; propranolol la  60  mg ; levothyroxine sodium  75  mcg ; 5% dextrose  100  ml ; levetiracetam  500  mg ; iso-osmotic sodium chloride  1  bag ; docusate sodium  100  mg ; senna  17.2  mg ; influenza vaccine quadrivalent  0.5  ml ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; morphine sulfate  2  mg ; dexamethasone  4  mg ; sodium chloride 0.9%  1000  ml ; lorazepam  0.5  mg ; 
 
white f 26 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  126  mg dl$famotidine  20  mg ; citalopram  40  mg ; propranolol la  60  mg ; levothyroxine sodium  75  mcg ; 5% dextrose  100  ml ; levetiracetam  500  mg ; iso-osmotic sodium chloride  1  bag ; docusate sodium  100  mg ; senna  17.2  mg ; influenza vaccine quadrivalent  0.5  ml ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; morphine sulfate  2  mg ; dexamethasone  4  mg ; sodium chloride 0.9%  1000  ml ; lorazepam  0.5  mg ; drospirenone-ethinyl estradiol  3-0.03  mg ; heparin  5000  unit ; 
 
white f 26 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  126  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  85  mg dl$famotidine  20  mg ; citalopram  40  mg ; propranolol la  60  mg ; levothyroxine sodium  75  mcg ; 5% dextrose  100  ml ; levetiracetam  500  mg ; iso-osmotic sodium chloride  1  bag ; docusate sodium  100  mg ; senna  17.2  mg ; influenza vaccine quadrivalent  0.5  ml ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; morphine sulfate  2  mg ; sodium chloride 0.9%  1000  ml ; lorazepam  0.5  mg ; drospirenone-ethinyl estradiol  3-0.03  mg ; heparin  5000  unit ; oxycodone (immediate release)  5  mg ; 
 
white f 92 $temp  98.2  heartrate  94.0  resprate  18.0  o2sat  100.0  sbp  157.0  dbp  59.0  rhythm    pain  9  ; temp  98.2  heartrate  83.0  resprate  18.0  o2sat  100.0  sbp  161.0  dbp  64.0  rhythm    pain  0  ; temp  98.2  heartrate  84.0  resprate  18.0  o2sat  100.0  sbp  144.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  160  mg dl$aspirin ec  81  mg ; amlodipine  5  mg ; levothyroxine sodium  88  mcg ; metoprolol succinate xl  50  mg ; 
postprocedural hypothyroidism pain in left arm fall from chair, initial encounter hypo-osmolality and hyponatremia unspecified place or not applicable traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter urinary tract infection, site not specified essential (primary) hypertension hypo-osmolality and hyponatremia postprocedural hypothyroidism anemia in other chronic diseases classified elsewhere rheumatic tricuspid insufficiency vitamin d deficiency, unspecified nonrheumatic pulmonary valve insufficiency major depressive disorder, single episode, unspecified hypertensive heart disease with heart failure chronic atrial fibrillation other nonspecific abnormal finding of lung field other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified unspecified dementia without behavioral disturbance personal history of tuberculosis type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema other abnormal findings in urine chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants acute diastolic (congestive) heart failure essential (primary) hypertension zoster without complications hypo-osmolality and hyponatremia type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of anticoagulants chronic obstructive pulmonary disease, unspecified major depressive disorder, single episode, unspecified encounter for immunization unspecified atrial fibrillation unspecified dementia without behavioral disturbance primary osteoarthritis, unspecified wrist cellulitis of left upper limb hypothyroidism, unspecified insomnia, unspecified hyperkalemia acute kidney failure, unspecified 
white f 92 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  111  mg dl$aspirin ec  81  mg ; amlodipine  5  mg ; levothyroxine sodium  88  mcg ; metoprolol succinate xl  50  mg ; acetaminophen  650  mg ; senna  8.6  mg ; fentanyl citrate  25-50  mcg ; ondansetron  4  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; losartan potassium  25  mg ; docusate sodium  100  mg ; bag  1  bag ; magnesium sulfate  2  gm ; metoprolol tartrate  50  mg ; metoprolol tartrate  25  mg ; 
postprocedural hypothyroidism pain in left arm fall from chair, initial encounter hypo-osmolality and hyponatremia unspecified place or not applicable traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter urinary tract infection, site not specified essential (primary) hypertension hypo-osmolality and hyponatremia postprocedural hypothyroidism anemia in other chronic diseases classified elsewhere rheumatic tricuspid insufficiency vitamin d deficiency, unspecified nonrheumatic pulmonary valve insufficiency major depressive disorder, single episode, unspecified hypertensive heart disease with heart failure chronic atrial fibrillation other nonspecific abnormal finding of lung field other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified unspecified dementia without behavioral disturbance personal history of tuberculosis type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema other abnormal findings in urine chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants acute diastolic (congestive) heart failure essential (primary) hypertension zoster without complications hypo-osmolality and hyponatremia type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of anticoagulants chronic obstructive pulmonary disease, unspecified major depressive disorder, single episode, unspecified encounter for immunization unspecified atrial fibrillation unspecified dementia without behavioral disturbance primary osteoarthritis, unspecified wrist cellulitis of left upper limb hypothyroidism, unspecified insomnia, unspecified hyperkalemia acute kidney failure, unspecified 
white f 92 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  101  mg dl$aspirin ec  81  mg ; amlodipine  5  mg ; levothyroxine sodium  88  mcg ; acetaminophen  650  mg ; senna  8.6  mg ; losartan potassium  25  mg ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; metoprolol tartrate  25  mg ; warfarin  1  mg ; sodium chloride 0.9%  1000  ml ; furosemide  20  mg ; lidocaine 1%  2  ml ; 
postprocedural hypothyroidism pain in left arm fall from chair, initial encounter hypo-osmolality and hyponatremia unspecified place or not applicable traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter urinary tract infection, site not specified essential (primary) hypertension hypo-osmolality and hyponatremia postprocedural hypothyroidism anemia in other chronic diseases classified elsewhere rheumatic tricuspid insufficiency vitamin d deficiency, unspecified nonrheumatic pulmonary valve insufficiency major depressive disorder, single episode, unspecified hypertensive heart disease with heart failure chronic atrial fibrillation other nonspecific abnormal finding of lung field other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified unspecified dementia without behavioral disturbance personal history of tuberculosis type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema other abnormal findings in urine chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants acute diastolic (congestive) heart failure essential (primary) hypertension zoster without complications hypo-osmolality and hyponatremia type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of anticoagulants chronic obstructive pulmonary disease, unspecified major depressive disorder, single episode, unspecified encounter for immunization unspecified atrial fibrillation unspecified dementia without behavioral disturbance primary osteoarthritis, unspecified wrist cellulitis of left upper limb hypothyroidism, unspecified insomnia, unspecified hyperkalemia acute kidney failure, unspecified 
white f 92 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  95  mg dl$aspirin ec  81  mg ; amlodipine  5  mg ; levothyroxine sodium  88  mcg ; acetaminophen  650  mg ; senna  8.6  mg ; losartan potassium  25  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; warfarin  1  mg ; furosemide  20  mg ; lidocaine 1%  2  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 
postprocedural hypothyroidism pain in left arm fall from chair, initial encounter hypo-osmolality and hyponatremia unspecified place or not applicable traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter urinary tract infection, site not specified essential (primary) hypertension hypo-osmolality and hyponatremia postprocedural hypothyroidism anemia in other chronic diseases classified elsewhere rheumatic tricuspid insufficiency vitamin d deficiency, unspecified nonrheumatic pulmonary valve insufficiency major depressive disorder, single episode, unspecified hypertensive heart disease with heart failure chronic atrial fibrillation other nonspecific abnormal finding of lung field other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified unspecified dementia without behavioral disturbance personal history of tuberculosis type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema other abnormal findings in urine chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants acute diastolic (congestive) heart failure essential (primary) hypertension zoster without complications hypo-osmolality and hyponatremia type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of anticoagulants chronic obstructive pulmonary disease, unspecified major depressive disorder, single episode, unspecified encounter for immunization unspecified atrial fibrillation unspecified dementia without behavioral disturbance primary osteoarthritis, unspecified wrist cellulitis of left upper limb hypothyroidism, unspecified insomnia, unspecified hyperkalemia acute kidney failure, unspecified 
white f 92 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  90  mg dl$aspirin ec  81  mg ; amlodipine  5  mg ; levothyroxine sodium  88  mcg ; acetaminophen  650  mg ; senna  8.6  mg ; losartan potassium  25  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; warfarin  1  mg ; furosemide  20  mg ; lidocaine 1%  2  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; warfarin  3  mg ; 
postprocedural hypothyroidism pain in left arm fall from chair, initial encounter hypo-osmolality and hyponatremia unspecified place or not applicable traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter urinary tract infection, site not specified essential (primary) hypertension hypo-osmolality and hyponatremia postprocedural hypothyroidism anemia in other chronic diseases classified elsewhere rheumatic tricuspid insufficiency vitamin d deficiency, unspecified nonrheumatic pulmonary valve insufficiency major depressive disorder, single episode, unspecified hypertensive heart disease with heart failure chronic atrial fibrillation other nonspecific abnormal finding of lung field other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified unspecified dementia without behavioral disturbance personal history of tuberculosis type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema other abnormal findings in urine chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants acute diastolic (congestive) heart failure essential (primary) hypertension zoster without complications hypo-osmolality and hyponatremia type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of anticoagulants chronic obstructive pulmonary disease, unspecified major depressive disorder, single episode, unspecified encounter for immunization unspecified atrial fibrillation unspecified dementia without behavioral disturbance primary osteoarthritis, unspecified wrist cellulitis of left upper limb hypothyroidism, unspecified insomnia, unspecified hyperkalemia acute kidney failure, unspecified 
white f 92 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  87  mg dl$aspirin ec  81  mg ; amlodipine  5  mg ; levothyroxine sodium  88  mcg ; acetaminophen  650  mg ; senna  8.6  mg ; losartan potassium  25  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; furosemide  20  mg ; warfarin  3  mg ; enoxaparin sodium  60  mg ; warfarin  5  mg ; 
postprocedural hypothyroidism pain in left arm fall from chair, initial encounter hypo-osmolality and hyponatremia unspecified place or not applicable traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter urinary tract infection, site not specified essential (primary) hypertension hypo-osmolality and hyponatremia postprocedural hypothyroidism anemia in other chronic diseases classified elsewhere rheumatic tricuspid insufficiency vitamin d deficiency, unspecified nonrheumatic pulmonary valve insufficiency major depressive disorder, single episode, unspecified hypertensive heart disease with heart failure chronic atrial fibrillation other nonspecific abnormal finding of lung field other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified unspecified dementia without behavioral disturbance personal history of tuberculosis type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema other abnormal findings in urine chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants acute diastolic (congestive) heart failure essential (primary) hypertension zoster without complications hypo-osmolality and hyponatremia type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of anticoagulants chronic obstructive pulmonary disease, unspecified major depressive disorder, single episode, unspecified encounter for immunization unspecified atrial fibrillation unspecified dementia without behavioral disturbance primary osteoarthritis, unspecified wrist cellulitis of left upper limb hypothyroidism, unspecified insomnia, unspecified hyperkalemia acute kidney failure, unspecified 
white f 92 $nan$nan$aspirin ec  81  mg ; amlodipine  5  mg ; levothyroxine sodium  88  mcg ; acetaminophen  650  mg ; senna  8.6  mg ; losartan potassium  25  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; furosemide  20  mg ; enoxaparin sodium  60  mg ; warfarin  5  mg ; 
postprocedural hypothyroidism pain in left arm fall from chair, initial encounter hypo-osmolality and hyponatremia unspecified place or not applicable traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter urinary tract infection, site not specified essential (primary) hypertension hypo-osmolality and hyponatremia postprocedural hypothyroidism anemia in other chronic diseases classified elsewhere rheumatic tricuspid insufficiency vitamin d deficiency, unspecified nonrheumatic pulmonary valve insufficiency major depressive disorder, single episode, unspecified hypertensive heart disease with heart failure chronic atrial fibrillation other nonspecific abnormal finding of lung field other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified unspecified dementia without behavioral disturbance personal history of tuberculosis type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema other abnormal findings in urine chronic obstructive pulmonary disease, unspecified long term (current) use of anticoagulants acute diastolic (congestive) heart failure essential (primary) hypertension zoster without complications hypo-osmolality and hyponatremia type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of anticoagulants chronic obstructive pulmonary disease, unspecified major depressive disorder, single episode, unspecified encounter for immunization unspecified atrial fibrillation unspecified dementia without behavioral disturbance primary osteoarthritis, unspecified wrist cellulitis of left upper limb hypothyroidism, unspecified insomnia, unspecified hyperkalemia acute kidney failure, unspecified 
white m 70 $temp  100.6  heartrate  83.0  resprate  18.0  o2sat  95.0  sbp  129.0  dbp  66.0  rhythm    pain  5  ; temp  100.8  heartrate  83.0  resprate  18.0  o2sat  95.0  sbp  129.0  dbp  66.0  rhythm    pain  5  ; temp  97.9  heartrate  80.0  resprate  16.0  o2sat  95.0  sbp  123.0  dbp  72.0  rhythm    pain  0  $hematology blood hematocrit  38.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  125  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  39  # hpf; chemistry blood glucose  128  mg dl$nan
obesity, unspecified acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) personal history of nicotine dependence acute on chronic systolic (congestive) heart failure paroxysmal atrial fibrillation unsteadiness on feet constipation, unspecified cardiomyopathy, unspecified obstructive sleep apnea (adult) (pediatric) body mass index (bmi) 35.0-35.9, adult atherosclerotic heart disease of native coronary artery without angina pectoris anxiety disorder, unspecified type 2 diabetes mellitus with hyperglycemia gout, unspecified long term (current) use of anticoagulants gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis pure hypercholesterolemia atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension personal history of nicotine dependence presence of cardiac pacemaker hypoxemia type 2 diabetes mellitus without complications gout, unspecified long term (current) use of antithrombotics/antiplatelets body mass index (bmi) 38.0-38.9, adult other obesity due to excess calories chest pain, unspecified paroxysmal atrial fibrillation personal history of nicotine dependence obstructive sleep apnea (adult) (pediatric) atherosclerotic heart disease of native coronary artery without angina pectoris chronic diastolic (congestive) heart failure type 2 diabetes mellitus without complications pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis paroxysmal atrial fibrillation gout, unspecified long term (current) use of insulin encounter for immunization essential (primary) hypertension chronic diastolic heart failure coronary atherosclerosis of native coronary artery muscle weakness (generalized)
white m 70 $temp  98.9  heartrate  85.0  resprate  16.0  o2sat  95.0  sbp  118.0  dbp  71.0  rhythm    pain  0  $hematology blood hematocrit  34.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood glucose  111  mg dl$acetaminophen  650  mg ; allopurinol  100  mg ; allopurinol  300  mg ; amlodipine  5  mg ; atorvastatin  40  mg ; eplerenone  25  mg ; eplerenone  50  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium oxide  400  mg ; metoprolol succinate xl  25  mg ; omeprazole  20  mg ; torsemide  60  mg ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; insulin  51  unit ; insulin  17  unit ; dofetilide  500  mcg ; insulin  70  unit ; insulin  14  unit ; heparin  5000  unit ; insulin  73  unit ; insulin  13  unit ; 
obesity, unspecified acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) personal history of nicotine dependence acute on chronic systolic (congestive) heart failure paroxysmal atrial fibrillation unsteadiness on feet constipation, unspecified cardiomyopathy, unspecified obstructive sleep apnea (adult) (pediatric) body mass index (bmi) 35.0-35.9, adult atherosclerotic heart disease of native coronary artery without angina pectoris anxiety disorder, unspecified type 2 diabetes mellitus with hyperglycemia gout, unspecified long term (current) use of anticoagulants gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis pure hypercholesterolemia atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension personal history of nicotine dependence presence of cardiac pacemaker hypoxemia type 2 diabetes mellitus without complications gout, unspecified long term (current) use of antithrombotics/antiplatelets body mass index (bmi) 38.0-38.9, adult other obesity due to excess calories chest pain, unspecified paroxysmal atrial fibrillation personal history of nicotine dependence obstructive sleep apnea (adult) (pediatric) atherosclerotic heart disease of native coronary artery without angina pectoris chronic diastolic (congestive) heart failure type 2 diabetes mellitus without complications pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis paroxysmal atrial fibrillation gout, unspecified long term (current) use of insulin encounter for immunization essential (primary) hypertension chronic diastolic heart failure coronary atherosclerosis of native coronary artery muscle weakness (generalized)
white m 70 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  184  mg dl$heparin  5000  unit ; insulin  73  unit ; insulin  13  unit ; 
obesity, unspecified acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) personal history of nicotine dependence acute on chronic systolic (congestive) heart failure paroxysmal atrial fibrillation unsteadiness on feet constipation, unspecified cardiomyopathy, unspecified obstructive sleep apnea (adult) (pediatric) body mass index (bmi) 35.0-35.9, adult atherosclerotic heart disease of native coronary artery without angina pectoris anxiety disorder, unspecified type 2 diabetes mellitus with hyperglycemia gout, unspecified long term (current) use of anticoagulants gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis pure hypercholesterolemia atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension personal history of nicotine dependence presence of cardiac pacemaker hypoxemia type 2 diabetes mellitus without complications gout, unspecified long term (current) use of antithrombotics/antiplatelets body mass index (bmi) 38.0-38.9, adult other obesity due to excess calories chest pain, unspecified paroxysmal atrial fibrillation personal history of nicotine dependence obstructive sleep apnea (adult) (pediatric) atherosclerotic heart disease of native coronary artery without angina pectoris chronic diastolic (congestive) heart failure type 2 diabetes mellitus without complications pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis paroxysmal atrial fibrillation gout, unspecified long term (current) use of insulin encounter for immunization essential (primary) hypertension chronic diastolic heart failure coronary atherosclerosis of native coronary artery muscle weakness (generalized)
white m 70 $nan$nan$heparin  5000  unit ; insulin  73  unit ; insulin  13  unit ; triamcinolone acetonide 0.1% cream  1  appl ; aspirin  81  mg ; desonide 0.05% cream  1  appl ; apixaban  5  mg ; 
obesity, unspecified acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) personal history of nicotine dependence acute on chronic systolic (congestive) heart failure paroxysmal atrial fibrillation unsteadiness on feet constipation, unspecified cardiomyopathy, unspecified obstructive sleep apnea (adult) (pediatric) body mass index (bmi) 35.0-35.9, adult atherosclerotic heart disease of native coronary artery without angina pectoris anxiety disorder, unspecified type 2 diabetes mellitus with hyperglycemia gout, unspecified long term (current) use of anticoagulants gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis pure hypercholesterolemia atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension personal history of nicotine dependence presence of cardiac pacemaker hypoxemia type 2 diabetes mellitus without complications gout, unspecified long term (current) use of antithrombotics/antiplatelets body mass index (bmi) 38.0-38.9, adult other obesity due to excess calories chest pain, unspecified paroxysmal atrial fibrillation personal history of nicotine dependence obstructive sleep apnea (adult) (pediatric) atherosclerotic heart disease of native coronary artery without angina pectoris chronic diastolic (congestive) heart failure type 2 diabetes mellitus without complications pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis paroxysmal atrial fibrillation gout, unspecified long term (current) use of insulin encounter for immunization essential (primary) hypertension chronic diastolic heart failure coronary atherosclerosis of native coronary artery muscle weakness (generalized)
white m 70 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  44  mg dl; hematology urine wbc  9  # hpf; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  110  mg dl$insulin  73  unit ; insulin  13  unit ; triamcinolone acetonide 0.1% cream  1  appl ; aspirin  81  mg ; desonide 0.05% cream  1  appl ; apixaban  5  mg ; phenazopyridine  100  mg ; 
obesity, unspecified acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) personal history of nicotine dependence acute on chronic systolic (congestive) heart failure paroxysmal atrial fibrillation unsteadiness on feet constipation, unspecified cardiomyopathy, unspecified obstructive sleep apnea (adult) (pediatric) body mass index (bmi) 35.0-35.9, adult atherosclerotic heart disease of native coronary artery without angina pectoris anxiety disorder, unspecified type 2 diabetes mellitus with hyperglycemia gout, unspecified long term (current) use of anticoagulants gastro-esophageal reflux disease without esophagitis hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease acute on chronic systolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis pure hypercholesterolemia atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension personal history of nicotine dependence presence of cardiac pacemaker hypoxemia type 2 diabetes mellitus without complications gout, unspecified long term (current) use of antithrombotics/antiplatelets body mass index (bmi) 38.0-38.9, adult other obesity due to excess calories chest pain, unspecified paroxysmal atrial fibrillation personal history of nicotine dependence obstructive sleep apnea (adult) (pediatric) atherosclerotic heart disease of native coronary artery without angina pectoris chronic diastolic (congestive) heart failure type 2 diabetes mellitus without complications pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis paroxysmal atrial fibrillation gout, unspecified long term (current) use of insulin encounter for immunization essential (primary) hypertension chronic diastolic heart failure coronary atherosclerosis of native coronary artery muscle weakness (generalized)
white f 19 $temp  98.3  heartrate  106.0  resprate  16.0  o2sat  98.0  sbp  118.0  dbp  63.0  rhythm    pain  0  $hematology blood hematocrit  48.0  %; hematology blood hemoglobin  15.5  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.7  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  63  mg dl; chemistry blood lactate dehydrogenase (ld)  242  iu l; chemistry blood albumin  3.5  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; lorazepam  0.25  mg ; lidocaine 1%  2  ml ; lidocaine 1%  1  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; albumin 5%   25  g ; 
 
white f 19 $nan$hematology blood hematocrit  42.7  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  80  mg dl; blood gas blood lactate  1.5  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; albumin 5%   25  g ; 
 
white f 19 $nan$hematology blood hematocrit  46.6  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  88  mg dl; blood gas blood lactate  1.4  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; albumin 5%   25  g ; acetaminophen  325  mg ; lactated ringers  1000  ml ; 
 
white f 19 $nan$hematology blood hematocrit  44.2  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  71  mg dl; blood gas blood lactate  2.0  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; acetaminophen  325  mg ; lactated ringers  1000  ml ; metoprolol tartrate  12.5  mg ; lisinopril  5  mg ; 
 
white f 19 $nan$hematology blood hematocrit  47.5  %; hematology blood hemoglobin  15.3  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  74  mg dl; blood gas blood lactate  2.1  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; lisinopril  2.5  mg ; 
 
white f 19 $nan$hematology blood hematocrit  46.8  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  195  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; lisinopril  2.5  mg ; prednisone  50  mg ; diphenhydramine  50  mg ; 
 
white f 19 $nan$hematology blood hematocrit  43.7  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  321  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; lisinopril  2.5  mg ; prednisone  50  mg ; diphenhydramine  50  mg ; d5 1 2ns  1000  ml ; 
 
white f 19 $nan$hematology blood hematocrit  43.8  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.5  ; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  99  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; lisinopril  2.5  mg ; acetaminophen  500  mg ; 
 
white f 19 $nan$hematology blood hematocrit  43.6  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; lisinopril  2.5  mg ; acetaminophen  500  mg ; senna  8.6  mg ; 
 
white f 19 $nan$hematology blood hematocrit  21.2  %; hematology blood hematocrit  44.2  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  196  k ul; hematology blood platelet count  62  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  4.3  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  5.6  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  80  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; lisinopril  2.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
white f 19 $nan$hematology blood hematocrit  45.1  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  85  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; lisinopril  2.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
white f 19 $nan$hematology blood hematocrit  45.6  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; lisinopril  2.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
white f 19 $nan$hematology blood hematocrit  41.7  %; hematology blood hematocrit  39.9  %; hematology blood hematocrit  41.3  %; hematology blood hemoglobin  13.1  g dl; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  184  k ul; hematology blood platelet count  157  k ul; hematology blood platelet count  117  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  72  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  421  iu l; chemistry blood lactate dehydrogenase (ld)  1595  iu l; chemistry blood albumin  3.6  g dl; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.4  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; lisinopril  2.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; phenylephrine  60  mg ; soln  50  ml ; fentanyl citrate  25-100  mcg ; furosemide  20  mg ; ondansetron  4  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; cepastat (phenol) lozenge  1-2  loz ; sodium chloride 0.9%  flush  10  ml ; furosemide  10  mg ; 
 
white f 19 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  91  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood bilirubin, total  3.1  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  920  iu l; chemistry blood lactate dehydrogenase (ld)  486  iu l; chemistry blood lactate dehydrogenase (ld)  370  iu l; chemistry blood albumin  3.2  g dl; blood gas blood lactate  1.4  mmol l$senna  8.6  mg ; docusate sodium  100  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; cepastat (phenol) lozenge  1-2  loz ; sodium chloride 0.9%  flush  10  ml ; furosemide  10  mg ; 
 
white f 19 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  86  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, indirect  1.8  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood bilirubin, total  3.1  mg dl; chemistry blood glucose  73  mg dl; chemistry blood bilirubin, direct  1.6  mg dl$senna  8.6  mg ; docusate sodium  100  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; cepastat (phenol) lozenge  1-2  loz ; sodium chloride 0.9%  flush  10  ml ; warfarin  5  mg ; argatroban  50  mg ; 
 
white f 19 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  82  mg dl$senna  8.6  mg ; docusate sodium  100  mg ; cepastat (phenol) lozenge  1-2  loz ; argatroban  50  mg ; 
 
white f 19 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  2.7  mg dl; chemistry blood glucose  83  mg dl$senna  8.6  mg ; docusate sodium  100  mg ; cepastat (phenol) lozenge  1-2  loz ; argatroban  50  mg ; potassium chloride  20  meq ; metoprolol tartrate  6.25  mg ; 
 
white f 19 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  82  mg dl$senna  8.6  mg ; docusate sodium  100  mg ; cepastat (phenol) lozenge  1-2  loz ; potassium chloride  20  meq ; metoprolol tartrate  6.25  mg ; 
 
white f 19 $nan$hematology blood hematocrit  45.2  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  117  mg dl$senna  8.6  mg ; docusate sodium  100  mg ; cepastat (phenol) lozenge  1-2  loz ; warfarin  7.5  mg ; 
 
white f 19 $nan$hematology blood hematocrit  41.5  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  295  k ul; hematology blood inr(pt)  2.7  ; chemistry blood bilirubin, total  2.0  mg dl$senna  8.6  mg ; docusate sodium  100  mg ; cepastat (phenol) lozenge  1-2  loz ; warfarin  7.5  mg ; 
 
white f 19 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  340  k ul; hematology blood inr(pt)  2.6  ; chemistry blood bilirubin, total  1.8  mg dl$senna  8.6  mg ; docusate sodium  100  mg ; cepastat (phenol) lozenge  1-2  loz ; warfarin  7.5  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
 
white f 19 $nan$hematology blood hematocrit  43.9  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  393  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  311  iu l$senna  8.6  mg ; docusate sodium  100  mg ; cepastat (phenol) lozenge  1-2  loz ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; warfarin  3  mg ; 
 
white f 19 $nan$hematology blood hematocrit  39.4  %; hematology blood hematocrit  41.2  %; hematology blood hemoglobin  13.0  g dl; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  432  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  263  iu l$senna  8.6  mg ; cepastat (phenol) lozenge  1-2  loz ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; warfarin  3  mg ; docusate sodium  200  mg ; aspirin  81  mg ; 
 
white f 19 $nan$nan$senna  8.6  mg ; cepastat (phenol) lozenge  1-2  loz ; sodium chloride 0.9%  flush  10-20  ml ; warfarin  3  mg ; docusate sodium  200  mg ; aspirin  81  mg ; 
 
black african american f 75 $temp  99.5  heartrate  86.0  resprate  18.0  o2sat  100.0  sbp  130.0  dbp  55.0  rhythm    pain  5  ; temp  98.2  heartrate  80.0  resprate  18.0  o2sat  100.0  sbp  151.0  dbp  76.0  rhythm    pain    $hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  64  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  134  mg dl$nan
personal history of methicillin resistant staphylococcus aureus infection other pancytopenia angiodysplasia of stomach and duodenum with bleeding acute posthemorrhagic anemia portal hypertension age-related osteoporosis without current pathological fracture urinary tract infection, site not specified unspecified cirrhosis of liver rheumatoid arthritis, unspecified diaphragmatic hernia without obstruction or gangrene personal history of other venous thrombosis and embolism personal history of malignant neoplasm of breast autoimmune hepatitis secondary esophageal varices without bleeding essential (primary) hypertension diarrhea, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified presence of right artificial hip joint unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere personal history of nicotine dependence angiodysplasia of stomach and duodenum with bleeding presence of right artificial hip joint secondary esophageal varices without bleeding presence of left artificial knee joint polyneuropathy, unspecified personal history of antineoplastic chemotherapy other pancytopenia rheumatoid arthritis, unspecified age-related osteoporosis without current pathological fracture acute posthemorrhagic anemia personal history of malignant neoplasm of breast urinary tract infection, site not specified heart failure, unspecified personal history of other venous thrombosis and embolism autoimmune hepatitis personal history of irradiation essential (primary) hypertension other cirrhosis of liver portal hypertension type 2 diabetes mellitus with diabetic neuropathy, unspecified diverticulosis of large intestine without perforation or abscess without bleeding secondary esophageal varices without bleeding personal history of urinary (tract) infections autoimmune hepatitis presence of left artificial knee joint angiodysplasia of stomach and duodenum with bleeding unspecified cirrhosis of liver constipation, unspecified
black african american f 75 $temp  98.6  heartrate  87.0  resprate  16.0  o2sat  100.0  sbp  155.0  dbp  63.0  rhythm    pain  0  ; temp  98.4  heartrate  80.0  resprate  16.0  o2sat  100.0  sbp  147.0  dbp  69.0  rhythm    pain  0  $hematology blood hematocrit  26.6  %; hematology blood hematocrit  30.7  %; hematology blood hematocrit  28.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  54  k ul; hematology blood platelet count  30  k ul; hematology blood platelet count  60  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  261  iu l; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; ursodiol  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; vial  1  vial ; pantoprazole  40  mg ; hydroxychloroquine sulfate  200  mg ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; trazodone  25  mg ; diphenhydramine  25  mg ; 
personal history of methicillin resistant staphylococcus aureus infection other pancytopenia angiodysplasia of stomach and duodenum with bleeding acute posthemorrhagic anemia portal hypertension age-related osteoporosis without current pathological fracture urinary tract infection, site not specified unspecified cirrhosis of liver rheumatoid arthritis, unspecified diaphragmatic hernia without obstruction or gangrene personal history of other venous thrombosis and embolism personal history of malignant neoplasm of breast autoimmune hepatitis secondary esophageal varices without bleeding essential (primary) hypertension diarrhea, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified presence of right artificial hip joint unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere personal history of nicotine dependence angiodysplasia of stomach and duodenum with bleeding presence of right artificial hip joint secondary esophageal varices without bleeding presence of left artificial knee joint polyneuropathy, unspecified personal history of antineoplastic chemotherapy other pancytopenia rheumatoid arthritis, unspecified age-related osteoporosis without current pathological fracture acute posthemorrhagic anemia personal history of malignant neoplasm of breast urinary tract infection, site not specified heart failure, unspecified personal history of other venous thrombosis and embolism autoimmune hepatitis personal history of irradiation essential (primary) hypertension other cirrhosis of liver portal hypertension type 2 diabetes mellitus with diabetic neuropathy, unspecified diverticulosis of large intestine without perforation or abscess without bleeding secondary esophageal varices without bleeding personal history of urinary (tract) infections autoimmune hepatitis presence of left artificial knee joint angiodysplasia of stomach and duodenum with bleeding unspecified cirrhosis of liver constipation, unspecified
black african american f 75 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  28.8  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  62  k ul; hematology blood platelet count  65  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  73  mg dl; chemistry blood lactate dehydrogenase (ld)  225  iu l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; ursodiol  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; vial  1  vial ; pantoprazole  40  mg ; hydroxychloroquine sulfate  200  mg ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  20  mg ; 
personal history of methicillin resistant staphylococcus aureus infection other pancytopenia angiodysplasia of stomach and duodenum with bleeding acute posthemorrhagic anemia portal hypertension age-related osteoporosis without current pathological fracture urinary tract infection, site not specified unspecified cirrhosis of liver rheumatoid arthritis, unspecified diaphragmatic hernia without obstruction or gangrene personal history of other venous thrombosis and embolism personal history of malignant neoplasm of breast autoimmune hepatitis secondary esophageal varices without bleeding essential (primary) hypertension diarrhea, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified presence of right artificial hip joint unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere personal history of nicotine dependence angiodysplasia of stomach and duodenum with bleeding presence of right artificial hip joint secondary esophageal varices without bleeding presence of left artificial knee joint polyneuropathy, unspecified personal history of antineoplastic chemotherapy other pancytopenia rheumatoid arthritis, unspecified age-related osteoporosis without current pathological fracture acute posthemorrhagic anemia personal history of malignant neoplasm of breast urinary tract infection, site not specified heart failure, unspecified personal history of other venous thrombosis and embolism autoimmune hepatitis personal history of irradiation essential (primary) hypertension other cirrhosis of liver portal hypertension type 2 diabetes mellitus with diabetic neuropathy, unspecified diverticulosis of large intestine without perforation or abscess without bleeding secondary esophageal varices without bleeding personal history of urinary (tract) infections autoimmune hepatitis presence of left artificial knee joint angiodysplasia of stomach and duodenum with bleeding unspecified cirrhosis of liver constipation, unspecified
black african american f 75 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  59  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; ursodiol  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; hydroxychloroquine sulfate  200  mg ; potassium chloride  20  meq ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  20  mg ; nadolol  20  mg ; potassium chloride  40  meq ; 
personal history of methicillin resistant staphylococcus aureus infection other pancytopenia angiodysplasia of stomach and duodenum with bleeding acute posthemorrhagic anemia portal hypertension age-related osteoporosis without current pathological fracture urinary tract infection, site not specified unspecified cirrhosis of liver rheumatoid arthritis, unspecified diaphragmatic hernia without obstruction or gangrene personal history of other venous thrombosis and embolism personal history of malignant neoplasm of breast autoimmune hepatitis secondary esophageal varices without bleeding essential (primary) hypertension diarrhea, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified presence of right artificial hip joint unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere personal history of nicotine dependence angiodysplasia of stomach and duodenum with bleeding presence of right artificial hip joint secondary esophageal varices without bleeding presence of left artificial knee joint polyneuropathy, unspecified personal history of antineoplastic chemotherapy other pancytopenia rheumatoid arthritis, unspecified age-related osteoporosis without current pathological fracture acute posthemorrhagic anemia personal history of malignant neoplasm of breast urinary tract infection, site not specified heart failure, unspecified personal history of other venous thrombosis and embolism autoimmune hepatitis personal history of irradiation essential (primary) hypertension other cirrhosis of liver portal hypertension type 2 diabetes mellitus with diabetic neuropathy, unspecified diverticulosis of large intestine without perforation or abscess without bleeding secondary esophageal varices without bleeding personal history of urinary (tract) infections autoimmune hepatitis presence of left artificial knee joint angiodysplasia of stomach and duodenum with bleeding unspecified cirrhosis of liver constipation, unspecified
black african american f 75 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  65  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; ursodiol  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; hydroxychloroquine sulfate  200  mg ; potassium chloride  20  meq ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  20  mg ; nadolol  20  mg ; potassium chloride  40  meq ; sucralfate  1  gm ; 
personal history of methicillin resistant staphylococcus aureus infection other pancytopenia angiodysplasia of stomach and duodenum with bleeding acute posthemorrhagic anemia portal hypertension age-related osteoporosis without current pathological fracture urinary tract infection, site not specified unspecified cirrhosis of liver rheumatoid arthritis, unspecified diaphragmatic hernia without obstruction or gangrene personal history of other venous thrombosis and embolism personal history of malignant neoplasm of breast autoimmune hepatitis secondary esophageal varices without bleeding essential (primary) hypertension diarrhea, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified presence of right artificial hip joint unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere personal history of nicotine dependence angiodysplasia of stomach and duodenum with bleeding presence of right artificial hip joint secondary esophageal varices without bleeding presence of left artificial knee joint polyneuropathy, unspecified personal history of antineoplastic chemotherapy other pancytopenia rheumatoid arthritis, unspecified age-related osteoporosis without current pathological fracture acute posthemorrhagic anemia personal history of malignant neoplasm of breast urinary tract infection, site not specified heart failure, unspecified personal history of other venous thrombosis and embolism autoimmune hepatitis personal history of irradiation essential (primary) hypertension other cirrhosis of liver portal hypertension type 2 diabetes mellitus with diabetic neuropathy, unspecified diverticulosis of large intestine without perforation or abscess without bleeding secondary esophageal varices without bleeding personal history of urinary (tract) infections autoimmune hepatitis presence of left artificial knee joint angiodysplasia of stomach and duodenum with bleeding unspecified cirrhosis of liver constipation, unspecified
black african american f 75 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; ursodiol  600  mg ; hydroxychloroquine sulfate  200  mg ; nadolol  20  mg ; sucralfate  1  gm ; 
personal history of methicillin resistant staphylococcus aureus infection other pancytopenia angiodysplasia of stomach and duodenum with bleeding acute posthemorrhagic anemia portal hypertension age-related osteoporosis without current pathological fracture urinary tract infection, site not specified unspecified cirrhosis of liver rheumatoid arthritis, unspecified diaphragmatic hernia without obstruction or gangrene personal history of other venous thrombosis and embolism personal history of malignant neoplasm of breast autoimmune hepatitis secondary esophageal varices without bleeding essential (primary) hypertension diarrhea, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified presence of right artificial hip joint unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere personal history of nicotine dependence angiodysplasia of stomach and duodenum with bleeding presence of right artificial hip joint secondary esophageal varices without bleeding presence of left artificial knee joint polyneuropathy, unspecified personal history of antineoplastic chemotherapy other pancytopenia rheumatoid arthritis, unspecified age-related osteoporosis without current pathological fracture acute posthemorrhagic anemia personal history of malignant neoplasm of breast urinary tract infection, site not specified heart failure, unspecified personal history of other venous thrombosis and embolism autoimmune hepatitis personal history of irradiation essential (primary) hypertension other cirrhosis of liver portal hypertension type 2 diabetes mellitus with diabetic neuropathy, unspecified diverticulosis of large intestine without perforation or abscess without bleeding secondary esophageal varices without bleeding personal history of urinary (tract) infections autoimmune hepatitis presence of left artificial knee joint angiodysplasia of stomach and duodenum with bleeding unspecified cirrhosis of liver constipation, unspecified
white f 59 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; lactated ringers  1000  ml ; insulin  0  unit ; quetiapine fumarate  25  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; lamotrigine  100  mg ; 
 
white f 51 $nan$nan$heparin  5000  unit ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; cepacol (sore throat lozenge)  1  loz ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; 

white f 51 $nan$nan$heparin  5000  unit ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; cepacol (sore throat lozenge)  1  loz ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chl (yellow cadd)  1  cadd ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 

white f 51 $nan$nan$heparin  5000  unit ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; cepacol (sore throat lozenge)  1  loz ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chl (yellow cadd)  1  cadd ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; d5 1 2ns  1000  ml ; phosphorus  500  mg ; acetaminophen iv  1000  mg ; 

white f 51 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; cepacol (sore throat lozenge)  1  loz ; chloraseptic throat spray  1  spry ; 0.9% sodium chl (yellow cadd)  1  cadd ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; d5 1 2ns  1000  ml ; phosphorus  500  mg ; acetaminophen iv  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; calcium carbonate  500  mg ; 

white f 51 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; cepacol (sore throat lozenge)  1  loz ; chloraseptic throat spray  1  spry ; 0.9% sodium chl (yellow cadd)  1  cadd ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; calcium carbonate  500  mg ; phosphorus  250  mg ; lactulose  15  ml ; oxycodone (immediate release)  5  mg ; acetaminophen  1000  mg ; oxycodone sr (oxycontin)  40  mg ; insulin  26  unit ; 

white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; cepacol (sore throat lozenge)  1  loz ; docusate sodium  100  mg ; polyethylene glycol  17  g ; lactulose  15  ml ; acetaminophen  1000  mg ; oxycodone sr (oxycontin)  40  mg ; omeprazole  40  mg ; lisinopril  5  mg ; hydrochlorothiazide  25  mg ; oxycodone sr (oxycontin)  80  mg ; 

white f 35 $nan$nan$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; 5% dextrose  50  ml ; clindamycin  900  mg ; 5% dextrose  250  ml ; gentamicin sulfate  400  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; acetaminophen  1000  mg ; ketorolac  30  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; 
calculus of kidney 
white f 35 $nan$nan$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; 5% dextrose  50  ml ; clindamycin  900  mg ; 5% dextrose  250  ml ; gentamicin sulfate  400  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; ketorolac  30  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; 
calculus of kidney 
white f 35 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; simethicone  40-80  mg ; bisacodyl  10  mg ; 
calculus of kidney 
white f 35 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; simethicone  40-80  mg ; milk of magnesia  30  ml ; 
calculus of kidney 
white f 35 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; simethicone  40-80  mg ; milk of magnesia  30  ml ; 
calculus of kidney 
hispanic latino m 50 $temp  98.1  heartrate  86.0  resprate  16.0  o2sat  99.0  sbp  134.0  dbp  93.0  rhythm    pain  2  $hematology blood hematocrit  41.1  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  5.0  g dl; blood gas blood lactate  2.1  mmol l$nan
 
hispanic latino m 50 $nan$hematology blood hematocrit  39.5  %; hematology blood hematocrit  35.6  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  194  k ul; hematology blood platelet count  149  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  159  mg dl$effient  10  mg ; aspirin  81  mg ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  20  mg ; vial  1  vial ; pantoprazole  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; hydromorphone (dilaudid)  0.24  mg ; diphenhydramine  25  mg ; simethicone  40-80  mg ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  30.6  %; hematology blood hematocrit  24.2  %; hematology blood hematocrit  32.4  %; hematology blood hematocrit  27.3  %; hematology blood hematocrit  25.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  243  k ul; hematology blood platelet count  128  k ul; hematology blood platelet count  132  k ul; chemistry blood anion gap  27  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  149  mg dl; chemistry blood glucose  203  mg dl; chemistry blood glucose  200  mg dl; blood gas blood free calcium  1.03  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood glucose  134  mg dl$effient  10  mg ; aspirin  81  mg ; heparin  5000  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; hydromorphone (dilaudid)  0.24  mg ; simethicone  40-80  mg ; metoprolol succinate xl  25  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lidocaine jelly 2% (urojet)  1  appl ; sodium chloride 0.9%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; metoprolol tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  25.3  %; hematology blood hematocrit  25.2  %; hematology blood hematocrit  28.1  %; hematology blood hematocrit  27.7  %; hematology blood hematocrit  27.9  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  126  k ul; hematology blood platelet count  145  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  153  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  124  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hemoglobin  11.9  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  133  meq l$acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; propofol  1000  mg ; propofol  200  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; metoprolol tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; aspirin  300  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  22.3  %; hematology blood hematocrit  27.6  %; hematology blood hematocrit  25.8  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  165  k ul; hematology blood platelet count  125  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  140  mg dl$acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; propofol  200  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; metoprolol tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; aspirin  300  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  26.4  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  111  mg dl; blood gas blood free calcium  1.13  mmol l$acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; aspirin  300  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; sodium chloride 0.9%  flush  10  ml ; furosemide  10  mg ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  27.7  %; hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  196  k ul; hematology blood platelet count  180  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  119  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.2  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  mod  mg dl$acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; aspirin  300  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; sodium chloride 0.9%  flush  10  ml ; furosemide  10  mg ; albumin 5% (12.5g   250ml)  12.5  g ; albumin 5% (12.5g   250ml)  25  g ; lorazepam  1  mg ; acetaminophen (liquid)  650  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  27.3  %; hematology blood hematocrit  25.5  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  227  k ul; hematology blood platelet count  230  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  122  mg dl$vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; aspirin  300  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; sodium chloride 0.9%  flush  10  ml ; lorazepam  1  mg ; acetaminophen (liquid)  650  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; bisacodyl  10  mg ; thiamine  100  mg ; polyethylene glycol  17  g ; aspirin  325  mg ; lorazepam  0.5  mg ; folic acid  1  mg ; multivitamins  1  tab ; multivitamins  5  ml ; docusate sodium (liquid)  100  mg ; albumin 5%   25  g ; nystatin oral suspension  5  ml ; albumin  25  g ; soln  100  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
 
hispanic latino m 50 $nan$nan$vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; bisacodyl  10  mg ; thiamine  100  mg ; aspirin  325  mg ; lorazepam  0.5  mg ; folic acid  1  mg ; multivitamins  5  ml ; docusate sodium (liquid)  100  mg ; albumin 5%   25  g ; nystatin oral suspension  5  ml ; albumin  25  g ; soln  100  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; olanzapine (disintegrating tablet)  5  mg ; haloperidol  0.5  mg ; haloperidol  0.5-1  mg ; metoprolol tartrate  12.5  mg ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  374  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  148  mg dl$vial  1  vial ; pantoprazole  40  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; aspirin  325  mg ; folic acid  1  mg ; multivitamins  5  ml ; docusate sodium (liquid)  100  mg ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  363  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  163  mg dl$vial  1  vial ; pantoprazole  40  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; aspirin  325  mg ; folic acid  1  mg ; multivitamins  5  ml ; docusate sodium (liquid)  100  mg ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  406  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  133  mg dl$vial  1  vial ; pantoprazole  40  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; aspirin  325  mg ; folic acid  1  mg ; multivitamins  5  ml ; docusate sodium (liquid)  100  mg ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; 
 
hispanic latino m 50 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  125  mg dl$vial  1  vial ; pantoprazole  40  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; aspirin  325  mg ; folic acid  1  mg ; multivitamins  5  ml ; docusate sodium (liquid)  100  mg ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; prasugrel  10  mg ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  475  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  107  mg dl$vial  1  vial ; pantoprazole  40  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; aspirin  325  mg ; folic acid  1  mg ; multivitamins  5  ml ; docusate sodium (liquid)  100  mg ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; prasugrel  10  mg ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; 
 
hispanic latino m 50 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  551  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  114  mg dl$aspirin  325  mg ; folic acid  1  mg ; multivitamins  5  ml ; docusate sodium (liquid)  100  mg ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; prasugrel  10  mg ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; 
 
white f 19 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole  500  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; 
 
white f 19 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole  500  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25  mg ; acetaminophen  1000  mg ; ciprofloxacin hcl  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
 
white f 19 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; ciprofloxacin hcl  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydromorphone (dilaudid)  0.5  mg ; d5 1 2ns  1000  ml ; dicyclomine  20  mg ; tramadol  50  mg ; moviprep  1  l ; 
 
white f 19 $nan$hematology blood hematocrit  39.6  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  300  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; ciprofloxacin hcl  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydromorphone (dilaudid)  0.5  mg ; d5 1 2ns  1000  ml ; dicyclomine  20  mg ; tramadol  50  mg ; moviprep  1  l ; hydrocortisone (rectal) 2.5% cream  1  appl ; lorazepam  0.25-0.5  mg ; lorazepam  0.5  mg ; 
 
white f 19 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; dicyclomine  20  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; lorazepam  0.25-0.5  mg ; lorazepam  0.5  mg ; 
 
white f 19 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, indirect  0.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; dicyclomine  20  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; loperamide  4  mg ; psyllium wafer  1-2  waf ; tramadol  25  mg ; 
 
white f 19 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  76  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; dicyclomine  20  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; psyllium wafer  1-2  waf ; tramadol  25  mg ; 
 
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; propranolol  20  mg ; benztropine mesylate  1  mg ; risperidone  2  mg ; clonidine  0.2  mg ; trazodone  50  mg ; haloperidol  5  mg ; benztropine mesylate  0.5  mg ; nadolol  20  mg ; famotidine  20  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; propranolol  20  mg ; benztropine mesylate  1  mg ; trazodone  50  mg ; haloperidol  5  mg ; nadolol  20  mg ; famotidine  20  mg ; lorazepam  1  mg ; quetiapine fumarate  100  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; benztropine mesylate  1  mg ; trazodone  50  mg ; haloperidol  5  mg ; nadolol  20  mg ; famotidine  20  mg ; lorazepam  1  mg ; quetiapine fumarate  100  mg ; haloperidol  10  mg ; atorvastatin  80  mg ; omeprazole  20  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$hematology blood hematocrit  45.1  %; hematology blood hematocrit  43.3  %; hematology blood hemoglobin  14.9  g dl; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  301  k ul; hematology blood platelet count  349  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  8.4  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  145  mg dl$acetaminophen  325-650  mg ; nadolol  20  mg ; famotidine  20  mg ; haloperidol  10  mg ; atorvastatin  80  mg ; omeprazole  20  mg ; aspirin  325  mg ; nitroglycerin sl  0.3  mg ; quetiapine fumarate  200  mg ; colchicine  0.6  mg ; indomethacin  50  mg ; diphenhydramine  50  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; nadolol  20  mg ; famotidine  20  mg ; haloperidol  10  mg ; atorvastatin  80  mg ; omeprazole  20  mg ; aspirin  325  mg ; nitroglycerin sl  0.3  mg ; quetiapine fumarate  200  mg ; colchicine  0.6  mg ; indomethacin  50  mg ; diphenhydramine  50  mg ; ondansetron  4  mg ; quetiapine fumarate  50  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; nadolol  20  mg ; famotidine  20  mg ; haloperidol  10  mg ; omeprazole  20  mg ; colchicine  0.6  mg ; indomethacin  50  mg ; ondansetron  4  mg ; quetiapine fumarate  50  mg ; quetiapine fumarate  400  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; nadolol  20  mg ; famotidine  20  mg ; haloperidol  10  mg ; omeprazole  20  mg ; colchicine  0.6  mg ; indomethacin  50  mg ; quetiapine fumarate  400  mg ; quetiapine fumarate  25  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; nadolol  20  mg ; famotidine  20  mg ; haloperidol  10  mg ; omeprazole  20  mg ; colchicine  0.6  mg ; indomethacin  50  mg ; quetiapine fumarate  25  mg ; quetiapine fumarate  700  mg ; lorazepam  0.5  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; famotidine  20  mg ; haloperidol  10  mg ; omeprazole  20  mg ; colchicine  0.6  mg ; indomethacin  50  mg ; quetiapine fumarate  700  mg ; lorazepam  0.5  mg ; quetiapine fumarate  800  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; famotidine  20  mg ; haloperidol  10  mg ; omeprazole  20  mg ; colchicine  0.6  mg ; indomethacin  50  mg ; lorazepam  0.5  mg ; quetiapine fumarate  800  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; famotidine  20  mg ; haloperidol  10  mg ; omeprazole  20  mg ; colchicine  0.6  mg ; indomethacin  50  mg ; lorazepam  0.5  mg ; quetiapine fumarate  800  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; famotidine  20  mg ; haloperidol  10  mg ; omeprazole  20  mg ; colchicine  0.6  mg ; indomethacin  50  mg ; lorazepam  0.5  mg ; quetiapine fumarate  800  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
black african american m 36 $nan$nan$acetaminophen  325-650  mg ; famotidine  20  mg ; haloperidol  10  mg ; omeprazole  20  mg ; colchicine  0.6  mg ; indomethacin  50  mg ; lorazepam  0.5  mg ; quetiapine fumarate  800  mg ; 
unspecified psychosis palpitations posttraumatic stress disorder unspecified essential hypertension
white m 62 $nan$nan$vitamin b complex w c  1  tab ; lisinopril  20  mg ; nifedipine cr  60  mg ; clopidogrel  75  mg ; aspirin  81  mg ; lansoprazole oral disintegrating tab  30  mg ; cinacalcet  90  mg ; 
other convulsions end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney congestive heart failure, unspecified carrier or suspected carrier of methicillin resistant staphylococcus aureus epilepsy, unspecified, without mention of intractable epilepsy unspecified viral hepatitis c without hepatic coma end stage renal disease combined systolic and diastolic heart failure, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation accidents occurring in other specified places hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease infection and inflammatory reaction due to other vascular device, implant, and graft awaiting organ transplant status unspecified derangement of joint, shoulder region cirrhosis of liver without mention of alcohol pyogenic arthritis, shoulder region complications of transplanted kidney peripheral vascular disease, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other complications due to renal dialysis device, implant, and graft other staphylococcal septicemia synovitis and tenosynovitis, unspecified end stage renal disease tobacco use disorder combined systolic and diastolic heart failure, unspecified congestive heart failure, unspecified epilepsy, unspecified, without mention of intractable epilepsy unspecified acquired hypothyroidism unspecified viral hepatitis c without hepatic coma hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease accidents occurring in other specified places surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified viral hepatitis c without hepatic coma carrier or suspected carrier of other specified bacterial diseases personal history of noncompliance with medical treatment, presenting hazards to health pedestrian injured in nontraffic accident involving other and unspecified motor vehicles infection with microorganisms resistant to penicillins epilepsy, unspecified, without mention of intractable epilepsy congestive heart failure, unspecified complications of transplanted kidney other sequelae of chronic liver disease unspecified acquired hypothyroidism combined systolic and diastolic heart failure, unspecified pulmonary collapse
white m 62 $nan$chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  6.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood glucose  97  mg dl$vitamin b complex w c  1  tab ; lisinopril  20  mg ; nifedipine cr  60  mg ; clopidogrel  75  mg ; aspirin  81  mg ; lansoprazole oral disintegrating tab  30  mg ; cinacalcet  90  mg ; lamotrigine  250  mg ; metoprolol tartrate  50  mg ; clonidine  0.1  mg ; phenytoin  100  mg ; rifaximin  200  mg ; phenytoin  200  mg ; levetiracetam  375  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; heparin flush (5000 units ml)  4000-11000  unit ; levetiracetam  250  mg ; acetaminophen  325  mg ; senna  1  tab ; acetaminophen  650  mg ; 
other convulsions end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney congestive heart failure, unspecified carrier or suspected carrier of methicillin resistant staphylococcus aureus epilepsy, unspecified, without mention of intractable epilepsy unspecified viral hepatitis c without hepatic coma end stage renal disease combined systolic and diastolic heart failure, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation accidents occurring in other specified places hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease infection and inflammatory reaction due to other vascular device, implant, and graft awaiting organ transplant status unspecified derangement of joint, shoulder region cirrhosis of liver without mention of alcohol pyogenic arthritis, shoulder region complications of transplanted kidney peripheral vascular disease, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other complications due to renal dialysis device, implant, and graft other staphylococcal septicemia synovitis and tenosynovitis, unspecified end stage renal disease tobacco use disorder combined systolic and diastolic heart failure, unspecified congestive heart failure, unspecified epilepsy, unspecified, without mention of intractable epilepsy unspecified acquired hypothyroidism unspecified viral hepatitis c without hepatic coma hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease accidents occurring in other specified places surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified viral hepatitis c without hepatic coma carrier or suspected carrier of other specified bacterial diseases personal history of noncompliance with medical treatment, presenting hazards to health pedestrian injured in nontraffic accident involving other and unspecified motor vehicles infection with microorganisms resistant to penicillins epilepsy, unspecified, without mention of intractable epilepsy congestive heart failure, unspecified complications of transplanted kidney other sequelae of chronic liver disease unspecified acquired hypothyroidism combined systolic and diastolic heart failure, unspecified pulmonary collapse
white m 62 $nan$nan$vitamin b complex w c  1  tab ; lisinopril  20  mg ; nifedipine cr  60  mg ; clopidogrel  75  mg ; aspirin  81  mg ; lansoprazole oral disintegrating tab  30  mg ; cinacalcet  90  mg ; lamotrigine  250  mg ; metoprolol tartrate  50  mg ; clonidine  0.1  mg ; rifaximin  200  mg ; phenytoin  200  mg ; levetiracetam  375  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; heparin flush (5000 units ml)  4000-11000  unit ; levetiracetam  250  mg ; acetaminophen  325  mg ; senna  1  tab ; acetaminophen  650  mg ; 
other convulsions end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney congestive heart failure, unspecified carrier or suspected carrier of methicillin resistant staphylococcus aureus epilepsy, unspecified, without mention of intractable epilepsy unspecified viral hepatitis c without hepatic coma end stage renal disease combined systolic and diastolic heart failure, unspecified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation accidents occurring in other specified places hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease infection and inflammatory reaction due to other vascular device, implant, and graft awaiting organ transplant status unspecified derangement of joint, shoulder region cirrhosis of liver without mention of alcohol pyogenic arthritis, shoulder region complications of transplanted kidney peripheral vascular disease, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other complications due to renal dialysis device, implant, and graft other staphylococcal septicemia synovitis and tenosynovitis, unspecified end stage renal disease tobacco use disorder combined systolic and diastolic heart failure, unspecified congestive heart failure, unspecified epilepsy, unspecified, without mention of intractable epilepsy unspecified acquired hypothyroidism unspecified viral hepatitis c without hepatic coma hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease accidents occurring in other specified places surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified viral hepatitis c without hepatic coma carrier or suspected carrier of other specified bacterial diseases personal history of noncompliance with medical treatment, presenting hazards to health pedestrian injured in nontraffic accident involving other and unspecified motor vehicles infection with microorganisms resistant to penicillins epilepsy, unspecified, without mention of intractable epilepsy congestive heart failure, unspecified complications of transplanted kidney other sequelae of chronic liver disease unspecified acquired hypothyroidism combined systolic and diastolic heart failure, unspecified pulmonary collapse
unknown f 48 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  28.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  338  k ul; hematology blood platelet count  330  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  257  mg dl; chemistry blood albumin  3.6  g dl; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  0.9  mmol l$bag  1  bag ; fentanyl citrate     ; influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; docusate sodium (liquid)  100  mg ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; propofol  200  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; fentanyl     ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; pantoprazole  80  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; aspirin  81  mg ; ceftriaxone  1  gm ; ceftriaxone  2  gm ; 5% dextrose  250  ml ; azithromycin   500  mg ; midazolam  100  mg ; midazolam  2  mg ; fentanyl citrate  100-200  mcg ; quetiapine fumarate  50  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; cisatracurium besylate  20  mg ; cisatracurium besylate  100  mg ; propofol  20  mg ; fentanyl citrate  100  mcg ; lamotrigine  100  mg ; acetaminophen  500-1000  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  299  k ul; hematology blood platelet count  270  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  11  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  143  mg dl; chemistry blood lactate dehydrogenase (ld)  284  iu l; chemistry blood albumin  3.1  g dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; cisatracurium besylate  20  mg ; cisatracurium besylate  100  mg ; propofol  20  mg ; fentanyl citrate  100  mcg ; lamotrigine  100  mg ; acetaminophen  500-1000  mg ; ibuprofen suspension  600  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  147  mg dl; chemistry blood glucose  115  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; lamotrigine  100  mg ; acetaminophen  500-1000  mg ; ibuprofen suspension  600  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; neutra-phos  1  pkt ; lactulose enema  1000  ml ; furosemide  20  mg ; acetaminophen iv  1000  mg ; ibuprofen  800  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  111  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; lamotrigine  100  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; neutra-phos  1  pkt ; lactulose  30  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  287  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  165  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.8  mmol l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; lamotrigine  100  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactulose  30  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; diazepam  10  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  122  mg dl; blood gas blood free calcium  1.16  mmol l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; lamotrigine  100  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactulose  30  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; diazepam  10  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  368  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  28  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  221  iu l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  0.8  mmol l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; lamotrigine  100  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactulose  30  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; diazepam  10  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  126  mg dl; chemistry blood lactate dehydrogenase (ld)  250  iu l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; lamotrigine  100  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactulose  30  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; diazepam  10  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; quetiapine fumarate  75  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  374  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  145  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; lamotrigine  100  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactulose  30  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; diazepam  10  mg ; quetiapine fumarate  75  mg ; 5% dextrose  40  ml ; furosemide  40  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  336  k ul; hematology blood platelet count  334  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology urine wbc  6  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  163  mg dl; chemistry blood glucose  158  mg dl; chemistry blood lactate dehydrogenase (ld)  315  iu l; chemistry blood albumin  3.4  g dl; hematology blood bands  8  %; blood gas blood lactate  1.3  mmol l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; lamotrigine  100  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactulose  30  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; diazepam  10  mg ; quetiapine fumarate  75  mg ; 5% dextrose  40  ml ; furosemide  40  mg ; senna  5  ml ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; hematology urine wbc  27  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  166  mg dl; blood gas blood lactate  1.2  mmol l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sw  400  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; quetiapine fumarate  75  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; tuberculin protein  0.1  ml ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  312  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  174  mg dl; chemistry blood lactate dehydrogenase (ld)  276  iu l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; tuberculin protein  0.1  ml ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  367  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  202  mg dl; chemistry blood lactate dehydrogenase (ld)  292  iu l; blood gas blood free calcium  1.17  mmol l; blood gas blood chloride, whole blood  113  meq l; blood gas blood glucose  193  mg dl; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood sodium, whole blood  146  meq l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; soln  100  ml ; haloperidol  0.25  mg ; haloperidol  2.5  mg ; psyllium wafer  1  waf ; aripiprazole  10  mg ; amitriptyline  25  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  367  k ul; hematology blood platelet count  387  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  146  mg dl; chemistry blood glucose  168  mg dl; chemistry blood lactate dehydrogenase (ld)  290  iu l; blood gas blood free calcium  1.19  mmol l; blood gas blood lactate  1.0  mmol l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; soln  100  ml ; haloperidol  2.5  mg ; amitriptyline  25  mg ; simethicone  40-80  mg ; venlafaxine  75  mg ; haloperidol  1-2.5  mg ; haloperidol  5  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  370  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  162  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; soln  100  ml ; amitriptyline  25  mg ; simethicone  40-80  mg ; venlafaxine  75  mg ; haloperidol  5  mg ; 5% dextrose  50  ml ; ethacrynate sodium  50  mg ; succinylcholine  120  mg ; propofol  100  mg ; methylprednisolone sodium succ  20  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  412  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  176  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; soln  100  ml ; amitriptyline  25  mg ; simethicone  40-80  mg ; venlafaxine  75  mg ; 5% dextrose  50  ml ; ethacrynate sodium  50  mg ; succinylcholine  120  mg ; propofol  100  mg ; methylprednisolone sodium succ  20  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  399  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  204  mg dl; chemistry blood glucose  186  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; soln  100  ml ; amitriptyline  25  mg ; simethicone  40-80  mg ; venlafaxine  75  mg ; methylprednisolone sodium succ  20  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  435  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  202  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; soln  100  ml ; amitriptyline  25  mg ; simethicone  40-80  mg ; venlafaxine  75  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  427  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  170  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; soln  100  ml ; amitriptyline  25  mg ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  10-20  ml ; haloperidol  2  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  426  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  189  mg dl; hematology blood bands  0  %$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; soln  100  ml ; amitriptyline  25  mg ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  10-20  ml ; haloperidol  2  mg ; olanzapine (disintegrating tablet)  5  mg ; lorazepam  1  mg ; 5% dextrose  150  ml ; vancomycin  250  mg ; vancomycin  1250  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  42  mg dl; hematology urine wbc  54  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  219  mg dl; blood gas blood lactate  1.3  mmol l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; propofol  10  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; soln  100  ml ; amitriptyline  25  mg ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  10-20  ml ; olanzapine (disintegrating tablet)  5  mg ; lorazepam  1  mg ; 5% dextrose  150  ml ; vancomycin  250  mg ; vancomycin  1250  mg ; hydromorphone (dilaudid)  0.25  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  219  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; soln  100  ml ; amitriptyline  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; vancomycin  1250  mg ; hydromorphone (dilaudid)  0.25  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  220  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; senna  5  ml ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; soln  100  ml ; amitriptyline  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; vancomycin  1250  mg ; hydromorphone (dilaudid)  0.25  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 5% dextrose  500  ml ; vancomycin  1500  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  241  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; soln  100  ml ; amitriptyline  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; hydromorphone (dilaudid)  0.25  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 5% dextrose  500  ml ; vancomycin  1500  mg ; prednisone  20  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  206  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; ibuprofen  400-600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; soln  100  ml ; amitriptyline  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; hydromorphone (dilaudid)  0.25  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; prednisone  20  mg ; lansoprazole oral disintegrating tab  30  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  160  mg dl$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; magnesium sulfate (latex free)  2  gm ; magnesium sulfate (latex free)  4  gm ; 0.9% sodium chloride  250  ml ; ibuprofen  400-600  mg ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; soln  100  ml ; amitriptyline  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; hydromorphone (dilaudid)  0.25  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; prednisone  20  mg ; lansoprazole oral disintegrating tab  30  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  172  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400-600  mg ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  143  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400-600  mg ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; amlodipine  10  mg ; baclofen  10  mg ; lisinopril  5  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  192  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400-600  mg ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; amlodipine  10  mg ; baclofen  10  mg ; lisinopril  5  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  19  mg dl; hematology urine wbc  9  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  182  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400-600  mg ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; amlodipine  10  mg ; baclofen  10  mg ; lisinopril  5  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  162  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400-600  mg ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; amlodipine  10  mg ; baclofen  10  mg ; lisinopril  5  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry urine chloride, urine  10  meq l; chemistry urine creatinine, urine  75  mg dl; chemistry urine potassium, urine  8  meq l; chemistry urine sodium, urine  12  meq l; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  172  mg dl; chemistry blood lactate dehydrogenase (ld)  267  iu l; chemistry blood albumin  3.4  g dl; blood gas blood lactate  1.0  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; amlodipine  10  mg ; baclofen  10  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; fluconazole  150  mg ; lorazepam  0.5-1  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  146  mg dl; chemistry blood % hemoglobin a1c  7.0  %$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; amlodipine  10  mg ; baclofen  10  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; fluconazole  150  mg ; lorazepam  0.5-1  mg ; baclofen  5  mg ; acetaminophen  325-650  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  133  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; amlodipine  10  mg ; lorazepam  0.5-1  mg ; baclofen  5  mg ; acetaminophen  325-650  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  361  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  141  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; amlodipine  10  mg ; lorazepam  0.5-1  mg ; baclofen  5  mg ; acetaminophen  325-650  mg ; dextromethorphan-guaifenesin (sugar free)  5  ml ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 48 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  124  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; polyethylene glycol  17  g ; miconazole powder 2%  1  appl ; senna  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; amlodipine  10  mg ; lorazepam  0.5-1  mg ; baclofen  5  mg ; acetaminophen  325-650  mg ; dextromethorphan-guaifenesin (sugar free)  5  ml ; ondansetron  4-8  mg ; ondansetron  8  mg ; 
hyposmolality and/or hyponatremia tobacco use disorder backache, unspecified other specified non-arthropod-borne viral diseases of central nervous system tachycardia, unspecified other chronic pain body mass index 32.0-32.9, adult obesity, unspecified major depressive affective disorder, single episode, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 54 $nan$nan$citalopram  20  mg ; atenolol  25  mg ; paliperidone er  6  mg ; 
unspecified essential hypertension paranoid type schizophrenia, unspecified
white f 54 $nan$nan$citalopram  20  mg ; atenolol  25  mg ; paliperidone er  6  mg ; influenza virus vaccine  0.5  ml ; lorazepam  1  mg ; olanzapine  2.5  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; 
unspecified essential hypertension paranoid type schizophrenia, unspecified
white f 54 $nan$nan$citalopram  20  mg ; atenolol  25  mg ; paliperidone er  6  mg ; influenza virus vaccine  0.5  ml ; lorazepam  1  mg ; olanzapine  2.5  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; olanzapine  5  mg ; 
unspecified essential hypertension paranoid type schizophrenia, unspecified
white f 54 $nan$nan$citalopram  20  mg ; atenolol  25  mg ; paliperidone er  6  mg ; influenza virus vaccine  0.5  ml ; lorazepam  1  mg ; olanzapine  2.5  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; olanzapine  7.5  mg ; 
unspecified essential hypertension paranoid type schizophrenia, unspecified
white f 54 $nan$nan$citalopram  20  mg ; atenolol  25  mg ; paliperidone er  6  mg ; influenza virus vaccine  0.5  ml ; lorazepam  1  mg ; olanzapine  2.5  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; olanzapine  10  mg ; 
unspecified essential hypertension paranoid type schizophrenia, unspecified
white f 54 $nan$nan$citalopram  20  mg ; atenolol  25  mg ; paliperidone er  6  mg ; influenza virus vaccine  0.5  ml ; lorazepam  1  mg ; olanzapine  2.5  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; olanzapine  10  mg ; 
unspecified essential hypertension paranoid type schizophrenia, unspecified
white f 54 $nan$nan$citalopram  20  mg ; atenolol  25  mg ; paliperidone er  6  mg ; influenza virus vaccine  0.5  ml ; lorazepam  1  mg ; olanzapine  2.5  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; olanzapine  10  mg ; 
unspecified essential hypertension paranoid type schizophrenia, unspecified
white f 54 $nan$nan$citalopram  20  mg ; atenolol  25  mg ; paliperidone er  6  mg ; influenza virus vaccine  0.5  ml ; lorazepam  1  mg ; olanzapine  2.5  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; olanzapine  10  mg ; 
unspecified essential hypertension paranoid type schizophrenia, unspecified
white m 60 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  39  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  257  mg dl$sodium chloride 0.9%  flush  3  ml ; lactulose  30  ml ; magnesium oxide  400  mg ; oxycodone (immediate release)  5-10  mg ; rifaximin  550  mg ; ursodiol  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  1000  ml ; ferrous sulfate  325  mg ; furosemide  20  mg ; multivitamins w minerals  1  tab ; spironolactone  50  mg ; acetaminophen  650  mg ; 
nicotine dependence, cigarettes, uncomplicated unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified awaiting organ transplant status type 2 diabetes mellitus without complications liver cell carcinoma unspecified cirrhosis of liver major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain major depressive disorder, single episode, unspecified chondrocostal junction syndrome [tietze] body mass index (bmi) 21.0-21.9, adult chronic pain due to trauma unspecified viral hepatitis c without hepatic coma malignant neoplasm of liver, primary, unspecified as to type awaiting organ transplant status angiodysplasia of stomach and duodenum without bleeding unspecified severe protein-calorie malnutrition secondary esophageal varices without bleeding type 2 diabetes mellitus without complications other hemorrhoids other cirrhosis of liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified essential hypertension hyposmolality and/or hyponatremia unspecified viral hepatitis c with hepatic coma tobacco use disorder other fluid overload thrombocytopenia, unspecified leukocytopenia, unspecified cirrhosis of liver without mention of alcohol cellulitis and abscess of foot, except toes
white m 60 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactulose  30  ml ; magnesium oxide  400  mg ; oxycodone (immediate release)  5-10  mg ; rifaximin  550  mg ; ursodiol  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  1000  ml ; ferrous sulfate  325  mg ; furosemide  20  mg ; multivitamins w minerals  1  tab ; spironolactone  50  mg ; acetaminophen  650  mg ; nadolol  60  mg ; pantoprazole  40  mg ; 
nicotine dependence, cigarettes, uncomplicated unspecified viral hepatitis c without hepatic coma anxiety disorder, unspecified awaiting organ transplant status type 2 diabetes mellitus without complications liver cell carcinoma unspecified cirrhosis of liver major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain major depressive disorder, single episode, unspecified chondrocostal junction syndrome [tietze] body mass index (bmi) 21.0-21.9, adult chronic pain due to trauma unspecified viral hepatitis c without hepatic coma malignant neoplasm of liver, primary, unspecified as to type awaiting organ transplant status angiodysplasia of stomach and duodenum without bleeding unspecified severe protein-calorie malnutrition secondary esophageal varices without bleeding type 2 diabetes mellitus without complications other hemorrhoids other cirrhosis of liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified essential hypertension hyposmolality and/or hyponatremia unspecified viral hepatitis c with hepatic coma tobacco use disorder other fluid overload thrombocytopenia, unspecified leukocytopenia, unspecified cirrhosis of liver without mention of alcohol cellulitis and abscess of foot, except toes
hispanic latino f 30 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; acetaminophen  500-1000  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; isotonic sodium chloride  50  ml ; gentamicin  80  mg ; 
 
hispanic latino f 30 $nan$hematology blood hematocrit  36.1  %$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; acetaminophen  500-1000  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; isotonic sodium chloride  50  ml ; gentamicin  80  mg ; oxycodone-acetaminophen  1-2  tab ; dibucaine  1  appl ; sertraline  50  mg ; 
 
hispanic latino f 30 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; acetaminophen  500-1000  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone-acetaminophen  1-2  tab ; dibucaine  1  appl ; sertraline  50  mg ; 
 
hispanic latino f 30 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; acetaminophen  500-1000  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone-acetaminophen  1-2  tab ; dibucaine  1  appl ; sertraline  50  mg ; 
 
hispanic latino f 31 $nan$nan$atenolol  25  mg ; enalapril maleate  2.5  mg ; atorvastatin  20  mg ; escitalopram oxalate  40  mg ; 
other chest pain long-term (current) use of anticoagulants long-term (current) use of non-steroidal anti-inflammatories (nsaid) unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia personal history of venous thrombosis and embolism long-term (current) use of aspirin other respiratory abnormalities hemorrhage of rectum and anus obstructive sleep apnea (adult)(pediatric) schizoaffective disorder, unspecified abdominal pain, unspecified site anemia, unspecified unspecified essential hypertension posttraumatic stress disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants personal history of venous thrombosis and embolism borderline personality disorder morbid obesity major depressive affective disorder, single episode, unspecified long-term (current) use of anticoagulants abdominal pain, other specified site pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity long-term (current) use of aspirin other chest pain borderline personality disorder cellulitis and abscess of trunk personal history of venous thrombosis and embolism posttraumatic stress disorder unspecified essential hypertension schizoaffective disorder, unspecified pure hypercholesterolemia morbid obesity cellulitis and abscess of trunk unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) schizoaffective disorder, unspecified peripheral vascular complications, not elsewhere classified acute venous embolism and thrombosis of deep veins of upper extremity posttraumatic stress disorder excessive or frequent menstruation morbid obesity diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 31 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  146  mg dl$vancomycin  1000  mg ; atenolol  25  mg ; enalapril maleate  2.5  mg ; atorvastatin  20  mg ; escitalopram oxalate  40  mg ; fluticasone propionate 110mcg  2  puff ; gabapentin  300  mg ; ropinirole  0.25  mg ; benztropine mesylate  1  mg ; haloperidol  1.5  mg ; iso-osmotic dextrose  200  ml ; quetiapine fumarate  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lamotrigine  200  mg ; albuterol 0.083% neb soln  1  neb ; zolpidem tartrate  5  mg ; insulin  0  unit ; morphine sulfate  2-4  mg ; d5w  300  ml ; linezolid  600  mg ; 0.9% sodium chloride  1000  ml ; 5% dextrose  500  ml ; vancomycin  1500  mg ; 
other chest pain long-term (current) use of anticoagulants long-term (current) use of non-steroidal anti-inflammatories (nsaid) unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia personal history of venous thrombosis and embolism long-term (current) use of aspirin other respiratory abnormalities hemorrhage of rectum and anus obstructive sleep apnea (adult)(pediatric) schizoaffective disorder, unspecified abdominal pain, unspecified site anemia, unspecified unspecified essential hypertension posttraumatic stress disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants personal history of venous thrombosis and embolism borderline personality disorder morbid obesity major depressive affective disorder, single episode, unspecified long-term (current) use of anticoagulants abdominal pain, other specified site pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity long-term (current) use of aspirin other chest pain borderline personality disorder cellulitis and abscess of trunk personal history of venous thrombosis and embolism posttraumatic stress disorder unspecified essential hypertension schizoaffective disorder, unspecified pure hypercholesterolemia morbid obesity cellulitis and abscess of trunk unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) schizoaffective disorder, unspecified peripheral vascular complications, not elsewhere classified acute venous embolism and thrombosis of deep veins of upper extremity posttraumatic stress disorder excessive or frequent menstruation morbid obesity diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 31 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  330  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood glucose  124  mg dl$atenolol  25  mg ; enalapril maleate  2.5  mg ; atorvastatin  20  mg ; escitalopram oxalate  40  mg ; fluticasone propionate 110mcg  2  puff ; gabapentin  300  mg ; ropinirole  0.25  mg ; quetiapine fumarate  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lamotrigine  200  mg ; albuterol 0.083% neb soln  1  neb ; zolpidem tartrate  5  mg ; insulin  0  unit ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1000  ml ; 5% dextrose  500  ml ; vancomycin  1500  mg ; morphine sulfate  4  mg ; 
other chest pain long-term (current) use of anticoagulants long-term (current) use of non-steroidal anti-inflammatories (nsaid) unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia personal history of venous thrombosis and embolism long-term (current) use of aspirin other respiratory abnormalities hemorrhage of rectum and anus obstructive sleep apnea (adult)(pediatric) schizoaffective disorder, unspecified abdominal pain, unspecified site anemia, unspecified unspecified essential hypertension posttraumatic stress disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants personal history of venous thrombosis and embolism borderline personality disorder morbid obesity major depressive affective disorder, single episode, unspecified long-term (current) use of anticoagulants abdominal pain, other specified site pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity long-term (current) use of aspirin other chest pain borderline personality disorder cellulitis and abscess of trunk personal history of venous thrombosis and embolism posttraumatic stress disorder unspecified essential hypertension schizoaffective disorder, unspecified pure hypercholesterolemia morbid obesity cellulitis and abscess of trunk unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) schizoaffective disorder, unspecified peripheral vascular complications, not elsewhere classified acute venous embolism and thrombosis of deep veins of upper extremity posttraumatic stress disorder excessive or frequent menstruation morbid obesity diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 31 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  372  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  146  mg dl$atenolol  25  mg ; enalapril maleate  2.5  mg ; atorvastatin  20  mg ; escitalopram oxalate  40  mg ; fluticasone propionate 110mcg  2  puff ; gabapentin  300  mg ; ropinirole  0.25  mg ; quetiapine fumarate  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lamotrigine  200  mg ; albuterol 0.083% neb soln  1  neb ; zolpidem tartrate  5  mg ; insulin  0  unit ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1000  ml ; 5% dextrose  500  ml ; vancomycin  1500  mg ; morphine sulfate  4  mg ; warfarin  5  mg ; 
other chest pain long-term (current) use of anticoagulants long-term (current) use of non-steroidal anti-inflammatories (nsaid) unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia personal history of venous thrombosis and embolism long-term (current) use of aspirin other respiratory abnormalities hemorrhage of rectum and anus obstructive sleep apnea (adult)(pediatric) schizoaffective disorder, unspecified abdominal pain, unspecified site anemia, unspecified unspecified essential hypertension posttraumatic stress disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants personal history of venous thrombosis and embolism borderline personality disorder morbid obesity major depressive affective disorder, single episode, unspecified long-term (current) use of anticoagulants abdominal pain, other specified site pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity long-term (current) use of aspirin other chest pain borderline personality disorder cellulitis and abscess of trunk personal history of venous thrombosis and embolism posttraumatic stress disorder unspecified essential hypertension schizoaffective disorder, unspecified pure hypercholesterolemia morbid obesity cellulitis and abscess of trunk unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) schizoaffective disorder, unspecified peripheral vascular complications, not elsewhere classified acute venous embolism and thrombosis of deep veins of upper extremity posttraumatic stress disorder excessive or frequent menstruation morbid obesity diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 31 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  385  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  116  mg dl$atenolol  25  mg ; enalapril maleate  2.5  mg ; atorvastatin  20  mg ; escitalopram oxalate  40  mg ; fluticasone propionate 110mcg  2  puff ; gabapentin  300  mg ; ropinirole  0.25  mg ; quetiapine fumarate  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lamotrigine  200  mg ; albuterol 0.083% neb soln  1  neb ; zolpidem tartrate  5  mg ; insulin  0  unit ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1000  ml ; 5% dextrose  500  ml ; vancomycin  1500  mg ; warfarin  5  mg ; hydromorphone (dilaudid)  0.125  mg ; ondansetron  4  mg ; 
other chest pain long-term (current) use of anticoagulants long-term (current) use of non-steroidal anti-inflammatories (nsaid) unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia personal history of venous thrombosis and embolism long-term (current) use of aspirin other respiratory abnormalities hemorrhage of rectum and anus obstructive sleep apnea (adult)(pediatric) schizoaffective disorder, unspecified abdominal pain, unspecified site anemia, unspecified unspecified essential hypertension posttraumatic stress disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants personal history of venous thrombosis and embolism borderline personality disorder morbid obesity major depressive affective disorder, single episode, unspecified long-term (current) use of anticoagulants abdominal pain, other specified site pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity long-term (current) use of aspirin other chest pain borderline personality disorder cellulitis and abscess of trunk personal history of venous thrombosis and embolism posttraumatic stress disorder unspecified essential hypertension schizoaffective disorder, unspecified pure hypercholesterolemia morbid obesity cellulitis and abscess of trunk unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) schizoaffective disorder, unspecified peripheral vascular complications, not elsewhere classified acute venous embolism and thrombosis of deep veins of upper extremity posttraumatic stress disorder excessive or frequent menstruation morbid obesity diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 31 $nan$nan$atenolol  25  mg ; enalapril maleate  2.5  mg ; atorvastatin  20  mg ; escitalopram oxalate  40  mg ; fluticasone propionate 110mcg  2  puff ; gabapentin  300  mg ; ropinirole  0.25  mg ; quetiapine fumarate  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lamotrigine  200  mg ; albuterol 0.083% neb soln  1  neb ; zolpidem tartrate  5  mg ; insulin  0  unit ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1000  ml ; warfarin  5  mg ; hydromorphone (dilaudid)  0.125  mg ; ondansetron  4  mg ; 
other chest pain long-term (current) use of anticoagulants long-term (current) use of non-steroidal anti-inflammatories (nsaid) unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia personal history of venous thrombosis and embolism long-term (current) use of aspirin other respiratory abnormalities hemorrhage of rectum and anus obstructive sleep apnea (adult)(pediatric) schizoaffective disorder, unspecified abdominal pain, unspecified site anemia, unspecified unspecified essential hypertension posttraumatic stress disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants personal history of venous thrombosis and embolism borderline personality disorder morbid obesity major depressive affective disorder, single episode, unspecified long-term (current) use of anticoagulants abdominal pain, other specified site pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity long-term (current) use of aspirin other chest pain borderline personality disorder cellulitis and abscess of trunk personal history of venous thrombosis and embolism posttraumatic stress disorder unspecified essential hypertension schizoaffective disorder, unspecified pure hypercholesterolemia morbid obesity cellulitis and abscess of trunk unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) schizoaffective disorder, unspecified peripheral vascular complications, not elsewhere classified acute venous embolism and thrombosis of deep veins of upper extremity posttraumatic stress disorder excessive or frequent menstruation morbid obesity diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 78 $temp  98.1  heartrate  70.0  resprate  18.0  o2sat  99.0  sbp  132.0  dbp  80.0  rhythm    pain  5  $hematology blood hematocrit  29.9  %; hematology blood hematocrit  29.4  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  220  k ul; hematology blood platelet count  224  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  6.2  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  532  mg dl; chemistry blood glucose  99  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; fluoxetine  10  mg ; simvastatin  20  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lactated ringers  1000  ml ; d5 1 2ns  1000  ml ; morphine sulfate  2  mg ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; 
 
white f 78 $nan$hematology blood hematocrit  28.5  %$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; fluoxetine  10  mg ; simvastatin  20  mg ; heparin  5000  unit ; d5 1 2ns  1000  ml ; morphine sulfate  2  mg ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; 
 
white f 78 $nan$hematology blood hematocrit  27.3  %$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; fluoxetine  10  mg ; simvastatin  20  mg ; heparin  5000  unit ; d5 1 2ns  1000  ml ; morphine sulfate  2  mg ; acetaminophen  1000  mg ; tramadol (ultram)  50  mg ; 
 
white f 78 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; fluoxetine  10  mg ; simvastatin  20  mg ; heparin  5000  unit ; tramadol (ultram)  50  mg ; 
 
white m 56 $temp  97.9  heartrate  55.0  resprate  16.0  o2sat  95.0  sbp  97.0  dbp  52.0  rhythm    pain  0  $hematology blood hematocrit  31.8  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  80  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  2.8  g dl; blood gas blood potassium, whole blood  4.5  meq l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; flecainide acetate  100  mg ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (250 50)   1  inh ; ipratropium-albuterol inhalation spray  1  inh ; ketoconazole 2%   1  appl ; oxycodone sr (oxycontin)  10  mg ; oxycodone sr (oxycontin)  20  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  12.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; prednisone  30  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; vitamin d  800  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; sulfameth trimethoprim ss  1  tab ; calcium carbonate  500  mg ; 
personal history of nicotine dependence anemia in other chronic diseases classified elsewhere hyperglycemia, unspecified bronchiectasis with (acute) exacerbation adverse effect of glucocorticoids and synthetic analogues, initial encounter unspecified bacterial pneumonia obesity, unspecified age-related osteoporosis without current pathological fracture unspecified cirrhosis of liver thrombocytopenia, unspecified other specified places as the place of occurrence of the external cause cushing's syndrome, unspecified acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis unspecified asthma, uncomplicated chronic atrial fibrillation body mass index (bmi) 31.0-31.9, adult alpha-1-antitrypsin deficiency accidental fall on or from sidewalk curb bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen personal history of pneumonia (recurrent) personal history of nicotine dependence influenza due to other identified influenza virus with other respiratory manifestations bronchiectasis with (acute) exacerbation other chronic pain obesity, unspecified unspecified asthma, uncomplicated other specified disorders of veins arteritis, unspecified chronic atrial fibrillation accidental fall on or from sidewalk curb anemia, unspecified bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen unspecified cirrhosis of liver emphysema, unspecified alpha-1-antitrypsin deficiency thrombocytopenia, unspecified body mass index (bmi) 31.0-31.9, adult other chronic pain resistance to multiple antimicrobial drugs unspecified asthma, uncomplicated diarrhea, unspecified obesity, unspecified bronchiectasis with acute lower respiratory infection personal history of nicotine dependence unspecified cirrhosis of liver
white m 56 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  69  mg dl; blood gas blood free calcium  1.16  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; flecainide acetate  100  mg ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (250 50)   1  inh ; ipratropium-albuterol inhalation spray  1  inh ; ketoconazole 2%   1  appl ; oxycodone sr (oxycontin)  10  mg ; oxycodone sr (oxycontin)  20  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  12.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; prednisone  30  mg ; heparin flush (10 units ml)  5  ml ; vitamin d  800  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; sulfameth trimethoprim ss  1  tab ; calcium carbonate  500  mg ; zolpidem tartrate  10  mg ; 0.9% sodium chloride  100  ml ; tobramycin sulfate  620  mg ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; 
personal history of nicotine dependence anemia in other chronic diseases classified elsewhere hyperglycemia, unspecified bronchiectasis with (acute) exacerbation adverse effect of glucocorticoids and synthetic analogues, initial encounter unspecified bacterial pneumonia obesity, unspecified age-related osteoporosis without current pathological fracture unspecified cirrhosis of liver thrombocytopenia, unspecified other specified places as the place of occurrence of the external cause cushing's syndrome, unspecified acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis unspecified asthma, uncomplicated chronic atrial fibrillation body mass index (bmi) 31.0-31.9, adult alpha-1-antitrypsin deficiency accidental fall on or from sidewalk curb bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen personal history of pneumonia (recurrent) personal history of nicotine dependence influenza due to other identified influenza virus with other respiratory manifestations bronchiectasis with (acute) exacerbation other chronic pain obesity, unspecified unspecified asthma, uncomplicated other specified disorders of veins arteritis, unspecified chronic atrial fibrillation accidental fall on or from sidewalk curb anemia, unspecified bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen unspecified cirrhosis of liver emphysema, unspecified alpha-1-antitrypsin deficiency thrombocytopenia, unspecified body mass index (bmi) 31.0-31.9, adult other chronic pain resistance to multiple antimicrobial drugs unspecified asthma, uncomplicated diarrhea, unspecified obesity, unspecified bronchiectasis with acute lower respiratory infection personal history of nicotine dependence unspecified cirrhosis of liver
white m 56 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; flecainide acetate  100  mg ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (250 50)   1  inh ; ipratropium-albuterol inhalation spray  1  inh ; ketoconazole 2%   1  appl ; oxycodone sr (oxycontin)  10  mg ; oxycodone sr (oxycontin)  20  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  12.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  800  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; sulfameth trimethoprim ss  1  tab ; calcium carbonate  500  mg ; zolpidem tartrate  10  mg ; 0.9% sodium chloride  100  ml ; tobramycin sulfate  620  mg ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; 
personal history of nicotine dependence anemia in other chronic diseases classified elsewhere hyperglycemia, unspecified bronchiectasis with (acute) exacerbation adverse effect of glucocorticoids and synthetic analogues, initial encounter unspecified bacterial pneumonia obesity, unspecified age-related osteoporosis without current pathological fracture unspecified cirrhosis of liver thrombocytopenia, unspecified other specified places as the place of occurrence of the external cause cushing's syndrome, unspecified acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis unspecified asthma, uncomplicated chronic atrial fibrillation body mass index (bmi) 31.0-31.9, adult alpha-1-antitrypsin deficiency accidental fall on or from sidewalk curb bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen personal history of pneumonia (recurrent) personal history of nicotine dependence influenza due to other identified influenza virus with other respiratory manifestations bronchiectasis with (acute) exacerbation other chronic pain obesity, unspecified unspecified asthma, uncomplicated other specified disorders of veins arteritis, unspecified chronic atrial fibrillation accidental fall on or from sidewalk curb anemia, unspecified bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen unspecified cirrhosis of liver emphysema, unspecified alpha-1-antitrypsin deficiency thrombocytopenia, unspecified body mass index (bmi) 31.0-31.9, adult other chronic pain resistance to multiple antimicrobial drugs unspecified asthma, uncomplicated diarrhea, unspecified obesity, unspecified bronchiectasis with acute lower respiratory infection personal history of nicotine dependence unspecified cirrhosis of liver
white m 56 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; flecainide acetate  100  mg ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (250 50)   1  inh ; ipratropium-albuterol inhalation spray  1  inh ; ketoconazole 2%   1  appl ; oxycodone sr (oxycontin)  10  mg ; oxycodone sr (oxycontin)  20  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; acetylcysteine 20%  3-5  ml ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  800  unit ; sulfameth trimethoprim ss  1  tab ; calcium carbonate  500  mg ; zolpidem tartrate  10  mg ; 0.9% sodium chloride  100  ml ; tobramycin sulfate  620  mg ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; meropenem  2000  mg ; prednisone  10  mg ; 
personal history of nicotine dependence anemia in other chronic diseases classified elsewhere hyperglycemia, unspecified bronchiectasis with (acute) exacerbation adverse effect of glucocorticoids and synthetic analogues, initial encounter unspecified bacterial pneumonia obesity, unspecified age-related osteoporosis without current pathological fracture unspecified cirrhosis of liver thrombocytopenia, unspecified other specified places as the place of occurrence of the external cause cushing's syndrome, unspecified acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis unspecified asthma, uncomplicated chronic atrial fibrillation body mass index (bmi) 31.0-31.9, adult alpha-1-antitrypsin deficiency accidental fall on or from sidewalk curb bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen personal history of pneumonia (recurrent) personal history of nicotine dependence influenza due to other identified influenza virus with other respiratory manifestations bronchiectasis with (acute) exacerbation other chronic pain obesity, unspecified unspecified asthma, uncomplicated other specified disorders of veins arteritis, unspecified chronic atrial fibrillation accidental fall on or from sidewalk curb anemia, unspecified bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen unspecified cirrhosis of liver emphysema, unspecified alpha-1-antitrypsin deficiency thrombocytopenia, unspecified body mass index (bmi) 31.0-31.9, adult other chronic pain resistance to multiple antimicrobial drugs unspecified asthma, uncomplicated diarrhea, unspecified obesity, unspecified bronchiectasis with acute lower respiratory infection personal history of nicotine dependence unspecified cirrhosis of liver
white m 56 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  75  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; flecainide acetate  100  mg ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (250 50)   1  inh ; ipratropium-albuterol inhalation spray  1  inh ; ketoconazole 2%   1  appl ; oxycodone sr (oxycontin)  10  mg ; oxycodone sr (oxycontin)  20  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; acetylcysteine 20%  3-5  ml ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  800  unit ; sulfameth trimethoprim ss  1  tab ; calcium carbonate  500  mg ; zolpidem tartrate  10  mg ; 0.9% sodium chloride  100  ml ; tobramycin sulfate  620  mg ; sodium chloride 0.9%  flush  10  ml ; meropenem  2000  mg ; prednisone  10  mg ; prednisone  5  mg ; 
personal history of nicotine dependence anemia in other chronic diseases classified elsewhere hyperglycemia, unspecified bronchiectasis with (acute) exacerbation adverse effect of glucocorticoids and synthetic analogues, initial encounter unspecified bacterial pneumonia obesity, unspecified age-related osteoporosis without current pathological fracture unspecified cirrhosis of liver thrombocytopenia, unspecified other specified places as the place of occurrence of the external cause cushing's syndrome, unspecified acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis unspecified asthma, uncomplicated chronic atrial fibrillation body mass index (bmi) 31.0-31.9, adult alpha-1-antitrypsin deficiency accidental fall on or from sidewalk curb bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen personal history of pneumonia (recurrent) personal history of nicotine dependence influenza due to other identified influenza virus with other respiratory manifestations bronchiectasis with (acute) exacerbation other chronic pain obesity, unspecified unspecified asthma, uncomplicated other specified disorders of veins arteritis, unspecified chronic atrial fibrillation accidental fall on or from sidewalk curb anemia, unspecified bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen unspecified cirrhosis of liver emphysema, unspecified alpha-1-antitrypsin deficiency thrombocytopenia, unspecified body mass index (bmi) 31.0-31.9, adult other chronic pain resistance to multiple antimicrobial drugs unspecified asthma, uncomplicated diarrhea, unspecified obesity, unspecified bronchiectasis with acute lower respiratory infection personal history of nicotine dependence unspecified cirrhosis of liver
white m 56 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; flecainide acetate  100  mg ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (250 50)   1  inh ; ipratropium-albuterol inhalation spray  1  inh ; ketoconazole 2%   1  appl ; oxycodone sr (oxycontin)  10  mg ; oxycodone sr (oxycontin)  20  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; acetylcysteine 20%  3-5  ml ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  800  unit ; sulfameth trimethoprim ss  1  tab ; calcium carbonate  500  mg ; zolpidem tartrate  10  mg ; 0.9% sodium chloride  100  ml ; tobramycin sulfate  620  mg ; sodium chloride 0.9%  flush  10  ml ; meropenem  2000  mg ; prednisone  5  mg ; 
personal history of nicotine dependence anemia in other chronic diseases classified elsewhere hyperglycemia, unspecified bronchiectasis with (acute) exacerbation adverse effect of glucocorticoids and synthetic analogues, initial encounter unspecified bacterial pneumonia obesity, unspecified age-related osteoporosis without current pathological fracture unspecified cirrhosis of liver thrombocytopenia, unspecified other specified places as the place of occurrence of the external cause cushing's syndrome, unspecified acute and chronic respiratory failure with hypoxia gastro-esophageal reflux disease without esophagitis unspecified asthma, uncomplicated chronic atrial fibrillation body mass index (bmi) 31.0-31.9, adult alpha-1-antitrypsin deficiency accidental fall on or from sidewalk curb bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen personal history of pneumonia (recurrent) personal history of nicotine dependence influenza due to other identified influenza virus with other respiratory manifestations bronchiectasis with (acute) exacerbation other chronic pain obesity, unspecified unspecified asthma, uncomplicated other specified disorders of veins arteritis, unspecified chronic atrial fibrillation accidental fall on or from sidewalk curb anemia, unspecified bronchiectasis with acute lower respiratory infection dependence on supplemental oxygen unspecified cirrhosis of liver emphysema, unspecified alpha-1-antitrypsin deficiency thrombocytopenia, unspecified body mass index (bmi) 31.0-31.9, adult other chronic pain resistance to multiple antimicrobial drugs unspecified asthma, uncomplicated diarrhea, unspecified obesity, unspecified bronchiectasis with acute lower respiratory infection personal history of nicotine dependence unspecified cirrhosis of liver
white f 81 $temp  97.6  heartrate  77.0  resprate  17.0  o2sat  98.0  sbp  180.0  dbp  69.0  rhythm    pain  0  $hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  373  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  167  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; amlodipine  5  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; metronidazole  500  mg ; insulin  0  unit ; mycophenolate mofetil  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; lactated ringers  1000  ml ; tacrolimus  0.5  mg ; levothyroxine sodium  50  mcg ; insulin  14  unit ; bag  1  bag ; magnesium sulfate  2  gm ; hydralazine  10  mg ; ondansetron  4  mg ; clonidine  0.1  mg ; clonidine  0.2  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  425  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  252  mg dl; blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; metronidazole  500  mg ; mycophenolate mofetil  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; lactated ringers  1000  ml ; tacrolimus  0.5  mg ; levothyroxine sodium  50  mcg ; insulin  14  unit ; bag  1  bag ; magnesium sulfate  2  gm ; hydralazine  10  mg ; ondansetron  4  mg ; clonidine  0.1  mg ; clonidine  0.2  mg ; insulin  10  unit ; ondansetron odt  4  mg ; lorazepam  0.5  mg ; prochlorperazine  25  mg ; ns  100  ml ; promethazine  6.25  mg ; furosemide  20  mg ; d5 1 2ns  1000  ml ; metoprolol tartrate  5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; mycophenolate mofetil  500  mg ; tacrolimus  0.5  mg ; levothyroxine sodium  50  mcg ; insulin  14  unit ; clonidine  0.1  mg ; clonidine  0.2  mg ; insulin  10  unit ; ns  100  ml ; promethazine  6.25  mg ; metoprolol tartrate  5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; furosemide  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  28.7  %; hematology blood hematocrit  30.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  308  k ul; hematology blood platelet count  328  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  79  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  77  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; mycophenolate mofetil  500  mg ; tacrolimus  0.5  mg ; levothyroxine sodium  50  mcg ; insulin  14  unit ; clonidine  0.1  mg ; clonidine  0.2  mg ; insulin  10  unit ; ns  100  ml ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  1000  ml ; lidocaine jelly 2% (glydo)  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; bag  2  bag ; magnesium sulfate  4  gm ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry urine chloride, urine  49  meq l; chemistry urine creatinine, urine  55  mg dl; chemistry urine sodium, urine  25  meq l; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  148  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; mycophenolate mofetil  500  mg ; tacrolimus  0.5  mg ; levothyroxine sodium  50  mcg ; insulin  14  unit ; clonidine  0.1  mg ; clonidine  0.2  mg ; insulin  10  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10-20  ml ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; clopidogrel  75  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  29.0  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  287  k ul; hematology blood platelet count  277  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  28  meq l; chemistry urine sodium, urine  20  meq l; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  136  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; insulin  14  unit ; clonidine  0.1  mg ; clonidine  0.2  mg ; insulin  10  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10-20  ml ; clopidogrel  75  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; insulin  14  unit ; clonidine  0.1  mg ; clonidine  0.2  mg ; insulin  10  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10-20  ml ; clopidogrel  75  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  69  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; insulin  14  unit ; clonidine  0.1  mg ; clonidine  0.2  mg ; insulin  10  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10-20  ml ; clopidogrel  75  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; insulin  14  unit ; clonidine  0.1  mg ; clonidine  0.2  mg ; insulin  10  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10-20  ml ; clopidogrel  75  mg ; albumin 25% (12.5g   50ml)  12.5  g ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  51  mg dl; chemistry blood glucose  150  mg dl; chemistry blood lactate dehydrogenase (ld)  146  iu l; chemistry blood albumin  3.0  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; insulin  14  unit ; clonidine  0.1  mg ; clonidine  0.2  mg ; insulin  10  unit ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10-20  ml ; clopidogrel  75  mg ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; ciprofloxacin hcl  500  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; clonidine  0.1  mg ; clonidine  0.2  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10-20  ml ; clopidogrel  75  mg ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; ciprofloxacin hcl  500  mg ; insulin  8  unit ; loperamide  2  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; clonidine  0.1  mg ; clonidine  0.2  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10-20  ml ; clopidogrel  75  mg ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; ciprofloxacin hcl  500  mg ; insulin  8  unit ; loperamide  2  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  89  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; clonidine  0.1  mg ; clonidine  0.2  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; clopidogrel  75  mg ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  8  unit ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  26.4  %; hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  250  k ul; hematology blood platelet count  241  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  124  mg dl; chemistry blood albumin  2.9  g dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; clonidine  0.1  mg ; clonidine  0.2  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; clopidogrel  75  mg ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  8  unit ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; oxycodone (immediate release)  2.5-5  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  41  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; clonidine  0.1  mg ; clonidine  0.2  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; clopidogrel  75  mg ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  8  unit ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; oxycodone (immediate release)  2.5-5  mg ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  127  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; clonidine  0.1  mg ; clonidine  0.2  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; clopidogrel  75  mg ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  8  unit ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; oxycodone (immediate release)  2.5-5  mg ; vitamin d  1000  unit ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 81 $nan$nan$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; calcitriol  0.25  mcg ; carvedilol  25  mg ; pantoprazole  40  mg ; mycophenolate mofetil  500  mg ; levothyroxine sodium  50  mcg ; clonidine  0.1  mg ; clonidine  0.2  mg ; docusate sodium  100  mg ; clopidogrel  75  mg ; ipratropium-albuterol neb  1  neb ; ciprofloxacin hcl  500  mg ; insulin  8  unit ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; oxycodone (immediate release)  2.5-5  mg ; vitamin d  1000  unit ; 
type 2 diabetes mellitus with other skin complications delirium due to known physiological condition hypo-osmolality and hyponatremia personal history of nicotine dependence long term (current) use of insulin non-pressure chronic ulcer of other part of left foot with unspecified severity peripheral vascular angioplasty status with implants and grafts type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene cellulitis of left toe type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic neuropathy, unspecified legal blindness, as defined in usa physical restraint status type 2 diabetes mellitus with diabetic nephropathy kidney transplant status background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of external operation (surgical) wound polyneuropathy in diabetes kidney replaced by transplant chronic diastolic heart failure car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident congestive heart failure, unspecified other postoperative infection diabetes with neurological manifestations, type ii or unspecified type, uncontrolled surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene occlusion and stenosis of carotid artery without mention of cerebral infarction anemia in chronic kidney disease background diabetic retinopathy hemorrhage complicating a procedure asthma, unspecified type, unspecified monoclonal paraproteinemia kidney replaced by transplant congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere personal history of other malignant neoplasm of skin diabetes with renal manifestations, type ii or unspecified type, uncontrolled chronic diastolic heart failure polyneuropathy in diabetes unspecified essential hypertension long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled ulcer of other part of foot
white f 55 $temp  97.8  heartrate  57.0  resprate  18.0  o2sat  98.0  sbp  135.0  dbp  44.0  rhythm    pain  0  ; temp  98.0  heartrate  63.0  resprate  14.0  o2sat  99.0  sbp  156.0  dbp  58.0  rhythm    pain  0  $hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood glucose  57  mg dl; blood gas blood lactate  0.9  mmol l$nan
long term (current) use of insulin hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer hyperlipidemia, unspecified other acute osteomyelitis, left ankle and foot essential (primary) hypertension presence of coronary angioplasty implant and graft nonrheumatic aortic (valve) stenosis atherosclerotic heart disease of native coronary artery without angina pectoris non-pressure chronic ulcer of other part of left foot with necrosis of bone unspecified visual loss methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic neuropathic arthropathy type 2 diabetes mellitus with other specified complication non-pressure chronic ulcer of left heel and midfoot with fat layer exposed type 2 diabetes mellitus with diabetic polyneuropathy essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with other skin complications type 2 diabetes mellitus with foot ulcer long term (current) use of insulin cellulitis of left lower limb hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic neuropathic arthropathy
white f 55 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ciprofloxacin hcl  750  mg ; ns  100  ml ; metronidazole  500  mg ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levothyroxine sodium  50  mcg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; amlodipine  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; gabapentin  300  mg ; labetalol  100  mg ; insulin  8  unit ; sodium chloride nasal  1-2  spry ; atorvastatin  80  mg ; 
long term (current) use of insulin hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer hyperlipidemia, unspecified other acute osteomyelitis, left ankle and foot essential (primary) hypertension presence of coronary angioplasty implant and graft nonrheumatic aortic (valve) stenosis atherosclerotic heart disease of native coronary artery without angina pectoris non-pressure chronic ulcer of other part of left foot with necrosis of bone unspecified visual loss methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic neuropathic arthropathy type 2 diabetes mellitus with other specified complication non-pressure chronic ulcer of left heel and midfoot with fat layer exposed type 2 diabetes mellitus with diabetic polyneuropathy essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with other skin complications type 2 diabetes mellitus with foot ulcer long term (current) use of insulin cellulitis of left lower limb hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic neuropathic arthropathy
white f 55 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ciprofloxacin hcl  750  mg ; ns  100  ml ; metronidazole  500  mg ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levothyroxine sodium  50  mcg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; amlodipine  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; gabapentin  300  mg ; labetalol  100  mg ; insulin  8  unit ; sodium chloride nasal  1-2  spry ; atorvastatin  80  mg ; insulin  15  unit ; 
long term (current) use of insulin hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer hyperlipidemia, unspecified other acute osteomyelitis, left ankle and foot essential (primary) hypertension presence of coronary angioplasty implant and graft nonrheumatic aortic (valve) stenosis atherosclerotic heart disease of native coronary artery without angina pectoris non-pressure chronic ulcer of other part of left foot with necrosis of bone unspecified visual loss methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic neuropathic arthropathy type 2 diabetes mellitus with other specified complication non-pressure chronic ulcer of left heel and midfoot with fat layer exposed type 2 diabetes mellitus with diabetic polyneuropathy essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with other skin complications type 2 diabetes mellitus with foot ulcer long term (current) use of insulin cellulitis of left lower limb hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic neuropathic arthropathy
white f 55 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levothyroxine sodium  50  mcg ; amlodipine  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; gabapentin  300  mg ; labetalol  100  mg ; insulin  8  unit ; sodium chloride nasal  1-2  spry ; atorvastatin  80  mg ; insulin  15  unit ; 
long term (current) use of insulin hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer hyperlipidemia, unspecified other acute osteomyelitis, left ankle and foot essential (primary) hypertension presence of coronary angioplasty implant and graft nonrheumatic aortic (valve) stenosis atherosclerotic heart disease of native coronary artery without angina pectoris non-pressure chronic ulcer of other part of left foot with necrosis of bone unspecified visual loss methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic neuropathic arthropathy type 2 diabetes mellitus with other specified complication non-pressure chronic ulcer of left heel and midfoot with fat layer exposed type 2 diabetes mellitus with diabetic polyneuropathy essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with other skin complications type 2 diabetes mellitus with foot ulcer long term (current) use of insulin cellulitis of left lower limb hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic neuropathic arthropathy
white f 55 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; nitroglycerin sl  0.3  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levothyroxine sodium  50  mcg ; amlodipine  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; gabapentin  300  mg ; labetalol  100  mg ; insulin  8  unit ; sodium chloride nasal  1-2  spry ; atorvastatin  80  mg ; insulin  15  unit ; 
long term (current) use of insulin hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer hyperlipidemia, unspecified other acute osteomyelitis, left ankle and foot essential (primary) hypertension presence of coronary angioplasty implant and graft nonrheumatic aortic (valve) stenosis atherosclerotic heart disease of native coronary artery without angina pectoris non-pressure chronic ulcer of other part of left foot with necrosis of bone unspecified visual loss methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic neuropathic arthropathy type 2 diabetes mellitus with other specified complication non-pressure chronic ulcer of left heel and midfoot with fat layer exposed type 2 diabetes mellitus with diabetic polyneuropathy essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with other skin complications type 2 diabetes mellitus with foot ulcer long term (current) use of insulin cellulitis of left lower limb hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic neuropathic arthropathy
white m 75 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  68  mg dl; chemistry blood lactate dehydrogenase (ld)  206  iu l; chemistry blood albumin  3.5  g dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; senna  1  tab ; pantoprazole  40  mg ; insulin  0  unit ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; heparin  5000  unit ; levofloxacin  250  mg ; levofloxacin  500  mg ; tiotropium bromide  1  cap ; aspirin ec  325  mg ; duloxetine  60  mg ; multivitamins  1  tab ; simvastatin  10  mg ; metoprolol tartrate  12.5  mg ; 
pulmonary insufficiency following trauma and surgery intervertebral disc disorder with myelopathy, cervical region diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled surg complic-respir syst pneumonitis due to inhalation of food or vomitus hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 75 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  152  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; senna  1  tab ; pantoprazole  40  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; levofloxacin  250  mg ; levofloxacin  500  mg ; aspirin ec  325  mg ; duloxetine  60  mg ; multivitamins  1  tab ; simvastatin  10  mg ; metoprolol tartrate  12.5  mg ; donepezil  5  mg ; insulin  24  unit ; 
pulmonary insufficiency following trauma and surgery intervertebral disc disorder with myelopathy, cervical region diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled surg complic-respir syst pneumonitis due to inhalation of food or vomitus hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 75 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; senna  1  tab ; pantoprazole  40  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; levofloxacin  250  mg ; levofloxacin  500  mg ; aspirin ec  325  mg ; duloxetine  60  mg ; multivitamins  1  tab ; simvastatin  10  mg ; metoprolol tartrate  12.5  mg ; donepezil  5  mg ; insulin  24  unit ; 
pulmonary insufficiency following trauma and surgery intervertebral disc disorder with myelopathy, cervical region diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled surg complic-respir syst pneumonitis due to inhalation of food or vomitus hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 87 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  4.2  ; chemistry blood glucose  116  mg dl$nan
 
white m 87 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  3.3  ; chemistry urine creatinine, urine  174  mg dl; chemistry urine sodium, urine  37  meq l; chemistry blood glucose  117  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; insulin  0  unit ; atorvastatin  10  mg ; aspirin ec  81  mg ; atenolol  50  mg ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; glipizide  2.5  mg ; donepezil  10  mg ; 
 
white m 87 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  118  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  114  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; atorvastatin  10  mg ; aspirin ec  81  mg ; atenolol  50  mg ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; glipizide  2.5  mg ; donepezil  10  mg ; lisinopril  10  mg ; furosemide  20  mg ; warfarin  5  mg ; 
 
white m 87 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood glucose  94  mg dl$senna  2  tab ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; atorvastatin  10  mg ; aspirin ec  81  mg ; atenolol  50  mg ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; glipizide  2.5  mg ; donepezil  10  mg ; lisinopril  10  mg ; furosemide  20  mg ; warfarin  5  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; 
 
white m 87 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  88  mg dl$senna  2  tab ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; atorvastatin  10  mg ; aspirin ec  81  mg ; atenolol  50  mg ; acetaminophen  650  mg ; glipizide  2.5  mg ; donepezil  10  mg ; lisinopril  10  mg ; furosemide  20  mg ; warfarin  5  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; 
 
white m 72 $nan$nan$atenolol  25  mg ; omeprazole  20  mg ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; heparin  5000  unit ; tamsulosin  0.4  mg ; 
fever, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction other acquired absence of organ abscess of liver unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction personal history of peptic ulcer disease acute cholecystitis unspecified essential hypertension acute and chronic cholecystitis diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux 
white m 72 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  133  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$atenolol  25  mg ; omeprazole  20  mg ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; heparin  5000  unit ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  500  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-1  mg ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5  mg ; sw  50  ml ; magnesium sulfate  2  gm ; acetaminophen  325-650  mg ; 
fever, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction other acquired absence of organ abscess of liver unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction personal history of peptic ulcer disease acute cholecystitis unspecified essential hypertension acute and chronic cholecystitis diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux 
white m 72 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  331  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  131  mg dl$atenolol  25  mg ; omeprazole  20  mg ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; heparin  5000  unit ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  500  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5  mg ; sw  50  ml ; magnesium sulfate  2  gm ; hydromorphone (dilaudid)  12.5  mg ; d5 1 2ns  1000  ml ; ns  100  ml ; dextrose 5%  100  ml ; 
fever, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction other acquired absence of organ abscess of liver unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction personal history of peptic ulcer disease acute cholecystitis unspecified essential hypertension acute and chronic cholecystitis diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux 
white m 72 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  400  k ul; hematology urine wbc  3-5  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$atenolol  25  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; heparin  5000  unit ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  12.5  mg ; d5 1 2ns  1000  ml ; ns  100  ml ; dextrose 5%  100  ml ; hydromorphone (dilaudid)  2-6  mg ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  2-4  mg ; ranitidine  150  mg ; 
fever, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction other acquired absence of organ abscess of liver unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction personal history of peptic ulcer disease acute cholecystitis unspecified essential hypertension acute and chronic cholecystitis diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux 
white m 72 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  360  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  116  mg dl$atenolol  25  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; heparin  5000  unit ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; dextrose 5%  100  ml ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  2-4  mg ; ranitidine  150  mg ; metoclopramide  10  mg ; 
fever, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction other acquired absence of organ abscess of liver unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction personal history of peptic ulcer disease acute cholecystitis unspecified essential hypertension acute and chronic cholecystitis diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux 
white m 72 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  103  mg dl$atenolol  25  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ns  100  ml ; dextrose 5%  100  ml ; oxycodone-acetaminophen  1-2  tab ; metoclopramide  10  mg ; bisacodyl  10  mg ; 
fever, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction other acquired absence of organ abscess of liver unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction personal history of peptic ulcer disease acute cholecystitis unspecified essential hypertension acute and chronic cholecystitis diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux 
white m 72 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  113  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$atenolol  25  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; heparin  5000  unit ; oxycodone-acetaminophen  1-2  tab ; metoclopramide  10  mg ; bisacodyl  10  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  2.5  mg ; ondansetron  4-8  mg ; aspirin  325  mg ; 
fever, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction other acquired absence of organ abscess of liver unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction personal history of peptic ulcer disease acute cholecystitis unspecified essential hypertension acute and chronic cholecystitis diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux 
white m 72 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  380  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  102  mg dl$atenolol  25  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; heparin  5000  unit ; oxycodone-acetaminophen  1-2  tab ; metoclopramide  10  mg ; ondansetron  4-8  mg ; aspirin  325  mg ; ciprofloxacin hcl  750  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
fever, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction other acquired absence of organ abscess of liver unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction personal history of peptic ulcer disease acute cholecystitis unspecified essential hypertension acute and chronic cholecystitis diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux 
white m 72 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  426  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  118  mg dl$atenolol  25  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; heparin  5000  unit ; oxycodone-acetaminophen  1-2  tab ; ondansetron  4-8  mg ; aspirin  325  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
fever, unspecified calculus of bile duct without mention of cholecystitis, without mention of obstruction other acquired absence of organ abscess of liver unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction personal history of peptic ulcer disease acute cholecystitis unspecified essential hypertension acute and chronic cholecystitis diaphragmatic hernia without mention of obstruction or gangrene esophageal reflux 
hispanic latino f 66 $nan$nan$insulin  15  unit ; insulin  24  unit ; 
peripheral vascular disease, unspecified hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants essential (primary) hypertension rheumatoid arthritis, unspecified paroxysmal atrial fibrillation ischemic cardiomyopathy elevated white blood cell count, unspecified acquired absence of left leg below knee presence of coronary angioplasty implant and graft postprocedural hypotension hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy presence of coronary angioplasty implant and graft gastro-esophageal reflux disease without esophagitis long term (current) use of insulin essential (primary) hypertension chronic systolic (congestive) heart failure non-st elevation (nstemi) myocardial infarction anemia in other chronic diseases classified elsewhere old myocardial infarction acquired absence of left leg below knee peripheral vascular disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris rheumatoid arthritis, unspecified long term (current) use of aspirin precipitous drop in hematocrit pressure ulcer of sacral region, stage 1 type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene atherosclerotic heart disease of native coronary artery without angina pectoris unspecified place or not applicable essential (primary) hypertension coronary angioplasty status rheumatoid arthritis, unspecified long term (current) use of insulin hyperlipidemia, unspecified hypo-osmolality and hyponatremia long term (current) use of systemic steroids old myocardial infarction dehiscence of amputation stump type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with gangrene pressure ulcer, stage i
hispanic latino f 66 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  433  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  110  mg dl$insulin  15  unit ; insulin  24  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; cyclobenzaprine  10  mg ; folic acid  1  mg ; gabapentin  600  mg ; hydroxyzine  25  mg ; metoprolol succinate xl  100  mg ; nitroglycerin sl  0.3  mg ; prednisone  5  mg ; ticagrelor  90  mg ; tramadol  50  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
peripheral vascular disease, unspecified hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants essential (primary) hypertension rheumatoid arthritis, unspecified paroxysmal atrial fibrillation ischemic cardiomyopathy elevated white blood cell count, unspecified acquired absence of left leg below knee presence of coronary angioplasty implant and graft postprocedural hypotension hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy presence of coronary angioplasty implant and graft gastro-esophageal reflux disease without esophagitis long term (current) use of insulin essential (primary) hypertension chronic systolic (congestive) heart failure non-st elevation (nstemi) myocardial infarction anemia in other chronic diseases classified elsewhere old myocardial infarction acquired absence of left leg below knee peripheral vascular disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris rheumatoid arthritis, unspecified long term (current) use of aspirin precipitous drop in hematocrit pressure ulcer of sacral region, stage 1 type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene atherosclerotic heart disease of native coronary artery without angina pectoris unspecified place or not applicable essential (primary) hypertension coronary angioplasty status rheumatoid arthritis, unspecified long term (current) use of insulin hyperlipidemia, unspecified hypo-osmolality and hyponatremia long term (current) use of systemic steroids old myocardial infarction dehiscence of amputation stump type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with gangrene pressure ulcer, stage i
hispanic latino f 66 $nan$nan$insulin  15  unit ; insulin  24  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; cyclobenzaprine  10  mg ; folic acid  1  mg ; gabapentin  600  mg ; hydroxyzine  25  mg ; metoprolol succinate xl  100  mg ; nitroglycerin sl  0.3  mg ; prednisone  5  mg ; ticagrelor  90  mg ; tramadol  50  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; metformin (glucophage)  500  mg ; 
peripheral vascular disease, unspecified hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants essential (primary) hypertension rheumatoid arthritis, unspecified paroxysmal atrial fibrillation ischemic cardiomyopathy elevated white blood cell count, unspecified acquired absence of left leg below knee presence of coronary angioplasty implant and graft postprocedural hypotension hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy presence of coronary angioplasty implant and graft gastro-esophageal reflux disease without esophagitis long term (current) use of insulin essential (primary) hypertension chronic systolic (congestive) heart failure non-st elevation (nstemi) myocardial infarction anemia in other chronic diseases classified elsewhere old myocardial infarction acquired absence of left leg below knee peripheral vascular disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris rheumatoid arthritis, unspecified long term (current) use of aspirin precipitous drop in hematocrit pressure ulcer of sacral region, stage 1 type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene atherosclerotic heart disease of native coronary artery without angina pectoris unspecified place or not applicable essential (primary) hypertension coronary angioplasty status rheumatoid arthritis, unspecified long term (current) use of insulin hyperlipidemia, unspecified hypo-osmolality and hyponatremia long term (current) use of systemic steroids old myocardial infarction dehiscence of amputation stump type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with gangrene pressure ulcer, stage i
white f 33 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  194  k ul$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
first-degree perineal laceration, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn 
white f 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
first-degree perineal laceration, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn 
white f 33 $temp  98.2  heartrate  87.0  resprate  16.0  o2sat  99.0  sbp  113.0  dbp  67.0  rhythm    pain    $nan$levothyroxine sodium  100  mcg ; insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3  ml ; bupropion (sustained release)  150  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; lactated ringers  1000  ml ; heparin  5000  unit ; 
 
white m 82 $nan$nan$metronidazole  500  mg ; 
long term (current) use of aspirin essential (primary) hypertension encounter for change or removal of drains hyperlipidemia, unspecified right upper quadrant pain personal history of nicotine dependence abnormal electrocardiogram [ecg] [ekg] presence of right artificial hip joint calculus of gallbladder and bile duct without cholecystitis without obstruction hyperlipidemia, unspecified essential (primary) hypertension personal history of nicotine dependence calculus of gallbladder with acute cholecystitis without obstruction retention of urine, unspecified perforation of gallbladder personal history of tobacco use unspecified disease of pericardium other and unspecified hyperlipidemia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension cardiac complications, not elsewhere classified atrial fibrillation calculus of gallbladder without mention of cholecystitis, without mention of obstruction accidents occurring in residential institution esophageal reflux 
white m 82 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  151  mg dl$metronidazole  500  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  20  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; 5% dextrose  100  ml ; naloxone  2  mg ; ciprofloxacin hcl  500  mg ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
long term (current) use of aspirin essential (primary) hypertension encounter for change or removal of drains hyperlipidemia, unspecified right upper quadrant pain personal history of nicotine dependence abnormal electrocardiogram [ecg] [ekg] presence of right artificial hip joint calculus of gallbladder and bile duct without cholecystitis without obstruction hyperlipidemia, unspecified essential (primary) hypertension personal history of nicotine dependence calculus of gallbladder with acute cholecystitis without obstruction retention of urine, unspecified perforation of gallbladder personal history of tobacco use unspecified disease of pericardium other and unspecified hyperlipidemia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension cardiac complications, not elsewhere classified atrial fibrillation calculus of gallbladder without mention of cholecystitis, without mention of obstruction accidents occurring in residential institution esophageal reflux 
white m 82 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  119  mg dl$bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  20  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; 5% dextrose  100  ml ; naloxone  2  mg ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  2  bag ; magnesium sulfate  4  gm ; 
long term (current) use of aspirin essential (primary) hypertension encounter for change or removal of drains hyperlipidemia, unspecified right upper quadrant pain personal history of nicotine dependence abnormal electrocardiogram [ecg] [ekg] presence of right artificial hip joint calculus of gallbladder and bile duct without cholecystitis without obstruction hyperlipidemia, unspecified essential (primary) hypertension personal history of nicotine dependence calculus of gallbladder with acute cholecystitis without obstruction retention of urine, unspecified perforation of gallbladder personal history of tobacco use unspecified disease of pericardium other and unspecified hyperlipidemia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension cardiac complications, not elsewhere classified atrial fibrillation calculus of gallbladder without mention of cholecystitis, without mention of obstruction accidents occurring in residential institution esophageal reflux 
white m 82 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  100  mg dl$bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  20  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; 5% dextrose  100  ml ; naloxone  2  mg ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  2  bag ; magnesium sulfate  4  gm ; sarna lotion  1  appl ; diphenhydramine  12.5  mg ; 
long term (current) use of aspirin essential (primary) hypertension encounter for change or removal of drains hyperlipidemia, unspecified right upper quadrant pain personal history of nicotine dependence abnormal electrocardiogram [ecg] [ekg] presence of right artificial hip joint calculus of gallbladder and bile duct without cholecystitis without obstruction hyperlipidemia, unspecified essential (primary) hypertension personal history of nicotine dependence calculus of gallbladder with acute cholecystitis without obstruction retention of urine, unspecified perforation of gallbladder personal history of tobacco use unspecified disease of pericardium other and unspecified hyperlipidemia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension cardiac complications, not elsewhere classified atrial fibrillation calculus of gallbladder without mention of cholecystitis, without mention of obstruction accidents occurring in residential institution esophageal reflux 
white m 82 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  102  mg dl$bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  20  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; sarna lotion  1  appl ; diphenhydramine  12.5  mg ; amlodipine  5  mg ; oxycodone (immediate release)  5  mg ; 
long term (current) use of aspirin essential (primary) hypertension encounter for change or removal of drains hyperlipidemia, unspecified right upper quadrant pain personal history of nicotine dependence abnormal electrocardiogram [ecg] [ekg] presence of right artificial hip joint calculus of gallbladder and bile duct without cholecystitis without obstruction hyperlipidemia, unspecified essential (primary) hypertension personal history of nicotine dependence calculus of gallbladder with acute cholecystitis without obstruction retention of urine, unspecified perforation of gallbladder personal history of tobacco use unspecified disease of pericardium other and unspecified hyperlipidemia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension cardiac complications, not elsewhere classified atrial fibrillation calculus of gallbladder without mention of cholecystitis, without mention of obstruction accidents occurring in residential institution esophageal reflux 
white m 82 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  20  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; ondansetron  4  mg ; sarna lotion  1  appl ; amlodipine  5  mg ; oxycodone (immediate release)  5  mg ; 
long term (current) use of aspirin essential (primary) hypertension encounter for change or removal of drains hyperlipidemia, unspecified right upper quadrant pain personal history of nicotine dependence abnormal electrocardiogram [ecg] [ekg] presence of right artificial hip joint calculus of gallbladder and bile duct without cholecystitis without obstruction hyperlipidemia, unspecified essential (primary) hypertension personal history of nicotine dependence calculus of gallbladder with acute cholecystitis without obstruction retention of urine, unspecified perforation of gallbladder personal history of tobacco use unspecified disease of pericardium other and unspecified hyperlipidemia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension cardiac complications, not elsewhere classified atrial fibrillation calculus of gallbladder without mention of cholecystitis, without mention of obstruction accidents occurring in residential institution esophageal reflux 
white m 82 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  20  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; ondansetron  4  mg ; sarna lotion  1  appl ; amlodipine  5  mg ; oxycodone (immediate release)  5  mg ; 
long term (current) use of aspirin essential (primary) hypertension encounter for change or removal of drains hyperlipidemia, unspecified right upper quadrant pain personal history of nicotine dependence abnormal electrocardiogram [ecg] [ekg] presence of right artificial hip joint calculus of gallbladder and bile duct without cholecystitis without obstruction hyperlipidemia, unspecified essential (primary) hypertension personal history of nicotine dependence calculus of gallbladder with acute cholecystitis without obstruction retention of urine, unspecified perforation of gallbladder personal history of tobacco use unspecified disease of pericardium other and unspecified hyperlipidemia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension cardiac complications, not elsewhere classified atrial fibrillation calculus of gallbladder without mention of cholecystitis, without mention of obstruction accidents occurring in residential institution esophageal reflux 
white m 82 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; omeprazole  20  mg ; simvastatin  20  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; ondansetron  4  mg ; sarna lotion  1  appl ; amlodipine  5  mg ; oxycodone (immediate release)  5  mg ; 
long term (current) use of aspirin essential (primary) hypertension encounter for change or removal of drains hyperlipidemia, unspecified right upper quadrant pain personal history of nicotine dependence abnormal electrocardiogram [ecg] [ekg] presence of right artificial hip joint calculus of gallbladder and bile duct without cholecystitis without obstruction hyperlipidemia, unspecified essential (primary) hypertension personal history of nicotine dependence calculus of gallbladder with acute cholecystitis without obstruction retention of urine, unspecified perforation of gallbladder personal history of tobacco use unspecified disease of pericardium other and unspecified hyperlipidemia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension cardiac complications, not elsewhere classified atrial fibrillation calculus of gallbladder without mention of cholecystitis, without mention of obstruction accidents occurring in residential institution esophageal reflux 
white m 65 $temp  97.7  heartrate  71.0  resprate  19.0  o2sat    sbp  119.0  dbp  68.0  rhythm    pain  8  $hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  36  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  124  mg dl; chemistry blood albumin  3.8  g dl; hematology blood bands  13  %$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.5-1  mg ; acyclovir  400  mg ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; vial  1  vial ; ondansetron  4  mg ; filgrastim  480  mcg ; lidocaine jelly 2% (urojet)  1  appl ; diltiazem extended-release  120  mg ; metoprolol succinate xl  25  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; d5 1 2ns  1000  ml ; 5% dextrose  100  ml ; morphine sulfate  1-2  mg ; lorazepam  0.5  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  28  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  127  mg dl; chemistry blood lactate dehydrogenase (ld)  113  iu l; chemistry blood albumin  3.3  g dl; hematology blood bands  16  %$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; vial  1  vial ; ondansetron  4  mg ; filgrastim  480  mcg ; lidocaine jelly 2% (urojet)  1  appl ; diltiazem extended-release  120  mg ; metoprolol succinate xl  25  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; d5 1 2ns  1000  ml ; 5% dextrose  100  ml ; morphine sulfate  1-2  mg ; lorazepam  0.5  mg ; cyanocobalamin  100  mcg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  34  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  100  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; vial  1  vial ; ondansetron  4  mg ; filgrastim  480  mcg ; diltiazem extended-release  120  mg ; metoprolol succinate xl  25  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; d5 1 2ns  1000  ml ; 5% dextrose  100  ml ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; amino acids 4.25%-dextrose 5%  1000  ml ; oxymetazoline  1  spry ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  38  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  121  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; vial  1  vial ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; metoprolol succinate xl  25  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; 5% dextrose  100  ml ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; amino acids 4.25%-dextrose 5%  1000  ml ; oxymetazoline  1  spry ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  112  iu l; chemistry blood albumin  3.2  g dl; hematology blood bands  1  %$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; vial  1  vial ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; metoprolol succinate xl  25  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; 5% dextrose  100  ml ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; oxymetazoline  1  spry ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  120  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; vial  1  vial ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; metoprolol succinate xl  25  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; 5% dextrose  100  ml ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; oxymetazoline  1  spry ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  69  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  124  iu l; chemistry blood albumin  3.2  g dl; hematology blood bands  3  %$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; metoprolol succinate xl  25  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  78  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  133  iu l; chemistry blood albumin  3.2  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  88  mg dl; chemistry blood lactate dehydrogenase (ld)  107  iu l; chemistry blood albumin  3.2  g dl; blood gas blood lactate  1.9  mmol l$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; simethicone  40-80  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  107  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  82  mg dl; chemistry blood lactate dehydrogenase (ld)  123  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  119  iu l; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  61  mg dl; chemistry blood lactate dehydrogenase (ld)  109  iu l; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  77  mg dl; chemistry blood lactate dehydrogenase (ld)  95  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; guaifenesin-codeine phosphate  5-10  ml ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  10  ml ; simethicone  40-80  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; potassium chloride (powder)  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  105  iu l; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; ondansetron  4  mg ; diltiazem extended-release  120  mg ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; simethicone  40-80  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; potassium chloride (powder)  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; moviprep  1  l ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  68  mg dl; chemistry blood lactate dehydrogenase (ld)  104  iu l; chemistry blood albumin  3.6  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; cyanocobalamin  100  mcg ; simethicone  40-80  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  81  mg dl; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; aspirin  81  mg ; loperamide  2  mg ; gabapentin  300  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  85  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; aspirin  81  mg ; loperamide  2  mg ; gabapentin  300  mg ; nystatin cream  1  appl ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; aspirin  81  mg ; loperamide  2  mg ; gabapentin  300  mg ; nystatin cream  1  appl ; gabapentin  600  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  93  mg dl; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; aspirin  81  mg ; loperamide  2  mg ; nystatin cream  1  appl ; gabapentin  600  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  113  iu l$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; aspirin  81  mg ; loperamide  2  mg ; nystatin cream  1  appl ; gabapentin  600  mg ; moviprep  4  l ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  97  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; aspirin  81  mg ; loperamide  2  mg ; nystatin cream  1  appl ; gabapentin  600  mg ; moviprep  4  l ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  117  iu l$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; aspirin  81  mg ; loperamide  2  mg ; nystatin cream  1  appl ; gabapentin  600  mg ; moviprep  4  l ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  111  iu l; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; loperamide  2  mg ; nystatin cream  1  appl ; gabapentin  600  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; loperamide  2  mg ; nystatin cream  1  appl ; gabapentin  600  mg ; oxycodone (immediate release)   5  mg ; gabapentin  900  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; loperamide  2  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; gabapentin  900  mg ; magnesium citrate  300  ml ; erythromycin  500  mg ; neomycin sulfate  500  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  34.0  %; hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (100 50)  1  inh ; montelukast  10  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; morphine sulfate  1-2  mg ; simethicone  40-80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol succinate xl  12.5  mg ; lisinopril  30  mg ; loperamide  2  mg ; nystatin cream  1  appl ; gabapentin  900  mg ; magnesium citrate  300  ml ; erythromycin  500  mg ; neomycin sulfate  500  mg ; acetaminophen  1000  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  130  mg dl$acetaminophen  1000  mg ; lactated ringers  1000  ml ; metoprolol tartrate  5  mg ; hydromorphone (dilaudid)  20  mg ; metoclopramide  10  mg ; albuterol inhaler  2  puff ; ketorolac  15  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  113  mg dl$acetaminophen  1000  mg ; lactated ringers  1000  ml ; metoprolol tartrate  5  mg ; metoclopramide  10  mg ; albuterol inhaler  2  puff ; ketorolac  15  mg ; tamsulosin  0.4  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$nan$acetaminophen  1000  mg ; lactated ringers  1000  ml ; metoprolol tartrate  5  mg ; metoclopramide  10  mg ; albuterol inhaler  2  puff ; ketorolac  15  mg ; tamsulosin  0.4  mg ; hydralazine  20  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  99  mg dl$metoclopramide  10  mg ; albuterol inhaler  2  puff ; ketorolac  15  mg ; tamsulosin  0.4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; trazodone  25  mg ; sw  400  ml ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  101  mg dl$metoclopramide  10  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; trazodone  25  mg ; sw  400  ml ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $nan$nan$metoclopramide  10  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; trazodone  25  mg ; 
coronary artery anomaly other and unspecified hyperlipidemia obstructive chronic bronchitis with (acute) exacerbation gout, unspecified old myocardial infarction lumbago hypertrophy of breast acquired absence of kidney unspecified essential hypertension dizziness and giddiness hypoxemia multiple myeloma, without mention of having achieved remission abdominal pain, unspecified site cardiomegaly need for prophylactic vaccination and inoculation against influenza acquired absence of intestine (large) (small) personal history of malignant neoplasm of large intestine tobacco use disorder long-term (current) use of aspirin peripheral stem cells replaced by transplant other postprocedural status intestinal infection due to other organism, not elsewhere classified multiple myeloma, without mention of having achieved remission personal history of antineoplastic chemotherapy personal history of malignant neoplasm of large intestine acquired absence of kidney influenza with pneumonia bacterial pneumonia, unspecified chronic airway obstruction, not elsewhere classified old myocardial infarction acute kidney failure, unspecified tobacco use disorder gout, unspecified other and unspecified hyperlipidemia peripheral stem cells replaced by transplant unspecified essential hypertension prinzmetal angina personal history of malignant neoplasm of large intestine acquired absence of kidney multiple myeloma, without mention of having achieved remission chronic airway obstruction, not elsewhere classified coronary artery anomaly peripheral stem cells replaced by transplant subendocardial infarction, initial episode of care gout, unspecified unspecified essential hypertension other and unspecified hyperlipidemia esophageal reflux
white m 65 $temp  97.7  heartrate  74.0  resprate  18.0  o2sat  98.0  sbp  108.0  dbp  67.0  rhythm    pain  4  $hematology blood hematocrit  42.8  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  240  mg dl; chemistry blood glucose  186  mg dl$tamsulosin  0.4  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; morphine sulfate  1-2  mg ; senna  17.2  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactated ringers  1000  ml ; oxycodone (immediate release)  5  mg ; insulin  0  unit ; aspirin  325  mg ; 
 
white f 84 $temp  98.8  heartrate  78.0  resprate  16.0  o2sat  97.0  sbp  150.0  dbp  70.0  rhythm    pain  0  ; temp  97.6  heartrate    resprate  16.0  o2sat  98.0  sbp  150.0  dbp  52.0  rhythm    pain    ; temp    heartrate  75.0  resprate  20.0  o2sat  99.0  sbp  145.0  dbp  68.0  rhythm    pain    $hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  309  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  3.6  g dl$nan
non-st elevation (nstemi) myocardial infarction acute embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral acute on chronic diastolic (congestive) heart failure hypothyroidism, unspecified proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere urinary tract infection, site not specified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease transient cerebral ischemic attack, unspecified nontoxic single thyroid nodule epilepsy, unspecified, not intractable, without status epilepticus patient room in hospital as the place of occurrence of the external cause adverse effect of diagnostic agents, initial encounter pure hypercholesterolemia, unspecified adhesive capsulitis of right shoulder abnormal weight loss body mass index (bmi) 29.0-29.9, adult other nonspecific abnormal finding of lung field unspecified asthma, uncomplicated personal history of nicotine dependence rheumatoid arthritis, unspecified chronic obstructive pulmonary disease, unspecified spinal stenosis, site unspecified long term (current) use of anticoagulants acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) fall from other slipping, tripping, or stumbling pain in joint, shoulder region open wound of nose, unspecified site, without mention of complication need for prophylactic vaccination and inoculation against tetanus-diphtheria [td] (dt) chronic obstructive asthma, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pain in joint, lower leg unspecified acquired hypothyroidism home accidents hyposmolality and/or hyponatremia myopathy in endocrine diseases classified elsewhere epilepsy, unspecified, without mention of intractable epilepsy spinal stenosis, unspecified region chronic kidney disease, stage iii (moderate) edema abrasion or friction burn of hip, thigh, leg, and ankle, without mention of infection closed fracture of surgical neck of humerus
white m 76 $temp    heartrate  80.0  resprate  18.0  o2sat    sbp  107.0  dbp  67.0  rhythm    pain    ; temp  97.6  heartrate  68.0  resprate  20.0  o2sat  99.0  sbp  140.0  dbp  68.0  rhythm    pain  0  ; temp  97.6  heartrate  65.0  resprate  18.0  o2sat  97.0  sbp  199.0  dbp  83.0  rhythm    pain  0  $hematology blood hematocrit  42.8  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  182  k ul; chemistry blood creatinine  1.4  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  125  mg dl; blood gas blood hematocrit, calculated  45  %; blood gas blood hemoglobin  15.1  g dl; blood gas blood potassium, whole blood  3.0  meq l; blood gas blood sodium, whole blood  143  meq l; blood gas blood carboxyhemoglobin  2  %; blood gas blood methemoglobin  0  %$nan
 
white m 76 $nan$hematology blood hematocrit  43.0  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  94  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; docusate sodium  100  mg ; potassium chloride  80  meq ; clopidogrel  300  mg ; atorvastatin  80  mg ; heparin  1000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin  81  mg ; amlodipine  10  mg ; ramipril  10  mg ; 
 
white m 51 $temp  98.0  heartrate  57.0  resprate  18.0  o2sat  99.0  sbp  142.0  dbp  94.0  rhythm    pain  4  ; temp  97.8  heartrate  68.0  resprate  18.0  o2sat  100.0  sbp  140.0  dbp  89.0  rhythm    pain  3  $hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  136  iu l; chemistry blood albumin  3.7  g dl; hematology blood bands  1  %$enoxaparin sodium  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; nicotine patch  21  mg ; nicotine lozenge  4  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; docusate sodium  100  mg ; ramelteon  8  mg ; enoxaparin sodium  110  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin flush (100 units ml)  5  ml ; 
hyperlipidemia, unspecified cellulitis of groin family history of malignant neoplasm of breast cellulitis of left lower limb hodgkin lymphoma, unspecified, lymph nodes of multiple sites essential (primary) hypertension nicotine dependence, cigarettes, uncomplicated 
white m 51 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  91  mg dl; hematology blood bands  1  %$0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; nicotine patch  21  mg ; nicotine lozenge  4  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; docusate sodium  100  mg ; ramelteon  8  mg ; enoxaparin sodium  110  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
hyperlipidemia, unspecified cellulitis of groin family history of malignant neoplasm of breast cellulitis of left lower limb hodgkin lymphoma, unspecified, lymph nodes of multiple sites essential (primary) hypertension nicotine dependence, cigarettes, uncomplicated 
white m 51 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  175  iu l; chemistry blood albumin  3.9  g dl; hematology blood bands  2  %$0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; nicotine patch  21  mg ; nicotine lozenge  4  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; docusate sodium  100  mg ; ramelteon  8  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; ondansetron  8  mg ; sodium chloride 0.9%  1000  ml ; fosaprepitant  150  mg ; 0.9% sodium chloride  150  ml ; dexamethasone sod phosphate  12  mg ; clindamycin  300  mg ; 
hyperlipidemia, unspecified cellulitis of groin family history of malignant neoplasm of breast cellulitis of left lower limb hodgkin lymphoma, unspecified, lymph nodes of multiple sites essential (primary) hypertension nicotine dependence, cigarettes, uncomplicated 
white m 51 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  213  mg dl; chemistry blood lactate dehydrogenase (ld)  199  iu l; chemistry blood albumin  4.3  g dl; hematology blood bands  0  %; blood gas blood sodium, whole blood  137  meq l$0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; nicotine patch  21  mg ; nicotine lozenge  4  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; ramelteon  8  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; ondansetron  8  mg ; sodium chloride 0.9%  1000  ml ; fosaprepitant  150  mg ; 0.9% sodium chloride  150  ml ; dexamethasone sod phosphate  12  mg ; clindamycin  300  mg ; neutra-phos  2  pkt ; 
hyperlipidemia, unspecified cellulitis of groin family history of malignant neoplasm of breast cellulitis of left lower limb hodgkin lymphoma, unspecified, lymph nodes of multiple sites essential (primary) hypertension nicotine dependence, cigarettes, uncomplicated 
white f 47 $nan$nan$bupropion (sustained release)  150  mg ; montelukast sodium  10  mg ; omeprazole  40  mg ; 
 
white f 47 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood glucose  96  mg dl$bupropion (sustained release)  150  mg ; montelukast sodium  10  mg ; omeprazole  40  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; famotidine  20  mg ; metronidazole (flagyl)  500  mg ; morphine sulfate ir  15-30  mg ; zolpidem tartrate  5-10  mg ; fluticasone propionate 110mcg  2  puff ; diazepam  5  mg ; bupropion (sustained release)  300  mg ; 
 
white f 47 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood glucose  90  mg dl$montelukast sodium  10  mg ; omeprazole  40  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; famotidine  20  mg ; metronidazole (flagyl)  500  mg ; morphine sulfate ir  15-30  mg ; zolpidem tartrate  5-10  mg ; fluticasone propionate 110mcg  2  puff ; diazepam  5  mg ; bupropion (sustained release)  300  mg ; polyethylene glycol  17  g ; 
 
white f 47 $nan$nan$montelukast sodium  10  mg ; omeprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; famotidine  20  mg ; metronidazole (flagyl)  500  mg ; morphine sulfate ir  15-30  mg ; zolpidem tartrate  5-10  mg ; fluticasone propionate 110mcg  2  puff ; bupropion (sustained release)  300  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; 
 
hispanic latino m 62 $temp  100.2  heartrate  96.0  resprate  16.0  o2sat  100.0  sbp  131.0  dbp  76.0  rhythm    pain    ; temp    heartrate  91.0  resprate  16.0  o2sat  100.0  sbp  128.0  dbp  73.0  rhythm    pain    ; temp    heartrate  95.0  resprate  16.0  o2sat  100.0  sbp  121.0  dbp  68.0  rhythm    pain    ; temp    heartrate  97.0  resprate  16.0  o2sat  97.0  sbp  109.0  dbp  70.0  rhythm    pain    ; temp  99.0  heartrate  95.0  resprate  16.0  o2sat  96.0  sbp  134.0  dbp  68.0  rhythm    pain  0  ; temp    heartrate  90.0  resprate  16.0  o2sat  100.0  sbp  108.0  dbp  66.0  rhythm    pain  0  ; temp  98.4  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  453  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.6  ; hematology urine wbc  1  # hpf; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  3.5  g dl; blood gas blood free calcium  1.00  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  92  mg dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood calculated bicarbonate, whole blood  21  meq l$nan
amyotrophic lateral sclerosis dependence on respirator, status unspecified pleural effusion car driver injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of pulmonary embolism personal history of venous thrombosis and embolism tracheostomy status sepsis other and unspecified coagulation defects car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status calculus of bile duct with other cholecystitis, with obstruction cholangitis unspecified acquired hypothyroidism unspecified septicemia 
hispanic latino m 62 $temp  98.9  heartrate  83.0  resprate  16.0  o2sat  98.0  sbp  103.0  dbp  67.0  rhythm  sinus rhythm  pain  0  ; temp  97.7  heartrate  88.0  resprate  16.0  o2sat  98.0  sbp  122.0  dbp  70.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  466  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  72  mg dl; chemistry blood lactate dehydrogenase (ld)  420  iu l; chemistry blood albumin  3.4  g dl; blood gas blood lactate  0.7  mmol l$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; scopolamine patch  1  ptch ; polyethylene glycol  17  g ; albuterol-ipratropium  3  puff ; glycopyrrolate  2  mg ; ferrous sulfate (liquid)  300  mg ; rilutek  50  mg ; enoxaparin sodium  80  mg ; lansoprazole oral disintegrating tab  30  mg ; warfarin  2  mg ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  500  ml ; albuterol-ipratropium  6  puff ; 
amyotrophic lateral sclerosis dependence on respirator, status unspecified pleural effusion car driver injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of pulmonary embolism personal history of venous thrombosis and embolism tracheostomy status sepsis other and unspecified coagulation defects car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status calculus of bile duct with other cholecystitis, with obstruction cholangitis unspecified acquired hypothyroidism unspecified septicemia 
hispanic latino m 62 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  424  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood creatinine  0.1  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  186  mg dl; chemistry blood lactate dehydrogenase (ld)  250  iu l$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; polyethylene glycol  17  g ; glycopyrrolate  2  mg ; ferrous sulfate (liquid)  300  mg ; rilutek  50  mg ; lansoprazole oral disintegrating tab  30  mg ; warfarin  2  mg ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  500  ml ; albuterol-ipratropium  6  puff ; acetaminophen  325-650  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride  20  meq ; warfarin  3  mg ; acetaminophen iv  1000  mg ; 0.9% sodium chloride  1000  ml ; calcium carbonate  500  mg ; 
amyotrophic lateral sclerosis dependence on respirator, status unspecified pleural effusion car driver injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of pulmonary embolism personal history of venous thrombosis and embolism tracheostomy status sepsis other and unspecified coagulation defects car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status calculus of bile duct with other cholecystitis, with obstruction cholangitis unspecified acquired hypothyroidism unspecified septicemia 
hispanic latino m 62 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.1  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  6.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  130  mg dl; blood gas blood lactate  0.6  mmol l$sodium chloride 0.9%  flush  3  ml ; glycopyrrolate  2  mg ; ferrous sulfate (liquid)  300  mg ; rilutek  50  mg ; lansoprazole oral disintegrating tab  30  mg ; warfarin  2  mg ; albuterol-ipratropium  6  puff ; acetaminophen  325-650  mg ; warfarin  3  mg ; acetaminophen iv  1000  mg ; 0.9% sodium chloride  1000  ml ; calcium carbonate  500  mg ; neutra-phos  2  pkt ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10  ml ; 
amyotrophic lateral sclerosis dependence on respirator, status unspecified pleural effusion car driver injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of pulmonary embolism personal history of venous thrombosis and embolism tracheostomy status sepsis other and unspecified coagulation defects car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status calculus of bile duct with other cholecystitis, with obstruction cholangitis unspecified acquired hypothyroidism unspecified septicemia 
hispanic latino m 62 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  412  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; glycopyrrolate  2  mg ; ferrous sulfate (liquid)  300  mg ; rilutek  50  mg ; lansoprazole oral disintegrating tab  30  mg ; warfarin  2  mg ; albuterol-ipratropium  6  puff ; acetaminophen  325-650  mg ; calcium carbonate  500  mg ; neutra-phos  2  pkt ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10  ml ; 
amyotrophic lateral sclerosis dependence on respirator, status unspecified pleural effusion car driver injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of pulmonary embolism personal history of venous thrombosis and embolism tracheostomy status sepsis other and unspecified coagulation defects car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status calculus of bile duct with other cholecystitis, with obstruction cholangitis unspecified acquired hypothyroidism unspecified septicemia 
hispanic latino m 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; glycopyrrolate  2  mg ; ferrous sulfate (liquid)  300  mg ; rilutek  50  mg ; lansoprazole oral disintegrating tab  30  mg ; warfarin  2  mg ; albuterol-ipratropium  6  puff ; acetaminophen  325-650  mg ; calcium carbonate  500  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  flush  10  ml ; 
amyotrophic lateral sclerosis dependence on respirator, status unspecified pleural effusion car driver injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of pulmonary embolism personal history of venous thrombosis and embolism tracheostomy status sepsis other and unspecified coagulation defects car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status calculus of bile duct with other cholecystitis, with obstruction cholangitis unspecified acquired hypothyroidism unspecified septicemia 
white f 91 $temp    heartrate  95.0  resprate  18.0  o2sat  92.0  sbp  164.0  dbp  68.0  rhythm    pain    ; temp    heartrate  87.0  resprate  18.0  o2sat  94.0  sbp    dbp    rhythm    pain    ; temp    heartrate  89.0  resprate  16.0  o2sat  94.0  sbp  157.0  dbp  70.0  rhythm    pain  0  ; temp  100.4  heartrate  94.0  resprate  20.0  o2sat  96.0  sbp  175.0  dbp  72.0  rhythm    pain  0  ; temp    heartrate  88.0  resprate  18.0  o2sat  94.0  sbp  118.0  dbp  84.0  rhythm    pain  0  ; temp  99.7  heartrate  84.0  resprate  15.0  o2sat  95.0  sbp  159.0  dbp  63.0  rhythm    pain  0  ; temp    heartrate  75.0  resprate  19.0  o2sat  95.0  sbp  177.0  dbp  70.0  rhythm    pain  0  ; temp  98.9  heartrate  88.0  resprate  16.0  o2sat  95.0  sbp  160.0  dbp  82.0  rhythm    pain  0  ; temp  100.5  heartrate  89.0  resprate  16.0  o2sat  95.0  sbp  167.0  dbp  70.0  rhythm    pain  0  ; temp    heartrate  91.0  resprate  18.0  o2sat  96.0  sbp  181.0  dbp  70.0  rhythm    pain  0  ; temp  98.1  heartrate  83.0  resprate  18.0  o2sat  95.0  sbp  145.0  dbp  91.0  rhythm    pain  0  $nan$amlodipine  10  mg ; aspirin  81  mg ; atenolol  100  mg ; bisacodyl  10  mg ; clopidogrel  75  mg ; folic acid  1  mg ; furosemide  40  mg ; lisinopril  40  mg ; losartan potassium  50  mg ; ranitidine  150  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; 
secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified adrenal cortical steroids causing adverse effects in therapeutic use venous (peripheral) insufficiency, unspecified congestive heart failure, unspecified iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery do not resuscitate status acute on chronic diastolic heart failure percutaneous transluminal coronary angioplasty status unspecified essential hypertension venous (peripheral) insufficiency, unspecified osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh acute on chronic diastolic heart failure percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery right bundle branch block and left anterior fascicular block obesity, unspecified congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension pure hypercholesterolemia percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified coronary atherosclerosis of native coronary artery acute on chronic diastolic heart failure unspecified essential hypertension asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled paroxysmal ventricular tachycardia other and unspecified hyperlipidemia anemia, unspecified venous (peripheral) insufficiency, unspecified pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other postoperative infection percutaneous transluminal coronary angioplasty status other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally venous (peripheral) insufficiency, unspecified cellulitis and abscess of trunk other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure unspecified essential hypertension adrenal cortical steroids causing adverse effects in therapeutic use osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh venous (peripheral) insufficiency, unspecified unspecified essential hypertension
white f 91 $nan$nan$amlodipine  10  mg ; aspirin  81  mg ; atenolol  100  mg ; bisacodyl  10  mg ; clopidogrel  75  mg ; folic acid  1  mg ; furosemide  40  mg ; lisinopril  40  mg ; losartan potassium  50  mg ; ranitidine  150  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; albuterol 0.083% neb soln  1  neb ; oseltamivir  75  mg ; glipizide  5  mg ; bromday  1  drop ; senna  2  tab ; simvastatin  20  mg ; calcium carbonate  500  mg ; 
secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified adrenal cortical steroids causing adverse effects in therapeutic use venous (peripheral) insufficiency, unspecified congestive heart failure, unspecified iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery do not resuscitate status acute on chronic diastolic heart failure percutaneous transluminal coronary angioplasty status unspecified essential hypertension venous (peripheral) insufficiency, unspecified osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh acute on chronic diastolic heart failure percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery right bundle branch block and left anterior fascicular block obesity, unspecified congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension pure hypercholesterolemia percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified coronary atherosclerosis of native coronary artery acute on chronic diastolic heart failure unspecified essential hypertension asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled paroxysmal ventricular tachycardia other and unspecified hyperlipidemia anemia, unspecified venous (peripheral) insufficiency, unspecified pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other postoperative infection percutaneous transluminal coronary angioplasty status other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally venous (peripheral) insufficiency, unspecified cellulitis and abscess of trunk other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure unspecified essential hypertension adrenal cortical steroids causing adverse effects in therapeutic use osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh venous (peripheral) insufficiency, unspecified unspecified essential hypertension
white f 91 $nan$nan$amlodipine  10  mg ; aspirin  81  mg ; atenolol  100  mg ; bisacodyl  10  mg ; clopidogrel  75  mg ; folic acid  1  mg ; furosemide  40  mg ; lisinopril  40  mg ; losartan potassium  50  mg ; ranitidine  150  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; albuterol 0.083% neb soln  1  neb ; oseltamivir  75  mg ; glipizide  5  mg ; bromday  1  drop ; senna  2  tab ; simvastatin  20  mg ; calcium carbonate  500  mg ; 
secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified adrenal cortical steroids causing adverse effects in therapeutic use venous (peripheral) insufficiency, unspecified congestive heart failure, unspecified iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery do not resuscitate status acute on chronic diastolic heart failure percutaneous transluminal coronary angioplasty status unspecified essential hypertension venous (peripheral) insufficiency, unspecified osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh acute on chronic diastolic heart failure percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery right bundle branch block and left anterior fascicular block obesity, unspecified congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension pure hypercholesterolemia percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified coronary atherosclerosis of native coronary artery acute on chronic diastolic heart failure unspecified essential hypertension asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled paroxysmal ventricular tachycardia other and unspecified hyperlipidemia anemia, unspecified venous (peripheral) insufficiency, unspecified pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other postoperative infection percutaneous transluminal coronary angioplasty status other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally venous (peripheral) insufficiency, unspecified cellulitis and abscess of trunk other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure unspecified essential hypertension adrenal cortical steroids causing adverse effects in therapeutic use osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh venous (peripheral) insufficiency, unspecified unspecified essential hypertension
white f 91 $nan$nan$amlodipine  10  mg ; aspirin  81  mg ; atenolol  100  mg ; bisacodyl  10  mg ; clopidogrel  75  mg ; folic acid  1  mg ; furosemide  40  mg ; lisinopril  40  mg ; losartan potassium  50  mg ; ranitidine  150  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; albuterol 0.083% neb soln  1  neb ; oseltamivir  75  mg ; glipizide  5  mg ; bromday  1  drop ; senna  2  tab ; simvastatin  20  mg ; calcium carbonate  500  mg ; albuterol inhaler  2  puff ; 
secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified adrenal cortical steroids causing adverse effects in therapeutic use venous (peripheral) insufficiency, unspecified congestive heart failure, unspecified iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery do not resuscitate status acute on chronic diastolic heart failure percutaneous transluminal coronary angioplasty status unspecified essential hypertension venous (peripheral) insufficiency, unspecified osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh acute on chronic diastolic heart failure percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery right bundle branch block and left anterior fascicular block obesity, unspecified congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension pure hypercholesterolemia percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified coronary atherosclerosis of native coronary artery acute on chronic diastolic heart failure unspecified essential hypertension asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled paroxysmal ventricular tachycardia other and unspecified hyperlipidemia anemia, unspecified venous (peripheral) insufficiency, unspecified pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other postoperative infection percutaneous transluminal coronary angioplasty status other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally venous (peripheral) insufficiency, unspecified cellulitis and abscess of trunk other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure unspecified essential hypertension adrenal cortical steroids causing adverse effects in therapeutic use osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh venous (peripheral) insufficiency, unspecified unspecified essential hypertension
white f 91 $nan$nan$amlodipine  10  mg ; aspirin  81  mg ; atenolol  100  mg ; bisacodyl  10  mg ; clopidogrel  75  mg ; folic acid  1  mg ; furosemide  40  mg ; lisinopril  40  mg ; losartan potassium  50  mg ; ranitidine  150  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; albuterol 0.083% neb soln  1  neb ; oseltamivir  75  mg ; glipizide  5  mg ; bromday  1  drop ; senna  2  tab ; simvastatin  20  mg ; calcium carbonate  500  mg ; albuterol inhaler  2  puff ; 
secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified adrenal cortical steroids causing adverse effects in therapeutic use venous (peripheral) insufficiency, unspecified congestive heart failure, unspecified iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery do not resuscitate status acute on chronic diastolic heart failure percutaneous transluminal coronary angioplasty status unspecified essential hypertension venous (peripheral) insufficiency, unspecified osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh acute on chronic diastolic heart failure percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery right bundle branch block and left anterior fascicular block obesity, unspecified congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension pure hypercholesterolemia percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified coronary atherosclerosis of native coronary artery acute on chronic diastolic heart failure unspecified essential hypertension asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled paroxysmal ventricular tachycardia other and unspecified hyperlipidemia anemia, unspecified venous (peripheral) insufficiency, unspecified pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery other postoperative infection percutaneous transluminal coronary angioplasty status other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally venous (peripheral) insufficiency, unspecified cellulitis and abscess of trunk other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hematoma complicating a procedure unspecified essential hypertension adrenal cortical steroids causing adverse effects in therapeutic use osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh venous (peripheral) insufficiency, unspecified unspecified essential hypertension
hispanic latino m 57 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  313  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  284  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; senna  1  tab ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; diazepam  5  mg ; insulin  50  unit ; heparin  5000  unit ; aspirin  81  mg ; atenolol  50  mg ; lisinopril  10  mg ; simvastatin  20  mg ; levofloxacin  750  mg ; ns  1000  ml ; ibuprofen  600  mg ; 
depressive disorder, not elsewhere classified other chest pain pain in joint, shoulder region other and unspecified hyperlipidemia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 57 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; insulin  0  unit ; senna  1  tab ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; diazepam  5  mg ; insulin  50  unit ; heparin  5000  unit ; aspirin  81  mg ; atenolol  50  mg ; simvastatin  20  mg ; levofloxacin  750  mg ; ns  1000  ml ; ibuprofen  600  mg ; 
depressive disorder, not elsewhere classified other chest pain pain in joint, shoulder region other and unspecified hyperlipidemia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 59 $nan$nan$acetaminophen  1000  mg ; heparin  5000  unit ; 
 
unknown f 59 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  118  mg dl$acetaminophen  1000  mg ; heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; pantoprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; codeine sulfate  30  mg ; lorazepam  1-2  mg ; zolpidem tartrate  5  mg ; 
 
unknown f 59 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  172  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; pantoprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; codeine sulfate  30  mg ; lorazepam  1-2  mg ; zolpidem tartrate  5  mg ; d5 1 2ns  1000  ml ; topiramate (topamax)  50  mg ; lactated ringers  1000  ml ; senna  8.6  mg ; topiramate (topamax)  75  mg ; docusate sodium  100  mg ; mirtazapine  30  mg ; 
 
unknown f 59 $nan$hematology blood hematocrit  34.0  %; hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  186  k ul; hematology blood platelet count  181  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  136  mg dl$d5 1 2ns  1000  ml ; lactated ringers  1000  ml ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
unknown f 59 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  103  mg dl$d5 1 2ns  1000  ml ; lactated ringers  1000  ml ; senna  8.6  mg ; docusate sodium  100  mg ; quetiapine fumarate  25  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; docusate sodium (liquid)  100  mg ; acetaminophen iv  1000  mg ; bag  1  bag ; magnesium sulfate  4  gm ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5-1  mg ; 
 
unknown f 59 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  89  mg dl$senna  8.6  mg ; docusate sodium (liquid)  100  mg ; acetaminophen iv  1000  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; sodium chloride 0.9%  flush  10-20  ml ; acetylcysteine 20%  3-5  ml ; ciprofloxacin hcl  500  mg ; potassium chloride  40  meq ; 
 
unknown f 59 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  98  mg dl$senna  8.6  mg ; docusate sodium (liquid)  100  mg ; acetaminophen iv  1000  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; sodium chloride 0.9%  flush  10-20  ml ; acetylcysteine 20%  3-5  ml ; ciprofloxacin hcl  500  mg ; potassium chloride  40  meq ; furosemide  20  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 
 
unknown f 59 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  174  mg dl; chemistry blood glucose  85  mg dl$senna  8.6  mg ; docusate sodium (liquid)  100  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; sodium chloride 0.9%  flush  10-20  ml ; acetylcysteine 20%  3-5  ml ; furosemide  20  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; oxycodone (immediate release)  5  mg ; oxycodone (immediate release)  5-10  mg ; 
 
unknown f 59 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  95  mg dl$senna  8.6  mg ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; acetylcysteine 20%  3-5  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; oxycodone (immediate release)  5-10  mg ; rivaroxaban  20  mg ; lidocaine 5% patch  1  ptch ; oxycodone (immediate release)  10-15  mg ; guaifenesin er  1200  mg ; quetiapine fumarate  50  mg ; 
 
unknown f 59 $nan$nan$senna  8.6  mg ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; rivaroxaban  20  mg ; lidocaine 5% patch  1  ptch ; oxycodone (immediate release)  10-15  mg ; guaifenesin er  1200  mg ; quetiapine fumarate  50  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; lorazepam  2  mg ; 
 
unknown f 59 $nan$nan$senna  8.6  mg ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; rivaroxaban  20  mg ; lidocaine 5% patch  1  ptch ; oxycodone (immediate release)  10-15  mg ; guaifenesin er  1200  mg ; quetiapine fumarate  50  mg ; ondansetron  4  mg ; lorazepam  2  mg ; calcium carbonate  500  mg ; lorazepam  4  mg ; 
 
unknown f 59 $nan$nan$senna  8.6  mg ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; rivaroxaban  20  mg ; lidocaine 5% patch  1  ptch ; oxycodone (immediate release)  10-15  mg ; guaifenesin er  1200  mg ; quetiapine fumarate  50  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; 
 
unknown f 59 $nan$nan$senna  8.6  mg ; docusate sodium (liquid)  100  mg ; sodium chloride 0.9%  flush  10-20  ml ; rivaroxaban  20  mg ; lidocaine 5% patch  1  ptch ; oxycodone (immediate release)  10-15  mg ; guaifenesin er  1200  mg ; quetiapine fumarate  50  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; ramelteon  8  mg ; 
 
unknown f 59 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  556  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  10-20  ml ; rivaroxaban  20  mg ; oxycodone (immediate release)  10-15  mg ; guaifenesin er  1200  mg ; quetiapine fumarate  50  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; ramelteon  8  mg ; calcium carbonate  500-1000  mg ; 
 
unknown f 59 $nan$nan$sodium chloride 0.9%  flush  10-20  ml ; rivaroxaban  20  mg ; oxycodone (immediate release)  10-15  mg ; guaifenesin er  1200  mg ; quetiapine fumarate  50  mg ; ondansetron  4  mg ; ramelteon  8  mg ; calcium carbonate  500-1000  mg ; 
 
white f 51 $temp  98.7  heartrate  84.0  resprate  16.0  o2sat  98.0  sbp  140.0  dbp  94.0  rhythm    pain  0  $hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.6  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, indirect  4.6  mg dl; chemistry blood bilirubin, total  16.6  mg dl; chemistry blood glucose  81  mg dl; chemistry blood bilirubin, direct  12.0  mg dl$iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  mg ; potassium chloride  60  meq ; lactated ringers  1000  ml ; phytonadione  5  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; piperacillin-tazobactam  4.5  g ; nicotine patch  14  mg ; 
hypopotassemia tobacco use disorder disorders of phosphorus metabolism disorders of magnesium metabolism cholangitis chronic pancreatitis diarrhea dysphagia, unspecified anemia of other chronic disease acute alcoholic hepatitis obstruction of bile duct alcoholic cirrhosis of liver anxiety state, unspecified septicemia due to escherichia coli [e. coli] abnormal coagulation profile other and unspecified alcohol dependence, continuous urinary tract infection, site not specified varices of other sites other severe protein-calorie malnutrition other and unspecified escherichia coli [e. coli] acute pancreatitis acute posthemorrhagic anemia family history of malignant neoplasm of breast other and unspecified alcohol dependence, unspecified bacteremia personal history of venous thrombosis and embolism constipation, unspecified chronic pancreatitis angiodysplasia of stomach and duodenum with hemorrhage person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident body mass index less than 19, adult cyst and pseudocyst of pancreas driver of special construction vehicle injured in traffic accident alcoholic cirrhosis of liver tobacco use disorder chronic pancreatitis other diseases of spleen acute pancreatitis cyst and pseudocyst of pancreas other and unspecified alcohol dependence, unspecified
white f 51 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  2.7  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  2  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  17.1  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; piperacillin-tazobactam  4.5  g ; nicotine patch  14  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; folic acid  1  mg ; multivitamins  1  tab ; thiamine  100  mg ; neutra-phos  1  pkt ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; potassium chloride (powder)  40  meq ; neutra-phos  2  pkt ; heparin  5000  unit ; 
hypopotassemia tobacco use disorder disorders of phosphorus metabolism disorders of magnesium metabolism cholangitis chronic pancreatitis diarrhea dysphagia, unspecified anemia of other chronic disease acute alcoholic hepatitis obstruction of bile duct alcoholic cirrhosis of liver anxiety state, unspecified septicemia due to escherichia coli [e. coli] abnormal coagulation profile other and unspecified alcohol dependence, continuous urinary tract infection, site not specified varices of other sites other severe protein-calorie malnutrition other and unspecified escherichia coli [e. coli] acute pancreatitis acute posthemorrhagic anemia family history of malignant neoplasm of breast other and unspecified alcohol dependence, unspecified bacteremia personal history of venous thrombosis and embolism constipation, unspecified chronic pancreatitis angiodysplasia of stomach and duodenum with hemorrhage person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident body mass index less than 19, adult cyst and pseudocyst of pancreas driver of special construction vehicle injured in traffic accident alcoholic cirrhosis of liver tobacco use disorder chronic pancreatitis other diseases of spleen acute pancreatitis cyst and pseudocyst of pancreas other and unspecified alcohol dependence, unspecified
white f 51 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  2  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, indirect  4.9  mg dl; chemistry blood bilirubin, total  19.0  mg dl; chemistry blood glucose  82  mg dl; chemistry blood bilirubin, direct  14.1  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; piperacillin-tazobactam  4.5  g ; nicotine patch  14  mg ; folic acid  1  mg ; multivitamins  1  tab ; thiamine  100  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; potassium chloride (powder)  40  meq ; neutra-phos  2  pkt ; heparin  5000  unit ; spironolactone  25  mg ; 
hypopotassemia tobacco use disorder disorders of phosphorus metabolism disorders of magnesium metabolism cholangitis chronic pancreatitis diarrhea dysphagia, unspecified anemia of other chronic disease acute alcoholic hepatitis obstruction of bile duct alcoholic cirrhosis of liver anxiety state, unspecified septicemia due to escherichia coli [e. coli] abnormal coagulation profile other and unspecified alcohol dependence, continuous urinary tract infection, site not specified varices of other sites other severe protein-calorie malnutrition other and unspecified escherichia coli [e. coli] acute pancreatitis acute posthemorrhagic anemia family history of malignant neoplasm of breast other and unspecified alcohol dependence, unspecified bacteremia personal history of venous thrombosis and embolism constipation, unspecified chronic pancreatitis angiodysplasia of stomach and duodenum with hemorrhage person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident body mass index less than 19, adult cyst and pseudocyst of pancreas driver of special construction vehicle injured in traffic accident alcoholic cirrhosis of liver tobacco use disorder chronic pancreatitis other diseases of spleen acute pancreatitis cyst and pseudocyst of pancreas other and unspecified alcohol dependence, unspecified
white f 51 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  17.8  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; piperacillin-tazobactam  4.5  g ; nicotine patch  14  mg ; folic acid  1  mg ; multivitamins  1  tab ; thiamine  100  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; spironolactone  25  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; 
hypopotassemia tobacco use disorder disorders of phosphorus metabolism disorders of magnesium metabolism cholangitis chronic pancreatitis diarrhea dysphagia, unspecified anemia of other chronic disease acute alcoholic hepatitis obstruction of bile duct alcoholic cirrhosis of liver anxiety state, unspecified septicemia due to escherichia coli [e. coli] abnormal coagulation profile other and unspecified alcohol dependence, continuous urinary tract infection, site not specified varices of other sites other severe protein-calorie malnutrition other and unspecified escherichia coli [e. coli] acute pancreatitis acute posthemorrhagic anemia family history of malignant neoplasm of breast other and unspecified alcohol dependence, unspecified bacteremia personal history of venous thrombosis and embolism constipation, unspecified chronic pancreatitis angiodysplasia of stomach and duodenum with hemorrhage person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident body mass index less than 19, adult cyst and pseudocyst of pancreas driver of special construction vehicle injured in traffic accident alcoholic cirrhosis of liver tobacco use disorder chronic pancreatitis other diseases of spleen acute pancreatitis cyst and pseudocyst of pancreas other and unspecified alcohol dependence, unspecified
white f 51 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  18.2  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; nicotine patch  14  mg ; folic acid  1  mg ; multivitamins  1  tab ; thiamine  100  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; spironolactone  25  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; trazodone  50  mg ; trazodone  50-75  mg ; 
hypopotassemia tobacco use disorder disorders of phosphorus metabolism disorders of magnesium metabolism cholangitis chronic pancreatitis diarrhea dysphagia, unspecified anemia of other chronic disease acute alcoholic hepatitis obstruction of bile duct alcoholic cirrhosis of liver anxiety state, unspecified septicemia due to escherichia coli [e. coli] abnormal coagulation profile other and unspecified alcohol dependence, continuous urinary tract infection, site not specified varices of other sites other severe protein-calorie malnutrition other and unspecified escherichia coli [e. coli] acute pancreatitis acute posthemorrhagic anemia family history of malignant neoplasm of breast other and unspecified alcohol dependence, unspecified bacteremia personal history of venous thrombosis and embolism constipation, unspecified chronic pancreatitis angiodysplasia of stomach and duodenum with hemorrhage person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident body mass index less than 19, adult cyst and pseudocyst of pancreas driver of special construction vehicle injured in traffic accident alcoholic cirrhosis of liver tobacco use disorder chronic pancreatitis other diseases of spleen acute pancreatitis cyst and pseudocyst of pancreas other and unspecified alcohol dependence, unspecified
white f 51 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  16.9  mg dl$sodium chloride 0.9%  flush  3  ml ; nicotine patch  14  mg ; folic acid  1  mg ; multivitamins  1  tab ; thiamine  100  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; trazodone  50-75  mg ; furosemide  20  mg ; spironolactone  50  mg ; 
hypopotassemia tobacco use disorder disorders of phosphorus metabolism disorders of magnesium metabolism cholangitis chronic pancreatitis diarrhea dysphagia, unspecified anemia of other chronic disease acute alcoholic hepatitis obstruction of bile duct alcoholic cirrhosis of liver anxiety state, unspecified septicemia due to escherichia coli [e. coli] abnormal coagulation profile other and unspecified alcohol dependence, continuous urinary tract infection, site not specified varices of other sites other severe protein-calorie malnutrition other and unspecified escherichia coli [e. coli] acute pancreatitis acute posthemorrhagic anemia family history of malignant neoplasm of breast other and unspecified alcohol dependence, unspecified bacteremia personal history of venous thrombosis and embolism constipation, unspecified chronic pancreatitis angiodysplasia of stomach and duodenum with hemorrhage person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident body mass index less than 19, adult cyst and pseudocyst of pancreas driver of special construction vehicle injured in traffic accident alcoholic cirrhosis of liver tobacco use disorder chronic pancreatitis other diseases of spleen acute pancreatitis cyst and pseudocyst of pancreas other and unspecified alcohol dependence, unspecified
black african american m 65 $temp  98.1  heartrate  70.0  resprate  18.0  o2sat  99.0  sbp  116.0  dbp  64.0  rhythm    pain    $hematology blood hematocrit  39.8  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  73  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  358  iu l; blood gas blood lactate  1.6  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; lactated ringers  1000  ml ; doxycycline hyclate  100  mg ; acetaminophen  1000  mg ; tramadol (ultram)  25  mg ; ondansetron  4  mg ; lorazepam  0.25  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; 
 
black african american m 65 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; doxycycline hyclate  100  mg ; tramadol (ultram)  25  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; 
 
white m 56 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  104  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood chloride, whole blood  111  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood glucose  173  mg dl; blood gas blood glucose  191  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  38  %; blood gas blood hemoglobin  12.7  g dl; blood gas blood hemoglobin  12.8  g dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  138  meq l$lisinopril  10  mg ; sertraline  100  mg ; metformin (glucophage)  1000  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; insulin  0  unit ; hydromorphone (dilaudid)  12.5  mg ; docusate sodium  100  mg ; lorazepam  0.5-1  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white m 56 $nan$nan$lisinopril  10  mg ; sertraline  100  mg ; metformin (glucophage)  1000  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; insulin  0  unit ; docusate sodium  100  mg ; lorazepam  0.5-1  mg ; dexamethasone  4  mg ; oxycodone (immediate release)   5-15  mg ; lorazepam  0.5  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white m 56 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  170  mg dl$lisinopril  10  mg ; sertraline  100  mg ; metformin (glucophage)  1000  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; insulin  0  unit ; docusate sodium  100  mg ; dexamethasone  4  mg ; oxycodone (immediate release)   5-15  mg ; lorazepam  0.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white m 56 $nan$hematology blood hematocrit  32.2  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  189  k ul; hematology blood platelet count  181  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  435  mg dl; chemistry blood glucose  141  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood potassium, whole blood  2.8  meq l$bag  100  ml ; lisinopril  10  mg ; sertraline  100  mg ; metformin (glucophage)  1000  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; insulin  0  unit ; docusate sodium  100  mg ; oxycodone (immediate release)   5-15  mg ; lorazepam  0.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; metoprolol tartrate  5  mg ; labetalol  10  mg ; gabapentin  300  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; hydromorphone (dilaudid)  0.5-1  mg ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200-400  ml ; potassium chloride  20-40  meq ; sw  400-600  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; propofol  1000  mg ; propofol  200  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; potassium chl 20 meq   1000 ml ns  1000  ml ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white m 56 $nan$hematology blood hematocrit  35.1  %; hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  210  k ul; hematology blood platelet count  220  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  163  mg dl$bag  100  ml ; lisinopril  10  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; insulin  0  unit ; docusate sodium  100  mg ; oxycodone (immediate release)   5-15  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; hydromorphone (dilaudid)  0.5-1  mg ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200-400  ml ; potassium chloride  20-40  meq ; sw  400-600  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; propofol  1000  mg ; propofol  200  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; potassium chl 20 meq   1000 ml ns  1000  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; furosemide  20  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white m 56 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  154  mg dl$bag  100  ml ; lisinopril  10  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; insulin  0  unit ; oxycodone (immediate release)   5-15  mg ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200-400  ml ; potassium chloride  20-40  meq ; sw  400-600  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; propofol  200  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; furosemide  20  mg ; senna  1  tab ; bisacodyl  10  mg ; furosemide  10  mg ; 5% dextrose  100  ml ; furosemide  100  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white m 56 $nan$nan$bag  100  ml ; lisinopril  10  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-15  mg ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sw  200-400  ml ; potassium chloride  20-40  meq ; sw  400-600  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; propofol  200  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; senna  1  tab ; bisacodyl  10  mg ; furosemide  10  mg ; 5% dextrose  100  ml ; furosemide  100  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white m 56 $nan$nan$lisinopril  10  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-15  mg ; bisacodyl  10  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white m 56 $nan$nan$lisinopril  10  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-15  mg ; bisacodyl  10  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; magnesium citrate  300  ml ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white m 56 $nan$nan$lisinopril  10  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-15  mg ; bisacodyl  10  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white m 56 $nan$nan$lisinopril  10  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-15  mg ; bisacodyl  10  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; 
unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled spinal stenosis, lumbar region, without neurogenic claudication displacement of lumbar intervertebral disc without myelopathy
white f 58 $nan$nan$ferrous sulfate  325  mg ; 
 
white f 58 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; ferrous sulfate  325  mg ; influenza virus vaccine  0.5  ml ; hydromorphone (dilaudid)  2-4  mg ; pantoprazole  40  mg ; bupropion (sustained release)  150  mg ; docusate sodium  100  mg ; miralax  17  gm ; zyrtec  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; simethicone  40-80  mg ; ns  1000  ml ; 1 2 ns  1000  ml ; 
 
white f 58 $nan$nan$ferrous sulfate  325  mg ; docusate sodium  100  mg ; miralax  17  gm ; zyrtec  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; simethicone  40-80  mg ; ns  1000  ml ; 1 2 ns  1000  ml ; 
 
white f 56 $nan$nan$citalopram  5  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; 
 
white f 56 $nan$nan$ondansetron  4  mg ; 
 
white m 70 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  149  mg dl; chemistry blood lactate dehydrogenase (ld)  202  iu l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; artificial tears  1-2  drop ; atorvastatin  20  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; doxycycline hyclate  100  mg ; omeprazole  20  mg ; fentanyl patch  12  mcg h ; ferrous gluconate  324  mg ; gabapentin  100  mg ; lactulose  15  ml ; miconazole powder 2%  1  appl ; mupirocin ointment 2%  1  appl ; nephrocaps  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin-dextromethorphan  5  ml ; 
methicillin resistant staphylococcus aureus septicemia end stage renal disease diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pressure ulcer, heel bloodstream infection due to central venous catheter body mass index 45.0-49.9, adult morbid obesity obstructive sleep apnea (adult)(pediatric) long-term (current) use of insulin polyneuropathy in diabetes diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation pressure ulcer, unstageable sepsis chronic airway obstruction, not elsewhere classified background diabetic retinopathy kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure long-term (current) use of anticoagulants constipation, unspecified chronic airway obstruction, not elsewhere classified anemia, unspecified renal dialysis status atrial fibrillation long-term (current) use of insulin infection and inflammatory reaction due to other vascular device, implant, and graft mononeuritis of lower limb, unspecified arthropathy, unspecified, lower leg end stage renal disease body mass index 45.0-49.9, adult abnormal coagulation profile hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease obstructive sleep apnea (adult)(pediatric) long-term (current) use of anticoagulants diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled morbid obesity background diabetic retinopathy anticoagulants causing adverse effects in therapeutic use kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes personal history of methicillin resistant staphylococcus aureus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux hyperpotassemia kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled
white m 70 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood glucose  138  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; artificial tears  1-2  drop ; atorvastatin  20  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; fentanyl patch  12  mcg h ; ferrous gluconate  324  mg ; gabapentin  100  mg ; lactulose  15  ml ; miconazole powder 2%  1  appl ; mupirocin ointment 2%  1  appl ; nephrocaps  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin-dextromethorphan  5  ml ; apixaban  5  mg ; sodium chloride 0.9%  1000  ml ; heparin dwell (1000 units ml)  2000-8000  unit ; neomycin-polymyxin-bacitracin  1  appl ; doxercalciferol  4  mcg ; 
methicillin resistant staphylococcus aureus septicemia end stage renal disease diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pressure ulcer, heel bloodstream infection due to central venous catheter body mass index 45.0-49.9, adult morbid obesity obstructive sleep apnea (adult)(pediatric) long-term (current) use of insulin polyneuropathy in diabetes diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation pressure ulcer, unstageable sepsis chronic airway obstruction, not elsewhere classified background diabetic retinopathy kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure long-term (current) use of anticoagulants constipation, unspecified chronic airway obstruction, not elsewhere classified anemia, unspecified renal dialysis status atrial fibrillation long-term (current) use of insulin infection and inflammatory reaction due to other vascular device, implant, and graft mononeuritis of lower limb, unspecified arthropathy, unspecified, lower leg end stage renal disease body mass index 45.0-49.9, adult abnormal coagulation profile hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease obstructive sleep apnea (adult)(pediatric) long-term (current) use of anticoagulants diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled morbid obesity background diabetic retinopathy anticoagulants causing adverse effects in therapeutic use kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes personal history of methicillin resistant staphylococcus aureus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux hyperpotassemia kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled
white m 70 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; artificial tears  1-2  drop ; atorvastatin  20  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; fentanyl patch  12  mcg h ; ferrous gluconate  324  mg ; lactulose  15  ml ; miconazole powder 2%  1  appl ; mupirocin ointment 2%  1  appl ; nephrocaps  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin-dextromethorphan  5  ml ; apixaban  5  mg ; sodium chloride 0.9%  1000  ml ; heparin dwell (1000 units ml)  2000-8000  unit ; neomycin-polymyxin-bacitracin  1  appl ; doxercalciferol  4  mcg ; 
methicillin resistant staphylococcus aureus septicemia end stage renal disease diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pressure ulcer, heel bloodstream infection due to central venous catheter body mass index 45.0-49.9, adult morbid obesity obstructive sleep apnea (adult)(pediatric) long-term (current) use of insulin polyneuropathy in diabetes diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation pressure ulcer, unstageable sepsis chronic airway obstruction, not elsewhere classified background diabetic retinopathy kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure long-term (current) use of anticoagulants constipation, unspecified chronic airway obstruction, not elsewhere classified anemia, unspecified renal dialysis status atrial fibrillation long-term (current) use of insulin infection and inflammatory reaction due to other vascular device, implant, and graft mononeuritis of lower limb, unspecified arthropathy, unspecified, lower leg end stage renal disease body mass index 45.0-49.9, adult abnormal coagulation profile hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease obstructive sleep apnea (adult)(pediatric) long-term (current) use of anticoagulants diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled morbid obesity background diabetic retinopathy anticoagulants causing adverse effects in therapeutic use kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes personal history of methicillin resistant staphylococcus aureus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled esophageal reflux hyperpotassemia kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled
white m 60 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  504  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  138  mg dl; hematology blood bands  0  %$nan
 
white m 60 $nan$blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood chloride, whole blood  97  meq l; blood gas blood glucose  130  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hemoglobin  11.9  g dl; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood sodium, whole blood  136  meq l$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; chlorthalidone  25  mg ; atenolol  50  mg ; uroxatral  10  mg ; taztia xt  300  mg ; famotidine  20  mg ; hydromorphone (dilaudid)  12.5  mg ; propofol  1000  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 
 
white m 60 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  466  k ul$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; atenolol  50  mg ; uroxatral  10  mg ; taztia xt  300  mg ; famotidine  20  mg ; hydromorphone (dilaudid)  12.5  mg ; propofol  1000  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyclobenzaprine  5  mg ; oxycodone sr (oxycontin)  10  mg ; 
 
white m 60 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; atenolol  50  mg ; uroxatral  10  mg ; taztia xt  300  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyclobenzaprine  5  mg ; oxycodone sr (oxycontin)  10  mg ; 
 
white m 60 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; atenolol  50  mg ; uroxatral  10  mg ; taztia xt  300  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyclobenzaprine  5  mg ; oxycodone sr (oxycontin)  10  mg ; cepacol (menthol)  1  loz ; 
 
white m 60 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; atenolol  50  mg ; uroxatral  10  mg ; taztia xt  300  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyclobenzaprine  5  mg ; oxycodone sr (oxycontin)  10  mg ; cepacol (menthol)  1  loz ; 
 
white m 60 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; atenolol  50  mg ; uroxatral  10  mg ; taztia xt  300  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyclobenzaprine  5  mg ; oxycodone sr (oxycontin)  10  mg ; cepacol (menthol)  1  loz ; oxycodone sr (oxycontin)  20  mg ; 
 
white m 60 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; docusate sodium  100  mg ; atenolol  50  mg ; uroxatral  10  mg ; taztia xt  300  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyclobenzaprine  5  mg ; cepacol (menthol)  1  loz ; oxycodone sr (oxycontin)  20  mg ; 
 
unknown m 85 $nan$hematology blood hematocrit  30.8  %; hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  159  k ul; hematology blood platelet count  159  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  211  mg dl; chemistry blood glucose  124  mg dl; chemistry blood lactate dehydrogenase (ld)  222  iu l; chemistry blood albumin  3.6  g dl; chemistry blood % hemoglobin a1c  10.7  %$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; aspirin ec  81  mg ; pantoprazole  40  mg ; metoprolol tartrate  12.5  mg ; citalopram  30  mg ; glipizide xl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  250  ml ; heparin sodium  25,000  unit ; lorazepam  1  mg ; albuterol 0.083% neb soln  1  neb ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; acetaminophen  325-650  mg ; d5w  250  ml ; nitroglycerin  100  mg ; metoprolol tartrate  25  mg ; haloperidol  1  mg ; haloperidol  2.5  mg ; ipratropium bromide neb  1  neb ; furosemide  40  mg ; 
 
unknown m 85 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  107  mg dl; blood gas blood free calcium  1.14  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; aspirin ec  81  mg ; glipizide xl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lorazepam  1  mg ; albuterol 0.083% neb soln  1  neb ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; acetaminophen  325-650  mg ; d5w  250  ml ; nitroglycerin  100  mg ; metoprolol tartrate  25  mg ; haloperidol  1  mg ; haloperidol  2.5  mg ; ipratropium bromide neb  1  neb ; furosemide  40  mg ; diazepam  5  mg ; diazepam  5-10  mg ; mupirocin ointment 2%  1  appl ; venlafaxine xr  75  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  1100  unit ; docusate sodium  100  mg ; polyethylene glycol  17  g ; 
 
unknown m 85 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  84  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; aspirin ec  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  1  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; acetaminophen  325-650  mg ; ipratropium bromide neb  1  neb ; mupirocin ointment 2%  1  appl ; venlafaxine xr  75  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  1100  unit ; docusate sodium  100  mg ; polyethylene glycol  17  g ; atorvastatin  80  mg ; 
 
unknown m 85 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; aspirin ec  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; acetaminophen  325-650  mg ; ipratropium bromide neb  1  neb ; mupirocin ointment 2%  1  appl ; venlafaxine xr  75  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; polyethylene glycol  17  g ; atorvastatin  80  mg ; hydromorphone (dilaudid)  0.5  mg ; clopidogrel  75  mg ; 
 
black african american m 64 $nan$nan$ranitidine  150  mg ; warfarin  6  mg ; 
 
black african american m 64 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood glucose  167  mg dl$ranitidine  150  mg ; warfarin  6  mg ; 1 2 ns  1000  ml ; oxcarbazepine  300  mg ; hydroxychloroquine sulfate  200  mg ; divalproex (delayed release)  500  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; risperidone  3  mg ; albuterol 0.083% neb soln  1  neb ; latanoprost 0.005% ophth. soln.  1  drop ; ciprofloxacin hcl  500  mg ; insulin  0  unit ; ipratropium bromide neb  1  neb ; 
 
black african american m 64 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood glucose  90  mg dl$ranitidine  150  mg ; warfarin  6  mg ; oxcarbazepine  300  mg ; hydroxychloroquine sulfate  200  mg ; divalproex (delayed release)  500  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; risperidone  3  mg ; albuterol 0.083% neb soln  1  neb ; latanoprost 0.005% ophth. soln.  1  drop ; ciprofloxacin hcl  500  mg ; insulin  0  unit ; ipratropium bromide neb  1  neb ; albuterol inhaler  4  puff ; ipratropium bromide mdi  3  puff ; sodium polystyrene sulfonate  15  gm ; warfarin  2  mg ; warfarin  5  mg ; 
 
black african american m 64 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  88  mg dl$ranitidine  150  mg ; oxcarbazepine  300  mg ; hydroxychloroquine sulfate  200  mg ; divalproex (delayed release)  500  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; risperidone  3  mg ; latanoprost 0.005% ophth. soln.  1  drop ; ciprofloxacin hcl  500  mg ; insulin  0  unit ; albuterol inhaler  4  puff ; ipratropium bromide mdi  3  puff ; sodium polystyrene sulfonate  15  gm ; warfarin  2  mg ; warfarin  5  mg ; furosemide  20  mg ; sodium polystyrene sulfonate  30  gm ; 
 
black african american m 64 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  89  mg dl$ranitidine  150  mg ; oxcarbazepine  300  mg ; hydroxychloroquine sulfate  200  mg ; divalproex (delayed release)  500  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; risperidone  3  mg ; latanoprost 0.005% ophth. soln.  1  drop ; ciprofloxacin hcl  500  mg ; insulin  0  unit ; albuterol inhaler  4  puff ; ipratropium bromide mdi  3  puff ; warfarin  2  mg ; warfarin  5  mg ; furosemide  20  mg ; sodium polystyrene sulfonate  30  gm ; carvedilol  3.125  mg ; 
 
black african american m 64 $nan$nan$ranitidine  150  mg ; oxcarbazepine  300  mg ; hydroxychloroquine sulfate  200  mg ; divalproex (delayed release)  500  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; risperidone  3  mg ; latanoprost 0.005% ophth. soln.  1  drop ; ciprofloxacin hcl  500  mg ; insulin  0  unit ; albuterol inhaler  4  puff ; ipratropium bromide mdi  3  puff ; warfarin  2  mg ; warfarin  5  mg ; furosemide  20  mg ; carvedilol  3.125  mg ; 
 
asian m 70 $nan$hematology blood hematocrit  31.2  %; hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  271  k ul; hematology blood platelet count  271  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  253  mg dl; chemistry blood glucose  165  mg dl$lisinopril  5  mg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; morphine sulfate  1-6  mg ; hydromorphone (dilaudid)  2-6  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; promethazine  12.5-25  mg ; diphenhydramine  50  mg ; diphenhydramine  12.5-50  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; albuterol-ipratropium  1-2  puff ; lorazepam  1  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; insulin  40  unit ; docusate sodium  100  mg ; furosemide  80  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  65  unit ; hydromorphone (dilaudid)  0.25  mg ; 
fever, unspecified long-term (current) use of insulin pure hypercholesterolemia morbid obesity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic kidney disease, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group a infected postoperative seroma unspecified essential hypertension pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other postoperative infection diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled seroma complicating a procedure chronic kidney disease, unspecified other and unspecified hyperlipidemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity osteoarthrosis, unspecified whether generalized or localized, shoulder region other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) edema of male genital organs depressive disorder, not elsewhere classified tobacco use disorder pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infected postoperative seroma other specified disorders of male genital organs long-term (current) use of insulin dermatophytosis of foot morbid obesity removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypotension, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site personal history of malignant neoplasm of testis chronic kidney disease, unspecified chronic airway obstruction, not elsewhere classified other noninfectious disorders of lymphatic channels chronic kidney disease, unspecified family history of diabetes mellitus family history of stroke (cerebrovascular) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
asian m 70 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  246  k ul$lisinopril  5  mg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; morphine sulfate  1-6  mg ; hydromorphone (dilaudid)  2-6  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; promethazine  12.5-25  mg ; diphenhydramine  50  mg ; diphenhydramine  12.5-50  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; albuterol-ipratropium  1-2  puff ; lorazepam  1  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; insulin  40  unit ; docusate sodium  100  mg ; furosemide  80  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  65  unit ; hydromorphone (dilaudid)  0.25  mg ; insulin  30  unit ; 
fever, unspecified long-term (current) use of insulin pure hypercholesterolemia morbid obesity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic kidney disease, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group a infected postoperative seroma unspecified essential hypertension pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other postoperative infection diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled seroma complicating a procedure chronic kidney disease, unspecified other and unspecified hyperlipidemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity osteoarthrosis, unspecified whether generalized or localized, shoulder region other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) edema of male genital organs depressive disorder, not elsewhere classified tobacco use disorder pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infected postoperative seroma other specified disorders of male genital organs long-term (current) use of insulin dermatophytosis of foot morbid obesity removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypotension, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site personal history of malignant neoplasm of testis chronic kidney disease, unspecified chronic airway obstruction, not elsewhere classified other noninfectious disorders of lymphatic channels chronic kidney disease, unspecified family history of diabetes mellitus family history of stroke (cerebrovascular) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
asian m 70 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  256  k ul$lisinopril  5  mg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; morphine sulfate  1-6  mg ; hydromorphone (dilaudid)  2-6  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; promethazine  12.5-25  mg ; diphenhydramine  50  mg ; diphenhydramine  12.5-50  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; albuterol-ipratropium  1-2  puff ; lorazepam  1  mg ; docusate sodium  100  mg ; furosemide  80  mg ; insulin  30  unit ; lr  1000  ml ; insulin  35  unit ; 
fever, unspecified long-term (current) use of insulin pure hypercholesterolemia morbid obesity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic kidney disease, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group a infected postoperative seroma unspecified essential hypertension pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other postoperative infection diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled seroma complicating a procedure chronic kidney disease, unspecified other and unspecified hyperlipidemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity osteoarthrosis, unspecified whether generalized or localized, shoulder region other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) edema of male genital organs depressive disorder, not elsewhere classified tobacco use disorder pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infected postoperative seroma other specified disorders of male genital organs long-term (current) use of insulin dermatophytosis of foot morbid obesity removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypotension, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site personal history of malignant neoplasm of testis chronic kidney disease, unspecified chronic airway obstruction, not elsewhere classified other noninfectious disorders of lymphatic channels chronic kidney disease, unspecified family history of diabetes mellitus family history of stroke (cerebrovascular) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
asian m 70 $nan$hematology blood hematocrit  25.4  %; hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry urine chloride, urine  28  meq l; chemistry urine creatinine, urine  134  mg dl; chemistry urine potassium, urine  34  meq l; chemistry urine sodium, urine  39  meq l; chemistry urine urea nitrogen, urine  565  mg dl; chemistry blood glucose  98  mg dl$simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; morphine sulfate  1-6  mg ; hydromorphone (dilaudid)  2-6  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; promethazine  12.5-25  mg ; diphenhydramine  50  mg ; diphenhydramine  12.5-50  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; albuterol-ipratropium  1-2  puff ; lorazepam  1  mg ; docusate sodium  100  mg ; insulin  30  unit ; insulin  35  unit ; 0.9% sodium chloride  1000  ml ; 
fever, unspecified long-term (current) use of insulin pure hypercholesterolemia morbid obesity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic kidney disease, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group a infected postoperative seroma unspecified essential hypertension pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other postoperative infection diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled seroma complicating a procedure chronic kidney disease, unspecified other and unspecified hyperlipidemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity osteoarthrosis, unspecified whether generalized or localized, shoulder region other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) edema of male genital organs depressive disorder, not elsewhere classified tobacco use disorder pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infected postoperative seroma other specified disorders of male genital organs long-term (current) use of insulin dermatophytosis of foot morbid obesity removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypotension, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site personal history of malignant neoplasm of testis chronic kidney disease, unspecified chronic airway obstruction, not elsewhere classified other noninfectious disorders of lymphatic channels chronic kidney disease, unspecified family history of diabetes mellitus family history of stroke (cerebrovascular) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
asian m 70 $nan$nan$simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; morphine sulfate  1-6  mg ; hydromorphone (dilaudid)  2-6  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; promethazine  12.5-25  mg ; diphenhydramine  50  mg ; diphenhydramine  12.5-50  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; albuterol-ipratropium  1-2  puff ; lorazepam  1  mg ; docusate sodium  100  mg ; insulin  35  unit ; 0.9% sodium chloride  1000  ml ; 
fever, unspecified long-term (current) use of insulin pure hypercholesterolemia morbid obesity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic kidney disease, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group a infected postoperative seroma unspecified essential hypertension pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other postoperative infection diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled seroma complicating a procedure chronic kidney disease, unspecified other and unspecified hyperlipidemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity osteoarthrosis, unspecified whether generalized or localized, shoulder region other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) edema of male genital organs depressive disorder, not elsewhere classified tobacco use disorder pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infected postoperative seroma other specified disorders of male genital organs long-term (current) use of insulin dermatophytosis of foot morbid obesity removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypotension, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site personal history of malignant neoplasm of testis chronic kidney disease, unspecified chronic airway obstruction, not elsewhere classified other noninfectious disorders of lymphatic channels chronic kidney disease, unspecified family history of diabetes mellitus family history of stroke (cerebrovascular) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
white f 92 $nan$nan$clopidogrel  75  mg ; simvastatin  10  mg ; folic acid  1  mg ; amlodipine  5  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia ulcer of other part of foot atherosclerosis of native arteries of the extremities with ulceration stricture of artery other complications due to other vascular device, implant, and graft chronic kidney disease, stage iii (moderate) other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a car injured in collision with car, pick-up truck or van chronic lymphoid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism pedestrian injured in nontraffic accident involving other and unspecified motor vehicles unspecified essential hypertension spontaneous ecchymoses infection with microorganisms resistant to penicillins alzheimer's disease secondary thrombocytopenia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site dementia in conditions classified elsewhere without behavioral disturbance swelling of limb pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other accident caused by striking against or being struck accidentally by objects or persons blood vessel replaced by other means atherosclerosis of native arteries of the extremities, unspecified chronic lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia aneurysm of artery of lower extremity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dementia in conditions classified elsewhere without behavioral disturbance personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular complications, not elsewhere classified aneurysm of artery of upper extremity alzheimer's disease ulcer of other part of foot hematoma complicating a procedure unspecified essential hypertension atherosclerosis of native arteries of the extremities with gangrene other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with gangrene 
white f 92 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  85  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood glucose  96  mg dl$clopidogrel  75  mg ; simvastatin  10  mg ; folic acid  1  mg ; amlodipine  5  mg ; metoprolol tartrate  25  mg ; heparin  5000  unit ; docusate sodium  100  mg ; vancomycin  1000  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; donepezil  10  mg ; sodium chloride 0.9%  flush  3  ml ; hydralazine  10  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; acetaminophen  650  mg ; senna  1  tab ; amlodipine  2.5  mg ; metoprolol succinate xl  50  mg ; 0.9% sodium chloride  1000  ml ; ciprofloxacin hcl  250  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia ulcer of other part of foot atherosclerosis of native arteries of the extremities with ulceration stricture of artery other complications due to other vascular device, implant, and graft chronic kidney disease, stage iii (moderate) other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a car injured in collision with car, pick-up truck or van chronic lymphoid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism pedestrian injured in nontraffic accident involving other and unspecified motor vehicles unspecified essential hypertension spontaneous ecchymoses infection with microorganisms resistant to penicillins alzheimer's disease secondary thrombocytopenia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site dementia in conditions classified elsewhere without behavioral disturbance swelling of limb pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other accident caused by striking against or being struck accidentally by objects or persons blood vessel replaced by other means atherosclerosis of native arteries of the extremities, unspecified chronic lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia aneurysm of artery of lower extremity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dementia in conditions classified elsewhere without behavioral disturbance personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular complications, not elsewhere classified aneurysm of artery of upper extremity alzheimer's disease ulcer of other part of foot hematoma complicating a procedure unspecified essential hypertension atherosclerosis of native arteries of the extremities with gangrene other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with gangrene 
white f 92 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  82  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood glucose  103  mg dl$clopidogrel  75  mg ; simvastatin  10  mg ; folic acid  1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; vancomycin  1000  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; donepezil  10  mg ; sodium chloride 0.9%  flush  3  ml ; hydralazine  10  mg ; acetaminophen  650  mg ; senna  1  tab ; metoprolol succinate xl  50  mg ; ciprofloxacin hcl  250  mg ; aspirin  81  mg ; amlodipine  10  mg ; d5ns  500  ml ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia ulcer of other part of foot atherosclerosis of native arteries of the extremities with ulceration stricture of artery other complications due to other vascular device, implant, and graft chronic kidney disease, stage iii (moderate) other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a car injured in collision with car, pick-up truck or van chronic lymphoid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism pedestrian injured in nontraffic accident involving other and unspecified motor vehicles unspecified essential hypertension spontaneous ecchymoses infection with microorganisms resistant to penicillins alzheimer's disease secondary thrombocytopenia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site dementia in conditions classified elsewhere without behavioral disturbance swelling of limb pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other accident caused by striking against or being struck accidentally by objects or persons blood vessel replaced by other means atherosclerosis of native arteries of the extremities, unspecified chronic lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia aneurysm of artery of lower extremity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dementia in conditions classified elsewhere without behavioral disturbance personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular complications, not elsewhere classified aneurysm of artery of upper extremity alzheimer's disease ulcer of other part of foot hematoma complicating a procedure unspecified essential hypertension atherosclerosis of native arteries of the extremities with gangrene other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with gangrene 
white f 92 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  90  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry urine creatinine, urine  128  mg dl; chemistry blood glucose  101  mg dl; chemistry urine protein creatinine ratio  1.5  ratio$clopidogrel  75  mg ; simvastatin  10  mg ; folic acid  1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; vancomycin  1000  mg ; donepezil  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; metoprolol succinate xl  50  mg ; ciprofloxacin hcl  250  mg ; amlodipine  10  mg ; metoprolol succinate xl  100  mg ; heparin flush (10 units ml)  2  ml ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia ulcer of other part of foot atherosclerosis of native arteries of the extremities with ulceration stricture of artery other complications due to other vascular device, implant, and graft chronic kidney disease, stage iii (moderate) other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a car injured in collision with car, pick-up truck or van chronic lymphoid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism pedestrian injured in nontraffic accident involving other and unspecified motor vehicles unspecified essential hypertension spontaneous ecchymoses infection with microorganisms resistant to penicillins alzheimer's disease secondary thrombocytopenia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site dementia in conditions classified elsewhere without behavioral disturbance swelling of limb pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other accident caused by striking against or being struck accidentally by objects or persons blood vessel replaced by other means atherosclerosis of native arteries of the extremities, unspecified chronic lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia aneurysm of artery of lower extremity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dementia in conditions classified elsewhere without behavioral disturbance personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular complications, not elsewhere classified aneurysm of artery of upper extremity alzheimer's disease ulcer of other part of foot hematoma complicating a procedure unspecified essential hypertension atherosclerosis of native arteries of the extremities with gangrene other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with gangrene 
white f 92 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  98  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  267  iu l$clopidogrel  75  mg ; simvastatin  10  mg ; folic acid  1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; donepezil  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; ciprofloxacin hcl  250  mg ; amlodipine  10  mg ; metoprolol succinate xl  100  mg ; heparin flush (10 units ml)  2  ml ; 5% dextrose  250  ml ; vancomycin  750  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia ulcer of other part of foot atherosclerosis of native arteries of the extremities with ulceration stricture of artery other complications due to other vascular device, implant, and graft chronic kidney disease, stage iii (moderate) other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a car injured in collision with car, pick-up truck or van chronic lymphoid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism pedestrian injured in nontraffic accident involving other and unspecified motor vehicles unspecified essential hypertension spontaneous ecchymoses infection with microorganisms resistant to penicillins alzheimer's disease secondary thrombocytopenia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site dementia in conditions classified elsewhere without behavioral disturbance swelling of limb pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other accident caused by striking against or being struck accidentally by objects or persons blood vessel replaced by other means atherosclerosis of native arteries of the extremities, unspecified chronic lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia aneurysm of artery of lower extremity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dementia in conditions classified elsewhere without behavioral disturbance personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular complications, not elsewhere classified aneurysm of artery of upper extremity alzheimer's disease ulcer of other part of foot hematoma complicating a procedure unspecified essential hypertension atherosclerosis of native arteries of the extremities with gangrene other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with gangrene 
white f 92 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  90  k ul; hematology blood platelet count  89  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  94  mg dl$clopidogrel  75  mg ; simvastatin  10  mg ; folic acid  1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; donepezil  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; amlodipine  10  mg ; metoprolol succinate xl  100  mg ; heparin flush (10 units ml)  2  ml ; 5% dextrose  250  ml ; vancomycin  750  mg ; acetaminophen  1000  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia ulcer of other part of foot atherosclerosis of native arteries of the extremities with ulceration stricture of artery other complications due to other vascular device, implant, and graft chronic kidney disease, stage iii (moderate) other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a car injured in collision with car, pick-up truck or van chronic lymphoid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism pedestrian injured in nontraffic accident involving other and unspecified motor vehicles unspecified essential hypertension spontaneous ecchymoses infection with microorganisms resistant to penicillins alzheimer's disease secondary thrombocytopenia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site dementia in conditions classified elsewhere without behavioral disturbance swelling of limb pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other accident caused by striking against or being struck accidentally by objects or persons blood vessel replaced by other means atherosclerosis of native arteries of the extremities, unspecified chronic lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia aneurysm of artery of lower extremity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dementia in conditions classified elsewhere without behavioral disturbance personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular complications, not elsewhere classified aneurysm of artery of upper extremity alzheimer's disease ulcer of other part of foot hematoma complicating a procedure unspecified essential hypertension atherosclerosis of native arteries of the extremities with gangrene other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with gangrene 
white f 92 $nan$hematology blood hematocrit  22.3  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  93  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  71  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood glucose  102  mg dl$clopidogrel  75  mg ; simvastatin  10  mg ; folic acid  1  mg ; docusate sodium  100  mg ; donepezil  10  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; amlodipine  10  mg ; metoprolol succinate xl  100  mg ; heparin flush (10 units ml)  2  ml ; 5% dextrose  250  ml ; vancomycin  750  mg ; acetaminophen  1000  mg ; morphine sulfate  1-2  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia ulcer of other part of foot atherosclerosis of native arteries of the extremities with ulceration stricture of artery other complications due to other vascular device, implant, and graft chronic kidney disease, stage iii (moderate) other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a car injured in collision with car, pick-up truck or van chronic lymphoid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism pedestrian injured in nontraffic accident involving other and unspecified motor vehicles unspecified essential hypertension spontaneous ecchymoses infection with microorganisms resistant to penicillins alzheimer's disease secondary thrombocytopenia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site dementia in conditions classified elsewhere without behavioral disturbance swelling of limb pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other accident caused by striking against or being struck accidentally by objects or persons blood vessel replaced by other means atherosclerosis of native arteries of the extremities, unspecified chronic lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia aneurysm of artery of lower extremity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dementia in conditions classified elsewhere without behavioral disturbance personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular complications, not elsewhere classified aneurysm of artery of upper extremity alzheimer's disease ulcer of other part of foot hematoma complicating a procedure unspecified essential hypertension atherosclerosis of native arteries of the extremities with gangrene other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with gangrene 
white f 92 $nan$hematology blood hematocrit  18.0  %; chemistry blood creatinine  2.3  mg dl$simvastatin  10  mg ; folic acid  1  mg ; docusate sodium  100  mg ; donepezil  10  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; amlodipine  10  mg ; metoprolol succinate xl  100  mg ; heparin flush (10 units ml)  2  ml ; 5% dextrose  250  ml ; vancomycin  750  mg ; acetaminophen  1000  mg ; morphine sulfate  1-2  mg ; lidocaine 0.5%  10  ml ; furosemide  40  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia ulcer of other part of foot atherosclerosis of native arteries of the extremities with ulceration stricture of artery other complications due to other vascular device, implant, and graft chronic kidney disease, stage iii (moderate) other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a car injured in collision with car, pick-up truck or van chronic lymphoid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism pedestrian injured in nontraffic accident involving other and unspecified motor vehicles unspecified essential hypertension spontaneous ecchymoses infection with microorganisms resistant to penicillins alzheimer's disease secondary thrombocytopenia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site dementia in conditions classified elsewhere without behavioral disturbance swelling of limb pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other accident caused by striking against or being struck accidentally by objects or persons blood vessel replaced by other means atherosclerosis of native arteries of the extremities, unspecified chronic lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia aneurysm of artery of lower extremity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dementia in conditions classified elsewhere without behavioral disturbance personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular complications, not elsewhere classified aneurysm of artery of upper extremity alzheimer's disease ulcer of other part of foot hematoma complicating a procedure unspecified essential hypertension atherosclerosis of native arteries of the extremities with gangrene other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with gangrene 
white f 92 $nan$hematology blood hematocrit  30.9  %; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.5  meq l$simvastatin  10  mg ; folic acid  1  mg ; docusate sodium  100  mg ; donepezil  10  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; amlodipine  10  mg ; metoprolol succinate xl  100  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  1000  mg ; furosemide  40  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pure hypercholesterolemia ulcer of other part of foot atherosclerosis of native arteries of the extremities with ulceration stricture of artery other complications due to other vascular device, implant, and graft chronic kidney disease, stage iii (moderate) other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a car injured in collision with car, pick-up truck or van chronic lymphoid leukemia, without mention of having achieved remission personal history of venous thrombosis and embolism pedestrian injured in nontraffic accident involving other and unspecified motor vehicles unspecified essential hypertension spontaneous ecchymoses infection with microorganisms resistant to penicillins alzheimer's disease secondary thrombocytopenia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site dementia in conditions classified elsewhere without behavioral disturbance swelling of limb pure hypercholesterolemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other accident caused by striking against or being struck accidentally by objects or persons blood vessel replaced by other means atherosclerosis of native arteries of the extremities, unspecified chronic lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia aneurysm of artery of lower extremity other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation dementia in conditions classified elsewhere without behavioral disturbance personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular complications, not elsewhere classified aneurysm of artery of upper extremity alzheimer's disease ulcer of other part of foot hematoma complicating a procedure unspecified essential hypertension atherosclerosis of native arteries of the extremities with gangrene other persistent mental disorders due to conditions classified elsewhere unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with gangrene 
white m 21 $temp  98.3  heartrate  85.0  resprate  18.0  o2sat  98.0  sbp  133.0  dbp  72.0  rhythm    pain    ; temp  98.1  heartrate  72.0  resprate  18.0  o2sat  99.0  sbp  125.0  dbp  70.0  rhythm    pain  0  ; temp  98.0  heartrate  78.0  resprate  16.0  o2sat  97.0  sbp  119.0  dbp  71.0  rhythm    pain  asleep  ; temp  98.0  heartrate  75.0  resprate  18.0  o2sat  100.0  sbp  120.0  dbp  74.0  rhythm    pain  0  $hematology urine wbc  2  # hpf$nan
tobacco use other stimulant use, unspecified, uncomplicated autistic disorder other problems related to lifestyle abuse of other non-psychoactive substances anxiety disorder, unspecified ehlers-danlos syndromes family history of other mental and behavioral disorders attention-deficit hyperactivity disorder, unspecified type unspecified mood [affective] disorder personal history of self-harm cannabis use, unspecified, uncomplicated bipolar disorder, unspecified hallucinogen use, unspecified, uncomplicated hallucinogen use, unspecified, uncomplicated drug induced retention of urine long qt syndrome public park as the place of occurrence of the external cause unspecified asthma, uncomplicated hypokalemia poisoning by antitussives, intentional self-harm, initial encounter nicotine dependence, cigarettes, uncomplicated major depressive disorder, recurrent severe without psychotic features family history of other mental and behavioral disorders ehlers-danlos syndromes 
white f 67 $nan$hematology blood hematocrit  39.0  %; hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  319  k ul; hematology blood platelet count  319  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  97  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; trazodone  25  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; atorvastatin  80  mg ; pantoprazole  40  mg ; metoprolol tartrate  12.5  mg ; ranitidine  300  mg ; albuterol inhaler  1-2  puff ; lorazepam  1  mg ; aspirin ec  81  mg ; clopidogrel  75  mg ; furosemide  20  mg ; levothyroxine sodium  75  mcg ; amlodipine  5  mg ; sertraline  50  mg ; 
constipation, unspecified mitral valve insufficiency and aortic valve insufficiency myalgia and myositis, unspecified surgical or other procedure not carried out because of contraindication unspecified acquired hypothyroidism personal history of hodgkin's disease personal history of irradiation, presenting hazards to health person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial esophageal reflux other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of tobacco use congestive heart failure, unspecified unspecified essential hypertension unspecified acquired hypothyroidism esophageal reflux unspecified intestinal obstruction hodgkin's disease, unspecified type, lymph nodes of multiple sites diverticulosis of colon (without mention of hemorrhage) unspecified essential hypertension esophageal reflux unspecified acquired hypothyroidism pure hypercholesterolemia other and unspecified ovarian cyst benign neoplasm of ovary 
white f 67 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; trazodone  25  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; atorvastatin  80  mg ; pantoprazole  40  mg ; metoprolol tartrate  12.5  mg ; ranitidine  300  mg ; albuterol inhaler  1-2  puff ; lorazepam  1  mg ; aspirin ec  81  mg ; clopidogrel  75  mg ; furosemide  20  mg ; levothyroxine sodium  75  mcg ; amlodipine  5  mg ; sertraline  50  mg ; 
constipation, unspecified mitral valve insufficiency and aortic valve insufficiency myalgia and myositis, unspecified surgical or other procedure not carried out because of contraindication unspecified acquired hypothyroidism personal history of hodgkin's disease personal history of irradiation, presenting hazards to health person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial esophageal reflux other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of tobacco use congestive heart failure, unspecified unspecified essential hypertension unspecified acquired hypothyroidism esophageal reflux unspecified intestinal obstruction hodgkin's disease, unspecified type, lymph nodes of multiple sites diverticulosis of colon (without mention of hemorrhage) unspecified essential hypertension esophageal reflux unspecified acquired hypothyroidism pure hypercholesterolemia other and unspecified ovarian cyst benign neoplasm of ovary 
white f 58 $temp  97.6  heartrate  92.0  resprate  18.0  o2sat  97.0  sbp  104.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  96  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; metformin (glucophage)  500  mg ; lisinopril  5  mg ; lidocaine 1%  2  ml ; lorazepam  0.5  mg ; 
 
white f 58 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  359  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  91  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; senna  8.6  mg ; docusate sodium  100  mg ; lisinopril  5  mg ; lidocaine 1%  2  ml ; zolpidem tartrate  5  mg ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25  mg ; bottle  300  ml ; gammagard liquid  30  g ; 
 
white f 58 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  101  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; senna  8.6  mg ; docusate sodium  100  mg ; lisinopril  5  mg ; zolpidem tartrate  5  mg ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25  mg ; bottle  300  ml ; gammagard liquid  30  g ; naproxen  500  mg ; 
 
white f 58 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  345  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; senna  8.6  mg ; docusate sodium  100  mg ; lisinopril  5  mg ; bottle  300  ml ; gammagard liquid  30  g ; naproxen  500  mg ; 
 
white f 58 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  211  mg dl$sodium chloride 0.9%  flush  3  ml ; multivitamins  1  tab ; senna  8.6  mg ; docusate sodium  100  mg ; lisinopril  5  mg ; bottle  300  ml ; gammagard liquid  30  g ; naproxen  500  mg ; insulin  0  unit ; trazodone  25  mg ; 
 
white f 58 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; multivitamins  1  tab ; senna  8.6  mg ; docusate sodium  100  mg ; lisinopril  5  mg ; bottle  300  ml ; gammagard liquid  30  g ; naproxen  500  mg ; insulin  0  unit ; 
 
white f 58 $nan$nan$sodium chloride 0.9%  flush  3  ml ; multivitamins  1  tab ; senna  8.6  mg ; docusate sodium  100  mg ; lisinopril  5  mg ; bottle  300  ml ; gammagard liquid  30  g ; naproxen  500  mg ; insulin  0  unit ; 
 
white m 64 $nan$hematology blood hematocrit  21.5  %; hematology blood hematocrit  21.9  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  6.6  g dl; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  116  k ul; hematology blood platelet count  128  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  11.7  mg dl; chemistry blood creatinine  9.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  106  mg dl; chemistry blood urea nitrogen  72  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  88  mg dl$neomycin-polymyxin-bacitracin  1  appl ; sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; amlodipine  10  mg ; calcitriol  1  mcg ; calcium carbonate  500  mg ; diphenoxylate-atropine  1  tab ; famotidine  20  mg ; loratadine  10  mg ; metoprolol tartrate  25  mg ; terazosin  2  mg ; cyanocobalamin  1000  mcg ; sevelamer carbonate  1600  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 
intestinal bypass or anastomosis status regional enteritis of unspecified site lumbago hypovolemia monoclonal paraproteinemia acute kidney failure, unspecified malignant neoplasm of ileum anemia in neoplastic disease anemia in chronic kidney disease secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes splenomegaly hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of antineoplastic chemotherapy disorders of phosphorus metabolism chronic kidney disease, stage iii (moderate) acidosis hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other pancytopenia personal history of tobacco use personal history of venous thrombosis and embolism esophageal reflux other malaise and fatigue acquired absence of intestine (large) (small) unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of venous thrombosis and embolism fistula of intestine, excluding rectum and anus family history of malignant neoplasm of prostate long-term (current) use of anticoagulants regional enteritis of unspecified site esophageal reflux other postoperative infection other chronic pulmonary heart diseases peritoneal adhesions (postoperative) (postinfection) pneumonia, organism unspecified family history of malignant neoplasm of trachea, bronchus, and lung atrial fibrillation other iatrogenic hypotension malignant neoplasm of small intestine, unspecified site pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident anemia, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified 
white m 64 $nan$nan$docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; amlodipine  10  mg ; calcitriol  1  mcg ; calcium carbonate  500  mg ; diphenoxylate-atropine  1  tab ; loratadine  10  mg ; metoprolol tartrate  25  mg ; terazosin  2  mg ; cyanocobalamin  1000  mcg ; sevelamer carbonate  1600  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 
intestinal bypass or anastomosis status regional enteritis of unspecified site lumbago hypovolemia monoclonal paraproteinemia acute kidney failure, unspecified malignant neoplasm of ileum anemia in neoplastic disease anemia in chronic kidney disease secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes splenomegaly hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of antineoplastic chemotherapy disorders of phosphorus metabolism chronic kidney disease, stage iii (moderate) acidosis hypopotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other pancytopenia personal history of tobacco use personal history of venous thrombosis and embolism esophageal reflux other malaise and fatigue acquired absence of intestine (large) (small) unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of venous thrombosis and embolism fistula of intestine, excluding rectum and anus family history of malignant neoplasm of prostate long-term (current) use of anticoagulants regional enteritis of unspecified site esophageal reflux other postoperative infection other chronic pulmonary heart diseases peritoneal adhesions (postoperative) (postinfection) pneumonia, organism unspecified family history of malignant neoplasm of trachea, bronchus, and lung atrial fibrillation other iatrogenic hypotension malignant neoplasm of small intestine, unspecified site pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident anemia, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified 
black african american m 26 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; citalopram hydrobromide  10  mg ; trazodone  25  mg ; albuterol inhaler  1-2  puff ; 
cannabis dependence, unspecified legal circumstances driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in traffic accident other, mixed, or unspecified drug abuse, unspecified physical restraints status unspecified drug-induced mental disorder asthma, unspecified type, unspecified 
black african american m 26 $nan$hematology blood hematocrit  44.0  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  5.1  g dl$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; citalopram hydrobromide  10  mg ; trazodone  25  mg ; albuterol inhaler  1-2  puff ; citalopram hydrobromide  20  mg ; chloraseptic throat spray  1  spry ; 
cannabis dependence, unspecified legal circumstances driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in traffic accident other, mixed, or unspecified drug abuse, unspecified physical restraints status unspecified drug-induced mental disorder asthma, unspecified type, unspecified 
black african american f 67 $temp  96.4  heartrate  120.0  resprate  18.0  o2sat  100.0  sbp  164.0  dbp  89.0  rhythm    pain  4  ; temp    heartrate  98.0  resprate  16.0  o2sat  99.0  sbp  153.0  dbp  88.0  rhythm    pain  0  ; temp    heartrate  90.0  resprate  16.0  o2sat  98.0  sbp  136.0  dbp  78.0  rhythm    pain  0  $hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  158  mg dl; chemistry blood albumin  4.6  g dl$nan
 
white m 83 $temp  98.0  heartrate  86.0  resprate  16.0  o2sat  96.0  sbp  192.0  dbp  89.0  rhythm    pain  3  $hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  87  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; lactated ringers  1000  ml ; acetaminophen  650  mg ; acyclovir  400  mg ; folic acid  1  mg ; metoprolol succinate xl  25  mg ; omeprazole  40  mg ; oxycodone (immediate release)   5  mg ; pravastatin  10  mg ; terazosin  2  mg ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; senna  17.2  mg ; ns  100  ml ; docusate sodium  200  mg ; olanzapine (disintegrating tablet)  2.5  mg ; 
other specified metabolic disorders long-term (current) use of non-steroidal anti-inflammatories (nsaid) other and unspecified hyperlipidemia immune thrombocytopenic purpura leukocytosis, unspecified abdominal aneurysm without mention of rupture atrial fibrillation pathologic fracture of vertebrae autoimmune hemolytic anemias enlargement of lymph nodes accidents occurring in unspecified place backache, unspecified closed fracture of two ribs unspecified fall personal history of tobacco use other alteration of consciousness dementia, unspecified, without behavioral disturbance personal history of other malignant neoplasm of skin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits accidents occurring in residential institution hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) antidepressants causing adverse effects in therapeutic use other specified metabolic disorders cerebral degeneration, unspecified unspecified fall candidiasis of mouth home accidents leukocytosis, unspecified immune thrombocytopenic purpura drug-induced delirium closed fracture of lumbar vertebra without mention of spinal cord injury enlargement of lymph nodes paroxysmal ventricular tachycardia autoimmune hemolytic anemias debility, unspecified other b-complex deficiencies other specified disorders of liver retention of urine, unspecified personal history of tobacco use atrial fibrillation smooth muscle relaxants causing adverse effects in therapeutic use headache physical restraints status pneumonia, organism unspecified constipation, unspecified encephalopathy, unspecified enlargement of lymph nodes atrial fibrillation
white m 83 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  135  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; acyclovir  400  mg ; folic acid  1  mg ; metoprolol succinate xl  25  mg ; omeprazole  40  mg ; oxycodone (immediate release)   5  mg ; pravastatin  10  mg ; terazosin  2  mg ; senna  17.2  mg ; ns  100  ml ; docusate sodium  200  mg ; olanzapine (disintegrating tablet)  2.5  mg ; polyethylene glycol  17  g ; acetaminophen  975  mg ; trazodone  25  mg ; 
other specified metabolic disorders long-term (current) use of non-steroidal anti-inflammatories (nsaid) other and unspecified hyperlipidemia immune thrombocytopenic purpura leukocytosis, unspecified abdominal aneurysm without mention of rupture atrial fibrillation pathologic fracture of vertebrae autoimmune hemolytic anemias enlargement of lymph nodes accidents occurring in unspecified place backache, unspecified closed fracture of two ribs unspecified fall personal history of tobacco use other alteration of consciousness dementia, unspecified, without behavioral disturbance personal history of other malignant neoplasm of skin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits accidents occurring in residential institution hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) antidepressants causing adverse effects in therapeutic use other specified metabolic disorders cerebral degeneration, unspecified unspecified fall candidiasis of mouth home accidents leukocytosis, unspecified immune thrombocytopenic purpura drug-induced delirium closed fracture of lumbar vertebra without mention of spinal cord injury enlargement of lymph nodes paroxysmal ventricular tachycardia autoimmune hemolytic anemias debility, unspecified other b-complex deficiencies other specified disorders of liver retention of urine, unspecified personal history of tobacco use atrial fibrillation smooth muscle relaxants causing adverse effects in therapeutic use headache physical restraints status pneumonia, organism unspecified constipation, unspecified encephalopathy, unspecified enlargement of lymph nodes atrial fibrillation
white m 83 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  78  mg dl$moviprep  1  l ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acyclovir  400  mg ; folic acid  1  mg ; metoprolol succinate xl  25  mg ; omeprazole  40  mg ; oxycodone (immediate release)   5  mg ; pravastatin  10  mg ; terazosin  2  mg ; ns  100  ml ; docusate sodium  200  mg ; olanzapine (disintegrating tablet)  2.5  mg ; polyethylene glycol  17  g ; acetaminophen  975  mg ; trazodone  25  mg ; hemorrhoidal suppository  1  supp ; 
other specified metabolic disorders long-term (current) use of non-steroidal anti-inflammatories (nsaid) other and unspecified hyperlipidemia immune thrombocytopenic purpura leukocytosis, unspecified abdominal aneurysm without mention of rupture atrial fibrillation pathologic fracture of vertebrae autoimmune hemolytic anemias enlargement of lymph nodes accidents occurring in unspecified place backache, unspecified closed fracture of two ribs unspecified fall personal history of tobacco use other alteration of consciousness dementia, unspecified, without behavioral disturbance personal history of other malignant neoplasm of skin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits accidents occurring in residential institution hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) antidepressants causing adverse effects in therapeutic use other specified metabolic disorders cerebral degeneration, unspecified unspecified fall candidiasis of mouth home accidents leukocytosis, unspecified immune thrombocytopenic purpura drug-induced delirium closed fracture of lumbar vertebra without mention of spinal cord injury enlargement of lymph nodes paroxysmal ventricular tachycardia autoimmune hemolytic anemias debility, unspecified other b-complex deficiencies other specified disorders of liver retention of urine, unspecified personal history of tobacco use atrial fibrillation smooth muscle relaxants causing adverse effects in therapeutic use headache physical restraints status pneumonia, organism unspecified constipation, unspecified encephalopathy, unspecified enlargement of lymph nodes atrial fibrillation
white m 83 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  86  mg dl$moviprep  1  l ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acyclovir  400  mg ; folic acid  1  mg ; metoprolol succinate xl  25  mg ; omeprazole  40  mg ; oxycodone (immediate release)   5  mg ; pravastatin  10  mg ; terazosin  2  mg ; docusate sodium  200  mg ; olanzapine (disintegrating tablet)  2.5  mg ; polyethylene glycol  17  g ; acetaminophen  975  mg ; hemorrhoidal suppository  1  supp ; potassium chloride  60  meq ; ondansetron  4-8  mg ; 
other specified metabolic disorders long-term (current) use of non-steroidal anti-inflammatories (nsaid) other and unspecified hyperlipidemia immune thrombocytopenic purpura leukocytosis, unspecified abdominal aneurysm without mention of rupture atrial fibrillation pathologic fracture of vertebrae autoimmune hemolytic anemias enlargement of lymph nodes accidents occurring in unspecified place backache, unspecified closed fracture of two ribs unspecified fall personal history of tobacco use other alteration of consciousness dementia, unspecified, without behavioral disturbance personal history of other malignant neoplasm of skin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits accidents occurring in residential institution hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) antidepressants causing adverse effects in therapeutic use other specified metabolic disorders cerebral degeneration, unspecified unspecified fall candidiasis of mouth home accidents leukocytosis, unspecified immune thrombocytopenic purpura drug-induced delirium closed fracture of lumbar vertebra without mention of spinal cord injury enlargement of lymph nodes paroxysmal ventricular tachycardia autoimmune hemolytic anemias debility, unspecified other b-complex deficiencies other specified disorders of liver retention of urine, unspecified personal history of tobacco use atrial fibrillation smooth muscle relaxants causing adverse effects in therapeutic use headache physical restraints status pneumonia, organism unspecified constipation, unspecified encephalopathy, unspecified enlargement of lymph nodes atrial fibrillation
white m 83 $nan$hematology blood hematocrit  41.3  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  91  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acyclovir  400  mg ; folic acid  1  mg ; metoprolol succinate xl  25  mg ; omeprazole  40  mg ; pravastatin  10  mg ; terazosin  2  mg ; docusate sodium  200  mg ; olanzapine (disintegrating tablet)  2.5  mg ; polyethylene glycol  17  g ; hemorrhoidal suppository  1  supp ; potassium chloride  60  meq ; ondansetron  4-8  mg ; 
other specified metabolic disorders long-term (current) use of non-steroidal anti-inflammatories (nsaid) other and unspecified hyperlipidemia immune thrombocytopenic purpura leukocytosis, unspecified abdominal aneurysm without mention of rupture atrial fibrillation pathologic fracture of vertebrae autoimmune hemolytic anemias enlargement of lymph nodes accidents occurring in unspecified place backache, unspecified closed fracture of two ribs unspecified fall personal history of tobacco use other alteration of consciousness dementia, unspecified, without behavioral disturbance personal history of other malignant neoplasm of skin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits accidents occurring in residential institution hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) antidepressants causing adverse effects in therapeutic use other specified metabolic disorders cerebral degeneration, unspecified unspecified fall candidiasis of mouth home accidents leukocytosis, unspecified immune thrombocytopenic purpura drug-induced delirium closed fracture of lumbar vertebra without mention of spinal cord injury enlargement of lymph nodes paroxysmal ventricular tachycardia autoimmune hemolytic anemias debility, unspecified other b-complex deficiencies other specified disorders of liver retention of urine, unspecified personal history of tobacco use atrial fibrillation smooth muscle relaxants causing adverse effects in therapeutic use headache physical restraints status pneumonia, organism unspecified constipation, unspecified encephalopathy, unspecified enlargement of lymph nodes atrial fibrillation
black african american f 50 $temp  97.1  heartrate  107.0  resprate  16.0  o2sat    sbp  146.0  dbp  99.0  rhythm    pain  0  ; temp  97.1  heartrate  105.0  resprate  16.0  o2sat  100.0  sbp  127.0  dbp  79.0  rhythm    pain  0  ; temp  97.4  heartrate  102.0  resprate  16.0  o2sat  100.0  sbp  121.0  dbp  84.0  rhythm    pain  0  $chemistry blood creatinine  0.6  mg dl; chemistry blood urea nitrogen  13  mg dl; blood gas blood lactate  3.2  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  223  mg dl; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood calculated bicarbonate, whole blood  15  meq l$atorvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; quetiapine fumarate  25  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; lithium  900  mg ; clozapine  600  mg ; clozapine  50  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled fever, unspecified bipolar disorder, unspecified polyneuropathy in diabetes posttraumatic stress disorder obesity, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified encephalopathy, unspecified personal history of tobacco use other and unspecified hyperlipidemia constipation, unspecified bipolar disorder, unspecified schizoaffective disorder, unspecified other and unspecified hyperlipidemia diabetes with unspecified complication, type ii or unspecified type, uncontrolled unspecified essential hypertension bipolar i disorder, most recent episode (or current) mixed, severe, specified as with psychotic behavior posttraumatic stress disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled borderline personality disorder physical restraints status pure hypercholesterolemia constipation, unspecified suicidal ideation posttraumatic stress disorder bipolar disorder, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled suicidal ideation hallucinations obesity, unspecified pure hypercholesterolemia depressive disorder, not elsewhere classified suicidal ideation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension pure hypercholesterolemia catatonic type schizophrenia, chronic with acute exacerbation posttraumatic stress disorder escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site suicidal ideation posttraumatic stress disorder other bipolar disorders other specified cardiac dysrhythmias unspecified essential hypertension bacteremia
black african american f 50 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  223  mg dl; blood gas blood lactate  1.2  mmol l$atorvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; quetiapine fumarate  25  mg ; senna  1  tab ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; lithium  900  mg ; clozapine  600  mg ; clozapine  50  mg ; divalproex (extended release)  1500  mg ; divalproex (extended release)  500  mg ; fluphenazine  2  mg ; fluphenazine  5  mg ; quetiapine fumarate  25-50  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled fever, unspecified bipolar disorder, unspecified polyneuropathy in diabetes posttraumatic stress disorder obesity, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified encephalopathy, unspecified personal history of tobacco use other and unspecified hyperlipidemia constipation, unspecified bipolar disorder, unspecified schizoaffective disorder, unspecified other and unspecified hyperlipidemia diabetes with unspecified complication, type ii or unspecified type, uncontrolled unspecified essential hypertension bipolar i disorder, most recent episode (or current) mixed, severe, specified as with psychotic behavior posttraumatic stress disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled borderline personality disorder physical restraints status pure hypercholesterolemia constipation, unspecified suicidal ideation posttraumatic stress disorder bipolar disorder, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled suicidal ideation hallucinations obesity, unspecified pure hypercholesterolemia depressive disorder, not elsewhere classified suicidal ideation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension pure hypercholesterolemia catatonic type schizophrenia, chronic with acute exacerbation posttraumatic stress disorder escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site suicidal ideation posttraumatic stress disorder other bipolar disorders other specified cardiac dysrhythmias unspecified essential hypertension bacteremia
white m 78 $nan$nan$1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; amiodarone  200  mg ; aspirin  81  mg ; simvastatin  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; furosemide  40  mg ; milk of magnesia  30  ml ; trazodone  25  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; acetaminophen (liquid)  650  mg ; carbidopa-levodopa (25-100)  1  tab ; guaifenesin  5-10  ml ; bacitracin ointment  1  appl ; heparin  5000  unit ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident cellulitis and abscess of trunk other gastrostomy complications chronic airway obstruction, not elsewhere classified esophageal reflux other and unspecified hyperlipidemia urinary tract infection, site not specified infection of gastrostomy pneumonia, organism unspecified scoliosis [and kyphoscoliosis], idiopathic pulmonary collapse surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pseudomonas infection in conditions classified elsewhere and of unspecified site atrial fibrillation other dependence on machines, supplemental oxygen paralysis agitans other and unspecified hyperlipidemia anxiety state, unspecified hyperpotassemia acute respiratory failure dehydration car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status urinary tract infection, site not specified pseudomonas infection in conditions classified elsewhere and of unspecified site dysphagia, unspecified atrial fibrillation personal history of venous thrombosis and embolism scoliosis [and kyphoscoliosis], idiopathic chronic airway obstruction, not elsewhere classified paralysis agitans pneumonia due to pseudomonas esophageal reflux anxiety state, unspecified pneumonitis due to inhalation of food or vomitus esophageal reflux gastrostomy status atrial fibrillation unspecified deficiency anemia paralysis agitans car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytosis, unspecified unspecified essential hypertension personal history of venous thrombosis and embolism obstructive chronic bronchitis with (acute) exacerbation hyperosmolality and/or hypernatremia paralysis agitans atrial fibrillation
white m 78 $nan$nan$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; simvastatin  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; furosemide  40  mg ; milk of magnesia  30  ml ; trazodone  25  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; acetaminophen (liquid)  650  mg ; carbidopa-levodopa (25-100)  1  tab ; guaifenesin  5-10  ml ; bacitracin ointment  1  appl ; heparin  5000  unit ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident cellulitis and abscess of trunk other gastrostomy complications chronic airway obstruction, not elsewhere classified esophageal reflux other and unspecified hyperlipidemia urinary tract infection, site not specified infection of gastrostomy pneumonia, organism unspecified scoliosis [and kyphoscoliosis], idiopathic pulmonary collapse surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pseudomonas infection in conditions classified elsewhere and of unspecified site atrial fibrillation other dependence on machines, supplemental oxygen paralysis agitans other and unspecified hyperlipidemia anxiety state, unspecified hyperpotassemia acute respiratory failure dehydration car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status urinary tract infection, site not specified pseudomonas infection in conditions classified elsewhere and of unspecified site dysphagia, unspecified atrial fibrillation personal history of venous thrombosis and embolism scoliosis [and kyphoscoliosis], idiopathic chronic airway obstruction, not elsewhere classified paralysis agitans pneumonia due to pseudomonas esophageal reflux anxiety state, unspecified pneumonitis due to inhalation of food or vomitus esophageal reflux gastrostomy status atrial fibrillation unspecified deficiency anemia paralysis agitans car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytosis, unspecified unspecified essential hypertension personal history of venous thrombosis and embolism obstructive chronic bronchitis with (acute) exacerbation hyperosmolality and/or hypernatremia paralysis agitans atrial fibrillation
white m 78 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  152  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; simvastatin  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; milk of magnesia  30  ml ; trazodone  25  mg ; acetaminophen (liquid)  650  mg ; carbidopa-levodopa (25-100)  1  tab ; guaifenesin  5-10  ml ; bacitracin ointment  1  appl ; heparin  5000  unit ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident cellulitis and abscess of trunk other gastrostomy complications chronic airway obstruction, not elsewhere classified esophageal reflux other and unspecified hyperlipidemia urinary tract infection, site not specified infection of gastrostomy pneumonia, organism unspecified scoliosis [and kyphoscoliosis], idiopathic pulmonary collapse surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation pseudomonas infection in conditions classified elsewhere and of unspecified site atrial fibrillation other dependence on machines, supplemental oxygen paralysis agitans other and unspecified hyperlipidemia anxiety state, unspecified hyperpotassemia acute respiratory failure dehydration car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident gastrostomy status urinary tract infection, site not specified pseudomonas infection in conditions classified elsewhere and of unspecified site dysphagia, unspecified atrial fibrillation personal history of venous thrombosis and embolism scoliosis [and kyphoscoliosis], idiopathic chronic airway obstruction, not elsewhere classified paralysis agitans pneumonia due to pseudomonas esophageal reflux anxiety state, unspecified pneumonitis due to inhalation of food or vomitus esophageal reflux gastrostomy status atrial fibrillation unspecified deficiency anemia paralysis agitans car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident leukocytosis, unspecified unspecified essential hypertension personal history of venous thrombosis and embolism obstructive chronic bronchitis with (acute) exacerbation hyperosmolality and/or hypernatremia paralysis agitans atrial fibrillation
white m 82 $nan$nan$aspirin  325  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; 
 
white m 82 $nan$hematology blood hematocrit  42.4  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  72  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  157  mg dl$aspirin  325  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; metoprolol tartrate  37.5  mg ; pneumococcal vac polyvalent  0.5  ml ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; methylprednisolone sodium succ  125  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; heparin  2000-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; azithromycin  250  mg ; diltiazem extended-release  120  mg ; prednisone  60  mg ; furosemide  20  mg ; heparin  750-1500  unit ; sodium polystyrene sulfonate  30  gm ; morphine sulfate ir  15-30  mg ; gabapentin  300  mg ; 
 
white m 82 $nan$hematology blood hematocrit  43.9  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  186  mg dl$aspirin  325  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; metoprolol tartrate  37.5  mg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; insulin  0  unit ; azithromycin  250  mg ; diltiazem extended-release  120  mg ; prednisone  60  mg ; furosemide  20  mg ; sodium polystyrene sulfonate  30  gm ; morphine sulfate ir  15-30  mg ; gabapentin  300  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; furosemide  60  mg ; tiotropium bromide  1  cap ; vitamin d  800  unit ; albuterol inhaler  1-2  puff ; salmeterol xinafoate diskus (50 mcg)  1  inh ; 
 
white m 82 $nan$hematology blood hematocrit  47.9  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  78  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  138  mg dl$aspirin  325  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; metoprolol tartrate  37.5  mg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; insulin  0  unit ; azithromycin  250  mg ; diltiazem extended-release  120  mg ; prednisone  60  mg ; morphine sulfate ir  15-30  mg ; gabapentin  300  mg ; furosemide  60  mg ; tiotropium bromide  1  cap ; vitamin d  800  unit ; albuterol inhaler  1-2  puff ; salmeterol xinafoate diskus (50 mcg)  1  inh ; calcium carbonate  500  mg ; fluticasone propionate 110mcg  4  puff ; prednisone  50  mg ; 
 
white m 82 $nan$hematology blood hematocrit  46.1  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  93  mg dl; chemistry urine creatinine, urine  81  mg dl; chemistry urine sodium, urine  50  meq l; chemistry urine urea nitrogen, urine  808  mg dl; hematology urine wbc  76  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  123  mg dl; hematology blood bands  0  %$aspirin  325  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; metoprolol tartrate  37.5  mg ; simvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; insulin  0  unit ; azithromycin  250  mg ; diltiazem extended-release  120  mg ; morphine sulfate ir  15-30  mg ; gabapentin  300  mg ; tiotropium bromide  1  cap ; vitamin d  800  unit ; albuterol inhaler  1-2  puff ; salmeterol xinafoate diskus (50 mcg)  1  inh ; calcium carbonate  500  mg ; fluticasone propionate 110mcg  4  puff ; prednisone  50  mg ; diltiazem  30  mg ; acetylcysteine 20%  2  ml ; xopenex neb  0.63  mg ; lorazepam  0.5  mg ; guaifenesin  5-10  ml ; 
 
white m 82 $nan$hematology blood hematocrit  42.3  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  77  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  150  mg dl; blood gas blood lactate  2.4  mmol l$ceftriaxone  1  gm ; aspirin  325  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; insulin  0  unit ; azithromycin  250  mg ; diltiazem extended-release  120  mg ; morphine sulfate ir  15-30  mg ; gabapentin  300  mg ; tiotropium bromide  1  cap ; vitamin d  800  unit ; albuterol inhaler  1-2  puff ; salmeterol xinafoate diskus (50 mcg)  1  inh ; calcium carbonate  500  mg ; fluticasone propionate 110mcg  4  puff ; prednisone  50  mg ; diltiazem  30  mg ; lorazepam  0.5  mg ; guaifenesin  5-10  ml ; metoprolol tartrate  50  mg ; diltiazem  45  mg ; levofloxacin  750  mg ; iso-osmotic dextrose  50  ml ; 
 
white m 82 $nan$hematology blood hematocrit  43.0  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  65  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  110  mg dl$ceftriaxone  1  gm ; aspirin  325  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; insulin  0  unit ; morphine sulfate ir  15-30  mg ; gabapentin  300  mg ; tiotropium bromide  1  cap ; vitamin d  800  unit ; albuterol inhaler  1-2  puff ; salmeterol xinafoate diskus (50 mcg)  1  inh ; calcium carbonate  500  mg ; fluticasone propionate 110mcg  4  puff ; prednisone  50  mg ; guaifenesin  5-10  ml ; metoprolol tartrate  50  mg ; iso-osmotic dextrose  50  ml ; prednisone  40  mg ; levofloxacin  500  mg ; diltiazem  60  mg ; furosemide  40  mg ; 
 
white m 82 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  97  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  137  mg dl$aspirin  325  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; insulin  0  unit ; morphine sulfate ir  15-30  mg ; gabapentin  300  mg ; tiotropium bromide  1  cap ; vitamin d  800  unit ; albuterol inhaler  1-2  puff ; salmeterol xinafoate diskus (50 mcg)  1  inh ; calcium carbonate  500  mg ; fluticasone propionate 110mcg  4  puff ; guaifenesin  5-10  ml ; metoprolol tartrate  50  mg ; prednisone  40  mg ; levofloxacin  500  mg ; diltiazem  60  mg ; furosemide  40  mg ; neutra-phos  1  pkt ; diltiazem extended-release  240  mg ; ciprofloxacin hcl  500  mg ; morphine sulfate (oral soln.)  5-10  mg ; 
 
white m 82 $nan$hematology blood hematocrit  45.7  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  168  mg dl$aspirin  325  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; insulin  0  unit ; gabapentin  300  mg ; tiotropium bromide  1  cap ; vitamin d  800  unit ; albuterol inhaler  1-2  puff ; salmeterol xinafoate diskus (50 mcg)  1  inh ; calcium carbonate  500  mg ; fluticasone propionate 110mcg  4  puff ; guaifenesin  5-10  ml ; metoprolol tartrate  50  mg ; prednisone  40  mg ; neutra-phos  1  pkt ; diltiazem extended-release  240  mg ; ciprofloxacin hcl  500  mg ; morphine sulfate (oral soln.)  5-10  mg ; 
 
white m 82 $nan$nan$aspirin  325  mg ; finasteride  5  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; insulin  0  unit ; gabapentin  300  mg ; tiotropium bromide  1  cap ; vitamin d  800  unit ; albuterol inhaler  1-2  puff ; salmeterol xinafoate diskus (50 mcg)  1  inh ; calcium carbonate  500  mg ; fluticasone propionate 110mcg  4  puff ; guaifenesin  5-10  ml ; metoprolol tartrate  50  mg ; prednisone  40  mg ; diltiazem extended-release  240  mg ; ciprofloxacin hcl  500  mg ; morphine sulfate (oral soln.)  5-10  mg ; 
 
other m 44 $temp  97.8  heartrate  75.0  resprate  24.0  o2sat  94.0  sbp  136.0  dbp  83.0  rhythm    pain  0  ; temp  98.3  heartrate  73.0  resprate  28.0  o2sat  93.0  sbp  124.0  dbp  80.0  rhythm    pain  0  $hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  345  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  110  mg dl; hematology blood bands  0  %$nan
pure hypercholesterolemia asthma, unspecified type, unspecified polydipsia unspecified essential hypertension anxiety state, unspecified do not resuscitate status esophageal reflux other diuretics causing adverse effects in therapeutic use depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified vitamin d deficiency body mass index 36.0-36.9, adult hyposmolality and/or hyponatremia disorders of magnesium metabolism tobacco use disorder overweight other and unspecified hyperlipidemia unspecified essential hypertension alcohol abuse, unspecified hyposmolality and/or hyponatremia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified tobacco use disorder electrolyte and fluid disorders not elsewhere classified myalgia and myositis, unspecified esophageal reflux
other m 44 $temp  98.3  heartrate  80.0  resprate  29.0  o2sat  92.0  sbp  148.0  dbp  83.0  rhythm    pain  0  ; temp    heartrate  79.0  resprate  20.0  o2sat  93.0  sbp  142.0  dbp  81.0  rhythm    pain  0  ; temp    heartrate  80.0  resprate  25.0  o2sat  93.0  sbp  160.0  dbp  104.0  rhythm    pain  0  ; temp    heartrate  79.0  resprate  19.0  o2sat  95.0  sbp  146.0  dbp  82.0  rhythm    pain  sleeping  ; temp  98.5  heartrate  81.0  resprate  24.0  o2sat  95.0  sbp  129.0  dbp  66.0  rhythm    pain  sleeping  ; temp    heartrate  85.0  resprate  18.0  o2sat  95.0  sbp  152.0  dbp  85.0  rhythm    pain  3  ; temp  98.8  heartrate  87.0  resprate  21.0  o2sat  91.0  sbp  156.0  dbp  93.0  rhythm    pain    ; temp    heartrate    resprate    o2sat  94.0  sbp    dbp    rhythm    pain    ; temp    heartrate    resprate    o2sat  91.0  sbp    dbp    rhythm    pain    ; temp    heartrate  87.0  resprate  24.0  o2sat  95.0  sbp  157.0  dbp  95.0  rhythm    pain  1  ; temp    heartrate  80.0  resprate  24.0  o2sat  96.0  sbp  104.0  dbp  52.0  rhythm    pain  0  ; temp  98.7  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp  98.5  heartrate  89.0  resprate  22.0  o2sat  95.0  sbp  163.0  dbp  90.0  rhythm    pain    ; temp  98.5  heartrate  85.0  resprate  23.0  o2sat  96.0  sbp  153.0  dbp  86.0  rhythm    pain  5  $chemistry urine creatinine, urine  73  mg dl; chemistry urine potassium, urine  24  meq l; chemistry urine urea nitrogen, urine  455  mg dl; hematology urine wbc  1  # hpf$nan
pure hypercholesterolemia asthma, unspecified type, unspecified polydipsia unspecified essential hypertension anxiety state, unspecified do not resuscitate status esophageal reflux other diuretics causing adverse effects in therapeutic use depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified vitamin d deficiency body mass index 36.0-36.9, adult hyposmolality and/or hyponatremia disorders of magnesium metabolism tobacco use disorder overweight other and unspecified hyperlipidemia unspecified essential hypertension alcohol abuse, unspecified hyposmolality and/or hyponatremia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified tobacco use disorder electrolyte and fluid disorders not elsewhere classified myalgia and myositis, unspecified esophageal reflux
other m 44 $temp  98.0  heartrate  90.0  resprate  24.0  o2sat  97.0  sbp  138.0  dbp  78.0  rhythm    pain  5  ; temp  98.1  heartrate  88.0  resprate  24.0  o2sat  97.0  sbp  152.0  dbp  88.0  rhythm    pain  5  $hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  387  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  108  mg dl; hematology blood bands  1  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; guaifenesin  5-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; atenolol  100  mg ; citalopram  80  mg ; clonazepam  1  mg ; lisinopril  40  mg ; nifedipine (extended release)  90  mg ; omeprazole  20  mg ; quetiapine fumarate  200  mg ; tramadol  50  mg ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bupropion xl (once daily)  300  mg ; vial  1  vial ; ceftriaxone  1  gm ; azithromycin  250  mg ; oseltamivir  75  mg ; potassium chloride  60  meq ; 
pure hypercholesterolemia asthma, unspecified type, unspecified polydipsia unspecified essential hypertension anxiety state, unspecified do not resuscitate status esophageal reflux other diuretics causing adverse effects in therapeutic use depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified vitamin d deficiency body mass index 36.0-36.9, adult hyposmolality and/or hyponatremia disorders of magnesium metabolism tobacco use disorder overweight other and unspecified hyperlipidemia unspecified essential hypertension alcohol abuse, unspecified hyposmolality and/or hyponatremia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified tobacco use disorder electrolyte and fluid disorders not elsewhere classified myalgia and myositis, unspecified esophageal reflux
other m 44 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  450  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  88  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; guaifenesin  5-10  ml ; albuterol 0.083% neb soln  1  neb ; atenolol  100  mg ; citalopram  80  mg ; clonazepam  1  mg ; lisinopril  40  mg ; nifedipine (extended release)  90  mg ; omeprazole  20  mg ; quetiapine fumarate  200  mg ; tramadol  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bupropion xl (once daily)  300  mg ; azithromycin  250  mg ; oseltamivir  75  mg ; potassium chloride  60  meq ; 
pure hypercholesterolemia asthma, unspecified type, unspecified polydipsia unspecified essential hypertension anxiety state, unspecified do not resuscitate status esophageal reflux other diuretics causing adverse effects in therapeutic use depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified vitamin d deficiency body mass index 36.0-36.9, adult hyposmolality and/or hyponatremia disorders of magnesium metabolism tobacco use disorder overweight other and unspecified hyperlipidemia unspecified essential hypertension alcohol abuse, unspecified hyposmolality and/or hyponatremia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified tobacco use disorder electrolyte and fluid disorders not elsewhere classified myalgia and myositis, unspecified esophageal reflux
white m 70 $nan$nan$pravastatin  20  mg ; metoprolol xl (toprol xl)  100  mg ; allopurinol  100  mg ; spironolactone  25  mg ; warfarin  1  mg ; clonidine  0.1  mg ; tamsulosin  0.4  mg ; 
 
white m 70 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  356  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  249  mg dl; chemistry blood lactate dehydrogenase (ld)  137  iu l; chemistry blood % hemoglobin a1c  6.8  %$pravastatin  20  mg ; metoprolol xl (toprol xl)  100  mg ; allopurinol  100  mg ; spironolactone  25  mg ; warfarin  1  mg ; clonidine  0.1  mg ; tamsulosin  0.4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; insulin  0  unit ; captopril  12.5  mg ; insulin  35  unit ; 
 
white f 86 $temp    heartrate  105.0  resprate  28.0  o2sat  91.0  sbp  134.0  dbp  80.0  rhythm    pain  0  ; temp    heartrate  103.0  resprate  22.0  o2sat  97.0  sbp  122.0  dbp  61.0  rhythm    pain  0  ; temp  97.4  heartrate  102.0  resprate  15.0  o2sat  99.0  sbp  100.0  dbp  58.0  rhythm    pain  0  ; temp  98.2  heartrate  99.0  resprate  26.0  o2sat  98.0  sbp  133.0  dbp  45.0  rhythm    pain  0  ; temp    heartrate  96.0  resprate  15.0  o2sat  97.0  sbp  105.0  dbp  52.0  rhythm    pain  0  $hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  524  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  72  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  127  mg dl; chemistry blood albumin  4.0  g dl; hematology blood bands  1  %; blood gas blood lactate  2.5  mmol l$nan
chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified generalized skin eruption due to drugs and medicaments taken internally tinea pedis encounter for examination for normal comparison and control in clinical research program personal history of nicotine dependence eosinophilia hyperlipidemia, unspecified aneurysm of artery of lower extremity rheumatic disorders of both mitral and aortic valves unspecified place in hospital as the place of occurrence of the external cause hypo-osmolality and hyponatremia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified personal history of other malignant neoplasm of large intestine unspecified atrial flutter acute on chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis acute kidney failure, unspecified pulmonary fibrosis, unspecified unspecified asthma, uncomplicated gout, unspecified urinary tract infection, site not specified acute posthemorrhagic anemia hyperkalemia other postprocedural shock, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other pneumothorax acute respiratory failure with hypoxia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic obstructive pulmonary disease, unspecified gout, unspecified dyspnea, unspecified unspecified asthma, uncomplicated personal history of other malignant neoplasm of large intestine rheumatic disorders of both mitral and aortic valves pure hypercholesterolemia gastro-esophageal reflux disease without esophagitis atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 3 (moderate) 
white f 86 $temp  97.9  heartrate  97.0  resprate  16.0  o2sat  99.0  sbp  127.0  dbp  59.0  rhythm    pain  sleeping  $hematology blood hematocrit  26.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  515  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  81  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  142  mg dl; blood gas blood lactate  2.6  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen (liquid)  650  mg ; allopurinol  100  mg ; ascorbic acid  500  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; ferrous gluconate  324  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; furosemide  40  mg ; guaifenesin  10  ml ; lansoprazole oral disintegrating tab  30  mg ; metoprolol tartrate  25  mg ; multivitamins  5  ml ; simvastatin  20  mg ; tiotropium bromide  1  cap ; dextrose 5%  150  ml ; levofloxacin  750  mg ; sodium chloride 0.9%  1000  ml ; lidocaine 5% patch  1  ptch ; oxycodone (immediate release)   2.5  mg ; ondansetron  4  mg ; docusate sodium (liquid)  100  mg ; metoclopramide  10  mg ; lidocaine 1%  10  ml ; ns syringe (intrapleural)  50  ml ; talc (sterile)  2.5  g ; d5 1 2ns  1000  ml ; 
chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified generalized skin eruption due to drugs and medicaments taken internally tinea pedis encounter for examination for normal comparison and control in clinical research program personal history of nicotine dependence eosinophilia hyperlipidemia, unspecified aneurysm of artery of lower extremity rheumatic disorders of both mitral and aortic valves unspecified place in hospital as the place of occurrence of the external cause hypo-osmolality and hyponatremia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified personal history of other malignant neoplasm of large intestine unspecified atrial flutter acute on chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis acute kidney failure, unspecified pulmonary fibrosis, unspecified unspecified asthma, uncomplicated gout, unspecified urinary tract infection, site not specified acute posthemorrhagic anemia hyperkalemia other postprocedural shock, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other pneumothorax acute respiratory failure with hypoxia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic obstructive pulmonary disease, unspecified gout, unspecified dyspnea, unspecified unspecified asthma, uncomplicated personal history of other malignant neoplasm of large intestine rheumatic disorders of both mitral and aortic valves pure hypercholesterolemia gastro-esophageal reflux disease without esophagitis atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 3 (moderate) 
white f 86 $nan$hematology blood hematocrit  20.9  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  6.2  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  372  k ul; hematology blood platelet count  384  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  79  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  133  mg dl; blood gas blood lactate  2.1  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen (liquid)  650  mg ; allopurinol  100  mg ; ascorbic acid  500  mg ; aspirin ec  81  mg ; ferrous gluconate  324  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; guaifenesin  10  ml ; lansoprazole oral disintegrating tab  30  mg ; multivitamins  5  ml ; simvastatin  20  mg ; tiotropium bromide  1  cap ; dextrose 5%  150  ml ; levofloxacin  750  mg ; sodium chloride 0.9%  1000  ml ; lidocaine 5% patch  1  ptch ; oxycodone (immediate release)   2.5  mg ; ondansetron  4  mg ; docusate sodium (liquid)  100  mg ; metoclopramide  10  mg ; d5 1 2ns  1000  ml ; 
chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified generalized skin eruption due to drugs and medicaments taken internally tinea pedis encounter for examination for normal comparison and control in clinical research program personal history of nicotine dependence eosinophilia hyperlipidemia, unspecified aneurysm of artery of lower extremity rheumatic disorders of both mitral and aortic valves unspecified place in hospital as the place of occurrence of the external cause hypo-osmolality and hyponatremia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified personal history of other malignant neoplasm of large intestine unspecified atrial flutter acute on chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis acute kidney failure, unspecified pulmonary fibrosis, unspecified unspecified asthma, uncomplicated gout, unspecified urinary tract infection, site not specified acute posthemorrhagic anemia hyperkalemia other postprocedural shock, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other pneumothorax acute respiratory failure with hypoxia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic obstructive pulmonary disease, unspecified gout, unspecified dyspnea, unspecified unspecified asthma, uncomplicated personal history of other malignant neoplasm of large intestine rheumatic disorders of both mitral and aortic valves pure hypercholesterolemia gastro-esophageal reflux disease without esophagitis atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 3 (moderate) 
white f 86 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  70  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  145  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen (liquid)  650  mg ; allopurinol  100  mg ; ascorbic acid  500  mg ; aspirin ec  81  mg ; ferrous gluconate  324  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; guaifenesin  10  ml ; lansoprazole oral disintegrating tab  30  mg ; multivitamins  5  ml ; simvastatin  20  mg ; tiotropium bromide  1  cap ; lidocaine 5% patch  1  ptch ; ondansetron  4  mg ; docusate sodium (liquid)  100  mg ; metoclopramide  10  mg ; oxycodone liquid  2.5  mg ; ipratropium bromide neb  1  neb ; 
chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified generalized skin eruption due to drugs and medicaments taken internally tinea pedis encounter for examination for normal comparison and control in clinical research program personal history of nicotine dependence eosinophilia hyperlipidemia, unspecified aneurysm of artery of lower extremity rheumatic disorders of both mitral and aortic valves unspecified place in hospital as the place of occurrence of the external cause hypo-osmolality and hyponatremia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified personal history of other malignant neoplasm of large intestine unspecified atrial flutter acute on chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis acute kidney failure, unspecified pulmonary fibrosis, unspecified unspecified asthma, uncomplicated gout, unspecified urinary tract infection, site not specified acute posthemorrhagic anemia hyperkalemia other postprocedural shock, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other pneumothorax acute respiratory failure with hypoxia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic obstructive pulmonary disease, unspecified gout, unspecified dyspnea, unspecified unspecified asthma, uncomplicated personal history of other malignant neoplasm of large intestine rheumatic disorders of both mitral and aortic valves pure hypercholesterolemia gastro-esophageal reflux disease without esophagitis atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 3 (moderate) 
white f 86 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood glucose  144  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen (liquid)  650  mg ; allopurinol  100  mg ; ascorbic acid  500  mg ; aspirin ec  81  mg ; ferrous gluconate  324  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; guaifenesin  10  ml ; lansoprazole oral disintegrating tab  30  mg ; multivitamins  5  ml ; simvastatin  20  mg ; tiotropium bromide  1  cap ; lidocaine 5% patch  1  ptch ; ondansetron  4  mg ; docusate sodium (liquid)  100  mg ; metoclopramide  10  mg ; oxycodone liquid  2.5  mg ; ipratropium bromide neb  1  neb ; 
chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified generalized skin eruption due to drugs and medicaments taken internally tinea pedis encounter for examination for normal comparison and control in clinical research program personal history of nicotine dependence eosinophilia hyperlipidemia, unspecified aneurysm of artery of lower extremity rheumatic disorders of both mitral and aortic valves unspecified place in hospital as the place of occurrence of the external cause hypo-osmolality and hyponatremia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified personal history of other malignant neoplasm of large intestine unspecified atrial flutter acute on chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis acute kidney failure, unspecified pulmonary fibrosis, unspecified unspecified asthma, uncomplicated gout, unspecified urinary tract infection, site not specified acute posthemorrhagic anemia hyperkalemia other postprocedural shock, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other pneumothorax acute respiratory failure with hypoxia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic obstructive pulmonary disease, unspecified gout, unspecified dyspnea, unspecified unspecified asthma, uncomplicated personal history of other malignant neoplasm of large intestine rheumatic disorders of both mitral and aortic valves pure hypercholesterolemia gastro-esophageal reflux disease without esophagitis atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 3 (moderate) 
white f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen (liquid)  650  mg ; allopurinol  100  mg ; ascorbic acid  500  mg ; aspirin ec  81  mg ; ferrous gluconate  324  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; guaifenesin  10  ml ; lansoprazole oral disintegrating tab  30  mg ; multivitamins  5  ml ; simvastatin  20  mg ; tiotropium bromide  1  cap ; lidocaine 5% patch  1  ptch ; ondansetron  4  mg ; docusate sodium (liquid)  100  mg ; metoclopramide  10  mg ; ipratropium bromide neb  1  neb ; 
chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified generalized skin eruption due to drugs and medicaments taken internally tinea pedis encounter for examination for normal comparison and control in clinical research program personal history of nicotine dependence eosinophilia hyperlipidemia, unspecified aneurysm of artery of lower extremity rheumatic disorders of both mitral and aortic valves unspecified place in hospital as the place of occurrence of the external cause hypo-osmolality and hyponatremia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified personal history of other malignant neoplasm of large intestine unspecified atrial flutter acute on chronic diastolic (congestive) heart failure gastro-esophageal reflux disease without esophagitis acute kidney failure, unspecified pulmonary fibrosis, unspecified unspecified asthma, uncomplicated gout, unspecified urinary tract infection, site not specified acute posthemorrhagic anemia hyperkalemia other postprocedural shock, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other pneumothorax acute respiratory failure with hypoxia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic obstructive pulmonary disease, unspecified gout, unspecified dyspnea, unspecified unspecified asthma, uncomplicated personal history of other malignant neoplasm of large intestine rheumatic disorders of both mitral and aortic valves pure hypercholesterolemia gastro-esophageal reflux disease without esophagitis atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 3 (moderate) 
white m 81 $nan$hematology blood hematocrit  29.3  %; hematology blood hematocrit  26.5  %; hematology blood hematocrit  25.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  231  k ul; hematology blood platelet count  216  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  107  mg dl; blood gas blood lactate  2.2  mmol l$senna  1  tab ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; ciprofloxacin hcl  500  mg ; hydrocortisone  20  mg ; pantoprazole  40  mg ; hydrocodone-acetaminophen  1  tab ; milk of magnesia  30  ml ; 0.9% sodium chloride  500  ml ; docusate sodium (liquid)  100  mg ; ketoconazole  200  mg ; oxycodone sr (oxycontin)  10  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; pravastatin  40  mg ; vitamin d  400  unit ; ferrous sulfate  325  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; lr  1000  ml ; meropenem  500  mg ; piperacillin-tazobactam  4.5  g ; 
secondary malignant neoplasm of bone and bone marrow other and unspecified hyperlipidemia aortic valve disorders mitral valve disorders chronic kidney disease, unspecified inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified other chronic pulmonary heart diseases hydronephrosis personal history of malignant neoplasm of prostate unspecified essential hypertension diverticulosis of colon (without mention of hemorrhage) calculus of ureter infection and inflammatory reaction due to other genitourinary device, implant, and graft urinary tract infection, site not specified atrial fibrillation constipation, unspecified secondary malignant neoplasm of lung anemia, unspecified acute on chronic diastolic heart failure hematuria, unspecified unspecified drug or medicinal substance causing adverse effects in therapeutic use congestive heart failure, unspecified pseudomonas infection in conditions classified elsewhere and of unspecified site obesity, unspecified atrial fibrillation other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate secondary malignant neoplasm of lung secondary malignant neoplasm of bone and bone marrow hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders chronic kidney disease, unspecified heart disease, unspecified 
white m 81 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  26.4  %; hematology blood hematocrit  28.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  191  k ul; hematology blood platelet count  191  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  6.6  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood glucose  158  mg dl; chemistry blood glucose  143  mg dl; blood gas blood lactate  1.2  mmol l$senna  1  tab ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; hydrocortisone  20  mg ; pantoprazole  40  mg ; hydrocodone-acetaminophen  1  tab ; milk of magnesia  30  ml ; 0.9% sodium chloride  500  ml ; ketoconazole  200  mg ; oxycodone sr (oxycontin)  10  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; pravastatin  40  mg ; vitamin d  400  unit ; ferrous sulfate  325  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; lr  1000  ml ; meropenem  500  mg ; piperacillin-tazobactam  4.5  g ; hydrocortisone na succ.  100  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; morphine sulfate  2  mg ; metoprolol tartrate  12.5  mg ; 
secondary malignant neoplasm of bone and bone marrow other and unspecified hyperlipidemia aortic valve disorders mitral valve disorders chronic kidney disease, unspecified inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified other chronic pulmonary heart diseases hydronephrosis personal history of malignant neoplasm of prostate unspecified essential hypertension diverticulosis of colon (without mention of hemorrhage) calculus of ureter infection and inflammatory reaction due to other genitourinary device, implant, and graft urinary tract infection, site not specified atrial fibrillation constipation, unspecified secondary malignant neoplasm of lung anemia, unspecified acute on chronic diastolic heart failure hematuria, unspecified unspecified drug or medicinal substance causing adverse effects in therapeutic use congestive heart failure, unspecified pseudomonas infection in conditions classified elsewhere and of unspecified site obesity, unspecified atrial fibrillation other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate secondary malignant neoplasm of lung secondary malignant neoplasm of bone and bone marrow hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders chronic kidney disease, unspecified heart disease, unspecified 
white m 81 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  167  mg dl; chemistry blood albumin  2.8  g dl$senna  1  tab ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; pantoprazole  40  mg ; hydrocodone-acetaminophen  1  tab ; milk of magnesia  30  ml ; ketoconazole  200  mg ; oxycodone sr (oxycontin)  10  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; pravastatin  40  mg ; vitamin d  400  unit ; ferrous sulfate  325  mg ; meropenem  500  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; morphine sulfate  2  mg ; metoprolol tartrate  12.5  mg ; hydrocortisone na succ.  50  mg ; sodium chloride 0.9%  flush  3  ml ; torsemide  20  mg ; neutra-phos  2  pkt ; 
secondary malignant neoplasm of bone and bone marrow other and unspecified hyperlipidemia aortic valve disorders mitral valve disorders chronic kidney disease, unspecified inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified other chronic pulmonary heart diseases hydronephrosis personal history of malignant neoplasm of prostate unspecified essential hypertension diverticulosis of colon (without mention of hemorrhage) calculus of ureter infection and inflammatory reaction due to other genitourinary device, implant, and graft urinary tract infection, site not specified atrial fibrillation constipation, unspecified secondary malignant neoplasm of lung anemia, unspecified acute on chronic diastolic heart failure hematuria, unspecified unspecified drug or medicinal substance causing adverse effects in therapeutic use congestive heart failure, unspecified pseudomonas infection in conditions classified elsewhere and of unspecified site obesity, unspecified atrial fibrillation other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate secondary malignant neoplasm of lung secondary malignant neoplasm of bone and bone marrow hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders chronic kidney disease, unspecified heart disease, unspecified 
white m 81 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  109  mg dl$senna  1  tab ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; pantoprazole  40  mg ; hydrocodone-acetaminophen  1  tab ; milk of magnesia  30  ml ; ketoconazole  200  mg ; oxycodone sr (oxycontin)  10  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; pravastatin  40  mg ; vitamin d  400  unit ; ferrous sulfate  325  mg ; metoprolol tartrate  12.5  mg ; hydrocortisone na succ.  50  mg ; sodium chloride 0.9%  flush  3  ml ; torsemide  20  mg ; neutra-phos  2  pkt ; trazodone  25  mg ; hydrocortisone  40  mg ; 
secondary malignant neoplasm of bone and bone marrow other and unspecified hyperlipidemia aortic valve disorders mitral valve disorders chronic kidney disease, unspecified inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified other chronic pulmonary heart diseases hydronephrosis personal history of malignant neoplasm of prostate unspecified essential hypertension diverticulosis of colon (without mention of hemorrhage) calculus of ureter infection and inflammatory reaction due to other genitourinary device, implant, and graft urinary tract infection, site not specified atrial fibrillation constipation, unspecified secondary malignant neoplasm of lung anemia, unspecified acute on chronic diastolic heart failure hematuria, unspecified unspecified drug or medicinal substance causing adverse effects in therapeutic use congestive heart failure, unspecified pseudomonas infection in conditions classified elsewhere and of unspecified site obesity, unspecified atrial fibrillation other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate secondary malignant neoplasm of lung secondary malignant neoplasm of bone and bone marrow hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders chronic kidney disease, unspecified heart disease, unspecified 
white m 81 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  128  mg dl$senna  1  tab ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; pantoprazole  40  mg ; hydrocodone-acetaminophen  1  tab ; milk of magnesia  30  ml ; ketoconazole  200  mg ; oxycodone sr (oxycontin)  10  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; pravastatin  40  mg ; vitamin d  400  unit ; ferrous sulfate  325  mg ; metoprolol tartrate  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; torsemide  20  mg ; trazodone  25  mg ; hydrocortisone  40  mg ; potassium chloride  40  meq ; potassium chloride  20  meq ; sw  100  ml ; magnesium sulfate  4  gm ; 
secondary malignant neoplasm of bone and bone marrow other and unspecified hyperlipidemia aortic valve disorders mitral valve disorders chronic kidney disease, unspecified inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified other chronic pulmonary heart diseases hydronephrosis personal history of malignant neoplasm of prostate unspecified essential hypertension diverticulosis of colon (without mention of hemorrhage) calculus of ureter infection and inflammatory reaction due to other genitourinary device, implant, and graft urinary tract infection, site not specified atrial fibrillation constipation, unspecified secondary malignant neoplasm of lung anemia, unspecified acute on chronic diastolic heart failure hematuria, unspecified unspecified drug or medicinal substance causing adverse effects in therapeutic use congestive heart failure, unspecified pseudomonas infection in conditions classified elsewhere and of unspecified site obesity, unspecified atrial fibrillation other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate secondary malignant neoplasm of lung secondary malignant neoplasm of bone and bone marrow hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders chronic kidney disease, unspecified heart disease, unspecified 
white m 81 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  104  mg dl$senna  1  tab ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; pantoprazole  40  mg ; hydrocodone-acetaminophen  1  tab ; milk of magnesia  30  ml ; ketoconazole  200  mg ; oxycodone sr (oxycontin)  10  mg ; calcium carbonate  500  mg ; pravastatin  40  mg ; vitamin d  400  unit ; ferrous sulfate  325  mg ; metoprolol tartrate  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; torsemide  20  mg ; potassium chloride  40  meq ; potassium chloride  20  meq ; sw  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 
secondary malignant neoplasm of bone and bone marrow other and unspecified hyperlipidemia aortic valve disorders mitral valve disorders chronic kidney disease, unspecified inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified other chronic pulmonary heart diseases hydronephrosis personal history of malignant neoplasm of prostate unspecified essential hypertension diverticulosis of colon (without mention of hemorrhage) calculus of ureter infection and inflammatory reaction due to other genitourinary device, implant, and graft urinary tract infection, site not specified atrial fibrillation constipation, unspecified secondary malignant neoplasm of lung anemia, unspecified acute on chronic diastolic heart failure hematuria, unspecified unspecified drug or medicinal substance causing adverse effects in therapeutic use congestive heart failure, unspecified pseudomonas infection in conditions classified elsewhere and of unspecified site obesity, unspecified atrial fibrillation other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate secondary malignant neoplasm of lung secondary malignant neoplasm of bone and bone marrow hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders chronic kidney disease, unspecified heart disease, unspecified 
white m 71 $nan$hematology blood hematocrit  35.2  %; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; simethicone  40-80  mg ; lorazepam  0.5  mg ; cepastat (phenol) lozenge  1  loz ; dabigatran etexilate  150  mg ; omeprazole  20  mg ; rosuvastatin calcium  10  mg ; multivitamins  1  tab ; amlodipine  10  mg ; atenolol  12.5  mg ; lisinopril  20  mg ; sucralfate  1  gm ; 
 
unknown f 55 $nan$nan$bisacodyl  10  mg ; 
displacement of cervical intervertebral disc without myelopathy 
unknown f 55 $nan$nan$bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; chloraseptic throat spray  1  spry ; hydrocodone-acetaminophen (5mg-500mg)  1-2  tab ; dexamethasone  6  mg ; 
displacement of cervical intervertebral disc without myelopathy 
unknown f 55 $nan$nan$bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; chloraseptic throat spray  1  spry ; hydrocodone-acetaminophen (5mg-500mg)  1-2  tab ; dexamethasone  6  mg ; 
displacement of cervical intervertebral disc without myelopathy 
white m 48 $nan$nan$nicotine patch  21  mg ; simvastatin  40  mg ; 
 
white m 48 $nan$hematology blood hematocrit  38.4  %; hematology blood hematocrit  36.9  %; hematology blood hemoglobin  13.3  g dl; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  179  k ul; hematology blood platelet count  161  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  182  mg dl$nicotine patch  21  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  650  mg ; ketorolac  15  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  1  tab ; lactated ringers  1000  ml ; hydrocodone-acetaminophen  1-2  tab ; 
 
white m 48 $nan$nan$nicotine patch  21  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; tamsulosin  0.4  mg ; docusate sodium  100  mg ; senna  1  tab ; lactated ringers  1000  ml ; hydrocodone-acetaminophen  1-2  tab ; 
 
white m 22 $nan$nan$influenza virus vaccine  0.5  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; d5 1 2ns  1000  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  40  mg ; 
 
white m 22 $nan$hematology blood hematocrit  42.0  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  96  mg dl$influenza virus vaccine  0.5  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; d5 1 2ns  1000  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  40  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; diphenhydramine  12.5-50  mg ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; 
 
white m 22 $nan$nan$influenza virus vaccine  0.5  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; diphenhydramine  12.5-50  mg ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; hydromorphone (dilaudid)  0.125  mg ; 
 
white m 22 $nan$nan$influenza virus vaccine  0.5  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; diphenhydramine  12.5-50  mg ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; hydromorphone (dilaudid)  0.125  mg ; 
 
other m 75 $nan$nan$amiodarone  200  mg ; aspirin  325  mg ; 
personal history of antineoplastic chemotherapy secondary malignant neoplasm of lung asthma, unspecified type, unspecified arthrodesis status secondary malignant neoplasm of bone and bone marrow coronary atherosclerosis of native coronary artery personal history of tobacco use chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified myoclonus esophageal reflux atrial fibrillation person boarding or alighting a car injured in collision with railway train or railway vehicle acquired absence of kidney anxiety state, unspecified obstructive sleep apnea (adult)(pediatric) secondary malignant neoplasm of other digestive organs and spleen anemia, unspecified personal history of malignant neoplasm of kidney person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle dementia, unspecified, without behavioral disturbance personal history of irradiation, presenting hazards to health secondary malignant neoplasm of brain and spinal cord personal history of malignant neoplasm of kidney encounter for change or removal of surgical wound dressing fever, unspecified unspecified essential hypertension long-term (current) use of antibiotics secondary malignant neoplasm of lung asthma, unspecified type, unspecified altered mental status secondary malignant neoplasm of bone and bone marrow anemia, unspecified backache, unspecified asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired absence of kidney personal history of malignant neoplasm of kidney unspecified essential hypertension late effect of radiation secondary malignant neoplasm of bone and bone marrow osteoarthrosis, unspecified whether generalized or localized, site unspecified disruption of wound, unspecified fever, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation secondary malignant neoplasm of lung
other m 75 $nan$hematology blood hematocrit  27.8  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  259  k ul; hematology blood platelet count  220  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  112  mg dl; chemistry blood albumin  4.0  g dl$amiodarone  200  mg ; aspirin  325  mg ; heparin flush (10 units ml)  2  ml ; 0.9% sodium chloride  100  ml ; morphine sulfate  500  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; docusate sodium  300  mg ; fentanyl patch  300  mcg h ; lactulose  30  ml ; lorazepam  0.5-1  mg ; magnesium citrate  150  ml ; fleet enema  1  enema ; ondansetron  8  mg ; oxycodone (immediate release)   120  mg ; omeprazole  40  mg ; bisacodyl  10  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; neutra-phos  2  pkt ; fluticasone-salmeterol diskus (250 50)   1  inh ; senna  1  tab ; axitinib  5  mg ; methadone  25  mg ; 
personal history of antineoplastic chemotherapy secondary malignant neoplasm of lung asthma, unspecified type, unspecified arthrodesis status secondary malignant neoplasm of bone and bone marrow coronary atherosclerosis of native coronary artery personal history of tobacco use chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified myoclonus esophageal reflux atrial fibrillation person boarding or alighting a car injured in collision with railway train or railway vehicle acquired absence of kidney anxiety state, unspecified obstructive sleep apnea (adult)(pediatric) secondary malignant neoplasm of other digestive organs and spleen anemia, unspecified personal history of malignant neoplasm of kidney person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle dementia, unspecified, without behavioral disturbance personal history of irradiation, presenting hazards to health secondary malignant neoplasm of brain and spinal cord personal history of malignant neoplasm of kidney encounter for change or removal of surgical wound dressing fever, unspecified unspecified essential hypertension long-term (current) use of antibiotics secondary malignant neoplasm of lung asthma, unspecified type, unspecified altered mental status secondary malignant neoplasm of bone and bone marrow anemia, unspecified backache, unspecified asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired absence of kidney personal history of malignant neoplasm of kidney unspecified essential hypertension late effect of radiation secondary malignant neoplasm of bone and bone marrow osteoarthrosis, unspecified whether generalized or localized, site unspecified disruption of wound, unspecified fever, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation secondary malignant neoplasm of lung
other m 75 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  96  mg dl$amiodarone  200  mg ; aspirin  325  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; docusate sodium  300  mg ; fentanyl patch  300  mcg h ; lactulose  30  ml ; lorazepam  0.5-1  mg ; magnesium citrate  150  ml ; fleet enema  1  enema ; omeprazole  40  mg ; bisacodyl  10  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; neutra-phos  2  pkt ; fluticasone-salmeterol diskus (250 50)   1  inh ; senna  1  tab ; axitinib  5  mg ; methadone  25  mg ; trazodone  25  mg ; morphine sulfate  100  mg ; calcium carbonate  1000  mg ; trazodone  50  mg ; 
personal history of antineoplastic chemotherapy secondary malignant neoplasm of lung asthma, unspecified type, unspecified arthrodesis status secondary malignant neoplasm of bone and bone marrow coronary atherosclerosis of native coronary artery personal history of tobacco use chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified myoclonus esophageal reflux atrial fibrillation person boarding or alighting a car injured in collision with railway train or railway vehicle acquired absence of kidney anxiety state, unspecified obstructive sleep apnea (adult)(pediatric) secondary malignant neoplasm of other digestive organs and spleen anemia, unspecified personal history of malignant neoplasm of kidney person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle dementia, unspecified, without behavioral disturbance personal history of irradiation, presenting hazards to health secondary malignant neoplasm of brain and spinal cord personal history of malignant neoplasm of kidney encounter for change or removal of surgical wound dressing fever, unspecified unspecified essential hypertension long-term (current) use of antibiotics secondary malignant neoplasm of lung asthma, unspecified type, unspecified altered mental status secondary malignant neoplasm of bone and bone marrow anemia, unspecified backache, unspecified asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired absence of kidney personal history of malignant neoplasm of kidney unspecified essential hypertension late effect of radiation secondary malignant neoplasm of bone and bone marrow osteoarthrosis, unspecified whether generalized or localized, site unspecified disruption of wound, unspecified fever, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation secondary malignant neoplasm of lung
other m 75 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  276  k ul; hematology blood platelet count  259  k ul; chemistry blood calcium, total  8.3  mg dl$amiodarone  200  mg ; aspirin  325  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; fleet enema  1  enema ; omeprazole  40  mg ; bisacodyl  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; senna  1  tab ; axitinib  5  mg ; methadone  25  mg ; calcium carbonate  1000  mg ; trazodone  50  mg ; calcium carbonate  1500  mg ; 
personal history of antineoplastic chemotherapy secondary malignant neoplasm of lung asthma, unspecified type, unspecified arthrodesis status secondary malignant neoplasm of bone and bone marrow coronary atherosclerosis of native coronary artery personal history of tobacco use chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified myoclonus esophageal reflux atrial fibrillation person boarding or alighting a car injured in collision with railway train or railway vehicle acquired absence of kidney anxiety state, unspecified obstructive sleep apnea (adult)(pediatric) secondary malignant neoplasm of other digestive organs and spleen anemia, unspecified personal history of malignant neoplasm of kidney person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle dementia, unspecified, without behavioral disturbance personal history of irradiation, presenting hazards to health secondary malignant neoplasm of brain and spinal cord personal history of malignant neoplasm of kidney encounter for change or removal of surgical wound dressing fever, unspecified unspecified essential hypertension long-term (current) use of antibiotics secondary malignant neoplasm of lung asthma, unspecified type, unspecified altered mental status secondary malignant neoplasm of bone and bone marrow anemia, unspecified backache, unspecified asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired absence of kidney personal history of malignant neoplasm of kidney unspecified essential hypertension late effect of radiation secondary malignant neoplasm of bone and bone marrow osteoarthrosis, unspecified whether generalized or localized, site unspecified disruption of wound, unspecified fever, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation secondary malignant neoplasm of lung
other m 75 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  89  mg dl$amiodarone  200  mg ; aspirin  325  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; fleet enema  1  enema ; omeprazole  40  mg ; bisacodyl  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; senna  1  tab ; axitinib  5  mg ; methadone  25  mg ; trazodone  50  mg ; calcium carbonate  1500  mg ; hydromorphone (dilaudid)  20  mg ; maalox diphenhydramine lidocaine  15-30  ml ; 
personal history of antineoplastic chemotherapy secondary malignant neoplasm of lung asthma, unspecified type, unspecified arthrodesis status secondary malignant neoplasm of bone and bone marrow coronary atherosclerosis of native coronary artery personal history of tobacco use chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified myoclonus esophageal reflux atrial fibrillation person boarding or alighting a car injured in collision with railway train or railway vehicle acquired absence of kidney anxiety state, unspecified obstructive sleep apnea (adult)(pediatric) secondary malignant neoplasm of other digestive organs and spleen anemia, unspecified personal history of malignant neoplasm of kidney person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle dementia, unspecified, without behavioral disturbance personal history of irradiation, presenting hazards to health secondary malignant neoplasm of brain and spinal cord personal history of malignant neoplasm of kidney encounter for change or removal of surgical wound dressing fever, unspecified unspecified essential hypertension long-term (current) use of antibiotics secondary malignant neoplasm of lung asthma, unspecified type, unspecified altered mental status secondary malignant neoplasm of bone and bone marrow anemia, unspecified backache, unspecified asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired absence of kidney personal history of malignant neoplasm of kidney unspecified essential hypertension late effect of radiation secondary malignant neoplasm of bone and bone marrow osteoarthrosis, unspecified whether generalized or localized, site unspecified disruption of wound, unspecified fever, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation secondary malignant neoplasm of lung
other m 75 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  84  mg dl$amiodarone  200  mg ; aspirin  325  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; fleet enema  1  enema ; omeprazole  40  mg ; bisacodyl  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; senna  1  tab ; axitinib  5  mg ; methadone  25  mg ; trazodone  50  mg ; calcium carbonate  1500  mg ; hydromorphone (dilaudid)  20  mg ; maalox diphenhydramine lidocaine  15-30  ml ; hydromorphone (dilaudid)  32-40  mg ; methadone  30  mg ; 
personal history of antineoplastic chemotherapy secondary malignant neoplasm of lung asthma, unspecified type, unspecified arthrodesis status secondary malignant neoplasm of bone and bone marrow coronary atherosclerosis of native coronary artery personal history of tobacco use chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified myoclonus esophageal reflux atrial fibrillation person boarding or alighting a car injured in collision with railway train or railway vehicle acquired absence of kidney anxiety state, unspecified obstructive sleep apnea (adult)(pediatric) secondary malignant neoplasm of other digestive organs and spleen anemia, unspecified personal history of malignant neoplasm of kidney person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle dementia, unspecified, without behavioral disturbance personal history of irradiation, presenting hazards to health secondary malignant neoplasm of brain and spinal cord personal history of malignant neoplasm of kidney encounter for change or removal of surgical wound dressing fever, unspecified unspecified essential hypertension long-term (current) use of antibiotics secondary malignant neoplasm of lung asthma, unspecified type, unspecified altered mental status secondary malignant neoplasm of bone and bone marrow anemia, unspecified backache, unspecified asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired absence of kidney personal history of malignant neoplasm of kidney unspecified essential hypertension late effect of radiation secondary malignant neoplasm of bone and bone marrow osteoarthrosis, unspecified whether generalized or localized, site unspecified disruption of wound, unspecified fever, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation secondary malignant neoplasm of lung
other m 75 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  89  mg dl$amiodarone  200  mg ; aspirin  325  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; fleet enema  1  enema ; omeprazole  40  mg ; bisacodyl  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; senna  1  tab ; axitinib  5  mg ; calcium carbonate  1500  mg ; maalox diphenhydramine lidocaine  15-30  ml ; hydromorphone (dilaudid)  32-40  mg ; methadone  30  mg ; nystatin oral suspension  5  ml ; hydromorphone (dilaudid)  40  mg ; 
personal history of antineoplastic chemotherapy secondary malignant neoplasm of lung asthma, unspecified type, unspecified arthrodesis status secondary malignant neoplasm of bone and bone marrow coronary atherosclerosis of native coronary artery personal history of tobacco use chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified myoclonus esophageal reflux atrial fibrillation person boarding or alighting a car injured in collision with railway train or railway vehicle acquired absence of kidney anxiety state, unspecified obstructive sleep apnea (adult)(pediatric) secondary malignant neoplasm of other digestive organs and spleen anemia, unspecified personal history of malignant neoplasm of kidney person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle dementia, unspecified, without behavioral disturbance personal history of irradiation, presenting hazards to health secondary malignant neoplasm of brain and spinal cord personal history of malignant neoplasm of kidney encounter for change or removal of surgical wound dressing fever, unspecified unspecified essential hypertension long-term (current) use of antibiotics secondary malignant neoplasm of lung asthma, unspecified type, unspecified altered mental status secondary malignant neoplasm of bone and bone marrow anemia, unspecified backache, unspecified asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired absence of kidney personal history of malignant neoplasm of kidney unspecified essential hypertension late effect of radiation secondary malignant neoplasm of bone and bone marrow osteoarthrosis, unspecified whether generalized or localized, site unspecified disruption of wound, unspecified fever, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation secondary malignant neoplasm of lung
other m 75 $nan$nan$amiodarone  200  mg ; aspirin  325  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; fleet enema  1  enema ; omeprazole  40  mg ; bisacodyl  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; senna  1  tab ; axitinib  5  mg ; calcium carbonate  1500  mg ; maalox diphenhydramine lidocaine  15-30  ml ; hydromorphone (dilaudid)  32-40  mg ; methadone  30  mg ; nystatin oral suspension  5  ml ; hydromorphone (dilaudid)  40  mg ; hydromorphone (dilaudid)  48  mg ; hydromorphone (dilaudid)  40-48  mg ; zofran odt  8  mg ; 
personal history of antineoplastic chemotherapy secondary malignant neoplasm of lung asthma, unspecified type, unspecified arthrodesis status secondary malignant neoplasm of bone and bone marrow coronary atherosclerosis of native coronary artery personal history of tobacco use chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified myoclonus esophageal reflux atrial fibrillation person boarding or alighting a car injured in collision with railway train or railway vehicle acquired absence of kidney anxiety state, unspecified obstructive sleep apnea (adult)(pediatric) secondary malignant neoplasm of other digestive organs and spleen anemia, unspecified personal history of malignant neoplasm of kidney person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle dementia, unspecified, without behavioral disturbance personal history of irradiation, presenting hazards to health secondary malignant neoplasm of brain and spinal cord personal history of malignant neoplasm of kidney encounter for change or removal of surgical wound dressing fever, unspecified unspecified essential hypertension long-term (current) use of antibiotics secondary malignant neoplasm of lung asthma, unspecified type, unspecified altered mental status secondary malignant neoplasm of bone and bone marrow anemia, unspecified backache, unspecified asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired absence of kidney personal history of malignant neoplasm of kidney unspecified essential hypertension late effect of radiation secondary malignant neoplasm of bone and bone marrow osteoarthrosis, unspecified whether generalized or localized, site unspecified disruption of wound, unspecified fever, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation secondary malignant neoplasm of lung
other m 75 $nan$nan$amiodarone  200  mg ; aspirin  325  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; fleet enema  1  enema ; omeprazole  40  mg ; bisacodyl  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; senna  1  tab ; axitinib  5  mg ; calcium carbonate  1500  mg ; maalox diphenhydramine lidocaine  15-30  ml ; nystatin oral suspension  5  ml ; hydromorphone (dilaudid)  48  mg ; hydromorphone (dilaudid)  40-48  mg ; zofran odt  8  mg ; 
personal history of antineoplastic chemotherapy secondary malignant neoplasm of lung asthma, unspecified type, unspecified arthrodesis status secondary malignant neoplasm of bone and bone marrow coronary atherosclerosis of native coronary artery personal history of tobacco use chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified myoclonus esophageal reflux atrial fibrillation person boarding or alighting a car injured in collision with railway train or railway vehicle acquired absence of kidney anxiety state, unspecified obstructive sleep apnea (adult)(pediatric) secondary malignant neoplasm of other digestive organs and spleen anemia, unspecified personal history of malignant neoplasm of kidney person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle dementia, unspecified, without behavioral disturbance personal history of irradiation, presenting hazards to health secondary malignant neoplasm of brain and spinal cord personal history of malignant neoplasm of kidney encounter for change or removal of surgical wound dressing fever, unspecified unspecified essential hypertension long-term (current) use of antibiotics secondary malignant neoplasm of lung asthma, unspecified type, unspecified altered mental status secondary malignant neoplasm of bone and bone marrow anemia, unspecified backache, unspecified asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acquired absence of kidney personal history of malignant neoplasm of kidney unspecified essential hypertension late effect of radiation secondary malignant neoplasm of bone and bone marrow osteoarthrosis, unspecified whether generalized or localized, site unspecified disruption of wound, unspecified fever, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation secondary malignant neoplasm of lung
white m 73 $temp  98.7  heartrate  80.0  resprate  16.0  o2sat  99.0  sbp  99.0  dbp  47.0  rhythm    pain  0  $hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  127  mg dl; hematology blood bands  12  %$atorvastatin  10  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; furosemide  80  mg ; omeprazole  20  mg ; metoprolol tartrate  12.5  mg ; tamsulosin  0.4  mg ; mesalamine enema  4  gm ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; fluticasone propionate nasal  2  spry ; levothyroxine sodium  112  mcg ; montelukast  10  mg ; multivitamins  1  tab ; prednisone  60  mg ; spironolactone  25  mg ; metoprolol succinate xl  25  mg ; warfarin  12.5  mg ; 
ulcer of anus and rectum unspecified place or not applicable obstructive sleep apnea (adult) (pediatric) peripheral vascular disease, unspecified gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms hypothyroidism, unspecified acute kidney failure, unspecified hemorrhage of anus and rectum acute posthemorrhagic anemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of prosthetic heart valve personal history of irradiation acute on chronic diastolic (congestive) heart failure diverticulosis of large intestine without perforation or abscess without bleeding chronic kidney disease, unspecified chronic obstructive pulmonary disease, unspecified personal history of malignant neoplasm of prostate endocarditis, valve unspecified personal history of nicotine dependence presence of cardiac pacemaker presence of aortocoronary bypass graft long term (current) use of aspirin chronic passive congestion of liver unspecified asthma, uncomplicated radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure angiodysplasia of colon without hemorrhage presence of right artificial knee joint myelofibrosis gastric varices rheumatic tricuspid insufficiency atherosclerosis of coronary artery bypass graft(s) without angina pectoris long term (current) use of anticoagulants presence of cardiac pacemaker acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation chronic kidney disease, unspecified acute kidney failure, unspecified sick sinus syndrome unspecified asthma, uncomplicated family history of ischemic heart disease and other diseases of the circulatory system personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified iron deficiency anemia, unspecified myelofibrosis chronic passive congestion of liver presence of prosthetic heart valve hypothyroidism, unspecified
white m 73 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  2.8  $sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; fluticasone propionate nasal  2  spry ; levothyroxine sodium  112  mcg ; montelukast  10  mg ; multivitamins  1  tab ; prednisone  60  mg ; spironolactone  25  mg ; metoprolol succinate xl  25  mg ; warfarin  12.5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; 
ulcer of anus and rectum unspecified place or not applicable obstructive sleep apnea (adult) (pediatric) peripheral vascular disease, unspecified gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms hypothyroidism, unspecified acute kidney failure, unspecified hemorrhage of anus and rectum acute posthemorrhagic anemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of prosthetic heart valve personal history of irradiation acute on chronic diastolic (congestive) heart failure diverticulosis of large intestine without perforation or abscess without bleeding chronic kidney disease, unspecified chronic obstructive pulmonary disease, unspecified personal history of malignant neoplasm of prostate endocarditis, valve unspecified personal history of nicotine dependence presence of cardiac pacemaker presence of aortocoronary bypass graft long term (current) use of aspirin chronic passive congestion of liver unspecified asthma, uncomplicated radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure angiodysplasia of colon without hemorrhage presence of right artificial knee joint myelofibrosis gastric varices rheumatic tricuspid insufficiency atherosclerosis of coronary artery bypass graft(s) without angina pectoris long term (current) use of anticoagulants presence of cardiac pacemaker acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation chronic kidney disease, unspecified acute kidney failure, unspecified sick sinus syndrome unspecified asthma, uncomplicated family history of ischemic heart disease and other diseases of the circulatory system personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified iron deficiency anemia, unspecified myelofibrosis chronic passive congestion of liver presence of prosthetic heart valve hypothyroidism, unspecified
white m 73 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; fluticasone propionate nasal  2  spry ; levothyroxine sodium  112  mcg ; montelukast  10  mg ; multivitamins  1  tab ; prednisone  60  mg ; spironolactone  25  mg ; metoprolol succinate xl  25  mg ; warfarin  12.5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; furosemide  60  mg ; 
ulcer of anus and rectum unspecified place or not applicable obstructive sleep apnea (adult) (pediatric) peripheral vascular disease, unspecified gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms hypothyroidism, unspecified acute kidney failure, unspecified hemorrhage of anus and rectum acute posthemorrhagic anemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of prosthetic heart valve personal history of irradiation acute on chronic diastolic (congestive) heart failure diverticulosis of large intestine without perforation or abscess without bleeding chronic kidney disease, unspecified chronic obstructive pulmonary disease, unspecified personal history of malignant neoplasm of prostate endocarditis, valve unspecified personal history of nicotine dependence presence of cardiac pacemaker presence of aortocoronary bypass graft long term (current) use of aspirin chronic passive congestion of liver unspecified asthma, uncomplicated radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure angiodysplasia of colon without hemorrhage presence of right artificial knee joint myelofibrosis gastric varices rheumatic tricuspid insufficiency atherosclerosis of coronary artery bypass graft(s) without angina pectoris long term (current) use of anticoagulants presence of cardiac pacemaker acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation chronic kidney disease, unspecified acute kidney failure, unspecified sick sinus syndrome unspecified asthma, uncomplicated family history of ischemic heart disease and other diseases of the circulatory system personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified iron deficiency anemia, unspecified myelofibrosis chronic passive congestion of liver presence of prosthetic heart valve hypothyroidism, unspecified
black african american f 28 $nan$nan$citalopram hydrobromide  10  mg ; oxcarbazepine  450  mg ; albuterol inhaler  1-2  puff ; ondansetron  4-8  mg ; lr  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; codeine sulfate  30-60  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; lorazepam  0.5  mg ; oxcarbazepine  1200  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy asthma, unspecified type, unspecified epilepsy complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication other cardiovascular diseases of mother, antepartum condition or complication other specified complications of pregnancy, antepartum condition or complication obsessive-compulsive disorders mental disorders of mother, antepartum condition or complication depressive disorder, not elsewhere classified mitral valve disorders anxiety state, unspecified other postprocedural status obsessive-compulsive disorders epilepsy, unspecified, without mention of intractable epilepsy unspecified symptom associated with female genital organs other acute pain other chronic pain tobacco use disorder bipolar disorder, unspecified extrinsic asthma, unspecified attention deficit disorder with hyperactivity abdominal pain, other specified site 
black african american f 28 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  123  k ul$citalopram hydrobromide  10  mg ; oxcarbazepine  450  mg ; albuterol inhaler  1-2  puff ; ondansetron  4-8  mg ; lr  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; codeine sulfate  30-60  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; lorazepam  0.5  mg ; oxcarbazepine  1200  mg ; pantoprazole  40  mg ; folic acid  1  mg ; ondansetron odt  4  mg ; oxcarbazepine  300  mg ; oxcarbazepine  600  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy asthma, unspecified type, unspecified epilepsy complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication other cardiovascular diseases of mother, antepartum condition or complication other specified complications of pregnancy, antepartum condition or complication obsessive-compulsive disorders mental disorders of mother, antepartum condition or complication depressive disorder, not elsewhere classified mitral valve disorders anxiety state, unspecified other postprocedural status obsessive-compulsive disorders epilepsy, unspecified, without mention of intractable epilepsy unspecified symptom associated with female genital organs other acute pain other chronic pain tobacco use disorder bipolar disorder, unspecified extrinsic asthma, unspecified attention deficit disorder with hyperactivity abdominal pain, other specified site 
black african american f 28 $nan$nan$citalopram hydrobromide  10  mg ; oxcarbazepine  450  mg ; albuterol inhaler  1-2  puff ; ondansetron  4-8  mg ; lr  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; codeine sulfate  30-60  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; lorazepam  0.5  mg ; pantoprazole  40  mg ; folic acid  1  mg ; ondansetron odt  4  mg ; oxcarbazepine  300  mg ; oxcarbazepine  600  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy asthma, unspecified type, unspecified epilepsy complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication other cardiovascular diseases of mother, antepartum condition or complication other specified complications of pregnancy, antepartum condition or complication obsessive-compulsive disorders mental disorders of mother, antepartum condition or complication depressive disorder, not elsewhere classified mitral valve disorders anxiety state, unspecified other postprocedural status obsessive-compulsive disorders epilepsy, unspecified, without mention of intractable epilepsy unspecified symptom associated with female genital organs other acute pain other chronic pain tobacco use disorder bipolar disorder, unspecified extrinsic asthma, unspecified attention deficit disorder with hyperactivity abdominal pain, other specified site 
white m 70 $nan$nan$citalopram hydrobromide  20  mg ; atenolol  25  mg ; simvastatin  10  mg ; lisinopril  2.5  mg ; fexofenadine  180  mg ; 
contracture of palmar fascia other malignant lymphomas, unspecified site, extranodal and solid organ sites encounter for antineoplastic chemotherapy atrial fibrillation ostium secundum type atrial septal defect atrial fibrillation other and unspecified hyperlipidemia cerebral aneurysm, nonruptured encounter for antineoplastic immunotherapy ostium secundum type atrial septal defect long-term (current) use of anticoagulants unspecified essential hypertension personal history of other diseases of circulatory system other malignant lymphomas, unspecified site, extranodal and solid organ sites contracture of palmar fascia 
white m 70 $nan$hematology blood hematocrit  42.5  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  3.5  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  101  mg dl$citalopram hydrobromide  20  mg ; atenolol  25  mg ; simvastatin  10  mg ; lisinopril  2.5  mg ; fexofenadine  180  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; pneumococcal vac polyvalent  0.5  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; 5% dextrose  500  ml ; methotrexate sodium  6240  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; sodium bicarbonate  90  meq ; warfarin  2.5  mg ; sodium bicarbonate  1300  mg ; levetiracetam  250  mg ; 
contracture of palmar fascia other malignant lymphomas, unspecified site, extranodal and solid organ sites encounter for antineoplastic chemotherapy atrial fibrillation ostium secundum type atrial septal defect atrial fibrillation other and unspecified hyperlipidemia cerebral aneurysm, nonruptured encounter for antineoplastic immunotherapy ostium secundum type atrial septal defect long-term (current) use of anticoagulants unspecified essential hypertension personal history of other diseases of circulatory system other malignant lymphomas, unspecified site, extranodal and solid organ sites contracture of palmar fascia 
white m 70 $nan$hematology blood hematocrit  41.4  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  102  mg dl$citalopram hydrobromide  20  mg ; atenolol  25  mg ; simvastatin  10  mg ; lisinopril  2.5  mg ; fexofenadine  180  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  500  ml ; methotrexate sodium  6240  mg ; 5% dextrose  50  ml ; ondansetron  24  mg ; sodium bicarbonate  90  meq ; warfarin  2.5  mg ; sodium bicarbonate  1300  mg ; levetiracetam  250  mg ; leucovorin calcium  25  mg ; leucovorin calcium  15  mg ; leucovorin calcium  40  mg ; 
contracture of palmar fascia other malignant lymphomas, unspecified site, extranodal and solid organ sites encounter for antineoplastic chemotherapy atrial fibrillation ostium secundum type atrial septal defect atrial fibrillation other and unspecified hyperlipidemia cerebral aneurysm, nonruptured encounter for antineoplastic immunotherapy ostium secundum type atrial septal defect long-term (current) use of anticoagulants unspecified essential hypertension personal history of other diseases of circulatory system other malignant lymphomas, unspecified site, extranodal and solid organ sites contracture of palmar fascia 
white m 70 $nan$chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  104  mg dl$citalopram hydrobromide  20  mg ; atenolol  25  mg ; simvastatin  10  mg ; lisinopril  2.5  mg ; fexofenadine  180  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium bicarbonate  1300  mg ; levetiracetam  250  mg ; leucovorin calcium  25  mg ; leucovorin calcium  15  mg ; leucovorin calcium  40  mg ; warfarin  2  mg ; 
contracture of palmar fascia other malignant lymphomas, unspecified site, extranodal and solid organ sites encounter for antineoplastic chemotherapy atrial fibrillation ostium secundum type atrial septal defect atrial fibrillation other and unspecified hyperlipidemia cerebral aneurysm, nonruptured encounter for antineoplastic immunotherapy ostium secundum type atrial septal defect long-term (current) use of anticoagulants unspecified essential hypertension personal history of other diseases of circulatory system other malignant lymphomas, unspecified site, extranodal and solid organ sites contracture of palmar fascia 
white m 70 $nan$nan$citalopram hydrobromide  20  mg ; atenolol  25  mg ; simvastatin  10  mg ; lisinopril  2.5  mg ; fexofenadine  180  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; pneumococcal vac polyvalent  0.5  ml ; levetiracetam  250  mg ; leucovorin calcium  40  mg ; 
contracture of palmar fascia other malignant lymphomas, unspecified site, extranodal and solid organ sites encounter for antineoplastic chemotherapy atrial fibrillation ostium secundum type atrial septal defect atrial fibrillation other and unspecified hyperlipidemia cerebral aneurysm, nonruptured encounter for antineoplastic immunotherapy ostium secundum type atrial septal defect long-term (current) use of anticoagulants unspecified essential hypertension personal history of other diseases of circulatory system other malignant lymphomas, unspecified site, extranodal and solid organ sites contracture of palmar fascia 
white m 80 $temp  97.7  heartrate  92.0  resprate  18.0  o2sat  96.0  sbp  99.0  dbp  64.0  rhythm    pain  1  ; temp  97.8  heartrate  90.0  resprate  20.0  o2sat  92.0  sbp  104.0  dbp  64.0  rhythm    pain  1  ; temp  98.0  heartrate  86.0  resprate  18.0  o2sat  93.0  sbp  99.0  dbp  63.0  rhythm    pain  1  $hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  7.5  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  170  iu l; chemistry blood albumin  2.6  g dl; blood gas blood lactate  2.0  mmol l$nan
 
white m 80 $temp    heartrate  77.0  resprate  16.0  o2sat  94.0  sbp  100.0  dbp  61.0  rhythm    pain  asleep   ; temp  98.0  heartrate  74.0  resprate  16.0  o2sat  93.0  sbp  106.0  dbp  67.0  rhythm    pain  0  ; temp    heartrate  68.0  resprate  14.0  o2sat  95.0  sbp  106.0  dbp  62.0  rhythm    pain  0  $hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, indirect  0.7  mg dl; chemistry blood bilirubin, total  7.0  mg dl; chemistry blood glucose  94  mg dl; chemistry blood bilirubin, direct  6.3  mg dl$senna  8.6  mg ; vial  1  vial ; cefepime  2  g ; metronidazole  500  mg ; acetaminophen  650  mg ; lactated ringers  1000  ml ; oxycodone (immediate release)  5  mg ; cefepime  1  g ; 0.9% sodium chloride  250  ml ; gentamicin sulfate  520  mg ; 
 
white m 80 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  76  mg dl; chemistry blood albumin  2.1  g dl$senna  8.6  mg ; vial  1  vial ; cefepime  2  g ; metronidazole  500  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; cefepime  1  g ; 0.9% sodium chloride  250  ml ; gentamicin sulfate  520  mg ; sodium chloride 0.9%  flush  3-10  ml ; 
 
white m 80 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  114  mg dl$senna  8.6  mg ; metronidazole  500  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; cefepime  1  g ; sodium chloride 0.9%  flush  3-10  ml ; 
 
white m 80 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  127  mg dl; chemistry blood lactate dehydrogenase (ld)  182  iu l$senna  8.6  mg ; metronidazole  500  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; cefepime  1  g ; sodium chloride 0.9%  flush  3-10  ml ; potassium chloride  40  meq ; ciprofloxacin hcl  500  mg ; 
 
white m 78 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.3  g dl$bisacodyl  10  mg ; senna  1  tab ; ns  100  ml ; metronidazole (flagyl)  500  mg ; pantoprazole  40  mg ; mexiletine  150  mg ; digoxin  0.125  mg ; digoxin  0.0625  mg ; docusate sodium (liquid)  100  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; carvedilol  3.125  mg ; bupropion  75  mg ; furosemide  10  mg ; simvastatin  80  mg ; aspirin  81  mg ; multivitamins  1  cap ; lisinopril  2.5  mg ; clotrimazole  1  troc ; nystatin oral suspension  5  ml ; lidocaine jelly 2% (urojet)  1  appl ; ns  500  ml ; azithromycin  250  mg ; warfarin  5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; docusate sodium  100  mg ; 
 
white m 78 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.8  ; hematology urine wbc  6  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  88  mg dl$ns  250  ml ; d5w  500  ml ; bisacodyl  10  mg ; senna  1  tab ; ns  100  ml ; metronidazole (flagyl)  500  mg ; pantoprazole  40  mg ; mexiletine  150  mg ; digoxin  0.125  mg ; digoxin  0.0625  mg ; carvedilol  3.125  mg ; bupropion  75  mg ; furosemide  10  mg ; simvastatin  80  mg ; aspirin  81  mg ; multivitamins  1  cap ; clotrimazole  1  troc ; nystatin oral suspension  5  ml ; lidocaine jelly 2% (urojet)  1  appl ; ns  500  ml ; azithromycin  250  mg ; warfarin  5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; docusate sodium  100  mg ; potassium chloride  20-40  meq ; d5w  250  ml ; potassium chloride  40  meq ; d5w  1000  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; lansoprazole oral disintegrating tab  30  mg ; captopril  6.25  mg ; 
 
white m 78 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  84  mg dl$ns  250  ml ; d5w  500  ml ; bisacodyl  10  mg ; senna  1  tab ; ns  100  ml ; metronidazole (flagyl)  500  mg ; mexiletine  150  mg ; digoxin  0.125  mg ; digoxin  0.0625  mg ; carvedilol  3.125  mg ; bupropion  75  mg ; simvastatin  80  mg ; aspirin  81  mg ; multivitamins  1  cap ; lidocaine jelly 2% (urojet)  1  appl ; azithromycin  250  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; docusate sodium  100  mg ; potassium chloride  20-40  meq ; d5w  250  ml ; potassium chloride  40  meq ; d5w  1000  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; lansoprazole oral disintegrating tab  30  mg ; captopril  6.25  mg ; captopril  12.5  mg ; warfarin  6  mg ; 
 
white m 78 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  89  mg dl$d5w  500  ml ; bisacodyl  10  mg ; senna  1  tab ; mexiletine  150  mg ; digoxin  0.125  mg ; digoxin  0.0625  mg ; carvedilol  3.125  mg ; bupropion  75  mg ; simvastatin  80  mg ; aspirin  81  mg ; multivitamins  1  cap ; lidocaine jelly 2% (urojet)  1  appl ; azithromycin  250  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; docusate sodium  100  mg ; potassium chloride  20-40  meq ; d5w  250  ml ; potassium chloride  40  meq ; d5w  1000  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; lansoprazole oral disintegrating tab  30  mg ; captopril  12.5  mg ; warfarin  6  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ferrous sulfate  325  mg ; cefpodoxime proxetil  100  mg ; carvedilol  6.25  mg ; 
 
white m 78 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  93  mg dl; hematology blood bands  0  %$d5w  500  ml ; bisacodyl  10  mg ; mexiletine  150  mg ; digoxin  0.125  mg ; digoxin  0.0625  mg ; bupropion  75  mg ; simvastatin  80  mg ; aspirin  81  mg ; multivitamins  1  cap ; lidocaine jelly 2% (urojet)  1  appl ; docusate sodium  100  mg ; potassium chloride  20-40  meq ; d5w  250  ml ; potassium chloride  40  meq ; d5w  1000  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; warfarin  6  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ferrous sulfate  325  mg ; carvedilol  6.25  mg ; carvedilol  12.5  mg ; 
 
white m 78 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood glucose  83  mg dl$d5w  500  ml ; bisacodyl  10  mg ; mexiletine  150  mg ; digoxin  0.125  mg ; digoxin  0.0625  mg ; bupropion  75  mg ; simvastatin  80  mg ; aspirin  81  mg ; multivitamins  1  cap ; lidocaine jelly 2% (urojet)  1  appl ; potassium chloride  20-40  meq ; d5w  250  ml ; potassium chloride  40  meq ; d5w  1000  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; warfarin  6  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ferrous sulfate  325  mg ; carvedilol  12.5  mg ; 
 
white m 78 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  300  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  3.7  ; hematology blood inr(pt)  4.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  106  mg dl; blood gas blood lactate  1.1  mmol l$d5w  500  ml ; bisacodyl  10  mg ; mexiletine  150  mg ; digoxin  0.125  mg ; digoxin  0.0625  mg ; bupropion  75  mg ; simvastatin  80  mg ; aspirin  81  mg ; multivitamins  1  cap ; lidocaine jelly 2% (urojet)  1  appl ; potassium chloride  20-40  meq ; d5w  250  ml ; potassium chloride  40  meq ; d5w  1000  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; warfarin  6  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ferrous sulfate  325  mg ; carvedilol  12.5  mg ; ns  1000  ml ; 
 
white m 78 $nan$hematology blood hematocrit  33.2  %; hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  3.7  ; hematology blood inr(pt)  3.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  123  mg dl; blood gas blood lactate  2.4  mmol l$d5w  500  ml ; bisacodyl  10  mg ; mexiletine  150  mg ; digoxin  0.125  mg ; digoxin  0.0625  mg ; bupropion  75  mg ; simvastatin  80  mg ; aspirin  81  mg ; multivitamins  1  cap ; lidocaine jelly 2% (urojet)  1  appl ; potassium chloride  20-40  meq ; d5w  250  ml ; potassium chloride  40  meq ; d5w  1000  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ferrous sulfate  325  mg ; carvedilol  12.5  mg ; ns  1000  ml ; 
 
white m 78 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  377  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood glucose  97  mg dl$d5w  500  ml ; bisacodyl  10  mg ; mexiletine  150  mg ; digoxin  0.125  mg ; digoxin  0.0625  mg ; bupropion  75  mg ; simvastatin  80  mg ; aspirin  81  mg ; multivitamins  1  cap ; lidocaine jelly 2% (urojet)  1  appl ; potassium chloride  20-40  meq ; d5w  250  ml ; potassium chloride  40  meq ; d5w  1000  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ferrous sulfate  325  mg ; carvedilol  12.5  mg ; warfarin  4  mg ; 
 
white m 78 $nan$nan$d5w  500  ml ; bisacodyl  10  mg ; mexiletine  150  mg ; digoxin  0.125  mg ; digoxin  0.0625  mg ; bupropion  75  mg ; simvastatin  80  mg ; aspirin  81  mg ; multivitamins  1  cap ; lidocaine jelly 2% (urojet)  1  appl ; potassium chloride  20-40  meq ; d5w  250  ml ; potassium chloride  40  meq ; d5w  1000  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ferrous sulfate  325  mg ; carvedilol  12.5  mg ; warfarin  4  mg ; 
 
black african american f 33 $temp  98.6  heartrate  82.0  resprate  16.0  o2sat  100.0  sbp  119.0  dbp  69.0  rhythm    pain  8  ; temp  98.0  heartrate  86.0  resprate  16.0  o2sat  100.0  sbp  109.0  dbp  61.0  rhythm    pain  7  ; temp  99.1  heartrate  68.0  resprate  16.0  o2sat  100.0  sbp  103.0  dbp  57.0  rhythm    pain  7  ; temp  97.7  heartrate  64.0  resprate  16.0  o2sat  100.0  sbp  95.0  dbp  59.0  rhythm    pain    $hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  6.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  82  mg dl; blood gas blood potassium, whole blood  3.7  meq l$nan
lumbago morbid obesity body mass index 40.0-44.9, adult anemia of mother, delivered, with or without mention of antepartum condition other and unspecified cord entanglement, without mention of compression, complicating labor and delivery, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition maternal pyrexia during labor, unspecified, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn unspecified acquired hypothyroidism anemia, unspecified thyroid dysfunction of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident
white f 36 $nan$nan$nephrocaps  1  cap ; 
 
white f 36 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; erythromycin  250  mg ; amoxicillin  500  mg ; syringe  1  syr ; betamethasone sodium phos acet  12  mg ; sarna lotion  1  appl ; nicotine patch  14  mg ; 
 
white f 36 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; erythromycin  250  mg ; amoxicillin  500  mg ; syringe  1  syr ; betamethasone sodium phos acet  12  mg ; sarna lotion  1  appl ; nicotine patch  14  mg ; clotrimazole cream  1  appl ; 
 
white f 36 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; erythromycin  250  mg ; sarna lotion  1  appl ; nicotine patch  14  mg ; mupirocin cream 2%  1  appl ; hydrocerin  1  appl ; 
 
white f 36 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; erythromycin  250  mg ; sarna lotion  1  appl ; nicotine patch  14  mg ; mupirocin cream 2%  1  appl ; hydrocerin  1  appl ; 
 
white f 36 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; erythromycin  250  mg ; sarna lotion  1  appl ; nicotine patch  14  mg ; mupirocin cream 2%  1  appl ; hydrocerin  1  appl ; ranitidine  150  mg ; 
 
white f 36 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; erythromycin  250  mg ; sarna lotion  1  appl ; nicotine patch  14  mg ; mupirocin cream 2%  1  appl ; hydrocerin  1  appl ; ranitidine  150  mg ; 
 
white f 36 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  347  k ul; hematology urine wbc  8  # hpf$nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; erythromycin  250  mg ; sarna lotion  1  appl ; nicotine patch  14  mg ; mupirocin cream 2%  1  appl ; hydrocerin  1  appl ; ranitidine  150  mg ; 
 
white f 36 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; erythromycin  250  mg ; sarna lotion  1  appl ; nicotine patch  14  mg ; mupirocin cream 2%  1  appl ; hydrocerin  1  appl ; ranitidine  150  mg ; 
 
hispanic latino f 52 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  6.4  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  10  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  137  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; chemistry blood lactate dehydrogenase (ld)  203  iu l; chemistry blood albumin  2.8  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  0.5  mmol l; blood gas blood chloride, whole blood  114  meq l; blood gas blood glucose  93  mg dl; blood gas blood hematocrit, calculated  20  %; blood gas blood hemoglobin  6.6  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  138  meq l$dextrose 5%  150  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol-ipratropium  1-2  puff ; multivitamins  1  cap ; ondansetron  4  mg ; amlodipine  10  mg ; atovaquone suspension  750  mg ; colchicine  0.6  mg ; folic acid  1  mg ; prednisone  10  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; vitamin d  400  unit ; famotidine  40  mg ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; calcium carbonate  500  mg ; omeprazole  40  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; levofloxacin  750  mg ; methylprednisolone sodium succ  125  mg ; furosemide  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; acetaminophen  1000  mg ; acetaminophen  325-650  mg ; 
acidosis osteoporosis, unspecified esophageal reflux other chronic pulmonary heart diseases postinflammatory pulmonary fibrosis systemic lupus erythematosus anemia of other chronic disease chronic kidney disease, unspecified degenerative skin disorders aseptic necrosis of head and neck of femur dehydration acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified iridocyclitis unspecified essential hypertension aseptic necrosis of head and neck of femur other specified diffuse diseases of connective tissue diphtheria, unspecified bacteremia esophageal reflux other and unspecified infection due to central venous catheter adrenal cortical steroids causing adverse effects in therapeutic use degenerative skin disorders osteoporosis, unspecified pathologic fracture of vertebrae esophageal reflux chronic kidney disease, stage iii (moderate) other chronic pulmonary heart diseases systemic lupus erythematosus long-term (current) use of steroids pneumococcal pneumonia [streptococcus pneumoniae pneumonia] other specified diffuse diseases of connective tissue acute pericarditis, unspecified candidiasis of mouth anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified anemia, unspecified esophageal reflux unspecified essential hypertension degenerative skin disorders other specified diffuse diseases of connective tissue barrett's esophagus candidal esophagitis abdominal pain, other specified site diarrhea diaphragmatic hernia without mention of obstruction or gangrene anemia of other chronic disease
hispanic latino f 52 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  315  k ul; hematology blood platelet count  314  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  221  mg dl; chemistry blood glucose  134  mg dl$dextrose 5%  150  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol-ipratropium  1-2  puff ; multivitamins  1  cap ; ondansetron  4  mg ; amlodipine  10  mg ; atovaquone suspension  750  mg ; colchicine  0.6  mg ; folic acid  1  mg ; prednisone  10  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; vitamin d  400  unit ; famotidine  40  mg ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; calcium carbonate  500  mg ; omeprazole  40  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; levofloxacin  750  mg ; methylprednisolone sodium succ  125  mg ; furosemide  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; acetaminophen  325-650  mg ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; sw  100  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; lidocaine 5% patch  1  ptch ; prednisone  20  mg ; potassium chloride  40  meq ; potassium chloride  80  meq ; 
acidosis osteoporosis, unspecified esophageal reflux other chronic pulmonary heart diseases postinflammatory pulmonary fibrosis systemic lupus erythematosus anemia of other chronic disease chronic kidney disease, unspecified degenerative skin disorders aseptic necrosis of head and neck of femur dehydration acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified iridocyclitis unspecified essential hypertension aseptic necrosis of head and neck of femur other specified diffuse diseases of connective tissue diphtheria, unspecified bacteremia esophageal reflux other and unspecified infection due to central venous catheter adrenal cortical steroids causing adverse effects in therapeutic use degenerative skin disorders osteoporosis, unspecified pathologic fracture of vertebrae esophageal reflux chronic kidney disease, stage iii (moderate) other chronic pulmonary heart diseases systemic lupus erythematosus long-term (current) use of steroids pneumococcal pneumonia [streptococcus pneumoniae pneumonia] other specified diffuse diseases of connective tissue acute pericarditis, unspecified candidiasis of mouth anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified anemia, unspecified esophageal reflux unspecified essential hypertension degenerative skin disorders other specified diffuse diseases of connective tissue barrett's esophagus candidal esophagitis abdominal pain, other specified site diarrhea diaphragmatic hernia without mention of obstruction or gangrene anemia of other chronic disease
hispanic latino f 52 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  320  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol-ipratropium  1-2  puff ; multivitamins  1  cap ; ondansetron  4  mg ; amlodipine  10  mg ; atovaquone suspension  750  mg ; folic acid  1  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; vitamin d  400  unit ; famotidine  40  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; omeprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  325-650  mg ; lidocaine 5% patch  1  ptch ; prednisone  20  mg ; heparin  5000  unit ; atovaquone suspension  1500  mg ; oxycodone (immediate release)   2.5  mg ; 
acidosis osteoporosis, unspecified esophageal reflux other chronic pulmonary heart diseases postinflammatory pulmonary fibrosis systemic lupus erythematosus anemia of other chronic disease chronic kidney disease, unspecified degenerative skin disorders aseptic necrosis of head and neck of femur dehydration acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified iridocyclitis unspecified essential hypertension aseptic necrosis of head and neck of femur other specified diffuse diseases of connective tissue diphtheria, unspecified bacteremia esophageal reflux other and unspecified infection due to central venous catheter adrenal cortical steroids causing adverse effects in therapeutic use degenerative skin disorders osteoporosis, unspecified pathologic fracture of vertebrae esophageal reflux chronic kidney disease, stage iii (moderate) other chronic pulmonary heart diseases systemic lupus erythematosus long-term (current) use of steroids pneumococcal pneumonia [streptococcus pneumoniae pneumonia] other specified diffuse diseases of connective tissue acute pericarditis, unspecified candidiasis of mouth anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified anemia, unspecified esophageal reflux unspecified essential hypertension degenerative skin disorders other specified diffuse diseases of connective tissue barrett's esophagus candidal esophagitis abdominal pain, other specified site diarrhea diaphragmatic hernia without mention of obstruction or gangrene anemia of other chronic disease
hispanic latino f 52 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol-ipratropium  1-2  puff ; multivitamins  1  cap ; ondansetron  4  mg ; amlodipine  10  mg ; folic acid  1  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; vitamin d  400  unit ; famotidine  40  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; omeprazole  40  mg ; acetaminophen  325-650  mg ; lidocaine 5% patch  1  ptch ; prednisone  20  mg ; heparin  5000  unit ; atovaquone suspension  1500  mg ; calcium gluconate  4  g ; 
acidosis osteoporosis, unspecified esophageal reflux other chronic pulmonary heart diseases postinflammatory pulmonary fibrosis systemic lupus erythematosus anemia of other chronic disease chronic kidney disease, unspecified degenerative skin disorders aseptic necrosis of head and neck of femur dehydration acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified iridocyclitis unspecified essential hypertension aseptic necrosis of head and neck of femur other specified diffuse diseases of connective tissue diphtheria, unspecified bacteremia esophageal reflux other and unspecified infection due to central venous catheter adrenal cortical steroids causing adverse effects in therapeutic use degenerative skin disorders osteoporosis, unspecified pathologic fracture of vertebrae esophageal reflux chronic kidney disease, stage iii (moderate) other chronic pulmonary heart diseases systemic lupus erythematosus long-term (current) use of steroids pneumococcal pneumonia [streptococcus pneumoniae pneumonia] other specified diffuse diseases of connective tissue acute pericarditis, unspecified candidiasis of mouth anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified anemia, unspecified esophageal reflux unspecified essential hypertension degenerative skin disorders other specified diffuse diseases of connective tissue barrett's esophagus candidal esophagitis abdominal pain, other specified site diarrhea diaphragmatic hernia without mention of obstruction or gangrene anemia of other chronic disease
hispanic latino f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol-ipratropium  1-2  puff ; multivitamins  1  cap ; ondansetron  4  mg ; amlodipine  10  mg ; folic acid  1  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; vitamin d  400  unit ; famotidine  40  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; omeprazole  40  mg ; acetaminophen  325-650  mg ; lidocaine 5% patch  1  ptch ; prednisone  20  mg ; heparin  5000  unit ; atovaquone suspension  1500  mg ; calcium gluconate  4  g ; 
acidosis osteoporosis, unspecified esophageal reflux other chronic pulmonary heart diseases postinflammatory pulmonary fibrosis systemic lupus erythematosus anemia of other chronic disease chronic kidney disease, unspecified degenerative skin disorders aseptic necrosis of head and neck of femur dehydration acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified iridocyclitis unspecified essential hypertension aseptic necrosis of head and neck of femur other specified diffuse diseases of connective tissue diphtheria, unspecified bacteremia esophageal reflux other and unspecified infection due to central venous catheter adrenal cortical steroids causing adverse effects in therapeutic use degenerative skin disorders osteoporosis, unspecified pathologic fracture of vertebrae esophageal reflux chronic kidney disease, stage iii (moderate) other chronic pulmonary heart diseases systemic lupus erythematosus long-term (current) use of steroids pneumococcal pneumonia [streptococcus pneumoniae pneumonia] other specified diffuse diseases of connective tissue acute pericarditis, unspecified candidiasis of mouth anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified anemia, unspecified esophageal reflux unspecified essential hypertension degenerative skin disorders other specified diffuse diseases of connective tissue barrett's esophagus candidal esophagitis abdominal pain, other specified site diarrhea diaphragmatic hernia without mention of obstruction or gangrene anemia of other chronic disease
white m 55 $nan$nan$d5w  50  ml ; ondansetron  24  mg ; folic acid  1  mg ; lisinopril  30  mg ; 
 
white m 55 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  88  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  202  iu l; chemistry blood albumin  3.7  g dl$d5w  50  ml ; ondansetron  24  mg ; folic acid  1  mg ; lisinopril  30  mg ; heparin flush cvl  (100 units ml)  1  ml ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; mitoxantrone hcl  16  mg ; ns  500  ml ; etoposide  200  mg ; cytarabine  2000  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; ns  1000  ml ; prednisolone acetate 1% ophth. susp.  2  drop ; heparin flush (10 units ml)  2  ml ; 
 
white m 55 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  68  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, indirect  0.9  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  111  mg dl; chemistry blood lactate dehydrogenase (ld)  197  iu l; chemistry blood albumin  3.7  g dl; chemistry blood bilirubin, direct  0.2  mg dl$d5w  50  ml ; ondansetron  24  mg ; folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; mitoxantrone hcl  16  mg ; ns  500  ml ; etoposide  200  mg ; cytarabine  2000  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; prednisolone acetate 1% ophth. susp.  2  drop ; heparin flush (10 units ml)  2  ml ; 
 
white m 55 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, indirect  0.7  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  166  iu l; chemistry blood albumin  3.4  g dl; chemistry blood bilirubin, direct  0.2  mg dl$d5w  50  ml ; ondansetron  24  mg ; folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; mitoxantrone hcl  16  mg ; ns  500  ml ; etoposide  200  mg ; cytarabine  2000  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; prednisolone acetate 1% ophth. susp.  2  drop ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; dexamethasone  10  mg ; 
 
white m 55 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  48  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  156  mg dl; chemistry blood lactate dehydrogenase (ld)  189  iu l; chemistry blood albumin  3.7  g dl$d5w  50  ml ; ondansetron  24  mg ; folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; mitoxantrone hcl  16  mg ; ns  500  ml ; etoposide  200  mg ; cytarabine  2000  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; prednisolone acetate 1% ophth. susp.  2  drop ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; dexamethasone  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white m 55 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  37  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  163  mg dl; chemistry blood lactate dehydrogenase (ld)  171  iu l; chemistry blood albumin  3.6  g dl$d5w  50  ml ; ondansetron  24  mg ; folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; mitoxantrone hcl  16  mg ; ns  500  ml ; etoposide  200  mg ; cytarabine  2000  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; prednisolone acetate 1% ophth. susp.  2  drop ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; dexamethasone  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white m 55 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  27  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  116  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l; chemistry blood albumin  3.5  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; mitoxantrone hcl  16  mg ; ns  500  ml ; etoposide  200  mg ; cytarabine  2000  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; prednisolone acetate 1% ophth. susp.  2  drop ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  250  ml ; potassium phosphate  15  mmol ; voriconazole  200  mg ; 
 
white m 55 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  17  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  155  iu l; chemistry blood albumin  3.6  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; prednisolone acetate 1% ophth. susp.  2  drop ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  250  ml ; potassium phosphate  15  mmol ; voriconazole  200  mg ; 
 
white m 55 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  16  k ul; hematology blood platelet count  37  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, indirect  1.1  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  137  iu l; chemistry blood albumin  3.8  g dl; chemistry blood bilirubin, direct  0.3  mg dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; prednisolone acetate 1% ophth. susp.  2  drop ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  250  ml ; potassium phosphate  15  mmol ; voriconazole  200  mg ; acetaminophen  650  mg ; 
 
white m 55 $nan$hematology blood hematocrit  25.7  %; hematology blood hematocrit  25.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  106  k ul; hematology blood platelet count  80  k ul; hematology blood platelet count  97  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  123  mg dl; chemistry blood lactate dehydrogenase (ld)  135  iu l; chemistry blood albumin  3.9  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  250  ml ; potassium phosphate  15  mmol ; acetaminophen  650  mg ; diphenhydramine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  126  iu l; chemistry blood albumin  3.9  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  250  ml ; potassium phosphate  15  mmol ; diphenhydramine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  62  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  113  iu l; chemistry blood albumin  3.9  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; 
 
white m 55 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  107  mg dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; 
 
white m 55 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  34  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  103  iu l; chemistry blood albumin  3.6  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; 
 
white m 55 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  23  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  144  mg dl; chemistry blood lactate dehydrogenase (ld)  129  iu l; chemistry blood albumin  3.8  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ciprofloxacin hcl  500  mg ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; iso-osmotic dextrose  200  ml ; sarna lotion  1  appl ; 
 
white m 55 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  114  iu l; chemistry blood albumin  3.5  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; iso-osmotic dextrose  200  ml ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  31  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  124  iu l; chemistry blood albumin  3.6  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; iso-osmotic dextrose  200  ml ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  22  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  123  iu l; chemistry blood albumin  3.6  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; iso-osmotic dextrose  200  ml ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  10  k ul; hematology blood platelet count  46  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  105  iu l; chemistry blood albumin  3.7  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; iso-osmotic dextrose  200  ml ; sarna lotion  1  appl ; hydroxyzine  25  mg ; ns  1000  ml ; 
 
white m 55 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  43  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  114  iu l; chemistry blood albumin  3.9  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; iso-osmotic dextrose  200  ml ; sarna lotion  1  appl ; hydroxyzine  25  mg ; ns  1000  ml ; 
 
white m 55 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  32  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  111  mg dl; chemistry blood lactate dehydrogenase (ld)  110  iu l; chemistry blood albumin  4.0  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; ns  1000  ml ; 
 
white m 55 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  26  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  128  mg dl; chemistry blood lactate dehydrogenase (ld)  105  iu l; chemistry blood albumin  3.7  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; ns  1000  ml ; 
 
white m 55 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  21  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  111  mg dl; chemistry blood lactate dehydrogenase (ld)  109  iu l; chemistry blood albumin  3.9  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  10  k ul; hematology blood platelet count  62  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  111  iu l; chemistry blood albumin  3.9  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  47  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  121  mg dl; chemistry blood lactate dehydrogenase (ld)  114  iu l; chemistry blood albumin  4.1  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  29  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  133  mg dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  30  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  114  iu l; chemistry blood albumin  4.1  g dl; hematology blood bands  0  %$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  26  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  128  mg dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  25  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  132  mg dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  42  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  123  iu l; chemistry blood albumin  4.2  g dl; hematology blood bands  0  %$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  42  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  99  mg dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  39  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  116  mg dl; chemistry blood lactate dehydrogenase (ld)  137  iu l; hematology blood bands  0  %$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  116  iu l; chemistry blood albumin  4.4  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  68  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  133  mg dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  69  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  142  iu l; chemistry blood albumin  4.0  g dl$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; d5w  50  ml ; aztreonam  1000  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 55 $nan$nan$folic acid  1  mg ; lisinopril  30  mg ; clobetasol propionate 0.05% cream  1  appl ; lorazepam  0.5-2  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; ns  250  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; sarna lotion  1  appl ; hydroxyzine  25  mg ; 
 
white m 73 $nan$nan$fondaparinux  2.5  mg ; citalopram  20  mg ; docusate sodium (liquid)  50  mg ; 
iatrogenic cerebrovascular infarction or hemorrhage personal history of traumatic fracture pneumonitis due to inhalation of food or vomitus drug induced neutropenia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use ostium secundum type atrial septal defect cerebral embolism with cerebral infarction severe sepsis acute kidney failure, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other fluid overload chickenpox with other specified complications surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of traumatic brain injury knee joint replacement herpes zoster with other nervous system complications other tracheostomy complications persistent vomiting unspecified protein-calorie malnutrition diarrhea fever presenting with conditions classified elsewhere acute venous embolism and thrombosis of deep vessels of distal lower extremity esophageal reflux unspecified septicemia secondary malignant neoplasm of other specified sites paroxysmal ventricular tachycardia passenger of special construction vehicle injured in traffic accident malignant neoplasm of other specified sites of hypopharynx antineoplastic chemotherapy induced pancytopenia body mass index between 19-24, adult mucositis (ulcerative) due to antineoplastic therapy other and unspecified hyperlipidemia hyperosmolality and/or hypernatremia unspecified vascular insufficiency of intestine diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
white m 73 $temp  98.5  heartrate  74.0  resprate  16.0  o2sat  96.0  sbp  122.0  dbp  70.0  rhythm    pain  0  $hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  88  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  104  mg dl$fondaparinux  2.5  mg ; citalopram  20  mg ; docusate sodium (liquid)  50  mg ; risperidone oral solution  1  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; lactated ringers  1000  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; trazodone  25  mg ; insulin  0  unit ; 
iatrogenic cerebrovascular infarction or hemorrhage personal history of traumatic fracture pneumonitis due to inhalation of food or vomitus drug induced neutropenia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use ostium secundum type atrial septal defect cerebral embolism with cerebral infarction severe sepsis acute kidney failure, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other fluid overload chickenpox with other specified complications surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of traumatic brain injury knee joint replacement herpes zoster with other nervous system complications other tracheostomy complications persistent vomiting unspecified protein-calorie malnutrition diarrhea fever presenting with conditions classified elsewhere acute venous embolism and thrombosis of deep vessels of distal lower extremity esophageal reflux unspecified septicemia secondary malignant neoplasm of other specified sites paroxysmal ventricular tachycardia passenger of special construction vehicle injured in traffic accident malignant neoplasm of other specified sites of hypopharynx antineoplastic chemotherapy induced pancytopenia body mass index between 19-24, adult mucositis (ulcerative) due to antineoplastic therapy other and unspecified hyperlipidemia hyperosmolality and/or hypernatremia unspecified vascular insufficiency of intestine diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
white m 73 $nan$nan$fondaparinux  2.5  mg ; citalopram  20  mg ; docusate sodium (liquid)  50  mg ; risperidone oral solution  1  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; lactated ringers  1000  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; trazodone  25  mg ; insulin  0  unit ; 
iatrogenic cerebrovascular infarction or hemorrhage personal history of traumatic fracture pneumonitis due to inhalation of food or vomitus drug induced neutropenia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use ostium secundum type atrial septal defect cerebral embolism with cerebral infarction severe sepsis acute kidney failure, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other fluid overload chickenpox with other specified complications surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of traumatic brain injury knee joint replacement herpes zoster with other nervous system complications other tracheostomy complications persistent vomiting unspecified protein-calorie malnutrition diarrhea fever presenting with conditions classified elsewhere acute venous embolism and thrombosis of deep vessels of distal lower extremity esophageal reflux unspecified septicemia secondary malignant neoplasm of other specified sites paroxysmal ventricular tachycardia passenger of special construction vehicle injured in traffic accident malignant neoplasm of other specified sites of hypopharynx antineoplastic chemotherapy induced pancytopenia body mass index between 19-24, adult mucositis (ulcerative) due to antineoplastic therapy other and unspecified hyperlipidemia hyperosmolality and/or hypernatremia unspecified vascular insufficiency of intestine diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
white f 66 $temp  97.7  heartrate  60.0  resprate  24.0  o2sat  100.0  sbp  89.0  dbp  36.0  rhythm    pain  0  $hematology blood hematocrit  23.3  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  141  k ul; hematology blood platelet count  105  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  3.9  ; hematology blood inr(pt)  2.7  ; hematology blood inr(pt)  2.5  ; chemistry urine chloride, urine  10  meq l; chemistry urine creatinine, urine  102  mg dl; chemistry urine potassium, urine  44  meq l; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  4.3  mg dl; chemistry blood glucose  296  mg dl; chemistry blood albumin  2.1  g dl; blood gas blood free calcium  1.00  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood lactate  3.7  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood lactate  4.1  mmol l; blood gas blood lactate  4.1  mmol l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  250  ml ; azithromycin   500  mg ; fludrocortisone acetate  0.3  mg ; midodrine  15  mg ; sodium chloride 0.9%  1000  ml ; aspirin  81  mg ; lactulose  30  ml ; levothyroxine sodium  150  mcg ; multivitamins w minerals  1  tab ; nystatin oral suspension  5  ml ; omeprazole  20  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; topiramate (topamax)  50  mg ; sertraline  100  mg ; insulin  0  unit ; primidone  100  mg ; ondansetron  4  mg ; norepinephrine  8  mg ; 5% dextrose  50  ml ; phytonadione  5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
 
white f 66 $nan$hematology blood hematocrit  22.8  %; hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  90  k ul; hematology blood platelet count  92  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  4.7  mg dl; chemistry blood glucose  306  mg dl; chemistry blood glucose  265  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  250  ml ; azithromycin   500  mg ; fludrocortisone acetate  0.3  mg ; midodrine  15  mg ; sodium chloride 0.9%  1000  ml ; aspirin  81  mg ; levothyroxine sodium  150  mcg ; multivitamins w minerals  1  tab ; nystatin oral suspension  5  ml ; omeprazole  20  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; topiramate (topamax)  50  mg ; sertraline  100  mg ; insulin  0  unit ; primidone  100  mg ; ondansetron  4  mg ; norepinephrine  8  mg ; 5% dextrose  50  ml ; phytonadione  5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; lactulose enema  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; micafungin  100  mg ; lidocaine jelly 2% (urojet)  1  appl ; sodium chloride 0.9%  flush  3  ml ; 
 
white f 66 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  97  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  64  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  6.3  mg dl; chemistry blood glucose  319  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood potassium, whole blood  3.4  meq l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; fludrocortisone acetate  0.3  mg ; midodrine  15  mg ; aspirin  81  mg ; levothyroxine sodium  150  mcg ; multivitamins w minerals  1  tab ; nystatin oral suspension  5  ml ; omeprazole  20  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; topiramate (topamax)  50  mg ; sertraline  100  mg ; insulin  0  unit ; primidone  100  mg ; ondansetron  4  mg ; norepinephrine  8  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; lactulose enema  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; lidocaine jelly 2% (urojet)  1  appl ; sodium chloride 0.9%  flush  3  ml ; albumin 25% (12.5g   50ml)  12.5  g ; insulin  6  unit ; acetaminophen (liquid)  650  mg ; albuterol 0.083% neb soln  1  neb ; albumin 25% (12.5g   50ml)  50  g ; potassium chloride (powder)  60  meq ; ambisome  425  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; etomidate  10  mg ; succinylcholine  100  mg ; propofol  1000  mg ; propofol  200  mg ; 5% dextrose  225  ml ; ambisome  450  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; phenylephrine  60  mg ; 
 
white f 66 $nan$hematology blood hematocrit  21.3  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  68  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  64  mg dl; chemistry blood urea nitrogen  67  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, indirect  3.0  mg dl; chemistry blood bilirubin, total  6.7  mg dl; chemistry blood glucose  306  mg dl; chemistry blood glucose  296  mg dl; chemistry blood glucose  310  mg dl; chemistry blood lactate dehydrogenase (ld)  585  iu l; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.8  mmol l; chemistry blood bilirubin, direct  3.7  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; fludrocortisone acetate  0.3  mg ; midodrine  15  mg ; aspirin  81  mg ; levothyroxine sodium  150  mcg ; multivitamins w minerals  1  tab ; nystatin oral suspension  5  ml ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; topiramate (topamax)  50  mg ; sertraline  100  mg ; insulin  0  unit ; primidone  100  mg ; ondansetron  4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  3  ml ; albumin 25% (12.5g   50ml)  12.5  g ; insulin  6  unit ; acetaminophen (liquid)  650  mg ; albuterol 0.083% neb soln  1  neb ; albumin 25% (12.5g   50ml)  50  g ; potassium chloride (powder)  60  meq ; soln  50  ml ; fentanyl citrate  2.5  mg ; etomidate  10  mg ; succinylcholine  100  mg ; propofol  1000  mg ; propofol  200  mg ; 5% dextrose  225  ml ; ambisome  450  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; phenylephrine  60  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 
 
white f 66 $nan$hematology blood hematocrit  22.2  %; hematology blood hematocrit  26.4  %; hematology blood hematocrit  28.0  %; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  47  k ul; hematology blood platelet count  56  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood urea nitrogen  71  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, indirect  3.3  mg dl; chemistry blood bilirubin, total  8.0  mg dl; chemistry blood glucose  246  mg dl; chemistry blood glucose  242  mg dl; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  2.8  mmol l; chemistry blood bilirubin, direct  4.7  mg dl; hematology urine bilirubin  mod  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; fludrocortisone acetate  0.3  mg ; midodrine  15  mg ; aspirin  81  mg ; levothyroxine sodium  150  mcg ; nystatin oral suspension  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; topiramate (topamax)  50  mg ; sertraline  100  mg ; insulin  0  unit ; primidone  100  mg ; ondansetron  4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  3  ml ; insulin  6  unit ; acetaminophen (liquid)  650  mg ; albuterol 0.083% neb soln  1  neb ; soln  50  ml ; fentanyl citrate  2.5  mg ; 5% dextrose  225  ml ; ambisome  450  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; phenylephrine  60  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; furosemide  40  mg ; furosemide  250  mg ; insulin  12  unit ; metoprolol tartrate  5  mg ; diltiazem  15  mg ; diltiazem  20  mg ; diltiazem  30  mg ; diltiazem  60  mg ; lactated ringers  1000  ml ; lansoprazole oral disintegrating tab  30  mg ; multivitamins  5  ml ; furosemide  80  mg ; 5% dextrose  100  ml ; diltiazem  125  mg ; albumin 25% (12.5g   50ml)  75  g ; 
 
white f 66 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  49  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  74  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, indirect  3.4  mg dl; chemistry blood bilirubin, total  8.5  mg dl; chemistry blood glucose  317  mg dl; blood gas blood free calcium  1.22  mmol l; blood gas blood lactate  2.7  mmol l; chemistry blood bilirubin, direct  5.1  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; fludrocortisone acetate  0.3  mg ; aspirin  81  mg ; levothyroxine sodium  150  mcg ; nystatin oral suspension  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; topiramate (topamax)  50  mg ; sertraline  100  mg ; insulin  0  unit ; primidone  100  mg ; ondansetron  4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  3  ml ; insulin  6  unit ; acetaminophen (liquid)  650  mg ; albuterol 0.083% neb soln  1  neb ; soln  50  ml ; fentanyl citrate  2.5  mg ; 5% dextrose  225  ml ; ambisome  450  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; furosemide  40  mg ; insulin  12  unit ; metoprolol tartrate  5  mg ; diltiazem  15  mg ; diltiazem  20  mg ; diltiazem  30  mg ; lansoprazole oral disintegrating tab  30  mg ; multivitamins  5  ml ; 5% dextrose  100  ml ; diltiazem  125  mg ; albumin 25% (12.5g   50ml)  75  g ; sodium chloride 3% (hypertonic)  500  ml ; soln.  500  ml ; mannitol 20 %  100  g ; d5w  300  ml ; linezolid  600  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; 
 
white f 66 $nan$hematology blood hematocrit  21.1  %; hematology blood hematocrit  23.6  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  46  k ul; hematology blood platelet count  39  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  75  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, indirect  3.2  mg dl; chemistry blood bilirubin, total  7.2  mg dl; chemistry blood glucose  285  mg dl; chemistry blood lactate dehydrogenase (ld)  387  iu l; chemistry blood albumin  2.8  g dl; blood gas blood free calcium  1.34  mmol l; blood gas blood lactate  2.5  mmol l; chemistry blood bilirubin, direct  4.0  mg dl$bag  500  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; fludrocortisone acetate  0.3  mg ; aspirin  81  mg ; levothyroxine sodium  150  mcg ; nystatin oral suspension  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; topiramate (topamax)  50  mg ; insulin  0  unit ; primidone  100  mg ; ondansetron  4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  3  ml ; insulin  6  unit ; acetaminophen (liquid)  650  mg ; albuterol 0.083% neb soln  1  neb ; 5% dextrose  225  ml ; ambisome  450  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; insulin  12  unit ; lansoprazole oral disintegrating tab  30  mg ; multivitamins  5  ml ; 5% dextrose  100  ml ; diltiazem  125  mg ; sodium chloride 3% (hypertonic)  500  ml ; soln.  500  ml ; mannitol 20 %  100  g ; d5w  300  ml ; linezolid  600  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; insulin  15  unit ; insulin  18  unit ; sertraline  50  mg ; insulin  4  unit ; artificial tears  1-2  drop ; levothyroxine sodium  75  mcg ; furosemide  60  mg ; 
 
white f 66 $nan$hematology blood hematocrit  22.5  %; hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  32  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  76  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  5.8  mg dl; chemistry blood glucose  248  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; fludrocortisone acetate  0.3  mg ; aspirin  81  mg ; levothyroxine sodium  150  mcg ; nystatin oral suspension  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; ondansetron  4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  3  ml ; insulin  6  unit ; acetaminophen (liquid)  650  mg ; albuterol 0.083% neb soln  1  neb ; 5% dextrose  225  ml ; ambisome  450  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; insulin  12  unit ; lansoprazole oral disintegrating tab  30  mg ; multivitamins  5  ml ; insulin  15  unit ; insulin  18  unit ; sertraline  50  mg ; insulin  4  unit ; artificial tears  1-2  drop ; levothyroxine sodium  75  mcg ; furosemide  60  mg ; insulin  22  unit ; sterile water  200  ml ; potassium chloride  80  meq ; acetaminophen iv  1000  mg ; 
 
white f 66 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  39  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  74  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  4.8  mg dl; chemistry blood glucose  175  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; fludrocortisone acetate  0.3  mg ; aspirin  81  mg ; nystatin oral suspension  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; ondansetron  4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  6  unit ; acetaminophen (liquid)  650  mg ; albuterol 0.083% neb soln  1  neb ; 5% dextrose  225  ml ; ambisome  450  mg ; insulin  12  unit ; lansoprazole oral disintegrating tab  30  mg ; multivitamins  5  ml ; insulin  15  unit ; insulin  18  unit ; artificial tears  1-2  drop ; insulin  22  unit ; sterile water  200  ml ; potassium chloride  80  meq ; acetaminophen iv  1000  mg ; morphine sulfate  1  mg ; morphine sulfate  1-2  mg ; hyoscyamine  0.125  mg ; lorazepam  0.5-2  mg ; 
 
white f 66 $nan$nan$ondansetron  4  mg ; acetaminophen (liquid)  650  mg ; artificial tears  1-2  drop ; morphine sulfate  1-2  mg ; hyoscyamine  0.125  mg ; lorazepam  0.5-2  mg ; glycopyrrolate  0.1  mg ; morphine sulfate  100  mg ; 
 
white f 66 $nan$nan$ondansetron  4  mg ; acetaminophen (liquid)  650  mg ; artificial tears  1-2  drop ; lorazepam  0.5-2  mg ; morphine sulfate  100  mg ; 
 
white m 56 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  122  mg dl$docusate sodium  100  mg ; atorvastatin  10  mg ; cyclobenzaprine  10  mg ; fluoxetine  20  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; senna  8.6  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; sumatriptan succinate  50  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diazepam  5  mg ; hydromorphone (dilaudid)  0.25  mg ; morphine sr (ms contin)  30  mg ; 
quadriplegia, unspecified degeneration of cervical intervertebral disc other chronic pain lumbago hemorrhage complicating a procedure unspecified disease of spinal cord other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hematoma complicating a procedure depressive disorder, not elsewhere classified 
white m 56 $nan$nan$docusate sodium  100  mg ; atorvastatin  10  mg ; fluoxetine  20  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; senna  8.6  mg ; sumatriptan succinate  50  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diazepam  5  mg ; hydromorphone (dilaudid)  0.25  mg ; morphine sr (ms contin)  30  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; 
quadriplegia, unspecified degeneration of cervical intervertebral disc other chronic pain lumbago hemorrhage complicating a procedure unspecified disease of spinal cord other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hematoma complicating a procedure depressive disorder, not elsewhere classified 
white m 56 $nan$nan$docusate sodium  100  mg ; atorvastatin  10  mg ; fluoxetine  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  8.6  mg ; sumatriptan succinate  50  mg ; diazepam  5  mg ; hydromorphone (dilaudid)  0.25  mg ; morphine sr (ms contin)  30  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; 
quadriplegia, unspecified degeneration of cervical intervertebral disc other chronic pain lumbago hemorrhage complicating a procedure unspecified disease of spinal cord other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hematoma complicating a procedure depressive disorder, not elsewhere classified 
unknown m 23 $nan$chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  115  mg dl; blood gas blood lactate  1.7  mmol l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; propofol  1000  mg ; propofol  200  mg ; propofol  100  mg ; heparin  5000  unit ; multivitamin iv  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1000  ml ; folic acid  1  mg ; 
 
black african american f 76 $temp    heartrate  71.0  resprate  16.0  o2sat  100.0  sbp    dbp    rhythm    pain    ; temp  98.6  heartrate  98.0  resprate  22.0  o2sat  100.0  sbp  133.0  dbp  68.0  rhythm    pain  0  ; temp  98.9  heartrate  77.0  resprate  22.0  o2sat  100.0  sbp  113.0  dbp  77.0  rhythm    pain  4  $nan$insulin  50  unit ; insulin  25  unit ; insulin  15  unit ; 
background diabetic retinopathy long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) acute on chronic diastolic heart failure alkalosis other dependence on machines, supplemental oxygen diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other specified disorders of skin other and unspecified hyperlipidemia long-term (current) use of insulin polyneuropathy in diabetes chronic obstructive asthma, unspecified diseases of tricuspid valve supraventricular premature beats asthma, unspecified type, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) morbid obesity anxiety state, unspecified family history of ischemic heart disease congestive heart failure, unspecified unspecified essential hypertension asthma, unspecified type, unspecified body mass index 45.0-49.9, adult metabolic encephalopathy do not resuscitate status obstructive sleep apnea (adult)(pediatric) pedal cycle driver injured in noncollision transport accident in nontraffic accident acute on chronic diastolic heart failure family history of diabetes mellitus family history of ischemic heart disease long-term (current) use of insulin person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident congestive heart failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified acute kidney failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object atrial fibrillation
black african american f 76 $temp  99.4  heartrate  85.0  resprate  21.0  o2sat  98.0  sbp  122.0  dbp  56.0  rhythm    pain  9  $hematology blood hematocrit  37.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  46  mg dl; hematology urine wbc  60  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  87  mg dl; blood gas blood lactate  2.7  mmol l; hematology urine glucose  300  mg dl$insulin  50  unit ; insulin  25  unit ; insulin  15  unit ; sodium chloride 0.9%  flush  3  ml ; amlodipine  5  mg ; aspirin  81  mg ; docusate sodium  100  mg ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (250 50)   1  inh ; gabapentin  800  mg ; ipratropium-albuterol neb  1  neb ; metoprolol succinate xl  50  mg ; heparin  5000  unit ; paroxetine  20  mg ; pravastatin  80  mg ; sarna lotion  1  appl ; torsemide  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; insulin  0  unit ; furosemide  100  mg ; trazodone  50  mg ; hydroxyzine  25  mg ; gabapentin  300  mg ; morphine sulfate  2-4  mg ; 
background diabetic retinopathy long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) acute on chronic diastolic heart failure alkalosis other dependence on machines, supplemental oxygen diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other specified disorders of skin other and unspecified hyperlipidemia long-term (current) use of insulin polyneuropathy in diabetes chronic obstructive asthma, unspecified diseases of tricuspid valve supraventricular premature beats asthma, unspecified type, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) morbid obesity anxiety state, unspecified family history of ischemic heart disease congestive heart failure, unspecified unspecified essential hypertension asthma, unspecified type, unspecified body mass index 45.0-49.9, adult metabolic encephalopathy do not resuscitate status obstructive sleep apnea (adult)(pediatric) pedal cycle driver injured in noncollision transport accident in nontraffic accident acute on chronic diastolic heart failure family history of diabetes mellitus family history of ischemic heart disease long-term (current) use of insulin person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident congestive heart failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified acute kidney failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object atrial fibrillation
black african american f 76 $nan$chemistry blood anion gap  10  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  223  mg dl; chemistry blood glucose  208  mg dl$insulin  25  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; paroxetine  20  mg ; pravastatin  80  mg ; sarna lotion  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; furosemide  100  mg ; trazodone  50  mg ; hydroxyzine  25  mg ; gabapentin  300  mg ; torsemide  60  mg ; 
background diabetic retinopathy long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) acute on chronic diastolic heart failure alkalosis other dependence on machines, supplemental oxygen diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other specified disorders of skin other and unspecified hyperlipidemia long-term (current) use of insulin polyneuropathy in diabetes chronic obstructive asthma, unspecified diseases of tricuspid valve supraventricular premature beats asthma, unspecified type, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) morbid obesity anxiety state, unspecified family history of ischemic heart disease congestive heart failure, unspecified unspecified essential hypertension asthma, unspecified type, unspecified body mass index 45.0-49.9, adult metabolic encephalopathy do not resuscitate status obstructive sleep apnea (adult)(pediatric) pedal cycle driver injured in noncollision transport accident in nontraffic accident acute on chronic diastolic heart failure family history of diabetes mellitus family history of ischemic heart disease long-term (current) use of insulin person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident congestive heart failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified acute kidney failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object atrial fibrillation
black african american f 76 $nan$chemistry blood anion gap  16  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  57  mg dl; chemistry urine creatinine, urine  131  mg dl; chemistry urine potassium, urine  80  meq l; chemistry urine sodium, urine  17  meq l; chemistry urine urea nitrogen, urine  329  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  216  mg dl; chemistry blood glucose  178  mg dl; blood gas blood lactate  3.2  mmol l$insulin  25  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; paroxetine  20  mg ; pravastatin  80  mg ; sarna lotion  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; trazodone  50  mg ; hydroxyzine  25  mg ; gabapentin  300  mg ; torsemide  60  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; capsaicin 0.025%  1  appl ; loratadine  10  mg ; ranitidine  150  mg ; 
background diabetic retinopathy long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) acute on chronic diastolic heart failure alkalosis other dependence on machines, supplemental oxygen diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other specified disorders of skin other and unspecified hyperlipidemia long-term (current) use of insulin polyneuropathy in diabetes chronic obstructive asthma, unspecified diseases of tricuspid valve supraventricular premature beats asthma, unspecified type, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) morbid obesity anxiety state, unspecified family history of ischemic heart disease congestive heart failure, unspecified unspecified essential hypertension asthma, unspecified type, unspecified body mass index 45.0-49.9, adult metabolic encephalopathy do not resuscitate status obstructive sleep apnea (adult)(pediatric) pedal cycle driver injured in noncollision transport accident in nontraffic accident acute on chronic diastolic heart failure family history of diabetes mellitus family history of ischemic heart disease long-term (current) use of insulin person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident congestive heart failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified acute kidney failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object atrial fibrillation
black african american f 76 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  347  mg dl; blood gas blood lactate  2.3  mmol l$insulin  25  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; paroxetine  20  mg ; pravastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; trazodone  50  mg ; gabapentin  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; capsaicin 0.025%  1  appl ; loratadine  10  mg ; ranitidine  150  mg ; insulin  30  unit ; 
background diabetic retinopathy long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) acute on chronic diastolic heart failure alkalosis other dependence on machines, supplemental oxygen diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other specified disorders of skin other and unspecified hyperlipidemia long-term (current) use of insulin polyneuropathy in diabetes chronic obstructive asthma, unspecified diseases of tricuspid valve supraventricular premature beats asthma, unspecified type, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) morbid obesity anxiety state, unspecified family history of ischemic heart disease congestive heart failure, unspecified unspecified essential hypertension asthma, unspecified type, unspecified body mass index 45.0-49.9, adult metabolic encephalopathy do not resuscitate status obstructive sleep apnea (adult)(pediatric) pedal cycle driver injured in noncollision transport accident in nontraffic accident acute on chronic diastolic heart failure family history of diabetes mellitus family history of ischemic heart disease long-term (current) use of insulin person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident congestive heart failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified acute kidney failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object atrial fibrillation
black african american f 76 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  94  mg dl; blood gas blood lactate  2.4  mmol l$insulin  25  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; paroxetine  20  mg ; pravastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; trazodone  50  mg ; gabapentin  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; loratadine  10  mg ; insulin  30  unit ; insulin  14  unit ; insulin  10  unit ; 
background diabetic retinopathy long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) acute on chronic diastolic heart failure alkalosis other dependence on machines, supplemental oxygen diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other specified disorders of skin other and unspecified hyperlipidemia long-term (current) use of insulin polyneuropathy in diabetes chronic obstructive asthma, unspecified diseases of tricuspid valve supraventricular premature beats asthma, unspecified type, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) morbid obesity anxiety state, unspecified family history of ischemic heart disease congestive heart failure, unspecified unspecified essential hypertension asthma, unspecified type, unspecified body mass index 45.0-49.9, adult metabolic encephalopathy do not resuscitate status obstructive sleep apnea (adult)(pediatric) pedal cycle driver injured in noncollision transport accident in nontraffic accident acute on chronic diastolic heart failure family history of diabetes mellitus family history of ischemic heart disease long-term (current) use of insulin person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident congestive heart failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified acute kidney failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object atrial fibrillation
black african american f 76 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  159  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; paroxetine  20  mg ; pravastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; trazodone  50  mg ; gabapentin  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; loratadine  10  mg ; insulin  30  unit ; insulin  10  unit ; 
background diabetic retinopathy long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) acute on chronic diastolic heart failure alkalosis other dependence on machines, supplemental oxygen diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other specified disorders of skin other and unspecified hyperlipidemia long-term (current) use of insulin polyneuropathy in diabetes chronic obstructive asthma, unspecified diseases of tricuspid valve supraventricular premature beats asthma, unspecified type, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) morbid obesity anxiety state, unspecified family history of ischemic heart disease congestive heart failure, unspecified unspecified essential hypertension asthma, unspecified type, unspecified body mass index 45.0-49.9, adult metabolic encephalopathy do not resuscitate status obstructive sleep apnea (adult)(pediatric) pedal cycle driver injured in noncollision transport accident in nontraffic accident acute on chronic diastolic heart failure family history of diabetes mellitus family history of ischemic heart disease long-term (current) use of insulin person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident congestive heart failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified acute kidney failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object atrial fibrillation
black african american f 76 $nan$chemistry blood anion gap  18  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  218  mg dl; chemistry blood glucose  69  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; paroxetine  20  mg ; pravastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; trazodone  50  mg ; gabapentin  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; loratadine  10  mg ; insulin  30  unit ; torsemide  40  mg ; 
background diabetic retinopathy long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) acute on chronic diastolic heart failure alkalosis other dependence on machines, supplemental oxygen diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other specified disorders of skin other and unspecified hyperlipidemia long-term (current) use of insulin polyneuropathy in diabetes chronic obstructive asthma, unspecified diseases of tricuspid valve supraventricular premature beats asthma, unspecified type, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) morbid obesity anxiety state, unspecified family history of ischemic heart disease congestive heart failure, unspecified unspecified essential hypertension asthma, unspecified type, unspecified body mass index 45.0-49.9, adult metabolic encephalopathy do not resuscitate status obstructive sleep apnea (adult)(pediatric) pedal cycle driver injured in noncollision transport accident in nontraffic accident acute on chronic diastolic heart failure family history of diabetes mellitus family history of ischemic heart disease long-term (current) use of insulin person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident congestive heart failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified acute kidney failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object atrial fibrillation
black african american f 76 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; paroxetine  20  mg ; pravastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; trazodone  50  mg ; gabapentin  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; loratadine  10  mg ; insulin  30  unit ; torsemide  40  mg ; 
background diabetic retinopathy long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) acute on chronic diastolic heart failure alkalosis other dependence on machines, supplemental oxygen diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other specified disorders of skin other and unspecified hyperlipidemia long-term (current) use of insulin polyneuropathy in diabetes chronic obstructive asthma, unspecified diseases of tricuspid valve supraventricular premature beats asthma, unspecified type, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) morbid obesity anxiety state, unspecified family history of ischemic heart disease congestive heart failure, unspecified unspecified essential hypertension asthma, unspecified type, unspecified body mass index 45.0-49.9, adult metabolic encephalopathy do not resuscitate status obstructive sleep apnea (adult)(pediatric) pedal cycle driver injured in noncollision transport accident in nontraffic accident acute on chronic diastolic heart failure family history of diabetes mellitus family history of ischemic heart disease long-term (current) use of insulin person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident congestive heart failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified acute kidney failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object atrial fibrillation
black african american f 76 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; paroxetine  20  mg ; pravastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; trazodone  50  mg ; gabapentin  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; loratadine  10  mg ; insulin  30  unit ; 
background diabetic retinopathy long-term (current) use of aspirin osteoarthrosis, unspecified whether generalized or localized, site unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) acute on chronic diastolic heart failure alkalosis other dependence on machines, supplemental oxygen diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other specified disorders of skin other and unspecified hyperlipidemia long-term (current) use of insulin polyneuropathy in diabetes chronic obstructive asthma, unspecified diseases of tricuspid valve supraventricular premature beats asthma, unspecified type, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) morbid obesity anxiety state, unspecified family history of ischemic heart disease congestive heart failure, unspecified unspecified essential hypertension asthma, unspecified type, unspecified body mass index 45.0-49.9, adult metabolic encephalopathy do not resuscitate status obstructive sleep apnea (adult)(pediatric) pedal cycle driver injured in noncollision transport accident in nontraffic accident acute on chronic diastolic heart failure family history of diabetes mellitus family history of ischemic heart disease long-term (current) use of insulin person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident congestive heart failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified acute kidney failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object atrial fibrillation
white m 21 $nan$hematology blood hematocrit  49.3  %; hematology blood hemoglobin  16.9  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  124  mg dl$nan
 
white m 21 $nan$hematology blood hematocrit  43.3  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  6  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  98  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; 
 
white m 21 $nan$hematology blood hematocrit  42.9  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; 
 
white f 34 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn second-degree perineal laceration, delivered, with or without mention of antepartum condition abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition
white f 34 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn second-degree perineal laceration, delivered, with or without mention of antepartum condition abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition
white f 34 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn second-degree perineal laceration, delivered, with or without mention of antepartum condition abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition
white f 73 $nan$hematology blood hematocrit  42.7  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  522  k ul; blood gas blood lactate  3.0  mmol l; blood gas blood chloride, whole blood  90  meq l; blood gas blood glucose  110  mg dl; blood gas blood hematocrit, calculated  40  %; blood gas blood hemoglobin  13.4  g dl; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood sodium, whole blood  130  meq l; blood gas blood calculated bicarbonate, whole blood  28  meq l$nan
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$hematology blood hematocrit  34  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  515  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  108  mg dl$0.45% sodium chloride  1000  ml ; hydrocortisone na succ.  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 0.9% sodium chloride  1000  ml ; acetaminophen  325  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; miconazole powder 2%  1  appl ; clindamycin  1  appl ; clopidogrel  75  mg ; lamotrigine  200  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lamotrigine  100  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  538  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  222  mg dl; chemistry blood albumin  3.4  g dl$hydrocortisone na succ.  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; acetaminophen  325  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; miconazole powder 2%  1  appl ; clindamycin  1  appl ; clopidogrel  75  mg ; lamotrigine  200  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lamotrigine  100  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  650  mg ; morphine sulfate  5  mg ; hydrocortisone na succ.  75  mg ; trazodone  12.5  mg ; lorazepam  0.5  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  505  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  146  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; miconazole powder 2%  1  appl ; clindamycin  1  appl ; clopidogrel  75  mg ; lamotrigine  200  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lamotrigine  100  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  650  mg ; morphine sulfate  5  mg ; hydrocortisone na succ.  75  mg ; trazodone  12.5  mg ; lorazepam  0.5  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocortisone na succ.  50  mg ; lorazepam  1  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  493  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  116  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; miconazole powder 2%  1  appl ; clindamycin  1  appl ; clopidogrel  75  mg ; lamotrigine  200  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lamotrigine  100  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  650  mg ; morphine sulfate  5  mg ; trazodone  12.5  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocortisone na succ.  50  mg ; lorazepam  1  mg ; hydrocortisone  10  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lorazepam  2  mg ; hydrocortisone  5  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  480  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  111  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; miconazole powder 2%  1  appl ; clindamycin  1  appl ; clopidogrel  75  mg ; lamotrigine  200  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lamotrigine  100  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  650  mg ; morphine sulfate  5  mg ; trazodone  12.5  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocortisone  10  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lorazepam  2  mg ; hydrocortisone  5  mg ; ibuprofen  400  mg ; acetaminophen  1000  mg ; pantoprazole  40  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  506  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  124  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; miconazole powder 2%  1  appl ; clindamycin  1  appl ; clopidogrel  75  mg ; lamotrigine  200  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lamotrigine  100  mg ; lidocaine 5% patch  1  ptch ; morphine sulfate  5  mg ; trazodone  12.5  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocortisone  10  mg ; lorazepam  2  mg ; hydrocortisone  5  mg ; ibuprofen  400  mg ; acetaminophen  1000  mg ; pantoprazole  40  mg ; vitamin d  400  unit ; morphine sr (ms contin)  15  mg ; ibuprofen  600  mg ; calcium carbonate  500  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$hematology urine wbc  19  # hpf$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; miconazole powder 2%  1  appl ; clindamycin  1  appl ; clopidogrel  75  mg ; lamotrigine  200  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lamotrigine  100  mg ; lidocaine 5% patch  1  ptch ; morphine sulfate  5  mg ; trazodone  12.5  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocortisone  10  mg ; lorazepam  2  mg ; hydrocortisone  5  mg ; acetaminophen  1000  mg ; pantoprazole  40  mg ; vitamin d  400  unit ; morphine sr (ms contin)  15  mg ; ibuprofen  600  mg ; calcium carbonate  500  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; miconazole powder 2%  1  appl ; clindamycin  1  appl ; clopidogrel  75  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lidocaine 5% patch  1  ptch ; morphine sulfate  5  mg ; trazodone  12.5  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocortisone  10  mg ; lorazepam  2  mg ; hydrocortisone  5  mg ; acetaminophen  1000  mg ; vitamin d  400  unit ; morphine sr (ms contin)  15  mg ; ibuprofen  600  mg ; calcium carbonate  500  mg ; alendronate sodium  70  mg ; sarna lotion  1  appl ; doxycycline hyclate  100  mg ; calcitonin salmon  200  unit ; ondansetron  4  mg ; clotrimazole cream  1  appl ; metformin (glucophage)  850  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  600  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  93  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; miconazole powder 2%  1  appl ; clopidogrel  75  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lidocaine 5% patch  1  ptch ; morphine sulfate  5  mg ; trazodone  12.5  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocortisone  10  mg ; lorazepam  2  mg ; hydrocortisone  5  mg ; acetaminophen  1000  mg ; vitamin d  400  unit ; morphine sr (ms contin)  15  mg ; ibuprofen  600  mg ; calcium carbonate  500  mg ; alendronate sodium  70  mg ; doxycycline hyclate  100  mg ; calcitonin salmon  200  unit ; ondansetron  4  mg ; clotrimazole cream  1  appl ; metformin (glucophage)  850  mg ; clobetasol propionate 0.05% ointment  1  appl ; hydroxyzine  25  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  121  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; clopidogrel  75  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lidocaine 5% patch  1  ptch ; morphine sulfate  5  mg ; trazodone  12.5  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocortisone  10  mg ; lorazepam  2  mg ; hydrocortisone  5  mg ; acetaminophen  1000  mg ; vitamin d  400  unit ; morphine sr (ms contin)  15  mg ; ibuprofen  600  mg ; calcium carbonate  500  mg ; alendronate sodium  70  mg ; calcitonin salmon  200  unit ; ondansetron  4  mg ; clotrimazole cream  1  appl ; metformin (glucophage)  850  mg ; clobetasol propionate 0.05% ointment  1  appl ; hydroxyzine  25  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 73 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  111  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; clopidogrel  75  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; lidocaine 5% patch  1  ptch ; morphine sulfate  5  mg ; trazodone  12.5  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocortisone  10  mg ; lorazepam  2  mg ; hydrocortisone  5  mg ; acetaminophen  1000  mg ; vitamin d  400  unit ; morphine sr (ms contin)  15  mg ; ibuprofen  600  mg ; calcium carbonate  500  mg ; alendronate sodium  70  mg ; calcitonin salmon  200  unit ; ondansetron  4  mg ; clotrimazole cream  1  appl ; metformin (glucophage)  850  mg ; clobetasol propionate 0.05% ointment  1  appl ; hydroxyzine  25  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other disorders of coccyx bipolar disorder, unspecified osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis bipolar disorder, unspecified panhypopituitarism epilepsy, unspecified, without mention of intractable epilepsy encephalopathy, unspecified acute kidney failure, unspecified other acne rash and other nonspecific skin eruption hyposmolality and/or hyponatremia unspecified acquired hypothyroidism urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled difficulty in walking osteoporosis, unspecified cushing's syndrome other and unspecified noninfectious gastroenteritis and colitis other chest pain abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peritoneal abscess unspecified acquired hypothyroidism colostomy status panhypopituitarism tobacco use disorder epilepsy, unspecified, without mention of intractable epilepsy bipolar disorder, unspecified abnormality of gait diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of trunk 
white f 84 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  162  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; trazodone  50  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; hydromorphone  20  mg ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.25  mg ; 
 
white f 84 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  108  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; trazodone  50  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; hydromorphone  20  mg ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  40  mg ; simvastatin  10  mg ; 
 
white f 84 $nan$hematology blood hematocrit  31.2  %; hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  227  k ul; hematology blood platelet count  243  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  122  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; trazodone  50  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  40  mg ; simvastatin  10  mg ; amoxicillin  500  mg ; 
 
white f 84 $nan$nan$multivitamins  1  cap ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; trazodone  50  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; enoxaparin sodium  40  mg ; simvastatin  10  mg ; amoxicillin  500  mg ; losartan potassium  100  mg ; 
 
asian f 36 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; 
second-degree perineal laceration, delivered, with or without mention of antepartum condition other forms of migraine, without mention of intractable migraine without mention of status migrainosus other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn elderly primigravida, delivered, with or without mention of antepartum condition post term pregnancy, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident thrombocytopenia, unspecified coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, antepartum condition or complication other forms of migraine, without mention of intractable migraine without mention of status migrainosus 
asian f 36 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; 
second-degree perineal laceration, delivered, with or without mention of antepartum condition other forms of migraine, without mention of intractable migraine without mention of status migrainosus other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn elderly primigravida, delivered, with or without mention of antepartum condition post term pregnancy, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident thrombocytopenia, unspecified coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, antepartum condition or complication other forms of migraine, without mention of intractable migraine without mention of status migrainosus 
asian f 36 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; 
second-degree perineal laceration, delivered, with or without mention of antepartum condition other forms of migraine, without mention of intractable migraine without mention of status migrainosus other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn elderly primigravida, delivered, with or without mention of antepartum condition post term pregnancy, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident thrombocytopenia, unspecified coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, antepartum condition or complication other forms of migraine, without mention of intractable migraine without mention of status migrainosus 
white m 68 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; 
 
white m 68 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  92  mg dl$pravastatin  80  mg ; aspirin ec  325  mg ; clopidogrel  75  mg ; d5w  1000  ml ; sodium bicarbonate  150  meq ; atropine sulfate  0.5  mg ; d5w  250  ml ; nitroglycerin  100  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; pantoprazole  40  mg ; heparin  5000  unit ; docusate sodium  100  mg ; carvedilol  12.5  mg ; ezetimibe  10  mg ; 
 
white f 59 $nan$nan$vitamin d  50,000  unit ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  124  mg dl; chemistry blood lactate dehydrogenase (ld)  458  iu l; hematology blood bands  0  %$vitamin d  50,000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; atovaquone suspension  1500  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fludrocortisone acetate  0.05  mg ; metoprolol tartrate  25  mg ; multivitamins  1  tab ; ondansetron  4  mg ; pantoprazole  40  mg ; prednisone  10  mg ; valganciclovir  450  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; neutra-phos  2  pkt ; lorazepam  0.25  mg ; lidocaine 1%  2  ml ; lactated ringers  1000  ml ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  131  mg dl; chemistry blood lactate dehydrogenase (ld)  419  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %$bag  1  bag ; vitamin d  50,000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; atovaquone suspension  1500  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fludrocortisone acetate  0.05  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; prednisone  10  mg ; valganciclovir  450  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; neutra-phos  2  pkt ; lorazepam  0.25  mg ; lidocaine 1%  2  ml ; lactated ringers  1000  ml ; multivitamins w minerals  1  tab ; vitamin b complex  1  cap ; 5% dextrose  250  ml ; thiamine  300  mg ; lorazepam  0.5  mg ; lidocaine 2%  10  ml ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  95  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  124  mg dl; chemistry blood lactate dehydrogenase (ld)  369  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %$bag  1  bag ; vitamin d  50,000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; atovaquone suspension  1500  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fludrocortisone acetate  0.05  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; prednisone  10  mg ; valganciclovir  450  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; lactated ringers  1000  ml ; multivitamins w minerals  1  tab ; vitamin b complex  1  cap ; 5% dextrose  250  ml ; thiamine  300  mg ; lorazepam  0.5  mg ; lidocaine 2%  10  ml ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  116  mg dl; chemistry blood lactate dehydrogenase (ld)  340  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  2  %$bag  1  bag ; vitamin d  50,000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; atovaquone suspension  1500  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fludrocortisone acetate  0.05  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; prednisone  10  mg ; valganciclovir  450  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; lactated ringers  1000  ml ; multivitamins w minerals  1  tab ; vitamin b complex  1  cap ; 5% dextrose  250  ml ; thiamine  300  mg ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; azithromycin  600  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  89  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  347  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %; hematology blood wbc count  2.3  k ul$bag  1  bag ; vitamin d  50,000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; atovaquone suspension  1500  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fludrocortisone acetate  0.05  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; prednisone  10  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; lactated ringers  1000  ml ; multivitamins w minerals  1  tab ; vitamin b complex  1  cap ; 5% dextrose  250  ml ; thiamine  300  mg ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; micafungin  100  mg ; valganciclovir  900  mg ; azithromycin  1200  mg ; micafungin  50  mg ; hydrocortisone na succ.  50  mg ; bag  200  ml ; gammagard liquid  20  g ; acetaminophen  650  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  75  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  143  mg dl; chemistry blood lactate dehydrogenase (ld)  413  iu l; chemistry blood albumin  2.7  g dl$bag  1  bag ; vitamin d  50,000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; atovaquone suspension  1500  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fludrocortisone acetate  0.05  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; prednisone  10  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; lactated ringers  1000  ml ; multivitamins w minerals  1  tab ; vitamin b complex  1  cap ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; valganciclovir  900  mg ; azithromycin  1200  mg ; micafungin  50  mg ; hydrocortisone na succ.  50  mg ; bag  200  ml ; gammagard liquid  20  g ; acetaminophen  650  mg ; lidocaine 2%  20  ml ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  86  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  413  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  1  %$bag  1  bag ; vitamin d  50,000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; atovaquone suspension  1500  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fludrocortisone acetate  0.05  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; prednisone  10  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; lactated ringers  1000  ml ; multivitamins w minerals  1  tab ; vitamin b complex  1  cap ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; valganciclovir  900  mg ; azithromycin  1200  mg ; micafungin  50  mg ; acetaminophen  650  mg ; lidocaine 2%  20  ml ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  84  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  142  mg dl; chemistry blood lactate dehydrogenase (ld)  413  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$bag  1  bag ; vitamin d  50,000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; atovaquone suspension  1500  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; fludrocortisone acetate  0.05  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; lactated ringers  1000  ml ; multivitamins w minerals  1  tab ; vitamin b complex  1  cap ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; valganciclovir  900  mg ; azithromycin  1200  mg ; micafungin  50  mg ; acetaminophen  650  mg ; methylprednisolone sodium succ  15  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; loperamide  2  mg ; syringe (sterile water)  6  ml ; pentamidine-inhalation  300  mg ; budesonide  3  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  135  mg dl; chemistry blood lactate dehydrogenase (ld)  321  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; loperamide  2  mg ; syringe (sterile water)  6  ml ; pentamidine-inhalation  300  mg ; methylprednisolone sodium succ  20  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  86  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  359  iu l; chemistry blood albumin  2.8  g dl; hematology blood bands  1  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; d5 1 2ns  1000  ml ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  471  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; d5 1 2ns  1000  ml ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  525  iu l; chemistry blood albumin  3.5  g dl; hematology blood bands  3  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; bottle  200  ml ; sodium chloride 0.9%  1000  ml ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  63  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry urine chloride, urine  99  meq l; chemistry urine creatinine, urine  6  mg dl; chemistry urine potassium, urine  9  meq l; chemistry urine sodium, urine  105  meq l; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  382  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; bottle  200  ml ; sodium chloride 0.9%  1000  ml ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  65  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry urine chloride, urine  67  meq l; chemistry urine creatinine, urine  8  mg dl; chemistry urine potassium, urine  16  meq l; chemistry urine sodium, urine  76  meq l; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  387  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  2  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; sodium chloride 0.9%  1000  ml ; methylprednisolone sodium succ  5  mg ; sodium chloride  1  gm ; methylprednisolone sodium succ  10  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  31.4  %; hematology blood hematocrit  29.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  91  k ul; hematology blood platelet count  67  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  452  iu l; chemistry blood lactate dehydrogenase (ld)  415  iu l; chemistry blood albumin  3.2  g dl; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %; hematology blood bands  3  %; blood gas blood lactate  0.9  mmol l$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; sodium chloride 0.9%  1000  ml ; methylprednisolone sodium succ  5  mg ; sodium chloride  1  gm ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; simethicone  40-80  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  65  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  88  mg dl; chemistry blood lactate dehydrogenase (ld)  359  iu l; chemistry blood albumin  2.9  g dl$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; sodium chloride 0.9%  1000  ml ; simethicone  40-80  mg ; clonazepam  0.25  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  65  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  418  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  1  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; sodium chloride 0.9%  1000  ml ; simethicone  40-80  mg ; clonazepam  0.25  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  55  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  464  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; sodium chloride 0.9%  1000  ml ; simethicone  40-80  mg ; clonazepam  0.25  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  56  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  439  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  9  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; sodium chloride 0.9%  1000  ml ; simethicone  40-80  mg ; clonazepam  0.25  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  384  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; sodium chloride 0.9%  1000  ml ; simethicone  40-80  mg ; clonazepam  0.25  mg ; methylprednisolone sodium succ  12.5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  85  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  371  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; simethicone  40-80  mg ; clonazepam  0.25  mg ; methylprednisolone sodium succ  12.5  mg ; multivitamins  5  ml ; dronabinol  2.5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  68  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  352  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  3  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; simethicone  40-80  mg ; clonazepam  0.25  mg ; methylprednisolone sodium succ  12.5  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  79  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  364  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; methylprednisolone sodium succ  11  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  66  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  282  iu l; chemistry blood albumin  2.7  g dl; hematology blood bands  0  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; methylprednisolone sodium succ  11  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  82  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  317  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; 5% dextrose  100  ml ; acyclovir  250  mg ; vial  1  vial ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; methylprednisolone sodium succ  11  mg ; acyclovir  400  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  72  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  265  iu l; chemistry blood albumin  2.8  g dl$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; micafungin  50  mg ; vial  1  vial ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; methylprednisolone sodium succ  11  mg ; acyclovir  400  mg ; fluconazole  400  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  68  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  244  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$bag  1  bag ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; vial  1  vial ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; methylprednisolone sodium succ  11  mg ; acyclovir  400  mg ; fluconazole  400  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  75  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; acyclovir  400  mg ; prednisone  4  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  82  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  186  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  1  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; acyclovir  400  mg ; prednisone  4  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  90  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  174  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; acyclovir  400  mg ; prednisone  4  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  90  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  127  mg dl; chemistry blood lactate dehydrogenase (ld)  179  iu l; chemistry blood albumin  3.2  g dl; hematology blood bands  1  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; acyclovir  400  mg ; prednisone  4  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  104  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  186  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  1  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; acyclovir  400  mg ; prednisone  4  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  97  mg dl; hematology blood bands  3  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; acyclovir  400  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  117  mg dl; chemistry blood lactate dehydrogenase (ld)  209  iu l; chemistry blood albumin  3.3  g dl; hematology blood bands  3  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  7.5  mg ; acyclovir  400  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  231  iu l; chemistry blood albumin  3.4  g dl; hematology blood bands  3  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; acyclovir  400  mg ; mirtazapine  15  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  228  iu l; chemistry blood albumin  3.2  g dl; hematology blood bands  2  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; acyclovir  400  mg ; mirtazapine  15  mg ; prednisone  7.5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  212  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; acyclovir  400  mg ; mirtazapine  15  mg ; prednisone  7.5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  184  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; acyclovir  400  mg ; mirtazapine  15  mg ; prednisone  7.5  mg ; bag  250  ml ; gammagard liquid  25  g ; fexofenadine  60  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  99  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  5.6  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine chloride, urine  225  meq l; chemistry urine sodium, urine  110  meq l; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  253  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; acyclovir  400  mg ; mirtazapine  15  mg ; prednisone  7.5  mg ; bag  250  ml ; gammagard liquid  25  g ; fexofenadine  60  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  74  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  221  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  9  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; acyclovir  400  mg ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  214  iu l; chemistry blood albumin  3.2  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; acyclovir  400  mg ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  149  mg dl; chemistry blood lactate dehydrogenase (ld)  197  iu l; chemistry blood albumin  3.0  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; acyclovir  400  mg ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  41  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  189  iu l; chemistry blood albumin  2.9  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; acyclovir  400  mg ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  57  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  239  iu l; chemistry blood albumin  3.5  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  39  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  182  iu l; chemistry blood albumin  3.0  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  54  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  209  iu l; chemistry blood albumin  3.2  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  32  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  185  iu l$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  69  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  223  iu l; chemistry blood albumin  3.5  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  40  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  202  iu l; chemistry blood albumin  3.2  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  58  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  217  iu l; chemistry blood albumin  3.2  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  60  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  223  iu l; hematology blood bands  1  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  207  iu l; chemistry blood albumin  3.2  g dl; hematology blood bands  0  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  47  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  178  iu l; chemistry blood albumin  3.0  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  49  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  124  mg dl; chemistry blood lactate dehydrogenase (ld)  189  iu l; chemistry blood albumin  3.1  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
white f 59 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  241  iu l; chemistry blood albumin  3.6  g dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; clonazepam  0.25  mg ; multivitamins  5  ml ; mirtazapine  15  mg ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; prednisone  5  mg ; 
complications of transplanted organ, stem cell urinary frequency chronic myeloid leukemia, without mention of having achieved remission cytomegaloviral disease antiviral drugs causing adverse effects in therapeutic use hyposmolality and/or hyponatremia leukocytopenia, unspecified chronic graft-versus-host disease diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids personal history of other malignant neoplasm of skin intestinal disaccharidase deficiencies and disaccharide malabsorption infectious mononucleosis other abnormal glucose other disorders of neurohypophysis personal history of other malignant neoplasm of skin complications of transplanted organ, stem cell unspecified vitamin d deficiency infectious mononucleosis immune thrombocytopenic purpura antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use rash and other nonspecific skin eruption chronic myeloid leukemia, in remission graft-versus-host disease, unspecified candidiasis of mouth antifungal antibiotics causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified essential hypertension other pancytopenia intussusception long-term (current) use of antibiotics viremia, unspecified drug-induced delirium personal history of antineoplastic chemotherapy peripheral stem cells replaced by transplant long-term (current) use of steroids toxic myopathy cytomegaloviral disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified cardiac dysrhythmias adrenal cortical steroids causing adverse effects in therapeutic use anxiety state, unspecified hypovolemia defibrination syndrome post-transplant lymphoproliferative disorder (ptld) solitary pulmonary nodule pneumonia, organism unspecified
asian m 42 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  112  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5  mg ; oxybutynin  5  mg ; belladonna & opium (16.2 30mg)  1  supp ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; 
 
asian m 42 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.5  mg ; oxybutynin  5  mg ; belladonna & opium (16.2 30mg)  1  supp ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  1000  ml ; 
 
black african american m 36 $nan$nan$polyethylene glycol  17  g ; 
diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis acute kidney failure, unspecified leukocytosis, unspecified alkalosis hyposmolality and/or hyponatremia long-term (current) use of insulin unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis unspecified essential hypertension constipation, unspecified tachycardia, unspecified unspecified essential hypertension gastroparesis long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled dehydration hyposmolality and/or hyponatremia benign essential hypertension anemia, unspecified long-term (current) use of insulin other, mixed, or unspecified drug abuse, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled person feigning illness person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident gastroparesis insomnia, unspecified gastroparesis constipation, unspecified hyposmolality and/or hyponatremia depressive disorder, not elsewhere classified acidosis diabetes with neurological manifestations, type i [juvenile type], uncontrolled unspecified essential hypertension hyposmolality and/or hyponatremia diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled unspecified essential hypertension gastroparesis anemia, unspecified 
black african american m 36 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  152  mg dl; chemistry blood lactate dehydrogenase (ld)  343  iu l; chemistry blood albumin  4.2  g dl; blood gas blood lactate  2.0  mmol l; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  11.4  g dl; hematology urine glucose  1000  mg dl; hematology urine bilirubin  neg  mg dl$polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  1  tab ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  500  ml ; insulin  18  unit ; metoclopramide  10  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.5-1  mg ; heparin  5000  unit ; d5 1 2ns  1000  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin flush (10 units ml)  2  ml ; 
diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis acute kidney failure, unspecified leukocytosis, unspecified alkalosis hyposmolality and/or hyponatremia long-term (current) use of insulin unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis unspecified essential hypertension constipation, unspecified tachycardia, unspecified unspecified essential hypertension gastroparesis long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled dehydration hyposmolality and/or hyponatremia benign essential hypertension anemia, unspecified long-term (current) use of insulin other, mixed, or unspecified drug abuse, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled person feigning illness person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident gastroparesis insomnia, unspecified gastroparesis constipation, unspecified hyposmolality and/or hyponatremia depressive disorder, not elsewhere classified acidosis diabetes with neurological manifestations, type i [juvenile type], uncontrolled unspecified essential hypertension hyposmolality and/or hyponatremia diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled unspecified essential hypertension gastroparesis anemia, unspecified 
black african american m 36 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  180  iu l; chemistry blood albumin  4.0  g dl$polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; insulin  18  unit ; metoclopramide  10  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.5-1  mg ; heparin  5000  unit ; d5 1 2ns  1000  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin flush (10 units ml)  2  ml ; insulin  36  unit ; bag  50  ml ; magnesium sulfate  2  gm ; 
diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis acute kidney failure, unspecified leukocytosis, unspecified alkalosis hyposmolality and/or hyponatremia long-term (current) use of insulin unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis unspecified essential hypertension constipation, unspecified tachycardia, unspecified unspecified essential hypertension gastroparesis long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled dehydration hyposmolality and/or hyponatremia benign essential hypertension anemia, unspecified long-term (current) use of insulin other, mixed, or unspecified drug abuse, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled person feigning illness person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident gastroparesis insomnia, unspecified gastroparesis constipation, unspecified hyposmolality and/or hyponatremia depressive disorder, not elsewhere classified acidosis diabetes with neurological manifestations, type i [juvenile type], uncontrolled unspecified essential hypertension hyposmolality and/or hyponatremia diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled unspecified essential hypertension gastroparesis anemia, unspecified 
black african american m 36 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  108  mg dl$polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; heparin flush (10 units ml)  2  ml ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; 
diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis acute kidney failure, unspecified leukocytosis, unspecified alkalosis hyposmolality and/or hyponatremia long-term (current) use of insulin unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis unspecified essential hypertension constipation, unspecified tachycardia, unspecified unspecified essential hypertension gastroparesis long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled dehydration hyposmolality and/or hyponatremia benign essential hypertension anemia, unspecified long-term (current) use of insulin other, mixed, or unspecified drug abuse, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled person feigning illness person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident gastroparesis insomnia, unspecified gastroparesis constipation, unspecified hyposmolality and/or hyponatremia depressive disorder, not elsewhere classified acidosis diabetes with neurological manifestations, type i [juvenile type], uncontrolled unspecified essential hypertension hyposmolality and/or hyponatremia diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled unspecified essential hypertension gastroparesis anemia, unspecified 
black african american m 36 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  86  mg dl$polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; heparin flush (10 units ml)  2  ml ; hydromorphone (dilaudid)  2-4  mg ; 
diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis acute kidney failure, unspecified leukocytosis, unspecified alkalosis hyposmolality and/or hyponatremia long-term (current) use of insulin unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis unspecified essential hypertension constipation, unspecified tachycardia, unspecified unspecified essential hypertension gastroparesis long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled dehydration hyposmolality and/or hyponatremia benign essential hypertension anemia, unspecified long-term (current) use of insulin other, mixed, or unspecified drug abuse, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled person feigning illness person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident gastroparesis insomnia, unspecified gastroparesis constipation, unspecified hyposmolality and/or hyponatremia depressive disorder, not elsewhere classified acidosis diabetes with neurological manifestations, type i [juvenile type], uncontrolled unspecified essential hypertension hyposmolality and/or hyponatremia diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled unspecified essential hypertension gastroparesis anemia, unspecified 
black african american f 89 $nan$nan$levothyroxine sodium  125  mcg ; hydrochlorothiazide  12.5  mg ; losartan potassium  50  mg ; metoprolol succinate xl  50  mg ; clopidogrel  75  mg ; aspirin  81  mg ; vitamin d  800  unit ; simvastatin  40  mg ; 
urinary tract infection, site not specified asthma, unspecified type, unspecified unspecified essential hypertension esophageal reflux unspecified fall dehydration closed fracture of one rib postsurgical hypothyroidism other specified metabolic disorders unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg other and unspecified hyperlipidemia asthma, unspecified type, unspecified esophageal reflux other and unspecified hyperlipidemia abnormality of gait old myocardial infarction altered mental status percutaneous transluminal coronary angioplasty status other specified analgesics and antipyretics causing adverse effects in therapeutic use rheumatoid arthritis disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma cardiac pacemaker in situ coronary atherosclerosis of native coronary artery unspecified essential hypertension asthma, unspecified type, unspecified disorder of bone and cartilage, unspecified generalized hyperhidrosis osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status esophageal reflux cardiac pacemaker in situ acute kidney failure, unspecified other chronic pain other postprocedural status depressive disorder, not elsewhere classified other and unspecified hyperlipidemia dehydration chills (without fever) old myocardial infarction disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma percutaneous transluminal coronary angioplasty status asthma, unspecified type, unspecified other and unspecified hyperlipidemia
black african american f 89 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  96  mg dl$levothyroxine sodium  125  mcg ; hydrochlorothiazide  12.5  mg ; losartan potassium  50  mg ; metoprolol succinate xl  50  mg ; clopidogrel  75  mg ; aspirin  81  mg ; vitamin d  800  unit ; simvastatin  40  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; fluticasone propionate nasal  1  spry ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; senna  1  tab ; acetaminophen  650  mg ; calcium carbonate  500  mg ; mirtazapine  15  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; aspirin  325  mg ; fluoxetine  40  mg ; losartan potassium  25  mg ; potassium chloride  20  meq ; ferrous sulfate  325  mg ; 
urinary tract infection, site not specified asthma, unspecified type, unspecified unspecified essential hypertension esophageal reflux unspecified fall dehydration closed fracture of one rib postsurgical hypothyroidism other specified metabolic disorders unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg other and unspecified hyperlipidemia asthma, unspecified type, unspecified esophageal reflux other and unspecified hyperlipidemia abnormality of gait old myocardial infarction altered mental status percutaneous transluminal coronary angioplasty status other specified analgesics and antipyretics causing adverse effects in therapeutic use rheumatoid arthritis disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma cardiac pacemaker in situ coronary atherosclerosis of native coronary artery unspecified essential hypertension asthma, unspecified type, unspecified disorder of bone and cartilage, unspecified generalized hyperhidrosis osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status esophageal reflux cardiac pacemaker in situ acute kidney failure, unspecified other chronic pain other postprocedural status depressive disorder, not elsewhere classified other and unspecified hyperlipidemia dehydration chills (without fever) old myocardial infarction disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma percutaneous transluminal coronary angioplasty status asthma, unspecified type, unspecified other and unspecified hyperlipidemia
black african american f 89 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  6.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  91  mg dl$levothyroxine sodium  125  mcg ; hydrochlorothiazide  12.5  mg ; metoprolol succinate xl  50  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; fluticasone propionate nasal  1  spry ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; senna  1  tab ; acetaminophen  650  mg ; calcium carbonate  500  mg ; mirtazapine  15  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; aspirin  325  mg ; fluoxetine  40  mg ; losartan potassium  25  mg ; potassium chloride  20  meq ; ferrous sulfate  325  mg ; fluticasone propionate 110mcg  2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; morphine sulfate  1-5  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; 
urinary tract infection, site not specified asthma, unspecified type, unspecified unspecified essential hypertension esophageal reflux unspecified fall dehydration closed fracture of one rib postsurgical hypothyroidism other specified metabolic disorders unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg other and unspecified hyperlipidemia asthma, unspecified type, unspecified esophageal reflux other and unspecified hyperlipidemia abnormality of gait old myocardial infarction altered mental status percutaneous transluminal coronary angioplasty status other specified analgesics and antipyretics causing adverse effects in therapeutic use rheumatoid arthritis disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma cardiac pacemaker in situ coronary atherosclerosis of native coronary artery unspecified essential hypertension asthma, unspecified type, unspecified disorder of bone and cartilage, unspecified generalized hyperhidrosis osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status esophageal reflux cardiac pacemaker in situ acute kidney failure, unspecified other chronic pain other postprocedural status depressive disorder, not elsewhere classified other and unspecified hyperlipidemia dehydration chills (without fever) old myocardial infarction disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma percutaneous transluminal coronary angioplasty status asthma, unspecified type, unspecified other and unspecified hyperlipidemia
black african american f 89 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  101  mg dl$levothyroxine sodium  125  mcg ; hydrochlorothiazide  12.5  mg ; metoprolol succinate xl  50  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; fluticasone propionate nasal  1  spry ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; senna  1  tab ; acetaminophen  650  mg ; calcium carbonate  500  mg ; mirtazapine  15  mg ; aspirin  325  mg ; fluoxetine  40  mg ; losartan potassium  25  mg ; potassium chloride  20  meq ; ferrous sulfate  325  mg ; fluticasone propionate 110mcg  2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; morphine sulfate  1-5  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; heparin flush (10 units ml)  2  ml ; 
urinary tract infection, site not specified asthma, unspecified type, unspecified unspecified essential hypertension esophageal reflux unspecified fall dehydration closed fracture of one rib postsurgical hypothyroidism other specified metabolic disorders unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg other and unspecified hyperlipidemia asthma, unspecified type, unspecified esophageal reflux other and unspecified hyperlipidemia abnormality of gait old myocardial infarction altered mental status percutaneous transluminal coronary angioplasty status other specified analgesics and antipyretics causing adverse effects in therapeutic use rheumatoid arthritis disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma cardiac pacemaker in situ coronary atherosclerosis of native coronary artery unspecified essential hypertension asthma, unspecified type, unspecified disorder of bone and cartilage, unspecified generalized hyperhidrosis osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status esophageal reflux cardiac pacemaker in situ acute kidney failure, unspecified other chronic pain other postprocedural status depressive disorder, not elsewhere classified other and unspecified hyperlipidemia dehydration chills (without fever) old myocardial infarction disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma percutaneous transluminal coronary angioplasty status asthma, unspecified type, unspecified other and unspecified hyperlipidemia
black african american f 89 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood glucose  82  mg dl$bisacodyl  10  mg ; levothyroxine sodium  125  mcg ; hydrochlorothiazide  12.5  mg ; metoprolol succinate xl  50  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; fluticasone propionate nasal  1  spry ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; senna  1  tab ; acetaminophen  650  mg ; calcium carbonate  500  mg ; mirtazapine  15  mg ; aspirin  325  mg ; fluoxetine  40  mg ; losartan potassium  25  mg ; potassium chloride  20  meq ; ferrous sulfate  325  mg ; fluticasone propionate 110mcg  2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; morphine sulfate  1-5  mg ; heparin flush (10 units ml)  2  ml ; potassium chloride (powder)  20  meq ; polyethylene glycol  17  g ; maalox lidocaine  15-30  ml ; 
urinary tract infection, site not specified asthma, unspecified type, unspecified unspecified essential hypertension esophageal reflux unspecified fall dehydration closed fracture of one rib postsurgical hypothyroidism other specified metabolic disorders unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg other and unspecified hyperlipidemia asthma, unspecified type, unspecified esophageal reflux other and unspecified hyperlipidemia abnormality of gait old myocardial infarction altered mental status percutaneous transluminal coronary angioplasty status other specified analgesics and antipyretics causing adverse effects in therapeutic use rheumatoid arthritis disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma cardiac pacemaker in situ coronary atherosclerosis of native coronary artery unspecified essential hypertension asthma, unspecified type, unspecified disorder of bone and cartilage, unspecified generalized hyperhidrosis osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status esophageal reflux cardiac pacemaker in situ acute kidney failure, unspecified other chronic pain other postprocedural status depressive disorder, not elsewhere classified other and unspecified hyperlipidemia dehydration chills (without fever) old myocardial infarction disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma percutaneous transluminal coronary angioplasty status asthma, unspecified type, unspecified other and unspecified hyperlipidemia
black african american f 89 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood glucose  73  mg dl$bisacodyl  10  mg ; levothyroxine sodium  125  mcg ; hydrochlorothiazide  12.5  mg ; metoprolol succinate xl  50  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; fluticasone propionate nasal  1  spry ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; senna  1  tab ; acetaminophen  650  mg ; calcium carbonate  500  mg ; mirtazapine  15  mg ; aspirin  325  mg ; fluoxetine  40  mg ; losartan potassium  25  mg ; potassium chloride  20  meq ; ferrous sulfate  325  mg ; fluticasone propionate 110mcg  2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; morphine sulfate  1-5  mg ; heparin flush (10 units ml)  2  ml ; potassium chloride (powder)  20  meq ; 
urinary tract infection, site not specified asthma, unspecified type, unspecified unspecified essential hypertension esophageal reflux unspecified fall dehydration closed fracture of one rib postsurgical hypothyroidism other specified metabolic disorders unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg other and unspecified hyperlipidemia asthma, unspecified type, unspecified esophageal reflux other and unspecified hyperlipidemia abnormality of gait old myocardial infarction altered mental status percutaneous transluminal coronary angioplasty status other specified analgesics and antipyretics causing adverse effects in therapeutic use rheumatoid arthritis disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma cardiac pacemaker in situ coronary atherosclerosis of native coronary artery unspecified essential hypertension asthma, unspecified type, unspecified disorder of bone and cartilage, unspecified generalized hyperhidrosis osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status esophageal reflux cardiac pacemaker in situ acute kidney failure, unspecified other chronic pain other postprocedural status depressive disorder, not elsewhere classified other and unspecified hyperlipidemia dehydration chills (without fever) old myocardial infarction disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma percutaneous transluminal coronary angioplasty status asthma, unspecified type, unspecified other and unspecified hyperlipidemia
black african american f 89 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  365  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood glucose  87  mg dl$bisacodyl  10  mg ; levothyroxine sodium  125  mcg ; hydrochlorothiazide  12.5  mg ; metoprolol succinate xl  50  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; fluticasone propionate nasal  1  spry ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; senna  1  tab ; acetaminophen  650  mg ; calcium carbonate  500  mg ; mirtazapine  15  mg ; aspirin  325  mg ; fluoxetine  40  mg ; losartan potassium  25  mg ; potassium chloride  20  meq ; ferrous sulfate  325  mg ; fluticasone propionate 110mcg  2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; morphine sulfate  1-5  mg ; heparin flush (10 units ml)  2  ml ; 
urinary tract infection, site not specified asthma, unspecified type, unspecified unspecified essential hypertension esophageal reflux unspecified fall dehydration closed fracture of one rib postsurgical hypothyroidism other specified metabolic disorders unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg other and unspecified hyperlipidemia asthma, unspecified type, unspecified esophageal reflux other and unspecified hyperlipidemia abnormality of gait old myocardial infarction altered mental status percutaneous transluminal coronary angioplasty status other specified analgesics and antipyretics causing adverse effects in therapeutic use rheumatoid arthritis disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma cardiac pacemaker in situ coronary atherosclerosis of native coronary artery unspecified essential hypertension asthma, unspecified type, unspecified disorder of bone and cartilage, unspecified generalized hyperhidrosis osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status esophageal reflux cardiac pacemaker in situ acute kidney failure, unspecified other chronic pain other postprocedural status depressive disorder, not elsewhere classified other and unspecified hyperlipidemia dehydration chills (without fever) old myocardial infarction disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma percutaneous transluminal coronary angioplasty status asthma, unspecified type, unspecified other and unspecified hyperlipidemia
black african american f 89 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  83  mg dl$bisacodyl  10  mg ; levothyroxine sodium  125  mcg ; hydrochlorothiazide  12.5  mg ; metoprolol succinate xl  50  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; fluticasone propionate nasal  1  spry ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; senna  1  tab ; acetaminophen  650  mg ; calcium carbonate  500  mg ; mirtazapine  15  mg ; aspirin  325  mg ; fluoxetine  40  mg ; losartan potassium  25  mg ; potassium chloride  20  meq ; ferrous sulfate  325  mg ; fluticasone propionate 110mcg  2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; morphine sulfate  1-5  mg ; heparin flush (10 units ml)  2  ml ; furosemide  20  mg ; 
urinary tract infection, site not specified asthma, unspecified type, unspecified unspecified essential hypertension esophageal reflux unspecified fall dehydration closed fracture of one rib postsurgical hypothyroidism other specified metabolic disorders unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg other and unspecified hyperlipidemia asthma, unspecified type, unspecified esophageal reflux other and unspecified hyperlipidemia abnormality of gait old myocardial infarction altered mental status percutaneous transluminal coronary angioplasty status other specified analgesics and antipyretics causing adverse effects in therapeutic use rheumatoid arthritis disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma cardiac pacemaker in situ coronary atherosclerosis of native coronary artery unspecified essential hypertension asthma, unspecified type, unspecified disorder of bone and cartilage, unspecified generalized hyperhidrosis osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status esophageal reflux cardiac pacemaker in situ acute kidney failure, unspecified other chronic pain other postprocedural status depressive disorder, not elsewhere classified other and unspecified hyperlipidemia dehydration chills (without fever) old myocardial infarction disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma percutaneous transluminal coronary angioplasty status asthma, unspecified type, unspecified other and unspecified hyperlipidemia
black african american f 89 $nan$nan$bisacodyl  10  mg ; levothyroxine sodium  125  mcg ; hydrochlorothiazide  12.5  mg ; metoprolol succinate xl  50  mg ; clopidogrel  75  mg ; vitamin d  800  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; fluticasone propionate nasal  1  spry ; heparin  5000  unit ; latanoprost 0.005% ophth. soln.  1  drop ; senna  1  tab ; acetaminophen  650  mg ; calcium carbonate  500  mg ; mirtazapine  15  mg ; aspirin  325  mg ; fluoxetine  40  mg ; losartan potassium  25  mg ; potassium chloride  20  meq ; ferrous sulfate  325  mg ; fluticasone propionate 110mcg  2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; morphine sulfate  1-5  mg ; heparin flush (10 units ml)  2  ml ; furosemide  20  mg ; 
urinary tract infection, site not specified asthma, unspecified type, unspecified unspecified essential hypertension esophageal reflux unspecified fall dehydration closed fracture of one rib postsurgical hypothyroidism other specified metabolic disorders unspecified glaucoma osteoarthrosis, localized, not specified whether primary or secondary, lower leg other and unspecified hyperlipidemia asthma, unspecified type, unspecified esophageal reflux other and unspecified hyperlipidemia abnormality of gait old myocardial infarction altered mental status percutaneous transluminal coronary angioplasty status other specified analgesics and antipyretics causing adverse effects in therapeutic use rheumatoid arthritis disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma cardiac pacemaker in situ coronary atherosclerosis of native coronary artery unspecified essential hypertension asthma, unspecified type, unspecified disorder of bone and cartilage, unspecified generalized hyperhidrosis osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension percutaneous transluminal coronary angioplasty status esophageal reflux cardiac pacemaker in situ acute kidney failure, unspecified other chronic pain other postprocedural status depressive disorder, not elsewhere classified other and unspecified hyperlipidemia dehydration chills (without fever) old myocardial infarction disorders of bursae and tendons in shoulder region, unspecified unspecified glaucoma percutaneous transluminal coronary angioplasty status asthma, unspecified type, unspecified other and unspecified hyperlipidemia
white f 71 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  10.3  mg dl; chemistry blood glucose  145  mg dl; chemistry blood lactate dehydrogenase (ld)  225  iu l; chemistry blood albumin  4.5  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  2  spry ; lidocaine 5% patch  1  ptch ; multivitamins  1  tab ; oxycodone (immediate release)   5  mg ; vitamin d  400  unit ; dexamethasone  20  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; acyclovir  400  mg ; 
secondary malignant neoplasm of bone and bone marrow family history of malignant neoplasm of breast need for prophylactic vaccination and inoculation against influenza difficulty in walking disorder of bone and cartilage, unspecified other specified visual disturbances person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident unspecified disorder of joint, pelvic region and thigh
white f 71 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  187  iu l; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  2  spry ; multivitamins  1  tab ; oxycodone (immediate release)   5  mg ; vitamin d  400  unit ; acetaminophen  650  mg ; docusate sodium  100  mg ; acyclovir  400  mg ; heparin  5000  unit ; syringe (chemo)  2  ml ; bortezomib  2  mg ; sodium chloride 0.9%  1000  ml ; vitamin b complex  1  cap ; aspirin  81  mg ; 
secondary malignant neoplasm of bone and bone marrow family history of malignant neoplasm of breast need for prophylactic vaccination and inoculation against influenza difficulty in walking disorder of bone and cartilage, unspecified other specified visual disturbances person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident unspecified disorder of joint, pelvic region and thigh
white f 71 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  309  iu l; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  2  spry ; multivitamins  1  tab ; vitamin d  400  unit ; acetaminophen  650  mg ; docusate sodium  100  mg ; acyclovir  400  mg ; heparin  5000  unit ; syringe (chemo)  2  ml ; bortezomib  2  mg ; sodium chloride 0.9%  1000  ml ; vitamin b complex  1  cap ; aspirin  81  mg ; 
secondary malignant neoplasm of bone and bone marrow family history of malignant neoplasm of breast need for prophylactic vaccination and inoculation against influenza difficulty in walking disorder of bone and cartilage, unspecified other specified visual disturbances person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident unspecified disorder of joint, pelvic region and thigh
white f 71 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  289  iu l; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  2  spry ; multivitamins  1  tab ; vitamin d  400  unit ; acetaminophen  650  mg ; docusate sodium  100  mg ; acyclovir  400  mg ; heparin  5000  unit ; syringe (chemo)  2  ml ; bortezomib  2  mg ; sodium chloride 0.9%  1000  ml ; vitamin b complex  1  cap ; aspirin  81  mg ; 
secondary malignant neoplasm of bone and bone marrow family history of malignant neoplasm of breast need for prophylactic vaccination and inoculation against influenza difficulty in walking disorder of bone and cartilage, unspecified other specified visual disturbances person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident unspecified disorder of joint, pelvic region and thigh
white f 71 $nan$nan$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  2  spry ; multivitamins  1  tab ; vitamin d  400  unit ; acetaminophen  650  mg ; docusate sodium  100  mg ; acyclovir  400  mg ; heparin  5000  unit ; syringe (chemo)  2  ml ; bortezomib  2  mg ; sodium chloride 0.9%  1000  ml ; vitamin b complex  1  cap ; aspirin  81  mg ; 
secondary malignant neoplasm of bone and bone marrow family history of malignant neoplasm of breast need for prophylactic vaccination and inoculation against influenza difficulty in walking disorder of bone and cartilage, unspecified other specified visual disturbances person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident unspecified disorder of joint, pelvic region and thigh
black african american f 35 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  304  k ul$aspirin  121.5  mg ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; 0.9% sodium chloride  100  ml ; morphine sulfate  100  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; heparin  5000  unit ; docusate sodium  100  mg ; 
malignant neoplasm of upper-outer quadrant of left female breast estrogen receptor negative status [er-] encounter for prophylactic removal of breast family history of malignant neoplasm of breast genetic susceptibility to malignant neoplasm of breast sickle-cell trait 39 weeks gestation of pregnancy precipitate labor other infection carrier state complicating childbirth genetic susceptibility to malignant neoplasm of breast herpesviral infection of other urogenital tract single live birth second degree perineal laceration during delivery pre-existing essential hypertension complicating childbirth labor and delivery complicated by cord around neck, without compression, not applicable or unspecified other infections with a predominantly sexual mode of transmission complicating childbirth streptococcus b carrier state complicating childbirth unspecified pre-existing hypertension complicating childbirth other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating childbirth other infections with a predominantly sexual mode of transmission complicating childbirth second degree perineal laceration during delivery gestational diabetes mellitus in childbirth, insulin controlled genetic carrier of other disease single live birth 38 weeks gestation of pregnancy other specified complications of labor and delivery herpesviral infection of urogenital system, unspecified other secondary thrombocytopenia other infection carrier state complicating childbirth abnormality in fetal heart rate and rhythm complicating labor and delivery pre-existing hypertension with pre-eclampsia, third trimester 
black african american f 35 $nan$nan$aspirin  121.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; 0.9% sodium chloride  100  ml ; morphine sulfate  100  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; 
malignant neoplasm of upper-outer quadrant of left female breast estrogen receptor negative status [er-] encounter for prophylactic removal of breast family history of malignant neoplasm of breast genetic susceptibility to malignant neoplasm of breast sickle-cell trait 39 weeks gestation of pregnancy precipitate labor other infection carrier state complicating childbirth genetic susceptibility to malignant neoplasm of breast herpesviral infection of other urogenital tract single live birth second degree perineal laceration during delivery pre-existing essential hypertension complicating childbirth labor and delivery complicated by cord around neck, without compression, not applicable or unspecified other infections with a predominantly sexual mode of transmission complicating childbirth streptococcus b carrier state complicating childbirth unspecified pre-existing hypertension complicating childbirth other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating childbirth other infections with a predominantly sexual mode of transmission complicating childbirth second degree perineal laceration during delivery gestational diabetes mellitus in childbirth, insulin controlled genetic carrier of other disease single live birth 38 weeks gestation of pregnancy other specified complications of labor and delivery herpesviral infection of urogenital system, unspecified other secondary thrombocytopenia other infection carrier state complicating childbirth abnormality in fetal heart rate and rhythm complicating labor and delivery pre-existing hypertension with pre-eclampsia, third trimester 
black african american f 35 $nan$nan$aspirin  121.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
malignant neoplasm of upper-outer quadrant of left female breast estrogen receptor negative status [er-] encounter for prophylactic removal of breast family history of malignant neoplasm of breast genetic susceptibility to malignant neoplasm of breast sickle-cell trait 39 weeks gestation of pregnancy precipitate labor other infection carrier state complicating childbirth genetic susceptibility to malignant neoplasm of breast herpesviral infection of other urogenital tract single live birth second degree perineal laceration during delivery pre-existing essential hypertension complicating childbirth labor and delivery complicated by cord around neck, without compression, not applicable or unspecified other infections with a predominantly sexual mode of transmission complicating childbirth streptococcus b carrier state complicating childbirth unspecified pre-existing hypertension complicating childbirth other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating childbirth other infections with a predominantly sexual mode of transmission complicating childbirth second degree perineal laceration during delivery gestational diabetes mellitus in childbirth, insulin controlled genetic carrier of other disease single live birth 38 weeks gestation of pregnancy other specified complications of labor and delivery herpesviral infection of urogenital system, unspecified other secondary thrombocytopenia other infection carrier state complicating childbirth abnormality in fetal heart rate and rhythm complicating labor and delivery pre-existing hypertension with pre-eclampsia, third trimester 
black african american f 35 $nan$nan$aspirin  121.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
malignant neoplasm of upper-outer quadrant of left female breast estrogen receptor negative status [er-] encounter for prophylactic removal of breast family history of malignant neoplasm of breast genetic susceptibility to malignant neoplasm of breast sickle-cell trait 39 weeks gestation of pregnancy precipitate labor other infection carrier state complicating childbirth genetic susceptibility to malignant neoplasm of breast herpesviral infection of other urogenital tract single live birth second degree perineal laceration during delivery pre-existing essential hypertension complicating childbirth labor and delivery complicated by cord around neck, without compression, not applicable or unspecified other infections with a predominantly sexual mode of transmission complicating childbirth streptococcus b carrier state complicating childbirth unspecified pre-existing hypertension complicating childbirth other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating childbirth other infections with a predominantly sexual mode of transmission complicating childbirth second degree perineal laceration during delivery gestational diabetes mellitus in childbirth, insulin controlled genetic carrier of other disease single live birth 38 weeks gestation of pregnancy other specified complications of labor and delivery herpesviral infection of urogenital system, unspecified other secondary thrombocytopenia other infection carrier state complicating childbirth abnormality in fetal heart rate and rhythm complicating labor and delivery pre-existing hypertension with pre-eclampsia, third trimester 
white m 60 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  468  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  106  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ibuprofen  800  mg ; morphine sulfate  2-4  mg ; morphine sulfate  4-8  mg ; morphine sulfate ir  15  mg ; ns  1000  ml ; pantoprazole  40  mg ; docusate sodium  100  mg ; heparin  5000  unit ; tuberculin protein  0.1  ml ; levofloxacin  750  mg ; 
esophageal reflux unspecified disease of pericardium other and unspecified hyperlipidemia 
white m 60 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  533  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  257  iu l$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ibuprofen  800  mg ; morphine sulfate  4-8  mg ; morphine sulfate ir  15  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; heparin  5000  unit ; tuberculin protein  0.1  ml ; colchicine  0.6  mg ; 
esophageal reflux unspecified disease of pericardium other and unspecified hyperlipidemia 
white m 60 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  669  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  276  iu l$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ibuprofen  800  mg ; morphine sulfate  4-8  mg ; morphine sulfate ir  15  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; heparin  5000  unit ; colchicine  0.6  mg ; 
esophageal reflux unspecified disease of pericardium other and unspecified hyperlipidemia 
white m 60 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  700  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  231  iu l$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ibuprofen  800  mg ; morphine sulfate ir  15  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; heparin  5000  unit ; colchicine  0.6  mg ; 
esophageal reflux unspecified disease of pericardium other and unspecified hyperlipidemia 
white m 60 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  771  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ibuprofen  800  mg ; morphine sulfate ir  15  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; colchicine  0.6  mg ; 
esophageal reflux unspecified disease of pericardium other and unspecified hyperlipidemia 
white m 84 $nan$nan$spironolactone  12.5  mg ; aspirin ec  81  mg ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  42.6  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood glucose  132  mg dl$spironolactone  12.5  mg ; aspirin ec  81  mg ; furosemide  40  mg ; colesevelam  625  mg ; heparin  5000  unit ; furosemide  80  mg ; carvedilol  6.25  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  20  meq ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  25  mg ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  43.0  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood glucose  118  mg dl$spironolactone  12.5  mg ; aspirin ec  81  mg ; colesevelam  625  mg ; heparin  5000  unit ; furosemide  80  mg ; carvedilol  6.25  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  20  meq ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  25  mg ; spironolactone  25  mg ; furosemide  120  mg ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  45.5  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry urine urea nitrogen, urine  453  mg dl; hematology urine wbc  3-5  # hpf; chemistry blood glucose  112  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl; hematology urine calcium oxalate crystals  rare  $aspirin ec  81  mg ; colesevelam  625  mg ; heparin  5000  unit ; carvedilol  6.25  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  25  mg ; spironolactone  25  mg ; furosemide  120  mg ; captopril  3.125  mg ; metolazone  5  mg ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  43.9  %; hematology blood hematocrit  42.4  %; hematology blood hemoglobin  14.2  g dl; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  137  k ul; hematology blood platelet count  137  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  210  mg dl$aspirin ec  81  mg ; colesevelam  625  mg ; heparin  5000  unit ; carvedilol  6.25  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; trazodone  25  mg ; spironolactone  25  mg ; furosemide  120  mg ; metolazone  5  mg ; d5w  100  ml ; furosemide  100  mg ; ondansetron odt  4  mg ; ns  250  ml ; zolpidem tartrate  5  mg ; milrinone  20  mg ; d5w  1  dose ; milrinone  50  mcg kg ; insulin  0  unit ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  41.9  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  127  mg dl$aspirin ec  81  mg ; colesevelam  625  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron odt  4  mg ; zolpidem tartrate  5  mg ; d5w  1  dose ; milrinone  50  mcg kg ; insulin  0  unit ; carvedilol  9.375  mg ; potassium chloride  40  meq ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  247  mg dl$aspirin ec  81  mg ; colesevelam  625  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron odt  4  mg ; zolpidem tartrate  5  mg ; insulin  0  unit ; carvedilol  9.375  mg ; potassium chloride  40  meq ; magnesium oxide  140  mg ; digoxin  0.25  mg ; digoxin  0.125  mg ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.0  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood glucose  125  mg dl$aspirin ec  81  mg ; colesevelam  625  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron odt  4  mg ; zolpidem tartrate  5  mg ; insulin  0  unit ; magnesium oxide  140  mg ; digoxin  0.25  mg ; digoxin  0.125  mg ; captopril  6.25  mg ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  133  mg dl$aspirin ec  81  mg ; colesevelam  625  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron odt  4  mg ; zolpidem tartrate  5  mg ; insulin  0  unit ; captopril  6.25  mg ; potassium chloride  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; captopril  12.5  mg ; captopril  18.75  mg ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  107  mg dl$aspirin ec  81  mg ; colesevelam  625  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron odt  4  mg ; zolpidem tartrate  5  mg ; insulin  0  unit ; potassium chloride  80  meq ; sw  100  ml ; magnesium sulfate  4  gm ; captopril  18.75  mg ; neutra-phos  2  pkt ; lisinopril  5  mg ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  93  mg dl$aspirin ec  81  mg ; colesevelam  625  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron odt  4  mg ; zolpidem tartrate  5  mg ; insulin  0  unit ; captopril  18.75  mg ; neutra-phos  2  pkt ; lisinopril  5  mg ; furosemide  60  mg ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white m 84 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood glucose  97  mg dl$aspirin ec  81  mg ; colesevelam  625  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron odt  4  mg ; zolpidem tartrate  5  mg ; lisinopril  5  mg ; furosemide  60  mg ; 
helicobacter pylori [h. pylori] acute kidney failure, unspecified other specified gastritis, without mention of hemorrhage acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ congestive heart failure, unspecified paroxysmal ventricular tachycardia aortocoronary bypass status
white f 76 $temp    heartrate    resprate    o2sat  87.0  sbp    dbp    rhythm    pain    ; temp  97.8  heartrate  81.0  resprate  12.0  o2sat  95.0  sbp  110.0  dbp  54.0  rhythm    pain    $hematology blood hematocrit  39.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  167  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; clopidogrel  75  mg ; lisinopril  2.5  mg ; rosuvastatin calcium  40  mg ; trazodone  50  mg ; furosemide  40  mg ; metoprolol tartrate  12.5  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; azithromycin  500  mg ; heparin  5000  unit ; prednisone  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
white f 76 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  142  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; clopidogrel  75  mg ; lisinopril  2.5  mg ; rosuvastatin calcium  40  mg ; trazodone  50  mg ; furosemide  40  mg ; metoprolol tartrate  12.5  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; azithromycin  500  mg ; heparin  5000  unit ; prednisone  40  mg ; docusate sodium  100  mg ; azithromycin  250  mg ; torsemide  10  mg ; 
 
white m 33 $nan$hematology blood hematocrit  36.2  %; hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  429  k ul; hematology blood platelet count  386  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  83  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; gabapentin  600  mg ; lorazepam  2  mg ; morphine sr (ms contin)  120  mg ; oxycodone (immediate release)   30  mg ; enoxaparin sodium  30  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; dexamethasone  10  mg ; 
disruption of external operation (surgical) wound person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle secondary malignant neoplasm of other specified sites seroma complicating a procedure other acute postoperative pain personal history of malignant neoplasm of other sites secondary malignant neoplasm of bone and bone marrow other chronic pain ostium secundum type atrial septal defect other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of irradiation, presenting hazards to health opioid type dependence, in remission personal history of antineoplastic chemotherapy malignant neoplasm of connective and other soft tissue of lower limb, including hip surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation nausea alone person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of antineoplastic chemotherapy ostium secundum type atrial septal defect personal history of irradiation, presenting hazards to health secondary malignant neoplasm of bone and bone marrow local infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure secondary malignant neoplasm of other specified sites other complications due to internal joint prosthesis phlebitis and thrombophlebitis of other sites opioid type dependence, in remission knee joint replacement other acute postoperative pain malignant neoplasm of connective and other soft tissue of lower limb, including hip malignant neoplasm of long bones of lower limb ostium secundum type atrial septal defect personal history of antineoplastic chemotherapy secondary malignant neoplasm of other specified sites person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified drug dependence, in remission personal history of irradiation, presenting hazards to health tobacco use disorder local infection due to central venous catheter antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anorexia cellulitis and abscess of trunk drug induced neutropenia ostium secundum type atrial septal defect malignant neoplasm of connective and other soft tissue of lower limb, including hip encounter for antineoplastic chemotherapy encounter for radiotherapy driver of pick-up truck or van injured in noncollision transport accident in nontraffic accident
white m 33 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  377  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  10  ml ; acetaminophen  1000  mg ; gabapentin  600  mg ; lorazepam  2  mg ; morphine sr (ms contin)  120  mg ; oxycodone (immediate release)   30  mg ; enoxaparin sodium  30  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; dexamethasone  10  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; syringe (chemo)  30  ml ; doxorubicin  60  mg ; mesna  5980  mg ; ifosfamide  5975  mg ; 0.45% sodium chloride  1000  ml ; 0.9% sodium chloride  150  ml ; fosaprepitant  150  mg ; morphine sr (ms contin)  100  mg ; ondansetron  4  mg ; ondansetron  8  mg ; 
disruption of external operation (surgical) wound person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle secondary malignant neoplasm of other specified sites seroma complicating a procedure other acute postoperative pain personal history of malignant neoplasm of other sites secondary malignant neoplasm of bone and bone marrow other chronic pain ostium secundum type atrial septal defect other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of irradiation, presenting hazards to health opioid type dependence, in remission personal history of antineoplastic chemotherapy malignant neoplasm of connective and other soft tissue of lower limb, including hip surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation nausea alone person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of antineoplastic chemotherapy ostium secundum type atrial septal defect personal history of irradiation, presenting hazards to health secondary malignant neoplasm of bone and bone marrow local infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure secondary malignant neoplasm of other specified sites other complications due to internal joint prosthesis phlebitis and thrombophlebitis of other sites opioid type dependence, in remission knee joint replacement other acute postoperative pain malignant neoplasm of connective and other soft tissue of lower limb, including hip malignant neoplasm of long bones of lower limb ostium secundum type atrial septal defect personal history of antineoplastic chemotherapy secondary malignant neoplasm of other specified sites person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified drug dependence, in remission personal history of irradiation, presenting hazards to health tobacco use disorder local infection due to central venous catheter antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anorexia cellulitis and abscess of trunk drug induced neutropenia ostium secundum type atrial septal defect malignant neoplasm of connective and other soft tissue of lower limb, including hip encounter for antineoplastic chemotherapy encounter for radiotherapy driver of pick-up truck or van injured in noncollision transport accident in nontraffic accident
white m 33 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  10  ml ; acetaminophen  1000  mg ; gabapentin  600  mg ; oxycodone (immediate release)   30  mg ; enoxaparin sodium  30  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; dexamethasone  10  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; syringe (chemo)  30  ml ; doxorubicin  60  mg ; mesna  5980  mg ; ifosfamide  5975  mg ; 0.9% sodium chloride  150  ml ; fosaprepitant  150  mg ; morphine sr (ms contin)  100  mg ; ondansetron  4  mg ; 
disruption of external operation (surgical) wound person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle secondary malignant neoplasm of other specified sites seroma complicating a procedure other acute postoperative pain personal history of malignant neoplasm of other sites secondary malignant neoplasm of bone and bone marrow other chronic pain ostium secundum type atrial septal defect other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of irradiation, presenting hazards to health opioid type dependence, in remission personal history of antineoplastic chemotherapy malignant neoplasm of connective and other soft tissue of lower limb, including hip surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation nausea alone person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of antineoplastic chemotherapy ostium secundum type atrial septal defect personal history of irradiation, presenting hazards to health secondary malignant neoplasm of bone and bone marrow local infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure secondary malignant neoplasm of other specified sites other complications due to internal joint prosthesis phlebitis and thrombophlebitis of other sites opioid type dependence, in remission knee joint replacement other acute postoperative pain malignant neoplasm of connective and other soft tissue of lower limb, including hip malignant neoplasm of long bones of lower limb ostium secundum type atrial septal defect personal history of antineoplastic chemotherapy secondary malignant neoplasm of other specified sites person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified drug dependence, in remission personal history of irradiation, presenting hazards to health tobacco use disorder local infection due to central venous catheter antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anorexia cellulitis and abscess of trunk drug induced neutropenia ostium secundum type atrial septal defect malignant neoplasm of connective and other soft tissue of lower limb, including hip encounter for antineoplastic chemotherapy encounter for radiotherapy driver of pick-up truck or van injured in noncollision transport accident in nontraffic accident
white m 33 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  369  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  10  ml ; acetaminophen  1000  mg ; gabapentin  600  mg ; oxycodone (immediate release)   30  mg ; enoxaparin sodium  30  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; dexamethasone  10  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; syringe (chemo)  30  ml ; doxorubicin  60  mg ; mesna  5980  mg ; ifosfamide  5975  mg ; morphine sr (ms contin)  100  mg ; ondansetron  4  mg ; 
disruption of external operation (surgical) wound person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle secondary malignant neoplasm of other specified sites seroma complicating a procedure other acute postoperative pain personal history of malignant neoplasm of other sites secondary malignant neoplasm of bone and bone marrow other chronic pain ostium secundum type atrial septal defect other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of irradiation, presenting hazards to health opioid type dependence, in remission personal history of antineoplastic chemotherapy malignant neoplasm of connective and other soft tissue of lower limb, including hip surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation nausea alone person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of antineoplastic chemotherapy ostium secundum type atrial septal defect personal history of irradiation, presenting hazards to health secondary malignant neoplasm of bone and bone marrow local infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure secondary malignant neoplasm of other specified sites other complications due to internal joint prosthesis phlebitis and thrombophlebitis of other sites opioid type dependence, in remission knee joint replacement other acute postoperative pain malignant neoplasm of connective and other soft tissue of lower limb, including hip malignant neoplasm of long bones of lower limb ostium secundum type atrial septal defect personal history of antineoplastic chemotherapy secondary malignant neoplasm of other specified sites person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified drug dependence, in remission personal history of irradiation, presenting hazards to health tobacco use disorder local infection due to central venous catheter antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anorexia cellulitis and abscess of trunk drug induced neutropenia ostium secundum type atrial septal defect malignant neoplasm of connective and other soft tissue of lower limb, including hip encounter for antineoplastic chemotherapy encounter for radiotherapy driver of pick-up truck or van injured in noncollision transport accident in nontraffic accident
white m 33 $nan$nan$sodium chloride 0.9%  flush  10  ml ; acetaminophen  1000  mg ; gabapentin  600  mg ; oxycodone (immediate release)   30  mg ; enoxaparin sodium  30  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; dexamethasone  10  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; lorazepam  0.5-2  mg ; syringe (chemo)  30  ml ; doxorubicin  60  mg ; mesna  5980  mg ; ifosfamide  5975  mg ; morphine sr (ms contin)  100  mg ; ondansetron  4  mg ; 
disruption of external operation (surgical) wound person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle secondary malignant neoplasm of other specified sites seroma complicating a procedure other acute postoperative pain personal history of malignant neoplasm of other sites secondary malignant neoplasm of bone and bone marrow other chronic pain ostium secundum type atrial septal defect other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of irradiation, presenting hazards to health opioid type dependence, in remission personal history of antineoplastic chemotherapy malignant neoplasm of connective and other soft tissue of lower limb, including hip surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation nausea alone person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of antineoplastic chemotherapy ostium secundum type atrial septal defect personal history of irradiation, presenting hazards to health secondary malignant neoplasm of bone and bone marrow local infection due to central venous catheter other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure secondary malignant neoplasm of other specified sites other complications due to internal joint prosthesis phlebitis and thrombophlebitis of other sites opioid type dependence, in remission knee joint replacement other acute postoperative pain malignant neoplasm of connective and other soft tissue of lower limb, including hip malignant neoplasm of long bones of lower limb ostium secundum type atrial septal defect personal history of antineoplastic chemotherapy secondary malignant neoplasm of other specified sites person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle unspecified drug dependence, in remission personal history of irradiation, presenting hazards to health tobacco use disorder local infection due to central venous catheter antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anorexia cellulitis and abscess of trunk drug induced neutropenia ostium secundum type atrial septal defect malignant neoplasm of connective and other soft tissue of lower limb, including hip encounter for antineoplastic chemotherapy encounter for radiotherapy driver of pick-up truck or van injured in noncollision transport accident in nontraffic accident
unknown m 60 $nan$nan$sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; nitroglycerin sl  0.4  mg ; trazodone  25  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; losartan potassium  25  mg ; metoprolol succinate xl  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; atorvastatin  80  mg ; 
 
unknown m 60 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  261  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; nitroglycerin sl  0.4  mg ; trazodone  25  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; losartan potassium  25  mg ; metoprolol succinate xl  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; atorvastatin  80  mg ; aspirin  81  mg ; isosorbide mononitrate (extended release)  30  mg ; 
 
black african american f 25 $nan$hematology blood hematocrit  35.0  %$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; dermoplast spray  1  spry ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn carrier or suspected carrier of group b streptococcus other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition other specified trauma to perineum and vulva, delivered, with or without mention of antepartum condition 
black african american f 25 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; dermoplast spray  1  spry ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn carrier or suspected carrier of group b streptococcus other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition other specified trauma to perineum and vulva, delivered, with or without mention of antepartum condition 
black african american f 25 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; dermoplast spray  1  spry ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn carrier or suspected carrier of group b streptococcus other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition other specified trauma to perineum and vulva, delivered, with or without mention of antepartum condition 
white m 64 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  59  meq l; chemistry urine creatinine, urine  32  mg dl; chemistry urine potassium, urine  16  meq l; chemistry urine sodium, urine  73  meq l; chemistry urine urea nitrogen, urine  292  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  226  iu l; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acyclovir  400  mg ; docusate sodium  100  mg ; fluconazole  400  mg ; folic acid  1  mg ; lorazepam  0.5-1  mg ; multivitamins  1  tab ; oxycodone (immediate release)  5  mg ; senna  8.6  mg ; tacrolimus  2  mg ; ursodiol  300  mg ; zolpidem tartrate  10  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; lisinopril  10  mg ; sulfameth trimethoprim ss  1  tab ; heparin flush (10 units ml)  2  ml ; 
essential (primary) hypertension personal history of nicotine dependence mantle cell lymphoma, extranodal and solid organ sites insomnia, unspecified anxiety disorder, unspecified fever, unspecified encounter for examination for normal comparison and control in clinical research program pruritus, unspecified diarrhea, unspecified mantle cell lymphoma, lymph nodes of multiple sites personal history of nicotine dependence essential (primary) hypertension anxiety disorder, unspecified other secondary thrombocytopenia anemia due to antineoplastic chemotherapy encounter for antineoplastic chemotherapy presence of right artificial knee joint mantle cell lymphoma, lymph nodes of multiple sites polyneuropathy, unspecified hypo-osmolality and hyponatremia essential (primary) hypertension hypotension, unspecified other secondary thrombocytopenia mantle cell lymphoma, unspecified site encounter for antineoplastic chemotherapy insomnia, unspecified constipation, unspecified personal history of nicotine dependence anemia in neoplastic disease insomnia, unspecified other secondary thrombocytopenia constipation, unspecified dehydration essential (primary) hypertension anemia, unspecified personal history of nicotine dependence abnormal weight loss mantle cell lymphoma, unspecified site hypo-osmolality and hyponatremia other secondary thrombocytopenia fluid overload, unspecified patient room in hospital as the place of occurrence of the external cause insomnia, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypoxemia other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of nicotine dependence mantle cell lymphoma, extranodal and solid organ sites
white m 64 $nan$nan$acyclovir  400  mg ; docusate sodium  100  mg ; fluconazole  400  mg ; folic acid  1  mg ; lorazepam  0.5-1  mg ; multivitamins  1  tab ; oxycodone (immediate release)  5  mg ; senna  8.6  mg ; tacrolimus  2  mg ; ursodiol  300  mg ; zolpidem tartrate  10  mg ; lisinopril  10  mg ; sulfameth trimethoprim ss  1  tab ; heparin flush (10 units ml)  2  ml ; 
essential (primary) hypertension personal history of nicotine dependence mantle cell lymphoma, extranodal and solid organ sites insomnia, unspecified anxiety disorder, unspecified fever, unspecified encounter for examination for normal comparison and control in clinical research program pruritus, unspecified diarrhea, unspecified mantle cell lymphoma, lymph nodes of multiple sites personal history of nicotine dependence essential (primary) hypertension anxiety disorder, unspecified other secondary thrombocytopenia anemia due to antineoplastic chemotherapy encounter for antineoplastic chemotherapy presence of right artificial knee joint mantle cell lymphoma, lymph nodes of multiple sites polyneuropathy, unspecified hypo-osmolality and hyponatremia essential (primary) hypertension hypotension, unspecified other secondary thrombocytopenia mantle cell lymphoma, unspecified site encounter for antineoplastic chemotherapy insomnia, unspecified constipation, unspecified personal history of nicotine dependence anemia in neoplastic disease insomnia, unspecified other secondary thrombocytopenia constipation, unspecified dehydration essential (primary) hypertension anemia, unspecified personal history of nicotine dependence abnormal weight loss mantle cell lymphoma, unspecified site hypo-osmolality and hyponatremia other secondary thrombocytopenia fluid overload, unspecified patient room in hospital as the place of occurrence of the external cause insomnia, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypoxemia other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of nicotine dependence mantle cell lymphoma, extranodal and solid organ sites
hispanic latino m 57 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  109  mg dl$0.9% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ondansetron  8  mg ; morphine sulfate  2-4  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; hydromorphone (dilaudid)  0.5  mg ; albuterol 0.083% neb soln  1  neb ; docusate sodium  100  mg ; omeprazole  20  mg ; lr  1000  ml ; prochlorperazine  10  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; heparin  5000  unit ; amitriptyline  10  mg ; 
asthma, unspecified type, unspecified pyelonephritis, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site constipation, unspecified urinary complications, not elsewhere classified nausea with vomiting dermatitis due to drugs and medicines taken internally other acute postoperative pain constipation, unspecified benign localized hyperplasia of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension chronic interstitial cystitis urinary complications, not elsewhere classified other non-narcotic analgesics causing adverse effects in therapeutic use nausea with vomiting 
hispanic latino m 57 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  158  iu l; chemistry blood albumin  3.5  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ondansetron  8  mg ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  0.5  mg ; albuterol 0.083% neb soln  1  neb ; docusate sodium  100  mg ; omeprazole  20  mg ; lr  1000  ml ; prochlorperazine  10  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; heparin  5000  unit ; amitriptyline  10  mg ; ketorolac  15  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; phenazopyridine  100  mg ; 
asthma, unspecified type, unspecified pyelonephritis, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site constipation, unspecified urinary complications, not elsewhere classified nausea with vomiting dermatitis due to drugs and medicines taken internally other acute postoperative pain constipation, unspecified benign localized hyperplasia of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension chronic interstitial cystitis urinary complications, not elsewhere classified other non-narcotic analgesics causing adverse effects in therapeutic use nausea with vomiting 